cell_line_id,drug_id,response
NCI-H1339,123631,3.731065146489379
BFTC-909,82146,3.493415453952883
TE-14,2749,2.1595293138620235
WM793,54618164,4.258619603305177
HOP-62,52912189,4.806129419715892
H-STS,3384730,2.3703448532527043
ESS-1,11238147,2.0354593401256382
Kasumi-2,9868037,2.67651294484719
Namalwa,71466578,1.7975023406641202
NCI-H196,2733526,3.542986663855977
ChaGo-K-1,9866186,1.9654387369279056
BT 286,246676,1.6855048913308266
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124
MJ,24797083,2.1256871707746976
PF-382,3854666,0.8290647153929614
LMSU,5291,4.5569666616011
ESS-1,2729026,3.152936804917953
SF539,135421197,1.037431947377599
JHUEM-7,12003241,-3.5765771521887246
Mono-Mac-1,16065773,1.4173575235689688
KE-39,5329102,2.0429162006260566
KMRC-20,24951314,2.492306253507562
HOP-62,57330099,3.6921695700920862
IST-Mes1,5329102,1.6787488330100182
Ri-1,26596,-3.083821338619051
Ri-1,16725315,3.0875224510373016
SW1783,46191454,4.39093757555096
HEC-108,56946209,-3.633344479104151
TE-14,6450551,3.6230287269279224
YD-8,44137675,3.4700993938772324
HCC2108,44137675,4.225822582282624
HEC-108,6852167,3.774395558261256
YD-8,9956119,4.565288309306219
SNU-1077,3854666,3.1308724985393255
Karpas-422,5281321,-2.196822682341022
SK-UT-1,7326481,2.0066663774179108
JHUEM-7,selumetinib-tretinoin (2-1 mol-mol),5.22880395365309
WM793,107970,2.3599025930331368
MIA PaCa-2,11497983,3.759815603301495
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
MIA PaCa-2,3384730,3.900659511222064
HEC-108,26596,-0.981636576627464
HuT 78,49793307,-3.123496799876953
LMSU,navitoclax-sorafenib (1-1 mol-mol),3.2151070813962286
AsPC-1,16038120,0.5677006157285766
Ri-1,9868037,1.6681879870423917
KO52,44489675,3.934012643953168
SK-UT-1,60700,0.6162687225827331
IST-Mes1,24821094,3.7341606082149776
HOP-62,15953870,3.4456314683727154
YD-38,446155,1.8612220546146192
KE-39,969516,3.3665912825733773
AsPC-1,81146,4.947223766743442
HCC2108,46199207,2.9189708638806313
YD-8,navitoclax-birinapant (1-1 mol-mol),3.490795645603815
AsPC-1,9933475,2.7319135281095908
LMSU,5287620,-1.1667958498443185
Kasumi-2,46191454,0.4638336944386738
TE 441.T,46926350,-6.6989678936733705
KO52,24785538,-0.0334605587751474
SW1783,tanespimycin-gemcitabine (1-1 mol-mol),1.8572225726753877
MIA PaCa-2,702558,5.663902265232039
TE 441.T,selumetinib-vorinostat (8-1 mol-mol),3.7277184259028378
GOS-3,119607,5.92961228058127
TE 441.T,56946209,-5.510252140122737
NCI-H1339,10427712,4.05819725251799
KYSE-450,10385095,1.1558983027763154
OE33,23635314,-2.3350122759353984
SNU-423,753704,4.654692815537345
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
AsPC-1,3825829,4.335500071907528
SNU-886,3634881,3.0881138995018107
HSC-3,navitoclax-piperlongumine (1-1 mol-mol),2.297950806600239
KE-39,1242560,3.7605808784005625
SNU-213,9903786,2.2891232968098887
RKN,135999136,4.319110081529012
ACC-MESO-1,BRD-K03911514,4.424297284892215
WM793,46843906,2.7108569638472666
JHUEM-7,10427712,3.9815551329629337
IST-Mes1,135398516,1.9830137838908624
HSC-3,135421197,2.8710443540281756
LMSU,7251185,3.0971316330728778
Becker,selumetinib-piperlongumine (8-1 mol-mol),4.766670876498908
Hs 611.T,6918638,0.1647262246694485
PF-382,31703,-3.3313130558613864
Mono-Mac-1,568763,-0.04140676124599
CML-T1,445091,4.10308804654236
KMRC-20,42642645,1.4773611251579275
WM793,24901704,3.981835922445403
HSC-3,72376,-2.5245503337218596
TE-14,568763,2.618980082462389
Kasumi-2,11656518,-0.8040408639715576
Hs 611.T,16722836,1.175996278286737
BT 248,119182,0.6885021238666414
Karpas-422,46926350,-4.5458503553552365
Karpas-422,60700,-1.504917229120135
BT 286,49766530,0.4498348011542866
EHEB,12003241,-2.0597430880681062
PF-382,44137675,2.4985862116087283
Kasumi-2,5494449,-3.67008601278043
BT 112,23725625,2.6047701146720774
BFTC-909,124202324,2.9321657702899295
SK-UT-1,123631,3.6786616828036
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
KE-39,selumetinib-navitoclax (8-1 mol-mol),1.4458639992966646
KYSE-180,5351362,1.0664205921449423
YD-8,2841722,4.733958021687277
CML-T1,11178236,-2.7580162479970634
RKO,11625818,4.5581118700811105
PE/CA-PJ41 (clone D2),9952709,3.673274575880338
KYSE-180,676352,2.6978947803601057
Kasumi-2,5329102,1.6326140590430216
SF539,56963564,-0.1880547909604584
Namalwa,148124,-8.376959890675789
OAW28,2746,2.637952220594215
B-CPAP,5351362,0.984097997363641
NCI-N87,11626560,1.9254713694635637
CML-T1,68056272,2.531220488236934
NCI-H196,73707398,1.4930546062583872
SNU-213,44486219,4.443724602041866
HCC2108,6918328,-0.0809019219950942
BT 248,3081361,2.663958705985954
ESS-1,navitoclax-birinapant (1-1 mol-mol),-5.210357307930014
BT 328,15953870,4.378443753461669
BT 286,5281321,-0.1981041613926186
SNU-216,969516,2.758026915780333
BT 286,3062316,3.138959885805486
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
SF539,11625818,4.190042053470209
HSC-3,24753719,4.387222706020441
ACC-MESO-1,2729026,3.1292375102639194
YD-8,9866186,2.735650020983901
PF-382,89928392,-0.2076371550725149
Lu-65,10385095,0.4710137676717799
BT 112,11719255,0.9914291642812176
SK-MEL-5,53495165,1.2994435982035408
RERF-LC-MS,5470400,2.5584942331402623
JHUEM-7,25126798,3.738067975046635
IST-Mes1,11404337,-0.5180157624887997
H-STS,216468,0.2818757493359613
KMS-12-BM,serdemetan-SCH-529074 (1-1 mol-mol),1.618935341635423
EHEB,vorinostat-carboplatin (1-1 mol-mol),1.7793348056073373
MIA PaCa-2,387447,-4.141831839994585
TE 441.T,445455,4.976483288324393
CML-T1,136227924,1.8923919385229255
LXF 289,5278396,2.6487510770020104
NOMO-1,135398738,0.7085728369009435
GOS-3,9866186,0.992376150226647
SNU-1077,docetaxel-tanespimycin (2-1 mol-mol),4.730062209802919
SW1573,4096211,3.236722527011662
NCI-H2030,107970,3.119598892281485
EHEB,3634881,2.279328443256432
SNU-423,24964624,2.37850111488742
SNU-216,31703,-0.3566749197029411
NCI-H929,4259181,0.6476848617762108
NCI-H929,5282054,1.6993370124309537
Ri-1,11683005,3.8644579101571663
ChaGo-K-1,9803433,4.814410473469276
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
AU565,54596490,4.681317358630495
JHUEM-7,327653,3.126202180618715
RKO,637858,2.400395947377078
KLE,11234052,3.5359444822792896
RKN,11178236,-3.061903912386503
BT 248,4259181,0.8166391520482507
BT 328,44589607,2.897724961441205
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
HEC-108,9929138,6.458847770997077
SK-MEL-5,3038522,3.2178299780365847
Ri-1,navitoclax-sorafenib (1-1 mol-mol),-2.8508296212987223
KE-39,53495165,3.300789650083116
KYSE-450,3503,2.083749354383258
SNU-423,56649450,3.705931646214938
Ri-1,3136844,3.150567247939398
IST-Mes1,11427553,1.720147340773497
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
NCI-N87,44589607,2.3758044537421026
PE/CA-PJ41 (clone D2),54619267,4.212913000042618
RKN,12003241,-0.3350096455718494
Lu-65,3136844,3.9390005430833184
RKO,9866186,0.3829002704071885
ChaGo-K-1,439501,-4.217436880778372
OE33,71466445,3.9319707229949703
RKN,637858,2.0099352926359533
RT-4,6852167,2.0895706527990376
MJ,11455910,1.0370030045754386
KLE,9549297,3.198164194460754
Karpas-422,123631,2.844969571562552
Becker,1242560,3.428661477159298
RERF-LC-MS,56946209,-3.4945734927118552
TE-14,selumetinib-UNC0638 (4-1 mol-mol),3.0620672493728427
KE-39,1750826,-2.36387280589116
Ri-1,53392493,0.5057181719967727
HuT 78,decitabine-carboplatin (1-1 mol-mol),2.461978095459001
SNU-1077,4261,2.6699673905919696
WM793,navitoclax-pluripotin (1-1 mol-mol),-0.4661023572804197
HuT 78,BRD-A02303741-navitoclax (2-1 mol-mol),0.2900830981041313
SNU-1077,6610216,4.195845914467317
IST-Mes1,11964036,1.5284066254046933
HuT 78,45279963,3.999861167525814
SK-MEL-5,3081361,2.7977779800137443
LMSU,2729026,3.1039498249859183
Mono-Mac-1,1641662,3.313449330193925
PE/CA-PJ41 (clone D2),carboplatin-UNC0638 (2-1 mol-mol),4.040525542410768
KMS-12-BM,49867926,3.4280203306526524
Panc 02.03,148198,-4.053337817942692
Ri-1,72199292,-0.2882406263972568
Becker,439501,-2.817437349005285
Mono-Mac-1,67156097,-3.048740001729215
JHUEM-7,vorinostat-carboplatin (1-1 mol-mol),3.6475944430152114
SNU-1077,148198,-1.03431054543621
AU565,11507802,1.2242731086346843
SK-UT-1,24797083,-0.5976783400947587
Namalwa,46843906,1.285132441004268
MIA PaCa-2,10231331,2.934704407633453
NCI-H2030,11625818,4.920098770684147
L3.3,1750826,0.7937145951404149
TE-14,123631,0.428908787786111
YD-38,613753,2.798212756613697
Becker,71466445,4.307879847711241
Lu-65,4578,4.325365526086933
RKO,11485656,2.16906736756012
Namalwa,9866186,-0.5798489087704481
YD-8,31703,-0.6418507819689356
JHUEM-7,1242560,3.5007407035321285
SNU-213,11612883,2.207970532635057
GOS-3,24797083,1.855899364684227
OE33,17755052,1.329278841200886
Hs 611.T,44489675,3.810034889959883
MIA PaCa-2,selumetinib-tretinoin (2-1 mol-mol),0.3935924528272985
Namalwa,9935249,0.8927496794896076
HEC-108,654092,0.6558774071347439
HuT 78,5287969,-1.62674651410725
HuT 78,25262965,-1.2447606076305184
OE33,24180719,3.6753594192286583
SF539,9936388,-8.641778658087059
HuT 78,9887053,1.4751024014992844
EHEB,71304818,2.7376303187441966
SNU-886,9911463,3.862708319776098
KO52,135398516,2.6603419606687564
SNU-423,3689413,-2.448438848320713
BT 286,2733526,2.614715736192337
HEC-108,159324,3.617209831238773
YD-8,327653,2.805787909326678
Hep 3B2.1-7,10074640,2.637469456252606
CML-T1,11317348,-0.5508465073970409
KO52,16013152,3.657905355539016
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
NCI-H929,selumetinib-vorinostat (8-1 mol-mol),1.6351341952434315
SF539,25183872,-1.8165850981931693
KYSE-450,9444,4.430571093374375
RKN,753704,4.966407297087677
SF295,5284329,5.188047752910472
OAW28,46224516,2.3854099680927523
Hs 611.T,17755052,-0.9587455713064612
ChaGo-K-1,462382,0.9099733724752056
GOS-3,387447,-4.946086426612472
RERF-LC-MS,24772860,-2.3078196081029136
SK-MEL-5,10074640,3.1391211801993806
Kasumi-2,1566236,1.00471674851072
TE 441.T,5278396,3.614745829557785
KYSE-180,9911463,4.116935332494812
HOP-62,135411,0.996647312538749
SK-MEL-5,44137675,4.284883260277097
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
BT 320,16725315,5.30580008906936
SNU-216,2949965,2.568714959584875
SNU-119,6852167,1.9740525769719148
BT 286,54613361,-1.8400709728794231
KE-39,navitoclax-piperlongumine (1-1 mol-mol),-0.2152074007553692
Hep 3B2.1-7,46398810,2.404873778989621
NCI-H196,42642645,1.4168604332758885
Becker,51039095,3.232874650132705
HEC-108,5278396,3.63044129466019
KLE,60750,-0.0537222566520801
SNU-216,navitoclax-MST-312 (1-1 mol-mol),1.1762974749345434
AsPC-1,5291,4.446798964395248
HEC-108,3815108,3.3299414273071273
NCI-H196,3543504,4.34188123098332
GOS-3,11404337,1.2142789078350222
TE-14,selumetinib-PLX-4032 (8-1 mol-mol),5.293913907002749
Hs 611.T,16736978,0.4246623410303011
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091
ACC-MESO-1,637858,3.0332515622117016
PE/CA-PJ41 (clone D2),44493528,4.345645378925518
NCI-H1339,6505803,-2.1203038529931857
Kasumi-2,46926350,-4.426429724391801
ESS-1,1566236,1.5560500313895365
SF295,6918328,0.1842414717583212
Mono-Mac-1,53481919,3.5538110484829835
NCI-H1339,11222830,1.781857962831655
MIA PaCa-2,24951314,0.8451751507215038
RKO,54626689,4.750442055573677
YD-8,3025944,4.131674769368578
SNU-423,16038120,1.4003538126035056
Lu-65,23725625,4.934264541765965
HOP-62,6610216,4.033430969864694
SNU-216,11317348,6.023030542317429
HCC2108,11404337,0.8287580393905775
AU565,16736978,1.4090353018278403
YD-8,650361,3.8896393800715297
RKO,135421197,1.472175761257966
NCI-H929,10184653,1.0865277300085363
AsPC-1,1750826,-1.5700020776253725
HCC2108,104842,-1.1232837273374026
Hep 3B2.1-7,25262965,0.8423182993165146
SK-UT-1,54613361,0.5908991855322304
SK-UT-1,969516,2.241121714943991
KE-39,11625818,4.741005492826134
KE-39,11609586,3.026982810256724
TE 441.T,selumetinib-MK-2206 (8-1 mol-mol),2.916322573945283
KMS-12-BM,5329102,1.2155421851150237
JHUEM-7,5311281,0.9593410501369758
OAW28,44607531,1.5392912313773788
L3.3,65064,4.762523259447735
Mono-Mac-1,15983966,-5.789773098471852
SNU-886,6852167,1.7356740395835049
ACC-MESO-1,135398744,5.83972457285084
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
SF539,3634881,2.419481014685841
OAW28,9840324,5.735695909737487
LXF 289,10184653,0.2846387514020494
RERF-LC-MS,46174525,5.020740506928848
Mono-Mac-1,5282054,2.9932927644562053
Panc 02.03,24951314,2.3006835537528585
SK-UT-1,4521392,4.374260531561281
KO52,3062316,2.7101880307468047
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
MIA PaCa-2,119182,1.3201769074657816
BT 328,9549297,2.748428048509406
KYSE-180,322968,4.83956254664213
OAW28,3825829,4.635564939734502
HSC-3,135411,0.4070318982819898
SNU-216,17755052,-1.633790764199148
NCI-N87,439501,-2.2970478950560715
GOS-3,25262965,-1.0893957364274085
BT 328,241158,5.267624320159163
GOS-3,10296883,4.354871301885758
KYSE-180,24772860,-1.944704874720706
SW1783,45279963,3.6721383023604095
Ri-1,6918328,-4.123040432896102
YD-38,5278396,3.842438825501423
NCI-H1339,219104,4.587065461273761
SF539,25102847,1.4843193904497096
Hep 3B2.1-7,11497983,3.837054379025077
SK-MEL-28,5470400,1.2133275140914848
HOP-62,3854666,3.243198417563859
ACC-MESO-1,44620216,5.38480031222097
YD-38,46224516,2.9311306290981185
H-STS,11222830,1.7144208699256454
HuT 78,2828334,5.4247855811567645
PF-382,11396600,2.839145334831077
HuT 78,11647372,0.6475379223076121
SNU-213,100016,6.954868306659309
AsPC-1,44493528,4.313387127964929
RERF-LC-MS,45279963,3.7797867340420215
PF-382,46191454,0.6842895726793522
KYSE-450,241158,4.285328470501583
ChaGo-K-1,24180719,4.090680478392621
KYSE-180,56963564,-0.5572024388331268
AU565,444795,4.595530435398324
OE33,erlotinib-PLX-4032 (2-1 mol-mol),4.063980868806332
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
SW1573,24964624,5.100144587499453
LXF 289,23635314,-2.0420734326640253
Mono-Mac-1,24797083,1.4926989883124837
KMS-12-BM,16219061,2.3730211419345477
PE/CA-PJ41 (clone D2),5328940,1.486645508379929
RT-4,4096211,1.036713829931397
Namalwa,71751553,4.989934392817737
YD-8,9825149,2.435749778516473
KMRC-20,piperlongumine-MST-312 (1-1 mol-mol),2.9533358433546444
NCI-H929,5566,2.7784584402230266
WM793,168312962,3.5645743239810574
RKN,24951314,1.3743916622304369
Becker,16722836,2.963672271821801
LMSU,2746,4.6094970791668315
RKO,6438330,2.4839059464581785
SW1783,6252,4.426958357245536
RT-4,9926054,1.7601963161522494
ACC-MESO-1,1716436,3.110385863355361
Panc 02.03,6917907,-5.450554920776264
SK-MEL-28,3815108,3.819854777392354
Karpas-422,vorinostat-navitoclax (4-1 mol-mol),0.5946112460810862
BT 248,5978,2.367827241369892
SNU-216,42611257,3.1766256251755767
YD-8,9915743,1.4308611377432014
OE33,3854666,4.486907351479266
Karpas-422,71466445,2.788648588655379
Namalwa,9926054,1.683884099727144
SK-MEL-5,selumetinib-JQ-1 (4-1 mol-mol),2.584301952935506
HCC2108,11612883,2.2731271711462573
Kasumi-2,2742550,3.256021563602066
SW1783,322968,0.9146856362556636
KLE,46398810,3.130465535353637
OE33,3634881,3.388109632090494
BFTC-909,11656518,3.71751997684089
OAW28,44491742,4.754653012158477
SK-UT-1,151289,2.928498055248494
AsPC-1,5280436,2.0433035906644696
KYSE-180,44185566,2.1212784922440258
SNU-216,24771867,2.909916707277168
NOMO-1,16720766,-1.891739380903732
NCI-H929,11396600,-1.497885086375298
SK-MEL-5,5351362,2.366559176054297
ESS-1,navitoclax-piperlongumine (1-1 mol-mol),0.9788398984790389
KMRC-20,49766530,-1.4976923868030616
OAW28,11455910,2.4986666790908583
Karpas-422,11609586,2.991831439823751
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
OAW28,216239,4.152270593115834
KE-39,3503,2.236149027269379
Ri-1,24978538,-4.011089430683387
L3.3,3503,3.0907711446371
KMS-12-BM,vorinostat-carboplatin (1-1 mol-mol),0.7008192168713556
LMSU,446155,-0.7885997290913209
AU565,135398516,2.596290086865212
Panc 02.03,10231331,3.962628244123872
Kasumi-2,JQ-1-navitoclax (2-1 mol-mol),-2.2721346445712896
L3.3,387447,-2.8513357804813553
BT 286,16736978,0.9709442496573794
KMRC-20,carboplatin-etoposide (40-17 mol-mol),4.439397714943588
KO52,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.410719813767284
KYSE-180,25126798,3.589811911556444
NCI-H929,6918878,1.2577940998028925
ACC-MESO-1,439501,-2.1177142805540163
LMSU,387447,-4.878284727647071
ChaGo-K-1,104842,-0.5641432467884121
TE-14,SNX-2112-bortezomib (250-1 mol-mol),-2.4021869864872603
AsPC-1,107985,-4.227741895863185
JHUEM-7,5746,1.3503095363365143
KMS-12-BM,9840324,5.159975426829893
BT 286,676352,1.7872148842320963
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
LXF 289,5282054,3.512278681739004
TE 441.T,42611257,3.348993947419179
BFTC-909,25105715,3.3944682152224455
H-STS,11494412,-0.8730313423515421
JHUEM-7,6918878,3.0932283055268512
KE-39,4261,1.550964775863626
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
SNU-886,36314,-4.506581052227643
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
RERF-LC-MS,9926054,1.8051014319834384
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
LMSU,57519531,3.754499553388688
KMRC-20,JQ-1-MK-0752 (1-1 mol-mol),6.181134550910211
OAW28,2749,3.2113189756487683
SK-MEL-28,24748573,5.3109310210303455
SNU-119,doxorubicin-navitoclax (2-1 mol-mol),-1.1544106992080023
WM793,17759555,4.44870242372694
NCI-H196,6918837,-2.8537078535104583
LMSU,tanespimycin-gemcitabine (1-1 mol-mol),1.1507117487410143
LMSU,selumetinib-PLX-4032 (8-1 mol-mol),4.555801564467133
IST-Mes1,44607530,1.064599314990069
JHUEM-7,56963564,-0.4105683890675542
Ri-1,12001922,2.5045482624061552
WM793,89928392,1.2506486576555742
PE/CA-PJ41 (clone D2),12001922,2.6504343623639732
LXF 289,9926054,2.043368643335034
Hep 3B2.1-7,5566,2.9169630024130724
Namalwa,25062766,1.6047548376295822
HCC2108,67291369,1.6270621345157394
KO52,9927531,4.721929704585103
SNU-119,9907093,3.854419311028708
L3.3,11640390,3.7293417266479905
SF539,9549297,3.209839506985017
KE-39,16725315,3.5990851811512403
Hs 611.T,613753,2.8165703811915597
BT 320,5328940,3.389766935980773
BT 328,73707398,2.390014521827579
PE/CA-PJ41 (clone D2),6450551,5.006652312044534
Mono-Mac-1,3825829,3.369538014411621
YD-8,JQ-1-UNC0638 (2-1 mol-mol),2.771778742465765
LXF 289,67291369,3.4412292386368746
HOP-62,9840324,5.857824813653661
JHUEM-7,66577038,3.1107179638386175
Becker,24753719,4.281079864002637
SNU-119,selumetinib-UNC0638 (4-1 mol-mol),3.591039220835182
HSC-3,969516,2.431912353028137
ACC-MESO-1,56946209,-1.916659581654868
B-CPAP,72193861,0.4999551540918637
NCI-H929,54639024,4.491044339124744
JHUEM-7,3384730,5.064840535114842
SK-MEL-5,16722836,2.463448660750138
Mono-Mac-1,60750,-0.2214723919691935
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
TE 441.T,262093,1.5238346929960052
KLE,9823820,3.7832200192550047
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
EHEB,54618771,1.2042140049426533
SNU-213,10113978,3.0551192339322784
MJ,1641662,2.6485771241185474
SNU-119,159324,3.0008353242690045
AsPC-1,4521392,4.0696198883268275
HOP-62,ISOX-bortezomib (250-1 mol-mol),0.9515306322664672
YD-38,44507138,1.6474032536163992
ESS-1,67291369,3.683100317554582
Mono-Mac-1,72376,-4.015210702515702
BT 286,carboplatin-UNC0638 (2-1 mol-mol),2.636766097165947
NCI-H929,24772860,-3.485705594224342
SNU-119,208908,1.7146109385017043
KMRC-20,2874250,5.815904450932631
SK-UT-1,25154868,1.7438224060222909
RKO,44137675,4.282234128328841
OAW28,71680916,5.167013104004298
SW1783,56649450,2.1130846621058756
OE33,5329102,3.567520971541263
HSC-3,52947716,-4.848984018159716
Hep 3B2.1-7,753704,5.157243531098819
ChaGo-K-1,445091,3.937856738391293
BT 286,5329102,1.7447783077398489
JHUEM-7,71576739,4.492980004205545
OAW28,56946209,-4.450705744661636
SNU-423,6610355,5.092253202079039
TE 441.T,1242560,3.25377311649576
HuT 78,135928012,5.03508248735035
KE-39,24772860,-2.1888261700101954
NCI-H2030,3503,2.737633424778545
SNU-1077,selumetinib-decitabine (4-1 mol-mol),5.435287074602724
B-CPAP,654092,-0.163277958019971
SK-MEL-28,6918289,3.2211222821081327
KMS-12-BM,656346,0.20048229693813
SNU-1077,2828334,5.956147733949382
SNU-216,9952709,3.2961556134652743
ESS-1,2858523,3.2684495269565703
SNU-216,11178236,-4.968620812635702
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
TE-14,1716436,4.07265498806864
TE-14,4259181,-3.298060588196884
LXF 289,54454,1.7599180903835134
NCI-H2030,12001922,2.618392132225964
SNU-1077,969516,4.920096093874863
PE/CA-PJ41 (clone D2),54678924,3.100957634297122
OAW28,11612883,3.952715585132085
Kasumi-2,44589607,0.7324041454669186
YD-8,5287620,-1.9715121639799928
Lu-65,24785538,0.987209197048792
YD-8,56649450,2.606046956482712
SNU-216,10184653,-2.329073802450239
NCI-H1339,24771867,3.8469201935046815
HuT 78,374536,0.782001012085031
EHEB,135411,-0.07398268976703
HuT 78,702558,5.694592487661442
SNU-119,navitoclax-birinapant (1-1 mol-mol),1.664402595144999
JHUEM-7,3025986,-1.7101726787729836
SNU-119,5284373,1.050197910759818
KO52,11396600,3.051627581840025
TE 441.T,5282054,2.066281782246845
Hs 611.T,navitoclax-pluripotin (1-1 mol-mol),-3.3446923826201305
Lu-65,6918837,-1.5228157707828325
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
SW1783,JQ-1-MK-0752 (1-1 mol-mol),2.969975074260421
NCI-H196,168312962,5.424811162336187
MIA PaCa-2,11507802,0.9401760079454452
BT 498,135659046,3.899086642972748
ESS-1,445643,4.277333724215148
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
KLE,1750826,-1.5621795259056923
SW1783,36314,3.6045625119114506
SNU-423,216468,4.240235187700666
EHEB,3503,1.3671280774661785
L3.3,24901704,4.5240834828138095
SNU-216,156414,-1.34829160644196
KLE,salermide-PLX-4032 (12-1 mol-mol),5.565306669496566
Lu-65,409805,4.990129571781812
SNU-423,6914657,-3.262772881758693
SW1573,2729026,2.4001203305493397
SK-UT-1,5566,3.086414513691759
SW1573,11178236,-2.507507612037206
YD-8,44185566,2.6803137078691868
Ri-1,carboplatin-UNC0638 (2-1 mol-mol),3.0584033044093277
BFTC-909,5278396,3.473037688340168
BT 286,148198,-5.76188834046235
BT 112,11152667,1.095866512531577
BT 320,doxorubicin-navitoclax (2-1 mol-mol),-0.1344051428167206
Mono-Mac-1,46224516,3.2819327915906005
TE 441.T,2130404,2.865967675854056
HCC2108,selumetinib-tretinoin (2-1 mol-mol),5.736477688995886
OE33,702558,5.7298924677891625
LMSU,71304818,3.266059532186748
ESS-1,11494412,1.0604335653802026
Lu-65,selumetinib-JQ-1 (4-1 mol-mol),-0.4610963672816198
ESS-1,6918878,4.817127721204009
TE-14,selumetinib-piperlongumine (8-1 mol-mol),4.350440406210289
IST-Mes1,4578,4.452023444310014
TE-14,11175137,2.8824808413518443
HCC2108,327653,2.5162191828052713
ChaGo-K-1,65064,5.311703145942276
Namalwa,5479543,3.3225711466724324
Kasumi-2,selumetinib-UNC0638 (4-1 mol-mol),3.1045685976717623
Hs 611.T,16013152,4.086907930455013
MIA PaCa-2,148198,-3.7289909178632383
AU565,66577038,2.656766135213886
CML-T1,9903786,2.526700219209825
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
NCI-H209,53392493,2.3383319571831023
LMSU,25154868,5.828737682964474
RKN,16741245,1.555254881894904
SNU-423,60700,1.632231011146198
KMRC-20,11175137,3.0694696383235645
RKN,219104,3.4277527780329096
SNU-886,selumetinib-tretinoin (2-1 mol-mol),2.050620006893266
BT 286,2828334,6.031620597313496
NCI-H929,73707386,0.8452841513210776
RKO,5978,-3.7617282032773582
HOP-62,24951314,0.9173922976891838
ChaGo-K-1,11707110,3.866052585258933
HuT 78,49867930,4.292430272792475
RT-4,24772860,-3.0358788359895543
Kasumi-2,46843906,1.3893397569967554
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
CML-T1,9908783,6.154706718384333
SNU-886,81146,5.0685074142197175
RERF-LC-MS,24964624,3.0594292113466515
Becker,81146,4.883737622281325
KE-39,5280436,3.8449675100084417
OAW28,51039095,2.7471743585791075
YD-38,navitoclax-MST-312 (1-1 mol-mol),0.6131752469119803
SNU-216,doxorubicin-navitoclax (2-1 mol-mol),-0.3226565332452495
HOP-62,11152667,-0.1983015993822777
IST-Mes1,11955716,-2.3343063309165095
NCI-N87,4917,2.911504588829893
RKO,4917,3.097539294413192
AU565,24772860,3.3222909323637455
LXF 289,159324,2.685439807189008
TE 441.T,crizotinib-PLX-4032 (2-1 mol-mol),0.249854268469704
HCC2108,doxorubicin-navitoclax (2-1 mol-mol),-0.6309858314473922
TE 441.T,24785538,-1.9188481727224669
EHEB,alisertib-navitoclax (2-1 mol-mol),-1.9971610366443435
AsPC-1,6450551,4.162604073037061
KMS-12-BM,3854666,-0.1079800642722917
BT 498,16725315,5.273722715780474
SNU-119,selumetinib-vorinostat (8-1 mol-mol),2.4531148017097726
MIA PaCa-2,5278396,3.2881813032043303
SNU-423,31703,0.0890706535618343
AsPC-1,374536,-1.7506249493921369
B-CPAP,89183176,5.401425967113139
SNU-216,11234052,4.859150413061991
TE-14,52947716,3.1732034672795875
BFTC-909,374536,2.594742723017773
AsPC-1,613753,3.1774382169580355
SK-UT-1,24821094,3.742351584541763
TE 441.T,16219061,3.7718744241522346
L3.3,119607,5.267929584666067
SNU-886,24785538,0.7681311411213433
Lu-65,7251185,3.101114407523891
Ri-1,219104,2.628053406762598
RKN,2729026,3.0549768432694377
SK-UT-1,4096211,5.814618826658096
GOS-3,crizotinib-PLX-4032 (2-1 mol-mol),1.48580275068934
Ri-1,10127622,5.1327863724648095
KMRC-20,navitoclax-MST-312 (1-1 mol-mol),3.022643345531742
PE/CA-PJ41 (clone D2),445455,4.423683569648825
BT 112,49766530,0.144276899282749
LMSU,72376,0.2338050828767356
KE-39,3081361,1.3988203553755596
PF-382,72376,-3.2964560616169587
NCI-H196,31703,0.16997276013656
RERF-LC-MS,3825829,3.876424055067748
ESS-1,54618305,4.255754792589274
HOP-62,doxorubicin-navitoclax (2-1 mol-mol),-0.946699681174633
Namalwa,637858,0.9589719241333216
BT 286,decitabine-navitoclax (2-1 mol-mol),-0.0152132620036723
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
OAW28,5280436,5.165372214799318
CML-T1,5746,-2.1549173035879803
Kasumi-2,72199292,0.0568572050486096
SNU-423,5351362,1.1925295534620222
HCC2108,24180719,3.7452058347449033
MIA PaCa-2,11238147,1.7640354118108326
KYSE-180,selumetinib-UNC0638 (4-1 mol-mol),4.875323970784825
YD-38,6610216,4.740393089069458
LMSU,375860,0.9440264058556476
Panc 02.03,25126798,4.246913180768056
OAW28,31703,0.1585101679236112
WM793,5280436,4.679936736167119
AsPC-1,1716436,2.9196038383716205
SK-UT-1,56649450,4.279287497438238
SK-UT-1,71304818,1.4453829824044986
PF-382,54143018,-0.5673202131057219
HEC-108,6438330,3.5129329347136027
OAW28,11609586,2.8574541529278883
HCC2108,44259,2.0867454916119077
AsPC-1,285033,-0.5419823336362324
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
RKN,15983966,-2.847635435689191
RKN,168313047,2.366456695786382
L3.3,568763,0.380782352657369
HCC2108,54613361,-0.9116007524668512
AU565,136227924,2.2371309282915184
MJ,2858523,3.220847662201125
SK-MEL-5,11977753,-1.7055633614852417
HEC-108,11626560,2.4526082617686793
GOS-3,4477,0.980296597324464
YD-38,11152667,-0.8447422607526522
Ri-1,5329102,1.1587105315253556
BT 286,25227462,1.03002877262914
Karpas-422,66577038,2.9957151824734503
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
SF539,6918736,-1.352397505308771
Lu-65,11178236,-3.716931959445397
SNU-216,53393127,3.716530473529192
Kasumi-2,doxorubicin-navitoclax (2-1 mol-mol),-4.049414259936193
RKO,2841722,4.522769482159767
IST-Mes1,60700,-0.0817355864677207
BT 320,9935249,2.6939509810826294
YD-8,crizotinib-PLX-4032 (2-1 mol-mol),1.7734837444184717
ChaGo-K-1,6918837,-3.3217715787792064
SK-MEL-5,44507138,3.312693142083379
ESS-1,4917,3.7890836888483626
OE33,5328940,1.6046897075970823
NCI-H929,66577038,3.051859645281257
Mono-Mac-1,168313016,3.482496352370787
RKN,53392493,3.005817826052642
TE-14,5470400,-0.7410754005193283
KLE,322968,2.787841827259593
Ri-1,9866186,1.7713313048291
Becker,73707398,1.456292128842472
RKO,25154868,3.654559992823761
RERF-LC-MS,123631,2.7610356359897104
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
SF539,3136844,3.725452843586701
LXF 289,selumetinib-BRD-A02303741 (4-1 mol-mol),3.5296053048894116
RKN,53232,2.2291100881655037
HuT 78,53232,2.0901683388522385
Mono-Mac-1,2874250,-1.2814848013351932
PF-382,51039095,2.24186796125132
KMS-12-BM,11609586,2.2614384485200625
ACC-MESO-1,36462,2.9779299416618237
KYSE-180,9936388,-5.3897473887689
WM793,969516,2.5069941114188485
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
KO52,9956119,3.9050821856051185
Mono-Mac-1,10077130,2.3094568580600296
NCI-H2030,10302451,2.0984974298740484
PE/CA-PJ41 (clone D2),5287969,-1.8325693318378895
SF539,49867930,4.3730716554773235
RKN,5328940,2.201806852003849
KMS-12-BM,11167602,1.7675298654448677
IST-Mes1,52912189,1.1075207421426316
CML-T1,54618305,-5.881736901302383
Panc 02.03,446155,2.721578883226381
L3.3,24951314,1.4054712073944002
EHEB,54619267,5.440652083155126
SNU-216,crizotinib-PLX-4032 (2-1 mol-mol),2.2475648646248025
HSC-3,4477,-0.923461709035426
HuT 78,5284329,2.4236179223209513
ESS-1,148198,-4.109415572856481
KE-39,vorinostat-carboplatin (1-1 mol-mol),2.810386853434761
SW1783,selumetinib-navitoclax (8-1 mol-mol),1.5346000994793692
Namalwa,selumetinib-UNC0638 (4-1 mol-mol),4.558272137526928
Kasumi-2,selumetinib-PLX-4032 (8-1 mol-mol),4.8744745414665145
BFTC-909,10113978,3.8739618499623094
L3.3,446155,3.865906870912223
SW1783,24785538,4.897756498421733
OAW28,6917907,-5.603755883192341
Namalwa,2733526,4.369977932427766
SF295,6918878,3.614414318774816
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
ESS-1,11977753,-1.6513872956899434
BT 498,piperlongumine-MST-312 (1-1 mol-mol),2.0235754447154353
Hs 611.T,24785538,0.938467091147352
ESS-1,44462760,5.293674505936234
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
NCI-H1339,9911830,3.231454639260267
BT 498,5287969,-1.4350798060054029
JHUEM-7,119182,0.6933164692379293
H-STS,11364421,-4.998126775681505
AsPC-1,9840324,5.861158829716173
BT 112,doxorubicin-navitoclax (2-1 mol-mol),-3.3405934698905555
ChaGo-K-1,tretinoin-carboplatin (2-1 mol-mol),5.128629678798782
KYSE-450,navitoclax-sorafenib (1-1 mol-mol),2.514511411707921
PE/CA-PJ41 (clone D2),25150857,3.0802622094811176
Ri-1,11507802,0.4513555699201265
Hs 611.T,9887053,1.7338078284968432
TE 441.T,23725625,5.29244610855438
MIA PaCa-2,2126,5.698167859697367
RKO,11717001,3.92417498432234
KMS-12-BM,16741245,2.1137703099951537
ESS-1,409805,3.6702401515474135
TE-14,71304818,2.537898681049355
BT 286,42642645,0.4820370250639494
LXF 289,44202524,1.498501439362416
HSC-3,25126798,3.3699831224465604
TE 441.T,3634881,3.217168446108213
HSC-3,44137675,3.228104265957375
L3.3,44137675,3.3686484205760783
SF539,3689413,-2.2250008276513107
SF539,36462,1.0067932013019132
Karpas-422,navitoclax-gemcitabine (1-1 mol-mol),-3.5481331212227034
SW1573,9935249,2.8664920450292852
Mono-Mac-1,11404337,-0.2219879905670924
YD-8,2126,4.624858365561851
BT 328,123631,3.6473377820687847
Ri-1,4788,4.0169402339890805
B-CPAP,decitabine-navitoclax (2-1 mol-mol),0.863745737663407
RT-4,6610355,4.842396120436743
Becker,6918328,0.7436877244681701
CML-T1,10231331,3.71504818577299
B-CPAP,1716436,3.297193822138579
KMRC-20,6505803,2.060614018584274
NOMO-1,10184653,1.080224838410231
Karpas-422,4261,0.072362955193048
Kasumi-2,16038120,1.393585308421038
PF-382,327653,2.393380485895892
YD-8,SNX-2112-bortezomib (250-1 mol-mol),-1.2949761873623031
MIA PaCa-2,1566236,1.8703719885196528
TE 441.T,156422,3.746221772014217
HCC2108,322968,3.4619795366418105
RKO,46191454,0.9841477576830012
SNU-119,135440466,2.0351079961049905
HCC2108,11175137,3.2094968416883827
KO52,11497983,-3.595547093152317
OAW28,53495165,3.30177539085494
PE/CA-PJ41 (clone D2),2828334,6.340821215170622
KYSE-180,3385,2.5391949123618036
SNU-216,SNX-2112-bortezomib (250-1 mol-mol),-2.7353446692772363
SNU-423,448949,2.1424419878841756
L3.3,675434,4.909949648038981
Karpas-422,25150857,1.000258872901277
KLE,6184667,2.425235268333095
H-STS,25150857,2.2324697691811277
BT 248,9936388,1.117792201973615
SF539,46398810,1.675879123276388
PE/CA-PJ41 (clone D2),374536,4.452656033627249
Hep 3B2.1-7,6505803,-0.5491843508320539
WM793,3543504,4.269438666760458
KLE,52912189,2.543092460133613
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
YD-8,11175137,2.9389718766102906
SK-MEL-28,123631,2.412238783254816
EHEB,2708,3.688555693681277
SW1573,53245473,3.5468633352222287
Hep 3B2.1-7,374536,3.6821717267000103
OAW28,322968,3.926433659329745
Namalwa,tretinoin-carboplatin (2-1 mol-mol),4.711706284787402
NCI-H929,2841722,4.211619881266404
BT 328,2729026,2.3236347104871924
RT-4,10127622,3.667218475131435
NCI-N87,11213558,1.0018400483751706
Mono-Mac-1,decitabine-carboplatin (1-1 mol-mol),4.37925675376224
HOP-62,969516,4.328157237863545
BT 328,25227462,1.995910036473872
SNU-119,6918289,2.523909001846346
BT 498,6914657,-3.1017002535917717
Panc 02.03,25062766,3.7424097220448207
SNU-119,4261,2.6486100655772407
HSC-3,6505803,-2.979370598270903
NCI-N87,15983966,-4.100894125332804
KE-39,71466445,5.518940973386278
KO52,selumetinib-piperlongumine (8-1 mol-mol),-0.5207684143564267
BT 112,3825829,4.160828844250468
TE-14,54619267,4.240613760232744
KYSE-180,36314,2.411334755990669
RKN,9935249,4.428036529076262
ESS-1,10127622,5.583352628786162
AU565,11626560,1.628517095800036
Namalwa,6184667,1.9403980705347172
PF-382,168312962,-0.0454286282986012
Kasumi-2,613753,2.4327594137588235
Panc 02.03,107985,-4.238430695688479
NCI-H209,25062766,1.4599836041351384
Mono-Mac-1,6252,0.8274718864145973
SNU-423,JQ-1-navitoclax (2-1 mol-mol),1.222088007808966
YD-38,11609586,2.6866258489707815
SNU-423,6852167,2.5596210289916765
Becker,23635314,-3.772928939412857
SK-UT-1,tanespimycin-gemcitabine (1-1 mol-mol),-2.178654952286891
HSC-3,4917,2.997958577945977
B-CPAP,216345,4.206842261809917
SNU-886,285033,-1.8858880502892013
HEC-108,6184667,5.152766799175181
JHUEM-7,285033,-3.151788648314247
Namalwa,9903786,1.5886639412240358
BT 248,9952709,2.726522372177628
BT 112,44607531,0.6377481559529096
Becker,702558,5.747196665834739
CML-T1,44543605,3.785822858271075
KYSE-450,44137675,3.8479858767038944
RT-4,2828334,5.9208370423124554
SNU-216,9967941,3.401351668838213
Namalwa,3543504,3.3437849281345247
H-STS,2729026,3.2634172065243656
SF539,11404337,-0.0923032150573938
NCI-N87,159324,0.0331676951949142
YD-8,57330099,4.8709299916964905
B-CPAP,vorinostat-carboplatin (1-1 mol-mol),2.390336914365316
SNU-423,9911830,2.1086837652762473
WM793,10127622,2.6063340682647325
RERF-LC-MS,24753719,5.208830602571573
AU565,54765302,2.5229399839825604
Namalwa,selumetinib-PLX-4032 (8-1 mol-mol),4.791848826949847
ChaGo-K-1,2749,2.1238985145265215
BT 248,89928392,0.7552276073317185
NCI-H209,navitoclax-gemcitabine (1-1 mol-mol),-1.5210743778486835
KMRC-20,654092,-1.274296745742125
SF539,9444,4.192195040935243
KO52,5470400,-0.2484424992521816
BT 320,54678924,3.6890866492224106
AsPC-1,135984461,3.722049898583642
AU565,5278396,3.257778157431963
SK-MEL-28,piperlongumine-MST-312 (1-1 mol-mol),2.3735820734622006
SNU-886,54618771,-0.5899639628082597
SNU-1077,11234052,3.386244403850262
SK-MEL-5,20959075,-1.933058848264935
SNU-423,4521392,4.30152676997697
NCI-H929,10427712,4.4181705669387865
SNU-216,100016,6.2010021575017085
SNU-119,156414,0.2348404717120807
OAW28,11222830,1.7030270245193828
Lu-65,46843906,3.4533673258167954
SNU-213,60700,1.9168120227571512
RT-4,60700,0.1864967839530102
SNU-1077,selumetinib-MK-2206 (8-1 mol-mol),3.771389515092964
HuT 78,16725315,3.3290051312719284
BFTC-909,23939,4.493588141952023
HuT 78,11625818,3.646817685983461
KLE,9927531,4.8057879583658405
SNU-423,11964036,2.2479137081458203
Hs 611.T,19582717,3.30705627833961
B-CPAP,168313016,4.426367892913076
SK-UT-1,16720766,0.6075309431652871
L3.3,5282054,4.901570069575592
YD-38,104842,-1.5188595036514532
NCI-H2030,24856436,2.270745300131024
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
AU565,568763,-0.2996152351915113
NCI-H929,2733487,7.111048494668631
KLE,444795,4.58251515525995
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159
WM793,ISOX-bortezomib (250-1 mol-mol),0.962793485948776
HOP-62,119182,-0.9189096668150032
SNU-216,72193861,1.899693938246185
KMRC-20,969516,3.471126157495644
KMRC-20,16722836,1.4149264521986569
AU565,1716436,0.9342430141979629
PE/CA-PJ41 (clone D2),11396600,3.63156445822279
KO52,5113032,4.556788931704779
RKN,11404337,0.6786980557761386
YD-38,selumetinib-UNC0638 (4-1 mol-mol),1.2165328685019954
PF-382,10184653,0.9152232637437828
SNU-216,44566777,-0.1164976312937838
SNU-1077,2945648,2.7051928991882073
SF539,219104,3.671344894380296
HSC-3,54454,1.5891555650857276
MJ,19582717,5.308710561122589
RERF-LC-MS,445643,4.345437949323675
SNU-119,SNX-2112-bortezomib (250-1 mol-mol),-2.290476264848759
KE-39,10074640,3.0601585781096268
NCI-N87,374536,0.3041613365805376
EHEB,65064,3.0143976665527368
B-CPAP,9866186,1.8476989957521583
RKN,12001922,2.582060834791438
KO52,216345,3.536975928684328
RKN,656346,1.677354805367284
Lu-65,JQ-1-MK-0752 (1-1 mol-mol),3.396249910599845
HuT 78,71729975,0.9717002340056357
SF295,168313047,3.539588092733674
Panc 02.03,2828334,6.385741192046609
Hep 3B2.1-7,24951314,1.1281957792330906
KE-39,6623618,2.180925070245112
AsPC-1,53392493,3.5744228182767164
Becker,11977753,-2.20370670195944
SNU-216,135875424,3.0610068784934885
SK-MEL-5,9825149,2.3906358989800163
Kasumi-2,54618305,4.391643278203803
KE-39,4259181,-0.84210776373342
MJ,285033,-3.775120913328887
HOP-62,3062316,-0.1499106985099995
HEC-108,5738263,3.298542747172543
AU565,5280436,3.6175977861549473
SNU-1077,72193861,2.5371059791462276
SNU-423,54619267,4.1428626977074074
TE-14,400769,-0.918938158881206
HOP-62,44589607,4.744731792767849
PF-382,49766530,-3.617209334662046
SNU-1077,crizotinib-PLX-4032 (2-1 mol-mol),3.011939718165651
KYSE-450,5328940,1.9152649667159072
NCI-H1339,24951314,1.5659987762809044
WM793,285033,-1.0395353883933165
AsPC-1,126941,-0.909933311518488
NCI-H2030,6917907,-6.031841495353539
Hs 611.T,9915743,-0.4075331774048215
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
HEC-108,54613361,0.1609074083651108
BT 112,4477,0.3430018022640513
NCI-H1339,71466445,4.88090882012996
HuT 78,25161177,3.1402397670522877
SNU-423,11178236,-5.066365028213152
HCC2108,6623618,2.894339950820384
SF295,49766530,-1.8796707032595965
Lu-65,JQ-1-carboplatin (1-1 mol-mol),1.9478415319376168
ESS-1,6917907,-5.9598430612808455
TE-14,11178236,-0.8618088962131637
BFTC-909,56946209,-2.8280109825858943
L3.3,262093,4.054875705556861
NCI-H1339,2113511,5.7247036401777445
Kasumi-2,11955716,-2.6016781088205665
HSC-3,375860,-0.7997603409835673
Namalwa,252682,5.816097793824885
AsPC-1,3062316,2.757974416117501
SF539,6450551,0.8241072018867992
PE/CA-PJ41 (clone D2),1641662,5.7786463138338595
BT 112,54143018,0.6919547440728372
Lu-65,24797083,-0.526956987968481
KE-39,44487872,4.457727251314366
OE33,5281321,-2.864418891042976
KO52,89928392,0.7106504990592801
KE-39,25195348,3.12017559444377
SNU-886,1285940,4.4592277116209775
EHEB,439501,-2.4217048608799097
ESS-1,1242560,3.6553625997250143
Namalwa,selumetinib-BRD-A02303741 (4-1 mol-mol),5.907304131340107
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
OAW28,462382,0.1410996491293406
YD-8,11317348,1.928861961863856
Hep 3B2.1-7,24785538,0.8305444997148282
Kasumi-2,60750,-5.618830215487252
JHUEM-7,46174525,4.16654361698855
SNU-119,10127622,3.9443492007002146
KYSE-450,12003241,-0.0119879221972118
KLE,2708,3.7521843050752457
SNU-119,44202524,1.6419079750813077
BT 498,439501,-2.816531814980934
Mono-Mac-1,tretinoin-carboplatin (2-1 mol-mol),3.5434770977176107
WM793,49766530,-0.085641441031448
CML-T1,107985,-4.139753917879256
EHEB,24753719,3.508920403296929
ESS-1,375860,-0.234699059648963
RERF-LC-MS,9825149,2.3136516136403595
NCI-N87,123631,-0.3933912143385343
IST-Mes1,25126798,3.982374188902535
OAW28,15983966,1.5707780698474574
KMRC-20,5738263,3.585563727578386
NCI-H1339,107985,-2.3926548683095885
RT-4,16741245,3.9190611982266503
KE-39,25102847,2.4320728341381517
SF539,24753719,4.7612365798691405
SK-MEL-5,piperlongumine-MST-312 (1-1 mol-mol),1.8829016872652296
Lu-65,1750826,-0.7879341098892302
RERF-LC-MS,2729026,3.1361811776879644
SNU-119,9840324,5.792176147063417
HuT 78,6436223,-5.212835622139217
Mono-Mac-1,9929138,7.711944602530317
Mono-Mac-1,71680916,6.133858126249924
HCC2108,10302451,4.138705922344902
HSC-3,49850262,4.538780600428152
SK-MEL-28,3038522,4.0586102618779245
MIA PaCa-2,11152667,-2.2461765608848663
SNU-119,24748573,1.250225793254589
PE/CA-PJ41 (clone D2),vorinostat-navitoclax (4-1 mol-mol),2.2069497935289992
L3.3,71304818,3.108733273598676
KLE,selumetinib-UNC0638 (4-1 mol-mol),3.976187739409722
SF295,piperlongumine-MST-312 (1-1 mol-mol),4.017972735534295
KMS-12-BM,JQ-1-navitoclax (2-1 mol-mol),-3.0294043604496363
JHUEM-7,176870,2.1277798122521094
PF-382,3136844,3.510785171533077
NCI-H196,1716436,5.019622183878195
SNU-216,selumetinib-navitoclax (8-1 mol-mol),2.3249400693013804
IST-Mes1,44202524,3.78616908386864
SNU-213,17759555,3.674310368381118
LXF 289,9929138,7.38651684018349
Ri-1,56949517,1.825800201043262
BT 286,42611257,5.657257060628102
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383
Hs 611.T,156414,0.8748600228800256
KE-39,2828334,6.422070101852093
KLE,24856436,-1.53848530026464
KE-39,5278396,4.063811246360968
SNU-216,46215462,1.4229536083265848
SF539,25262965,0.0170335462798406
SK-MEL-28,4261,2.2324553955764115
NCI-H2030,104842,-1.6635448144651332
SW1573,3025986,2.659291536752942
LXF 289,60700,2.2902498510351528
AsPC-1,9911830,2.936776162598985
HCC2108,9911830,2.581322243172156
HCC2108,49793307,-2.77688699099991
SF539,navitoclax-gemcitabine (1-1 mol-mol),-3.026639158537806
BT 112,46398810,1.9166680275447008
SNU-119,156422,3.70265719969244
KYSE-180,2858523,2.9324338012206845
SK-UT-1,6252,5.554705519214965
SNU-1077,11640390,2.9587298758438316
Karpas-422,23635314,-3.907281565392564
IST-Mes1,carboplatin-etoposide (40-17 mol-mol),4.371414865626411
RKO,71680916,5.910552922648844
JHUEM-7,969516,2.4810699197008654
ESS-1,salermide-PLX-4032 (12-1 mol-mol),5.510207558856386
Mono-Mac-1,12003241,-3.167077714646063
TE-14,5278396,3.451892990607735
SNU-423,11214940,1.835230705261515
Hep 3B2.1-7,24753719,3.3025122123493573
KE-39,2945648,3.0904060650662477
WM793,3081361,2.8594902062102374
Hs 611.T,54678924,2.8409575384591736
BT 112,3025986,-1.5928563780305742
MJ,5566,1.0904788098650933
ESS-1,selumetinib-UNC0638 (4-1 mol-mol),4.619112844343245
SNU-216,navitoclax-sorafenib (1-1 mol-mol),2.0000007108124236
SNU-119,2126,3.7232553571891143
L3.3,20959075,-2.193253801628986
NCI-N87,676352,1.7095816234371617
EHEB,44185566,1.5991961670911994
RKO,4705,3.750134101835121
OAW28,984333,0.3792215902143511
Kasumi-2,49793307,-4.053216594075624
Becker,11396600,4.49881996506653
SF295,vorinostat-navitoclax (4-1 mol-mol),2.085594905196653
HOP-62,SNX-2112-bortezomib (250-1 mol-mol),-0.1631695835975933
TE-14,9907093,4.298951887624449
ACC-MESO-1,44259,2.1931156888577807
AU565,11234052,4.466615830851295
BT 328,637858,2.786285777963434
KYSE-450,753704,5.119991159407921
B-CPAP,11175137,3.0252495703695668
Becker,135398516,2.479609320225028
LXF 289,25062766,1.8533275351899623
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713
BFTC-909,6450551,3.0302116860685886
EHEB,11364421,-3.039867247755455
HOP-62,753704,5.052379590990168
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
H-STS,9911463,3.056276034663577
Mono-Mac-1,selumetinib-MK-2206 (8-1 mol-mol),1.4468247405197736
Lu-65,44241473,4.745952871370416
KMRC-20,11404337,0.8151706043014814
NCI-H1339,71304818,2.557154987327623
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
H-STS,25126798,3.914537201699023
KYSE-180,54618305,5.290256883782679
JHUEM-7,24771867,-0.3037567272373623
RERF-LC-MS,54618771,0.9955970244631366
Hs 611.T,60700,-2.724608043740349
SK-MEL-5,54143018,1.420602942100165
Karpas-422,6450551,2.30422397059455
Hep 3B2.1-7,400769,-0.6414390690663336
BFTC-909,17755052,1.7621152527207813
WM793,9911463,3.794379463406426
ChaGo-K-1,67156097,-0.5727402535165194
BT 328,selumetinib-BRD-A02303741 (4-1 mol-mol),6.07719627140778
KLE,73707386,3.2783445744557307
PE/CA-PJ41 (clone D2),3081361,1.7117945154872471
AsPC-1,46191454,4.573546152494067
YD-38,1750826,-0.2473780942075642
TE 441.T,55508,3.9822994435950902
PF-382,11214940,-0.2172300020723663
BT 112,285033,-2.2130720086668836
RERF-LC-MS,24180719,3.6010609924552455
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
SF539,navitoclax-MST-312 (1-1 mol-mol),0.2156471617471034
GOS-3,25183872,-0.8854682014750674
SK-UT-1,46398810,3.3711222617391456
SNU-1077,65064,5.355049721805472
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
Ri-1,carboplatin-etoposide (40-17 mol-mol),0.6778426114886354
KO52,42642645,-0.8739064396706098
Ri-1,46907787,-1.1077031577889345
KYSE-180,60700,1.3499298515602995
KYSE-180,36462,3.219917830306027
NCI-H1339,17755052,2.4500760972098785
KYSE-180,44137675,3.5547718056396
TE-14,9915743,-2.4468727006504483
Lu-65,10296883,3.98979643435714
Kasumi-2,42611257,3.9292605095902857
TE 441.T,JQ-1-vorinostat (2-1 mol-mol),1.924106246622056
NCI-H196,439501,-2.4399998682634023
Kasumi-2,5746,-4.326746041624573
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
OAW28,52912189,1.8010258653688298
SK-UT-1,3025944,4.81857732958154
NCI-H1339,6610355,4.7012470310276875
Mono-Mac-1,49850262,2.484321321634945
KO52,426756,3.509057105571762
HCC2108,6917907,-5.24436050839449
Lu-65,3038522,2.02089993104325
MIA PaCa-2,6505803,-3.969520749405985
HuT 78,119607,5.154111912943426
NCI-H196,568763,0.2988260029434089
B-CPAP,135984461,1.7006873444468935
SK-UT-1,16741245,3.1689132411737244
PE/CA-PJ41 (clone D2),10127622,2.6959246171276625
SNU-886,tanespimycin-gemcitabine (1-1 mol-mol),2.0847122709866097
CML-T1,2729026,1.0181320426336582
HEC-108,46191454,0.932122354999318
Kasumi-2,3038522,2.07744827479205
YD-8,89928392,1.3533989026988826
GOS-3,navitoclax-pluripotin (1-1 mol-mol),1.020256272208372
SK-MEL-5,erlotinib-PLX-4032 (2-1 mol-mol),2.9162129014385783
AsPC-1,11427553,3.0222816384498237
RT-4,46398810,2.84559074478432
BT 498,16065773,3.101291116370222
BT 328,16065773,3.5166527038097906
HSC-3,219104,4.05954551765257
AU565,16038120,1.417918520815656
AsPC-1,10231331,1.7826677656602696
PF-382,16725315,0.8059260614794377
LMSU,4917,3.70267650395279
KE-39,3384730,3.7070900081119
Kasumi-2,9911830,1.88551459110434
GOS-3,17755052,3.2453279413753147
NCI-H929,46199207,3.0580701159443766
BT 286,5328940,1.8588280079046673
SW1573,54618164,4.339091959582753
Karpas-422,decitabine-carboplatin (1-1 mol-mol),1.1507447768473271
KO52,25161177,1.7926893873102905
WM793,46398810,3.0163067396292944
KE-39,25262965,-0.0093824287359457
KMS-12-BM,selumetinib-piperlongumine (8-1 mol-mol),2.5465910856240512
MIA PaCa-2,135928012,3.7841811685806337
GOS-3,56649450,5.993657371981695
Lu-65,66577038,2.7956766049340147
B-CPAP,409805,5.0770120967965795
SF539,11455910,0.0331728686867912
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253
TE 441.T,5311,1.6876547835303894
NCI-H1339,23635314,-3.53807234526192
Lu-65,25062766,2.685201295328945
HCC2108,119182,4.202789641454693
TE-14,4917,3.116532733648005
LMSU,24797083,1.8363127025251853
TE-14,7251185,3.069214722812887
Becker,5311,1.7921665195219072
HOP-62,25105715,3.068755512136371
SF539,11214940,4.4904347227847845
L3.3,168312962,-1.2002539688883909
LMSU,3081361,2.668477326227084
IST-Mes1,selumetinib-MK-2206 (8-1 mol-mol),3.5229121932796423
SF539,44202524,1.2344769857738371
OE33,637858,2.678273035808489
TE-14,11964036,0.758879773642312
EHEB,73707386,3.258970186799186
ESS-1,carboplatin-UNC0638 (2-1 mol-mol),3.6411517750033986
Lu-65,9911463,3.1807959522129905
YD-8,10113978,1.4967891530862965
IST-Mes1,4096211,2.0722665154973052
KE-39,5311,1.0787821402256168
SNU-1077,52912189,3.050441247854127
SK-UT-1,piperlongumine-MST-312 (1-1 mol-mol),2.2334203788003277
TE-14,2945648,3.3536514379865596
Karpas-422,135398516,0.8464676443060564
BT 248,46398810,1.9244684206215508
OAW28,168312962,3.352489814007426
OE33,1566236,1.7756816603120642
Mono-Mac-1,11175137,2.381238246388858
IST-Mes1,4477,0.8135431021107292
LMSU,16736978,1.7346374327663163
AsPC-1,11609586,3.135544943212619
KMS-12-BM,227681,1.85871490335109
ESS-1,56963564,0.4189689637772429
TE-14,vorinostat-navitoclax (4-1 mol-mol),1.7878412556891814
BT 498,16038120,2.0506806363109655
SNU-1077,JQ-1-navitoclax (2-1 mol-mol),0.5291421057412008
YD-38,selumetinib-vorinostat (8-1 mol-mol),0.9831282675647876
Hep 3B2.1-7,5278396,2.438013509739587
SNU-1077,44241473,4.729716696280308
RKO,11507802,1.7455765117352984
Kasumi-2,123631,2.0188728462797885
KO52,53232,4.022283845582505
Karpas-422,9926054,1.7787061620357676
KYSE-450,56946209,-4.220503618005704
L3.3,11625818,4.38532777510286
RKN,44202524,1.6880658914716755
KE-39,6852167,2.989668764419295
SNU-213,262093,3.638008939275064
SNU-423,11167602,4.222331627049854
CML-T1,55508,2.709114480954857
KMS-12-BM,2742550,3.02175924738708
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
Ri-1,654092,-1.552094077000309
SNU-119,6610216,4.326307589827554
SW1783,15983966,1.9735277014133552
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
OAW28,753704,4.708152366597851
SK-MEL-5,6852167,3.3711794080976594
AsPC-1,104842,0.0602967281328717
ACC-MESO-1,17755052,3.468527757653984
CML-T1,4917,2.5218741140394476
KLE,9936388,-3.639802417260702
HEC-108,11427553,3.7826747165213086
Mono-Mac-1,54618164,2.5791045372216703
SF539,66577038,2.975973060606957
B-CPAP,selumetinib-MK-2206 (8-1 mol-mol),4.4400365262321175
HSC-3,navitoclax-gemcitabine (1-1 mol-mol),-1.8598418032436657
Kasumi-2,9866186,-1.4043484015282397
Becker,107985,-2.6804749742466347
KO52,2733526,4.161479785187153
KLE,11485656,3.08308998793154
PE/CA-PJ41 (clone D2),24951314,2.460576025484623
Ri-1,72193861,-0.0805566209959442
SNU-886,135875424,2.126718157354228
YD-38,carboplatin-UNC0638 (2-1 mol-mol),3.201820043094107
SNU-886,6918878,0.4224764612922807
SF539,6852167,2.369096859709367
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
RKN,107985,-3.0900461086436404
WM793,44589607,3.080108180448729
RKO,5311,2.326095881991792
SK-MEL-28,5566,3.135754874944302
CML-T1,72734382,3.1811123479261276
B-CPAP,10074640,3.043104069078904
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
MJ,25227462,-4.25671431982025
NCI-H196,219104,4.963735754845671
AU565,54626689,4.66017141288812
LMSU,3503,1.6210474530909185
Lu-65,44486219,3.92826981701093
HOP-62,24964624,3.1243711395082543
CML-T1,3038522,2.3382153755761372
JHUEM-7,3081361,1.1903814732345688
B-CPAP,6918837,-2.529046056121727
Becker,serdemetan-SCH-529074 (1-1 mol-mol),3.075542184320411
SF539,5566,3.0115367431942865
H-STS,9887053,3.8773696813734246
CML-T1,100016,5.302267949835527
SK-MEL-28,168313047,3.5931899532955147
AsPC-1,57519531,4.317220146110072
KYSE-180,5280436,4.019735307251945
RKN,6918837,-0.6134153399361431
CML-T1,6918837,-4.73728443815153
KE-39,2708,5.6188157628289925
TE 441.T,56949517,4.629785609179926
NCI-H1339,168313200,4.075069570376525
Karpas-422,46907787,-1.7872558374884018
SNU-423,3503,1.990171514859812
Karpas-422,piperlongumine-MST-312 (1-1 mol-mol),1.2169544319971164
Becker,4261,2.108826753895035
Hs 611.T,71680916,3.9888572389737114
Panc 02.03,11707110,-0.717341284128793
KYSE-450,66577038,3.5261008260070232
YD-38,10385095,1.2654205909097365
Becker,5329102,2.932365308374823
B-CPAP,11609586,4.122165381910798
SNU-216,JQ-1-UNC0638 (2-1 mol-mol),2.1879565366107494
RT-4,53392493,2.7443643173433454
SNU-119,107970,2.4008728686512617
SNU-886,54143018,-0.1190337834405888
Ri-1,168313200,2.421861912259082
SNU-216,375860,0.5464638688972412
Mono-Mac-1,25183872,-0.3782943347176429
ChaGo-K-1,82146,3.945876441052169
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
HuT 78,71466380,2.9398406998655395
SW1573,3854666,2.927116287337192
SF539,navitoclax-birinapant (1-1 mol-mol),2.277929243582673
SNU-119,5566,3.0036278847764923
MIA PaCa-2,9935249,2.549119041340402
Ri-1,148198,-2.551976890306858
RERF-LC-MS,72193861,1.0218744083195843
KYSE-450,25102847,3.9805771767576057
PF-382,123631,2.005412532111485
KYSE-180,1242560,4.399331542534589
SK-UT-1,selumetinib-vorinostat (8-1 mol-mol),3.855507066103229
GOS-3,11214940,1.8063167684007233
HEC-108,2828334,6.315620913516899
SK-MEL-5,568763,0.9376173789152876
ChaGo-K-1,36462,1.940737547002896
NCI-H929,15953870,2.0316293430847594
Ri-1,46199207,2.0638864462459305
Hep 3B2.1-7,selumetinib-decitabine (4-1 mol-mol),2.836342370986182
HuT 78,16722836,0.3632946203875747
KE-39,24771867,5.944751904846296
SNU-1077,24951314,1.2105006017046815
Mono-Mac-1,65064,5.077395341935721
Becker,9884685,-0.0960658377350512
KMRC-20,16115403,-5.152191129792824
L3.3,654092,0.3260809528195456
HEC-108,25183872,-1.8518137093604925
SK-MEL-5,navitoclax-pluripotin (1-1 mol-mol),-0.5112819426570592
Karpas-422,6505803,-0.6034425689167541
IST-Mes1,9903786,2.7623614356082458
NCI-H929,71466445,3.0733288534415233
KMS-12-BM,208908,1.7484542711618651
JHUEM-7,11152667,-1.617539087588013
HOP-62,24978538,1.5301767800646526
LMSU,252682,6.355540941087888
BT 498,984333,1.6558618711250384
KE-39,421610,5.566154561454864
KE-39,5281672,4.420099730026252
HOP-62,6918328,-1.6775257144322653
ChaGo-K-1,6914657,-5.370737461229372
Hs 611.T,5738263,2.286334810299833
ESS-1,24821094,3.503483475384322
SNU-119,9915743,-0.9461018440857424
BT 328,71751553,4.608962030519419
KYSE-450,9866186,1.0868221005132463
SF539,135398516,2.131078137574097
NCI-H196,navitoclax-pluripotin (1-1 mol-mol),-1.16175177819381
ChaGo-K-1,81146,4.46891312687106
Lu-65,2708,5.479352175899552
KO52,613753,2.783890275158845
SF539,10113978,1.3805891441937308
Mono-Mac-1,9826308,-0.3549450293788487
ChaGo-K-1,vorinostat-navitoclax (4-1 mol-mol),2.2170061777318693
AsPC-1,23582824,1.2589428940506815
HOP-62,10172275,5.618844279452778
H-STS,11404337,-0.7903033287308603
YD-38,44589607,2.736235168586606
RERF-LC-MS,5460769,5.094680634820597
OAW28,969516,2.7253654251657573
HEC-108,375860,-0.0015834583996186
NCI-H1339,5281321,0.0024519736316222
Hs 611.T,8515,3.543970428456994
BT 328,24748573,3.666462316296569
SNU-216,6610355,4.747572050551597
SNU-886,25062766,2.1597541933468176
SNU-216,11485656,2.7250861397389463
B-CPAP,216468,4.208328548217155
Lu-65,6852167,2.6497392225444103
Karpas-422,9911463,4.381699719624804
HOP-62,piperlongumine-MST-312 (1-1 mol-mol),1.588875271586378
BT 328,136227331,5.061934875267611
KE-39,969516,3.3665912825733773
RKN,9887053,4.324470541002337
BT 498,carboplatin-UNC0638 (2-1 mol-mol),3.552975230735022
SF295,17759555,3.956575115387604
OAW28,31703,0.1585101679236112
IST-Mes1,136227924,2.313131576565863
EHEB,6918289,-4.286720857258569
NOMO-1,54678924,1.1055951494804663
NCI-H196,637858,3.0093076834066923
IST-Mes1,3825829,6.080187468224706
NOMO-1,26596,-2.074766602044621
EHEB,carboplatin-UNC0638 (2-1 mol-mol),3.0000584339231655
SNU-423,24797083,1.3709546558320778
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
AsPC-1,5351362,2.4874401689371033
BT 286,60750,-3.8919827883839937
TE-14,36462,2.704845630868705
SW1783,55283,4.5857048643674005
HuT 78,11364421,-5.802708456365859
Hep 3B2.1-7,31703,-0.3301761309822593
IST-Mes1,24785538,1.075792459113639
SNU-423,136227924,3.242018782370702
HuT 78,navitoclax-piperlongumine (1-1 mol-mol),-0.4618726000146174
PF-382,5311,0.2704502980561536
NCI-H929,156414,0.5091151756924145
IST-Mes1,44491742,4.903550558956352
GOS-3,54619267,4.509336729831847
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
KYSE-450,9926054,1.8553044985655331
KO52,49793307,-2.661951064063904
BT 248,568763,0.252168352363544
BT 112,54619267,3.469133833703133
AsPC-1,6505803,-1.959385905579291
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
SW1573,16722836,2.4665820842388606
Mono-Mac-1,445455,4.450423753030739
SNU-216,46398810,2.073816562442194
Lu-65,23635314,-2.532055940883662
PF-382,11175137,1.0890287092924258
RKN,387447,-2.9807645129134066
OAW28,44137675,4.561686598527574
RKN,54649381,4.194319964969153
YD-8,445643,3.7964641558738688
Hep 3B2.1-7,10427712,4.336192818143491
KMS-12-BM,15953870,2.0453814346354577
JHUEM-7,104842,-3.6182664698495928
Hep 3B2.1-7,selumetinib-vorinostat (8-1 mol-mol),2.071849268804795
AsPC-1,56649450,2.958633157592254
Karpas-422,219104,2.0781563371385814
ChaGo-K-1,10410894,3.5392929764573844
HuT 78,4578,4.42076549518963
AsPC-1,4917,3.701934006694463
BT 286,decitabine-carboplatin (1-1 mol-mol),3.3032754794024783
HEC-108,3689413,1.021712931431184
KE-39,4521392,3.820577252344618
KMS-12-BM,erlotinib-PLX-4032 (2-1 mol-mol),2.242242916875039
SK-MEL-28,11222830,1.7175848193972325
OAW28,656346,0.8948255988542453
SF539,selumetinib-BRD-A02303741 (4-1 mol-mol),4.342387271248252
SNU-119,11234052,4.141539950400205
RT-4,11626560,2.0350958135834656
RT-4,60750,-4.938890545189148
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
Panc 02.03,1750826,-0.0877771412327358
Becker,6450551,3.994700694716569
KMS-12-BM,613753,2.6976812863702277
H-STS,3081361,2.065492281733806
KE-39,1566236,2.837512341107075
RERF-LC-MS,11222830,1.7620759794741472
ChaGo-K-1,11955716,-2.075681705170589
EHEB,675434,4.751173059410473
HOP-62,2842253,6.129246689275758
KE-39,11455910,-0.1151631297895284
YD-38,3689413,0.3954861349850884
BT 248,9967941,3.931710866923424
NCI-H929,71466578,2.486095138204317
BT 328,9908783,5.49619417239086
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
SK-MEL-28,23725625,5.112081717822141
TE 441.T,52947716,-7.7315592116789
SF539,11317348,2.653231871522483
NCI-H2030,123631,3.869005003693507
BT 248,11257553,3.3794437157400754
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
KYSE-450,71304818,3.197699947963966
KMRC-20,4261,2.986732904038728
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
SNU-1077,5738263,3.1464059503037576
OAW28,24785538,1.1869022382798196
Mono-Mac-1,6918878,0.1376589659678193
KO52,11955716,-1.8953160699263083
KO52,65064,5.236519181387881
KE-39,445643,4.20721403949293
RERF-LC-MS,26596,-1.2372341703529914
SNU-216,5470400,1.1191844243922604
RERF-LC-MS,5566,3.05978093065268
YD-8,16038120,0.5633322906687026
BT 248,54454,4.901618168416747
Lu-65,119182,2.80605755326457
Mono-Mac-1,46398810,0.3910224062096548
AU565,73707398,1.1644887368044523
OE33,vorinostat-navitoclax (4-1 mol-mol),1.1238349202976667
MIA PaCa-2,6918837,-4.665998901916337
MIA PaCa-2,11228183,3.414312638187762
ACC-MESO-1,16725315,4.549788243222949
AsPC-1,135440466,2.1679547773967314
RKN,148198,-1.0178445286580065
HuT 78,54618305,4.369358935790669
KO52,10302451,3.962918157421803
HOP-62,5702613,3.604813520455167
SK-UT-1,doxorubicin-navitoclax (2-1 mol-mol),-1.417611513602161
Mono-Mac-1,15953870,2.971889199477423
PE/CA-PJ41 (clone D2),3854666,3.9258785658494166
SNU-213,1641662,3.634972560428031
HEC-108,148198,-2.2464200337513587
NCI-H929,6918736,-2.069198249683734
TE-14,9935249,3.117284410933106
AU565,3676137,4.605193047317769
ESS-1,23635314,-3.6853445659402704
SNU-423,46926350,-3.9937351080347314
NOMO-1,9935249,2.770043096032674
NCI-N87,54454,3.669804409798402
HSC-3,navitoclax-birinapant (1-1 mol-mol),-1.4061179827525565
Ri-1,124202324,-0.3559734542715176
MIA PaCa-2,156422,4.184482659143903
AsPC-1,9926054,1.8957621767397328
Karpas-422,5746,0.513145379443875
SW1783,675434,4.251921967331538
JHUEM-7,23939,4.409621105076689
Lu-65,262093,3.3965218788249407
KE-39,3634881,3.3710219028006474
HCC2108,124202324,2.908828368060783
SK-MEL-28,56946209,0.4976009870921759
SNU-423,selumetinib-JQ-1 (4-1 mol-mol),2.511686996120453
CML-T1,BRD-K03911514,3.1384749532861234
KO52,216468,2.9064188892685383
SK-MEL-28,selumetinib-piperlongumine (8-1 mol-mol),1.8874017474559768
ACC-MESO-1,JQ-1-vorinostat (2-1 mol-mol),1.9444643692658088
NCI-H196,9868037,4.869553170308075
B-CPAP,54619267,2.2660883824751337
AsPC-1,9907093,4.363482739155403
Becker,71304818,1.6005732292475567
NCI-H2030,54454,1.7234672206469932
KYSE-180,135398738,4.479498150489159
KE-39,4259181,-0.84210776373342
TE 441.T,5281321,-3.2567101399905964
L3.3,135421197,2.5730452840447415
L3.3,4096211,2.2417011569185763
HCC2108,241158,3.0824386157377197
B-CPAP,44259,0.6950106705233007
SNU-1077,11396600,4.998092576249027
RT-4,36314,1.420570755930605
KYSE-180,107985,-3.532250408088534
SF539,400769,-1.0115362811049124
LXF 289,44589607,3.4320685896186585
YD-8,carboplatin-etoposide (40-17 mol-mol),3.699189794658081
KO52,16725315,3.1980251151125705
EHEB,60700,-2.619794830780626
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
RKO,135398516,4.318914396092429
NOMO-1,17755052,-0.2814114025249274
SNU-423,44202524,2.0073707598305717
Kasumi-2,3136844,3.733604332390159
RT-4,carboplatin-etoposide (40-17 mol-mol),3.317167056326169
SNU-886,9915743,1.7822621128192635
RT-4,vorinostat-carboplatin (1-1 mol-mol),3.924557304364806
OAW28,5281321,-1.4060991234994806
AU565,46191454,1.308540851634407
SK-MEL-5,3543504,4.4234969279720895
BT 248,11228183,2.0159399448324065
KO52,44462760,2.8997426516295617
NCI-H2030,262093,3.6307250181599215
SF295,11222830,2.002595135391655
L3.3,11964036,1.0452508880612652
MJ,24779724,5.157647123549832
KE-39,1641662,4.193135241199752
HCC2108,11960529,3.759811240772432
Becker,11222830,2.6019107885979635
KYSE-180,11640390,4.050800421029737
KE-39,1750826,-2.36387280589116
EHEB,56946209,-4.4781864641183065
MIA PaCa-2,24748573,2.471671606965887
AsPC-1,36462,3.6552458214160506
SNU-216,702558,4.895818993514928
ChaGo-K-1,49793307,-4.975701491282376
BT 248,72199292,1.1105829108074048
SNU-886,72199292,0.8312064221987397
HSC-3,9915743,0.268265478867946
ChaGo-K-1,17755052,3.6386676398619224
Ri-1,11625818,-4.483334986870143
SNU-213,6918837,-1.773615773856713
MJ,piperlongumine-MST-312 (1-1 mol-mol),1.1519621120420176
YD-38,4261,1.9941406880799275
PE/CA-PJ41 (clone D2),11707110,-0.8098927019350898
RKO,6852167,3.601912647929868
BT 328,selumetinib-tretinoin (2-1 mol-mol),5.411953573942954
Lu-65,selumetinib-piperlongumine (8-1 mol-mol),2.3460237733143106
RERF-LC-MS,327653,4.17889189356682
NCI-H1339,24797083,1.4150886054909655
LMSU,5287969,-1.920405728904364
SK-UT-1,2858523,3.0356672469783
AsPC-1,71680916,4.418583351869457
HEC-108,decitabine-navitoclax (2-1 mol-mol),0.2916022830293501
WM793,3025944,4.634648353889454
OAW28,613753,3.2856198284724742
Lu-65,6918736,-0.6279560102878885
Lu-65,11167602,5.906692389190635
KMRC-20,3503,3.139785484201302
WM793,JQ-1-vorinostat (2-1 mol-mol),2.1043160686090174
Lu-65,6918328,0.9220320643754802
KE-39,piperlongumine-MST-312 (1-1 mol-mol),2.040458418548574
SNU-119,656346,2.524643522978163
Panc 02.03,16741245,4.354855972582246
BT 248,122327,5.08009478305936
Panc 02.03,4521392,4.25988041093388
B-CPAP,selumetinib-PLX-4032 (8-1 mol-mol),2.742765597384798
KMS-12-BM,salermide-PLX-4032 (12-1 mol-mol),4.711885987308765
KE-39,52947716,3.3015192136458205
JHUEM-7,675434,3.8524415825681193
RKO,25183872,-1.1635703485572924
OE33,5287969,-1.9094288433640256
SNU-213,16736978,1.6823342314211165
SK-MEL-5,400769,-0.4151349609753891
BT 248,53392493,1.7075191079379444
RKN,20959075,-2.033811748726601
MIA PaCa-2,71680916,4.379626223011951
HOP-62,11222830,1.3014701308472565
RERF-LC-MS,3384730,3.247206310046507
KO52,46224516,1.1439524692050589
KE-39,219104,3.854039065759246
TE-14,25154868,4.8719382106388744
NCI-H196,3634881,3.1207995201203285
Kasumi-2,374536,-0.2175337956908027
SK-MEL-28,11626560,2.4011846012689424
HOP-62,54626689,3.8543822457381687
RT-4,168312962,1.4764557241805851
Hs 611.T,135411,0.3015901655387148
SNU-216,9908783,3.7818471710413606
HuT 78,5328940,1.35372142133129
KMS-12-BM,400769,-2.0250605176070864
HuT 78,10231331,-3.0866153075416376
SK-MEL-28,3025986,1.0141621518652342
BFTC-909,54649381,4.487285574329416
GOS-3,241158,4.584939515140501
HuT 78,navitoclax-pluripotin (1-1 mol-mol),-0.0445825989521908
SK-UT-1,135421197,2.4956722116312813
Mono-Mac-1,erlotinib-PLX-4032 (2-1 mol-mol),1.6620082119632882
LXF 289,10231331,2.4249622135671824
SNU-423,9866186,1.8570452912107576
BT 498,676352,2.3132532098483685
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248
KO52,46843906,1.029937825595367
Mono-Mac-1,11612883,1.2269352855269329
SNU-216,53232,1.858905103984356
NOMO-1,11152667,-1.8753376491976492
KMRC-20,3815108,3.353399483495532
Kasumi-2,151289,0.8385264971723331
HEC-108,46398810,3.0484074002567287
SF539,24775005,3.2878443565215987
Lu-65,46215462,1.222328166617798
KE-39,637858,2.1285067674718374
Hep 3B2.1-7,doxorubicin-navitoclax (2-1 mol-mol),-0.2796093527142125
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
NCI-H929,5470400,-1.7946579824155076
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
Becker,675434,4.855217201879122
AsPC-1,135421197,1.8824248695595285
BT 286,5280436,3.4211846964985937
KE-39,tanespimycin-gemcitabine (1-1 mol-mol),2.3625667461042363
RKO,42642645,1.3055497818976145
GOS-3,24964624,2.7234427755560233
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
KO52,4477,0.8813587896449887
NCI-N87,135875424,4.206412745126992
SK-MEL-28,73707398,1.5724586228934123
KO52,6852167,2.1234945146220645
Mono-Mac-1,176870,1.794271492997917
BT 112,53495165,-3.2644950718857255
NCI-H1339,16659841,4.177024509515593
RKO,3384730,1.0492755436091918
SNU-216,216345,4.791407156997153
KO52,54619267,3.343465510835603
KO52,11228183,-4.013409516363687
AsPC-1,53392493,3.5744228182767164
TE 441.T,11427553,0.678900025478344
MIA PaCa-2,1716436,3.209523428737418
RT-4,25102847,1.6194464271831264
Kasumi-2,11455910,-0.3707966959989963
AsPC-1,9926054,1.8957621767397328
NCI-H196,66577038,4.220953948603063
AU565,44607530,-0.2063452249558506
Karpas-422,54596558,3.601826483825698
OAW28,4261,1.5275003221448853
NCI-H2030,16115403,-5.109862467449794
Kasumi-2,10127622,5.115736544584973
L3.3,3825829,3.356100526361819
BT 498,24180125,4.887627247892678
NCI-H929,11152667,-0.508669926836867
AsPC-1,5479543,3.7451312348556582
Ri-1,10385095,0.3591008967084118
SNU-213,12003241,-1.127561281071067
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147
HuT 78,1716436,2.3325786548339207
OAW28,73707398,1.2451215877479735
Ri-1,24951314,-1.7836482207225228
MIA PaCa-2,9549297,2.915653478367295
Namalwa,56963564,-0.1426634179014898
Kasumi-2,68056272,3.4308739954935867
NOMO-1,16038120,-0.1786929053902652
OAW28,11214940,1.4072727029323666
Mono-Mac-1,216345,3.019133822225676
WM793,9840324,5.828227085394811
KYSE-180,168312962,3.1351492164159045
Panc 02.03,36462,3.4500230117265933
BFTC-909,11167602,2.8757137848929006
HEC-108,10127622,5.316186973162969
HOP-62,46224516,2.895420651410814
LXF 289,15983966,-1.3187435990338214
GOS-3,72193861,3.4413196800383044
NCI-H1339,4096211,2.291996517068488
Becker,25102847,2.1724805944053975
Karpas-422,4259181,-1.4276330915263615
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
ChaGo-K-1,11228183,3.5565369410830887
LMSU,675434,4.968873655762188
WM793,24797083,1.5845720068425453
GOS-3,docetaxel-tanespimycin (2-1 mol-mol),-1.4336653490933862
EHEB,400769,-1.1131056733057492
BT 248,4378219,1.4454405763629643
PF-382,16038120,-0.1734810985157941
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
Karpas-422,9908783,4.557264022303007
TE 441.T,10302451,3.78756460057488
NCI-H209,navitoclax-MST-312 (1-1 mol-mol),-1.744735354858028
BT 248,168312962,0.3799536225395565
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
TE-14,60700,-0.2266801281432034
PE/CA-PJ41 (clone D2),24180125,3.647059315463406
EHEB,vorinostat-navitoclax (4-1 mol-mol),0.5492722372244424
SF539,702558,3.162113771527059
MIA PaCa-2,44202524,1.484255372060884
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
Panc 02.03,1242560,3.876690059869664
WM793,72193861,2.0745792283120084
NCI-H929,9549297,1.69378915829561
MJ,decitabine-navitoclax (2-1 mol-mol),-0.3739812334084919
KO52,36314,-6.8423574459706025
Hs 611.T,2749,-1.7253515810899955
HOP-62,11626560,2.088889257155472
BT 248,5351362,1.0725587198101878
SNU-423,54626689,4.589502893592808
SNU-1077,16720766,-1.5512387650039812
Ri-1,52912189,-0.453209199025633
HEC-108,445455,5.031008976461082
B-CPAP,5978,-2.928384954309986
LXF 289,JQ-1-UNC0638 (2-1 mol-mol),0.6373974931870546
BFTC-909,44507138,2.8704731321552734
NCI-H929,72376,-2.0403577805803637
SNU-1077,89928392,2.605284731621756
Becker,5978,-2.9697287765936267
SK-MEL-5,5328940,2.4152084388950863
SNU-119,452548,0.641037029070195
Karpas-422,9935249,3.5194679685123695
NCI-N87,2749,1.4538564926114168
SNU-1077,selumetinib-navitoclax (8-1 mol-mol),2.57437827780129
BT 328,JQ-1-vorinostat (2-1 mol-mol),3.553838421661415
PE/CA-PJ41 (clone D2),42642645,1.5712136673163746
TE 441.T,613753,2.064133623362826
BT 498,327653,3.5489603001727477
RKN,16725315,3.256745916563384
BT 328,navitoclax-pluripotin (1-1 mol-mol),-1.2977497604117467
NCI-H929,2858523,2.982891394222708
TE 441.T,46215462,1.3266046767366175
LXF 289,11396600,4.152956454399736
JHUEM-7,9915743,2.288162918918336
Kasumi-2,11647372,-1.94314797775666
ChaGo-K-1,11719255,2.388380161244114
NCI-H2030,44507138,3.9074279242795744
RERF-LC-MS,246676,4.480243243269967
BT 498,5566,3.4106844889366523
OAW28,25195348,5.036760517156048
SNU-423,9936388,-4.810408284387772
HEC-108,44197249,3.927114018352238
KO52,5978,-3.230844863320846
NOMO-1,136227924,2.5449106490851263
BFTC-909,15983966,-4.834157449814871
ChaGo-K-1,969516,2.4869278268653163
HuT 78,25126798,3.93002512253093
BT 112,374536,1.8950859806063296
YD-8,11626560,1.5530364177818132
SNU-1077,46907787,0.7852146377897988
YD-8,65064,4.498532470774199
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
HuT 78,3825829,4.013992283960839
RKO,168313200,3.1169425006108455
Namalwa,5282054,2.488758086873497
GOS-3,5738263,2.3320703610233724
ESS-1,448949,2.571296753427842
LMSU,3825829,5.912113214968355
NCI-H196,vorinostat-navitoclax (4-1 mol-mol),2.1821758339508386
SK-MEL-28,1566236,1.6963201581644038
LXF 289,969516,2.6399649875984355
Becker,219104,4.4729058314747565
TE-14,navitoclax-MST-312 (1-1 mol-mol),1.4294421973877265
KYSE-180,107970,2.4041035075192196
LXF 289,10302451,1.735451917587997
YD-8,6438330,2.2083353285168377
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
Becker,5280436,0.2916845727306569
SW1573,3062316,2.075650426956439
SNU-213,51039095,3.053564627716872
Ri-1,6852167,-0.591407289651703
LMSU,12001922,2.4559246423075707
Lu-65,11455910,0.1308260352372195
BT 328,10427712,5.978304580808892
SF539,11234052,3.1104537569749353
MIA PaCa-2,126941,-4.274207418052814
GOS-3,135999136,4.682109520485855
SNU-423,12001922,2.3385317619154353
AU565,1239801,6.39587237663574
NCI-H196,53232,3.10060239776482
RKO,676352,2.3070338313311547
SF539,navitoclax-pluripotin (1-1 mol-mol),-1.4182272937250473
Ri-1,2708,3.183708199317031
NCI-N87,124202324,1.1856737577999816
Kasumi-2,JQ-1-MK-0752 (1-1 mol-mol),-0.4470190343146605
Hs 611.T,25161177,3.714857639299869
LMSU,5113032,4.833258964444667
BT 286,71304818,2.141622975364479
YD-8,568763,0.5213428887941817
RKO,54454,4.6965621210229225
LMSU,44491742,4.063120482610564
KMRC-20,3062316,1.6707904711783064
Ri-1,24753719,2.417177193104349
ESS-1,3689413,-0.979855371465586
AsPC-1,11964036,1.5618628535664978
KE-39,24180719,4.116999771545502
YD-38,5280436,4.585818685288783
KO52,151289,-0.2495262689960944
Kasumi-2,11238147,1.8873340406507049
Karpas-422,10026128,4.471871279969492
KMS-12-BM,44589607,1.1628348529963377
Mono-Mac-1,644241,2.275828690099689
Mono-Mac-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.6474160384820955
HOP-62,6852167,3.1179431190301226
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
PF-382,44507138,1.103120922160699
BT 498,10184653,2.419934801281735
NCI-H929,44632017,1.43603243468148
Karpas-422,67156097,-1.5831947892164298
NCI-H196,9927531,5.55374615852481
AsPC-1,5281672,6.419333790815674
YD-38,12003241,-0.5056624439731239
NCI-H1339,5351362,1.1725984936880274
KE-39,10231331,4.477976749120646
PF-382,400769,-1.377370522308466
NCI-H929,49766530,-2.4737600180853385
Ri-1,6918837,-5.1970473220815965
PF-382,452548,-2.9455036686626657
HEC-108,11507802,1.3993540262685686
B-CPAP,60700,-0.0698828360303767
KMRC-20,10074640,3.028506289108157
SK-UT-1,6450551,2.944918696564172
AsPC-1,123631,3.3144447888973048
YD-8,4477,1.1292057160395828
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
PF-382,11609586,2.2064607585026006
CML-T1,16115403,-5.689263243746957
SNU-213,72193861,4.636092164190722
RERF-LC-MS,25262965,-1.1343637554659964
Lu-65,24821094,3.811678046554743
RKO,44632017,0.9673312213076444
BT 112,54678924,1.7826120968253354
KLE,44185566,2.7760403729820085
LMSU,10113978,1.557712519717613
AsPC-1,24964624,2.5492070232527424
Karpas-422,6918638,-0.9922508328121828
SNU-423,53301938,4.291386023792434
MIA PaCa-2,11707110,-3.540833689463187
Namalwa,25102847,2.0079159113458416
NCI-H196,17759555,3.3296273563754366
NCI-H1339,16736978,2.50497962887706
Karpas-422,9967941,3.787920675391452
KLE,159324,3.6720597167388
Hep 3B2.1-7,5282054,4.195654910352121
KMS-12-BM,12003241,-2.27657533610394
HSC-3,6918736,-2.0241587603134468
LXF 289,16736978,1.6084503302226174
YD-8,4705,3.8146154447521146
Lu-65,44566777,0.2365389638707438
BT 320,3062316,3.917549487062472
SW1573,5281321,-2.072955292880288
SK-UT-1,3854666,2.1786369520498283
AsPC-1,81146,4.947223766743442
AU565,400769,-0.800888344050601
KYSE-180,44259,1.7448132984126952
KLE,5470400,-2.677220539970202
GOS-3,135875424,4.516628943420056
LMSU,135440466,2.4580470994052916
LXF 289,753704,4.962227230589067
TE-14,151289,1.2863290145875046
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
BT 248,2858523,2.3138600326756436
NCI-N87,10302451,0.4744399528749561
AU565,11455910,2.266336610800082
BT 328,9903786,4.817171686681598
Panc 02.03,637858,2.766769284687194
KE-39,9952709,5.01466122235801
PE/CA-PJ41 (clone D2),119607,6.048359521662391
SNU-213,159324,3.5982392765945344
IST-Mes1,9840324,6.735519666210419
SW1573,53495165,2.229023421141798
Kasumi-2,71466445,1.815897736576068
CML-T1,15983966,-4.817800919639036
Panc 02.03,23725625,6.172373492037936
Hs 611.T,4378219,1.8492709684076516
NOMO-1,24821094,3.1222382635594967
NCI-H929,vorinostat-navitoclax (4-1 mol-mol),1.516172419894528
Hs 611.T,216239,1.7794585451064322
KMS-12-BM,1239801,3.0053615870296753
YD-38,5311281,4.380428486061311
ChaGo-K-1,15983966,1.9276890630052224
Lu-65,24856436,-0.4374218733087953
KMRC-20,23939,4.421386297224866
HOP-62,49846579,1.8418614881366409
NCI-H1339,56649450,3.8809889102274777
SNU-1077,23725625,5.509681038807162
HSC-3,44507138,1.907572830390568
RERF-LC-MS,46907787,3.883745984979501
SK-UT-1,carboplatin-UNC0638 (2-1 mol-mol),5.634306420745063
Panc 02.03,3062316,2.5231792980774
TE-14,BRD-K55473186,3.7462141776356783
HCC2108,navitoclax-MST-312 (1-1 mol-mol),1.0917424387869863
JHUEM-7,9903786,1.8726211891462523
H-STS,erlotinib-PLX-4032 (2-1 mol-mol),4.123094127064452
SF539,4378219,1.830086902499326
Lu-65,462382,0.8396815057149729
L3.3,11626560,2.44177024695359
SNU-423,selumetinib-piperlongumine (8-1 mol-mol),2.5953943474884382
AsPC-1,25062766,3.1635616497742283
EHEB,navitoclax-pluripotin (1-1 mol-mol),-1.9165707205627271
BFTC-909,5566,2.8568699448622263
TE 441.T,5287620,1.2195653034476974
Karpas-422,36314,4.062786595955015
L3.3,ISOX-bortezomib (250-1 mol-mol),1.440349868344241
Becker,2729026,3.1227212581970676
YD-8,421610,4.166965318185822
RERF-LC-MS,46843906,4.323049782377064
BT 112,49793307,-3.616736826753609
YD-38,serdemetan-SCH-529074 (1-1 mol-mol),1.8475478354025596
YD-8,654092,-0.8686607010204063
AsPC-1,11234052,4.540853045838434
YD-38,676352,3.0652558990883314
KLE,5311,0.8745221025044583
HOP-62,10127622,3.013635555271906
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
ESS-1,15953870,4.251182517456194
TE-14,10385095,2.0741734466244424
RKN,65628,4.337575078598336
Mono-Mac-1,3503,2.12876225643187
BT 320,64971,4.224921006781723
SK-UT-1,3825829,4.314395004241866
OE33,selumetinib-decitabine (4-1 mol-mol),3.309412318087147
ESS-1,3634881,3.263518505021081
YD-38,56946209,-4.099178938106398
BT 320,135440466,3.8135283916877625
ESS-1,3038522,2.815775388267638
LXF 289,11609586,2.9430338892136354
KMRC-20,24964624,2.981124341507829
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
PE/CA-PJ41 (clone D2),24901704,5.573857851352778
MIA PaCa-2,2858523,3.008435530858324
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
ChaGo-K-1,44566777,1.853342184320177
HuT 78,5281321,-2.4358925400623797
ESS-1,11364421,-5.252170636700316
NCI-H1339,5328940,2.364550013342955
ChaGo-K-1,11427553,2.807543556240953
Ri-1,46398810,1.4854612845408548
NCI-H929,10410894,3.741769756077017
BT 286,72193861,1.711789672532825
PF-382,44819697,-3.258888383810068
EHEB,11507802,1.0533498675891693
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
YD-8,60700,2.5320757446413222
Becker,36314,4.027610361260836
CML-T1,ISOX-bortezomib (250-1 mol-mol),-0.7676441178316211
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
BFTC-909,168312962,2.436518653578315
BFTC-909,23635314,-1.3241610546701814
SNU-119,441298,2.074764290405071
SK-UT-1,44462760,4.294065343841732
TE-14,6505803,-1.7378811047388565
Namalwa,3025944,3.875856836212888
AsPC-1,5566,3.190935368909542
AU565,374536,-0.7311314672583101
SNU-886,10074640,3.87726874978677
SNU-216,107985,-4.706172049082236
NCI-H1339,1716436,3.037375145615222
MIA PaCa-2,9825149,2.044745621395805
RERF-LC-MS,71304818,2.1402027844306986
TE 441.T,11317348,4.029228044972443
KE-39,11257553,6.200460761986464
SK-MEL-28,6184667,2.5329996148763163
HOP-62,2749,1.4001550595714545
BT 498,25183872,0.1229262427220635
KO52,selumetinib-vorinostat (8-1 mol-mol),-0.9100667251350252
JHUEM-7,44498493,4.377210363637701
YD-8,15547703,3.876361457328563
SNU-213,9936388,2.0534039631402994
BT 328,24821094,3.7290564258342904
PF-382,3543504,2.094275160861191
ChaGo-K-1,46199207,2.6380266258494784
SNU-1077,5278396,3.261977388263693
Ri-1,24180719,3.165444216400886
KLE,3815108,3.3721583314849695
BT 112,11640390,4.0217292152504
Ri-1,9911830,1.4351255803096743
HOP-62,9825149,2.2210675279898897
SF295,17755052,2.9611170281076613
NCI-H929,23635314,-2.487103154782492
IST-Mes1,387447,-3.626604128124616
SK-MEL-5,46843906,3.395392152130591
Kasumi-2,241158,2.967162139629707
NCI-N87,11609586,1.5678533381622328
SNU-216,135928012,4.770569050642353
Karpas-422,3038522,3.6277226222899697
HCC2108,2113511,6.206167164976693
Kasumi-2,119607,5.143919911790516
NOMO-1,71304818,2.372593058500035
SNU-886,decitabine-navitoclax (2-1 mol-mol),-8.577955246496893
NCI-H2030,54618771,3.292263250244386
ESS-1,3062316,-1.8450260242136765
Kasumi-2,104842,-5.6475576104946565
ChaGo-K-1,10296883,3.916138257208464
BT 286,11396600,2.040730461375106
LXF 289,4259181,0.8555931132792622
AsPC-1,19582717,4.191920632274723
SNU-886,BRD-K27188169-navitoclax (2-1 mol-mol),-4.5731831283745095
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
Namalwa,9956119,3.303198891097498
EHEB,44259,0.6162293307337288
SNU-423,11977753,-2.3250413939058663
RERF-LC-MS,25062766,1.7296886540377192
YD-38,400769,-0.713411362177007
SF539,46907787,0.2074640579250286
NCI-N87,53232,3.890681715203442
KMS-12-BM,1641662,2.032988332793844
NCI-H1339,42642645,1.6149753620501943
SF295,400769,0.0619568045666215
Panc 02.03,676352,3.0262590525496895
JHUEM-7,5335621,4.966853078493816
ACC-MESO-1,9803433,3.719754418164016
SF539,6918328,-0.3520383633660662
YD-8,selumetinib-PLX-4032 (8-1 mol-mol),2.7404084947043077
HCC2108,71466445,4.412506412183148
OAW28,4521392,4.353680801577448
Hs 611.T,24821094,0.9445558353923768
TE-14,navitoclax-PLX-4032 (1-1 mol-mol),4.073268000219647
Ri-1,4521392,3.929629680901149
SF539,9887053,4.243548054334724
B-CPAP,51039095,2.4263361872279456
AsPC-1,54618164,4.187549957668634
BT 498,135423438,1.8216974125096568
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
OAW28,51037431,5.214608262969992
KE-39,136227331,5.536038659908766
LMSU,969516,2.7485422702500215
ESS-1,445455,4.4559986013916815
EHEB,148198,-2.104475544842142
KE-39,16013152,4.246331494143776
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062
BT 320,24771867,4.382883452747231
B-CPAP,11612883,2.7358118615928366
SNU-423,9927531,5.196680575825113
EHEB,135984461,4.428627188495882
KE-39,2874250,5.478930029290199
YD-8,selumetinib-tretinoin (2-1 mol-mol),6.635581773153188
NCI-H929,439501,-2.3111413664478513
SNU-213,11964036,0.9260625837749188
Hs 611.T,54626689,4.8749619996750475
SF295,24772860,-1.4622312055585494
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026
NOMO-1,136227331,3.913043208951298
NCI-H929,5284616,-3.61642631777644
YD-38,702558,5.795263485649205
Karpas-422,11977753,-4.357975408639603
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057
SW1783,10074640,3.756288001729743
SNU-216,navitoclax-birinapant (1-1 mol-mol),2.3534531780783667
KMS-12-BM,54454,3.3056700898570277
NCI-H1339,serdemetan-SCH-529074 (1-1 mol-mol),2.9330051590353583
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
SNU-216,11497983,3.958297162007762
SNU-423,644241,4.521136945345214
SK-UT-1,54678924,1.6137433728432382
Namalwa,24180125,2.5255693450157697
ACC-MESO-1,9911463,4.148709224081578
BT 112,5281321,0.9074041531401555
Ri-1,100016,4.838113149785687
SNU-1077,71304818,2.134778117100761
Lu-65,36462,1.7650112764581103
NCI-H1339,3689413,0.3064961832206241
Lu-65,salermide-PLX-4032 (12-1 mol-mol),5.2610627077792635
ChaGo-K-1,16720766,0.9883407566157564
TE-14,44462760,4.457889131283873
ESS-1,9840324,5.937640700336064
TE-14,49793307,-2.215277168072713
KE-39,675434,4.431531195571141
LMSU,53392493,3.125828973482696
H-STS,168312962,2.3265280063565177
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
LXF 289,2708,6.094251503540483
YD-8,11656518,3.459144048405474
YD-8,selumetinib-MK-2206 (8-1 mol-mol),2.9104774003059415
SF539,9868037,3.16067122997076
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
KE-39,3676137,4.663329391632706
SK-MEL-5,262093,3.0272532373657848
HOP-62,676352,2.0582091635847704
JHUEM-7,53392493,1.8634549643352745
Karpas-422,vorinostat-carboplatin (1-1 mol-mol),1.8240625772492975
OE33,9840324,5.824552886504982
AU565,1242560,3.5510894145829286
KLE,89928392,0.0725246038766898
SNU-213,4259181,0.9824949084518934
Hs 611.T,25102847,2.1388544065059687
NCI-H2030,11427553,3.3992931563100615
SK-MEL-28,5329102,2.8419143811814913
RT-4,17755052,3.016553259782671
LMSU,crizotinib-PLX-4032 (2-1 mol-mol),1.7173193927866348
HOP-62,5351362,1.162394565524452
ChaGo-K-1,11175137,2.6738271502007183
HuT 78,322968,0.3476030188480727
LMSU,26596,2.3008598244356935
OE33,docetaxel-tanespimycin (2-1 mol-mol),0.0839374715830857
TE-14,119607,5.463307114433471
AU565,11175137,1.8234152921093247
ChaGo-K-1,6852167,1.9816298194521569
H-STS,selumetinib-JQ-1 (4-1 mol-mol),1.7397587853483405
Mono-Mac-1,3136844,3.2810332522096575
Panc 02.03,5460769,1.6540560754425335
NOMO-1,5978,-2.430694050184869
SNU-213,613753,3.1734091192238503
KO52,52947716,2.706684159725711
KYSE-180,SNX-2112-bortezomib (250-1 mol-mol),-2.01002465261766
BT 498,46224516,2.4804026956741736
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
Mono-Mac-1,156414,-0.6734994653601284
SNU-216,11213558,0.8182724505522939
CML-T1,11455910,-0.3388293365451558
BFTC-909,3025986,-2.0399601309440336
KE-39,10074640,3.0601585781096268
CML-T1,2945648,2.7633194270668877
L3.3,15953870,4.520919895902943
YD-8,135398516,2.8864583978084473
RT-4,navitoclax-piperlongumine (1-1 mol-mol),1.919426217940122
BT 320,24821094,3.905918214519909
AsPC-1,25062766,3.1635616497742283
SNU-119,5479543,5.507463423789633
HOP-62,644241,3.1135369440994767
LXF 289,53495165,1.0389398894889437
Panc 02.03,216468,3.8655539989600176
BT 328,6436223,-4.925516012264063
SF539,serdemetan-SCH-529074 (1-1 mol-mol),2.2539127331776077
AU565,9840324,5.90463961449661
GOS-3,44241473,4.447421169667303
HuT 78,5470400,1.1962895680163173
TE 441.T,54639701,4.699929542545323
BT 112,JQ-1-UNC0638 (2-1 mol-mol),2.705069065658094
ChaGo-K-1,selumetinib-navitoclax (8-1 mol-mol),4.9648562061893395
NCI-H929,72193861,0.6140343557798097
NCI-N87,100016,7.118039999797619
KE-39,6918837,-3.138673306335868
OE33,JQ-1-vorinostat (2-1 mol-mol),0.5031627227324542
RERF-LC-MS,66577038,3.051572744120707
Namalwa,49766530,-1.8902019897608628
SK-MEL-5,5460769,5.96903783579764
KYSE-180,135398516,2.6781533642805933
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
LMSU,89928392,1.5528019914558755
B-CPAP,2858523,3.8252210780622753
SNU-213,16720766,5.717733687016699
Mono-Mac-1,72967,4.124255908419064
B-CPAP,67156097,-1.5064504611567109
NCI-N87,24856436,-1.0645338149753525
SW1783,11396600,4.918648417758992
SK-UT-1,44185566,3.0890330795466125
L3.3,12003241,-0.3315333583144895
SF539,2874250,6.295568507703997
Hs 611.T,BRD-A02303741-navitoclax (2-1 mol-mol),1.1146059217016966
Ri-1,9967941,2.161012496352715
SF539,56646779,2.3266434385228667
NCI-H196,11455910,1.326317749713535
WM793,4521392,4.34292186054555
Namalwa,carboplatin-etoposide (40-17 mol-mol),0.1635376118774288
KE-39,9866186,5.4228444415850525
SNU-216,9933475,1.608495726084367
OAW28,vorinostat-navitoclax (4-1 mol-mol),-0.0627411194762238
Mono-Mac-1,selumetinib-tretinoin (2-1 mol-mol),2.434810789058858
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
KYSE-180,11152667,-0.8702132503194517
Lu-65,51039095,3.031508710595903
Kasumi-2,25161177,3.916701757551495
KO52,crizotinib-PLX-4032 (2-1 mol-mol),0.3620509137021238
HSC-3,135398738,0.4499542950984881
NCI-H929,151289,1.2109794778223528
AsPC-1,24753719,4.618559637878285
Hs 611.T,11640390,3.307087841181284
GOS-3,3634881,3.062788872748443
SK-UT-1,17755052,4.751735459117679
HSC-3,387447,-4.149874850312051
KO52,9935249,-1.4350246650055785
SW1783,24779724,3.9128595943603544
KMRC-20,6450551,3.0929190017182058
KMS-12-BM,637858,0.99115660334439
RT-4,9967941,2.350248504826165
Lu-65,135659046,2.9879940161565206
YD-38,24180719,4.600103743095947
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177
SNU-119,11497983,3.6896133673877207
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
PE/CA-PJ41 (clone D2),3025944,5.40545678004527
HEC-108,44620216,4.0504389741939635
SNU-216,2126,4.983009808045007
MJ,11152667,-1.2121300476072767
HEC-108,15953870,3.7106591750651736
BFTC-909,3465537,1.8561429441463555
PF-382,135398516,1.2279645894951243
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
NCI-N87,11238147,1.7339284670687316
NCI-H929,24785538,-4.700293187910172
LXF 289,44819697,0.5606163889857397
SNU-423,135421197,3.0122188559971725
Hs 611.T,51037431,3.420580051721121
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
EHEB,1242560,2.6348256954742757
Mono-Mac-1,46174525,3.0671616962684336
NOMO-1,168312962,2.6221164331885003
YD-38,4521392,4.3096596325383185
PE/CA-PJ41 (clone D2),11640390,3.953492019863505
CML-T1,11964036,0.6626338262041811
AU565,54618305,4.305835133395234
TE-14,11455910,0.8853432614856256
KE-39,6184667,4.527415561727204
NCI-H1339,3062316,3.21375908835857
KO52,702558,3.3833897196407645
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
SNU-423,44137675,3.771329187315914
NCI-H196,54454,2.43861256379555
Namalwa,24978538,3.895308829975735
PF-382,3825829,3.5943460783681207
KE-39,49766530,-2.0647642539816715
BFTC-909,2749,2.0212973698927184
OAW28,10296883,4.314409366833216
HOP-62,1285940,3.1997778552050895
Becker,24772860,-1.986740443990647
OE33,11222830,1.7569805272585186
KMS-12-BM,168313047,1.7734190846374434
KE-39,11213558,4.569088998170507
EHEB,2828334,6.1224071915617735
OE33,72376,-2.0753030447695933
NCI-H1339,5746,0.6163516648320136
MIA PaCa-2,9826308,0.6670683268194105
CML-T1,navitoclax-birinapant (1-1 mol-mol),0.167080687914587
TE 441.T,25154868,5.000611195687775
RT-4,3038522,5.726431253424827
H-STS,148198,-3.664450029895992
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
PE/CA-PJ41 (clone D2),4261,2.790759894736724
Mono-Mac-1,24180719,2.2518396015404174
KYSE-180,5311281,3.969841054896334
SF295,9866186,-0.0910697648043791
CML-T1,6450551,-1.1017942434712815
KLE,3503,3.2050182631848094
NCI-H929,selumetinib-MK-2206 (8-1 mol-mol),-0.3553721950271566
SNU-423,702558,5.708440861926304
EHEB,107985,-3.431566617096362
Panc 02.03,54618771,1.0884531427161812
SK-UT-1,3503,1.0072553452312891
Panc 02.03,71466380,5.929652601038649
KE-39,10427712,4.785980320384278
Mono-Mac-1,42642645,-3.779947759429327
MIA PaCa-2,3136844,3.9100198187620223
KYSE-450,10074640,3.7244937676634735
HCC2108,54618305,4.9170237432018435
RT-4,10074640,3.33667314177338
TE 441.T,11175137,1.619787178375928
LXF 289,60750,-4.482846219959503
ESS-1,9935249,3.3777402733386617
HEC-108,51039095,3.663645596248864
BFTC-909,55508,3.078625314561866
KE-39,10302451,3.0941257531868858
AsPC-1,9956119,2.16125044927063
NCI-H196,11396600,4.033022120096851
Becker,2858523,3.0599242132907154
NOMO-1,72193861,0.7304873005319745
SK-UT-1,9840324,5.285920653944741
HOP-62,107970,2.340316246371355
BT 498,selumetinib-vorinostat (8-1 mol-mol),4.296908663159793
Ri-1,3689413,-2.346816387466721
SNU-119,2113511,5.762989771313452
HCC2108,44507138,1.6442706606036075
WM793,4788,5.954303225972929
Karpas-422,24772860,-2.5980734738396567
OAW28,66577038,2.5027239379183666
Karpas-422,46191454,-0.7986292729302961
OAW28,2828334,6.258958244852924
BT 286,selumetinib-tretinoin (2-1 mol-mol),-0.3313816649086816
Becker,2828334,6.24127035036214
NOMO-1,16741245,4.369418152152245
SNU-119,10074640,2.593103189576663
Becker,11152667,-0.0638370344727879
Namalwa,135423438,1.9520788575137753
RKO,375860,-0.2095842697906711
RKO,3062316,2.656751778030552
SF539,135659046,3.181821233210504
Hs 611.T,135984461,2.1518456912790507
H-STS,374536,1.4789763498998243
PE/CA-PJ41 (clone D2),644241,2.3238637219547904
Kasumi-2,10302451,2.501538159290375
L3.3,2858523,3.1166554672991604
Namalwa,24772860,-2.8459289590629937
Lu-65,selumetinib-PLX-4032 (8-1 mol-mol),0.9230228492906724
Mono-Mac-1,2945648,2.7963825561825204
Hep 3B2.1-7,24772860,-2.4877708229560698
OE33,navitoclax-sorafenib (1-1 mol-mol),5.131240989911406
HSC-3,5281321,-1.07888071456113
SK-UT-1,11964036,2.7372114325499055
AsPC-1,11485656,3.206693439346989
MIA PaCa-2,46174525,4.06698670372721
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
Becker,89928392,3.138737458608371
NCI-H929,16038120,-2.3089398873167872
BT 112,15953870,4.403390528576976
SNU-1077,73707398,1.6899308948113645
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
H-STS,BRD-K55473186,4.025612277112804
KLE,JQ-1-MK-0752 (1-1 mol-mol),2.9937546834772375
PE/CA-PJ41 (clone D2),445643,4.252936471702768
BT 320,44507138,4.949888097685237
B-CPAP,11507802,1.067948865191383
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636
RKO,4477,1.7070595719756474
NCI-H929,19582717,2.600948271168246
SNU-423,71680916,4.325393035834424
Lu-65,252682,6.482866894813884
SF539,navitoclax-sorafenib (1-1 mol-mol),1.515354296874044
BT 112,1317464,4.14615022758794
KE-39,52912189,1.824719595124253
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
ChaGo-K-1,73707371,4.824221553271621
CML-T1,11626560,-0.8907703496754931
BT 320,3854666,3.86904800273952
CML-T1,54619267,3.062776009775362
NCI-H929,60750,-4.1339317564443965
HSC-3,44493528,4.631982422980787
TE-14,11609586,3.0408936509554914
CML-T1,decitabine-navitoclax (2-1 mol-mol),-1.9117963719087396
RKO,9956119,3.3077949428120195
SNU-119,73707398,0.7345911888158907
SW1783,9911463,3.515685844560525
ACC-MESO-1,46398810,3.3906393593614745
Kasumi-2,4378219,6.192429128955844
GOS-3,4788,6.125814579723799
SNU-886,9884685,0.7167053677402274
YD-8,44819697,-2.7739089583765684
SF295,44202524,4.053119392508637
Ri-1,400769,-2.1174667362307087
NCI-N87,54618771,0.8863121899707505
SNU-1077,3384730,1.7373502464877797
ChaGo-K-1,4378219,2.361959907819356
LXF 289,44493528,4.295099384269069
EHEB,9887053,2.923841050224105
Panc 02.03,168313200,4.226618217059218
RERF-LC-MS,16741245,3.282184197465347
Namalwa,426756,1.9219137313726855
ESS-1,82146,4.445932191029335
AsPC-1,54613361,2.957295670472447
KMRC-20,31703,0.9785031203773554
KMRC-20,11222830,2.077538911005185
SNU-886,445091,2.7467604761461097
Karpas-422,selumetinib-JQ-1 (4-1 mol-mol),-0.3387810810596827
BFTC-909,216345,4.226804426652683
Kasumi-2,BRD9876-MK-1775 (4-1 mol-mol),0.2372012332768771
OAW28,16065773,3.4526029247448973
MJ,BRD-A02303741-navitoclax (2-1 mol-mol),1.2837915647364595
MJ,119182,-0.7805536216457877
HCC2108,5566,3.06575659173901
NCI-H1339,11955716,-2.7317911742466285
SF539,5278396,3.068667570965669
Karpas-422,10410894,3.8052707227541194
PF-382,44489675,3.595955687856044
Kasumi-2,119182,-4.8733294561059255
IST-Mes1,docetaxel-tanespimycin (2-1 mol-mol),2.3952937403433685
SNU-886,9967941,1.858584505430476
SK-MEL-5,6610355,5.037380249558903
SNU-1077,2708,5.365576184997209
JHUEM-7,4259181,0.2879228284005847
CML-T1,5284329,2.20205002414717
WM793,11626560,2.3104279907190124
SNU-886,6438330,2.3407499785849524
KMS-12-BM,375860,-0.7808796284755947
ESS-1,11707110,4.9124560181161385
GOS-3,16722836,1.9168472063673057
PF-382,6252,-3.946421345482259
OE33,4788,6.0138200333522756
KLE,10427712,3.718999940973947
YD-38,46907787,-0.5393505828045682
Ri-1,151289,-0.1682876676947949
IST-Mes1,3854666,2.0681561223579075
HuT 78,5311,-0.4427844433748262
LXF 289,89183176,5.264029999533809
Karpas-422,31703,-1.45582270104394
SK-UT-1,322968,4.5187212828437815
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
Namalwa,11167602,1.8297854280338213
TE 441.T,44632017,0.997805663061036
Ri-1,448949,1.2663271999958974
NCI-H1339,3825829,4.0280644624374435
SNU-213,6917907,-4.366757744444296
MIA PaCa-2,11167602,2.3171919978995636
OE33,selumetinib-PLX-4032 (8-1 mol-mol),2.872439488722446
Kasumi-2,9823820,3.05022407511669
Lu-65,6610216,3.857091251569688
IST-Mes1,9911463,4.127098730346426
HSC-3,44259,0.63507415156471
Panc 02.03,11955716,-1.8470517927785437
KE-39,3025944,4.4635566230619945
KLE,387447,-3.4483101569970804
BT 328,6505803,-1.1568571975604598
KMS-12-BM,54618164,3.5838118675433783
MIA PaCa-2,100016,4.223400842588871
GOS-3,126941,-1.2183252312090715
Namalwa,56946209,-6.682218305307108
BT 112,16736978,2.096742119081054
H-STS,25195348,4.556158906706763
MJ,navitoclax-pluripotin (1-1 mol-mol),-0.5584925920323
KYSE-180,5113032,5.165592461043619
AsPC-1,46191454,4.573546152494067
KMS-12-BM,66577038,2.5748125108917312
GOS-3,11364421,2.246503341599216
BT 112,241158,4.111283984788845
CML-T1,decitabine-carboplatin (1-1 mol-mol),-0.978509690631207
NCI-H196,11656518,3.2090738426987477
SNU-886,9868037,2.869419012431549
KO52,439501,-3.705469726802315
IST-Mes1,3081361,1.9096346363157353
Karpas-422,71304818,1.7040784922976946
HEC-108,126941,-2.7817702272816267
Hs 611.T,46224516,0.7122499414823305
PE/CA-PJ41 (clone D2),44486219,4.283609923317521
Becker,25126798,3.953102552375253
SK-MEL-28,16065773,2.9091581541249223
EHEB,9936388,-5.642934540589324
BFTC-909,6918328,0.6354681535452512
RT-4,6610216,4.294846652425395
HSC-3,5287620,-2.9957645044589594
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
KE-39,44589607,3.0776272038529475
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
AsPC-1,16725315,5.210607806565737
SNU-1077,54618164,4.137569965283994
SNU-213,9840324,5.94367014011524
KMS-12-BM,156422,3.026990510346846
HCC2108,4259181,0.1536721114746798
SK-UT-1,11717001,5.457019686559972
NCI-H196,12001922,1.8660420195191385
LXF 289,selumetinib-vorinostat (8-1 mol-mol),2.464198116249673
HOP-62,JQ-1-UNC0638 (2-1 mol-mol),1.583491465804524
NCI-H196,9926054,2.525003076989932
ESS-1,135421197,2.603718676668537
MIA PaCa-2,46398810,1.965688525236374
KE-39,24772860,-2.1888261700101954
MIA PaCa-2,6852167,2.446025976555517
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834
KO52,selumetinib-MK-2206 (8-1 mol-mol),-0.3185685393152556
SNU-213,6623618,2.3332354524548835
YD-8,2945648,2.8008863810505873
RT-4,5566,2.9903378984967546
LMSU,11152667,0.2226803323304874
Becker,6918736,-3.597074061250567
BT 498,66577038,3.2580433340261226
AU565,5738263,3.0246848768630334
RT-4,285033,-2.016111545796812
BT 498,11364421,2.0232467845321125
Ri-1,54639665,5.943871116773062
NCI-H196,54649381,4.303776340582988
LXF 289,208908,1.975389940693236
HSC-3,carboplatin-UNC0638 (2-1 mol-mol),3.049969024774373
NOMO-1,656346,0.9377734591624955
JHUEM-7,5460769,0.024222502884872
KE-39,11427553,2.9196701777014415
ESS-1,24753719,4.181647881164435
JHUEM-7,6917907,-5.779408240081831
B-CPAP,439501,-2.790842155958922
SK-MEL-28,crizotinib-PLX-4032 (2-1 mol-mol),1.1574831287891294
RERF-LC-MS,3025986,-0.71270364092759
SNU-216,16725315,4.715473045922443
HSC-3,135398516,2.17751858320145
SK-MEL-28,44185566,3.1920858927006983
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
AU565,3503,2.743681155949089
RKO,26596,-1.341584325458414
RT-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.18220229095385
KO52,2126,4.780292619636026
HuT 78,navitoclax-MST-312 (1-1 mol-mol),0.598412445003022
Namalwa,46398810,2.631129060708828
MIA PaCa-2,3543504,3.4240638805726493
SNU-423,44491742,3.863177146863686
SNU-119,11656518,-1.0487494422596892
BT 320,135411,3.5003751238841887
SNU-423,11234052,4.663718212669009
GOS-3,107970,2.255442380434802
TE-14,2858523,3.2662108159252945
WM793,568763,-0.2625590328104358
YD-8,11640390,3.0697082624281093
HOP-62,16038120,1.067804066373853
NOMO-1,11977753,-1.9426292333262003
SF539,568763,-0.1587178935899355
Namalwa,17755052,0.9119644675745306
NCI-H1339,9915743,3.628924415446368
MIA PaCa-2,1323703,5.702291663028901
HCC2108,135411,0.8115668550852202
NCI-N87,6610216,4.734758596227503
PF-382,11238147,1.430662922581268
TE 441.T,navitoclax-sorafenib (1-1 mol-mol),0.887728471369114
OAW28,23582824,0.6142488529896691
H-STS,11640390,4.3138571775142855
YD-8,2733526,3.5062367586766836
H-STS,11964036,1.8558762688812251
IST-Mes1,4521392,4.383284740471391
NCI-H929,46174525,3.514748643502036
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
Hep 3B2.1-7,16115403,-5.404378567626671
Lu-65,148198,-3.5921377356072397
ChaGo-K-1,11455910,-0.3769194241823518
BT 498,9933475,1.803791311469253
SNU-423,409805,5.272007162134597
NCI-H929,89928392,-0.45860298805955
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
KYSE-450,6852167,3.693304163934065
SF539,11485656,1.8649737443723855
MIA PaCa-2,644241,2.2485281362376677
Hs 611.T,24951314,0.9859373233713288
ACC-MESO-1,6505803,0.753585399472996
SNU-213,2749,2.01271461042932
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
KYSE-180,409805,5.709174911109602
TE-14,11167602,2.7334128910951514
KO52,4259181,-1.031664922111082
LMSU,navitoclax-pluripotin (1-1 mol-mol),-0.1706799905389637
OE33,6184667,3.9460581178751473
KYSE-180,26596,-0.879665743021705
JHUEM-7,54143018,1.2737177342737822
SNU-1077,11238147,4.353998599384084
EHEB,107970,2.1350318268920776
AU565,9952709,2.716124716701941
MIA PaCa-2,serdemetan-SCH-529074 (1-1 mol-mol),1.810745795416243
SNU-213,24951314,1.6516092011379235
BT 286,135875424,2.624951262486574
SNU-1077,49850262,4.98017250965326
OE33,piperlongumine-MST-312 (1-1 mol-mol),1.672425698921404
SNU-216,67156097,5.132066784918468
KO52,24771867,-3.917806210376699
JHUEM-7,44137675,1.945241597383145
NCI-N87,10113978,2.582247145825502
HOP-62,107985,-3.8044998203346383
IST-Mes1,crizotinib-PLX-4032 (2-1 mol-mol),1.4798286107475835
BT 498,4378219,1.6877979414326845
PF-382,24856436,-1.472575782331219
NCI-H209,9884685,0.4313294242687383
Kasumi-2,66577038,2.680052495523132
KYSE-180,5328940,1.5841327354029733
KYSE-180,44819697,-2.483025029894288
NCI-H929,6918289,2.8956061350920796
H-STS,426756,4.2891566150656875
SNU-1077,11214940,1.023851206507241
LXF 289,3543504,4.042070583449167
MIA PaCa-2,3634881,3.25947656124529
SK-MEL-28,ISOX-bortezomib (250-1 mol-mol),1.2537607855267825
NCI-N87,12001922,1.750767235665954
SF539,16219061,3.124474327572297
Mono-Mac-1,44493952,3.7343174451902144
SK-MEL-28,2945648,3.075728962525901
L3.3,23725625,5.56548732943537
RKO,24856436,0.2423564692967549
KMS-12-BM,4521392,3.943968483954013
SK-MEL-28,56963564,3.9128786084446543
SF539,9866186,-1.1784053961495549
YD-38,23635314,-2.822192874167392
SK-MEL-5,4705,2.45435106083484
SK-MEL-28,285033,0.2575434442384768
YD-8,11964036,1.157152109498934
Lu-65,5351362,2.5034830302649302
SNU-886,11222830,1.0742925940982535
HCC2108,452548,0.5467419816970324
Hs 611.T,5282054,2.2484999312435265
MJ,89928392,1.2062541110163645
BT 248,31703,-0.7981868387763399
BT 328,9884685,2.9316032553217166
Hep 3B2.1-7,89183176,5.237319789926979
AsPC-1,11656518,2.0782041289904845
Hep 3B2.1-7,selumetinib-navitoclax (8-1 mol-mol),1.8236870784242016
YD-38,654092,-0.0694963905270349
SNU-886,navitoclax-birinapant (1-1 mol-mol),-7.871373993775583
BT 112,10410894,4.183510098776423
IST-Mes1,tanespimycin-gemcitabine (1-1 mol-mol),1.7121373731851923
KLE,5291,4.081072995426117
OAW28,159324,2.7212056331712584
KYSE-450,5566,4.0898855069679785
AsPC-1,126941,-0.909933311518488
SW1783,19582717,6.868976405767061
KMS-12-BM,10074640,2.4619415387123365
PF-382,10113978,2.3756082009494066
OE33,crizotinib-PLX-4032 (2-1 mol-mol),1.49539015166903
AsPC-1,16720766,4.029008761480653
SF539,5282054,3.5125630378284667
HEC-108,49793307,-2.56694084675293
BT 112,5351362,1.3510507237988774
Ri-1,107970,1.039511049799593
Kasumi-2,49846579,-4.472892287565064
SNU-423,vorinostat-navitoclax (4-1 mol-mol),0.9372094532636858
Kasumi-2,5280436,2.9235164089126884
Kasumi-2,57330099,4.668594265491518
EHEB,carboplatin-etoposide (40-17 mol-mol),0.7214068333239794
SF539,56973724,2.7207033026610974
AsPC-1,11609586,3.135544943212619
SNU-1077,3543504,4.1557787883322606
RKO,216345,4.0768365061219525
NCI-H196,11647372,0.2932338575732979
OE33,24901704,3.637339861643036
TE-14,71751553,4.6389654689543205
RT-4,17759555,2.661650836721078
KYSE-180,11364421,-2.9692931824369864
TE 441.T,54639665,4.381195082349918
Karpas-422,216468,2.361145468845441
Mono-Mac-1,9926054,3.1061890381784187
NOMO-1,9840324,6.741383080584752
Mono-Mac-1,135411,-1.165468414197589
SF295,135411,-0.4035877293475021
Becker,6505803,-1.1443258225494983
SNU-1077,400769,-0.3055004816783465
PF-382,16720766,-1.1055655551486072
SNU-1077,alisertib-navitoclax (2-1 mol-mol),1.6049595607856426
NCI-H2030,441298,0.3914913419109978
HuT 78,54649381,3.65840256094047
LMSU,5566,3.0603699915448015
CML-T1,44489367,4.494553632990814
BFTC-909,9936388,1.702123766125507
AsPC-1,1566236,2.844580785967763
OAW28,24821094,3.6183900250040497
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112
PF-382,9908783,6.451315520536067
SNU-119,11152667,-1.7505046185564503
BT 286,327653,3.383263992676688
H-STS,6450551,1.5253926760198298
KLE,11964036,2.71484537703424
KYSE-450,56649450,5.522708558477712
RERF-LC-MS,12003241,-0.3897829713203344
H-STS,9907093,4.221434191899145
ChaGo-K-1,7251185,2.5727888380300588
KYSE-450,446155,3.327914204468242
Ri-1,20959075,-3.551913416843835
H-STS,53232,2.3734460475104275
KMS-12-BM,3503,1.8657686630799155
LMSU,4521392,4.5371268680912715
SK-UT-1,445091,4.399813328633606
SF539,24821094,1.7680388640350837
KMS-12-BM,5394,3.997526892316944
NCI-H2030,5311281,3.3563177503628276
SNU-886,66577038,3.44647688682178
ESS-1,11964036,1.685679354186414
SF539,1716436,2.913378639025297
JHUEM-7,16065773,2.5862180470687792
Ri-1,451668,0.865663462706742
HSC-3,2749,1.7452067990842526
Namalwa,24821094,3.0030570338350153
KE-39,9936388,1.1689372039333712
YD-8,3825829,4.049048632362995
KYSE-450,219104,4.59986524517568
AsPC-1,11152667,-0.9426796832875202
Mono-Mac-1,439501,-2.692243954974466
SNU-216,135411,3.273149769706094
SK-UT-1,5738263,2.328132593934741
Hs 611.T,3689413,-2.7004104072546133
OE33,16722836,2.4111815990528624
Hs 611.T,36314,3.613162965661777
Ri-1,3384730,1.0748430565234326
KO52,6917907,-6.077503902553056
YD-38,36462,2.856164296020876
HSC-3,5329102,2.5585253388451807
BT 498,53495165,2.4848345966210443
RKN,11625818,5.974552631000589
SF539,selumetinib-piperlongumine (8-1 mol-mol),3.2935785565458424
HOP-62,9911463,3.8769302944036266
CML-T1,3634881,2.472630922180769
SNU-423,25262965,-3.8107470635875007
EHEB,JQ-1-UNC0638 (2-1 mol-mol),1.0981019184979366
CML-T1,navitoclax-pluripotin (1-1 mol-mol),-4.409543307902375
ChaGo-K-1,25161177,4.340700387322654
BT 286,12001922,0.9308288717182952
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
KE-39,6918328,-0.2708141535303604
BT 112,46199207,1.816162023423103
TE-14,675434,4.393840052258565
L3.3,1716436,3.5741303666735633
KYSE-180,serdemetan-SCH-529074 (1-1 mol-mol),2.3762708337041993
MJ,421610,3.5833092727741427
TE-14,JQ-1-UNC0638 (2-1 mol-mol),1.1497905104271977
SK-UT-1,10385095,1.6809894125740852
YD-8,6450551,2.2155909562952685
RERF-LC-MS,73707398,2.0319367406190483
YD-8,241158,4.108189803137544
RKN,24797083,0.944322820476056
SNU-886,675434,3.265808885335484
LMSU,16722836,2.691296467692663
Lu-65,44607531,1.435733537882106
RKO,60700,-0.2024014556335324
Kasumi-2,15547703,3.1022786704275394
KO52,11222830,1.115568752483846
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
SF539,25161177,5.227921335860274
Becker,135440466,2.4812333782474703
SF539,vorinostat-carboplatin (1-1 mol-mol),2.36336585394669
KE-39,44489675,3.66901218347382
B-CPAP,9936388,2.314754665986152
SK-UT-1,5311281,3.3992849767981297
SW1783,5460769,4.078393209152703
Lu-65,navitoclax-sorafenib (1-1 mol-mol),1.3439919091242982
GOS-3,navitoclax-gemcitabine (1-1 mol-mol),-2.24576809498804
Panc 02.03,46398810,3.420081587494409
TE 441.T,6918328,0.4200582103899206
NCI-N87,1239801,5.115918121174403
TE 441.T,71304818,1.895657201116581
SNU-423,89928392,1.4625426886142474
BT 320,25105715,3.591126909496077
H-STS,5746,0.9486967341675628
NCI-N87,6914657,-3.795056001746233
SNU-1077,11222830,1.922347947337687
HSC-3,16115403,-5.41980643687828
KO52,10074640,3.368382528062951
SK-UT-1,navitoclax-sorafenib (1-1 mol-mol),1.7980583949597466
SNU-216,135999136,4.192311948123392
RERF-LC-MS,6918736,-1.8242544668906209
Karpas-422,serdemetan-SCH-529074 (1-1 mol-mol),0.955947916041782
TE 441.T,122327,3.79939442487586
SF539,2842253,5.830632520958069
NCI-H196,71466380,3.764128537230398
BT 248,71729975,1.811306833980593
Karpas-422,36462,0.1497993293193704
KO52,119182,-4.453173140639883
NOMO-1,ISOX-bortezomib (250-1 mol-mol),0.07871384473645
BT 320,53495165,1.9791180905331631
RKN,4261,1.529955054772996
SNU-119,navitoclax-MST-312 (1-1 mol-mol),1.0798653444132074
PE/CA-PJ41 (clone D2),168313016,6.324441458081494
LMSU,11222830,1.917017236141016
KMRC-20,2708,5.098804144930118
H-STS,148124,4.085792664518574
NCI-H929,5460769,1.81013287796662
NCI-H196,2828334,6.824622539446005
HEC-108,441298,2.5312141311049214
SNU-213,4788,5.9691408326864295
ChaGo-K-1,3503,2.0887417789054847
EHEB,serdemetan-SCH-529074 (1-1 mol-mol),1.3155569018374509
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
Ri-1,navitoclax-birinapant (1-1 mol-mol),-3.80942516814163
ChaGo-K-1,11609586,3.37979827578237
CML-T1,JQ-1-carboplatin (1-1 mol-mol),0.6334590834009667
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
Kasumi-2,2746,1.0036072682129122
KO52,6450551,0.7972942512543331
KO52,25126798,3.67676175110437
Karpas-422,5335621,3.688273816665903
NCI-H929,5978,-3.149795005815329
TE 441.T,5284616,2.983388290354193
IST-Mes1,4917,3.386112443694605
TE 441.T,71466380,5.412558378929979
SK-MEL-28,4917,3.066656209778127
SF539,44589607,2.1989651923928375
RERF-LC-MS,44491742,4.380479941679622
BT 248,1641662,4.808188715890419
NCI-H196,selumetinib-MK-2206 (8-1 mol-mol),3.486277291066986
RKN,6918328,0.5495182279950256
SNU-886,11317348,1.5463436352740425
OAW28,1716436,3.318226269910468
BT 248,135440466,3.298497559431859
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
SNU-886,10385095,1.1038149480439057
HuT 78,10184653,1.1494734571444012
LXF 289,11625818,3.3628594045115805
ESS-1,10322450,4.730793151305824
BT 320,selumetinib-UNC0638 (4-1 mol-mol),5.097773746306877
Mono-Mac-1,44202524,1.1420883070842414
OE33,25227462,-0.0519137832935216
HuT 78,25062766,1.4308476674773298
SNU-1077,637858,2.311785541808234
Mono-Mac-1,36462,0.1065012305215149
AsPC-1,135999136,4.3448843965381965
SK-MEL-5,24856436,1.066299696532792
HuT 78,24785538,1.710563314926326
SNU-1077,71680916,4.721412518258323
L3.3,656346,0.8770519202421161
RKO,9840324,5.302067215897717
ChaGo-K-1,24856436,-0.1076929992200115
SW1783,10302451,4.263014004956648
MIA PaCa-2,10322450,3.5979699373077585
KE-39,11497983,4.192627154878264
NCI-H929,6918837,-4.507848633334324
NCI-H1339,11178236,-2.640399828152474
Ri-1,docetaxel-tanespimycin (2-1 mol-mol),-8.150549947962872
Namalwa,81146,4.387935606174053
SNU-886,702558,5.095529116539229
IST-Mes1,6917907,-4.257425330675956
Hep 3B2.1-7,9825149,1.2107085723984887
SW1783,3825829,4.196997387332537
SF539,4788,3.861213831162074
HEC-108,2841722,7.354178437919021
SW1573,24821094,3.391149888356164
HCC2108,219104,3.718593761594277
KYSE-450,6918837,-1.1193045710295215
Namalwa,54765302,3.978814795169302
AsPC-1,16725315,5.210607806565737
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
B-CPAP,5566,3.019933897494269
OAW28,11497983,4.916879328733168
LMSU,72734382,6.104130077489303
SF539,3552672,1.9155568088960504
Becker,SNX-2112-bortezomib (250-1 mol-mol),-1.918322757641904
NCI-N87,44486219,4.180509732108111
SK-MEL-28,9911463,4.538912500786334
RERF-LC-MS,5291,3.9873816513243785
Karpas-422,136227924,2.027369566350396
RT-4,44486219,4.156179916043431
SNU-119,piperlongumine-MST-312 (1-1 mol-mol),1.9759808399995944
Kasumi-2,1750826,-5.270023181988586
Hs 611.T,3025986,-4.496645094049803
LXF 289,46199207,3.0446562724495676
RT-4,25062766,2.555082815499361
EHEB,11178236,-3.253133430351509
EHEB,46907787,0.323033594148826
IST-Mes1,4261,1.7623274186426838
JHUEM-7,6914657,-3.112365649276011
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
OAW28,44491742,4.754653012158477
BT 320,46843906,4.201274452576595
RERF-LC-MS,262093,3.104487938727744
PF-382,36314,2.7349440998972296
CML-T1,104842,-6.467154894462458
SF295,9911830,5.317347771430753
YD-8,49793307,-2.0913800226876704
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
NCI-H2030,3384730,4.123453898598414
PE/CA-PJ41 (clone D2),60750,-1.2354534688999257
Namalwa,969516,2.093862466919586
Lu-65,56946209,-5.150343216960287
SNU-216,3552672,2.006250184773747
Karpas-422,2871966,0.3090239295442658
LXF 289,123631,1.612545473594554
RT-4,24180719,5.152911409441223
BT 112,676352,1.6174631516365394
JHUEM-7,135875424,3.03961944002969
IST-Mes1,49793307,1.120791830462594
SF539,42611257,2.369438053162354
KMRC-20,9935249,4.274093683443108
IST-Mes1,11214940,2.2228722379077857
NCI-H2030,3543504,4.420171280073458
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
HEC-108,44819697,-1.05954599286061
Kasumi-2,445643,3.712609595977314
MIA PaCa-2,24964624,2.7455097221801963
SNU-1077,54618305,5.347093142592056
OAW28,54649381,3.786658613217657
SF539,44185566,2.0579628999661117
YD-8,72734382,4.785719030428051
Becker,168312962,-1.1419404426539477
Namalwa,2749,0.8772609351903448
JHUEM-7,5287969,-2.561176724900928
SNU-119,322968,3.936087902128088
SW1573,126941,-1.0305779796426808
HuT 78,11228183,1.5356428914171083
NOMO-1,46907787,-1.215006340822028
HEC-108,navitoclax-birinapant (1-1 mol-mol),1.0122779025542474
PF-382,23939,6.138736968520051
KE-39,3136844,4.342976017638663
NCI-H196,2841722,5.547130593063546
LXF 289,9907093,2.975231625485398
SNU-423,135440466,2.852751796609215
KE-39,10231331,4.477976749120646
PE/CA-PJ41 (clone D2),24753719,4.254731595705647
HOP-62,11234052,3.9644322290477305
NCI-N87,11485656,1.873926788766734
BFTC-909,3081361,3.110656330811392
NCI-H929,53232,1.3774173243264964
SF539,5329102,1.5729222878136029
BT 286,56946209,-3.3525827059100983
YD-38,44607531,0.7317750141243352
KMRC-20,5282054,4.2383021010346065
Ri-1,60700,-4.577046497029594
KE-39,navitoclax-gemcitabine (1-1 mol-mol),0.4577354128073778
OAW28,4261,1.5275003221448853
HEC-108,6610216,4.664785359409005
Panc 02.03,9911830,3.8856260346392903
SNU-119,44489367,5.127022911687477
KO52,462382,0.1087271140115314
HEC-108,409805,5.771065107307232
KE-39,66577038,2.843797644710323
EHEB,selumetinib-navitoclax (8-1 mol-mol),1.9472378662197067
JHUEM-7,9933475,1.5880397804267905
KYSE-450,3025986,1.0073883663070609
RKN,11427553,3.6372919842764424
RT-4,11234052,4.441535600719637
RKN,11497983,4.544575984994342
KE-39,carboplatin-UNC0638 (2-1 mol-mol),3.611149814611224
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631
AU565,11152667,-0.8659767610796402
RERF-LC-MS,3543504,3.1700226881436193
TE 441.T,10322450,2.5137861182837207
SF295,navitoclax-sorafenib (1-1 mol-mol),0.8492487168306413
SF539,3025986,-1.0860147813868546
KYSE-450,11178236,-2.864393215026398
Kasumi-2,6918638,-1.1951505869280743
SF539,46174525,5.071115867258652
JHUEM-7,44566777,-0.2375299751384852
HuT 78,53392493,1.254063263001093
Lu-65,216468,3.4441373873325714
ESS-1,135875424,3.182582939188363
WM793,3815108,3.0627718438622487
HOP-62,60750,-0.8412438712824618
AU565,5287969,-1.6574542255158256
SK-UT-1,11955716,-2.40204232410625
HuT 78,11214940,1.6478986529716984
BT 112,selumetinib-JQ-1 (4-1 mol-mol),2.692883041543946
SF295,15953870,3.68553477527874
HOP-62,vorinostat-carboplatin (1-1 mol-mol),1.8572569013705305
Hs 611.T,5978,-6.322089417024284
AsPC-1,24901704,4.152315193440913
NCI-H2030,5566,3.4824857655700328
HSC-3,11964036,1.6239434474378724
SNU-119,54619267,3.4840179257423447
SF539,tretinoin-navitoclax (4-1 mol-mol),2.6465654261890617
RERF-LC-MS,46926350,-4.177207395055215
MJ,5329102,2.173311571701512
HuT 78,54618771,-0.2261201753145263
SNU-213,3025986,-0.5037045377366649
Namalwa,44486219,4.008979005623025
OE33,navitoclax-piperlongumine (1-1 mol-mol),3.1148131946028013
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
RKN,24771867,0.8860225124393014
PF-382,6918837,-4.619504053552648
RT-4,12001922,1.7739058895208752
SNU-216,44589607,2.546181662293819
RKN,11214940,-1.342915177510304
SW1783,135440466,3.5592190192568114
NCI-H1339,25154868,5.0319171953179085
Lu-65,11485656,2.4652445580433713
BFTC-909,2949965,3.0294119536880197
RKN,44819697,0.8547407464301948
Mono-Mac-1,JQ-1-navitoclax (2-1 mol-mol),-1.3007467584542969
Becker,selumetinib-PLX-4032 (8-1 mol-mol),4.580169016551391
SNU-119,135411,0.3740085311650424
SF295,24748573,2.395821918737598
BT 320,9887053,4.397401387197895
Kasumi-2,5311037,4.15499666746129
GOS-3,5311,2.439895727975568
LXF 289,452548,0.2436004430663324
Ri-1,JQ-1-navitoclax (2-1 mol-mol),-3.4544449292269586
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
Lu-65,44543605,5.217530079977961
SNU-1077,15983966,0.623370554406356
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
SNU-216,9825149,2.4338095218248794
NCI-H929,6623618,2.0780887581605714
Ri-1,selumetinib-UNC0638 (4-1 mol-mol),2.6892324005846873
NCI-H929,vorinostat-carboplatin (1-1 mol-mol),1.7849297289104662
EHEB,9825149,2.329615332433461
Panc 02.03,135875424,4.996461687769912
YD-8,24856436,0.1714275656823875
LMSU,65064,5.4965008599922145
GOS-3,46199207,3.558565735467231
CML-T1,4261,-0.2906672064872484
B-CPAP,9935249,3.6331972825505474
SNU-216,445643,4.002544643771802
Panc 02.03,11485656,5.602754460209725
PE/CA-PJ41 (clone D2),navitoclax-sorafenib (1-1 mol-mol),3.206224908291627
TE 441.T,UNC0638-navitoclax (1-1 mol-mol),1.000062005612718
HuT 78,9884685,0.1724524998439705
BT 320,5282054,5.407913205549652
CML-T1,124202324,0.7419542279604492
RERF-LC-MS,6918328,0.3946668064090056
KYSE-180,46191454,1.2517200441796488
OAW28,9907093,4.094861416701174
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433
AU565,44137675,3.533476650788096
BT 112,72376,-2.818069890055989
HOP-62,135928012,5.236707943844288
HCC2108,4788,5.8441996671956105
Hep 3B2.1-7,71304818,2.2516759869447136
MIA PaCa-2,262093,3.1147038686055812
ESS-1,73707398,0.9452333213652502
BT 286,23635314,-1.7525741606507157
HEC-108,24753719,4.945792887212488
HOP-62,148198,-4.07466395157971
YD-8,3552672,2.336510078255813
MIA PaCa-2,613000,2.1639468020666826
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
Mono-Mac-1,2842253,3.804079975263365
IST-Mes1,9825149,1.824146809937508
HCC2108,6918878,2.040858445754197
BT 248,12001922,0.9128950259060647
RERF-LC-MS,5311281,3.366561586065275
RT-4,5287620,-2.3596459820452376
Lu-65,168312962,-1.2301817974016382
NCI-N87,6918736,-4.217256713101777
ESS-1,9884685,0.689834242395422
SK-MEL-28,9825149,2.466048508580774
OAW28,54619267,3.96587417417148
CML-T1,984333,-1.4387494949343358
HuT 78,serdemetan-SCH-529074 (1-1 mol-mol),1.8219869196237213
Kasumi-2,navitoclax-piperlongumine (1-1 mol-mol),-3.156994425462095
Hs 611.T,36462,-1.281964415022038
SF539,44607531,1.4805513890450512
TE 441.T,navitoclax-PLX-4032 (1-1 mol-mol),0.6188347089805195
L3.3,11497983,4.314112910656769
HSC-3,60700,-0.4613248471359459
Mono-Mac-1,9868037,1.9108517803242744
TE 441.T,4261,0.6291431544827749
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
MJ,49793307,-2.108453133471835
BT 112,16038120,1.1181319044078708
WM793,navitoclax-MST-312 (1-1 mol-mol),0.5700872528599389
LMSU,67156097,1.321844393975608
KYSE-180,12003241,-0.805265861116592
ESS-1,3854666,1.0692309253016814
NCI-H1339,66577038,3.2327996972148347
SF539,11427553,1.911717552312056
NCI-H2030,1242560,4.6842326187617624
H-STS,135421197,1.21674084203813
BT 320,44819697,2.9489346663339187
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874
RKO,5351362,1.5688417029382893
NCI-N87,44819697,-2.3159908553894932
SF539,2126,3.755804454049341
MJ,navitoclax-gemcitabine (1-1 mol-mol),-4.243920613796683
PE/CA-PJ41 (clone D2),4378219,4.605247392620583
YD-8,6918736,6.385524567287694
Mono-Mac-1,44589607,4.674636084948172
SNU-119,25126798,4.429154191215383
Ri-1,66577038,2.5588645698684807
IST-Mes1,16038120,1.0913997834143612
Kasumi-2,navitoclax-MST-312 (1-1 mol-mol),-2.959240355083437
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
TE 441.T,5702613,3.453881896146182
Becker,25150857,3.3425977387372385
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
AsPC-1,446155,5.1652347554602995
KE-39,5328940,1.2417733744928583
SF295,613753,3.096512023119067
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
Hep 3B2.1-7,4477,-0.0557749869807642
RERF-LC-MS,219104,4.628133490361187
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
RERF-LC-MS,2746,3.2731211053052647
GOS-3,2858523,3.344991232469259
YD-8,44607531,1.5829374298976635
KE-39,25161177,3.7405174690773366
PE/CA-PJ41 (clone D2),2729026,3.125352392959333
TE-14,16038120,1.4445788120789431
TE 441.T,104842,-4.99363646788543
RKO,5329102,2.192208184281935
KE-39,49766530,-2.0647642539816715
B-CPAP,219104,3.4420114060064084
MIA PaCa-2,168312962,3.279024851833566
TE-14,9911463,3.9221721376636816
Becker,9907093,5.038379174054834
MJ,46398810,2.7370882768174596
LMSU,445643,3.9937426860066982
Lu-65,25102847,1.5685038357748828
Ri-1,ISOX-bortezomib (250-1 mol-mol),-0.9947623817494354
SNU-119,135875424,4.208481763945608
Hs 611.T,selumetinib-vorinostat (8-1 mol-mol),2.75896517659524
RERF-LC-MS,46398810,3.3112335021243977
SNU-423,3136844,4.260601533804775
Panc 02.03,53232,6.367991743549877
BT 286,444795,5.07961620697437
KE-39,11494412,5.804036993573256
EHEB,6505803,-0.4928001321157277
SK-UT-1,135411,0.7872586171820456
WM793,vorinostat-navitoclax (4-1 mol-mol),2.767153736935034
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
Hep 3B2.1-7,56946209,-4.073417170136715
SW1783,selumetinib-BRD-A02303741 (4-1 mol-mol),5.401452883960348
MIA PaCa-2,9927531,4.662028210048159
Hs 611.T,107985,-4.128065548423904
KYSE-450,ISOX-bortezomib (250-1 mol-mol),0.3236912354061821
CML-T1,644241,-4.543158274485358
NCI-H209,36314,-3.490565280489779
MIA PaCa-2,selumetinib-MK-2206 (8-1 mol-mol),0.8333069562699312
H-STS,46191454,1.9033796822973523
LMSU,10322450,5.4992145641719095
KE-39,carboplatin-UNC0638 (2-1 mol-mol),3.611149814611224
ESS-1,24771867,2.6208219680257328
BT 328,docetaxel-tanespimycin (2-1 mol-mol),-0.9357205348249352
BT 248,24951314,2.138284126904765
BT 286,56973724,2.44646115047201
H-STS,36314,2.0613869853420685
Karpas-422,44137675,-1.3828937962979793
HSC-3,11404337,-0.7786873247989411
BT 328,46199207,1.7290666248648392
KMS-12-BM,3385,3.988129125134885
TE-14,51039095,3.4231923727642934
AsPC-1,44137675,4.002233175780649
SK-UT-1,JQ-1-vorinostat (2-1 mol-mol),2.752157861333336
HOP-62,JQ-1-navitoclax (2-1 mol-mol),0.645936379150377
KYSE-450,44486219,4.896382772199078
RT-4,10410894,2.6613455189649913
PF-382,119607,4.835768261227938
SNU-886,3465537,4.952996907212378
Lu-65,241158,4.2277525357675705
Kasumi-2,46199207,3.5720995907025803
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
NOMO-1,4788,5.067002306940809
BT 248,135999136,1.3787773380664552
BT 248,11497983,5.371692371312494
WM793,400769,-0.3284339771877358
Hs 611.T,15953870,4.69578906059893
KMRC-20,4917,2.994813665263991
SNU-423,10231331,4.762188035854746
Hs 611.T,241158,2.625430045012582
BFTC-909,6918289,3.427790661189136
NCI-H196,11626560,2.389103282911341
NCI-H1339,navitoclax-MST-312 (1-1 mol-mol),0.9103160746312428
LXF 289,24951314,1.0119406639366386
LMSU,25227462,1.468686757541464
L3.3,36314,2.044128713808568
BT 328,10074640,3.6733046849863986
CML-T1,56946209,-4.816302217893272
SNU-1077,54613361,5.090510226411371
KE-39,24951314,0.9296568060846556
LXF 289,tanespimycin-gemcitabine (1-1 mol-mol),-0.7803553761989187
BT 286,9911463,3.0735360087935364
L3.3,56963564,0.8777502284965835
KMRC-20,72376,-0.7899915244048435
ESS-1,5978,-3.0981583425056787
RERF-LC-MS,462382,0.9319597157341816
KO52,3825829,1.880917675310284
YD-8,navitoclax-pluripotin (1-1 mol-mol),-0.5711065804436923
BT 320,4259181,1.858689674297262
KYSE-180,1641662,2.753321741973846
Hs 611.T,3634881,1.9623654970627349
OAW28,72193861,2.7871547903709266
KMRC-20,selumetinib-piperlongumine (8-1 mol-mol),4.530795169334645
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
SF539,168313200,1.6661816240555782
NCI-N87,3825829,3.9513849877108207
OE33,1641662,3.6587847982037087
SNU-886,2113511,6.091216991292669
NOMO-1,5281672,5.39154363605107
KMRC-20,124202324,3.9491419219303943
ACC-MESO-1,docetaxel-tanespimycin (2-1 mol-mol),1.2731409547027943
SNU-423,56946209,-4.392308882184761
Namalwa,3854666,0.1539435938538964
H-STS,5282054,2.573359833272533
OAW28,45279963,4.210324099066774
BT 498,216239,4.010979166713856
GOS-3,5351362,2.3365334015432686
SNU-886,4477,-0.049698052487978
LXF 289,53232,1.5859701947912777
NCI-H1339,375860,-0.3541433845632409
Mono-Mac-1,navitoclax-birinapant (1-1 mol-mol),-0.6305584759579668
Kasumi-2,23635314,-3.2137156100627973
PE/CA-PJ41 (clone D2),selumetinib-PLX-4032 (8-1 mol-mol),1.9711272671568492
BT 328,9803433,4.554547423924098
Namalwa,SNX-2112-bortezomib (250-1 mol-mol),-3.7975545956256505
KE-39,1242560,3.7605808784005625
BT 248,6450551,3.394353011187604
Kasumi-2,24772860,-3.0702303943568197
OAW28,1641662,3.6011202742070014
KE-39,25227462,2.8999512206362867
Becker,3689413,0.4493271202500121
EHEB,15953870,4.2659113550785595
SK-UT-1,46926350,-4.372914941162361
HOP-62,6914657,-3.9101561019120807
H-STS,16659841,4.209446171340807
RT-4,10385095,2.2650869360881742
SK-MEL-5,4788,5.599702300257514
OAW28,6918638,0.0048657249331401
NCI-H2030,2749,4.339658606449754
BT 328,31703,-0.2898094024615853
AsPC-1,4259181,1.083384461798112
WM793,42642645,1.6343237729440876
HuT 78,11404337,-1.1966282759274738
RKN,5280436,4.161667428331563
BFTC-909,4261,3.835594401773327
BFTC-909,439501,-2.4866456286351095
OAW28,5287620,-1.6233190690502424
AsPC-1,44462760,4.701078704400346
NCI-H2030,selumetinib-navitoclax (8-1 mol-mol),1.6765527243716944
NCI-H1339,148198,-2.9438729710882963
KYSE-180,5311,1.7867284684655886
TE-14,54143018,-0.7694237201008571
SNU-213,54649381,3.760371456180229
YD-38,637858,1.9824428087241075
Ri-1,262093,1.5615741003890895
MIA PaCa-2,12003241,-0.7993036743010778
SNU-213,49850262,3.7235778033832054
GOS-3,136227924,2.1351760440562533
SNU-886,23725625,4.310392340682066
ESS-1,54678924,1.5705216909139783
SK-UT-1,3689413,-2.3572164451465105
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
LXF 289,36314,1.2391029615263165
JHUEM-7,selumetinib-JQ-1 (4-1 mol-mol),0.2978252775763586
HuT 78,54618795,2.390754899552402
L3.3,navitoclax-piperlongumine (1-1 mol-mol),3.3771859534422703
SNU-119,3081361,1.3460457927796947
SF295,4788,5.92202321962467
HCC2108,11485656,2.4652137706419137
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
KLE,23725625,2.7746440048356
OAW28,72193861,2.7871547903709266
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
NCI-N87,5746,-2.0970985848352837
Hs 611.T,tanespimycin-gemcitabine (1-1 mol-mol),-4.917658608482378
Hs 611.T,10296883,2.1070249605904574
LXF 289,5566,2.9960878643930218
H-STS,71304818,2.454900724059108
EHEB,11396600,3.4241723821303314
Mono-Mac-1,448949,1.4047243456978296
TE 441.T,10074640,3.840762234626516
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
AsPC-1,24821094,4.10595231639086
IST-Mes1,3503,2.9550990055374413
AsPC-1,676352,1.9564823338284063
H-STS,4259181,0.3091139042767585
TE 441.T,3136844,3.779446579435195
AsPC-1,11228183,2.8237254667802474
TE 441.T,71751553,4.471943805545609
KE-39,selumetinib-UNC0638 (4-1 mol-mol),3.3038481766151704
EHEB,17759555,3.693788336759982
NCI-H929,6610216,4.64058383232424
NCI-H929,5328940,1.4271750635710874
BT 498,426756,4.604365420016062
TE 441.T,9549297,3.3617461996176523
KO52,216239,1.4330207183659796
Kasumi-2,decitabine-navitoclax (2-1 mol-mol),-3.2819175731867927
SW1573,11238147,3.4967804964098517
HCC2108,11507802,2.2568660355978607
AU565,44566777,1.2994228207825576
KE-39,5282054,2.8493216674901896
L3.3,439501,-0.248470622878828
EHEB,5278396,3.4775281227216936
SF539,387447,-5.002674810102925
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
Becker,322968,4.664074347969188
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
NCI-H196,selumetinib-navitoclax (8-1 mol-mol),4.633179682093875
WM793,5328940,2.305774199257107
TE 441.T,JQ-1-carboplatin (1-1 mol-mol),3.6275074638677465
SNU-886,24951314,1.1149346729448562
KMRC-20,24901704,3.0273609194565276
JHUEM-7,168312962,3.604501244150348
Becker,7251185,3.049813442259434
SK-MEL-28,6918328,1.6260259804772523
SNU-119,126941,-2.8871019003996574
NCI-N87,208908,-2.7799590207113014
Hs 611.T,5329102,0.9131536765756388
ChaGo-K-1,11214940,4.722023398176141
RKO,3689413,3.093382349703003
Namalwa,2733487,3.3542570551345356
LMSU,31703,0.876277005526271
Mono-Mac-1,9444,2.9638254439415546
OAW28,72376,-0.5739552302850919
EHEB,3552672,2.013023360686031
BT 286,5494449,1.808530334685148
ChaGo-K-1,2742550,3.263905661793297
BFTC-909,452548,0.7682850038212578
RKN,73707398,1.136221501718042
Namalwa,44607531,1.0104056237764891
HSC-3,56946209,-3.5059514829840603
RT-4,387447,-3.0484703414890744
SW1573,71680916,4.0865163925225385
SNU-119,9926054,2.3608984923700036
BT 320,6610216,4.229919303269505
HuT 78,7251185,-0.7654974545197635
Karpas-422,73707438,3.942643719433516
HuT 78,216345,3.2083234120467004
HOP-62,7251185,3.793199027205306
Namalwa,7326481,3.2837850445002483
RT-4,135928012,3.02526945611553
AsPC-1,11707110,-3.3734075653106506
AU565,613000,0.5241513608694668
NCI-H1339,25227462,-0.3202555792543043
CML-T1,216468,0.1350088901202253
BT 328,12001922,1.7973322325176817
BT 498,4705,4.208148450276773
KE-39,11609586,3.026982810256724
Namalwa,448949,1.3938539452302794
YD-38,135875424,3.801699719504721
NCI-H2030,969516,2.9415471646637186
SNU-119,5280436,3.876478127021692
KYSE-180,5329102,2.581374775055639
ESS-1,JQ-1-MK-0752 (1-1 mol-mol),0.8350024005295179
Kasumi-2,25154868,4.0151171723744765
JHUEM-7,6852167,1.350724801432494
ACC-MESO-1,9935249,4.592258833593908
ChaGo-K-1,3025944,4.403252616983074
SNU-119,3025986,-1.122362641201654
MIA PaCa-2,ISOX-bortezomib (250-1 mol-mol),0.1760619682505216
Hs 611.T,5746,-0.904729846900881
KMRC-20,52912189,4.952328418850898
KYSE-180,216468,3.656318392003096
YD-8,73707398,1.1339237170250962
Karpas-422,ISOX-bortezomib (250-1 mol-mol),0.1595215058656458
BT 320,135999136,1.9088296274535188
KE-39,44241473,4.750329858029805
Lu-65,46398810,3.002641296730853
Namalwa,3634881,3.0415883550514806
BT 112,1566236,1.551499234243426
BT 286,6610216,4.050396966302166
KYSE-450,5113032,4.607851328424312
SNU-423,637858,2.0123731637810875
AsPC-1,136227924,3.2025742465891938
Panc 02.03,135440466,3.0724615257354153
Lu-65,11507802,1.055248828588956
KYSE-450,vorinostat-navitoclax (4-1 mol-mol),3.1121330202386974
HEC-108,452548,2.7369645386651307
L3.3,124202324,3.558321901620073
Becker,5351362,1.5904741458166467
OE33,15983966,1.5108968468845063
WM793,5566,3.1211189784720923
KMS-12-BM,53481919,3.061997154400898
RT-4,49793307,-1.8490869702405208
HuT 78,24978538,1.2584289097403791
TE 441.T,11485656,0.4823826130235241
RERF-LC-MS,60750,-4.1612389836176
KYSE-180,46907787,3.816228061036196
H-STS,15547703,3.2281511582174875
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
SF295,3689413,-1.7224429364651286
Lu-65,44607530,2.567077991420283
SF539,9933475,0.5324953409576078
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
SW1573,5280436,3.0542460563059253
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
PF-382,3025986,-1.4825966428556414
CML-T1,15953870,2.3626237456804025
B-CPAP,piperlongumine-MST-312 (1-1 mol-mol),1.4552601260130695
AsPC-1,448949,1.7535133746232512
SNU-119,3038522,3.3866164987543654
SNU-423,445091,4.024034893293104
Mono-Mac-1,676352,2.251881742384123
SNU-423,216239,2.7358843595153477
HEC-108,56963564,0.296809560260297
GOS-3,selumetinib-vorinostat (8-1 mol-mol),4.505292657728925
BT 112,11964036,2.3781270120302556
MJ,5460769,-0.0196671860810318
Kasumi-2,2949965,2.010544177145751
YD-8,10427712,4.808988209021756
NCI-H209,6918837,-5.3764922976435265
Mono-Mac-1,4378219,0.2241292373980127
RT-4,24964624,3.0687805889747977
WM793,2729026,2.380057317950378
Hep 3B2.1-7,54618771,-0.219926675598239
HOP-62,45279963,3.745399813788082
SW1783,9866186,2.9884922789438444
IST-Mes1,44607531,1.530053859314775
KMRC-20,46199207,3.496477573455405
NOMO-1,decitabine-carboplatin (1-1 mol-mol),1.4040518072476522
Ri-1,44607530,0.5403801994067887
Kasumi-2,4096211,1.078024917290252
OAW28,11427553,3.602344276440211
Ri-1,216468,0.3321468769751489
Kasumi-2,11494412,-0.1140662522158316
AsPC-1,11707110,-3.3734075653106506
Karpas-422,637858,1.0915898497737888
HOP-62,11178236,-4.948356936614416
LMSU,613753,3.288100775967615
AsPC-1,262093,3.2992304028365926
KYSE-450,11955716,-2.223741431662978
GOS-3,6918328,0.9203199321907972
Lu-65,60700,0.1842167213594187
RERF-LC-MS,16720766,0.5604118097796991
Ri-1,135984461,2.0671055438536547
KMRC-20,2729026,2.964214452435718
SNU-216,11507802,1.4243975230006038
H-STS,54678924,1.1797889556191294
AU565,56963564,-0.3705062094323867
SK-UT-1,31703,-1.1985979493610477
OAW28,46926350,-3.936437112233884
BT 320,5738263,4.511639431207419
HEC-108,136227924,3.134071919213167
ESS-1,54143018,0.807928117545995
NCI-H196,5746,2.0463177301204616
NCI-H1339,10127622,5.877682943538906
OE33,9926054,1.932041644306032
NCI-H929,168313016,5.007996140484685
PF-382,11427553,0.9124764521092824
L3.3,73707438,4.465616964273929
HOP-62,11640390,4.182571164758542
ChaGo-K-1,54618771,2.4705381408155183
SF539,56946209,-5.157192597253952
SNU-213,5566,2.8335437208552263
HSC-3,6610216,4.3028162807700365
L3.3,753704,5.0689754221003875
ChaGo-K-1,44493528,4.285653924871417
Mono-Mac-1,9884685,-0.2142901784268321
OE33,135440466,3.0626542754151744
HOP-62,241158,4.371363298737313
YD-8,11647372,1.2851189488565986
ACC-MESO-1,984333,1.021847289904778
OE33,6918638,-0.1523417231642655
HOP-62,53392493,3.6394168789685706
SF539,5328940,1.185373887783132
BT 286,11625818,4.774350290702803
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714
NCI-H196,49766530,0.4460348160421952
Namalwa,122327,4.141900721710582
BT 320,25150857,3.33324545252111
Mono-Mac-1,73707438,4.288707884159042
NCI-H929,carboplatin-UNC0638 (2-1 mol-mol),2.500876393607731
YD-8,16722836,1.043469744130907
AsPC-1,10296883,4.32215490848641
SNU-423,6918878,2.1961765683595824
PF-382,46199207,2.6598109327538286
SF295,3503,2.7159653827410355
BT 286,24978538,0.9384657669866732
SNU-216,3543504,4.444613120947592
NCI-H2030,crizotinib-PLX-4032 (2-1 mol-mol),2.9391292975387944
HCC2108,135999136,4.648622110630223
NCI-H929,11485656,1.7872822459041733
ESS-1,1750826,-1.919918883471636
HuT 78,3854666,0.8787104419208177
BT 286,11609586,2.876134676085447
KMRC-20,9907093,5.120567595099458
NCI-H929,159324,1.2295170877350825
SK-MEL-5,159324,3.0838844609903355
SF539,UNC0638-navitoclax (1-1 mol-mol),2.2023146643666323
PE/CA-PJ41 (clone D2),49867926,4.481140924469175
SNU-886,17759555,4.113713798253048
HOP-62,322968,4.873237616134347
HEC-108,119607,5.2604571432303
BT 248,3854666,2.6170510866367955
Ri-1,53495165,-1.735989283439336
BT 286,72376,-3.16729090401154
KLE,3038522,3.949469556770748
L3.3,676352,2.5109454639647373
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
ACC-MESO-1,24964624,3.857946270972098
B-CPAP,46199207,2.9698252348312963
B-CPAP,5738263,3.3747888621680207
TE-14,24821094,0.2881557601852942
YD-8,56973724,2.610030858184056
RT-4,9915743,2.2914033994891847
SK-MEL-5,5470400,0.7518880653915619
SW1783,4705,3.473081250569121
KO52,71466445,2.839981960673523
ACC-MESO-1,9926054,4.037988480167424
HEC-108,374536,1.892261126227868
ACC-MESO-1,9936388,3.1205070846652374
SK-MEL-5,11507802,1.1311799974762815
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919
KO52,156422,3.399553477356099
SNU-213,44241473,4.380911531659556
CML-T1,selumetinib-JQ-1 (4-1 mol-mol),0.8733678884698052
GOS-3,ISOX-bortezomib (250-1 mol-mol),0.1639381713704753
AU565,2858523,2.8415967437488443
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
PF-382,6917907,-6.431709944016271
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
KYSE-450,10302451,4.575458638647607
IST-Mes1,285033,-1.625614851116669
HCC2108,11640390,5.072951155223495
B-CPAP,57519531,4.004957994093651
IST-Mes1,10296883,4.238957650390159
EHEB,15547703,3.057077629561598
ChaGo-K-1,2949965,2.4204656541606533
KO52,984333,-0.7180338735578685
SNU-1077,31703,0.2109886329086631
TE 441.T,241158,4.026754207652904
BT 112,10427712,3.9873037991521594
Karpas-422,327653,2.503082809882216
RKO,6918328,0.803085247134139
SW1573,23725625,4.357604161446221
Ri-1,5311,-0.1594609946430047
SW1783,9911830,2.094357885918856
SNU-213,637858,2.227184287849749
HEC-108,piperlongumine-MST-312 (1-1 mol-mol),1.556813220853092
SNU-886,11213558,0.3239659195711419
AU565,2945648,3.081352201841014
Kasumi-2,11228183,-3.3606954683588057
HuT 78,5284373,3.1403236788776314
OAW28,11626560,1.7877294085158288
CML-T1,46398810,1.457844995716712
ChaGo-K-1,6610355,5.203089594311465
MIA PaCa-2,JQ-1-MK-0752 (1-1 mol-mol),0.7789496627710616
BT 286,24797083,-0.0799742333023719
MJ,6450551,1.4297502177824069
Hs 611.T,JQ-1-vorinostat (2-1 mol-mol),0.5452078653021686
ESS-1,426756,3.7262870837192503
KMS-12-BM,4096211,0.0697159534999253
MIA PaCa-2,42611257,3.5896213916046165
SK-UT-1,16038120,1.834689793828048
ChaGo-K-1,4917,3.3620383707745662
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
RT-4,56946209,-3.9033190222100824
LMSU,4705,3.840410851100799
KE-39,9927531,6.019185228760376
PE/CA-PJ41 (clone D2),66577038,3.48656665486357
PF-382,208908,1.8787534323757689
H-STS,44486219,3.861225962485261
B-CPAP,10410894,1.808776781971955
SF539,42642645,-0.0077042862761951
OAW28,637858,2.2776250733597085
BT 286,4378219,1.3689305744165488
SW1783,1750826,3.2712130388919856
NCI-H929,navitoclax-birinapant (1-1 mol-mol),3.0660069376670065
NCI-H209,60700,-5.0994667891224505
KO52,375860,-1.0348961069797258
Mono-Mac-1,44491742,3.632264372511232
SNU-216,24748573,1.6786194756017438
HSC-3,11222830,1.881269114654764
ESS-1,46215462,2.1404151141829986
Karpas-422,6438330,1.009867343899865
YD-38,54143018,-0.7993708531403734
HOP-62,navitoclax-pluripotin (1-1 mol-mol),-1.411092695129254
GOS-3,613753,3.227220710192061
Hs 611.T,168313200,3.4582352812742516
NCI-H209,piperlongumine-MST-312 (1-1 mol-mol),1.7207029898692474
YD-8,JQ-1-navitoclax (2-1 mol-mol),3.0006612821736978
Hep 3B2.1-7,17759555,3.58954952466779
NCI-N87,119607,4.916125105909822
TE 441.T,52912189,3.963434296707395
PF-382,11178236,-3.5800251896914217
Mono-Mac-1,25154868,4.051983982032292
SNU-216,4578,4.165906698786389
Ri-1,216345,2.96853089827557
ChaGo-K-1,6918328,0.4455436396012512
NCI-H929,11717001,3.5813087305608575
SNU-886,docetaxel-tanespimycin (2-1 mol-mol),-1.966397975894796
Karpas-422,6918837,-5.3439308234208065
SNU-213,5281321,2.4238033705571143
KLE,9825149,2.9770455391230506
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
NOMO-1,24797083,1.0415171353084307
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
YD-8,erlotinib-PLX-4032 (2-1 mol-mol),2.8218609512009603
AU565,3689413,0.8257687517728082
CML-T1,15547703,2.6642294109203823
SK-MEL-28,11364421,2.320063094924172
NCI-H1339,49793307,-2.796356491844092
SW1573,9911463,3.734935340044018
SF539,135984461,4.130188481564332
NCI-N87,2828334,6.0279909292271165
RERF-LC-MS,5351362,3.2669953777859493
SF539,24978538,1.3983076300277495
SNU-423,navitoclax-piperlongumine (1-1 mol-mol),0.9297060154176142
NCI-H2030,3025944,4.9407835702905
BT 248,9911830,3.0671224453630326
Namalwa,16722836,1.2777099451107474
OE33,16736978,1.4689201358854649
KMS-12-BM,10385095,1.107401404691538
BFTC-909,24748573,2.672786285704278
CML-T1,159324,0.3275039904336689
SNU-886,656346,1.184079596970836
HuT 78,11964036,-0.1137295311814781
TE-14,54618795,3.1512290522553568
KE-39,9907093,4.662236703806896
TE 441.T,11656518,1.3560894699369077
SF539,45100481,5.034110607379183
HOP-62,3465537,2.2363453693957536
PE/CA-PJ41 (clone D2),11507802,3.844244761379668
BFTC-909,BRD-K27188169,5.152610673434624
PF-382,6438330,0.2212428462176163
OE33,44819697,0.2875723166616361
KO52,5282054,2.455165915117943
ESS-1,44589607,2.6194620218883116
BT 112,135398516,1.757671095611884
KYSE-180,241158,4.333679160826191
PF-382,54619267,3.0349882951687124
B-CPAP,3854666,1.7042245826351512
SK-MEL-5,2749,2.076988980388519
EHEB,6918328,-0.9331880587360782
KYSE-180,64971,4.515399284830646
BT 320,navitoclax-piperlongumine (1-1 mol-mol),3.22781533773438
Karpas-422,5329102,1.479846875546867
BT 320,67291369,4.380585752028441
Lu-65,285033,-2.1331342476122925
MIA PaCa-2,9887053,3.4042551427681103
Hs 611.T,9908783,6.264389360711776
NCI-H196,9952709,3.608288450843416
BT 248,6610216,3.912037893092857
BT 320,9952709,2.926036005886834
AsPC-1,1242560,3.922175022537436
KO52,23635314,-5.1824728926411945
HEC-108,navitoclax-pluripotin (1-1 mol-mol),-0.960955516945734
AsPC-1,119607,5.550900919397946
HOP-62,702558,5.5009425061549315
SNU-1077,53232,1.8565166460541551
JHUEM-7,navitoclax-MST-312 (1-1 mol-mol),0.7965231198258467
WM793,168313047,2.1825025569441405
KO52,JQ-1-navitoclax (2-1 mol-mol),-2.7248025297093825
SK-MEL-5,4259181,0.9764517115857632
SNU-216,2871966,-0.923170924915774
KMS-12-BM,9952709,1.973172777433049
RERF-LC-MS,445091,4.218142840499499
KE-39,11404337,-0.6939323202576905
Namalwa,24775005,3.855969637926427
NCI-H2030,51039095,3.777820295346348
BT 112,104842,-6.929937328010905
HuT 78,9915743,-0.3205464670121912
PF-382,6852167,1.6136489506938916
Hep 3B2.1-7,11717001,1.6772570179474775
AsPC-1,4705,5.582464580618905
NCI-H2030,16725315,4.8179667053556345
ESS-1,126941,-4.948247383785425
AsPC-1,1716436,2.9196038383716205
BT 498,decitabine-navitoclax (2-1 mol-mol),3.07792952169354
RKO,56963564,0.5825206420774123
SK-UT-1,6918837,-1.386854700757193
BT 286,25150857,1.7551248829672594
NCI-H196,5351362,2.106735039915596
MIA PaCa-2,4259181,-0.2210176227464965
Becker,262093,3.305929946624271
RERF-LC-MS,11497983,4.204546577264711
Karpas-422,45279963,3.778546245126845
L3.3,100016,6.042484334243821
SK-MEL-28,11152667,4.172027715871216
LXF 289,11364421,-2.6687395721676577
MIA PaCa-2,selumetinib-JQ-1 (4-1 mol-mol),-0.019734255481758
ChaGo-K-1,5351362,0.7984355835079401
KYSE-180,6914657,-3.948494720102188
L3.3,168313047,3.843757543685879
LXF 289,46843906,2.101940493524925
HCC2108,2828334,6.718139410602479
Ri-1,51039095,1.9057143183426843
AsPC-1,1750826,-1.5700020776253725
NOMO-1,676352,2.3647709516043336
SK-UT-1,25150857,3.291116369436408
SNU-423,8515,4.7137159265579225
TE 441.T,3081361,2.6142066328682185
ACC-MESO-1,387447,-3.5837310917006384
Karpas-422,6610216,4.297042652021984
TE-14,12001922,2.3151035394403916
SF539,9825149,2.2900366045202674
Mono-Mac-1,navitoclax-pluripotin (1-1 mol-mol),-3.51267924056218
SNU-423,52947716,3.098528991071038
ESS-1,1716436,3.7627823141372874
BT 328,3689413,2.3836323832860673
BT 248,53481919,4.127258509947241
Panc 02.03,10184653,2.526680989613479
RERF-LC-MS,135875424,2.839581382146162
BFTC-909,44259,1.3269924163099676
RKO,9903786,4.184024439899693
LXF 289,219104,4.555444774518925
PE/CA-PJ41 (clone D2),serdemetan-SCH-529074 (1-1 mol-mol),2.6683290169301346
SK-UT-1,2749,1.8360529754995716
MIA PaCa-2,alisertib-navitoclax (2-1 mol-mol),-0.2545467399902864
KLE,54618305,4.289261640342655
SNU-213,11364421,1.2530815378633922
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
NCI-H929,107970,2.2964601738289687
PE/CA-PJ41 (clone D2),navitoclax-gemcitabine (1-1 mol-mol),-1.557578844999666
Lu-65,navitoclax-pluripotin (1-1 mol-mol),0.4971122254843966
SNU-216,56946209,-4.877294025941971
KMS-12-BM,135875424,3.5247186168283453
SNU-119,2945648,1.887531870064612
Ri-1,25126798,3.435804880824684
RERF-LC-MS,16722836,2.4162442447682193
KMS-12-BM,176870,2.4229038104943457
YD-8,12003241,-1.7142863629727714
H-STS,2749,1.0388085008681336
KMRC-20,637858,2.2731698678706027
H-STS,71466578,4.205777917887045
ChaGo-K-1,151289,0.8276592767141736
HuT 78,5284616,0.3056845634963596
LXF 289,42642645,0.485507292149712
H-STS,16736978,1.4661636218515657
BT 320,400769,-0.2737977451215982
HSC-3,5978,-1.2997783390438526
ESS-1,25195348,3.4553614671814903
HSC-3,25262965,-1.2196052378955902
Hs 611.T,selumetinib-BRD-A02303741 (4-1 mol-mol),5.110673163960407
YD-38,9926054,1.970357209117647
SNU-423,400769,-0.3777485753223125
GOS-3,selumetinib-PLX-4032 (8-1 mol-mol),5.581542151485772
YD-8,2742550,3.780440690417096
EHEB,73707438,3.85222556690395
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
Karpas-422,UNC0638-navitoclax (1-1 mol-mol),0.995215523956661
NCI-H196,216239,3.63042521476176
HEC-108,11238147,3.83834503247448
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
SK-UT-1,11364421,-4.077140333267383
B-CPAP,56963564,-0.6464241889145811
YD-38,126941,-2.780314283606951
ACC-MESO-1,6852167,4.128939666891623
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
ACC-MESO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.089233445562891
NOMO-1,216468,1.212023833941809
BT 248,753704,4.567621051188063
Kasumi-2,44607531,1.0542160339181526
Mono-Mac-1,89183176,3.560555620335071
KO52,54626689,4.497055456581237
ACC-MESO-1,57519531,4.624518995494161
HCC2108,638278,3.3485085363474285
MIA PaCa-2,11719255,3.34181844548168
IST-Mes1,25227462,1.492895446731939
KMS-12-BM,445091,3.61459918682191
PF-382,46398810,1.1284565194471994
RERF-LC-MS,104842,-3.024577047260716
OAW28,44185566,1.918306011480311
Hep 3B2.1-7,6918328,0.1282647742333688
KO52,16736978,2.222216886070048
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
KMRC-20,3384730,3.9096966997308744
Karpas-422,navitoclax-MST-312 (1-1 mol-mol),0.954674009908166
BFTC-909,44819697,-0.8003395289407239
NCI-H2030,selumetinib-UNC0638 (4-1 mol-mol),7.069935114019918
NCI-H929,46943432,-0.7846111801119194
BFTC-909,676352,2.5282943369079818
ChaGo-K-1,51037431,4.793639315792485
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
L3.3,2746,3.431089753490113
KYSE-180,72376,-2.661600784164128
BT 248,25161177,3.821794472212993
Karpas-422,11396600,4.033756538148708
KYSE-450,31703,1.0169298465386034
PF-382,54618305,4.182237982253296
Namalwa,5746,-1.3078798882420877
SNU-1077,135984461,3.620374859792411
NCI-H929,6610355,3.3413826828309983
IST-Mes1,2746,3.2096433183027604
ESS-1,54619267,4.300915522093122
IST-Mes1,409805,5.880779442140838
HOP-62,44819697,-1.199398229691176
OE33,5746,1.19489933136352
KMS-12-BM,36462,-0.0282673998252453
KE-39,6610216,4.077734835238396
NCI-H929,387447,-6.464991803110621
WM793,SNX-2112-bortezomib (250-1 mol-mol),-1.3644142128989931
ChaGo-K-1,136227331,4.028131370047934
Kasumi-2,6918837,-5.725087899258232
NCI-H929,262093,-0.1267697569252451
BT 498,135421197,2.801881228152874
CML-T1,9444,4.326131103147221
TE-14,107970,2.304242218577071
HOP-62,2126,3.9968391108859063
Kasumi-2,135398744,8.02054113805855
SNU-1077,2729026,3.1553914055465047
H-STS,216239,0.9162079464609584
YD-8,10074640,2.718644140629287
NOMO-1,227681,3.177880686522457
BT 112,selumetinib-vorinostat (8-1 mol-mol),2.3775465177087063
KLE,104842,-3.354831620063557
RT-4,3503,2.674693598756191
L3.3,375860,0.2158630030269858
SNU-886,445643,4.49357862319239
BT 112,25195348,3.9880227699607262
KO52,6610216,4.150836928578526
L3.3,9911463,4.128757247123474
KLE,5282054,1.2490004235770853
RKO,25150857,2.5785304193211247
RKN,285033,-0.0275118271199953
KLE,49766530,-2.017018761794788
SF539,11238147,1.3297186459142216
Namalwa,65628,3.512710693266535
HOP-62,66577038,2.1262593150280966
BT 286,4096211,1.723481586132858
SF295,73707398,1.6695998936889058
KMS-12-BM,3038522,3.0774694723408036
OE33,tretinoin-carboplatin (2-1 mol-mol),4.82616719932518
SNU-119,53481919,4.072571105351551
YD-8,24748573,2.6006584758291735
RKN,439501,-1.5558449248177562
ChaGo-K-1,navitoclax-piperlongumine (1-1 mol-mol),2.187526491756389
SNU-119,241158,3.4983662079339295
NCI-H1339,216345,4.473442061179046
Kasumi-2,216468,0.9994844042695143
BT 112,613753,3.334694062247594
BT 248,11955716,-0.8129800870812356
TE-14,6918837,-2.4656946388437255
H-STS,5460769,1.2422964505231244
NCI-H209,53495165,1.0251739222665532
Mono-Mac-1,11683005,4.367072031055066
AU565,53393127,4.519828407362072
BT 286,54678924,1.5355225095604494
SK-UT-1,selumetinib-MK-2206 (8-1 mol-mol),3.6848335310272495
SNU-423,selumetinib-BRD-A02303741 (4-1 mol-mol),4.623650435815717
NCI-H2030,navitoclax-pluripotin (1-1 mol-mol),-1.1596715614648436
OAW28,3854666,2.969576020962734
SK-MEL-5,452548,1.4563398029709325
ESS-1,16720766,-0.0466822400972705
SF539,54618164,4.674024000945265
OE33,11364421,2.1514891211235505
BT 498,25150857,2.6595117105682298
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
BT 112,12003241,0.1954695576836523
KLE,11960529,3.6757240900091808
AU565,216345,2.670108206329082
KMRC-20,carboplatin-UNC0638 (2-1 mol-mol),3.446275029594072
SF295,1242560,4.9592610385486315
BT 498,9952709,3.05743267810106
NCI-H929,JQ-1-vorinostat (2-1 mol-mol),-1.9493300173988888
LXF 289,navitoclax-MST-312 (1-1 mol-mol),0.8889120523673528
NCI-H2030,25183872,2.0534030913447174
KE-39,23582824,2.1696583807079275
L3.3,11175137,3.713617877823204
OAW28,168313200,4.298133692275281
KE-39,5281321,1.7518256992041978
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
Lu-65,72193861,1.4354922532582175
RT-4,tanespimycin-gemcitabine (1-1 mol-mol),-3.611548867798562
NCI-H929,16720766,0.2039883469088212
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
B-CPAP,BRD-K27188169,4.5022536360254986
BT 498,2828334,6.550760053460591
OAW28,3634881,3.2370607224140473
SNU-886,42611257,3.550012838833151
Ri-1,erlotinib-PLX-4032 (2-1 mol-mol),2.5965247245213434
SNU-423,6918736,-1.750514789581466
BT 328,5287620,-1.6650936654034112
HSC-3,3062316,0.7848248056146601
MIA PaCa-2,252682,6.325670827636382
OAW28,327653,3.155680016062074
NOMO-1,9884685,0.4754269892492985
BFTC-909,5335621,5.263558209813896
CML-T1,24772860,-2.9357343941167713
NOMO-1,46843906,1.7610241193794407
CML-T1,11364421,-5.082505847469849
SF295,148198,-2.5868327776728517
IST-Mes1,9926054,1.778703370274458
JHUEM-7,11427553,1.505680425653513
SNU-216,25262965,0.7721701443612651
Ri-1,51037431,2.2135682846198543
TE-14,46926350,-3.484137029842133
AU565,16722836,1.9939850778221897
NCI-H209,89928392,0.5845708332842495
LMSU,11964036,2.78018409031856
BT 320,selumetinib-MK-2206 (8-1 mol-mol),3.122937537933898
OE33,selumetinib-navitoclax (8-1 mol-mol),2.78652535811442
HuT 78,11609586,3.1698799239466857
PF-382,9927531,5.462558018035092
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
ESS-1,216345,4.629850284617237
TE 441.T,11507802,0.7950690798154194
L3.3,10427712,3.981964931961501
BT 286,tretinoin-navitoclax (4-1 mol-mol),3.1238797688457978
LMSU,5738263,3.8344484007304063
IST-Mes1,selumetinib-PLX-4032 (8-1 mol-mol),4.413511328522001
NCI-N87,9444,3.5890718830627923
HuT 78,676352,2.2606140524406984
MIA PaCa-2,19582717,4.60477521845353
ChaGo-K-1,JQ-1-vorinostat (2-1 mol-mol),1.2329864056769342
Lu-65,25126798,4.1024131872823055
SF539,selumetinib-vorinostat (8-1 mol-mol),3.0121970622277248
SNU-216,4917,2.962272493292141
SNU-423,6610216,4.208625011644533
OAW28,24901704,3.441244042276163
AU565,25195348,3.492226581515367
PF-382,23725625,4.463043593784131
KMS-12-BM,carboplatin-UNC0638 (2-1 mol-mol),1.757378560571638
IST-Mes1,54596558,4.6034089904468125
MJ,71466380,5.818114341591543
SNU-213,selumetinib-UNC0638 (4-1 mol-mol),1.1702895891126708
IST-Mes1,11612883,3.500237916670588
KYSE-180,12001922,1.7478221517465942
Ri-1,5281672,2.461757068656666
HEC-108,2874250,5.591629636654944
OAW28,3503,2.6573145013500743
AsPC-1,56946209,-4.100794030874608
NCI-H2030,135999136,3.784787341236107
B-CPAP,6918878,1.5397343685525162
RT-4,31703,-0.972901161484085
ChaGo-K-1,23582824,0.7783531266666978
KLE,1716436,1.7262214726363108
H-STS,3136844,3.9456833945347833
LMSU,44589607,3.054254488130367
KE-39,100016,6.665188081944046
KMS-12-BM,168312962,0.4292683974856141
BT 286,selumetinib-JQ-1 (4-1 mol-mol),-1.4917661989890287
LXF 289,44185566,2.4809324153017265
PE/CA-PJ41 (clone D2),9903786,4.971136415817363
YD-8,4788,6.071994479446302
TE-14,107985,-3.6830592516934697
HSC-3,51037431,1.551679435860501
ChaGo-K-1,6438330,2.487418493930481
SNU-119,44185566,1.946638032582097
YD-38,3385,3.5406106671082886
TE 441.T,navitoclax-gemcitabine (1-1 mol-mol),-3.872313979129053
KE-39,6436223,-3.3115059571357417
RERF-LC-MS,11404337,1.609147033115388
GOS-3,65064,3.2866798747983585
NCI-N87,25126798,3.678424158745535
KLE,6610216,4.690158924143472
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
Namalwa,119182,-4.266706274657806
IST-Mes1,8515,4.272788297141445
Kasumi-2,11640390,2.994278179386077
SNU-1077,46398810,3.015075111637921
SNU-119,3384730,4.617278289213739
Hs 611.T,23635314,-4.6983837296806135
BT 248,6852167,2.795606288509473
RKO,439501,-1.8401322759847645
SK-MEL-28,16725315,5.297717320845617
Becker,6918878,4.133877014709684
NOMO-1,135398744,6.340708200805823
KMRC-20,136227924,3.298573049161518
HEC-108,25150857,3.0835964658841246
PF-382,SNX-2112-bortezomib (250-1 mol-mol),-3.001055376524997
AU565,46926350,-5.126810871510528
BT 248,17755052,0.6696435234843453
Becker,246676,4.322247201161359
SF295,54618164,4.313739773462804
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
ESS-1,tretinoin-navitoclax (4-1 mol-mol),5.435469154170702
IST-Mes1,JQ-1-navitoclax (2-1 mol-mol),-0.6205173891711487
Mono-Mac-1,124202324,0.5742000490261943
KYSE-450,4788,5.909868922921636
BT 498,11396600,3.4855943403203704
OE33,6918328,-1.1967730377411518
HEC-108,3062316,2.505322411201139
SF539,5460769,-0.1125532875886319
KYSE-450,10296883,4.225795837642371
AU565,5978,-4.241011158819041
KMS-12-BM,374536,-3.694674622373437
OE33,6918837,-4.942667208986794
Ri-1,25154868,3.4929550535226124
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
MIA PaCa-2,969516,2.746520412230261
KO52,3465537,1.4492421646178062
Becker,44137675,2.3212832651934043
WM793,46224516,3.4822726042013055
HOP-62,salermide-PLX-4032 (12-1 mol-mol),4.05448827815528
Lu-65,151289,1.2132872341043388
ESS-1,vorinostat-carboplatin (1-1 mol-mol),3.745022747956192
NCI-H209,navitoclax-sorafenib (1-1 mol-mol),-1.0259538473904688
SF295,2841722,4.852383814735036
Kasumi-2,71466380,3.646549475683979
KO52,3136844,3.587765010729267
SK-MEL-5,15953870,5.041877344086934
RT-4,637858,2.2211102524324717
YD-8,11497983,4.407361911086299
AsPC-1,24180719,3.701309063973522
YD-38,4788,5.915705304294396
HOP-62,11455910,0.5971366632673413
JHUEM-7,17755052,0.3051122815290938
Hep 3B2.1-7,9935249,3.6352240530651008
SF539,6914657,-6.2311827891537295
MIA PaCa-2,6610216,4.225429520822784
RERF-LC-MS,10113978,3.210216765519601
SNU-1077,9911463,3.723863128468891
LMSU,decitabine-navitoclax (2-1 mol-mol),4.230073302056037
ChaGo-K-1,24797083,0.5545543122526493
Kasumi-2,3062316,1.0772152233383698
AU565,54649381,3.996593912741648
AsPC-1,49793307,-1.0458597957041098
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
NCI-H1339,11625818,4.666003310760862
SNU-423,46191454,1.8759847872608528
HOP-62,9936388,2.1829443174265997
ChaGo-K-1,10385095,0.7525502719591264
YD-8,1566236,1.8146289426775175
ESS-1,56946209,-5.121784419890302
PF-382,5284373,-1.433673800360202
YD-38,crizotinib-PLX-4032 (2-1 mol-mol),1.1156857231715736
SNU-216,5281321,-2.0921736744745156
Mono-Mac-1,241158,3.016187818443372
SF539,46215462,1.5811922555633615
AsPC-1,11178236,-3.0731642515052098
KO52,4705,3.2027960620979576
CML-T1,11152667,-2.6898641024331584
TE 441.T,89928392,-1.2176780680226276
MJ,11364421,-5.505393606714309
SK-MEL-28,11238147,3.8496418591646298
YD-8,3854666,3.395603852355968
IST-Mes1,24753719,4.106786270688489
LXF 289,24180719,2.719444673565486
Karpas-422,24797083,1.0070769014114518
HOP-62,9823820,6.013100500768476
SNU-886,53392493,1.7509874369346907
Panc 02.03,44185566,3.1312758482446976
Lu-65,5287969,-1.6782757581231496
LMSU,25262965,-0.9564445185198788
KYSE-180,10074640,3.100626219289962
SK-MEL-28,409805,5.67996042379304
TE 441.T,107970,1.1503901417213285
HEC-108,24951314,2.044375448042514
KE-39,46907787,0.5111190203360444
PF-382,3815108,1.747404185306998
ACC-MESO-1,136227924,3.807440016829928
NCI-H929,11625818,1.510489676264857
PE/CA-PJ41 (clone D2),11152667,0.8748020996772465
KMS-12-BM,10077130,2.5047652451380857
ESS-1,219104,3.183003735039725
BT 286,11364421,-4.053062558323996
SNU-1077,44607531,1.618519036163535
B-CPAP,12001922,1.695452056973735
LMSU,25062766,1.5653135657494996
HEC-108,400769,-0.3836243025224323
B-CPAP,54649381,3.6438923395842298
MIA PaCa-2,2729026,2.202536609030734
HEC-108,16038120,2.2224846611744957
KMRC-20,49793307,-1.1812176037357236
LXF 289,4096211,2.4023988219433337
EHEB,5329102,1.796828248778677
Karpas-422,53392493,1.7677914883062382
Kasumi-2,BRD-K55473186,1.9287541942318225
KMS-12-BM,2949965,2.1073962260494348
Becker,10427712,4.340316016638328
KMS-12-BM,44632017,-0.0018812054656874
KMS-12-BM,10231331,5.965261420703939
Panc 02.03,31703,0.91391851070637
SNU-886,49846579,-0.4717946703025019
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
HuT 78,46926350,-4.333378092380672
BT 248,24775005,3.1653639365719553
JHUEM-7,36314,3.1831920881425058
MJ,126941,-2.9129176545267055
B-CPAP,3025944,4.582050785449419
TE-14,135875424,2.9954156144381203
KE-39,5280436,3.8449675100084417
L3.3,969516,2.9670664389679677
Mono-Mac-1,25062766,0.4601096632803972
AU565,10385095,1.377392665812461
HuT 78,15953870,2.5576152772998832
Mono-Mac-1,25102847,1.794362073331052
SK-MEL-5,53232,2.3078145894982893
BT 286,421610,2.9885412691069195
SNU-1077,44819697,-0.6774807829742782
SF539,15953870,3.263207389755282
NCI-H1339,11485656,3.447182893453246
Hs 611.T,53232,2.2904107627158536
Ri-1,25262965,-4.2714913167069835
B-CPAP,6450551,2.6982491790934824
SW1573,6623618,2.3278245092002936
HSC-3,10302451,2.6157222782287795
BT 286,4917,2.072486515780226
RT-4,49850262,5.649428604777749
HuT 78,60700,-3.11385512766576
RERF-LC-MS,969516,2.2498421794663095
GOS-3,6918638,1.663921744527482
KMS-12-BM,11234052,1.039776638758491
AU565,15547703,3.2970552657128325
Namalwa,9825149,2.0206272190302887
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
NCI-N87,11222830,1.733835072175261
YD-8,3815108,3.012285181299406
BT 286,23582824,0.769238844518323
SNU-886,135440466,1.015207658153798
NCI-H196,124202324,2.494260717218826
SNU-119,carboplatin-UNC0638 (2-1 mol-mol),3.434233494695521
SNU-886,5738263,4.1230602968372585
NCI-H2030,3385,5.339957284168376
LMSU,5978,-1.3012469579809125
PE/CA-PJ41 (clone D2),613753,3.226711686840519
BT 498,3634881,2.0541278251409967
GOS-3,969516,3.7661148918393823
EHEB,6917907,-5.860529942502672
AsPC-1,tretinoin-carboplatin (2-1 mol-mol),4.763060903699729
SNU-886,6610216,4.570931249301276
GOS-3,JQ-1-UNC0638 (2-1 mol-mol),2.0742730655318233
YD-38,3025944,4.16116392503138
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
HuT 78,72199292,0.6737146382384092
BT 328,11167602,4.034112762840579
HEC-108,31703,-0.7744900613716049
BT 248,5284373,1.9481267041892785
KE-39,navitoclax-pluripotin (1-1 mol-mol),-0.4984280760345316
KE-39,613753,3.317859583771952
HCC2108,3025986,-0.2941479125016869
Karpas-422,241158,2.526232566496073
Hs 611.T,tretinoin-carboplatin (2-1 mol-mol),4.0918925815927585
HOP-62,613753,4.0419201274044445
OAW28,68056272,3.642995313586114
PE/CA-PJ41 (clone D2),selumetinib-decitabine (4-1 mol-mol),4.162814575364819
SNU-423,crizotinib-PLX-4032 (2-1 mol-mol),1.5840192780701718
HuT 78,carboplatin-etoposide (40-17 mol-mol),1.9720174218366708
Hep 3B2.1-7,984333,0.6518370088753827
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
SK-UT-1,67156097,0.3478511759074868
OAW28,3825829,4.635564939734502
HEC-108,6917907,-4.71711933146506
BT 328,5494449,3.740729289137561
SNU-119,selumetinib-tretinoin (2-1 mol-mol),0.2138866552869755
H-STS,462382,0.7084919916713189
TE 441.T,4578,4.2344005798027675
BT 286,9444,5.020908896473072
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
SF295,2733487,6.339386329894747
Becker,148198,-3.822753548425191
BT 112,44489675,3.682584405613984
OE33,135984461,4.2867065871619445
BT 498,6610216,4.077552585304459
OAW28,44486219,3.976522680156617
RKO,10385095,1.2981289243482117
KE-39,25150857,2.5807263536749607
IST-Mes1,42642645,0.3467837133172653
BT 248,54618771,0.8718785044821341
SF295,984333,0.3367134026999984
HSC-3,4261,2.5772280067300293
EHEB,638278,3.110605019807073
Panc 02.03,2708,5.654354843286421
BT 328,400769,0.7243238216549931
TE 441.T,44589607,-0.200979078237225
CML-T1,60168763,3.1201048573104395
MIA PaCa-2,46907787,-0.2565491752841508
NCI-N87,25102847,3.5806366762623645
KYSE-450,3854666,3.622949827534998
BT 248,10302451,3.817813130063646
NCI-H1339,11494412,1.0306883056063765
KO52,9911830,0.3090306906252232
HCC2108,5351362,2.023612240814503
Hs 611.T,71466380,4.28085906871445
BT 498,9936388,2.0435440687928614
TE-14,448949,2.4483560079301365
NCI-H196,65064,4.372824187509945
RKN,2828334,5.965623907482328
BT 328,selumetinib-JQ-1 (4-1 mol-mol),3.8675980198640465
BT 328,135398744,6.520469371663204
SK-UT-1,23635314,-1.1981704896676824
KLE,72734382,3.5646775287439505
HSC-3,135999136,4.352393936185964
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
LMSU,168312962,4.105800122245941
AsPC-1,25262965,-4.011117827244764
HuT 78,613753,2.0595917856735104
MIA PaCa-2,45279963,3.811404358081299
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
LXF 289,53392493,2.5437082258312804
MIA PaCa-2,6610355,4.178666278984774
WM793,67156097,1.6522934388361206
H-STS,vorinostat-navitoclax (4-1 mol-mol),1.152799818591655
ChaGo-K-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.484510987120187
NCI-H196,11178236,-1.2379232510907854
H-STS,387447,-5.130568890460207
Becker,54626689,5.068066609576423
SNU-886,9903786,2.951492144984292
Lu-65,1641662,3.4141993296588953
HSC-3,3825829,3.2177804213288757
KE-39,71304818,2.3198950996012515
Kasumi-2,7251185,0.9050560163252253
BT 286,71729975,1.6702484611001218
NCI-H196,49793307,-2.562819319116333
ChaGo-K-1,57519531,5.108001820042393
YD-38,BRD-A02303741-navitoclax (2-1 mol-mol),-0.2666516254735072
HOP-62,9444,4.365244468454382
OAW28,9911830,2.567685352724645
Namalwa,9549297,1.4031808932781888
SK-UT-1,53495165,1.179970512792514
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
HuT 78,44607531,1.3859547211867245
SK-MEL-28,5282054,3.2979328784688606
SNU-216,3081361,1.3320694095529937
Kasumi-2,11152667,-1.6921100461719016
Mono-Mac-1,135999136,5.618936483472871
CML-T1,2733487,8.178067655910914
Hep 3B2.1-7,11364421,1.1768671556641792
CML-T1,219104,2.3392357294314055
H-STS,44632017,0.7308222143683922
Becker,984333,0.835843884651037
AU565,11964036,0.1505437081667179
HOP-62,16219061,3.3311422412461185
Hs 611.T,135398516,0.8524576808653034
L3.3,119182,-1.782056546640076
YD-38,3384730,3.3867880230006477
RKN,216345,4.602972623005823
Kasumi-2,107970,1.3663131605888186
KYSE-450,44566777,1.0165509502605254
SW1783,2746,4.238030101530504
RT-4,piperlongumine-MST-312 (1-1 mol-mol),2.794941054913251
KYSE-450,126941,-4.1478729331459006
SF295,448949,2.9940610977103455
SK-MEL-5,23582824,0.6417142351505073
SNU-886,2708,4.666368688758876
AsPC-1,44566777,0.4941234322675649
BT 328,387447,-3.18043057197166
NCI-H196,11175137,3.231563975100378
SNU-119,148198,-2.509458516530883
AsPC-1,8515,4.986545700595871
NCI-H1339,262093,3.4716839644219246
SNU-216,54678924,1.994073400208429
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
KE-39,9908783,5.748750979730715
Hs 611.T,11497983,2.8823121008945236
KMS-12-BM,9929138,5.078790269314151
HEC-108,5287620,-1.2592050187487678
HuT 78,156414,0.7736660521630903
KMRC-20,15983966,1.928995908058428
BFTC-909,6252,5.031852570794812
BT 248,11175137,2.43855252671782
BT 286,135440466,0.9125155825882112
AsPC-1,66577038,3.0978373542257973
H-STS,16722836,2.295773784833407
H-STS,44137675,1.4047344665850907
HCC2108,17759555,3.761463468003181
RKN,168312962,-2.199105388969794
OAW28,23582824,0.6142488529896691
JHUEM-7,387447,-4.291919985887575
AU565,5311,0.7700744364318666
HOP-62,100016,6.313498249886369
SNU-886,5278396,3.692331874950952
LXF 289,71466578,4.726723075051965
Namalwa,54618164,3.970816819204835
EHEB,969516,2.488094363127618
OAW28,1566236,3.486252592676433
ChaGo-K-1,44489675,3.622154814470552
LXF 289,5329102,1.6667075021580833
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411
RKN,44197249,3.9607888926275217
TE 441.T,11625818,4.2092536605530135
SNU-423,5281321,-2.4024956410686817
RERF-LC-MS,71680916,4.2559060280924665
Kasumi-2,6918328,-2.1918789082401355
OAW28,16659841,4.936500838241895
BT 320,6852167,5.054396580410171
Mono-Mac-1,656346,0.8395847680643302
Lu-65,54618771,-0.448084270947246
Karpas-422,15547703,2.8004410697454687
SK-UT-1,5978,-1.5541444209487143
L3.3,135875424,3.974579804692541
SNU-1077,6917907,-0.4505142138964601
Ri-1,446155,3.1357563975714036
NCI-H1339,9884685,1.174532924558328
KE-39,navitoclax-piperlongumine (1-1 mol-mol),-0.2152074007553692
MIA PaCa-2,6918638,-0.2858557386208528
YD-8,42642645,0.5447742050526033
KE-39,11497983,4.192627154878264
BT 286,11507802,1.483541301011614
Karpas-422,9803433,6.366400015677791
GOS-3,73707398,2.285638026393688
SF295,24785538,2.7839874159397873
ChaGo-K-1,5287969,-1.0782192014553775
SNU-886,9825149,2.821873129999439
SNU-1077,BRD-K58730230,4.372466359234828
Ri-1,11964036,-3.160222236239868
ESS-1,11178236,-5.021714388014341
B-CPAP,100016,6.506572981316216
SW1783,441298,4.0307638761656435
SNU-1077,9935249,3.485135676518772
KE-39,56949517,4.944572827336268
MIA PaCa-2,54454,2.3541686076518253
Ri-1,1750826,-4.869262928717968
HCC2108,216345,4.433678918617411
KO52,25062766,2.019050283662434
NCI-H929,49793307,-4.29401842302784
HOP-62,2828334,6.524051840329246
L3.3,9956119,3.8207787288773063
OAW28,52912189,1.8010258653688298
ACC-MESO-1,decitabine-navitoclax (2-1 mol-mol),0.8720161508690694
LXF 289,9908783,5.689655754809611
KMRC-20,168313047,2.207569694794804
KE-39,9911830,2.572250482212608
SNU-886,11612883,1.6070499462687953
AsPC-1,24748573,4.519934140177759
PE/CA-PJ41 (clone D2),56649450,2.1051297783430187
RKO,4259181,-0.4049041326260317
NCI-H2030,676352,2.9901891656883683
Becker,568763,1.2199844224955132
PF-382,4521392,4.102056118448562
HSC-3,44543605,3.9014816323917816
HEC-108,crizotinib-PLX-4032 (2-1 mol-mol),2.8622947616000984
EHEB,9907093,3.575019057407179
SNU-119,crizotinib-PLX-4032 (2-1 mol-mol),2.378023446596204
Ri-1,navitoclax-MST-312 (1-1 mol-mol),-2.913946311421581
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
RKO,5566,3.2270609816668308
TE-14,54618164,4.303760954268937
TE-14,44607531,1.0565875774081055
AsPC-1,54626689,5.229882111208764
SNU-213,89928392,4.8113412324352
Hs 611.T,66577038,1.872094427168669
Lu-65,5746,1.255843467205462
SF295,53232,0.9695284418052078
KYSE-450,135999136,4.777760732357945
Hs 611.T,135421197,0.2639365806220374
NOMO-1,2858523,2.9127751570608136
ESS-1,selumetinib-decitabine (4-1 mol-mol),5.708912466990789
SW1573,5113032,6.532830278238065
NCI-H1339,60750,-4.602537649686373
AsPC-1,984333,1.2969820633088274
HOP-62,3136844,3.524389287742587
BT 286,JQ-1-navitoclax (2-1 mol-mol),1.691250716820441
GOS-3,439501,-3.404828566068769
YD-8,9908783,5.744379377370956
Lu-65,selumetinib-navitoclax (8-1 mol-mol),0.9088068792801124
SW1573,52912189,3.9296893768173065
SNU-119,9956119,2.9397923190583866
KYSE-180,navitoclax-birinapant (1-1 mol-mol),5.391613379714011
MIA PaCa-2,5284616,3.409206974987919
SNU-886,11507802,1.52809997396743
B-CPAP,444795,4.737983928137852
L3.3,4259181,-1.5745308976200183
KMS-12-BM,451668,-4.0111672438300126
KMRC-20,JQ-1-UNC0638 (2-1 mol-mol),2.8287414261232744
SNU-216,119607,5.474554011556866
YD-38,selumetinib-BRD-A02303741 (4-1 mol-mol),1.726529060394152
TE-14,24797083,1.7981487248976569
TE-14,crizotinib-PLX-4032 (2-1 mol-mol),2.790681196268514
JHUEM-7,72734382,4.444949272371647
Hs 611.T,23725625,2.1031489949937745
SF295,119182,-1.4526751303422951
NCI-H1339,44486219,3.922591489913905
YD-38,9911830,2.6731616519017827
SK-MEL-5,5282054,3.769587213204863
Becker,23582824,0.522211888016452
Kasumi-2,46224516,1.9043930771708657
JHUEM-7,carboplatin-etoposide (40-17 mol-mol),1.5968743771599203
AsPC-1,25126798,4.196072723195887
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
TE-14,3825829,4.1158266662634
OAW28,25062766,3.2225198305631464
TE 441.T,2746,2.0767838467856654
EHEB,72734382,4.1680701190018965
SK-MEL-28,JQ-1-UNC0638 (2-1 mol-mol),3.2511291788687218
BT 286,16722836,1.8037687633845072
ESS-1,11213558,1.497271752916858
SK-MEL-5,6918328,-0.2289900507197424
EHEB,9866186,-0.355142067370403
NCI-H1339,6914657,-1.8219556979894729
NCI-H2030,9444,3.598421183891499
RT-4,46843906,5.20167725568056
Becker,16013152,6.289892146912785
TE 441.T,3552672,1.4921637874892284
KMS-12-BM,322968,1.914773928139573
RERF-LC-MS,119607,4.38818595494476
RT-4,1641662,3.4681958034174647
Ri-1,375860,-0.316355066244252
SNU-886,216239,1.293630546683639
Namalwa,168313200,2.5159524673485074
ESS-1,44543605,4.6000400414532505
YD-8,11427553,2.049391717183717
Kasumi-2,23582824,0.0696466908969853
Hs 611.T,73707398,-1.1602307486634975
HSC-3,54618164,4.361792769190993
NCI-H196,2874250,-0.7115511680043887
PE/CA-PJ41 (clone D2),24748573,2.6616390878971297
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
HOP-62,7326481,2.9844448959210435
KYSE-450,439501,-3.185322034462323
JHUEM-7,10385095,0.8646007643870881
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
JHUEM-7,135421197,2.2083604774336973
KE-39,54678924,3.7130157242485184
LMSU,1641662,4.120981858702554
SNU-216,11404337,-0.7436610925810526
CML-T1,451668,-2.1837981176470738
OAW28,11625818,4.459236282412159
Namalwa,135659046,3.012855120581617
KE-39,2126,5.971386354859058
EHEB,16741245,4.711370152707264
YD-38,444795,4.9688300992603
NCI-H2030,11626560,2.673199757356022
Mono-Mac-1,650361,3.717997934004441
Hs 611.T,54618771,-1.6189149218844685
SNU-216,57330099,4.208941987405072
HOP-62,tretinoin-navitoclax (4-1 mol-mol),3.2080972792190017
Mono-Mac-1,9956119,3.892925870265635
ACC-MESO-1,10184653,2.2423096516125143
SNU-216,9911463,4.000497828097352
YD-38,42642645,1.3600120162800655
NCI-H929,54639665,4.443848049019438
SNU-213,72376,-0.8991790133219716
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
Hs 611.T,9826308,-1.2831822021204369
SNU-216,5566,3.0388673549220178
KE-39,135440466,2.490274182929518
BT 248,4788,5.6007343352714605
SNU-216,navitoclax-piperlongumine (1-1 mol-mol),1.18336766030724
PE/CA-PJ41 (clone D2),5284373,4.689780873278642
PE/CA-PJ41 (clone D2),24771867,3.741688569493883
NCI-H2030,6852167,3.664120569274895
KE-39,135421197,0.9510973278490732
SNU-213,11152667,-0.7142929754084242
PF-382,54618771,-0.2642287573533248
NCI-H196,doxorubicin-navitoclax (2-1 mol-mol),0.5112205720808501
SNU-216,4259181,-0.1596508841879307
BT 112,5746,-0.397041971069554
Hs 611.T,151289,0.7556153766832656
Mono-Mac-1,6438330,1.7309353539073105
LMSU,54596558,4.409593333652482
NCI-N87,15953870,2.623738434863841
AsPC-1,25154868,4.981069474579037
HSC-3,3689413,-2.2600837113951497
SK-MEL-5,serdemetan-SCH-529074 (1-1 mol-mol),2.407919605173646
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
SK-UT-1,10302451,4.065117068717504
ChaGo-K-1,1716436,2.640307012974755
RKO,25126798,4.002843113400742
KYSE-180,54143018,-0.6121199451945726
ChaGo-K-1,1750826,-1.5272683487068526
KMRC-20,9903786,3.936421872110463
KLE,JQ-1-navitoclax (2-1 mol-mol),-1.1752020177182094
ACC-MESO-1,11175137,3.3506590774184635
Lu-65,49867930,4.634333542704757
CML-T1,9967941,3.2676581028704503
LMSU,24753719,4.829555677738913
BT 286,6852167,3.4826351863854295
CML-T1,3854666,0.73725489161191
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937
SW1783,11719255,3.4036440848936063
SNU-213,10127622,-0.4888185859398967
CML-T1,168312962,-0.7219792388324245
BT 248,76446078,4.2307608716074565
SNU-423,4917,3.783227754006492
RKN,6918736,-2.1202784612128416
NCI-H929,9936388,-5.492803140929198
KE-39,4917,2.6993900205990866
KE-39,6918638,0.3873788369468276
KE-39,JQ-1-vorinostat (2-1 mol-mol),0.4197456531616845
PE/CA-PJ41 (clone D2),tanespimycin-gemcitabine (1-1 mol-mol),0.0543714562940706
LXF 289,11977753,-2.1467130480879217
Ri-1,156414,0.7366105303424468
BT 286,71751553,4.3381123592050015
EHEB,15983966,-3.458477351874515
NCI-H2030,JQ-1-UNC0638 (2-1 mol-mol),1.861719916285668
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
CML-T1,1750826,-4.284831191139796
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
PE/CA-PJ41 (clone D2),11427553,3.7565243742301617
Namalwa,11427553,1.1715511332950066
SNU-216,89183176,4.367459435091247
Ri-1,36462,-0.3836251292851517
BT 320,10184653,3.7290342309119686
Namalwa,44493528,4.097758002058851
SNU-216,262093,2.2180002949269793
EHEB,11152667,-1.348021466254982
NCI-H1339,6918837,-3.0709410358717713
SK-UT-1,23725625,5.077881708764169
OAW28,24964624,1.7856613849766505
AU565,3136844,3.8072298284959385
HuT 78,ISOX-bortezomib (250-1 mol-mol),-1.0650160762676202
NCI-H929,selumetinib-tretinoin (2-1 mol-mol),3.262087806301954
BT 286,25262965,-1.0999928306967477
BT 112,selumetinib-MK-2206 (8-1 mol-mol),3.149156895525344
BT 286,135423438,1.7051552017965996
SF295,216239,2.6819667616867804
B-CPAP,6918289,2.3955979884135856
ESS-1,JQ-1-vorinostat (2-1 mol-mol),1.066705942118914
OE33,5287620,-1.0908956094988789
KYSE-450,doxorubicin-navitoclax (2-1 mol-mol),0.7817120569576905
SNU-216,25227462,-0.5690075475952759
AsPC-1,4259181,1.083384461798112
KMS-12-BM,67291369,0.9867493208502254
OAW28,11977753,-1.87780111267196
Kasumi-2,5470400,-0.4099593110944021
BFTC-909,53232,2.9810373365160316
SW1573,9840324,5.095993559480237
JHUEM-7,148198,-3.5780143567355336
SNU-216,44607531,1.0987283628876423
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995
Hs 611.T,selumetinib-PLX-4032 (8-1 mol-mol),4.80293901868776
JHUEM-7,31703,-1.6318454147160704
SW1573,24951314,1.273840217876839
Kasumi-2,984333,-0.6107639841292208
SK-MEL-5,24901704,3.633567608703879
BT 320,navitoclax-sorafenib (1-1 mol-mol),2.857010837113841
KMRC-20,serdemetan-SCH-529074 (1-1 mol-mol),2.30805961058782
Ri-1,5284329,2.556131317651745
LMSU,6610216,5.122726082721053
JHUEM-7,navitoclax-PLX-4032 (1-1 mol-mol),2.564492004109999
SF539,ISOX-bortezomib (250-1 mol-mol),0.2487005267767388
SNU-423,16065773,3.3258076403763415
RKO,216468,3.08027711257304
Namalwa,11152667,-1.2838817681822148
YD-38,vorinostat-carboplatin (1-1 mol-mol),3.8658653780233174
TE-14,11977753,-1.046506407642015
BT 498,73707438,3.8032973142746944
EHEB,322968,2.810351153697849
SK-MEL-28,11609586,3.4405879062717384
HOP-62,9868037,3.695700187533532
BT 248,216345,4.501699374414374
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
HEC-108,637858,2.449708151119433
AU565,11625818,3.8205404098717457
KLE,446155,0.8514088628776029
Kasumi-2,73707398,-0.974822208153436
ESS-1,100016,6.502595194480242
KE-39,44589607,3.0776272038529475
HEC-108,168312962,-2.000701767765318
BT 320,72376,3.3397736941212433
Hs 611.T,322968,1.9991889288726985
Ri-1,selumetinib-vorinostat (8-1 mol-mol),1.7453072919465344
HOP-62,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7687331733710137
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788
NCI-H1339,11175137,2.789615167236726
PE/CA-PJ41 (clone D2),168313200,3.0210086537721574
AU565,52912189,3.2475583793468994
LMSU,5351362,1.3918765572974243
HEC-108,5329102,3.413313733369096
YD-8,17759555,4.675684554869825
SNU-423,11238147,2.877637999183568
CML-T1,637858,1.454745710944211
Hs 611.T,2945648,1.0461407300321148
KO52,JQ-1-vorinostat (2-1 mol-mol),-1.1971582258759
NCI-H209,568763,-1.9106467846038149
NCI-H929,5281672,4.191985707125186
KE-39,24797083,3.5589598878178497
SF539,54649381,3.7800507892247337
PE/CA-PJ41 (clone D2),selumetinib-piperlongumine (8-1 mol-mol),3.1639027929740977
IST-Mes1,2871966,0.3614602719279896
Ri-1,5351362,-0.2436544124268334
HOP-62,42642645,-0.4674089233275948
HEC-108,BRD-A02303741-carboplatin (1-1 mol-mol),4.399669755507875
SK-MEL-5,10385095,1.0393957169918682
ESS-1,16725315,4.522564141114606
SNU-216,439501,-2.844909600692544
EHEB,11175137,2.3201035229404186
HuT 78,9933475,1.6695706910823258
SNU-216,2842253,6.543596407087795
YD-8,135875424,4.059859189077627
BT 248,3465537,1.7130202551321618
NCI-H929,9866186,0.2477340085292711
Mono-Mac-1,135875424,3.0350686584049473
Karpas-422,5311281,1.673971319714702
MJ,53495165,-2.457565715339927
KE-39,46199207,2.43842073424698
KMRC-20,51037431,3.686624478209352
SNU-886,3503,1.4984016938588718
KO52,168312962,3.725113432796697
HEC-108,54143018,-0.2958313294856644
TE-14,5351362,1.5520567596648778
Panc 02.03,3634881,5.203302993958793
YD-8,8515,3.9380466861306616
Kasumi-2,navitoclax-PLX-4032 (1-1 mol-mol),-2.139769926295153
AsPC-1,12001922,2.2862775547931675
HOP-62,5494449,2.5914632586944757
Kasumi-2,57519531,1.2182883326717542
PF-382,selumetinib-PLX-4032 (8-1 mol-mol),4.556490015738598
Becker,54143018,0.9159558532527126
Ri-1,44632017,0.5070203922812767
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
Hs 611.T,44819697,-0.3560757455908935
KMS-12-BM,73707398,0.3620923628880652
OAW28,6918328,-0.6493981710218658
Becker,5278396,3.3842823728851896
SK-MEL-28,448949,3.238404607580412
KLE,11238147,4.019419041110989
NCI-H2030,5329102,2.740425855579455
SNU-1077,136227924,3.612132735883527
YD-38,docetaxel-tanespimycin (2-1 mol-mol),-6.046510152925682
BT 248,25126798,4.2564362718884965
RERF-LC-MS,54619267,3.9836959677109354
SW1783,2742550,4.177993888768022
Kasumi-2,24785538,0.7031648291020229
JHUEM-7,446155,2.408217764237835
PF-382,24180125,1.6002910588088834
B-CPAP,navitoclax-birinapant (1-1 mol-mol),0.9967286045428472
BT 286,9927531,5.383522650777723
BFTC-909,25262965,-1.7887871070762158
NCI-H929,54618771,0.737310556758401
YD-38,6918878,1.9544943666312664
WM793,9956119,2.719502921417229
SF295,10184653,2.7634367645890987
Hep 3B2.1-7,1750826,-1.655777027766404
BT 248,644241,1.8454939937856112
RKO,168312962,-2.5117583451491012
KYSE-180,44589607,3.5167084117795513
SK-MEL-28,44589607,3.4025366741016585
L3.3,216239,2.590745343804584
KYSE-450,107985,-2.5991622295290413
BT 112,1641662,3.733134142495612
H-STS,400769,-1.1927584059737322
PE/CA-PJ41 (clone D2),2746,3.71543902732957
PE/CA-PJ41 (clone D2),11612883,4.335668949701792
KE-39,24785538,4.0612751994912335
KO52,9887053,3.73966963035621
SNU-423,9884685,0.0513758273382596
PE/CA-PJ41 (clone D2),11317348,4.636596301807158
Hs 611.T,24964624,-0.7644006333245535
OAW28,4259181,0.9119817479539226
Hs 611.T,3011155,4.323994031754243
SK-MEL-5,11175137,3.02526064620366
SF295,65064,5.224650721968281
Ri-1,11152667,-3.7285428023246943
SNU-119,3543504,4.346237641095953
HuT 78,24856436,-0.4041118949053068
OE33,176870,4.3422171612501765
Mono-Mac-1,24978538,0.6361846953537684
Ri-1,89183176,4.051914916929391
Mono-Mac-1,3025986,-1.3623567960722094
ChaGo-K-1,24978538,3.0694714119392112
KMRC-20,tanespimycin-gemcitabine (1-1 mol-mol),3.002722893797395
WM793,16725315,3.226655824606768
AU565,24775005,3.4802015368768657
KMS-12-BM,49836020,4.363885927749537
KLE,11612883,3.331847823409616
YD-38,25262965,-1.039531503301445
TE-14,31703,-0.3184881435605857
HCC2108,24180125,3.362517679132719
YD-8,124202324,2.8742041026946596
NCI-H196,46398810,3.0723351173953386
SW1573,24797083,0.9725439959134782
NCI-N87,9903786,2.403456427338335
KO52,241158,3.6727095918533
LXF 289,3815108,3.5075214319549683
SNU-213,vorinostat-navitoclax (4-1 mol-mol),1.9866746230538823
RT-4,135411,2.3178037837243166
LXF 289,44607531,1.6515112206427849
SK-MEL-28,12001922,1.76503761159643
KMS-12-BM,11404337,-1.6165924780935808
SNU-423,11152667,0.7300251820386706
Karpas-422,19582717,2.669831317762961
SNU-213,46224516,2.251156317264964
B-CPAP,5746,2.211923482717491
BFTC-909,10184653,1.6906150005550105
B-CPAP,4477,0.711157079816854
L3.3,11238147,4.461700161811432
IST-Mes1,vorinostat-navitoclax (4-1 mol-mol),2.4210379040593972
SNU-213,doxorubicin-navitoclax (2-1 mol-mol),0.7570343879914795
BFTC-909,135398516,3.047749913114312
NOMO-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0823481762060787
AU565,2729026,2.5804084357046033
Lu-65,4705,2.2628868276979404
SNU-216,168312962,2.1007158447474743
AU565,72376,-1.9935205494525805
AU565,15983966,1.7541662071439053
SF539,3385,1.3053252400719229
OE33,11152667,-0.6577753900315373
TE-14,54613361,-1.0025611290728191
BT 286,53392493,1.7738214073447722
KO52,6184667,1.650378416289273
BFTC-909,25183872,0.7872065650622051
HEC-108,selumetinib-MK-2206 (8-1 mol-mol),4.526627272212327
AU565,445455,4.9301368045011955
GOS-3,44137675,4.312209162350938
NCI-H196,4788,5.975435744717622
CML-T1,135421197,0.9317392273651705
SW1783,9927531,4.46381053918724
ChaGo-K-1,SNX-2112-bortezomib (250-1 mol-mol),-0.1631401079810167
KE-39,2749,1.448224267904264
SF539,136227924,2.8154987155907905
SNU-886,25183872,0.04916046112461
HuT 78,9967941,3.6248756588046382
SF539,72376,-2.558258632142047
KLE,9903786,3.130074514321622
KE-39,9967941,2.56940062250581
NCI-H1339,445091,6.107545506766502
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
Hep 3B2.1-7,9549297,3.612635734062334
RKN,5978,-1.5379865785523688
RKN,15547703,3.1395613683678287
BFTC-909,5978,-2.385180460490498
Mono-Mac-1,11626560,0.7319803190138492
PE/CA-PJ41 (clone D2),5746,0.9508573023316716
Ri-1,selumetinib-piperlongumine (8-1 mol-mol),2.320305378407513
LMSU,SNX-2112-bortezomib (250-1 mol-mol),-0.6329010440725568
ESS-1,10385095,0.0154495368261296
SNU-216,23725625,5.133844991489014
Namalwa,46943432,0.650701651867592
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
SW1783,selumetinib-JQ-1 (4-1 mol-mol),4.8105600035571126
Lu-65,11626560,1.1319488815614032
SF295,44259,0.8800000851970594
SNU-216,6917907,-6.3927212972155445
SNU-119,5470400,-2.350709459089954
GOS-3,JQ-1-vorinostat (2-1 mol-mol),1.826489490547508
AsPC-1,24951314,2.0738112971970275
KMS-12-BM,52947716,-7.113059308361459
CML-T1,2828334,5.888296080725352
ESS-1,12003241,-1.211695248693708
KE-39,11485656,2.227722528153515
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
BT 498,1566236,3.668153571841636
PF-382,375860,-0.9454794315487792
SF539,54626689,2.4541626708766855
KYSE-450,285033,-1.7116882105667988
NCI-H929,12003241,-1.2414676879861424
RERF-LC-MS,11719255,3.775646564562419
KYSE-450,2749,3.233270096277708
Hs 611.T,selumetinib-MK-2206 (8-1 mol-mol),1.4654390706585927
MJ,56946209,-4.259299613292059
AU565,6918736,-3.127988177088939
KE-39,322968,3.9954940366420297
Namalwa,9933475,1.7779880022175991
ChaGo-K-1,148124,-2.510637409875074
HuT 78,navitoclax-birinapant (1-1 mol-mol),-0.5043518643676743
SK-UT-1,387447,-4.561746078529997
PF-382,124202324,0.9608672552424454
WM793,16038120,2.08609917753077
LMSU,44819697,-1.5946135282515452
SNU-216,JQ-1-vorinostat (2-1 mol-mol),0.1929169552366828
MIA PaCa-2,11396600,3.289038329533777
IST-Mes1,10074640,3.5425729050518053
LXF 289,11612883,1.9814919247106189
BFTC-909,4917,2.929839520827846
Mono-Mac-1,10026128,4.356045161202684
SNU-1077,107970,2.607215080284504
BFTC-909,11238147,5.503103761619835
BFTC-909,984333,1.0937084793466407
RT-4,11238147,3.737016422545975
YD-8,JQ-1-vorinostat (2-1 mol-mol),1.7372019591077774
KE-39,12001922,1.538248730222034
SNU-886,selumetinib-UNC0638 (4-1 mol-mol),2.5204736993113968
Mono-Mac-1,11152667,-4.583124026355614
SK-MEL-5,carboplatin-UNC0638 (2-1 mol-mol),3.55936398047261
HEC-108,20959075,-3.040145887697204
AsPC-1,49766530,-1.5554439905221051
CML-T1,24785538,1.8797614633691848
MIA PaCa-2,25183872,-0.1921951242743396
AsPC-1,5738263,4.8764899816054905
Mono-Mac-1,selumetinib-JQ-1 (4-1 mol-mol),0.1381126547939459
LXF 289,44486219,3.8558224358877298
YD-8,selumetinib-JQ-1 (4-1 mol-mol),3.141432259202229
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
YD-38,25126798,3.840262904092756
LMSU,107985,-1.9062813049718328
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
LMSU,9933475,1.3920899137371403
OAW28,5460769,4.044755256654475
NCI-H929,126941,-0.648952926168031
MJ,11234052,3.3276359247001124
NCI-H1339,135398738,5.033311384632643
KLE,124202324,2.798176787230371
JHUEM-7,5281321,-3.009296919443196
KYSE-180,2708,6.074726642360877
KYSE-450,12001922,2.3081029542586027
B-CPAP,46398810,2.9553918901926965
CML-T1,72376,-3.431780344099396
TE-14,2871966,0.4437222312458658
NOMO-1,168313200,3.152434526133537
BT 286,2749,-0.1297410045217301
Kasumi-2,135999136,3.771420948620172
TE-14,25150857,2.4184084482613506
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
KMS-12-BM,44607530,1.8742389530579
HOP-62,11214940,4.302935020611148
SW1783,73707398,1.417049584359394
NCI-N87,19582717,3.5520999296373437
AU565,227681,3.7153411694983887
B-CPAP,16720766,-0.0542134941135855
Lu-65,219104,4.835008857489988
RT-4,vorinostat-navitoclax (4-1 mol-mol),0.3971975472076162
HOP-62,10302451,2.804324049095648
Mono-Mac-1,159324,1.4923395471491
B-CPAP,6610355,5.531584540000207
MJ,23635314,-4.748597421317521
Panc 02.03,42642645,1.4849485241267697
SW1573,12001922,2.294011710402099
BT 286,11612883,1.7976038545897062
NCI-H1339,1641662,3.461186897446441
TE-14,2708,5.504190603838346
KE-39,tanespimycin-gemcitabine (1-1 mol-mol),2.3625667461042363
Hs 611.T,54596558,3.959669685296965
HuT 78,53495165,-2.7087413418511135
GOS-3,25227462,1.8095270845710951
PE/CA-PJ41 (clone D2),208908,3.026569932345668
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
SNU-423,10427712,5.313919411961389
Ri-1,24797083,-0.1682916491575397
CML-T1,selumetinib-tretinoin (2-1 mol-mol),2.254120654073675
BFTC-909,11178236,-2.4757289909406683
HOP-62,6918837,-2.6537320914215705
KMS-12-BM,9887053,-0.448618862637891
Karpas-422,168312962,2.0358328340743976
EHEB,44491742,5.293750317448726
HOP-62,49793307,1.9032662120533077
RERF-LC-MS,9903786,2.6182355767545213
Hs 611.T,45279963,3.56639954670695
NOMO-1,56946209,-4.862706213909506
SNU-423,9907093,5.098934107063476
SK-UT-1,navitoclax-piperlongumine (1-1 mol-mol),3.105185528724131
H-STS,6917907,-5.810162038338551
SF539,54613361,-1.5545710356973723
NCI-N87,375860,-0.928197184659684
SNU-423,9915743,2.488155909988838
Becker,10184653,1.6824622119630197
WM793,6610216,4.179764818643997
BFTC-909,54454,2.6967031082973527
AsPC-1,176870,5.289710540069244
SNU-119,89928392,1.8847686882331605
RERF-LC-MS,11626560,1.1998891680987491
EHEB,36314,1.738223816404837
KMS-12-BM,51039095,1.746743438142051
NOMO-1,3689413,-2.5325178418163174
BT 112,5113032,4.617227577008262
Karpas-422,9884685,-1.8579964706591168
WM793,2746,3.494212158504219
AU565,5328940,1.3384832652905083
AsPC-1,11396600,3.3240147605355506
SNU-213,12001922,1.7290947375839942
NCI-H1339,31703,-0.4400557205709002
SW1783,16065773,5.946044884546371
BT 328,44819697,-1.602072753607262
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163
TE 441.T,49793307,-2.249705238530148
KYSE-450,11485656,2.990129749938368
SNU-1077,11427553,3.133065225486414
ACC-MESO-1,44185566,3.81089645336787
Lu-65,5329102,2.383340911906642
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
PE/CA-PJ41 (clone D2),16038120,1.5447880430004386
SK-UT-1,selumetinib-JQ-1 (4-1 mol-mol),5.500503252581381
OAW28,12001922,1.8847589611064504
SK-MEL-28,9967941,2.8664024889360644
AsPC-1,9825149,2.485133390345911
ChaGo-K-1,72376,-1.2287910784221336
EHEB,JQ-1-MK-0752 (1-1 mol-mol),0.5958653616888636
OAW28,60700,1.95920843974679
B-CPAP,25126798,3.9395584253439258
KO52,6918638,-1.0658834160946808
SF539,25105715,3.397362341594616
OAW28,10385095,1.310156197215646
RERF-LC-MS,89928392,3.2509495975064193
KLE,navitoclax-sorafenib (1-1 mol-mol),-1.1377907715980664
MIA PaCa-2,9884685,0.7084207681532095
KMS-12-BM,2945648,2.2840305648054833
SW1783,5746,0.5250942021656682
BFTC-909,6438330,3.0201113942824436
CML-T1,46199207,2.0991647549590304
KMS-12-BM,5291,3.1050299402444095
ESS-1,136227924,3.049003867547222
H-STS,1716436,2.174736460628774
NCI-H1339,2746,3.2710965804253633
OAW28,3689413,-1.4375749125930504
SNU-213,5351362,2.981146821236434
TE-14,148124,-4.465123316500658
SNU-119,5460769,2.8404840787101593
AsPC-1,11178236,-3.0731642515052098
KE-39,51039095,2.7316148787408427
Hep 3B2.1-7,446155,3.475346948597935
RT-4,24821094,3.143156783053102
NCI-H929,5351362,0.2210032032775228
YD-8,1750826,-3.2226271071481123
JHUEM-7,24951314,1.2473556697176558
MIA PaCa-2,10302451,3.7253784601245945
ACC-MESO-1,100016,6.4652465436588775
SF295,10074640,3.6425650625535897
ChaGo-K-1,11647372,2.7758694049748813
YD-8,49867926,4.297673709287735
L3.3,374536,1.2868097755844614
SNU-119,9911463,2.8532899111041385
RERF-LC-MS,5329102,2.8374518121885637
SNU-119,44489127,4.960346134562833
CML-T1,24180125,2.207667320892802
L3.3,2749,2.0470310524130717
SNU-886,3825829,4.2404054797227735
SK-MEL-5,445455,5.188541554233024
SF295,1750826,-2.513397555573866
B-CPAP,alisertib-navitoclax (2-1 mol-mol),-0.5748876741449156
SF539,285033,-3.6653668217695183
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
BT 498,136227331,4.544114350665722
BT 286,crizotinib-PLX-4032 (2-1 mol-mol),1.6245444859080926
EHEB,46943432,1.4009693182531664
KYSE-180,446155,1.8141725427218347
KYSE-450,11222830,1.7445073399277342
TE 441.T,53392493,4.098968257206057
KLE,119182,1.982009911849402
SF295,25150857,3.038892661380135
SF295,5281321,-1.0284803078097726
HCC2108,vorinostat-carboplatin (1-1 mol-mol),3.476281574567543
LMSU,navitoclax-gemcitabine (1-1 mol-mol),0.2056426446886963
TE 441.T,72376,-2.0825298958308496
RERF-LC-MS,72734382,4.885789692793362
AU565,72199292,-0.5217195589045935
KYSE-180,44491742,6.4799420322622305
PE/CA-PJ41 (clone D2),vorinostat-carboplatin (1-1 mol-mol),4.068145028137521
Ri-1,753704,4.378804687168766
KO52,44486219,3.943229748737328
YD-8,25102847,2.057476964760047
JHUEM-7,4578,4.2382968636831535
LMSU,16038120,1.0642114594696983
NOMO-1,54649381,4.1030759428324455
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
NCI-H2030,66577038,4.032519015541418
SK-UT-1,3634881,3.231814398730286
AU565,44819697,-0.774785052988496
Ri-1,50905018,4.0972663844416255
SF295,126941,-0.9605474872122216
PF-382,12001922,1.3621804177433754
NOMO-1,148198,-5.33573798573566
Karpas-422,5287969,-2.2383567156782385
Namalwa,4788,5.300896204344617
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
BT 320,serdemetan-SCH-529074 (1-1 mol-mol),2.392228056514646
LMSU,57330099,5.920156910327882
KMS-12-BM,11214940,1.3088229833339329
CML-T1,148198,-3.9003291277504526
SNU-119,17755052,2.19432063910622
SF539,56649450,3.257832178779862
NCI-N87,444795,4.906796024963376
YD-38,72376,-2.7078002254952684
KE-39,89928392,0.902975111582136
NCI-H2030,4477,-1.1805863916245418
AsPC-1,5282054,4.143624610165464
JHUEM-7,24856436,-1.8426006966748285
NCI-N87,3634881,3.127468365851455
JHUEM-7,67156097,-2.2957753342542127
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
SNU-886,5311,1.5331540985514145
KO52,67156097,-3.4687606598121143
AsPC-1,71466380,6.178949844697013
IST-Mes1,24797083,1.4429650511590184
YD-38,60750,-3.418274798981765
PF-382,11455910,1.1839598995526908
SNU-1077,219104,4.067743553544223
Ri-1,16013152,3.7158961348364654
ESS-1,53392493,1.9514593982408732
HCC2108,5460769,1.78766929460534
Kasumi-2,52912189,-0.393622705419007
SK-UT-1,119607,5.172021096327679
PE/CA-PJ41 (clone D2),9956119,4.236330934104538
Mono-Mac-1,23635314,-2.2093510638454443
Hep 3B2.1-7,60700,3.115990637519541
H-STS,107970,1.855553720240211
NCI-H1339,11507802,1.2916680643182958
RERF-LC-MS,6914657,-3.1593675222943896
PE/CA-PJ41 (clone D2),53481919,4.4896734978648505
Karpas-422,56973724,1.6302850453134334
HCC2108,2729026,3.184070590056279
Karpas-422,72376,-3.24630837699648
TE-14,36314,4.067164205607542
RKO,44202524,1.4476976505001866
SK-MEL-28,11427553,4.064061219701421
L3.3,148198,-4.142602322676729
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
B-CPAP,11485656,2.2559715729134204
CML-T1,72193861,-0.1877801569331633
B-CPAP,20959075,-3.002686370695369
OE33,24964624,3.1725420320614095
BT 498,JQ-1-navitoclax (2-1 mol-mol),1.0517743513764657
HCC2108,969516,2.879700977011491
AsPC-1,53232,3.925663364010775
B-CPAP,54618164,4.142992093020013
KO52,17755052,4.2754643530208005
H-STS,6438330,0.2327591369771806
BT 112,11364421,2.5919971436685816
BT 248,11960529,3.73553983344596
RT-4,3025944,4.0203592479598225
NCI-H2030,11485656,2.3036086259885526
PE/CA-PJ41 (clone D2),44491742,4.176291442698054
PF-382,tretinoin-carboplatin (2-1 mol-mol),4.943732821506593
RKO,151289,1.190219151105647
SNU-119,374536,-1.8347712072853533
Lu-65,25195348,2.2063642677239
BT 328,3552672,2.1088972193148146
L3.3,6918837,-1.6341527445290025
B-CPAP,6852167,2.612580501807676
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187
Hs 611.T,46191454,-0.9464406791011892
SW1783,3689413,0.540292166648154
SW1783,10322450,4.230470764848986
RERF-LC-MS,168312962,0.3496483928324376
HuT 78,439501,-3.2848313932186315
JHUEM-7,9911830,1.3841062029972715
BT 248,6914657,-2.576788872604972
ACC-MESO-1,3038522,4.864795904430629
Panc 02.03,56946209,-4.513446270471167
HCC2108,46398810,2.6632695646236773
RERF-LC-MS,448949,1.7883798522328354
TE 441.T,36314,0.618723009103468
KYSE-450,6610216,4.803414401111398
AsPC-1,5460769,5.795061807453513
OAW28,9825149,1.8591620922463772
ESS-1,24951314,1.795276006384557
LXF 289,44137675,2.0502885463252665
SNU-1077,3815108,2.841716747219865
NCI-H196,11485656,3.8330163114503337
ACC-MESO-1,5280436,3.655257878531662
NCI-H929,984333,-0.3425783149230363
SW1783,44241473,6.157052132127655
GOS-3,262093,3.1165245547903804
SW1573,1750826,-4.895155026964416
Namalwa,9907093,3.9799374533472744
SW1573,53392493,3.256582971351183
RERF-LC-MS,135440466,2.007932851474071
SF295,6610216,4.890664911877899
NCI-N87,31703,-2.5850470675010175
KYSE-180,17755052,1.875580831960164
B-CPAP,44507138,1.9476690283796445
NOMO-1,52947716,-3.339302012338735
RKN,3503,2.6546301780010144
SW1573,44185566,2.872643000979188
KMS-12-BM,5284329,2.246794069285595
ChaGo-K-1,25150857,2.9122993230235377
SNU-423,322968,4.058645946597137
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
Hep 3B2.1-7,6610216,4.203161900181635
SK-UT-1,11178236,-3.1476087704036453
BFTC-909,2945648,3.347829093032643
NCI-H196,5329102,2.9936778783637674
KE-39,445643,4.20721403949293
BT 248,11238147,1.7431248737974965
BT 498,46199207,1.8437430927098404
B-CPAP,3384730,0.948588967959913
SK-UT-1,54618771,2.629062811355061
NCI-H196,9884685,-0.0340951711946578
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417
L3.3,637858,2.497804094781357
KMS-12-BM,5284373,1.9120963986235795
Mono-Mac-1,4259181,0.0400691688405866
PF-382,676352,1.5594037701134436
MIA PaCa-2,25154868,4.812022238902172
RT-4,9911463,3.5197462916355073
TE-14,25195348,4.552546722022142
MIA PaCa-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9197297717475186
ESS-1,11609586,3.461790355650639
Mono-Mac-1,selumetinib-piperlongumine (8-1 mol-mol),2.29885991355253
AsPC-1,71466380,6.178949844697013
HuT 78,11955716,-3.02864832586091
OAW28,11719255,3.92549874892824
TE-14,6610355,5.121175599302492
OE33,tanespimycin-gemcitabine (1-1 mol-mol),-2.5278604317727313
BT 320,66577038,3.2847085574393557
NCI-H196,serdemetan-SCH-529074 (1-1 mol-mol),2.347593030611278
KO52,navitoclax-piperlongumine (1-1 mol-mol),-2.989352719606275
H-STS,135411,0.6360583946211977
WM793,5278396,3.634614455861616
EHEB,16736978,1.931050460573665
BT 248,10074640,2.9402331094049265
BT 320,5281672,4.443718212515123
PE/CA-PJ41 (clone D2),44607531,0.8014998549696746
KYSE-180,3025944,4.407646494118587
GOS-3,753704,4.989890215550621
SNU-213,42642645,1.3935899873683228
B-CPAP,56946209,-3.554958382916866
SF539,151289,0.9968622519335693
SNU-119,9911830,2.5015276348474424
HOP-62,11497983,5.1549735187421275
Namalwa,5702613,5.916482169691303
Karpas-422,4096211,1.5644137887158134
HCC2108,119607,5.317172466903883
NOMO-1,12003241,-0.5951695723430065
KMS-12-BM,10127622,5.364692191971256
KMS-12-BM,5351362,1.0681546231333583
SK-MEL-5,675434,4.343298887458213
JHUEM-7,JQ-1-UNC0638 (2-1 mol-mol),-1.108952996086482
Karpas-422,285033,-4.28202596716821
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
AsPC-1,11626560,2.2683411612930637
LXF 289,16720766,0.4842655504206017
HCC2108,89183176,4.824317563947827
SNU-216,6438330,1.9826411062954432
SNU-1077,57519531,4.1391342628233945
JHUEM-7,71466445,4.651705041978002
IST-Mes1,107970,2.9610434925705773
KMRC-20,11427553,3.4952779275874826
SF539,65064,4.983930962156341
SNU-216,36462,2.86106389441445
RKO,104842,-2.5196749638548
KYSE-180,5287620,-1.547969048447004
TE-14,11497983,5.0471587627827885
SF539,11719255,2.415885825794134
Kasumi-2,44566777,1.2078773885517011
TE-14,4578,4.814976900495172
PE/CA-PJ41 (clone D2),3634881,3.643828975352439
CML-T1,445643,3.3065494006722327
Hep 3B2.1-7,46224516,4.480641922862564
BT 286,piperlongumine-MST-312 (1-1 mol-mol),0.9654454210734352
SNU-119,9952709,2.3650460687962997
RT-4,24785538,1.6038296110526935
BFTC-909,44607531,1.7004331217528663
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
HOP-62,12001922,2.1949882095207225
SW1783,1716436,2.7857036486954567
BT 286,24964624,0.7571254121052671
ESS-1,637858,1.315760041448024
KMRC-20,2113511,6.253781367833113
PE/CA-PJ41 (clone D2),selumetinib-vorinostat (8-1 mol-mol),2.0198593804037475
Hs 611.T,375860,-0.3365508956402739
TE 441.T,9840324,6.4205746910052675
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
NOMO-1,9825149,1.4944850939332062
Becker,piperlongumine-MST-312 (1-1 mol-mol),1.772213641328724
KMRC-20,2841722,4.772278882478543
KMS-12-BM,5281321,-2.748905186924615
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
Namalwa,piperlongumine-MST-312 (1-1 mol-mol),1.0108057304725468
OE33,16065773,2.0176883406007557
RKN,44185566,3.394049733904779
NCI-H929,65628,3.950811987229233
TE-14,60750,-2.768464568716924
BT 112,51037431,5.205147276612667
KYSE-180,168313047,3.1175173804941307
H-STS,6918638,-0.6396360846494638
KYSE-450,60700,2.353056656519086
Panc 02.03,9866186,1.4364847380387245
NCI-H196,5291,4.116968852005061
NCI-H1339,24180719,4.777839850801867
NOMO-1,navitoclax-birinapant (1-1 mol-mol),-1.0294989244517518
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
NOMO-1,4705,2.5023829157060926
MIA PaCa-2,241158,2.0398577340537587
HOP-62,11404337,-1.0489074115392232
MIA PaCa-2,3025944,4.191414132665553
BT 328,24771867,5.867133384354764
YD-8,984333,0.1177037476689329
KMRC-20,vorinostat-navitoclax (4-1 mol-mol),1.5374427074415018
NCI-H929,135440466,-1.839012232533784
NOMO-1,5291,3.5817896511091862
RKO,72376,-2.4980018930037673
HEC-108,54649381,3.8371593577221255
PE/CA-PJ41 (clone D2),44819697,0.0049812921739646
Hs 611.T,carboplatin-etoposide (40-17 mol-mol),-0.3193374895074411
SNU-213,5311281,1.2937037798945257
HuT 78,11317348,2.425204796310932
HuT 78,16736978,-0.4405557775162137
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
SK-MEL-28,10385095,3.2557901504831306
Karpas-422,11964036,-0.5881564027256297
CML-T1,5281321,-0.1268784610637486
ACC-MESO-1,44491742,5.613898283692527
BT 320,16038120,1.884341751706396
OAW28,89928392,1.6809049325642302
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
RERF-LC-MS,446155,1.000000375050646
SNU-216,11257553,1.0275699515884966
GOS-3,119182,1.862888663663923
PF-382,selumetinib-navitoclax (8-1 mol-mol),0.0511061030946494
NCI-H929,400769,-1.5124256482167764
BT 328,11485656,2.729036955069127
PE/CA-PJ41 (clone D2),135440466,2.731145594233653
SF539,445455,5.827598780000013
KMRC-20,656346,3.07452123258755
Lu-65,119607,4.501939294338365
SNU-423,445643,4.312080284928333
YD-38,5328940,-0.0056077388228541
HuT 78,984333,1.4807762289322746
SNU-119,216468,1.5589878703095297
KMS-12-BM,5311,-0.4045600227605066
NCI-H1339,54143018,0.7925743548274472
KE-39,23725625,5.622319720398273
HCC2108,46224516,5.492132817641468
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625
YD-38,10302451,0.2221462011029107
HOP-62,5951923,3.7670098609397336
CML-T1,9911463,2.5893115421622737
Karpas-422,15953870,3.6595418641007895
MIA PaCa-2,135875424,3.180139545836177
L3.3,24771867,2.302026780280536
SNU-1077,448949,1.5791911231397144
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
BFTC-909,36462,4.374665451212183
BT 286,11404337,-1.6660130116300145
AsPC-1,969516,2.9281765712067447
SNU-216,219104,3.3692374344662457
NCI-H2030,navitoclax-birinapant (1-1 mol-mol),0.6953114998601013
SNU-886,25154868,3.4253449790012804
HOP-62,navitoclax-gemcitabine (1-1 mol-mol),-2.339180571105395
PF-382,carboplatin-UNC0638 (2-1 mol-mol),1.6704329476660973
KMRC-20,11178236,-3.1714013325057686
BT 286,9926054,2.06315076189255
Panc 02.03,4477,0.984097917718396
Hs 611.T,73707371,4.8158547045226605
SF295,11404337,1.1305596027792637
KO52,4788,5.9251451184243455
TE-14,15547703,3.183280089151661
NCI-H929,24964624,-4.598319176525677
SK-UT-1,11222830,1.0435371315792576
BFTC-909,16219061,3.736019824418232
B-CPAP,54618771,-0.888157328254987
Kasumi-2,135440466,2.9310364314773376
BT 248,4917,1.8494335305709009
Ri-1,6917907,-8.102917987031867
KYSE-450,7251185,3.3097037107461897
JHUEM-7,5351362,1.1021792980329406
HOP-62,3038522,2.3481472611270884
KYSE-450,46398810,3.648883715738529
H-STS,119182,0.2834032478354432
ChaGo-K-1,445643,4.017836416998069
JHUEM-7,36462,0.060815321002826
Ri-1,9826308,-0.8124183287153022
BT 248,46199207,1.879415157386071
WM793,71466578,5.303096396012995
SNU-423,44185566,3.12747229468207
SNU-886,56946209,-2.6397102799841012
RT-4,selumetinib-vorinostat (8-1 mol-mol),2.4962461169474084
AU565,71304818,2.0398490425817144
BFTC-909,44486219,4.380685277356905
Mono-Mac-1,4477,0.9858317647029236
HEC-108,984333,1.245430533507037
Ri-1,5746,0.0852982082944755
KE-39,25150857,2.5807263536749607
KE-39,11222830,1.621114920928245
WM793,9926054,1.9861694749243135
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
KYSE-180,5460769,3.044274290576871
AsPC-1,5291,4.446798964395248
HuT 78,24772860,-3.0726220135578353
Mono-Mac-1,tretinoin-navitoclax (4-1 mol-mol),0.4415195445851007
HCC2108,5287620,-1.7107453647651585
Mono-Mac-1,docetaxel-tanespimycin (2-1 mol-mol),-7.241912251281891
Mono-Mac-1,salermide-PLX-4032 (12-1 mol-mol),4.403514285485615
KYSE-450,navitoclax-PLX-4032 (1-1 mol-mol),4.746447722583796
B-CPAP,637858,2.2733284631239044
BT 112,44566777,0.6331747644646614
SK-UT-1,53392493,1.8561003470526265
H-STS,selumetinib-BRD-A02303741 (4-1 mol-mol),5.187355615985605
BT 286,51039095,2.127259435113009
LXF 289,SNX-2112-bortezomib (250-1 mol-mol),-1.375165167974982
PE/CA-PJ41 (clone D2),11609586,3.386208915344469
SF539,135875424,2.4028504168317473
NCI-N87,36314,2.766113993056904
KO52,16065773,1.718324313076395
TE 441.T,9903786,2.9236317230426465
AU565,4788,5.691461260554478
ChaGo-K-1,46215462,1.7039822163377707
SNU-423,54618771,0.8845738276291084
SF295,5566,3.0439357019586746
TE-14,46843906,1.6085964044970718
AsPC-1,docetaxel-tanespimycin (2-1 mol-mol),-2.3470176928652204
BT 498,4261,5.558947340213016
BT 286,54619267,4.206221744763978
Ri-1,3025986,-1.4888288278969202
KE-39,135421197,0.9510973278490732
HuT 78,54678924,2.190206987497857
H-STS,49766530,-3.13255748664254
SF295,107970,2.6813754727325203
Namalwa,erlotinib-PLX-4032 (2-1 mol-mol),2.1227167490373
CML-T1,135411,-2.1332231058037796
BT 498,11427553,3.765674202927968
YD-38,156414,-3.156839755481009
KMRC-20,12003241,-0.2043728031762648
BT 498,1714884,3.499299815864629
BT 248,11494412,3.557230805764516
H-STS,6184667,4.225407258507326
YD-38,tanespimycin-gemcitabine (1-1 mol-mol),-1.3171548769509314
NCI-H196,9866186,2.281672090063059
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
SNU-119,124202324,4.249664634956003
SF539,107970,2.309030481029931
NCI-H1339,tanespimycin-gemcitabine (1-1 mol-mol),-1.510356876239625
Namalwa,24856436,-1.4734170848625472
H-STS,6914657,-2.765637177138319
L3.3,322968,4.952946424555438
ESS-1,3081361,3.291100160208869
HEC-108,3384730,3.335460233588695
KE-39,44462760,3.8715042571516993
RT-4,11640390,3.689473360751719
Namalwa,126941,-4.3558657962175396
RERF-LC-MS,11955716,-2.426679724944883
AsPC-1,11494412,3.580103428724827
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
KMRC-20,11214940,0.9068953612442124
JHUEM-7,42642645,-0.2590687534288647
HuT 78,675434,4.061234501182394
NOMO-1,15983966,-5.011559396504552
NCI-H1339,24785538,2.8561185149962456
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658
Hs 611.T,selumetinib-decitabine (4-1 mol-mol),3.479340016202746
Mono-Mac-1,9911830,2.1868049767694044
KYSE-450,3025944,4.332360551153181
RKO,24964624,3.0430796891613903
TE 441.T,46907787,3.123657521861764
KE-39,44491742,3.945663107977575
OE33,11427553,3.683958966235938
Mono-Mac-1,46215462,-0.6900076333947253
KYSE-180,16722836,1.8171321654098664
NCI-N87,11364421,-4.7214998150919065
SNU-1077,46901937,3.8594891831371503
KMS-12-BM,decitabine-navitoclax (2-1 mol-mol),-4.759135600180924
PF-382,10385095,1.1317259097020056
BT 328,73707438,3.7767552618386087
Hs 611.T,25062766,0.5386555117745635
AU565,44486219,4.217962962304986
HSC-3,16736978,3.722635885718807
KMS-12-BM,136227924,1.841540408480291
Kasumi-2,176870,2.2683953361762166
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
Ri-1,135999136,4.203993475326129
SNU-423,navitoclax-MST-312 (1-1 mol-mol),0.8206276110191193
NCI-H2030,107985,-3.4072882201526515
BT 248,25227462,1.1845227545958306
OAW28,107985,-3.5497769626209217
MJ,5394,2.8816454661396698
Hs 611.T,51039095,1.584846388229858
AsPC-1,3854666,3.565227366628202
HSC-3,452548,0.1992369898040848
SNU-216,54618164,4.432293411615551
CML-T1,25154868,3.739287072403725
Ri-1,107985,-4.133158976783472
BT 498,11494412,3.6640895055137017
BT 498,UNC0638-navitoclax (1-1 mol-mol),2.7043329045361393
Lu-65,navitoclax-birinapant (1-1 mol-mol),3.958849647004374
SNU-119,10184653,0.0248827318699143
Namalwa,11485656,1.3808834074055636
Lu-65,9866186,0.7836388553492847
OE33,53392493,1.6963254365441045
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015
OAW28,44489675,3.928609606447794
HuT 78,5566,2.7990159644878
SNU-886,60700,0.021220261997993
HCC2108,445091,6.46099491199368
JHUEM-7,216468,-0.983442120709978
SNU-216,568763,-0.2099527873774199
SK-MEL-28,6914657,-2.0042888154328344
KYSE-450,135411,0.9240917820052414
Ri-1,24964624,-1.9438756183580252
KYSE-180,9967941,4.960769213293647
TE 441.T,10184653,1.2967896851155565
SNU-423,53392493,1.705779071563144
Lu-65,9967941,2.1259265391153157
YD-38,11612883,2.6536932325208413
HEC-108,4261,2.7308504637450683
Karpas-422,tretinoin-navitoclax (4-1 mol-mol),2.3839667409839063
SNU-216,11175137,2.788278748187906
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
SNU-423,selumetinib-decitabine (4-1 mol-mol),4.775321711278399
Mono-Mac-1,71304818,2.050057377960679
SNU-119,BRD-K27188169-navitoclax (2-1 mol-mol),3.038273734124671
MIA PaCa-2,11717001,4.308928886902068
NCI-H1339,25105715,3.779280194220663
NCI-H929,5329102,0.3399377983022085
CML-T1,3011155,1.2837041284349135
HuT 78,11178236,-3.136781933116147
KYSE-450,11152667,0.9209824146572594
H-STS,5281321,-2.5049759040326616
SW1783,4788,5.6219233668192174
HSC-3,10074640,2.7864686905688676
NCI-H929,6917907,-6.25281779572784
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
HuT 78,2858523,3.1169604415364303
Panc 02.03,6914657,-4.005158687469553
KE-39,445091,4.999033906756457
Hs 611.T,9967941,3.710009045681017
CML-T1,11238147,1.550777100551064
SNU-886,11626560,2.6362040536999514
SNU-216,11427553,3.0406962885554467
SK-UT-1,5335621,5.433304981154406
YD-8,serdemetan-SCH-529074 (1-1 mol-mol),2.534681680043658
JHUEM-7,25183872,-0.5022360342939903
ACC-MESO-1,vorinostat-carboplatin (1-1 mol-mol),4.134498627348827
WM793,44486219,4.341209426760334
AsPC-1,89928392,1.5669078555551634
Hs 611.T,9933475,1.605311060153359
ESS-1,135398516,2.488999023139088
LXF 289,676352,2.537691956872654
NCI-N87,24180719,3.957157119616887
SNU-423,241158,3.874082799654454
HEC-108,2729026,3.096957715125247
KE-39,135999136,4.6219900849735325
NCI-H2030,11178236,-2.556772760717576
SNU-216,24901704,2.7455586339564126
SNU-216,9549297,3.882390204911674
IST-Mes1,107985,-3.865584471784785
PF-382,4788,5.110775522740739
KE-39,2729026,2.715568279593477
Ri-1,25062766,-0.0725185532276084
RKN,9911830,3.6623648245681744
ChaGo-K-1,262093,3.038007559777189
PF-382,56963564,-0.2593011060525333
BT 498,1716436,3.5174688270474923
Mono-Mac-1,151289,0.6331917318262559
B-CPAP,24964624,2.8727163930328863
SNU-213,4917,2.9300331249390226
BT 248,19582717,6.9976074882401464
Namalwa,44566777,-0.2625878239360741
KMRC-20,72193861,2.2130895784665148
Lu-65,44185566,3.028319442619555
BT 286,25062766,2.7885971140564365
RT-4,erlotinib-PLX-4032 (2-1 mol-mol),3.2445039768018624
KO52,400769,-1.2212933891917823
L3.3,selumetinib-UNC0638 (4-1 mol-mol),5.288673066884017
PE/CA-PJ41 (clone D2),5470400,1.7243098995077355
SW1783,crizotinib-PLX-4032 (2-1 mol-mol),3.4336355505770317
NCI-H2030,241158,3.7184725002314183
Panc 02.03,54678924,2.4878586568917536
ChaGo-K-1,6184667,1.7457874071867656
NCI-H196,57519531,4.101700077109555
NCI-H1339,2708,5.014409852934372
NCI-N87,46174525,4.699807035348161
Karpas-422,11175137,1.2910199720693991
SNU-119,11612883,2.57942029058091
WM793,3689413,0.565505634508756
AsPC-1,24797083,1.5655308519339004
Mono-Mac-1,44486219,3.9337809212248382
NCI-N87,5351362,0.9196567139345124
LXF 289,3634881,3.11935208210029
EHEB,25126798,3.800307973895597
Namalwa,72376,-3.07685992530759
SF539,73707398,1.0308821565374424
B-CPAP,17755052,3.4143751871388788
Becker,16741245,3.954379733751191
MIA PaCa-2,71466380,4.134783838185487
NCI-H929,124202324,1.4595728205494207
HuT 78,613000,1.4786721028886782
GOS-3,25102847,2.4743602573672585
Kasumi-2,selumetinib-piperlongumine (8-1 mol-mol),1.718006716449046
ESS-1,25126798,3.845580054250281
KMS-12-BM,10113978,1.9839556331980863
KYSE-180,11175137,2.9654350002556873
RERF-LC-MS,10410894,3.034247655874134
KO52,168313016,6.361073320142098
YD-8,24771867,2.3430098767377263
HuT 78,24964624,-2.2262621005839813
YD-38,11222830,1.7512115538590254
RKN,4378219,1.9905206425028277
NCI-H929,9868037,2.724281418576466
SW1783,17755052,3.585209697722452
AU565,53392493,1.7262495119460306
BFTC-909,135411,0.8518885281649031
SNU-213,5329102,2.6196578140344364
SNU-213,216345,4.485724357093233
ChaGo-K-1,42642645,1.188286091204559
BT 328,322968,2.861041928630023
Namalwa,5113032,4.637348749632831
RKN,46199207,3.372714950884571
OE33,11626560,2.1041567289537846
Karpas-422,44185566,3.020953804682189
Lu-65,25105715,3.7592032368034207
SNU-119,25150857,1.966340721822474
Karpas-422,11625818,1.3819021943398546
ChaGo-K-1,16065773,1.9755218058173556
HCC2108,54618771,2.799542688239582
YD-8,ISOX-bortezomib (250-1 mol-mol),1.1639507987176203
TE-14,JQ-1-carboplatin (1-1 mol-mol),0.3658378251951246
SW1783,3552672,4.975646737829227
KMRC-20,selumetinib-BRD-A02303741 (4-1 mol-mol),6.461263224770076
Lu-65,5311,2.276911477754005
SW1783,2858523,2.7249015392010425
NCI-N87,60700,-1.3451868063168757
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
NCI-H1339,5311,1.9237434970940073
SF539,11612883,2.0930175228596037
RERF-LC-MS,24785538,0.8057743011820994
BT 320,60700,5.739551872199599
HOP-62,5311281,2.99764161389912
JHUEM-7,82146,4.339540493770147
SNU-1077,11626560,2.319948092502867
OE33,60700,0.5372665759656965
Hs 611.T,3384730,1.4112873627117273
PE/CA-PJ41 (clone D2),5311,2.3549285264953284
Lu-65,4096211,2.271037978717641
LXF 289,crizotinib-PLX-4032 (2-1 mol-mol),1.666725560868834
SK-UT-1,6505803,-1.8087484782267416
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
BT 320,9825149,2.6279121601862676
Mono-Mac-1,24821094,1.2547339239391515
NCI-H196,11717001,4.441114574365772
KO52,9926054,1.7676529122170044
SNU-886,5329102,1.596812622524428
NCI-H2030,176870,5.856063157434044
SW1573,46398810,3.5765453048302933
Mono-Mac-1,24753719,5.146647018593083
L3.3,16720766,-1.973453330210062
SW1783,168313200,3.606419156743755
SW1783,24797083,1.3978272138606742
Hs 611.T,11178236,-6.535511147964887
OAW28,9915743,2.8675584787684456
YD-8,51039095,-0.2899532723267104
NOMO-1,53495165,-0.0338576092201104
SNU-216,60700,0.9165995392145524
HEC-108,3025944,5.148490920496766
NCI-H209,ISOX-bortezomib (250-1 mol-mol),1.9023291222008245
BT 286,67156097,2.119338660379996
Becker,tretinoin-carboplatin (2-1 mol-mol),4.919710353741397
HEC-108,doxorubicin-navitoclax (2-1 mol-mol),-1.1181452203598452
AU565,5329102,2.0441914674842008
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
Ri-1,16065773,0.7521068096426003
YD-38,44202524,1.2907890971172833
BFTC-909,54626689,4.365294423210906
ESS-1,19582717,4.154053780498712
MIA PaCa-2,11178236,-3.5313754625987843
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
SK-UT-1,1566236,1.7242203991960865
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
SK-MEL-5,67291369,2.77281330357191
ChaGo-K-1,5738263,3.7956881789600168
KLE,10127622,3.079839364113069
Panc 02.03,1641662,3.717230762709902
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
YD-8,208908,2.493595047729409
RT-4,3543504,4.339418344926718
OAW28,5311281,1.8509970799423736
IST-Mes1,3552672,2.081532957284865
KE-39,44493528,4.79040409668691
CML-T1,BRD-A02303741-navitoclax (2-1 mol-mol),1.3394174355089614
BFTC-909,60750,-1.7298046099952136
BT 328,4378219,2.241353375973062
ChaGo-K-1,73707398,1.0973603524165894
KE-39,71680916,5.592111276065997
Mono-Mac-1,5351362,0.6625592378948421
TE 441.T,12003241,-1.1939319008466374
AsPC-1,11497983,4.51017072011312
YD-38,409805,3.7875636051814663
KLE,107970,2.4969694624001546
Kasumi-2,3011155,3.05813684599445
JHUEM-7,alisertib-navitoclax (2-1 mol-mol),-1.3911406571635951
BT 248,BRD-K55473186,1.6909762369263868
EHEB,25150857,2.0197951403724224
PF-382,11228183,0.289303450699542
KLE,5738263,3.521072611240238
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
NCI-H1339,24772860,-1.8879714728988064
Hs 611.T,56963564,0.1633765045598278
KMS-12-BM,151289,-0.2601572179099301
Becker,5566,3.1215882284049097
NCI-N87,3081361,1.4568926260691408
GOS-3,11152667,0.5000513857969126
PE/CA-PJ41 (clone D2),135398516,2.8056220354575676
YD-8,6918289,3.053778903951025
JHUEM-7,salermide-PLX-4032 (12-1 mol-mol),5.137483886109144
B-CPAP,tanespimycin-gemcitabine (1-1 mol-mol),1.3298493303497043
Kasumi-2,JQ-1-vorinostat (2-1 mol-mol),-0.9081345169636283
KMS-12-BM,6852167,1.232935409292076
KYSE-180,navitoclax-sorafenib (1-1 mol-mol),1.4243310506512128
AU565,11214940,0.9865925706012508
Panc 02.03,448949,3.46549633046868
Kasumi-2,16722836,0.3444985018145829
Mono-Mac-1,25150857,1.766777170038874
YD-38,119182,-0.4684316617425549
IST-Mes1,10385095,2.3784865098232255
SNU-886,2858523,3.0096792141672837
OAW28,9884685,1.3567472374362477
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
NCI-N87,176870,1.1060804163410003
SNU-423,6918328,0.4022127106807914
SK-UT-1,135398738,5.687512813913111
KMRC-20,24180125,2.1292230700197874
BT 286,JQ-1-vorinostat (2-1 mol-mol),1.9328680890615244
RT-4,9911830,1.893497559140728
SNU-119,selumetinib-JQ-1 (4-1 mol-mol),2.003564395289463
SW1573,65628,4.136448104244246
WM793,vorinostat-carboplatin (1-1 mol-mol),3.963017303085571
BT 112,10184653,1.1503631618042085
SK-MEL-5,3062316,3.0724762007977917
SNU-886,31703,0.9003298590117994
KO52,navitoclax-gemcitabine (1-1 mol-mol),-4.345603571038749
RT-4,navitoclax-PLX-4032 (1-1 mol-mol),-0.362810350442769
MJ,2708,2.9106731157178194
EHEB,piperlongumine-MST-312 (1-1 mol-mol),1.299458892155912
BT 320,17755052,3.980908422662348
TE-14,11640390,3.827823856737784
CML-T1,2749,0.3257235213594381
BT 320,ISOX-bortezomib (250-1 mol-mol),1.4901983753773511
LMSU,5460769,3.9630418347665857
HuT 78,JQ-1-UNC0638 (2-1 mol-mol),-1.5524452367081547
PF-382,9444,3.9294096917802106
SNU-119,9549297,4.628289370369748
TE 441.T,5746,-0.3912335705950193
L3.3,409805,5.10307456372432
RT-4,11178236,-1.895969264263487
YD-8,54626689,4.483773401424057
HSC-3,9967941,3.1508151586249844
BT 112,11507802,1.1612523205296417
SK-MEL-28,216345,4.760826301733561
RKN,71680916,6.446363106372924
SW1573,5287620,-0.7347028317725576
OE33,135875424,4.864853081585439
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
KYSE-180,44507138,3.1582868511502524
WM793,11964036,2.6064351819040885
NCI-H196,5278396,5.36521769307123
L3.3,6610355,5.020819543145525
Hep 3B2.1-7,73707438,4.515086793447455
Mono-Mac-1,56973724,1.687151407906093
AsPC-1,135398516,2.7517064972229415
CML-T1,9927531,3.1672020542525674
AsPC-1,8515,4.986545700595871
NCI-H2030,439501,-1.2331748188079374
KMS-12-BM,51037431,3.9425054893267326
Hep 3B2.1-7,15983966,2.1753156236836904
SNU-213,JQ-1-UNC0638 (2-1 mol-mol),3.293883125689118
BT 112,2746,3.687274706255036
MIA PaCa-2,JQ-1-navitoclax (2-1 mol-mol),-0.3337062531421545
LMSU,BRD-K55473186,4.503625931723464
JHUEM-7,10296883,3.9492602271456065
GOS-3,44486219,4.351702661257634
EHEB,5328940,1.102391401728389
MJ,15983966,-4.500116759610759
PF-382,54618164,3.241191825495517
ACC-MESO-1,54649381,3.866115711509678
ACC-MESO-1,676352,2.9772350584924148
ESS-1,2871966,0.4858563694283366
AsPC-1,11214940,2.3233429785878443
GOS-3,salermide-PLX-4032 (12-1 mol-mol),5.528835129082399
BT 328,676352,2.591297575109724
JHUEM-7,11640390,3.5194655079391857
Lu-65,176870,3.853210265700402
SNU-216,vorinostat-carboplatin (1-1 mol-mol),1.9524115972675864
NCI-H196,54618305,5.68839138137451
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
SF295,24964624,2.4635902673217456
TE 441.T,10296883,4.028933328577424
HOP-62,135999136,4.132685432378933
LMSU,9803433,4.684361429379855
IST-Mes1,24964624,2.9505066533460464
SNU-119,24978538,0.7616052232036742
BFTC-909,107985,-3.700699007813787
HOP-62,46398810,2.3106949719473153
PF-382,44197249,4.457184218022553
Becker,11626560,1.902962201079582
MIA PaCa-2,11657048,4.878585794682366
HEC-108,702558,5.741783323073097
KYSE-450,9907093,5.309173304412392
NCI-H2030,5311,1.826556505271368
L3.3,16725315,5.215482090576187
KMRC-20,11396600,4.3348303945761835
BFTC-909,11228183,3.298719229946038
Ri-1,5281321,-3.06997364503604
AU565,51039095,3.3315580468624795
TE-14,navitoclax-sorafenib (1-1 mol-mol),2.6278003982474787
Hs 611.T,24180125,0.9846355561262036
L3.3,16038120,1.9292348544241311
PE/CA-PJ41 (clone D2),11977753,0.7680199278861632
Kasumi-2,156414,1.0465549823430256
YD-38,JQ-1-vorinostat (2-1 mol-mol),-1.3657042657685192
KMS-12-BM,11427553,1.3856549566874048
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
RKN,25150857,2.829513348324473
Karpas-422,168313200,3.637067495296451
Lu-65,docetaxel-tanespimycin (2-1 mol-mol),-4.94417117541267
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
LMSU,3038522,2.183221848979368
SNU-423,24901704,3.5814452106629053
TE 441.T,9866186,0.071586275661553
SNU-1077,selumetinib-PLX-4032 (8-1 mol-mol),4.363264972999689
Kasumi-2,49836020,6.151495097204233
SNU-119,24779724,4.340610631668066
SNU-216,5282054,2.7577918644529267
GOS-3,568763,1.0345737986601573
SNU-119,262093,2.598697839644185
CML-T1,2874250,4.926765314452629
RKO,16720766,-1.2722083569090707
HuT 78,4096211,1.1112538350998973
CML-T1,9823820,1.5491308586448294
SK-MEL-5,5566,3.097089595159475
LMSU,25105715,3.7531762313471466
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
WM793,2858523,3.206623504237894
SNU-216,89928392,1.393246340046015
RERF-LC-MS,5287969,-2.0564845219287555
Ri-1,9903786,-0.2937603570790111
AsPC-1,89928392,1.5669078555551634
RKO,54619267,4.028311361432676
KO52,6252,-1.3570123270027108
WM793,15953870,5.050143340220593
B-CPAP,crizotinib-PLX-4032 (2-1 mol-mol),1.2873163572314887
SW1783,5329102,3.5851018985132663
HuT 78,52947716,2.981697525257689
OAW28,11396600,3.5740319462685535
PF-382,68056272,3.167967878005275
Kasumi-2,49867930,4.763867340262508
RKO,16013152,4.038378204585466
HOP-62,selumetinib-decitabine (4-1 mol-mol),5.718310393718077
NCI-N87,104842,-4.261750557946528
KMS-12-BM,11364421,-6.458256547246502
NOMO-1,71466380,3.4384411266907295
KMRC-20,49850262,4.568150133018385
ACC-MESO-1,6918837,-1.6227702434824125
ACC-MESO-1,5746,2.848145912679028
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
PE/CA-PJ41 (clone D2),9935249,3.298572074942043
TE 441.T,doxorubicin-navitoclax (2-1 mol-mol),-3.743628559569693
ESS-1,568763,-1.0434791743348584
HuT 78,10385095,0.3743213193570641
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
AsPC-1,409805,5.083096669481897
Kasumi-2,44507138,0.9761318750595236
Karpas-422,24856436,0.2614680146489348
BFTC-909,135440466,2.535274686795805
NCI-H1339,44589607,3.107342644976079
AsPC-1,9911830,2.936776162598985
BT 320,123631,3.381923883037432
BT 286,216468,1.073793666658399
Mono-Mac-1,16722836,-1.2323126560129107
HCC2108,44241473,4.848973928948178
L3.3,54143018,0.1799627669965377
OE33,462382,0.892421497092823
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558
ACC-MESO-1,421610,5.247671500966904
TE 441.T,54765302,3.3707588990922615
SNU-119,vorinostat-carboplatin (1-1 mol-mol),4.187778089555317
KYSE-450,2729026,3.1949435983644414
BT 112,136227924,2.645928432247734
HEC-108,67156097,-0.2232306565612508
HSC-3,216345,4.289127923460728
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836
CML-T1,135398516,1.062716502546658
KYSE-450,1716436,4.321900870881558
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714
CML-T1,5351362,1.0869507822739353
H-STS,46174525,4.112955577900159
YD-8,73707440,4.452607469919264
SNU-213,2729026,3.0209743245550587
PF-382,6610355,4.684201543631857
CML-T1,9866186,-1.0355523545849354
HuT 78,82146,0.1378074486168638
AsPC-1,16722836,2.2980478994816425
Mono-Mac-1,6918328,-2.339991136558335
RKN,54454,2.1815674244706407
Hs 611.T,54613361,0.3967700579974597
L3.3,9866186,0.5756442482063215
ACC-MESO-1,4917,3.2089053418545985
HSC-3,53245473,3.709031325799373
HEC-108,676352,2.944885570053704
AsPC-1,49793307,-1.0458597957041098
HSC-3,vorinostat-carboplatin (1-1 mol-mol),2.340341905839153
BT 320,5311,2.686412240878293
JHUEM-7,JQ-1-navitoclax (2-1 mol-mol),-1.3593352546723596
Karpas-422,SNX-2112-bortezomib (250-1 mol-mol),-2.980575279346319
OAW28,135999136,1.5944266420299655
JHUEM-7,11222830,1.5565352005988358
KMS-12-BM,72734382,2.6336747797962445
HuT 78,25102847,2.213703306492941
ESS-1,5470400,4.483121200297247
CML-T1,73707398,-0.0310412376393591
HOP-62,568763,1.3742847398893925
RERF-LC-MS,4917,3.617944790726347
Hs 611.T,46926350,-4.631315490401831
BFTC-909,4378219,4.497242068417329
RKO,446155,4.170579555483674
SK-MEL-5,44819697,0.0744475735891143
SNU-213,44137675,2.701983719716649
EHEB,5460769,-1.3281679410072365
B-CPAP,675434,3.8124437970633194
KO52,docetaxel-tanespimycin (2-1 mol-mol),-5.1615589988724215
SW1783,51039095,4.654055453172231
CML-T1,44493528,3.9716542826771297
YD-38,11455910,1.5894943212861383
Karpas-422,25262965,-5.549042575691541
BT 320,71304818,2.914725517037444
SW1573,16741245,2.047879460545898
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
NCI-H1339,selumetinib-vorinostat (8-1 mol-mol),3.4752897958657245
KYSE-180,51039095,3.462973951569757
EHEB,57519531,1.438200929613056
ESS-1,54626689,4.894766460355583
ACC-MESO-1,ISOX-bortezomib (250-1 mol-mol),1.554730838176437
NCI-H196,navitoclax-birinapant (1-1 mol-mol),-1.0230250736340882
BT 286,374536,3.426675663898697
HSC-3,serdemetan-SCH-529074 (1-1 mol-mol),2.268504689753588
Ri-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.598711788254512
PE/CA-PJ41 (clone D2),119182,0.5370908024623297
PF-382,6918328,-1.623099323121265
TE 441.T,46191454,1.8143411605619288
Lu-65,2945648,3.2114774914815554
LMSU,9444,4.315048701595099
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
KMS-12-BM,119182,-2.8670798945659617
NOMO-1,135875424,3.068632733482165
B-CPAP,24901704,2.8811872687700277
WM793,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9195666143098356
EHEB,46398810,1.962348153679006
HuT 78,vorinostat-navitoclax (4-1 mol-mol),0.0137878809652615
NCI-H196,crizotinib-PLX-4032 (2-1 mol-mol),2.9036893656102247
CML-T1,5738263,2.8352523784169525
HuT 78,54765302,4.2796964156487665
Hs 611.T,carboplatin-UNC0638 (2-1 mol-mol),1.3943266036810182
SNU-119,3634881,2.8282944940557484
OAW28,10184653,1.1706980363621209
HuT 78,71304818,2.291662678403222
Karpas-422,73707398,0.5334637120665475
Namalwa,24951314,0.4623180672040747
ACC-MESO-1,navitoclax-piperlongumine (1-1 mol-mol),2.173592219651161
BT 112,decitabine-navitoclax (2-1 mol-mol),5.309394661219557
RERF-LC-MS,24797083,0.2985814331764478
NCI-N87,327653,3.392428289503534
L3.3,24964624,2.8332468869362115
Lu-65,25150857,3.0819218313756243
HSC-3,11427553,3.124864958342948
JHUEM-7,3062316,0.480363794433647
Hep 3B2.1-7,11609586,3.172957070034702
BT 248,44491742,4.160095989296475
BT 248,387447,-5.028656036950466
NOMO-1,54618164,3.731990472759892
KMS-12-BM,55283,1.3656241179048696
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
SNU-119,54618771,1.6343524810724477
IST-Mes1,5746,2.704326416379231
ChaGo-K-1,11167602,1.7675321969112785
HuT 78,10127622,5.47630186372846
KLE,135411,0.8012767106548482
EHEB,36462,-0.01305148556103
NCI-H209,52912189,1.270838689300851
CML-T1,24753719,1.910679313408318
SF295,241158,3.864746766488878
ChaGo-K-1,11364421,0.7626665652731202
LMSU,1566236,2.090789851327695
HOP-62,71680916,4.399993359816238
HuT 78,25154868,3.748850122707697
SW1783,doxorubicin-navitoclax (2-1 mol-mol),0.2822920316533508
JHUEM-7,3825829,4.01020461765645
Namalwa,71466380,3.6089451461716
IST-Mes1,439501,-2.4971864822052767
AsPC-1,76446078,5.483716778202627
Hep 3B2.1-7,JQ-1-vorinostat (2-1 mol-mol),1.6170565221791997
CML-T1,36462,-1.7431711247812498
AsPC-1,3689413,-2.062701377390924
MIA PaCa-2,3062316,2.7877907850834225
MIA PaCa-2,piperlongumine-MST-312 (1-1 mol-mol),1.1891376220003034
HOP-62,24748573,1.153820419307879
OE33,49867930,4.382431849404375
NCI-H209,5746,-1.6890980018136772
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
NCI-N87,76446078,4.157863043796239
L3.3,selumetinib-piperlongumine (8-1 mol-mol),4.6860683758170145
AsPC-1,11647372,4.7024563360539675
Hs 611.T,doxorubicin-navitoclax (2-1 mol-mol),-3.7368363030965654
OE33,107985,-4.064645418730777
KYSE-180,11234052,4.637440527326196
SNU-216,24180125,5.748491941008621
AsPC-1,crizotinib-PLX-4032 (2-1 mol-mol),1.9702112350407297
OE33,327653,3.4722328346839246
Mono-Mac-1,carboplatin-etoposide (40-17 mol-mol),0.946614563265474
OE33,selumetinib-JQ-1 (4-1 mol-mol),2.2373751377171938
H-STS,375860,-0.6907889018597777
NCI-H1339,135440466,2.8677664758976538
Panc 02.03,984333,0.8671961837803726
ESS-1,24797083,1.4472359872095728
HSC-3,25183872,-0.7081908982509552
TE-14,6918736,-1.9728740219926633
Ri-1,11640390,2.6738647112315888
BT 248,400769,-0.0166923245796401
BT 112,1242560,3.547587200922832
Karpas-422,5291,3.768859180081126
NCI-H196,2858523,3.100768547477784
Kasumi-2,6505803,-2.445084849944434
OAW28,71466578,4.4029072721322455
HSC-3,15547703,3.1084945046177297
RERF-LC-MS,54626689,4.221264321270605
Kasumi-2,11625818,2.3070585930223477
SNU-119,56946209,-3.841507017590091
BT 248,24180125,1.9773901044414168
SK-MEL-28,6610355,5.590676722177881
YD-38,ISOX-bortezomib (250-1 mol-mol),0.4693385843266243
RT-4,119182,-0.6626417510702334
BFTC-909,650361,3.8112149600795706
YD-38,9903786,2.8631306213752103
OE33,5280436,2.3782801743487547
SF539,5494449,1.5774689724302169
NOMO-1,53392493,1.775943290565707
SNU-216,208908,0.6957755014742779
OAW28,3854666,2.969576020962734
BT 112,11178236,-4.407924823586387
SW1573,159324,2.9705070550476274
SF539,11175137,2.017622399930718
B-CPAP,135411,1.7170212116885226
BT 248,3543504,4.235039119755324
HuT 78,2733526,3.230584673721713
MJ,11404337,2.657052353931515
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
KYSE-180,6918736,-2.1145791698894056
NCI-H929,selumetinib-UNC0638 (4-1 mol-mol),3.372508515122925
SF539,45279963,3.2464007819640583
ESS-1,10410894,3.4736910874659648
KYSE-180,44632017,0.527293974927918
OE33,16659841,4.96499269921396
AU565,3552672,1.7684242008913282
Namalwa,44491742,4.1395858329172235
SF539,24901704,2.077858553177028
MIA PaCa-2,208908,1.9500660669416612
NOMO-1,6918837,-4.687337521865761
Becker,2746,3.675450807498904
ChaGo-K-1,6917907,-5.942627725321459
SF539,54678924,1.2476819079209422
KE-39,44566777,-1.173452220483867
NCI-H929,36462,0.845260564861955
NCI-H1339,10296883,3.881669394748239
ChaGo-K-1,carboplatin-etoposide (40-17 mol-mol),3.333007724933194
NCI-H929,3038522,2.7996723936558943
ChaGo-K-1,44491742,3.5931231049771126
KMS-12-BM,54626689,3.649325161583167
NCI-H196,erlotinib-PLX-4032 (2-1 mol-mol),3.340004131800971
RKO,12003241,-0.2410566552434749
LXF 289,9825149,1.6285560242869113
YD-8,2749,4.008728292988675
BT 498,25161177,3.959327779504269
SF295,5328940,2.1232695938998924
B-CPAP,44607531,1.6956688742545236
CML-T1,71466445,2.0221424049362033
PE/CA-PJ41 (clone D2),9911463,4.289796480511007
KE-39,89928392,0.902975111582136
IST-Mes1,119182,0.8525106306178227
KLE,327653,1.7943752773136603
OAW28,53232,2.960609854482466
Lu-65,1716436,3.8267089675065376
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
OAW28,1750826,-3.338956149870334
GOS-3,3503,2.7215232573825605
NCI-N87,6252,-1.400414082532842
HuT 78,6184667,-1.7510976513907253
OAW28,65064,5.229460149894731
ESS-1,2733526,5.879363294342396
ACC-MESO-1,3689413,0.4162012666414902
HCC2108,selumetinib-BRD-A02303741 (4-1 mol-mol),4.391486059277941
PF-382,selumetinib-JQ-1 (4-1 mol-mol),-1.2412031100333754
NCI-H196,15953870,6.198131940680453
PF-382,46943432,0.0711232205860505
KMS-12-BM,46943432,-0.1840385129667849
CML-T1,vorinostat-carboplatin (1-1 mol-mol),1.2674452804454217
SNU-423,46843906,3.685857483562859
Mono-Mac-1,3676137,3.340146241767567
SNU-1077,15547703,3.1840803381638114
SF539,24856436,-1.421470853407074
Becker,216345,4.415529131137277
EHEB,20959075,-3.303490374431417
BT 112,25262965,-1.8877634388627147
NCI-H196,72376,-0.477527805208171
NCI-N87,16038120,-0.0105690503285029
KMRC-20,54619267,4.002299235726132
TE 441.T,vorinostat-navitoclax (4-1 mol-mol),0.6103917311018806
KYSE-180,67156097,-0.5044651468589622
Hep 3B2.1-7,11222830,1.7633990776161406
Karpas-422,11238147,1.4747635682905047
RT-4,444795,5.14749831666829
SK-UT-1,11455910,0.1513173468225572
KMRC-20,24753719,4.050847735561683
AU565,11955716,1.5670888997114951
JHUEM-7,24964624,1.3812203269919547
Ri-1,25183872,-2.275946767134655
SW1573,135875424,1.8143158468632437
BFTC-909,16720766,-0.0189955240044846
Namalwa,42642645,0.3352240740036911
KLE,UNC0638-navitoclax (1-1 mol-mol),-2.745432149551299
WM793,crizotinib-PLX-4032 (2-1 mol-mol),1.8719851046729632
SW1783,9903786,4.362374850125049
OE33,5978,3.3733453677762304
NCI-H2030,11404337,0.8105383061900018
NOMO-1,5311281,1.2143454060885572
NOMO-1,2708,4.2098167660909525
JHUEM-7,10074640,2.4809812187935436
YD-8,5281321,-0.940156182693946
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667
NCI-H929,6438330,0.6628289141006722
NCI-H2030,136227924,3.923759704530775
NCI-H929,67291369,2.695813932699893
YD-8,9868037,3.0733964994503244
NCI-H1339,56963564,0.5367795839570972
BT 328,crizotinib-PLX-4032 (2-1 mol-mol),2.7816896231682886
TE-14,tanespimycin-gemcitabine (1-1 mol-mol),-1.3668083775041322
OAW28,123631,1.649178742735097
SK-MEL-5,24821094,3.388741132646637
Ri-1,119182,-3.3874396370579096
RERF-LC-MS,11609586,3.546222239883878
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782
BT 286,136227924,1.3356746395497436
KYSE-180,262093,4.394400122480356
KMS-12-BM,9866186,1.4538422549800163
RKO,6450551,2.9764230599456782
Karpas-422,5113032,4.470757133109911
PE/CA-PJ41 (clone D2),6918837,-3.248214905194486
YD-8,126941,-2.1622153409475593
Lu-65,71304818,1.8437698958476676
BT 248,2742550,4.585670765822412
JHUEM-7,44185566,2.2115462684333855
Namalwa,984333,-1.466329732922578
BT 248,71751553,4.279070264679743
SNU-216,10427712,3.9705426888084214
HSC-3,107985,-3.2412158645238893
IST-Mes1,5311,2.113640627204962
CML-T1,409805,3.5817002644537683
JHUEM-7,24180719,2.9437043979916413
LMSU,400769,0.2687008392096283
RERF-LC-MS,54618164,3.9158352593779377
AU565,11222830,1.6780695218323665
SK-MEL-5,969516,2.7494090939853804
YD-38,159324,3.3433539214120516
Kasumi-2,navitoclax-gemcitabine (1-1 mol-mol),-5.447760787137567
KMRC-20,135411,1.924751982395428
ESS-1,2126,5.022491020211577
ChaGo-K-1,46398810,3.134133884392003
BFTC-909,2708,5.254338200716292
NCI-H196,16722836,1.435247078840738
NCI-H929,24856436,1.1628618903895551
SNU-119,568763,0.0507231945137797
SF295,ISOX-bortezomib (250-1 mol-mol),0.5576704948928314
Becker,11494412,0.142625338466196
AU565,12003241,-0.6235660341918571
HOP-62,selumetinib-vorinostat (8-1 mol-mol),1.8094917487163475
ChaGo-K-1,6505803,0.7391022920837463
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
KO52,24180719,3.93533100976642
LMSU,122327,5.769053061722797
BT 320,6438330,2.745053768259143
KE-39,44137675,4.4813975845381755
Karpas-422,135398738,1.4669923353082115
TE-14,54649381,3.7440272990463774
BFTC-909,23725625,7.000464253417552
TE 441.T,5284373,2.4067293610179106
KYSE-450,400769,-0.8881298454848809
SNU-213,448949,4.454578697012804
B-CPAP,9929138,3.6088246512600457
AsPC-1,168312962,4.080126214508297
RERF-LC-MS,11178236,-5.98494163410248
ACC-MESO-1,11427553,2.389819749095902
Karpas-422,9444,3.821620615279606
ACC-MESO-1,60700,4.823672327859709
SNU-216,446155,1.8144703535429705
YD-38,9866186,1.1653654970339402
Mono-Mac-1,11238147,2.129695973361118
IST-Mes1,navitoclax-gemcitabine (1-1 mol-mol),-2.5828122357465144
ChaGo-K-1,25126798,3.881957924411908
WM793,2708,5.5820491292106516
WM793,11640390,4.32157052643877
AU565,53232,3.892352285865555
KYSE-180,54619267,4.811647968153079
SK-MEL-28,654092,0.5441939646786474
ESS-1,10427712,4.097612541596862
BT 286,219104,3.403941737257678
EHEB,25262965,-0.476476540262067
SNU-1077,3062316,-1.266961456390888
CML-T1,151289,0.34759640697574
AU565,54596558,3.073830584555768
HOP-62,54619267,4.367790390641184
CML-T1,16038120,0.5708889366464743
LMSU,5328940,2.811876730497891
NCI-H196,24785538,2.9685310971552945
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152
KLE,16722836,1.577901881910007
KYSE-450,2858523,3.2293705558979813
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
OAW28,16038120,1.1273660282184277
WM793,24180719,3.9443550279133186
OE33,73707398,1.4892412668396968
BT 328,3025986,-0.1303666559009026
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
Kasumi-2,168313200,3.5619242662151342
YD-8,3634881,3.215634292733124
Karpas-422,9866186,1.3861554791089596
NCI-N87,1641662,2.907963520285112
MIA PaCa-2,168313200,1.759366617697624
RERF-LC-MS,53392493,1.949934555719578
SF295,19582717,3.4877179279198076
SNU-213,11234052,4.331616153144613
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
BT 328,135659046,3.8583019402961343
OAW28,676352,1.7843387493833531
TE-14,ISOX-bortezomib (250-1 mol-mol),0.689552332809445
Kasumi-2,26596,-3.0246532529835273
PF-382,5978,-2.969199585988814
KE-39,2749,1.448224267904264
KE-39,227681,3.9577273305254113
PE/CA-PJ41 (clone D2),148124,5.794245590172473
YD-38,erlotinib-PLX-4032 (2-1 mol-mol),-1.9947686006051497
Lu-65,3384730,2.7772804583801105
OAW28,46191454,1.726492969979986
Mono-Mac-1,136227331,4.247854438913471
Mono-Mac-1,51039095,1.3547034147730423
SK-MEL-5,2742550,3.3094903780657368
NCI-H929,3136844,3.56413576716979
KMS-12-BM,5278396,2.1546808929463164
BT 248,322968,2.9090533378149535
AU565,89928392,2.1536851128845904
EHEB,54649381,3.7669466213883425
Ri-1,44489675,3.6880997948063743
KYSE-180,54618164,4.682866725736199
AU565,24748573,1.9131971710517224
NCI-N87,5281321,-1.2852273423113845
Becker,44632017,0.5330266067422236
BT 248,11364421,0.4256883677591794
AU565,60750,-2.174078373186638
HSC-3,3815108,3.409091117249246
HuT 78,44607530,0.9490207020575367
Karpas-422,4917,3.0827412077879233
SNU-1077,6918878,4.982410606922502
Namalwa,3689413,-2.4943268400148715
PF-382,1716436,4.358638458244471
JHUEM-7,5287620,-2.16834390542723
H-STS,11609586,0.7770634294621763
HSC-3,16741245,1.8902841178977503
OAW28,6610355,6.153508691776863
BT 320,387447,-3.873135040539017
WM793,25126798,4.114576992305207
TE 441.T,10410894,2.617207939173619
KE-39,3854666,4.449857131704124
MIA PaCa-2,4096211,1.982360073504129
YD-8,44493528,4.2998537557563346
EHEB,984333,0.8159443893987631
SNU-213,24753719,4.370347771119096
PE/CA-PJ41 (clone D2),45279963,3.8380832697665217
KE-39,24775005,3.7793317686622903
EHEB,135999136,1.8833962574329148
NOMO-1,135440466,1.6123042261647436
EHEB,53232,2.0797733628932
Kasumi-2,448949,-0.5395388127141975
TE 441.T,3025986,2.750603927254004
KYSE-180,49793307,-3.1171537464519186
PF-382,24753719,2.156979591404902
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
SNU-886,16722836,1.47024614694785
Hs 611.T,445091,4.262324044397264
JHUEM-7,4261,0.9558193049766148
Hep 3B2.1-7,36462,2.768405314394988
KLE,168313016,5.53335411774071
TE 441.T,selumetinib-JQ-1 (4-1 mol-mol),4.709536906442107
BT 328,24180719,4.750415959710981
LXF 289,6450551,1.9915066986525345
KMS-12-BM,46215462,1.145613842689034
PF-382,5328940,0.3302899082502404
ESS-1,5479543,3.502329300494909
Karpas-422,387447,-5.164381252871863
KLE,5746,2.2077814730114373
SK-UT-1,104842,-1.774878693515325
HOP-62,15547703,4.560533258663546
HCC2108,107985,-3.038738614535184
SF539,675434,4.646875008530426
KE-39,10385095,1.3052459079941114
TE-14,5287969,-1.4099886323192448
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
BT 286,15953870,3.897211275702576
OE33,46926350,-4.3039480497161335
OAW28,24964624,1.7856613849766505
SNU-213,65064,5.569795489228084
NOMO-1,52912189,-0.5265680930430634
EHEB,JQ-1-carboplatin (1-1 mol-mol),0.4941102336804299
Karpas-422,44486219,3.855480246667008
Hep 3B2.1-7,44819697,-1.6757920452059003
Karpas-422,4788,5.537541042200492
KO52,selumetinib-navitoclax (8-1 mol-mol),-1.982956418902813
AU565,11977753,-1.5018138963846497
Mono-Mac-1,9927531,4.461355065468675
Kasumi-2,148198,-6.27183434225638
AsPC-1,11612883,5.278069767960674
SK-MEL-5,46398810,3.127286082204237
KYSE-180,3854666,2.7659153089015898
EHEB,selumetinib-vorinostat (8-1 mol-mol),1.837404923820544
YD-8,46215462,1.7489393153094872
Karpas-422,10302451,2.97293319769233
PE/CA-PJ41 (clone D2),24964624,3.1911374387835596
B-CPAP,JQ-1-navitoclax (2-1 mol-mol),0.5903029448050835
HOP-62,6438330,2.309996098194817
Lu-65,3825829,3.880703687258769
SK-UT-1,44819697,-1.700169587058806
YD-8,5351362,1.6415350348808246
SF295,9911463,4.265275017996558
IST-Mes1,49867926,4.44564652397053
SNU-1077,12003241,-1.4220834787906382
ACC-MESO-1,42642645,1.530706527419768
Becker,462382,1.302780642835376
MIA PaCa-2,24856436,0.1423625732406639
HOP-62,53393127,5.1983956780419165
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445
JHUEM-7,135440466,2.2183951118949
KMS-12-BM,navitoclax-pluripotin (1-1 mol-mol),-1.9896147371140072
PF-382,selumetinib-MK-2206 (8-1 mol-mol),1.294147913599038
AsPC-1,25126798,4.196072723195887
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
Mono-Mac-1,5291,3.566758148465558
CML-T1,5470400,-2.3275269381266326
SNU-213,selumetinib-navitoclax (8-1 mol-mol),0.185492688578574
HOP-62,10410894,2.567224758918039
SNU-886,12003241,-3.694795257520175
AsPC-1,6918837,-2.7365580441764155
RERF-LC-MS,44486219,4.018485879154908
RKO,16725315,5.119694523443236
SF539,JQ-1-navitoclax (2-1 mol-mol),0.5515785836007664
BT 248,156422,4.367304785746438
OE33,5566,3.228481945044996
YD-8,5746,2.1470622280203693
SNU-119,9825149,2.245076319827961
SNU-423,9933475,1.8756797921904032
Kasumi-2,15953870,2.7617758274096404
ESS-1,5281321,-2.6789892941924034
NCI-H209,54639126,3.775629749799949
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
AsPC-1,46843906,4.099754684530221
ChaGo-K-1,10302451,4.275291921166029
OE33,5460769,3.7320924588923465
BT 248,216239,2.185733710507839
AU565,119182,0.402305157716339
MIA PaCa-2,11214940,1.115390680902948
TE-14,JQ-1-MK-0752 (1-1 mol-mol),0.7868462182929333
BT 286,9933475,1.51807034446665
HOP-62,52947716,2.688391451350114
SF539,11507802,0.8173734074149668
TE 441.T,15983966,0.8494922312809629
SNU-423,JQ-1-carboplatin (1-1 mol-mol),4.402018355533478
SNU-119,409805,3.7561778624984585
SF295,3854666,4.284983950639361
PE/CA-PJ41 (clone D2),56946209,-4.305283227067405
SK-UT-1,11507802,0.5091133584540986
BFTC-909,44185566,2.75887016136311
BFTC-909,4096211,2.208598833058293
B-CPAP,31703,-0.7132300755185688
RKN,135398516,1.9656218312143572
BFTC-909,5281321,-1.6266730162675118
KYSE-180,135440466,2.158709883591087
Karpas-422,49793307,-4.95469591758221
KYSE-450,56963564,2.961228752582631
Hep 3B2.1-7,52947716,-4.451035580134199
Kasumi-2,5566,3.0024962406609874
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
BT 328,16219061,3.835550220565251
HuT 78,44486219,3.8943973878115985
BT 112,51039095,3.5175679175043437
AU565,375860,-0.7785666069738753
EHEB,16720766,0.2436071662953463
MIA PaCa-2,52912189,0.9006637264845482
ESS-1,57519531,1.5158364649894671
JHUEM-7,9866186,0.4648370468543082
Ri-1,24901704,1.5524847191985809
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
CML-T1,25105715,2.3891517916986684
SNU-886,selumetinib-PLX-4032 (8-1 mol-mol),2.129242673373235
KO52,25105715,3.69197677171084
KMRC-20,4096211,2.631082680972026
TE-14,9926054,1.5943832140078456
SW1783,2945648,3.5321993021385367
NCI-N87,156414,-4.435299577962505
LXF 289,11175137,1.607203821415342
KMS-12-BM,72376,-4.576610051960773
JHUEM-7,71680916,4.772874327895641
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322
KMRC-20,46224516,2.3490422835427944
Becker,409805,5.716119591245028
RT-4,16722836,1.304866960728928
CML-T1,65628,2.7154825762494057
H-STS,119607,5.558084402470166
HuT 78,148124,-4.9142161440271135
AsPC-1,25227462,2.9060868065293195
KLE,3062316,2.3443438252501183
PF-382,10074640,2.4256064634454884
AU565,11609586,0.8886557909894768
HuT 78,25183872,-2.0170798191492634
SK-UT-1,216239,1.4894515561019788
BT 112,31703,-2.420524319729687
OAW28,6917907,-5.603755883192341
HCC2108,crizotinib-PLX-4032 (2-1 mol-mol),1.5096161008299982
KE-39,9933475,1.400657947751707
PE/CA-PJ41 (clone D2),65628,4.385016080496858
SF295,selumetinib-UNC0638 (4-1 mol-mol),4.941629082671042
KE-39,3634881,3.3710219028006474
SNU-119,19582717,4.915003831541955
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
Panc 02.03,219104,4.2068478561753375
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076
BT 286,6438330,1.1975316745843965
SW1573,2858523,3.1892649395611556
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
EHEB,159324,2.208250970812642
SW1783,9936388,2.9056540363277796
Namalwa,25154868,4.619245763975098
BT 320,2126,5.543243224179777
L3.3,49793307,-1.834464681937742
SNU-423,44632017,1.3194020598896097
NCI-H1339,60700,-1.071708126122017
Namalwa,107985,-4.241523948583442
KLE,135440466,2.96482384763011
KO52,9826308,-1.4432821349389238
WM793,3634881,3.628870809117573
Mono-Mac-1,6450551,2.178466389519658
HEC-108,46199207,3.6826733270490646
ESS-1,navitoclax-MST-312 (1-1 mol-mol),0.1700305380207872
TE 441.T,4378219,2.137715670751678
PF-382,46907787,-1.0517755055208098
KYSE-180,73707398,1.6922150122396675
GOS-3,107985,-2.049266528770901
Mono-Mac-1,55508,1.7176981446448645
RKN,71304818,2.008207131108322
CML-T1,51039095,1.5406670560339248
TE-14,5738263,3.0368996929484715
SK-MEL-28,2858523,3.231693296931409
ChaGo-K-1,25195348,3.4341296169097464
SNU-216,11364421,-3.4931065773065564
SNU-216,15983966,-2.0364381172241854
SNU-1077,2733487,8.302697103942196
BT 498,67156097,5.308227092292175
KE-39,17755052,3.062972722223711
HuT 78,4917,3.0693457272323825
Hs 611.T,44632017,0.5782997876733177
EHEB,66577038,2.720898706959581
KLE,11609586,0.7062994369280325
PE/CA-PJ41 (clone D2),11175137,3.6725738856580663
BT 286,4261,6.4796291982462675
RKO,44819697,-0.2126149769206573
NCI-H209,54618771,0.4504113944457773
CML-T1,67156097,-2.1928175380469477
SNU-216,3634881,3.17164277995117
PE/CA-PJ41 (clone D2),56949517,4.369609998916364
YD-38,44137675,2.339878994758295
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
HSC-3,26596,-1.4868403003967878
CML-T1,10074640,0.1978471501959747
KLE,44589607,1.3436468299943964
NCI-H1339,46843906,4.205971108333302
SNU-423,285033,-0.8949782324990676
HSC-3,168312962,-2.4846947846374388
BT 286,71466380,5.082668290524384
ACC-MESO-1,11626560,2.83142802841304
TE 441.T,11396600,2.898111820402536
BT 112,tanespimycin-gemcitabine (1-1 mol-mol),-1.366722683150895
SK-MEL-5,168313047,1.975290985697176
SNU-213,16038120,0.5394155086125938
KO52,11238147,3.117687457157308
PF-382,5460769,-0.5383889446594711
BT 286,753704,4.971153206041931
Hs 611.T,57519531,0.5632668661616677
Hs 611.T,72376,-3.6545364456282514
Kasumi-2,135398738,1.5778578151552838
TE 441.T,44491742,3.759624787095016
SNU-1077,10231331,3.484337251970082
BFTC-909,3689413,0.9841636034152118
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
BFTC-909,54618164,4.281231487810877
SF539,135440466,1.1383079175014172
Lu-65,4477,0.0654724816795039
IST-Mes1,53232,2.11135293708232
KE-39,5311,1.0787821402256168
RT-4,135999136,6.151607962032574
YD-8,24978538,3.298771682891298
CML-T1,5280436,4.11670865979611
ACC-MESO-1,SNX-2112-bortezomib (250-1 mol-mol),0.0592821214299193
SF539,24771867,1.191281674737788
SNU-886,navitoclax-sorafenib (1-1 mol-mol),-7.4083537328702365
NOMO-1,375860,-0.5184264862355304
HEC-108,2749,4.864852970303599
OE33,3689413,1.522493576982794
Kasumi-2,6610355,3.4850778191475342
SK-MEL-5,72193861,2.262524849088693
HOP-62,5470400,1.633979056860879
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286
BFTC-909,1641662,3.805506520632872
YD-8,24964624,2.5606551305717455
NOMO-1,9907093,3.6530797436282434
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
KYSE-450,100016,6.589468110151047
AU565,44507138,1.5217719455679517
BT 286,3854666,0.3675459578647432
NCI-H929,selumetinib-piperlongumine (8-1 mol-mol),2.46209131947828
BT 286,5479543,2.409411999726575
YD-8,2858523,3.2041590177045665
TE 441.T,24775005,2.980118551888832
L3.3,53232,3.8050949011624806
KLE,9911463,3.5004519168580828
Ri-1,57519531,-0.0573484837377726
MJ,54143018,1.2156401491436408
SF539,216239,1.8940195388550165
SW1783,126941,4.818238928893187
SNU-119,6918328,1.4012338898143128
KMS-12-BM,55508,1.5916377605400036
SK-MEL-5,5329102,1.6824496733918386
SW1573,73707398,2.4757839790774123
ChaGo-K-1,11152667,-0.0716632534971208
ChaGo-K-1,16736978,2.0946881293148376
SF295,selumetinib-navitoclax (8-1 mol-mol),3.9987598351011937
SK-MEL-28,24964624,3.0237245783497144
ChaGo-K-1,25154868,5.309533626163277
WM793,16741245,6.304850832164104
SNU-423,11485656,3.131370831257297
KE-39,3815108,3.17346514425842
L3.3,57519531,2.574296584662942
Karpas-422,navitoclax-pluripotin (1-1 mol-mol),-0.031614077340192
Lu-65,135440466,0.7027414116594601
OAW28,135928012,4.847644989583831
Namalwa,5311037,3.6814678393714617
SNU-886,11427553,2.479878788580837
PF-382,selumetinib-vorinostat (8-1 mol-mol),2.136528432975779
SW1573,10385095,0.5068001344623563
BT 248,67156097,4.587573075901519
EHEB,23635314,-1.6580881181075813
ESS-1,71304818,2.8292725688978986
YD-38,11364421,-3.571577351726304
Becker,46398810,3.659842106831334
IST-Mes1,selumetinib-piperlongumine (8-1 mol-mol),4.502033014563436
ESS-1,60700,-2.9575309810678414
KMRC-20,66577038,2.939049648949199
SNU-119,24775005,4.181410107840803
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
NCI-H1339,10410894,3.449598840011211
SNU-216,10296883,4.064330575642344
BT 498,46926350,-3.9030297935889737
ChaGo-K-1,navitoclax-MST-312 (1-1 mol-mol),0.8501822165973897
SNU-423,1750826,-3.0329631786048923
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
NCI-H929,4477,0.4411881433632111
TE 441.T,erlotinib-PLX-4032 (2-1 mol-mol),2.6470834141543804
BT 286,10322450,5.184244057340175
KLE,3025986,-0.967724412977758
RKN,44137675,5.459450119186335
Hs 611.T,5328940,-0.422105766889467
SNU-423,25062766,1.7832585279986426
BT 320,15547703,5.516273739658597
KE-39,2733526,4.766803704899474
SNU-119,123631,0.6885393078398833
KYSE-450,984333,1.1711925405074113
SF295,11626560,2.404098314231099
SNU-1077,66577038,3.753869643566382
KYSE-180,2874250,4.41639153643559
OAW28,71466578,4.4029072721322455
NCI-N87,3503,2.784967297602414
H-STS,44462760,2.174167118730489
KO52,9952709,3.149976936491048
KMS-12-BM,46199207,2.5727127947453585
KO52,25227462,1.3400451170529613
MIA PaCa-2,11175137,2.616995003058467
ESS-1,25183872,-2.0695789812237058
HOP-62,54618795,3.319315700053197
BT 286,119607,5.752743449749315
AsPC-1,11719255,5.644609733763846
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
SF295,11152667,-1.2215974796941085
NCI-H2030,1750826,0.9676784509807878
BT 498,9911463,3.937995526968798
AU565,176870,1.580958212812136
LMSU,49867930,4.439231756123768
LXF 289,6918878,2.1668969721619833
PE/CA-PJ41 (clone D2),2749,1.4001288103335976
Hs 611.T,168312962,3.2856643728353925
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
SNU-423,122327,5.666841554231471
RKN,10302451,3.971829298943927
OE33,46843906,2.27506456486943
Lu-65,25183872,0.3383859794560597
KYSE-450,5278396,4.032614684188798
Hs 611.T,11427553,1.4904899541531251
TE 441.T,56649450,2.4399268990024012
Hep 3B2.1-7,BRD-A02303741-carboplatin (1-1 mol-mol),4.439487706091506
HCC2108,54618164,5.127082823492277
MIA PaCa-2,5978,-4.253866013054402
NCI-N87,613753,3.043533794547513
KYSE-180,carboplatin-etoposide (40-17 mol-mol),4.3219850025217434
Mono-Mac-1,navitoclax-piperlongumine (1-1 mol-mol),0.8484355222187875
BT 328,89928392,1.451353651421501
RERF-LC-MS,25161177,4.303824118845859
TE 441.T,44185566,1.1710583771356151
NOMO-1,25150857,2.063048355345986
Namalwa,BRD-A02303741-navitoclax (2-1 mol-mol),3.7105553400958384
EHEB,31703,-2.7035431722217744
Hep 3B2.1-7,12001922,1.6092774927634723
BT 286,54596558,4.09108298890371
SF539,9907093,3.8198522822567655
OE33,15953870,4.191063320508706
WM793,12001922,1.7029195893812905
CML-T1,3025986,-2.237853890359125
SF295,11238147,3.954653767747053
YD-8,9952709,3.080336399855263
EHEB,SNX-2112-bortezomib (250-1 mol-mol),-2.4396809580796908
EHEB,327653,2.436506136039934
Becker,375860,-0.5928207112259023
BFTC-909,11214940,1.666026285351028
ESS-1,445091,4.768128875501155
B-CPAP,107970,2.366266521836174
LXF 289,6918837,-2.0130943060067454
Namalwa,navitoclax-birinapant (1-1 mol-mol),3.1548931611021898
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704
KE-39,54639024,4.382341904180532
KMS-12-BM,16725315,3.09098323700468
Namalwa,salermide-PLX-4032 (12-1 mol-mol),5.130194684209192
WM793,2828334,6.191612506266247
NCI-H929,46191454,-1.4087002661466548
MIA PaCa-2,10296883,4.037005331930825
Becker,11955716,-1.4968569931897069
B-CPAP,52912189,3.2590712280352583
KE-39,24856436,3.387816018334062
Hs 611.T,2742550,3.744335328422511
SK-MEL-5,89183176,4.253397892442645
SF539,1239801,4.247259889123834
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509
LXF 289,25262965,-2.558275633709226
BT 328,6450551,3.790902491385394
Kasumi-2,6438330,0.3381981879114322
AU565,11719255,4.218610599596327
Namalwa,11507802,0.2634665018733878
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
CML-T1,49850262,2.3003389318393404
OAW28,16722836,1.5279923407751788
MJ,11213558,2.02705556252861
TE 441.T,53495165,-2.662306662249335
BT 498,53232,4.313794339780105
SNU-216,15547703,3.0901716634646874
KE-39,45279963,3.4988491023820716
NOMO-1,637858,1.0893367728071195
H-STS,46215462,1.7095245533302474
Karpas-422,5351362,1.828306864536144
OAW28,44607530,1.1070032957823266
NCI-H1339,439501,-1.6994812988125017
TE-14,11364421,-5.823097598159696
SK-MEL-28,selumetinib-UNC0638 (4-1 mol-mol),1.787760879928494
HuT 78,60750,-3.915840643388668
KMS-12-BM,2858523,2.6623892435665337
HuT 78,3025986,-0.0982635511462348
TE 441.T,11455910,0.1965703482136005
Namalwa,45279963,3.210185637005973
YD-38,54649381,3.807168630789832
OAW28,9884685,1.3567472374362477
SNU-886,241158,1.2144772988451973
RKO,984333,1.1849980625737155
NCI-N87,5287620,-2.9994225662437928
OAW28,3815108,1.950790900509605
ESS-1,46224516,3.2167819229259447
IST-Mes1,piperlongumine-MST-312 (1-1 mol-mol),2.506000344733661
NCI-H196,10074640,3.6788769373365016
KMRC-20,104842,-2.088943206569887
SK-UT-1,6914657,-5.220536780204265
NCI-H1339,44202524,1.827057501254713
TE-14,11152667,0.6332718687769578
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128
RT-4,72193861,1.6093035569826073
NCI-H929,11507802,0.9864152558176
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
GOS-3,8515,4.692167574261379
NCI-H929,9927531,5.740923779315927
KYSE-450,9936388,-0.9236320595886032
KMS-12-BM,15547703,2.7013494250638614
HCC2108,selumetinib-JQ-1 (4-1 mol-mol),3.0515246299931205
SNU-213,24180125,3.139959624084286
L3.3,vorinostat-carboplatin (1-1 mol-mol),3.49555187429186
HEC-108,216345,4.4823048447920755
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568
BT 328,53393127,6.034881823049704
EHEB,6610355,4.225572519993169
SNU-119,3815108,1.8360895016279837
RKN,51039095,3.7797830340785694
KYSE-450,navitoclax-MST-312 (1-1 mol-mol),1.0440074090451137
Lu-65,675434,4.6985998957044774
KYSE-450,tanespimycin-gemcitabine (1-1 mol-mol),0.8586762777270994
KE-39,123631,1.2600830788760988
AsPC-1,56973724,5.500241353025212
TE-14,2828334,6.478723150548911
SNU-1077,439501,-0.9206139201693064
EHEB,676352,2.3007932773454844
AU565,71751553,3.982904849419344
SK-MEL-5,54613361,0.715893590160925
ACC-MESO-1,135984461,6.029797163877839
SK-UT-1,46215462,2.208029425657124
NOMO-1,60750,-2.6028640292275567
SNU-216,387447,-4.222955466200769
Panc 02.03,5746,2.615751109567445
B-CPAP,2841722,3.84496663124297
BT 286,5311,2.9174041274412095
HuT 78,969516,2.200953925383129
Panc 02.03,6918638,1.5939476449475074
NCI-H196,15983966,-2.261561647250827
Kasumi-2,navitoclax-pluripotin (1-1 mol-mol),-2.9755028456871866
Karpas-422,11507802,1.0681748147748091
HSC-3,11178236,-3.0740013881602426
KE-39,104842,1.1494054436800256
B-CPAP,71466380,5.72068384087767
BFTC-909,123631,2.8792987518934403
HEC-108,3503,1.40407452628706
SK-MEL-5,156422,4.118853121070512
Namalwa,44185566,2.0464342011420085
SK-MEL-28,3689413,3.3385356968233744
BT 112,44202524,1.0325728707890818
ChaGo-K-1,10231331,4.797062827822195
RERF-LC-MS,216345,4.25766275770173
YD-8,11214940,1.0637832201595108
NCI-N87,24951314,0.3588892807295563
H-STS,9866186,-0.0944353973133468
B-CPAP,49793307,-2.3843688094258453
PE/CA-PJ41 (clone D2),11228183,3.3949317736120546
KE-39,2729026,2.715568279593477
SNU-216,6918328,-1.6385139859210605
NCI-N87,54143018,-0.5822633828546482
SK-MEL-5,3025986,1.0315417341364177
TE 441.T,123631,2.609571206523274
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
RKN,44589607,3.09715941328701
NCI-H2030,10410894,4.154952019474486
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868
BT 286,44607530,0.996307301304738
SNU-119,54143018,0.8882121695154049
H-STS,decitabine-carboplatin (1-1 mol-mol),5.177792515700317
Karpas-422,71680916,4.106507626467137
JHUEM-7,53232,2.6111749392558985
L3.3,135411,0.9568641453583406
SF539,9911830,1.1022803108352155
B-CPAP,44137675,4.622984618218968
CML-T1,3825829,3.084807192466588
MJ,9933475,2.437576054324945
Kasumi-2,2126,3.96137914347523
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
HuT 78,4477,0.82836425534414
AsPC-1,carboplatin-etoposide (40-17 mol-mol),5.367887581807261
SW1783,216239,3.3394693883957616
Ri-1,9911463,2.719411575193649
KE-39,2945648,3.0904060650662477
Panc 02.03,BRD-K55473186,4.513191364064351
SW1783,9926054,2.85460969526429
AsPC-1,54613361,2.957295670472447
BT 286,44819697,-3.4653794468599117
SNU-119,49766530,-2.6347810345662785
SNU-216,52947716,-1.051191200256004
RERF-LC-MS,53232,1.207294902086358
OAW28,11964036,1.3272537866850969
BT 320,selumetinib-vorinostat (8-1 mol-mol),4.325017392219319
HuT 78,19582717,2.6899137103246327
KE-39,24951314,0.9296568060846556
NCI-H1339,44491742,4.759108525431012
KO52,24951314,0.169569428706958
Hs 611.T,11494412,-0.0466996238947274
B-CPAP,753704,5.841811531303964
Hs 611.T,25183872,-1.844128869238045
NCI-H929,148198,-3.717368743483661
YD-38,2858523,3.190176264794637
HCC2108,5311,1.3772121830259485
AsPC-1,selumetinib-UNC0638 (4-1 mol-mol),1.8710456800697877
WM793,5282054,4.473294081689067
Kasumi-2,285033,-4.713748931161676
SNU-1077,613753,3.232559060750619
KO52,3503,1.43557058273406
Kasumi-2,11977753,-3.013388327331023
SK-UT-1,5470400,0.3907308309201836
Hs 611.T,ISOX-bortezomib (250-1 mol-mol),0.0926232298221139
SW1783,409805,4.510325829942446
KLE,241158,1.9293702793301108
Namalwa,16065773,1.7637307024944335
RKO,25062766,2.7314931301361476
MJ,67156097,-2.074825443329949
NCI-H196,46224516,2.3441046962939622
KMRC-20,216468,5.240233090076588
CML-T1,6914657,-6.7918120052462685
TE-14,5479543,5.724048245895776
RERF-LC-MS,4259181,-1.273108977623296
TE 441.T,216345,1.5099442643650116
SF295,322968,4.885131861384079
Ri-1,67291369,-0.1856261156826838
Namalwa,6252,-4.382124329646984
KE-39,5284616,2.799589028326303
KE-39,2828334,6.422070101852093
LMSU,285033,0.1916696238645653
KE-39,49846579,3.0202206585589564
PE/CA-PJ41 (clone D2),6438330,3.358991898439142
Ri-1,67156097,-2.9960843721421107
SNU-423,11396600,4.403909661334611
SNU-1077,vorinostat-carboplatin (1-1 mol-mol),3.2108686769377717
HuT 78,54626689,4.7254586853376175
SK-MEL-28,19582717,5.671095391465724
SF295,54618771,1.9072877365394525
Lu-65,126941,-4.746785925644256
SF295,2708,4.6592874760103795
SK-MEL-28,44607530,2.6983056844197257
PE/CA-PJ41 (clone D2),5291,3.994121753282621
Becker,3634881,3.7005490899104374
SNU-886,11167602,1.491891520160987
YD-8,2828334,6.23916264624694
HSC-3,6917907,-5.720511046177551
SNU-423,123631,3.30108094965045
KE-39,9911830,2.572250482212608
OAW28,6852167,2.294169410796982
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
SW1783,9823820,5.69470825765173
Hs 611.T,23582824,0.1140568808044189
NCI-N87,10385095,0.9731458206829144
WM793,148198,-1.495249919530428
BT 248,73707438,3.693804860778579
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854
JHUEM-7,2733526,4.791818477991272
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
KYSE-180,11178236,-2.9076352351606394
BT 248,11396600,1.9236183524788075
Mono-Mac-1,2858523,2.440143154781653
YD-8,selumetinib-UNC0638 (4-1 mol-mol),2.6843150773739453
LMSU,17755052,3.9730762231411703
TE 441.T,44819697,-3.063263646717018
GOS-3,2871966,0.5648988653696159
SW1573,5351362,2.395315345585997
BT 248,11178236,-4.1971988945266965
HOP-62,3503,1.774181520682938
GOS-3,9935249,3.5788705539521315
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
KYSE-180,23725625,5.7318866037383165
NCI-N87,135421197,1.227136310912881
OAW28,262093,2.853078829548121
EHEB,702558,6.933646693723644
NOMO-1,25183872,-0.6960845434284378
LMSU,46191454,1.9443488630816397
Karpas-422,JQ-1-UNC0638 (2-1 mol-mol),-1.394772143472039
H-STS,44202524,1.3266978322273313
Becker,387447,-3.92218262413233
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
H-STS,24821094,1.6491011840853225
ChaGo-K-1,12001922,1.4825695444436542
H-STS,11485656,0.1079902200809361
H-STS,72193861,0.730927574550533
SNU-216,25150857,2.6497407085575286
Lu-65,969516,2.532419728264248
KLE,5287620,0.9182057456501032
LXF 289,vorinostat-carboplatin (1-1 mol-mol),3.3134202255532053
KMS-12-BM,71466380,3.5437906276884696
ESS-1,135411,0.5252983253091638
BT 286,10074640,2.3159474451917452
NCI-H196,5328940,2.396861686321897
SK-MEL-5,216468,3.582933078212788
IST-Mes1,5328940,2.5729000547912397
ChaGo-K-1,25183872,-0.0943535025043812
BFTC-909,100016,5.8134150302243865
Lu-65,52947716,-5.122167932786324
BT 248,1750826,0.7778964775949998
ESS-1,4378219,1.976133617597145
SF539,100016,5.965471494853995
IST-Mes1,46199207,3.629760005921771
TE 441.T,322968,3.586599917424751
NOMO-1,159324,1.6027654254866297
Kasumi-2,51039095,2.172369026283552
NCI-H929,135875424,3.2591057623275006
BT 286,11175137,2.1679374278293246
HSC-3,44241473,4.97517832627678
HSC-3,23725625,4.627515506200981
TE 441.T,1750826,-1.7032858666361108
BT 328,24951314,3.0926880274607753
SNU-216,carboplatin-UNC0638 (2-1 mol-mol),3.775865800874376
Becker,3025944,4.190319243036172
HOP-62,1242560,3.5362921857618717
TE 441.T,carboplatin-UNC0638 (2-1 mol-mol),1.4833424452661312
OAW28,753704,4.708152366597851
BT 498,navitoclax-gemcitabine (1-1 mol-mol),3.75277818219556
BT 328,2708,7.776890663910961
EHEB,11640390,3.640025607015964
JHUEM-7,46398810,1.861705663086365
OAW28,11427553,3.602344276440211
Mono-Mac-1,selumetinib-decitabine (4-1 mol-mol),3.5994209939270885
RT-4,11404337,1.401838262846579
LMSU,11656518,3.057433571616044
OAW28,4096211,1.5501495805084426
Mono-Mac-1,9903786,0.9536797288397608
JHUEM-7,24797083,1.6268225461289076
KYSE-180,5281321,1.5873257175067956
HOP-62,selumetinib-navitoclax (8-1 mol-mol),2.307851384246924
L3.3,66577038,3.645952100238679
ESS-1,24785538,2.1020731787092943
LXF 289,11485656,2.2610473771175847
Becker,vorinostat-carboplatin (1-1 mol-mol),3.87916931787536
LMSU,2945648,2.8278602599693805
YD-8,637858,2.173572899934862
AU565,9935249,2.085801217703038
TE 441.T,alisertib-navitoclax (2-1 mol-mol),-0.8453426928769932
Ri-1,44491742,3.935960320926185
SW1783,24180719,4.7795575092347535
SNU-216,3038522,2.4857596476620376
LMSU,327653,3.6010830884894824
KMRC-20,navitoclax-pluripotin (1-1 mol-mol),-0.4667071263611014
TE 441.T,5351362,0.9223527014919144
SNU-886,9936388,-5.3251547250946825
RKN,3689413,-4.085525957083088
KE-39,3689413,-1.8420159541718293
BT 286,selumetinib-vorinostat (8-1 mol-mol),-2.316984046450598
CML-T1,702558,3.0833664933254235
HSC-3,1641662,3.3023853436193256
Lu-65,24753719,4.200901719906933
NCI-H929,3081361,2.990825939445924
NCI-H929,3025986,-2.370688030167058
PF-382,6450551,1.027271835386555
Namalwa,10427712,3.814538105116573
NCI-H1339,676352,2.5885839758095592
Ri-1,vorinostat-navitoclax (4-1 mol-mol),-3.0348365764984946
PF-382,44202524,1.2151421852046318
KYSE-450,5281321,2.0309467216777657
SNU-1077,5282054,4.106676604062682
HCC2108,49850262,3.743305220709595
ChaGo-K-1,135421197,1.864105940411698
KMS-12-BM,11612883,1.8629511117266817
SNU-216,24856436,0.1450337924373276
NCI-H196,49850262,3.6752240843993937
SK-MEL-5,439501,-0.7759362068872153
PF-382,16741245,3.010878138090118
SNU-886,375860,-0.100716733121392
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
WM793,5281321,-1.0068304363485172
TE 441.T,10385095,0.7638238428487356
ESS-1,107970,3.021792385864846
OAW28,44486219,3.976522680156617
Kasumi-2,6436223,-4.213376684231403
SNU-213,5311,1.6195658531629902
RKO,25102847,3.0524897378806033
Hep 3B2.1-7,322968,3.4200690068475508
JHUEM-7,6918638,0.5834631364682521
SNU-423,135411,0.8949713421437451
MIA PaCa-2,9823820,4.179730833084768
RERF-LC-MS,11964036,1.6707185338079893
AU565,107970,1.9067452119355752
Lu-65,71466380,3.872217675145991
BT 248,71576739,6.051378362255083
Mono-Mac-1,selumetinib-PLX-4032 (8-1 mol-mol),3.3595379048000016
SK-UT-1,136227924,4.460190875137593
SNU-423,25105715,3.517866626039398
ChaGo-K-1,tretinoin-navitoclax (4-1 mol-mol),4.3573110089788365
NCI-H929,135398738,4.7642664235998815
CML-T1,135440466,1.4712310181015782
KYSE-450,44607531,1.4871997171976696
KYSE-180,8515,4.449202894378201
NCI-H1339,409805,5.836206098158848
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
Hs 611.T,4788,5.886904507162304
KE-39,60700,1.8919776900280405
Lu-65,11955716,-2.4331112872150893
MIA PaCa-2,89928392,1.5224119152536262
Lu-65,44819697,-1.4367548400629455
KMS-12-BM,60700,-3.455544016540571
TE-14,126941,-3.8659791476469567
Karpas-422,1750826,0.2604258540554078
RERF-LC-MS,3854666,0.8294073497518095
TE-14,71466380,4.317857344031299
KLE,969516,4.2636253983089984
Namalwa,71680916,3.957958076797236
WM793,6918837,-0.893478746769829
GOS-3,46224516,1.1736861645065142
NCI-H1339,JQ-1-carboplatin (1-1 mol-mol),3.0025540987138326
SNU-886,6505803,-0.0303295506780238
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
TE 441.T,16722836,0.9060116885921192
KE-39,5351362,1.2382997191060965
ChaGo-K-1,4788,5.90494207062602
TE-14,100016,6.976624848230786
WM793,446155,3.930863255707362
Karpas-422,984333,0.9643586289419676
AU565,2746,2.9112036552039737
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
Panc 02.03,24785538,2.724480470289088
ESS-1,piperlongumine-MST-312 (1-1 mol-mol),0.6128133156835777
KO52,11625818,4.5522450622851105
SNU-119,10385095,1.2447707748514782
KO52,54613361,-1.011400617715983
ESS-1,49793307,-2.776813429548929
YD-38,4477,0.3282500775583097
Hep 3B2.1-7,10231331,1.1707245730964018
KYSE-450,24772860,-1.687862811669867
Ri-1,44486219,3.9245812935437794
ESS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.558730455952703
PF-382,66577038,2.531906234689114
ChaGo-K-1,9884685,1.4931363766033252
KMRC-20,11152667,-0.0779110822248748
B-CPAP,568763,0.5693864802501477
BT 328,4917,3.0980779681660375
ChaGo-K-1,16219061,2.7846250315534036
HOP-62,445091,4.12247730605986
EHEB,11625818,2.7353109359046615
YD-38,54454,1.8632122515216116
SNU-1077,446155,2.117109617978931
BFTC-909,24785538,3.0409365635840433
KE-39,5566,2.5519005230377574
LMSU,tretinoin-navitoclax (4-1 mol-mol),4.538664740757784
Hep 3B2.1-7,2729026,3.0424078117099222
OE33,11719255,3.780620794772801
SNU-119,25154868,4.579751406552007
BT 320,11214940,4.494237160276683
JHUEM-7,52912189,0.2472065202892593
SK-UT-1,36462,1.790037225485122
RERF-LC-MS,25154868,3.293982375318642
Hep 3B2.1-7,carboplatin-UNC0638 (2-1 mol-mol),4.182961554277728
SNU-1077,24785538,1.8612325565822845
GOS-3,9933475,1.7482363497307876
HEC-108,60700,1.732447929158594
HuT 78,11612883,1.5245291666063423
OAW28,44137675,4.561686598527574
RERF-LC-MS,2871966,0.0193381278585586
BT 112,6914657,-2.2779536161879044
ChaGo-K-1,9825149,2.134765038111806
LMSU,11485656,2.410376154528579
RERF-LC-MS,216239,1.5111459083459036
SNU-119,675434,5.343032629204847
BT 498,3465537,2.67100305933086
MJ,60750,-4.348443804943146
KYSE-180,2828334,7.128860440334806
KE-39,451668,5.747427565955262
JHUEM-7,erlotinib-PLX-4032 (2-1 mol-mol),1.849076309987276
BFTC-909,159324,4.114702101808939
KYSE-180,984333,0.4630057299456917
OE33,5470400,-2.8362706163601743
Mono-Mac-1,51037431,3.7216020490235624
Panc 02.03,11175137,3.7353172411310696
AU565,44632017,0.8977842888684593
Kasumi-2,54618771,-0.6876381814105375
SK-MEL-5,1242560,4.359269086710968
Namalwa,613753,2.874891192816088
Kasumi-2,5311,-0.335738593661984
Hs 611.T,1716436,1.70748477144168
HEC-108,44589607,3.4353145741514557
SK-UT-1,54618164,4.334674071191232
LXF 289,24901704,2.332916050939017
Lu-65,16013152,4.337400643693818
BT 328,219104,4.206978092049304
SNU-423,selumetinib-PLX-4032 (8-1 mol-mol),4.134751066727683
SNU-216,6436223,-5.776381478312599
SNU-119,638278,4.6940839403885555
SF295,49836020,5.953375339581455
L3.3,11507802,1.6932869737181035
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
RT-4,9936388,-6.517969541343547
Karpas-422,11647372,-0.5156950059246161
NOMO-1,2733487,3.664178503465112
L3.3,65628,4.284850303510067
OE33,25183872,-1.848598152169528
RT-4,5281672,5.093859609315912
OAW28,135398516,2.0767833136681437
ACC-MESO-1,448949,2.651018278601144
KO52,107985,-4.972333164700203
KYSE-180,452548,0.8760289796861696
HCC2108,568763,-0.0032676468194757
NOMO-1,19582717,2.563142509513499
RKO,5460769,5.660789679983863
Karpas-422,5287620,-4.326710186438937
NCI-H1339,16720766,0.3905164617769229
KE-39,52912189,1.824719595124253
SNU-119,66577038,3.3366072908443756
Karpas-422,448949,1.746149355007417
OE33,107970,1.9682278614825048
BT 112,52947716,-1.8173903777090337
PE/CA-PJ41 (clone D2),decitabine-navitoclax (2-1 mol-mol),4.0972631886919135
TE 441.T,2858523,3.209267360707008
MIA PaCa-2,11427553,1.2137196958123289
NCI-H929,17759555,3.669029016892366
SW1783,selumetinib-PLX-4032 (8-1 mol-mol),4.758526701715075
NCI-N87,9866186,-0.0362526715344146
BT 112,7251185,1.5687647885823757
OE33,52912189,2.434086733871051
SNU-119,9887053,3.651062425326841
RKN,119607,5.106543735080002
AsPC-1,7251185,2.99432826291256
BT 112,327653,2.6431646979441012
RKO,675434,4.252493680505022
CML-T1,135875424,3.5304182343940935
OAW28,119607,5.347849335106357
SNU-119,9935249,3.2348685245924726
KYSE-450,11609586,3.5646213291444324
TE-14,6436223,-4.414768579613021
SF539,23725625,5.199616438597248
HOP-62,9952709,2.3634226717159805
TE-14,3384730,1.7890988863095236
Ri-1,11609586,1.210615825815208
H-STS,4261,-1.5298596443260053
AsPC-1,45279963,4.120012544363151
LMSU,3634881,3.35269539341832
SK-MEL-5,44486219,4.423845629482486
HuT 78,11707110,-7.111344223172838
BT 286,65064,5.257116101297063
TE-14,6852167,2.6176714040781977
Namalwa,JQ-1-carboplatin (1-1 mol-mol),-0.7629380597950661
SNU-216,46191454,0.776571208563394
KE-39,25195348,3.12017559444377
AsPC-1,104842,0.0602967281328717
CML-T1,11485656,1.9899616795432975
NCI-N87,12003241,-2.470820657410725
PE/CA-PJ41 (clone D2),16720766,1.1856728493123077
MIA PaCa-2,10172275,4.620213928756893
SNU-1077,3825829,4.049018603201765
SK-UT-1,5329102,3.5213520964338207
EHEB,11609586,1.2753249269460478
BT 112,46843906,3.5145309028016953
KYSE-450,136227924,3.5350495950730645
Kasumi-2,3854666,0.5999676074569762
YD-8,5280436,4.27125727704808
Ri-1,6505803,0.1421500129584279
HuT 78,3062316,2.376024867755132
AsPC-1,44819697,-0.3025066533854976
GOS-3,16725315,5.248800956635294
YD-38,148198,-2.2054243046269044
BT 286,241158,3.931607244311501
RERF-LC-MS,11657048,4.330866638894723
SNU-216,5287969,-1.6544806621586654
KYSE-450,168313200,3.958386537902572
KYSE-450,24797083,1.908715906165
SNU-216,2858523,3.0909848672396847
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
ACC-MESO-1,135999136,6.41791740965286
PE/CA-PJ41 (clone D2),54618164,4.303600867099711
Karpas-422,selumetinib-UNC0638 (4-1 mol-mol),1.8652233950787973
NCI-H196,6918878,3.7948272154638825
H-STS,6918878,0.8588702567283845
CML-T1,carboplatin-UNC0638 (2-1 mol-mol),2.1290435317203023
TE-14,navitoclax-pluripotin (1-1 mol-mol),-0.0154318957409185
NOMO-1,9926054,1.6113291347040215
KMS-12-BM,445643,2.943383383902934
ACC-MESO-1,crizotinib-PLX-4032 (2-1 mol-mol),2.746301693286097
HuT 78,54613361,-0.8401705547778511
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967
BT 286,selumetinib-decitabine (4-1 mol-mol),-0.5242434333966475
SK-MEL-28,46191454,3.2888923577411333
RKO,568763,0.6942409100068829
KMRC-20,5311,1.9500827374985197
RKN,5281321,-0.4803497212669658
HSC-3,4096211,3.965550570092238
Kasumi-2,5743,-2.32743694805066
OE33,65628,4.337074317818266
ESS-1,44185566,3.0308522030936667
HOP-62,5746,1.5783238510950015
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
JHUEM-7,168313016,6.3518310954698824
HSC-3,46398810,2.2474004259842584
SNU-216,2945648,1.2585954802718622
KMRC-20,5329102,2.310119092431828
OAW28,11612883,3.952715585132085
NCI-H929,123631,2.2312857610244827
KMS-12-BM,3676137,3.133967205799227
IST-Mes1,17755052,1.8699185860343792
Mono-Mac-1,123631,1.906319126298777
SNU-213,4096211,4.225121711422805
Hep 3B2.1-7,piperlongumine-MST-312 (1-1 mol-mol),1.9337544959120967
BT 112,4378219,2.0035787751838057
OE33,11178236,-2.949746650584844
SNU-216,11167602,2.868305973285908
Kasumi-2,208908,2.161160996454662
ChaGo-K-1,122327,3.867171453362269
SNU-886,327653,2.660863736494067
KE-39,selumetinib-UNC0638 (4-1 mol-mol),3.3038481766151704
KYSE-450,16038120,1.4472769553293552
SF295,72376,0.6979097544539823
HuT 78,6505803,-1.3012174270497974
BFTC-909,12001922,1.803559970478093
Karpas-422,42642645,0.4716956796226118
OE33,3825829,6.240341971286144
KMRC-20,148198,-1.1031106323256945
YD-8,4917,3.030228999243137
KYSE-180,16038120,1.625383238797563
RT-4,serdemetan-SCH-529074 (1-1 mol-mol),2.3514467892397852
AU565,5284616,2.6982931675931914
HOP-62,54618164,5.192278696523286
BFTC-909,2113511,5.65564772398506
Kasumi-2,44607530,0.8991199704837235
SF539,11955716,-1.5322335585538187
SNU-216,5328940,0.816126960446068
HCC2108,1750826,-2.504101992023161
SNU-1077,navitoclax-gemcitabine (1-1 mol-mol),2.6315006611829004
SNU-423,navitoclax-PLX-4032 (1-1 mol-mol),2.701511272036536
NOMO-1,44493952,3.580250185381126
SNU-119,10026128,4.4148318530797885
SNU-1077,5280436,3.835908210015818
SF539,5287969,-1.7419223666366572
SF295,navitoclax-birinapant (1-1 mol-mol),2.8120952021298526
Namalwa,serdemetan-SCH-529074 (1-1 mol-mol),0.9967824467026186
KMS-12-BM,vorinostat-navitoclax (4-1 mol-mol),-0.3192913755194076
ESS-1,36462,-0.1255368808432747
SK-MEL-28,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6626824854303086
ChaGo-K-1,12003241,1.029111103028103
TE-14,5494449,3.33607935476747
YD-38,16736978,2.1471918071797975
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
KYSE-450,24856436,0.9513610633306496
WM793,5460769,5.840780592325561
LXF 289,52912189,-0.1394416798850269
HOP-62,421610,3.669034139736905
RERF-LC-MS,44185566,3.014427147988128
L3.3,5280436,4.8128342001361
KMRC-20,60700,0.7111086892810461
ESS-1,135398738,5.75744142626397
IST-Mes1,16720766,0.7299606902549882
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
KE-39,6852167,2.989668764419295
SK-MEL-28,5978,5.732425336762653
Ri-1,11977753,-4.917198176717717
Namalwa,3385,2.140825833931489
PF-382,52912189,-0.6597239458297713
KE-39,65064,5.11272287356881
CML-T1,25195348,1.1650045100950834
BT 248,25262965,0.9142276489527752
WM793,60750,-4.670115905093864
B-CPAP,5282054,3.7840154230687295
NCI-H929,52912189,-1.2648597734935654
HOP-62,25183872,-0.4191267821474728
BFTC-909,6914657,-4.61933610547547
RERF-LC-MS,375860,-0.2896823379882159
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
SK-UT-1,375860,0.2310503192742169
KYSE-180,637858,2.310022745659766
OAW28,44607530,1.1070032957823266
NCI-H1339,637858,2.289025775873357
B-CPAP,44241473,5.575826833143993
SF539,1285940,2.084694719582332
BT 498,2871966,3.3818803701608804
KE-39,JQ-1-carboplatin (1-1 mol-mol),1.0085240512621525
SK-MEL-5,168312962,-1.254533954039552
BT 286,16219061,2.6372151747686954
MIA PaCa-2,60700,-0.9449919961316452
HOP-62,54678924,2.041879666308894
L3.3,31703,-1.9667249709147607
BT 328,navitoclax-piperlongumine (1-1 mol-mol),2.639428516957035
KMS-12-BM,2746,1.2802142564618226
KYSE-450,5282054,4.505957787336516
IST-Mes1,11213558,3.9887472477266215
BT 286,BRD-K55473186,2.9341926558853784
EHEB,452548,-2.012657575306965
OAW28,67291369,5.503883029091299
ACC-MESO-1,11455910,1.4227308564953651
SNU-423,44566777,-0.8182000419835486
RT-4,24901704,2.5115033957059776
HuT 78,11719255,1.766568320704254
Mono-Mac-1,44241473,4.325172344907564
HuT 78,16013152,3.8354573431378185
PF-382,23635314,-2.865470025294806
WM793,9887053,4.971798307876137
BT 286,9929138,6.547331402872382
YD-8,71304818,2.9643287808222025
SW1573,54626689,3.958399976383255
Kasumi-2,400769,-1.337956311995758
LMSU,16065773,3.25664528889909
KE-39,73707398,1.3252144554958445
SK-UT-1,11625818,5.186074210783149
B-CPAP,JQ-1-UNC0638 (2-1 mol-mol),3.2358489904077974
Hep 3B2.1-7,46199207,3.3405336212593113
MIA PaCa-2,71751553,4.303479284138883
IST-Mes1,135398738,4.689828903809361
Kasumi-2,10410894,1.8135964606255892
CML-T1,5311281,3.0916675116608863
ACC-MESO-1,322968,5.3153065954738326
SNU-216,selumetinib-JQ-1 (4-1 mol-mol),1.428202673212368
BT 328,135875424,3.085389187382682
SK-UT-1,selumetinib-PLX-4032 (8-1 mol-mol),4.7803100019835005
SK-MEL-5,7326481,2.442811680167144
AsPC-1,676352,1.9564823338284063
ChaGo-K-1,2945648,2.7056269027367468
H-STS,16741245,6.378704245448754
Namalwa,navitoclax-piperlongumine (1-1 mol-mol),1.1479801451227785
TE 441.T,3854666,0.9289040865316472
HOP-62,11977753,-1.565204360127456
Lu-65,6914657,-3.6612157004781705
PE/CA-PJ41 (clone D2),16065773,1.8609668807275996
RKN,31703,-0.7196573309741882
KLE,135984461,1.6662233005465323
ESS-1,9936388,3.356877818481439
RERF-LC-MS,44566777,0.4059341966526995
CML-T1,44202524,1.467740802576286
NOMO-1,49793307,-3.1091933140229
Ri-1,409805,4.02318209858409
Hep 3B2.1-7,72193861,4.912921910575128
WM793,6610355,4.692334548375442
ESS-1,135999136,4.050088319286221
LXF 289,135421197,2.6553019911408056
KMS-12-BM,44607531,1.4229825608705295
RKO,16065773,3.3120716405166615
ACC-MESO-1,5460769,5.633127442709169
HuT 78,56963564,-0.3875963553009233
NCI-N87,11647372,-1.5140697510658656
KE-39,46907787,0.5111190203360444
SNU-423,15983966,-4.104535660378808
YD-8,25126798,3.822441714978281
MJ,42642645,-0.910764146609361
YD-38,9444,3.627999315336627
ACC-MESO-1,2749,1.8588259991256275
ESS-1,44819697,-1.0610912171108204
Ri-1,decitabine-navitoclax (2-1 mol-mol),-4.461207799698283
Namalwa,73707438,4.231902210564029
TE-14,119182,-0.544302547893501
Ri-1,168313047,1.4794526918566904
SNU-213,67156097,6.483469517568511
OAW28,208908,1.9779710002494069
KO52,4261,0.81751905802646
KMRC-20,322968,4.283184334248703
SF539,44241473,5.236379084530278
AsPC-1,1641662,3.9838157290035
AsPC-1,23725625,6.32859301599116
SNU-423,10410894,4.683863656413666
IST-Mes1,54454,3.4404607016766264
Lu-65,4259181,-0.4284059095013066
KE-39,JQ-1-navitoclax (2-1 mol-mol),0.0790402407130846
PF-382,vorinostat-carboplatin (1-1 mol-mol),1.5687292736817784
SNU-119,25195348,3.2417646819599444
KYSE-450,11494412,3.783526385415406
SK-MEL-28,2828334,6.345313377915581
Karpas-422,44462760,1.042048322720737
KO52,3081361,3.265083976806624
HuT 78,44491742,3.833204810123411
Kasumi-2,serdemetan-SCH-529074 (1-1 mol-mol),0.2929627524168506
CML-T1,5284616,-2.6047133462283276
SNU-1077,5281672,4.971178348467827
YD-8,17755052,1.5678870901115745
KYSE-180,11404337,-0.9460930401604244
NCI-H196,400769,-0.3348431458221283
Panc 02.03,702558,5.477624163348055
RKN,984333,1.094463938199557
NCI-H1339,216468,2.5099668441276006
BT 286,9840324,5.923668609002887
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
AsPC-1,4578,5.074011683523406
EHEB,16722836,1.130353250152493
NCI-H1339,54596490,5.682943703162134
Panc 02.03,89928392,1.630028817710481
KMS-12-BM,44185566,1.0129713840485208
AsPC-1,16736978,1.4850226649426823
KE-39,44607530,1.389048643742405
SNU-1077,374536,4.4212076979679305
Lu-65,89928392,1.711018630035882
KMRC-20,10385095,2.891783125869015
NCI-H1339,3025944,4.2584671750779615
KMS-12-BM,JQ-1-MK-0752 (1-1 mol-mol),-2.744831923995191
KYSE-450,89928392,1.680457877716282
KO52,4578,4.496766222375734
RKO,11427553,3.456895276763714
ChaGo-K-1,9926054,1.8139091606673228
GOS-3,19582717,5.639915925254865
Hs 611.T,5278396,3.7948314243215977
HEC-108,24978538,-0.9824677506425258
AU565,637858,2.0174799842455364
NCI-H929,219104,1.172196270408648
SNU-216,10385095,1.0317587818104637
KMS-12-BM,16736978,-0.4930730722396533
NCI-H196,6918289,3.1633997526775706
KYSE-180,24856436,3.3632320307562185
SNU-423,2746,3.5801912517104695
Ri-1,selumetinib-MK-2206 (8-1 mol-mol),0.0435914915818819
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
GOS-3,4917,3.642810744950485
Ri-1,322968,1.829437451733689
Hs 611.T,5287620,-2.413645738426364
ChaGo-K-1,4578,5.530144890731415
Kasumi-2,227681,1.7835466743963533
HCC2108,100016,5.291323338255078
WM793,4378219,1.9547593472491875
B-CPAP,16725315,3.8186556720671025
HEC-108,54619267,5.275779209173027
HCC2108,4477,-0.2147784559751654
SNU-216,54454,3.4585023319896497
BT 320,44607531,2.095455849416377
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
KE-39,9936388,1.1689372039333712
SK-UT-1,16725315,3.0339469216482127
ACC-MESO-1,10127622,5.935815768092786
Becker,9933475,2.3299360060402297
CML-T1,9935249,2.5956918222650507
HuT 78,44202524,1.902464587959626
BFTC-909,24964624,2.4776408698208003
NCI-N87,54613361,-1.4178620324204825
HuT 78,46215462,0.912768914225953
Namalwa,12001922,1.9514258181134656
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385
LXF 289,16722836,0.8079280065417594
SF295,676352,2.981550138485967
OAW28,9911463,4.007690751229585
Lu-65,439501,-2.896459054469027
PF-382,9866186,-0.181999891578736
YD-38,439501,-2.4363640234681347
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
MIA PaCa-2,135440466,1.742842838035012
OAW28,2858523,3.071437644261336
SNU-1077,1242560,3.950980625831431
Kasumi-2,53392493,1.5560274267449214
RKO,9908783,5.5436232623995805
Ri-1,9956119,1.7305193093233373
B-CPAP,3503,2.2508501900255213
TE 441.T,3062316,3.3189110651259437
HuT 78,42642645,0.2069800565131915
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
BFTC-909,8515,4.73152093133166
NCI-H2030,76446078,5.365957574929404
HOP-62,46199207,3.239522230883076
PF-382,3634881,2.1354287574506117
HOP-62,11656518,1.540061386933048
TE 441.T,6505803,-1.628255920679656
KMS-12-BM,56649450,0.982928705692675
Lu-65,10427712,4.072538471037268
H-STS,selumetinib-piperlongumine (8-1 mol-mol),2.659030814623116
LMSU,568763,1.244726818384242
TE-14,24951314,1.384333623307948
RERF-LC-MS,135999136,4.400683337930441
HuT 78,24771867,-2.8492074914531407
KO52,3038522,1.8551480195818488
Hep 3B2.1-7,71680916,4.65916730827728
Hep 3B2.1-7,16038120,-0.1087057777184335
SK-MEL-5,16725315,4.671402704829768
PE/CA-PJ41 (clone D2),969516,4.346091945294376
AsPC-1,11364421,-1.021042778985214
LXF 289,6914657,-2.1957863105134474
BT 112,148198,-3.0030353997640074
BT 328,3503,3.047903158140159
JHUEM-7,16722836,0.6728003897520018
KLE,navitoclax-MST-312 (1-1 mol-mol),-1.4508493438218537
KO52,24901704,1.8747752688503028
ESS-1,docetaxel-tanespimycin (2-1 mol-mol),-6.30643911780066
NCI-H929,9915743,0.0759555072139175
AsPC-1,11214940,2.3233429785878443
BT 112,156414,0.8059624645319847
SW1783,11656518,1.104179519424249
YD-8,25105715,3.325556248276192
NCI-H1339,72376,-1.8174283195884284
WM793,11960529,4.980101224880268
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
RT-4,11152667,0.7569607325973031
JHUEM-7,89928392,1.1586048072991315
KLE,11396600,3.656351561000123
BFTC-909,5287620,-2.871557478653834
ESS-1,11222830,1.000273173568511
ACC-MESO-1,selumetinib-JQ-1 (4-1 mol-mol),2.43285066252002
Mono-Mac-1,16736978,2.1360631840468898
CML-T1,selumetinib-piperlongumine (8-1 mol-mol),3.07705446138146
RERF-LC-MS,168313016,4.277512101574917
NCI-H1339,6917907,-5.63495602514643
SW1783,5335621,4.352005875752797
KMRC-20,44819697,1.1580347805946598
HSC-3,637858,2.0652307033731097
KE-39,3062316,1.989758349210964
Namalwa,navitoclax-MST-312 (1-1 mol-mol),0.9145161531931786
ChaGo-K-1,52947716,2.4825337083096564
KO52,JQ-1-MK-0752 (1-1 mol-mol),1.137098893083227
AU565,3025944,3.700689922668097
BT 498,44507138,4.476922300600167
NOMO-1,6918878,0.4522523514749809
HuT 78,17755052,0.1532683017086964
Hs 611.T,2708,2.861727852355751
GOS-3,31703,-1.1173409595108883
SW1783,11175137,2.286839278211157
LMSU,salermide-PLX-4032 (12-1 mol-mol),5.363735492393686
PF-382,44489367,4.604182803409816
L3.3,5329102,3.0035184311097245
CML-T1,446155,3.2304119453056632
Becker,637858,2.787561829247156
PE/CA-PJ41 (clone D2),753704,5.093510117133769
AsPC-1,2746,3.619198032462304
JHUEM-7,613753,2.971505518088734
HSC-3,3503,2.2677536339528044
HCC2108,navitoclax-pluripotin (1-1 mol-mol),-1.5801642437599936
KYSE-180,104842,-0.8703497694822725
TE-14,5282054,4.432967217136438
SK-MEL-5,71466578,3.722137827995549
NCI-H2030,5278396,3.8604955487006096
KYSE-450,selumetinib-piperlongumine (8-1 mol-mol),5.043149849236574
HuT 78,2874250,-2.74453547874646
SW1783,11427553,2.7214554119768253
KMS-12-BM,50905018,3.0779303184533076
Karpas-422,135411,0.9481856703320688
AsPC-1,9840324,5.861158829716173
Ri-1,168313016,3.43203331304281
BT 112,135411,-0.6618805280288009
PF-382,5329102,1.0797765060108404
JHUEM-7,46191454,0.2697350797052546
BT 498,246676,4.408890433497639
BFTC-909,5351362,0.3148685714677321
Kasumi-2,10427712,4.152130511624211
KO52,4521392,4.342251998569949
MIA PaCa-2,16736978,1.1146080849337705
KYSE-180,2742550,4.361413861886047
BT 328,7251185,2.5751215328420676
BT 286,216239,2.296063009751389
ACC-MESO-1,3384730,1.608685383996302
KO52,54765302,5.5636252834337565
TE 441.T,2742550,3.688066908856028
Mono-Mac-1,9967941,4.049384928851452
KE-39,11152667,0.74958800909379
BT 286,doxorubicin-navitoclax (2-1 mol-mol),-4.326574011981579
PF-382,9956119,2.18852743102483
PF-382,638278,2.364690037141532
KO52,11707110,-6.904897916995384
SF539,9826308,-0.4997268921639499
KMS-12-BM,44819697,-0.1317079524994108
LXF 289,25195348,5.284501520866742
OAW28,11404337,-1.5682838378564492
TE 441.T,6438330,1.0080434865499013
BT 328,24785538,0.2054381662017833
RKO,16722836,2.0172870973895085
L3.3,44507138,2.7873723049829544
SW1783,selumetinib-piperlongumine (8-1 mol-mol),3.7422302368862104
B-CPAP,2708,4.8825948055163835
Hep 3B2.1-7,135999136,2.2984722485990567
HEC-108,107970,2.8725679938480817
H-STS,1750826,-4.772155717820538
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
Mono-Mac-1,9887053,1.5534992217620511
NCI-H2030,409805,6.26321786552448
JHUEM-7,135984461,4.346774383555173
Namalwa,docetaxel-tanespimycin (2-1 mol-mol),-6.910303489948078
CML-T1,9907093,3.685523679081733
OE33,53495165,-2.9883375308758424
NOMO-1,4259181,0.2459758371125145
PF-382,9967941,3.320272765089539
NCI-N87,702558,5.013224249903468
JHUEM-7,119607,5.3622103716766905
Becker,8515,4.701222217711314
KLE,11640390,2.1380206941615514
NOMO-1,72376,-3.881755374018637
GOS-3,9911463,4.370946765627494
KMS-12-BM,54618305,3.825029881117321
SK-MEL-5,selumetinib-navitoclax (8-1 mol-mol),3.0996146071399093
Becker,doxorubicin-navitoclax (2-1 mol-mol),-0.0209389405027952
SK-UT-1,selumetinib-navitoclax (8-1 mol-mol),6.349573563603245
NCI-N87,219104,3.2437824126869415
HSC-3,5746,0.0203057913802775
HSC-3,46174525,4.198953944320053
TE-14,53245473,3.8089317117921846
OAW28,4788,5.61832216329738
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
NCI-N87,5335621,4.88881532131479
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
Ri-1,439501,-2.801888786170529
SNU-213,selumetinib-tretinoin (2-1 mol-mol),0.7321149203948827
LXF 289,168313016,5.746715572468322
SNU-1077,11404337,-0.4720370259421129
SF295,568763,0.589438080855472
TE 441.T,44566777,-1.2682865822917189
HCC2108,12001922,1.7040984021547378
NCI-H1339,24821094,3.97018187385564
AsPC-1,637858,2.8111542457272605
LMSU,135398744,6.91211293627059
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216
CML-T1,11609586,-0.1617986940719625
PF-382,9825149,1.7969028915446674
KO52,5281321,-1.995850617560654
Lu-65,9825149,1.987488121708482
SNU-213,49793307,-1.7137170581408678
Lu-65,23582824,0.2818334700004627
PE/CA-PJ41 (clone D2),44185566,3.1395351078001443
Lu-65,9956119,4.2489471675785975
YD-8,24951314,1.71060998865463
AsPC-1,71304818,2.27524368423619
Kasumi-2,BRD-A02303741-navitoclax (2-1 mol-mol),-1.941760845574772
TE-14,285033,-1.6140076799735457
YD-38,89183176,-2.2975625174244767
BT 286,135421197,2.331823163871174
PE/CA-PJ41 (clone D2),3689413,2.5059514962832536
SK-UT-1,24964624,3.065767628621786
GOS-3,1566236,2.0611902912111013
SNU-119,54618305,4.480526935824261
YD-38,9915743,-2.811758020987732
IST-Mes1,11485656,3.5408910362273835
SW1573,6917907,-6.296104468024424
NCI-H1339,135421197,3.8934160378835054
Panc 02.03,25154868,5.464083731960118
Lu-65,9444,4.326130099496892
BFTC-909,6852167,2.133526407129769
BT 112,6918638,0.7933014260092189
Hep 3B2.1-7,3099980,3.523994590060619
SW1783,44489675,4.313226705523417
TE-14,5291,3.8275001484723057
CML-T1,5978,-4.3443825686600785
AsPC-1,5287620,-2.2438477065180233
BT 498,16219061,3.633329359759088
SF539,52912189,0.594338957036255
BT 248,5479543,3.7849708026150406
Kasumi-2,52947716,-3.704060756771708
NCI-H929,3854666,0.9590353539059504
BFTC-909,24180125,2.699370118217823
CML-T1,25262965,-1.9815055926190612
KMS-12-BM,441298,3.3874000284739028
SNU-119,6918837,-0.1720170696149332
OAW28,24856436,0.1607500363529794
SNU-213,168313047,2.8352682390823234
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
Panc 02.03,5311,2.7910052639268415
Hs 611.T,439501,-3.691204716302381
ACC-MESO-1,salermide-PLX-4032 (12-1 mol-mol),5.911303184857687
HSC-3,2708,5.023023521923633
HSC-3,11364421,1.6206871903423576
TE 441.T,24978538,2.0567927172310028
HOP-62,2733526,2.706309948771008
SK-UT-1,637858,2.463996188946881
LMSU,selumetinib-JQ-1 (4-1 mol-mol),3.5274573633732773
LXF 289,11238147,3.4273419568352006
NCI-H196,89928392,1.4109494619621703
RKO,46398810,2.934390735401444
NCI-H1339,5978,-3.09040269698192
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885
Kasumi-2,5978,-3.933681438293164
BT 248,3634881,2.1213928087500413
AsPC-1,49766530,-1.5554439905221051
SW1783,46843906,3.6277750541017304
NCI-H929,44185566,1.267263970973427
CML-T1,11222830,0.9922056813064216
KYSE-180,10113978,4.975324753626726
ESS-1,44202524,1.7594814112354966
MIA PaCa-2,5287969,-2.3681939301530455
Karpas-422,11222830,1.5173095522321836
TE-14,vorinostat-carboplatin (1-1 mol-mol),3.4576074929446
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
Hep 3B2.1-7,135421197,0.863862977673099
Mono-Mac-1,3634881,2.4944168079015134
BFTC-909,46224516,1.8849058086882595
NCI-H196,11364421,-2.6143973725469105
Hep 3B2.1-7,124202324,2.4115397020619453
HSC-3,6914657,-4.096069958773948
AsPC-1,alisertib-navitoclax (2-1 mol-mol),1.2084192852647102
TE 441.T,24856436,-0.2818059712724387
OAW28,3081361,1.8855664708831448
Kasumi-2,9887053,0.7760357688642865
AsPC-1,135875424,4.124114476494282
HuT 78,67291369,-1.2460432819903486
BT 112,23582824,0.9685063545248322
SNU-216,9935249,2.9187421404972165
RKO,135999136,6.045591123054076
JHUEM-7,7251185,2.276113292965344
Kasumi-2,6252,-4.69021119640851
ESS-1,24964624,3.0338116933926735
KE-39,6918328,-0.2708141535303604
L3.3,176870,2.4076894274707947
PE/CA-PJ41 (clone D2),5978,4.677104950562766
BT 328,24775005,3.5424710463828624
YD-38,452548,0.3359210212160434
Lu-65,navitoclax-piperlongumine (1-1 mol-mol),3.0170876228722214
SNU-216,1566236,1.785015766563616
ChaGo-K-1,tanespimycin-gemcitabine (1-1 mol-mol),0.5067754366627312
ChaGo-K-1,erlotinib-PLX-4032 (2-1 mol-mol),3.5306775519247746
SF539,7326481,2.919170434383445
TE-14,148198,-4.134736941909179
NCI-H1339,24901704,4.008825025425333
Namalwa,selumetinib-JQ-1 (4-1 mol-mol),0.0869925670736783
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
OAW28,262093,2.853078829548121
MIA PaCa-2,1239801,4.687665562632846
Karpas-422,16720766,0.6661379613872315
SK-UT-1,11238147,3.508126296570063
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
SNU-886,107985,-2.815059265270472
RKN,9926054,2.8101544562472056
WM793,56946209,-4.12818494071316
Mono-Mac-1,9823820,2.873638007148911
NCI-H196,9911830,5.051951455628038
HSC-3,5311,1.6159558865121677
Ri-1,65628,2.1586840271379732
BFTC-909,11427553,2.7610941057010754
ChaGo-K-1,119607,5.482633007693178
ChaGo-K-1,702558,5.016721785533269
NCI-H2030,9903786,2.824655549380346
SW1783,42642645,1.5180122548711477
IST-Mes1,4259181,1.4706848514509867
SNU-1077,452548,1.172143593642621
SNU-216,5494449,1.9310955055256367
HEC-108,alisertib-navitoclax (2-1 mol-mol),-0.2691749995476873
ACC-MESO-1,15983966,1.990338557522609
AU565,9866186,0.5690553044247834
Lu-65,2828334,6.02552770752455
SNU-216,11612883,2.937874366044306
KO52,10184653,1.4838473316294571
BFTC-909,5329102,1.9658448878596055
Becker,44493528,4.387044567791122
Mono-Mac-1,25105715,3.239622858410376
BT 320,285033,5.611549861739741
TE 441.T,2749,0.2808222316332103
LMSU,navitoclax-piperlongumine (1-1 mol-mol),2.8977701094185586
SK-UT-1,73707398,0.9883439046575164
YD-8,carboplatin-UNC0638 (2-1 mol-mol),3.392730087781214
HSC-3,selumetinib-tretinoin (2-1 mol-mol),4.189404326176633
HSC-3,5282054,3.7905589736364647
EHEB,10113978,2.77276539003515
NCI-H1339,5460769,-0.265386406275254
GOS-3,54618771,2.751038853336045
YD-38,168313016,6.308402556942436
Kasumi-2,25102847,1.9985292692576584
BFTC-909,51039095,2.7594177275421403
TE 441.T,3465537,1.109247742302779
KO52,135875424,3.01966044425059
LXF 289,216345,3.67485776854348
BT 112,24772860,-3.2237648858189742
Kasumi-2,9826308,-0.3836015857314186
SK-UT-1,445643,4.614923035667888
KE-39,675434,4.431531195571141
TE 441.T,72199292,4.464736678161801
KO52,11626560,-0.7906152386558187
LMSU,5284616,3.630952322980812
BT 248,25150857,2.3784591591930635
OE33,10184653,1.4543634096464415
WM793,24821094,4.44664829967469
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533
BT 498,11719255,3.558741439213583
HSC-3,11485656,2.2428743548360863
HSC-3,9935249,4.975494741872852
LMSU,4261,2.446120037363317
LXF 289,3062316,-3.851151802003845
KO52,doxorubicin-navitoclax (2-1 mol-mol),-1.6802250262186946
H-STS,44566777,0.8546674055066537
BT 320,3634881,4.591305105456608
YD-38,44185566,1.975044849479651
EHEB,6918837,-4.415870025794879
SF539,446155,1.5612752979886544
RKO,52947716,-6.611161073849914
L3.3,24856436,2.4877361998822924
AsPC-1,11494412,3.580103428724827
Lu-65,135421197,2.266142941564523
RERF-LC-MS,439501,-1.3704502050640626
KMRC-20,56946209,-1.705053096437228
ChaGo-K-1,135423438,3.972168514727344
PF-382,4261,0.6206870573702211
Hs 611.T,46843906,1.902730681717527
LXF 289,409805,5.2068809837223435
ChaGo-K-1,54678924,2.2307192214046903
Panc 02.03,89183176,4.957506748320777
SNU-216,65064,5.2443933180383295
OE33,navitoclax-MST-312 (1-1 mol-mol),2.7767901134896604
SNU-886,24889392,3.4092549144778976
HCC2108,5281321,-0.1705555691898866
BT 328,24964624,2.9431698803975324
JHUEM-7,26596,-1.8551798961299688
MIA PaCa-2,17755052,2.071011142750117
LMSU,4788,5.893858428733075
HOP-62,54618771,0.1660184306238314
KMS-12-BM,24180719,3.687281269749717
NCI-N87,6505803,-6.101345662019038
BT 498,241158,4.164187123770961
PF-382,9903786,1.7632578420268197
PF-382,176870,2.767344828111714
SK-UT-1,10296883,3.957718672541511
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
TE-14,44202524,1.8111102949434932
SNU-423,613753,3.147569499194737
Hep 3B2.1-7,selumetinib-UNC0638 (4-1 mol-mol),2.3003422063073993
HSC-3,tanespimycin-gemcitabine (1-1 mol-mol),-1.3128890682956813
ESS-1,123631,3.705774293108517
RKO,10074640,2.8357111382750646
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904
JHUEM-7,3136844,4.744963133957354
SF295,crizotinib-PLX-4032 (2-1 mol-mol),2.36869335976651
B-CPAP,11238147,2.5075756320642197
ChaGo-K-1,984333,0.9481175577146016
H-STS,56963564,-0.0472332493661748
HSC-3,6852167,3.108712764007485
B-CPAP,72376,-1.8039181485690416
SNU-213,navitoclax-gemcitabine (1-1 mol-mol),2.580873398185735
AU565,71729975,2.800801196457704
HOP-62,44484893,4.694286333214486
OAW28,11178236,-3.057015425639644
SNU-213,5328940,2.4318019623760816
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
HuT 78,3543504,5.689885557286378
AU565,16720766,2.906162391657848
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
AsPC-1,400769,-0.2711365707281618
MIA PaCa-2,6438330,2.864716697344165
Ri-1,54678924,1.162364883135177
H-STS,10113978,4.065703828677869
Ri-1,navitoclax-pluripotin (1-1 mol-mol),-6.091181145598441
NOMO-1,107985,-4.118574275669005
SF539,24772860,-2.3648669148494856
MIA PaCa-2,44607530,2.2158687440672686
SK-MEL-5,9840324,5.050338860461006
ESS-1,5311,0.311650985953959
B-CPAP,3081361,3.333044863505124
OAW28,25150857,2.5691026408672957
YD-8,969516,3.325354242438773
TE 441.T,64971,3.267500054274099
MIA PaCa-2,24772860,-2.8067404690630435
TE 441.T,JQ-1-UNC0638 (2-1 mol-mol),1.283080729500337
SF295,selumetinib-piperlongumine (8-1 mol-mol),4.570084707393715
RKO,159324,3.5523933893017583
Panc 02.03,11964036,1.263021853424522
PE/CA-PJ41 (clone D2),11238147,5.476916752075203
LMSU,322968,4.855851656802344
GOS-3,6852167,4.136996914293619
KE-39,44137675,4.4813975845381755
OE33,3503,2.5193951312514655
SW1573,24180125,4.83914798243841
OAW28,6610216,3.9661844518771185
SNU-423,71466445,3.7020222675723646
SF539,46943432,2.0271543904998746
WM793,10231331,2.277080944837622
KE-39,60700,1.8919776900280405
SW1783,613753,4.7217707300915
KO52,52912189,-1.11352091818438
CML-T1,16736978,1.2014198902848654
Kasumi-2,54143018,-2.3900299530010405
HuT 78,3136844,3.938412897897032
SNU-216,675434,4.503602806823805
YD-38,51039095,2.9380633657207733
LXF 289,5113032,5.558232749512156
SF295,57519531,1.705733255061587
BT 112,11404337,-0.2767075951827175
KYSE-180,24753719,4.5603328664886815
OE33,54618164,4.547083841535975
LXF 289,89928392,2.4967474535679623
RERF-LC-MS,5281321,-2.2570738048063257
Kasumi-2,11507802,0.0513516992758086
CML-T1,10427712,1.89618534848285
RERF-LC-MS,72376,-2.3536044208150644
KLE,9868037,3.52213609317776
RKN,452548,0.7515073582009456
RERF-LC-MS,10302451,4.085913110869725
SF539,carboplatin-UNC0638 (2-1 mol-mol),3.439871222147057
B-CPAP,11214940,0.8407381176330342
BT 320,53301938,4.424260786877386
RT-4,54618771,0.6660630053371256
SK-MEL-5,4917,3.0625088748071656
MIA PaCa-2,navitoclax-piperlongumine (1-1 mol-mol),2.098278284226177
SK-UT-1,46843906,3.6979645993744032
ACC-MESO-1,4788,5.4001840643992605
PF-382,5284616,-4.488730736751072
PF-382,656346,-0.3937515411626462
HCC2108,11626560,1.2483680324780997
JHUEM-7,4788,5.917235759280994
SNU-423,selumetinib-MK-2206 (8-1 mol-mol),2.6852698386469136
KYSE-450,JQ-1-vorinostat (2-1 mol-mol),2.5632737661829488
BFTC-909,57519531,3.2286550647211025
NCI-H1339,327653,3.7168174136495735
HOP-62,2130404,3.6362735335083016
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
NCI-H1339,25183872,-0.470185695101433
SW1783,53495165,2.348659450699313
ESS-1,9915743,1.8900363437156489
KO52,126941,-4.363414933437974
LMSU,6917907,2.90407541957411
PF-382,36462,-0.7112012842580974
MIA PaCa-2,9911830,2.066034374401692
SNU-1077,119607,4.993790856001467
Ri-1,4477,0.9849203528472006
KE-39,6918837,-3.138673306335868
Namalwa,1239801,3.4041628695786432
Hs 611.T,46199207,2.9870879689298726
RKN,216468,4.351451769225332
BFTC-909,56963564,-0.1720168824982637
KE-39,11626560,1.956808029215874
KMRC-20,3825829,4.552870179452752
KLE,11222830,1.1739941214880287
EHEB,54143018,-0.2425574036169623
Becker,4477,0.418729890718949
SNU-423,462382,0.9019532186956488
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
BT 112,71680916,4.277413325515947
Lu-65,5311281,4.045906858909323
CML-T1,4788,4.608482830288328
KYSE-450,11612883,5.465517956514392
KYSE-450,46191454,2.021198534281789
BFTC-909,9868037,3.24226767674478
WM793,9907093,5.490749105587387
HOP-62,44607530,1.7731789756813656
BT 328,24856436,4.552904501266461
NCI-H1339,675434,4.467732679344732
HEC-108,selumetinib-UNC0638 (4-1 mol-mol),4.806918156541826
MJ,439501,-3.472446137047906
ACC-MESO-1,3854666,3.6033422587717854
YD-8,9926054,2.068126295394322
AsPC-1,11640390,5.159931420709134
SNU-216,25183872,-0.6946707113423909
ACC-MESO-1,6918289,4.071566792460107
KMRC-20,452548,1.1770836669609313
Ri-1,9936388,-7.695738985409057
LXF 289,51039095,1.6878089310027404
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
PF-382,10302451,0.8944755236764494
RKO,65064,4.5178366082525
KLE,10113978,4.613150784757447
BT 286,10127622,-1.2732169388544852
BT 286,73707398,0.9456567929994184
PE/CA-PJ41 (clone D2),11234052,5.082198224280487
BT 112,10074640,3.3091637914687073
Mono-Mac-1,46191454,0.1350664799202493
NCI-H1339,151289,1.086653425019276
WM793,10184653,0.3319580671106031
ChaGo-K-1,49766530,-1.5426741425236086
BT 112,24964624,1.8320643006347463
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
SF295,12001922,1.8411518312335016
Kasumi-2,2871966,-1.247169917955711
LMSU,46398810,2.8230145741890977
PE/CA-PJ41 (clone D2),387447,-3.919842712569756
BT 286,navitoclax-MST-312 (1-1 mol-mol),0.9465292199095277
SNU-216,9956119,4.016386926893835
RERF-LC-MS,44202524,1.2785968032229695
Hep 3B2.1-7,9926054,2.8753203525792026
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
KMRC-20,55283,3.082017581412527
ChaGo-K-1,alisertib-navitoclax (2-1 mol-mol),2.403809638873206
TE-14,2746,3.3749666856765304
Mono-Mac-1,JQ-1-carboplatin (1-1 mol-mol),-0.3034213126939502
L3.3,5566,3.1406901276995094
TE-14,42611257,3.491443930705766
CML-T1,11507802,-0.1369004319183971
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
NCI-H929,5281321,-2.264984865592431
Becker,151289,0.655779143245145
PE/CA-PJ41 (clone D2),11485656,2.035669448740327
Lu-65,11717001,3.784678462419639
Namalwa,23582824,0.1050889456769123
NCI-H929,selumetinib-navitoclax (8-1 mol-mol),2.7472624638867766
SNU-213,5280436,4.039307371149868
YD-38,5566,2.9447153211285997
Karpas-422,5278396,3.2041501178835414
IST-Mes1,navitoclax-MST-312 (1-1 mol-mol),2.625426297409908
AsPC-1,10385095,2.76496705920137
BT 112,119182,-1.0754477765372774
BT 498,24964624,2.135100588287655
KLE,16741245,4.352629336159379
OAW28,327653,3.155680016062074
LMSU,selumetinib-MK-2206 (8-1 mol-mol),3.140399649431559
B-CPAP,375860,-0.8507879875115774
GOS-3,637858,2.327239346274226
ChaGo-K-1,9840324,5.755771001589306
ChaGo-K-1,9823820,4.154977738904327
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
OE33,2746,2.7393344543249443
KO52,2749,1.7174149313892582
PE/CA-PJ41 (clone D2),46191454,4.0230795719044705
KMS-12-BM,11455910,-0.5978210432128618
SNU-216,44491742,4.347867819055225
ACC-MESO-1,12001922,2.4993315613358926
LXF 289,navitoclax-pluripotin (1-1 mol-mol),-1.4421954677948514
BT 112,24821094,1.850576537519091
TE 441.T,selumetinib-UNC0638 (4-1 mol-mol),2.335720091395641
KLE,navitoclax-gemcitabine (1-1 mol-mol),-1.442818690707718
HSC-3,2828334,6.4248099303253605
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096
KO52,11317348,-0.6673416896175152
NCI-H929,piperlongumine-MST-312 (1-1 mol-mol),3.099725979824717
HuT 78,568763,0.026722170308136
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
SNU-423,6505803,0.7785757061169877
LXF 289,107970,2.2922723928752307
KMS-12-BM,11238147,0.8062576818407409
L3.3,9926054,1.9335911906728165
TE 441.T,11964036,3.258752022533959
YD-8,46191454,1.6533383090175473
OAW28,6918837,-3.92509053266304
ESS-1,44607531,1.6327452604769903
NCI-H929,322968,-0.4532114476759251
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
NCI-H929,49850262,3.128406990217982
ChaGo-K-1,5702613,1.0084739984497502
NCI-H1339,9911463,4.3916675652750925
PF-382,tanespimycin-gemcitabine (1-1 mol-mol),-4.545409531146979
RKO,53232,4.485666667988006
OAW28,24180719,4.377592888188756
EHEB,3385,0.9451951233490862
BT 320,71751553,4.331550413851084
ChaGo-K-1,421610,2.67400864037601
SNU-1077,168312962,0.1799345841951062
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
HEC-108,16741245,3.4879989323714713
IST-Mes1,54618771,0.8929247318821524
JHUEM-7,462382,0.9048845181666758
MIA PaCa-2,52947716,1.6425946184377718
SNU-886,2746,2.8162256970394295
Hep 3B2.1-7,tretinoin-carboplatin (2-1 mol-mol),4.761305966090253
WM793,1750826,-0.77104860711207
KMS-12-BM,navitoclax-MST-312 (1-1 mol-mol),0.0074530885526159
SNU-119,49867926,4.1413838407199375
SNU-119,10302451,1.573205462567535
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024
YD-8,56946209,-4.261193272731818
NCI-H2030,carboplatin-etoposide (40-17 mol-mol),3.9396863916898575
Mono-Mac-1,55283,2.711605788635057
YD-8,16219061,3.09744286971822
RKN,25183872,-1.1518449365963386
KMRC-20,selumetinib-PLX-4032 (8-1 mol-mol),4.800972275106229
YD-8,2113511,5.249485368051986
Kasumi-2,409805,3.7279902229812114
RT-4,71466380,4.899760942476526
KO52,selumetinib-PLX-4032 (8-1 mol-mol),-1.2002620728634303
AsPC-1,613753,3.1774382169580355
AsPC-1,9825149,2.485133390345911
KLE,2113511,5.3070368791783915
KYSE-450,1641662,3.736286251526556
BT 498,9549297,1.944333767833654
Hs 611.T,44202524,0.9839909825075092
SF539,5978,-5.613486711901469
EHEB,44589607,1.92892141933537
KO52,44202524,1.2331460749640877
SW1783,4917,3.480222092567203
AsPC-1,6852167,3.622461858977091
ESS-1,6450551,2.4356422182289106
WM793,navitoclax-piperlongumine (1-1 mol-mol),2.3781458373034976
KYSE-450,262093,3.266752988649651
BT 498,51039095,3.6677678650771903
OAW28,11214940,1.4072727029323666
Hs 611.T,24978538,1.8342555493439971
NCI-H929,54618305,4.349731057515986
NCI-H929,JQ-1-MK-0752 (1-1 mol-mol),-3.6559725672275394
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
HCC2108,10231331,3.026437227257123
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
TE-14,alisertib-navitoclax (2-1 mol-mol),3.1926120569177305
RKN,3543504,4.234888347098623
ESS-1,9926054,1.828443058535804
NCI-H196,6917907,-4.1817502536593
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
BFTC-909,969516,2.723005004244225
NCI-H2030,4259181,1.1105893163636829
AsPC-1,2858523,3.256128469853813
KMRC-20,51039095,3.0958869754937424
OAW28,374536,3.018534312402979
SK-MEL-5,16720766,1.2054685868185928
SNU-216,ISOX-bortezomib (250-1 mol-mol),0.1706448686157683
SF539,56949517,4.748779906195386
ACC-MESO-1,119607,5.522701718625694
KE-39,216239,3.497758173664419
KMS-12-BM,49793307,-4.548343844172568
EHEB,decitabine-navitoclax (2-1 mol-mol),0.1121135025155182
SK-MEL-28,10296883,3.852008110979885
JHUEM-7,11955716,-2.804770203271417
Namalwa,3062316,1.228247623122234
Karpas-422,107985,-2.8458224127978733
NCI-H1339,24753719,4.233509766860094
Ri-1,4096211,0.8804339359424012
HCC2108,44484440,3.875901941244504
TE-14,3025986,-0.4853927435927206
HOP-62,72199292,2.0893543654643403
MIA PaCa-2,462382,0.4936091832075975
SNU-886,5287620,-2.170628852003526
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
KE-39,5278396,4.063811246360968
MIA PaCa-2,2749,1.5862657990210698
NCI-H2030,2858523,2.977003820472243
AU565,285033,-2.964869253470222
Karpas-422,tanespimycin-gemcitabine (1-1 mol-mol),-2.8780840785015944
KMS-12-BM,2130404,3.4441142127860696
KMS-12-BM,11717001,5.884192823277555
SNU-423,44607531,1.5801842386267164
SNU-216,9907093,3.375254195669079
TE 441.T,644241,1.5282801612003003
HSC-3,24772860,-2.421030928901566
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054
HSC-3,119607,5.3722262785741055
SNU-886,3025986,0.191528697071382
NCI-H929,73707398,-1.1294071073635834
TE-14,2949965,3.398761439739322
BT 112,44486219,4.929058970539822
LMSU,637858,2.7447242272748924
TE 441.T,246676,4.366193760638462
Karpas-422,9887053,3.894192278074615
RKN,24964624,2.2448388370498704
TE 441.T,613000,2.584906530054027
CML-T1,JQ-1-MK-0752 (1-1 mol-mol),0.6034690158877323
BT 112,5328940,1.9807564403861109
SNU-1077,2858523,3.01508829517467
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
RT-4,3689413,0.3652230576391069
SNU-1077,10385095,2.8092985891088444
SNU-119,selumetinib-piperlongumine (8-1 mol-mol),4.5887710430802215
RT-4,5328940,2.539742147157725
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
NOMO-1,10427712,4.067466468396052
ESS-1,119607,5.640066336706725
TE-14,navitoclax-birinapant (1-1 mol-mol),3.503571738112873
PF-382,2708,3.3018060761805774
LXF 289,322968,3.971478433961818
TE 441.T,6610216,4.146097180963395
KE-39,3062316,1.989758349210964
AsPC-1,11955716,-2.13511164723979
Namalwa,5460769,2.4239066035753054
NCI-H1339,6610216,4.6247766816350495
KMS-12-BM,9926054,1.301975129823355
B-CPAP,3689413,-2.370401360424748
SNU-119,3689413,-2.887862499697321
SNU-886,5328940,2.5802660020848696
SNU-423,984333,0.69154556302042
SNU-119,11647372,1.96438955117864
BT 112,15547703,3.043535770474186
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
KYSE-180,5738263,3.136309383400005
SNU-1077,24901704,2.743135685281435
GOS-3,11234052,4.638302294933858
KE-39,168312962,1.831477708522254
NCI-H196,selumetinib-BRD-A02303741 (4-1 mol-mol),5.304767119574239
OAW28,3689413,-1.4375749125930504
OE33,9915743,2.242004758711727
YD-8,5566,3.0799845846164047
KYSE-450,vorinostat-carboplatin (1-1 mol-mol),4.263576896954741
KO52,11404337,0.1772123930911338
RKN,107970,2.600341318615175
H-STS,5113032,5.339439762793735
EHEB,6184667,4.2340057403581115
BT 320,6918638,3.210777195522013
NOMO-1,168313047,1.7455342513633885
KMRC-20,3854666,4.622266524166492
Mono-Mac-1,10302451,2.661721795389531
EHEB,16038120,1.550937492892113
KO52,10322450,3.562187913985661
EHEB,3062316,0.0300315004197751
Becker,4578,4.452563048211831
Panc 02.03,135411,0.8368106867561712
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
YD-8,11485656,2.558902022570011
SNU-1077,17755052,2.9989648032129477
KMRC-20,5311281,2.943166998255785
KMS-12-BM,navitoclax-sorafenib (1-1 mol-mol),-0.3529677445590104
Hs 611.T,50905018,4.49675699957726
YD-38,11485656,2.58437498447116
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
Hs 611.T,216468,1.31218613653852
PE/CA-PJ41 (clone D2),11964036,2.080788440495361
SNU-216,4096211,2.421698037098144
HEC-108,219104,3.940802724544765
HSC-3,46191454,1.6824478443738038
NCI-N87,148198,-3.7864178683693774
Hs 611.T,71304818,1.7643501549477851
NCI-H1339,8515,4.704049354821168
SNU-1077,navitoclax-sorafenib (1-1 mol-mol),1.842498946009811
H-STS,135398516,1.890546081861667
Lu-65,135999136,6.05207061737822
SK-MEL-28,15983966,3.2325576409024306
LMSU,148198,-4.18626130759339
MIA PaCa-2,16013152,4.154236855192705
TE 441.T,5470400,5.687935465815988
NOMO-1,56649450,3.0749194455734012
YD-38,387447,-4.020257287464525
SNU-119,969516,3.8713828709310256
Karpas-422,25227462,-5.497189538867502
JHUEM-7,selumetinib-piperlongumine (8-1 mol-mol),2.711360769969603
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
OAW28,107985,-3.5497769626209217
SK-UT-1,selumetinib-piperlongumine (8-1 mol-mol),4.6362910530737595
KYSE-180,66577038,3.3144658202336945
JHUEM-7,11960529,4.681162039691551
HEC-108,4477,-0.1758732099665472
HCC2108,3025944,4.0723705952966975
Panc 02.03,241158,4.402915180139186
Karpas-422,10184653,0.6496260208856843
SK-MEL-5,16013152,4.084760192264916
Ri-1,71466445,1.3498732213426647
L3.3,10385095,1.3503663642800654
SNU-216,4261,2.1071310683491236
SW1573,9956119,4.0915863238100645
KE-39,17755052,3.062972722223711
SF295,44507138,3.2424072407553792
BT 112,24901704,4.366815856328311
JHUEM-7,65064,5.3351573700269
HSC-3,73707398,1.0290894823159855
Karpas-422,9933475,1.5593704380503386
NCI-H1339,3854666,1.1163933455881117
KO52,selumetinib-tretinoin (2-1 mol-mol),-1.7708890002818076
RKO,6252,0.5352436981906653
RKN,16065773,2.958619348149216
LXF 289,9935249,3.315625346230847
KMS-12-BM,387447,-5.588552036556516
KMRC-20,44486219,5.7591116026780815
SNU-119,9877608,5.864690809801913
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
YD-38,54686904,4.452675789569271
SNU-1077,262093,2.74279505858148
AU565,6918328,-1.0169109160359904
SNU-423,216345,4.297446622363854
TE-14,53392493,3.7810173274345567
KO52,11427553,-1.0437328756331057
SNU-886,72193861,1.870912317242216
TE 441.T,docetaxel-tanespimycin (2-1 mol-mol),-7.611222578121889
L3.3,11364421,-3.724172704719069
Hep 3B2.1-7,tanespimycin-gemcitabine (1-1 mol-mol),0.5954817730235583
NCI-H929,637858,-0.3950607584941885
IST-Mes1,1242560,3.612096070768593
RKO,60750,-2.2331483998906654
TE 441.T,54618305,3.9313540825452775
PF-382,9911830,1.7810920372451895
Kasumi-2,12001922,1.274437651383908
Hs 611.T,446155,2.082810696487054
NCI-H929,613753,3.174052302519367
SNU-423,vorinostat-carboplatin (1-1 mol-mol),3.904430843633692
LXF 289,20959075,-2.4089188058085
TE 441.T,60750,-4.3172121092953875
YD-38,65064,4.931541588162588
HOP-62,71466380,3.3648670809010603
BT 248,2749,1.3146464590197295
Namalwa,11640390,3.4518080924768952
Kasumi-2,10385095,0.5473944457717855
Lu-65,46199207,2.9869217661237233
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796
SK-MEL-5,9936388,2.3503506475790816
HSC-3,11626560,1.838283596867806
Hs 611.T,16038120,0.988688783392196
Karpas-422,11167602,5.140993072754682
ESS-1,10184653,2.852659542055244
ChaGo-K-1,409805,3.8445782197925022
NCI-H1339,10184653,2.376921574496489
BT 248,2945648,2.911977762170341
OE33,JQ-1-UNC0638 (2-1 mol-mol),1.6826826815341247
YD-38,241158,4.218003156068375
Becker,66577038,3.69605042943235
H-STS,66577038,3.1923549200255796
KYSE-450,168312962,-1.1635814375740514
NCI-H196,969516,3.973912934217039
RKN,9840324,5.059199694090175
PF-382,4917,2.62124804307342
Hs 611.T,11175137,1.3729243060665188
Kasumi-2,2733526,2.6717950038671003
SF539,10410894,2.254370966764811
EHEB,navitoclax-gemcitabine (1-1 mol-mol),-3.439930210813986
OAW28,5287620,-1.6233190690502424
Hep 3B2.1-7,24964624,2.658455822553618
Ri-1,136227924,2.363884089308993
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
TE 441.T,969516,2.20897919720769
ESS-1,selumetinib-PLX-4032 (8-1 mol-mol),4.921474213039296
SF539,1750826,-3.058718862660788
KO52,decitabine-carboplatin (1-1 mol-mol),3.5937342622341792
NCI-N87,44486093,4.414725106733636
ESS-1,675434,5.557520418917079
KE-39,44491742,3.945663107977575
SK-UT-1,9903786,5.78516391020833
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
KE-39,3543504,4.7094782670385475
KE-39,262093,2.516325504276674
YD-38,24951314,1.5391329353480026
SNU-1077,4477,-1.0120620923671768
ESS-1,327653,3.2040700098938837
SK-MEL-5,448949,2.5992925847880155
TE 441.T,5566,3.0387832662798964
Hep 3B2.1-7,327653,3.179957662955071
SK-MEL-28,2729026,2.910502254408236
PF-382,159324,-2.108239526563577
KMS-12-BM,5702613,3.076262318494198
OAW28,44489675,3.928609606447794
NCI-N87,24753719,4.36387060101307
H-STS,9927531,5.457961831541725
EHEB,176870,3.9888726880158054
AsPC-1,9936388,-0.8199656713038528
KO52,135421197,1.227280721989531
MIA PaCa-2,9926054,1.823118001934022
SF539,11497983,4.935206812157441
Panc 02.03,10302451,3.706546166543765
WM793,9936388,1.3359302595984517
BT 320,53393127,4.811652436573408
Panc 02.03,1716436,3.766168811644757
NCI-N87,446155,3.321702095578996
SK-MEL-5,19582717,3.136691731429188
PF-382,654092,-2.265760863591032
LXF 289,6438330,5.338014468481796
SNU-886,54626689,3.741397063281634
NCI-H1339,54619267,4.355528234226246
Namalwa,10302451,0.420511059814922
RT-4,3825829,3.4258833117884064
OAW28,5278396,3.588828047742794
NCI-H929,11609586,2.312289051564489
NCI-H929,selumetinib-JQ-1 (4-1 mol-mol),-1.4418974567272833
OAW28,10427712,4.195688642509306
KO52,16722836,0.8284373841019596
HOP-62,135421197,0.8812919220198131
KE-39,vorinostat-carboplatin (1-1 mol-mol),2.810386853434761
Karpas-422,5738263,2.386980222939564
KYSE-450,3689413,-0.3124621453247139
LXF 289,168313047,4.113002678801054
SNU-423,11222830,1.7618743718370904
JHUEM-7,168313200,3.430060131832228
YD-8,25154868,4.975027029918458
SNU-423,9911463,4.2882741176819446
HEC-108,6610355,5.333623813086721
ESS-1,selumetinib-tretinoin (2-1 mol-mol),5.525028519961577
Becker,12001922,2.507016459914465
HCC2108,selumetinib-navitoclax (8-1 mol-mol),2.406642843246067
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715
SNU-886,42642645,0.8705530909872051
HuT 78,11152667,-1.8885306635916228
YD-8,44507138,1.814494867453689
RT-4,selumetinib-navitoclax (8-1 mol-mol),2.485762476290879
RT-4,66577038,3.0506588017384635
CML-T1,4096211,0.5897034084412636
L3.3,44632017,1.809753180552785
MIA PaCa-2,10113978,3.4218122120666945
SNU-119,5746,1.4479530054186391
YD-38,navitoclax-piperlongumine (1-1 mol-mol),2.139179557452878
RKN,135440466,3.1815161125023033
B-CPAP,selumetinib-JQ-1 (4-1 mol-mol),2.8675411473634917
CML-T1,44185566,0.9347798856606148
KLE,3634881,3.3251841919327805
HCC2108,11427553,2.403363421771595
YD-38,176870,-1.365758615052037
NCI-H1339,107970,3.0174891180051793
HOP-62,6436223,-6.153690503126226
Mono-Mac-1,24772860,-4.461344884032207
SNU-423,675434,4.253270492704943
PF-382,24772860,-3.0726224407745435
AsPC-1,selumetinib-piperlongumine (8-1 mol-mol),2.3106029653407276
KE-39,4578,4.450266495583275
YD-8,446155,1.4211540199964532
RKO,5113032,5.90165838842917
OAW28,11497983,4.916879328733168
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
RERF-LC-MS,56963564,0.3267097404636779
H-STS,piperlongumine-MST-312 (1-1 mol-mol),1.017162018251856
HSC-3,148198,-2.120282407341815
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
GOS-3,24753719,4.687766883023854
SNU-213,5287620,-2.815537066378191
LMSU,56649450,5.764663213375745
AU565,23725625,4.73732544358888
LXF 289,11427553,2.4541082171467368
Karpas-422,decitabine-navitoclax (2-1 mol-mol),0.2837209997925243
AsPC-1,44185566,2.682305355629655
ChaGo-K-1,24951314,1.3256791863947055
TE 441.T,4096211,1.8114806464908777
ESS-1,89928392,1.2376133771759263
NCI-H1339,613000,2.637869291837759
PE/CA-PJ41 (clone D2),navitoclax-PLX-4032 (1-1 mol-mol),3.1934376543337395
CML-T1,6610216,3.6071739537574863
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
ChaGo-K-1,4096211,1.2191968259267876
SNU-119,3136844,3.853712010646443
RT-4,123631,3.0084600892391875
HCC2108,9967941,3.249509678327182
SNU-216,1474550,4.311507267346721
Hs 611.T,6610355,3.366431966674078
L3.3,10296883,4.354494828099719
Kasumi-2,5282054,2.4598760030877553
KMS-12-BM,2126,3.610569458867974
Namalwa,3136844,3.7255251235468143
WM793,11507802,2.1513003303084592
SK-MEL-5,10296883,3.4956550108222775
NCI-H929,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497346861051973
RT-4,5281321,-0.1129489879810674
SF539,445091,3.820067439228608
HCC2108,17755052,3.0973240129693833
BT 498,4477,1.03565930318758
CML-T1,44632017,0.7838820876699769
HOP-62,104842,-5.353293882155422
HEC-108,5311,1.8736355088080991
SK-UT-1,4261,3.439977939207012
KLE,426756,4.4338865892288295
LMSU,9911463,4.298553287365515
AU565,9911830,3.457946854316075
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635
KMS-12-BM,26596,-3.7364157309734822
OAW28,44607531,1.5392912313773788
RKO,5287620,-1.9975210326345276
B-CPAP,168313047,2.654561497495477
BT 286,9549297,1.6241378099255253
Hs 611.T,navitoclax-gemcitabine (1-1 mol-mol),-4.9472551912531895
KE-39,serdemetan-SCH-529074 (1-1 mol-mol),2.1213072373059885
OE33,16725315,5.2011012279074755
TE-14,11626560,2.6650461689071836
BT 498,selumetinib-navitoclax (8-1 mol-mol),3.9903083753932767
YD-8,9927531,5.007831795650313
Panc 02.03,6852167,4.143336119644561
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
Mono-Mac-1,vorinostat-navitoclax (4-1 mol-mol),-0.0754914405518991
RKO,107985,-4.24085601271806
SNU-423,46398810,2.9075797324730135
OAW28,46843906,3.2241568449076556
B-CPAP,135875424,3.307629887397838
KYSE-180,ISOX-bortezomib (250-1 mol-mol),0.5668882301656226
KYSE-180,navitoclax-piperlongumine (1-1 mol-mol),3.2533869345330446
SNU-1077,navitoclax-MST-312 (1-1 mol-mol),0.8913326642927005
Karpas-422,5978,-4.397865794233498
KO52,135659046,3.503950077041595
Lu-65,25154868,3.911083549863155
SK-MEL-28,11178236,-2.69133483363241
AU565,156422,4.303267692822867
PE/CA-PJ41 (clone D2),44589607,2.944412828787781
AU565,168312962,1.8906319972872971
SK-UT-1,54143018,1.4978372615780644
ACC-MESO-1,11238147,4.907932653734244
JHUEM-7,5291,3.7790279347789264
ACC-MESO-1,24771867,3.511510808680287
AsPC-1,445091,6.474898015897582
NCI-H929,16725315,0.430149891023638
BT 112,11612883,3.767323531047295
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
Lu-65,11238147,3.117637715446455
HEC-108,322968,3.0271522101080532
KMS-12-BM,25195348,1.3906161221402649
SNU-423,24951314,1.7762274267173075
RKN,9929138,7.419607622812729
TE 441.T,11228183,-0.1265557493209269
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
SK-MEL-5,3634881,3.4834319791934973
LXF 289,44632017,2.313535350982782
NOMO-1,6918736,-3.755126975181922
YD-8,54618771,-1.0700457769979232
BT 328,11955716,-1.056274858719932
SNU-216,25161177,4.203635980102748
SNU-119,5351362,0.9137342384395012
NCI-N87,11175137,1.8903805503335804
RKN,327653,3.2518035953304434
Kasumi-2,4259181,-0.4186991216348978
KLE,9840324,5.142146685631956
Lu-65,17755052,2.1688330235092197
H-STS,6918736,-3.6487860531030702
BT 286,11626560,1.3785689480454144
IST-Mes1,SNX-2112-bortezomib (250-1 mol-mol),1.249422428379272
Panc 02.03,409805,5.9877775932277615
B-CPAP,24753719,4.549431908166172
SF539,5738263,3.647048629199091
Ri-1,24180125,1.2545611778962542
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
L3.3,navitoclax-pluripotin (1-1 mol-mol),0.1565483194262438
Mono-Mac-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2613516674403331
SF539,67156097,-1.6249990290252014
Mono-Mac-1,selumetinib-UNC0638 (4-1 mol-mol),3.227378592409404
KO52,6438330,1.0398804577388443
Ri-1,54626689,4.174115404148546
SW1573,4705,3.887877577681455
Becker,11717001,6.335222819008729
HCC2108,11238147,2.303897319938246
Mono-Mac-1,56946209,-4.758871933449349
KMRC-20,JQ-1-navitoclax (2-1 mol-mol),2.637620979600235
HuT 78,68056272,3.666874851860886
JHUEM-7,24772860,-2.354213215472605
NCI-H1339,5282054,4.651074990998048
PF-382,73707386,2.646630293561946
HCC2108,56946209,-3.5616140091997397
HSC-3,444795,5.012644187656376
SF539,441298,1.510728884927333
NCI-H1339,5470400,1.0062090619219264
NCI-H929,16722836,-0.2091076703747729
SF539,5470400,1.793905767243159
NCI-N87,9911830,2.159086109533926
ACC-MESO-1,selumetinib-piperlongumine (8-1 mol-mol),5.193474652387318
SK-MEL-5,11497983,5.417293853746178
Kasumi-2,54613361,-0.9648217673530566
ChaGo-K-1,135659046,3.4410165185967743
HuT 78,5951923,5.985995138810963
BT 328,71729975,3.0990455270892365
SNU-1077,1641662,3.616725979118272
MJ,4578,3.855758936568702
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
Kasumi-2,3384730,0.4985599128931971
OAW28,44493528,4.631141764792384
YD-8,alisertib-navitoclax (2-1 mol-mol),2.5230617442547163
LXF 289,1716436,2.59582131383783
MIA PaCa-2,11626560,1.2394941984724543
BT 112,984333,1.584927202136717
CML-T1,374536,2.401691970017444
YD-8,25195348,5.853643444602765
HOP-62,decitabine-navitoclax (2-1 mol-mol),2.8967431057082806
BT 248,9911463,2.7908107916357436
PF-382,72193870,1.048942272028045
Hep 3B2.1-7,6623618,2.3517376851828726
OE33,46215462,1.585783977146365
AsPC-1,568763,2.040921390287386
YD-38,25183872,-0.9372891340826588
KMS-12-BM,6918837,-5.957807567575875
CML-T1,JQ-1-navitoclax (2-1 mol-mol),-0.3838204075177596
SNU-119,24785538,1.16814557127363
RT-4,2858523,3.0846585781360782
AsPC-1,tanespimycin-gemcitabine (1-1 mol-mol),0.4479893231727763
NOMO-1,10410894,2.884775843935945
RKN,4259181,0.9508926940780028
B-CPAP,54639701,4.512705510925618
BT 248,135411,2.4646623802818577
Hs 611.T,11964036,-0.4768166238763608
KE-39,selumetinib-MK-2206 (8-1 mol-mol),2.7514173486302544
RKO,6610355,5.147293026177706
OAW28,73707398,1.2451215877479735
CML-T1,salermide-PLX-4032 (12-1 mol-mol),4.618653772046038
B-CPAP,11222830,1.6970126110627293
SNU-119,135421197,4.049091304293704
RERF-LC-MS,42642645,-0.4358765804877467
TE-14,16720766,0.8168993099137034
GOS-3,11626560,1.8119824279577827
Kasumi-2,44489675,3.5763019986617106
NOMO-1,119182,-3.695250738066314
Ri-1,46215462,0.2208615859518133
SNU-1077,9926054,3.1436307505327123
WM793,selumetinib-JQ-1 (4-1 mol-mol),1.649848066078306
B-CPAP,11396600,0.7084279408075309
SF539,208908,1.982441475653256
OAW28,3503,2.6573145013500743
SNU-213,46398810,2.362902483781062
Karpas-422,67291369,2.023218261714344
ChaGo-K-1,2733526,4.06837326515645
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
KMS-12-BM,52912189,-1.6763978674189333
PF-382,135440466,1.8528493259308645
BT 286,6918837,-0.1947148263566605
SNU-216,148124,-4.152128230067924
SNU-216,44137675,2.116529403425987
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432
BT 328,alisertib-navitoclax (2-1 mol-mol),0.3590132286260764
NCI-H2030,5280436,3.82299409241294
Namalwa,9915743,0.490557645352366
AsPC-1,25183872,-0.8583413037674358
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
HCC2108,135423438,4.347791872690299
NCI-H929,11612883,0.7981291863125404
Ri-1,23725625,3.8050378563052702
SF539,44819697,-3.4306992197500255
NCI-H929,ISOX-bortezomib (250-1 mol-mol),-0.7959511173514853
RKO,11626560,1.596896929931414
SW1573,25154868,3.281093993360062
TE 441.T,148198,-7.570550283496053
Lu-65,44202524,1.40083991712789
YD-38,3825829,3.4785077609672057
BT 320,73707438,3.918904444875683
KYSE-180,navitoclax-MST-312 (1-1 mol-mol),1.0295834159957882
YD-8,159324,3.1492291636894416
ESS-1,54596490,4.349195883265103
BT 112,11455910,0.2027348347828513
BT 112,11609586,3.092948816829803
HSC-3,44589607,2.589263575512526
HSC-3,3384730,2.4690621301166926
SNU-1077,44259,2.0334917148068707
TE-14,2742550,4.106621802038204
SK-MEL-5,241158,4.170979949638567
YD-38,54618164,4.14569311536785
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
KO52,135440466,2.642581102340019
SK-MEL-5,53392493,3.062967220476644
OE33,44493528,4.497258048563181
Kasumi-2,16065773,1.6844864290683614
OE33,selumetinib-UNC0638 (4-1 mol-mol),3.180599015528826
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
YD-8,15953870,3.5713699030166186
B-CPAP,serdemetan-SCH-529074 (1-1 mol-mol),2.365307132566549
OAW28,135411,2.218427323792269
KMS-12-BM,132971,2.9129705347041495
JHUEM-7,51037431,4.159503637934766
AsPC-1,6914657,-2.819399047423078
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
HOP-62,6184667,2.366883795259722
RKO,1641662,3.3091455873155367
YD-8,9911830,1.9962756690281929
NCI-H1339,12001922,2.434231494820422
Lu-65,42642645,0.9193657310014032
TE-14,9866186,1.111834547028208
PE/CA-PJ41 (clone D2),7326481,6.5922799929982006
NCI-H196,9936388,-3.664647197542574
LXF 289,100016,7.121965810949268
RT-4,23582824,2.530849045703681
SK-MEL-28,1716436,3.730773917114669
Namalwa,10127622,5.61027703477677
SW1783,9956119,4.824776064092986
AsPC-1,11175137,3.2351214827225956
B-CPAP,168312962,-2.242670395698556
SNU-213,136227924,3.1812992174761696
NCI-H929,SNX-2112-bortezomib (250-1 mol-mol),-3.169119515826122
KMS-12-BM,6252,-2.6216972044804723
GOS-3,3011155,4.288572340636914
NCI-H1339,JQ-1-UNC0638 (2-1 mol-mol),1.853432296866984
H-STS,60700,-2.8002918740934044
KYSE-180,6505803,-2.0087833017185264
NCI-N87,11455910,1.6652699053284308
NCI-H929,67156097,-1.392693443988792
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819
LMSU,24180719,3.8300426500348177
L3.3,9840324,5.709572906398099
B-CPAP,656346,-0.1957120455939244
ACC-MESO-1,52912189,5.0178402045782535
KMS-12-BM,3136844,3.1587649853094795
KMRC-20,selumetinib-decitabine (4-1 mol-mol),6.46474564385979
SF539,16659841,3.270548926893477
HOP-62,42611257,2.6813799404980765
Panc 02.03,568763,0.7660787595735656
ESS-1,alisertib-navitoclax (2-1 mol-mol),-0.432728207962684
LXF 289,31703,0.1888440469000175
SNU-886,44507138,2.788331490062725
Lu-65,216239,1.7183510968964233
SNU-423,10113978,4.025124345725794
KMS-12-BM,5335621,3.708216955119463
SNU-1077,49766530,-1.9738465664800544
WM793,10074640,3.0714713533769573
CML-T1,11404337,-1.4571467715346416
KE-39,JQ-1-UNC0638 (2-1 mol-mol),1.0358339499253313
KMS-12-BM,46174525,2.6859136047743513
KO52,67291369,3.207372114299005
LMSU,1750826,-1.6926974789891744
KE-39,BRD-A02303741-navitoclax (2-1 mol-mol),0.7696843090662393
CML-T1,3025944,4.207605674746215
Kasumi-2,72193861,0.1525951303543335
L3.3,3038522,4.529448646795259
SNU-1077,vorinostat-navitoclax (4-1 mol-mol),1.5809730916962734
MIA PaCa-2,9933475,1.5811525433625937
Becker,1716436,3.8374444305943514
MIA PaCa-2,135411,0.8482732025592005
SNU-423,6918837,-3.1518084379325075
NOMO-1,54618771,-0.7336388686704796
BT 286,selumetinib-PLX-4032 (8-1 mol-mol),0.2510040812507161
SNU-216,72734382,5.426456747724787
NCI-N87,654092,-0.6954721735465327
ESS-1,17755052,2.168026535406177
KYSE-450,65064,5.6341173249680345
RKO,24951314,1.467797052763695
Karpas-422,25102847,2.7396004244892125
BT 286,7251185,1.6595733363638832
Ri-1,71466578,3.32101497363571
SNU-119,vorinostat-navitoclax (4-1 mol-mol),2.3396657030551684
EHEB,44819697,-0.6865336192844265
JHUEM-7,107985,-5.321387186988869
NCI-H1339,100016,8.285361450373896
BT 112,44632017,0.9715199152864828
HuT 78,3676137,4.565046002929079
SNU-216,241158,4.2881581162179305
PF-382,JQ-1-navitoclax (2-1 mol-mol),-1.4600589253273593
BT 286,227681,3.851915377022569
RT-4,3854666,3.7100044962154506
SNU-213,46199207,3.777420200975711
Hep 3B2.1-7,1641662,3.626354997928835
KMRC-20,16741245,3.9826803312414527
BFTC-909,9915743,2.0959000942543025
SNU-423,71304818,2.419735008623708
MIA PaCa-2,76446078,4.284259753564461
AsPC-1,44493528,4.313387127964929
SK-MEL-28,5281321,0.8314477877227711
SNU-119,9866186,2.2038278212817652
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
BT 286,3038522,2.41353060244286
TE 441.T,6450551,2.8437483634937215
SNU-119,25183872,-0.5002243893820045
JHUEM-7,16736978,0.2612625302248401
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
Kasumi-2,148124,-6.270957848916609
NCI-H1339,56946209,-4.9853882615502725
BT 328,327653,3.5942697932581344
YD-38,72193861,-0.2812075597733648
NCI-H929,1242560,2.1865471387936513
LXF 289,24785538,0.6202102990423739
RKO,16038120,2.1201165412688385
PE/CA-PJ41 (clone D2),6610216,4.420679698302765
SK-MEL-28,53392493,3.0895758155089363
BT 248,675434,4.340673839490162
GOS-3,57519531,1.810044257027968
Mono-Mac-1,4705,2.1526940159262593
AsPC-1,9967941,3.911764573168509
RKO,71304818,0.9175289508752972
RT-4,656346,1.221442346270773
MIA PaCa-2,54765302,3.634792833492495
Panc 02.03,5287620,-2.132468814908427
Karpas-422,1641662,3.5098065736940476
OE33,322968,2.6320987801023747
Ri-1,17759555,2.301771456031875
BT 248,5329102,2.143317374155595
PF-382,2729026,0.5855884852341721
BT 498,5282054,4.48015487257215
NCI-H209,11507802,-4.115441457622851
NCI-H196,1242560,5.26706022636309
BT 320,11494412,4.421767883618589
L3.3,9903786,3.5860218860878263
Namalwa,25227462,-4.7752798616367
HuT 78,50905018,2.5901860875051144
PE/CA-PJ41 (clone D2),3825829,4.527338573645581
IST-Mes1,135999136,4.360333625305844
KLE,54143018,-0.8237191874413499
B-CPAP,387447,-4.237504830751881
RT-4,11175137,3.2600224234362796
WM793,selumetinib-MK-2206 (8-1 mol-mol),3.306491798199423
HuT 78,25150857,0.8929430868058179
Hs 611.T,5280436,-0.4591533881724744
YD-8,82146,4.39228659038304
SK-MEL-28,31703,0.4439696500586977
L3.3,51037431,2.2305263064792396
H-STS,tretinoin-carboplatin (2-1 mol-mol),3.744726554678935
Becker,9444,4.396045476360631
BFTC-909,54619267,3.991913685478571
SNU-423,12003241,-1.4382544514663564
KMS-12-BM,9884685,-1.5036404450716507
OE33,216345,4.44282779465598
Kasumi-2,4578,4.103424218787652
NOMO-1,6450551,1.2307950565416117
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006
YD-38,1242560,3.082772810737216
RT-4,119607,4.891144020321078
SW1783,46907787,3.9046818317286944
Karpas-422,5311,0.5747268386466993
CML-T1,71466578,2.784294880886227
KO52,5335621,3.91616082408733
TE-14,135421197,1.7423329869648043
JHUEM-7,54618164,3.823825423336211
Lu-65,24951314,2.358893147950346
MIA PaCa-2,2113511,5.475319803599009
NCI-H196,1750826,-0.6704286653908172
RKO,72193861,0.7735395045157347
TE-14,5287620,-2.010012399945898
SF295,tanespimycin-gemcitabine (1-1 mol-mol),1.178179005676627
CML-T1,44486219,3.9826752825954306
KLE,24951314,0.9154688182188032
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934
Lu-65,ISOX-bortezomib (250-1 mol-mol),0.2931749043366788
BT 112,BRD-A02303741-navitoclax (2-1 mol-mol),4.211528826599794
KMRC-20,44491742,5.411645351023098
HOP-62,9967941,3.751035139313707
Mono-Mac-1,5738263,3.5727157948594757
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
Becker,135999136,4.331325475055123
NCI-H929,72734382,3.667669568515042
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
BT 248,9884685,-0.279602051509792
BT 328,54678924,4.095049817388681
MIA PaCa-2,4378219,1.989659969490472
HuT 78,6852167,0.2624976594092375
BT 112,71751553,4.665557673334606
HCC2108,44607531,1.6757338761058749
SK-MEL-28,4788,5.8874743333158985
Ri-1,54619267,3.0614981170968507
HOP-62,3676137,3.3254005331924725
Ri-1,2749,0.5134622353101342
SW1783,15953870,3.727401815787135
BT 248,5460769,4.810999932000391
PF-382,salermide-PLX-4032 (12-1 mol-mol),5.272425832636036
PF-382,100016,3.957595275699552
OE33,56946209,-5.317816942016512
SK-MEL-5,135421197,1.8346447693413537
KE-39,71680916,5.592111276065997
NCI-H2030,73707371,5.115486799100736
SNU-119,448949,1.6770558610697637
SNU-1077,44185566,3.0312162489563
NOMO-1,10113978,3.435868796737405
NCI-H196,107970,2.3706951810586068
SF295,135398516,2.385761524246111
LMSU,262093,3.167641110749879
BFTC-909,11222830,1.7098036316197358
Lu-65,676352,1.7416294973197106
GOS-3,4261,3.5553215793215185
Mono-Mac-1,9911463,2.4863663707883723
RERF-LC-MS,25195348,2.310586589861769
BT 328,25154868,6.16063190444204
OE33,9936388,2.0912313369341287
BT 498,409805,5.970409290821295
NCI-H196,10427712,5.32328303658605
SF539,644241,2.736795870753983
OE33,navitoclax-pluripotin (1-1 mol-mol),0.9170427891027672
BT 112,10231331,5.608675026595674
Becker,168313200,3.791120418398256
CML-T1,54618771,0.285641515878807
RKN,11640390,3.613472996393559
BT 328,3634881,2.884291919608293
LXF 289,54618305,4.64176895308047
Mono-Mac-1,24901704,1.857343620751862
SK-UT-1,11427553,3.3051570066468248
SNU-423,11228183,1.2661393913217065
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
GOS-3,3081361,3.4367790874806015
SNU-216,11222830,1.014411889305477
BT 328,selumetinib-PLX-4032 (8-1 mol-mol),4.625572383999939
Karpas-422,3062316,-0.3473307121830488
B-CPAP,2113511,4.9053992251679475
PF-382,409805,3.4085068464251997
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
SF539,71466380,4.199081692054065
AsPC-1,3062316,2.757974416117501
RERF-LC-MS,148198,-3.5927713028936834
IST-Mes1,89928392,1.562289834411229
Kasumi-2,135875424,2.5938758238859494
OAW28,71304818,3.062868675930112
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
SW1783,46215462,1.5074771125721502
NCI-H1339,3503,2.6374444046453034
Mono-Mac-1,10322450,2.242206847932455
BT 286,46224516,1.3699390915436929
RKO,445091,4.342692134156949
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
ChaGo-K-1,19582717,4.576534267477968
SNU-119,11609586,3.0973958164397013
MIA PaCa-2,8515,4.279549136929449
Karpas-422,selumetinib-tretinoin (2-1 mol-mol),4.3301952364803915
EHEB,2842253,6.477039888159031
KMS-12-BM,54649381,3.2424778032361186
SK-MEL-28,135875424,5.515491244041513
NCI-N87,6918328,-0.6140119948836108
NCI-H2030,322968,4.6726346667135035
Becker,1641662,3.409993688003908
BT 328,9956119,4.461775202302022
BT 286,1566236,1.6712159772486277
SNU-423,selumetinib-vorinostat (8-1 mol-mol),2.465169855614971
BT 328,4096211,3.6600455300853154
YD-8,6852167,2.601588502277786
NCI-H196,11152667,-0.3084820466732423
GOS-3,49766530,-1.0492623989714644
NCI-H1339,71751553,4.829519613793705
SNU-423,73707398,1.089223560310694
Namalwa,5281321,-2.3909967724743755
LXF 289,5351362,2.37199640031851
ESS-1,3385,5.777226471096733
HuT 78,10296883,2.429678266579514
HOP-62,11317348,4.640311098885742
WM793,serdemetan-SCH-529074 (1-1 mol-mol),2.1116726629279747
NOMO-1,3025944,3.969971169930392
NCI-H929,54619267,3.6660361188352306
Becker,56963564,0.0372017803501728
KMS-12-BM,1750826,-5.31704186496798
SK-UT-1,44566777,0.4643066266972094
PF-382,25062766,1.5708468674433018
SK-MEL-5,637858,2.5788242810991537
TE-14,1641662,3.6714613860593217
NCI-N87,637858,1.7879892218708664
SNU-423,45279963,4.04517438276715
YD-8,9935249,3.870405994417823
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
JHUEM-7,753704,4.187441379139962
H-STS,2858523,3.0091153865210103
PF-382,11612883,1.3339433579277435
EHEB,151289,0.953950234753323
Karpas-422,crizotinib-PLX-4032 (2-1 mol-mol),0.9999200358144872
BT 498,53392493,2.684342510752486
ACC-MESO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.857628487891416
KMS-12-BM,2828334,4.379653513423718
OE33,46174525,4.146144152426377
Kasumi-2,45279963,3.7710739544623233
SK-UT-1,ISOX-bortezomib (250-1 mol-mol),0.217311614583509
NCI-H1339,24964624,2.730311593553537
BFTC-909,89928392,2.1120581393996116
SNU-423,104842,0.5354825848611453
PE/CA-PJ41 (clone D2),25105715,3.71980975243517
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
KYSE-450,selumetinib-PLX-4032 (8-1 mol-mol),5.261174592535557
B-CPAP,44489367,4.992783705245297
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
B-CPAP,54613361,-1.5101356569841191
Mono-Mac-1,JQ-1-MK-0752 (1-1 mol-mol),-0.3425960696296795
PE/CA-PJ41 (clone D2),9825149,3.600795638985757
NCI-H196,4521392,4.497970742345613
AsPC-1,54626689,5.229882111208764
BFTC-909,6918837,-1.9878509916437357
H-STS,tanespimycin-gemcitabine (1-1 mol-mol),-4.299307238751318
Hep 3B2.1-7,3025986,0.9790399772963276
MIA PaCa-2,carboplatin-UNC0638 (2-1 mol-mol),3.385632682123634
KE-39,676352,2.0662009549778704
Ri-1,5287620,-1.9161748527305928
SNU-423,24785538,1.9416648635593148
PE/CA-PJ41 (clone D2),2871966,-1.530676226190852
SF539,637858,1.5175949767978318
JHUEM-7,54678924,1.7960871559050613
SNU-1077,638278,3.5420439981494254
Panc 02.03,9911463,4.953148943637795
NCI-H1339,1750826,-0.6854486173534331
Hs 611.T,44491742,3.458740390209698
ChaGo-K-1,5278396,3.4134345354269815
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
Hs 611.T,25126798,3.8367967681796697
BT 498,5329102,2.4000610555700885
Hep 3B2.1-7,vorinostat-navitoclax (4-1 mol-mol),1.71019933879999
HSC-3,9866186,-0.1394143358773219
KE-39,54626689,5.72659105113371
NCI-H1339,2729026,3.0533386554011295
BT 498,448949,2.374656639146098
WM793,53392493,3.001064949916278
BT 498,71304818,2.894673989277281
RERF-LC-MS,1566236,3.687566928717542
SNU-213,24180719,4.112073754783821
CML-T1,44819697,-2.8753334506591504
YD-38,24964624,2.635886673115533
BT 286,25161177,0.4506413025185109
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
JHUEM-7,12001922,1.974346294613864
Lu-65,6917907,-5.890074381403312
SNU-886,168312962,-3.108064596774625
KMS-12-BM,1242560,1.8091985739591805
HEC-108,5351362,1.2308965787917867
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
HEC-108,54618305,5.558551802909847
OE33,25150857,2.936522836186344
PF-382,1242560,1.4811412739619612
Karpas-422,135875424,4.0020075582939
SF295,16720766,0.3216166889304212
PF-382,2828334,5.600053849858772
CML-T1,24901704,0.2948239854297986
Karpas-422,89183176,2.312208291072324
SNU-423,15953870,5.451798235524798
IST-Mes1,25154868,5.0412707783574735
EHEB,3854666,0.7564347377790305
NCI-H929,25102847,2.528780215609897
BT 498,119182,1.205044713137845
NCI-H209,54143018,0.8491553630521773
KMS-12-BM,49850262,1.3155226448331834
SF539,2729026,2.548731779898503
NCI-N87,168312962,2.346349065468924
ESS-1,7251185,2.2330805866433834
Lu-65,6918638,0.8216407628444748
MIA PaCa-2,71466578,4.8412338676147275
Panc 02.03,2858523,3.458791746781272
ACC-MESO-1,3503,3.0585499361793915
KO52,409805,5.182082476499644
SF295,702558,5.622003718276879
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
HOP-62,navitoclax-sorafenib (1-1 mol-mol),1.723589528182747
NCI-H1339,25062766,2.7213199166868836
HEC-108,72376,-2.7240450345568905
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863
SNU-119,alisertib-navitoclax (2-1 mol-mol),-0.0715431732612024
Mono-Mac-1,374536,0.5970051529194348
PF-382,erlotinib-PLX-4032 (2-1 mol-mol),3.234247711308871
Kasumi-2,135411,-1.6102115279025644
ChaGo-K-1,46907787,2.3551908782612068
Namalwa,135421197,0.8963594643304925
ChaGo-K-1,selumetinib-PLX-4032 (8-1 mol-mol),4.737795315348964
JHUEM-7,71466380,4.245325443887442
EHEB,100016,6.596024177667571
SF539,81146,6.283283936863958
Namalwa,4578,4.251470718867193
BT 248,5738263,3.817096252163507
NCI-H1339,15547703,4.319443685848728
Karpas-422,119182,-3.501110473344757
Namalwa,11404337,-2.5348333703062575
SW1783,135411,2.3314592986122453
SNU-1077,5281321,-1.036948413736443
IST-Mes1,53392493,1.914417087858707
YD-8,9907093,4.458824128138645
OE33,241158,5.920302917932962
TE 441.T,15547703,2.8355011762775417
KO52,16038120,-0.794820665214537
HEC-108,navitoclax-sorafenib (1-1 mol-mol),2.4263859453349914
Hs 611.T,46907787,1.0011001882698198
ChaGo-K-1,carboplatin-UNC0638 (2-1 mol-mol),3.84747498040297
NCI-H2030,JQ-1-vorinostat (2-1 mol-mol),1.2465457151300732
EHEB,54613361,-0.7006236829490292
RKO,54618771,2.3159310195777985
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
LMSU,1242560,3.6890056089090937
Namalwa,36462,-1.022429039126246
L3.3,44543605,3.679570515799513
AsPC-1,11977753,1.3763157806720072
GOS-3,10074640,3.609406723020456
Kasumi-2,1716436,2.2552230484948477
TE-14,54678924,2.4580217895933334
Kasumi-2,613000,1.0071641049539857
KYSE-450,9911830,2.46681001783931
OE33,25195348,1.5538095022055836
SF295,10385095,1.9844654960624617
MJ,4917,2.3365129077988005
Namalwa,2746,1.3872498592399898
KE-39,126941,-2.7828178616251984
ChaGo-K-1,9936388,-4.876543253304364
KLE,17759555,3.4987624371380095
LMSU,6184667,3.2634858273175764
ACC-MESO-1,3025944,5.5965233945786865
TE-14,3025944,4.5268699531424845
SNU-1077,6505803,4.592101417459953
HOP-62,11657048,4.01244988008706
TE 441.T,2871966,-1.1981997879898243
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
AsPC-1,119607,5.550900919397946
MIA PaCa-2,327653,3.0320730676471572
OE33,984333,1.0291445437949012
HuT 78,6918736,-0.9922912481789786
OAW28,54649381,3.786658613217657
NOMO-1,6505803,0.1224616163714439
SNU-886,51039095,-2.8648807177568205
KYSE-180,445455,4.928349979351992
KYSE-180,52912189,6.205067529093029
KYSE-450,72193861,3.11569572197334
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
ChaGo-K-1,JQ-1-carboplatin (1-1 mol-mol),3.068818553236091
CML-T1,24771867,0.0964586614823225
SW1783,11238147,3.3496391304042747
AsPC-1,selumetinib-decitabine (4-1 mol-mol),2.5650434324640847
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
KYSE-180,5566,3.0696761250239204
SNU-119,44819697,-0.6073475651500764
BT 498,navitoclax-MST-312 (1-1 mol-mol),0.6566975328936648
KLE,doxorubicin-navitoclax (2-1 mol-mol),-2.507709419306591
SF539,selumetinib-UNC0638 (4-1 mol-mol),3.9589245906331314
SK-UT-1,carboplatin-etoposide (40-17 mol-mol),2.668759687344188
EHEB,3025986,-0.9608953944291202
YD-8,168313047,2.079031997957418
LXF 289,2729026,2.289348740995074
HEC-108,vorinostat-navitoclax (4-1 mol-mol),0.2481940777627734
HEC-108,5281321,-0.2460018354270553
Hep 3B2.1-7,123631,2.537990719576873
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143
ESS-1,44491742,4.277473074701454
OAW28,89928392,1.6809049325642302
SNU-1077,135999136,1.6213426965056292
RKN,11485656,2.343665915939472
WM793,44632017,4.453745957700664
NCI-H196,11964036,1.981444132546761
H-STS,7251185,1.0219328536539296
AU565,4261,1.5351844706992892
ESS-1,navitoclax-gemcitabine (1-1 mol-mol),-3.147832073684123
Ri-1,327653,2.467525677033306
PE/CA-PJ41 (clone D2),637858,2.8065176462831034
BFTC-909,613000,3.1980696015333137
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797
L3.3,107970,2.7957953106701305
AsPC-1,135440466,2.1679547773967314
MIA PaCa-2,54618771,1.4864580952045414
TE-14,5460769,2.4898485363417917
KMS-12-BM,9911830,2.539717819095299
Lu-65,10410894,2.9338236415664913
Hs 611.T,56649450,1.2987449899856396
EHEB,3825829,3.7186558518100705
KE-39,51039095,2.7316148787408427
NCI-H1339,387447,-3.859692304272627
BT 286,613753,3.3258744553617667
OAW28,11396600,3.5740319462685535
NOMO-1,46943432,0.592792127892358
KO52,11364421,-5.790016441966964
NCI-H209,11977753,-2.301420717847787
HuT 78,26596,-1.9929249611117947
SNU-886,71680916,4.355410406943834
Mono-Mac-1,11507802,1.0577941727742075
RERF-LC-MS,11640390,2.8932892314821927
Becker,44185566,3.0765843891002547
ChaGo-K-1,9907093,4.059324237981179
SNU-886,navitoclax-piperlongumine (1-1 mol-mol),-7.772241665279227
AsPC-1,72734382,6.119259394736332
H-STS,9915743,1.4562053378516668
BT 286,46199207,1.811364952788779
NCI-H1339,51037431,4.307498887080274
HSC-3,10385095,1.3564065222448
ChaGo-K-1,36314,-6.24793194508115
ESS-1,53495165,-2.215744312493367
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
Hs 611.T,702558,5.658700866639544
OAW28,409805,4.888216855585461
RKN,6610216,4.220445612403551
SK-MEL-28,44507138,4.029027628545452
RT-4,148198,-0.8360848986797086
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
KE-39,451668,5.747427565955262
Hs 611.T,54619267,3.857958253150578
TE-14,445643,5.402404326079723
HSC-3,216468,3.7445952975115735
Mono-Mac-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.6827347262468866
TE 441.T,462382,-0.1295044509688392
RERF-LC-MS,216468,3.2358353560937267
LMSU,10296883,4.275438301361486
Hs 611.T,374536,0.8136051559871417
AsPC-1,56649450,2.958633157592254
HSC-3,crizotinib-PLX-4032 (2-1 mol-mol),1.8583190838455068
MIA PaCa-2,2945648,3.161205294183321
ChaGo-K-1,135411,1.2465105696898682
NCI-H1339,26596,-1.3893901381267089
BT 248,57330099,3.914766288587865
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
NCI-H1339,984333,1.4866147707616064
Lu-65,11222830,1.16139858795039
MIA PaCa-2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7898327574016281
KE-39,53232,3.986419715634147
SK-MEL-28,44202524,4.379747746299274
YD-8,25183872,-0.0392840886179466
BT 286,44632017,1.4023340573889953
YD-8,2708,5.154021841255303
YD-38,11964036,-0.0659792164554548
Kasumi-2,31703,-3.912318367279324
SNU-423,10296883,4.1095294295281795
SK-MEL-5,51039095,2.8198767912934617
Panc 02.03,25227462,-1.0518848939229315
SK-MEL-5,9956119,4.059324967715587
PE/CA-PJ41 (clone D2),selumetinib-MK-2206 (8-1 mol-mol),1.5178122707062027
HSC-3,alisertib-navitoclax (2-1 mol-mol),0.6022178387515709
Hs 611.T,11507802,0.6290266602554199
JHUEM-7,5329102,1.651009676583094
ChaGo-K-1,3038522,3.351925167852242
MIA PaCa-2,JQ-1-vorinostat (2-1 mol-mol),1.48518441266489
NCI-H1339,navitoclax-PLX-4032 (1-1 mol-mol),5.73538695596653
OAW28,252682,6.460081465786461
AsPC-1,285033,-0.5419823336362324
AsPC-1,9967941,3.911764573168509
RKO,46843906,3.289277038806309
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
AsPC-1,5311,1.9705564216623497
KO52,11175137,1.294092661003282
RERF-LC-MS,24889392,5.73600211591012
IST-Mes1,11234052,4.921331368768723
KO52,11455910,0.9067852842316652
RERF-LC-MS,23635314,-3.639251677232653
BT 112,vorinostat-navitoclax (4-1 mol-mol),2.6221867944276993
LXF 289,216468,2.2889797638929683
SK-MEL-5,selumetinib-UNC0638 (4-1 mol-mol),3.1483964049439614
ACC-MESO-1,5282054,3.9636673696002593
KMRC-20,12001922,1.7493187520827975
ChaGo-K-1,56973724,4.0885467210720075
NCI-N87,9825149,1.7110175659097178
HCC2108,44489367,5.96526198558648
KLE,carboplatin-UNC0638 (2-1 mol-mol),5.218929523126634
MIA PaCa-2,3825829,4.074033438975014
ESS-1,3825829,4.02803833382595
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
Kasumi-2,carboplatin-UNC0638 (2-1 mol-mol),1.808252059410855
JHUEM-7,1566236,1.715043210679705
HEC-108,11404337,0.7883165010808656
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
Kasumi-2,44632017,0.7335001301015701
TE 441.T,5329102,1.5086836686423244
HSC-3,JQ-1-vorinostat (2-1 mol-mol),1.5521244042740985
BT 248,421610,3.3246840566564484
Mono-Mac-1,100016,3.734497226962008
NCI-H1339,16722836,2.785965080041655
KE-39,387447,-3.456484721663708
LXF 289,11222830,2.2114905387790755
TE-14,56946209,-3.8371276458520778
KE-39,9927531,6.019185228760376
Hep 3B2.1-7,4259181,-0.0551178259711273
NCI-H929,11178236,-4.166985560553255
Lu-65,6918878,4.903767394022953
LXF 289,46224516,3.632609368126253
NCI-H1339,4521392,4.328766571208621
KE-39,135440466,2.490274182929518
B-CPAP,24772860,0.4550512643264998
LMSU,11507802,1.3946784970655006
Ri-1,126941,-2.3172631680827687
AsPC-1,11626560,2.2683411612930637
AsPC-1,216239,1.707935704723652
NCI-H2030,54649500,6.42135485740904
ChaGo-K-1,1239801,5.4340716776967
SNU-216,24821094,-1.8638157046721129
SNU-216,1242560,3.492198623937285
KMRC-20,387447,-3.930757262228924
KE-39,24753719,4.8851025960405074
SNU-216,54649381,4.402747428048603
SW1783,5287620,-1.3610825750677231
Lu-65,5291,3.7552825058524184
AU565,1566236,1.7493429265082687
SK-MEL-5,6914657,-2.0624544709944113
ACC-MESO-1,54618771,0.8381740730227087
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
BT 286,135411,0.4622735027269605
Ri-1,15953870,1.4105014554932769
SNU-216,5280436,3.4535045578814016
HOP-62,2742550,5.0895590073246595
MJ,6917907,-5.708175674485562
H-STS,54618771,0.7523066402016166
LMSU,selumetinib-decitabine (4-1 mol-mol),5.339480518693171
HOP-62,168313200,1.5949515806080656
KE-39,4788,5.3862218822227925
RKO,24821094,3.7157598247146977
NCI-H929,24951314,0.3525234026902946
YD-8,53495165,0.9440837926278288
KE-39,1641662,4.193135241199752
SNU-119,1750826,-5.069173879827324
SNU-886,135398516,0.5445365742758462
YD-8,53481919,3.5018247603888404
OE33,9907093,3.924447394010023
SK-MEL-5,327653,4.002327934975705
SF539,16720766,-0.1257805364307158
KMS-12-BM,65628,3.1283199596989624
Hs 611.T,24772860,-2.634213469371387
OE33,136227924,2.987067512543954
TE 441.T,24821094,3.3384989046098945
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
PE/CA-PJ41 (clone D2),216345,4.750574762289649
Lu-65,alisertib-navitoclax (2-1 mol-mol),1.9804624556752644
WM793,409805,4.444302991596743
Hep 3B2.1-7,11427553,2.2734282767619876
Lu-65,57519531,4.867194285561449
Karpas-422,2858523,3.079059560811171
AsPC-1,11497983,4.51017072011312
Karpas-422,JQ-1-MK-0752 (1-1 mol-mol),-0.5305291148680019
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
MIA PaCa-2,1641662,3.4395946979479906
HuT 78,11222830,0.3543354397865786
OAW28,24180719,4.377592888188756
GOS-3,44819697,0.5869793417455883
SNU-423,16659841,3.4666021367210043
BFTC-909,6184667,3.207156937684644
SK-MEL-28,387447,-4.492461513664045
SF295,carboplatin-etoposide (40-17 mol-mol),1.823138350284034
ESS-1,10074640,3.3924948891566995
NCI-H929,25195348,3.383350427765997
HSC-3,66577038,2.898702066993284
CML-T1,25062766,1.440222571379222
KO52,53495165,-2.774880309384125
AsPC-1,salermide-PLX-4032 (12-1 mol-mol),5.331580657961115
SF295,2858523,2.846384878516906
TE 441.T,25262965,-3.433432645787497
JHUEM-7,11238147,1.5963726140500234
Lu-65,11494412,0.9324583231494612
SNU-119,135398516,2.000123320648024
PE/CA-PJ41 (clone D2),17755052,2.460417072837074
KYSE-450,25195348,3.344057018387479
Lu-65,16038120,0.5019241155175782
BFTC-909,15953870,3.192835350037467
PE/CA-PJ41 (clone D2),4259181,1.7662808489331707
SNU-886,24753719,3.844666745133929
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671
WM793,25183872,-1.026450709028654
RKO,3543504,4.836700902585943
ESS-1,11640390,3.6623137422227607
HuT 78,24753719,4.53725590635391
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
AsPC-1,10296883,4.32215490848641
SNU-1077,selumetinib-vorinostat (8-1 mol-mol),2.452404658166729
L3.3,8515,4.3523389716154455
KO52,UNC0638-navitoclax (1-1 mol-mol),-2.0411974213550965
RKO,4788,5.372325515812119
Kasumi-2,60700,-3.733340750045026
JHUEM-7,11507802,0.4184250140015549
OAW28,6918837,-3.92509053266304
OAW28,5335621,5.136061685098042
SNU-216,984333,0.2572508487705686
HOP-62,10296883,4.184861943544038
NCI-H1339,445455,5.209347585146279
BT 112,5287969,-2.475133352382641
NCI-H2030,100016,6.672614959068411
ESS-1,11625818,4.257377389303946
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
PE/CA-PJ41 (clone D2),5329102,2.79941940372049
KE-39,44607531,1.2324934173201474
RERF-LC-MS,148124,-5.592640359076286
H-STS,42642645,0.4333051661235175
LXF 289,9444,4.020808033871241
ESS-1,54454,2.499886449492877
SF295,selumetinib-vorinostat (8-1 mol-mol),2.6390667810596624
NCI-N87,969516,2.8189934287936733
LXF 289,51037431,5.679407317259089
KYSE-180,6623618,2.424847215991005
H-STS,637858,1.1585331861261023
ESS-1,46926350,-4.410058245118817
SNU-216,4521392,3.879147487551532
NOMO-1,11427553,1.1686106553832942
SNU-216,25126798,4.2068088728358735
KE-39,135984461,4.3782777468955745
SNU-423,9825149,2.365990280587489
KMRC-20,24771867,3.994101826039686
SK-UT-1,10410894,3.1994132701076308
KYSE-450,6917907,-5.14733530155551
SF539,82146,2.9766155224529576
L3.3,3025944,4.713949011742796
OAW28,5281321,-1.4060991234994806
SK-UT-1,5311,2.5232548896464824
ChaGo-K-1,JQ-1-navitoclax (2-1 mol-mol),1.7850200550969848
LMSU,3136844,4.51908400506557
PF-382,6610216,3.7963864090602737
HEC-108,54618771,2.78064765565191
Lu-65,selumetinib-decitabine (4-1 mol-mol),1.2509124043421416
Hep 3B2.1-7,3384730,4.3929373666383755
IST-Mes1,613753,3.190229377917506
TE 441.T,3038522,2.7230314239046707
SF539,241158,3.806550538894245
Hs 611.T,46901937,3.50612252080814
SK-MEL-28,11612883,5.069449441061208
OAW28,5281672,6.00346703144391
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
L3.3,54618164,4.298111449535211
BT 286,9935249,1.1744552926242438
Hs 611.T,56946209,-6.985017847440336
Hs 611.T,selumetinib-tretinoin (2-1 mol-mol),4.735509199758446
Hs 611.T,12001922,0.9714328775162276
Karpas-422,10427712,3.1818475677437252
KLE,alisertib-navitoclax (2-1 mol-mol),-2.1079832786046486
RERF-LC-MS,11707110,3.327368501952155
Namalwa,241158,1.6214493925930429
HuT 78,16038120,0.7817739501159142
RKN,11222830,1.5707482267531538
HEC-108,66577038,3.3902057561836436
RKN,3815108,2.827407220517517
WM793,168313016,5.214677912138177
SNU-1077,135875424,3.798963502018643
ACC-MESO-1,409805,5.492965963250371
Mono-Mac-1,327653,2.35680812589116
HOP-62,selumetinib-UNC0638 (4-1 mol-mol),2.92656902471884
Kasumi-2,9956119,1.4541571674658873
WM793,11396600,4.503186389543736
NCI-H929,6918328,-1.4176016400848788
KO52,327653,2.901066573817011
TE-14,23725625,6.225977205697723
TE 441.T,448949,1.4593910601153928
HuT 78,selumetinib-piperlongumine (8-1 mol-mol),-3.245208706353043
SF295,135999136,4.283449365552917
BT 286,16065773,1.7230000692404597
SNU-1077,JQ-1-vorinostat (2-1 mol-mol),1.661185971145615
KYSE-450,11427553,3.7801306516191384
NCI-H1339,vorinostat-navitoclax (4-1 mol-mol),1.6362880651435705
OAW28,10184653,1.1706980363621209
Kasumi-2,9884685,-1.7492969798518767
SNU-423,148198,-4.2261536044419765
SNU-886,24748573,0.9987877672847516
CML-T1,docetaxel-tanespimycin (2-1 mol-mol),-5.351471523499181
PF-382,122327,5.887975915813721
WM793,135999136,5.309745002054086
CML-T1,49793307,-4.188413118061572
BT 328,60700,3.9480451882670424
Ri-1,31703,-4.209857724033629
HOP-62,44489675,3.779587884252509
Hs 611.T,1641662,3.2038448944342637
OE33,49793307,-4.94968855926888
KYSE-180,124202324,3.3270800786084154
YD-8,9823820,4.576416589140342
NCI-H196,322968,4.769593139388762
HOP-62,3384730,2.596455739523981
Mono-Mac-1,6918837,-5.093539844656542
KE-39,100016,6.665188081944046
KO52,salermide-PLX-4032 (12-1 mol-mol),5.165396088213933
GOS-3,54618164,5.027817061073729
SK-MEL-5,SNX-2112-bortezomib (250-1 mol-mol),0.961953465517882
KMRC-20,11364421,1.2660239724990872
NCI-H929,89183176,-3.1165008066026085
Ri-1,46943432,0.5214586687647272
AU565,57330099,4.7929461834362606
KO52,136227924,2.4006650771153923
Hep 3B2.1-7,5470400,-2.616097768869996
Becker,6917907,-5.4473174275012886
HOP-62,25126798,4.500227959004911
NCI-H209,9887053,0.254400305901777
Mono-Mac-1,613753,2.716265313942883
MIA PaCa-2,44819697,-0.0792657567654076
Becker,3384730,3.8286453062751233
HOP-62,56649450,4.64353502741552
Kasumi-2,46174525,2.7896977924424218
KLE,44137675,4.105797549386638
SNU-886,5566,3.303161938775539
HOP-62,9933475,1.560150054597467
RKO,25105715,3.388469834531371
SK-UT-1,4477,-0.1518162613562077
SNU-886,644241,2.771156867357371
RT-4,216345,2.153757010037062
PF-382,11507802,0.1200647165763234
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
MIA PaCa-2,11485656,1.8953661577719088
BT 112,44819697,0.0659575190296443
TE-14,219104,4.149508556383155
H-STS,100016,5.985929376611731
AU565,2871966,0.5985779022023225
IST-Mes1,71466578,4.723128098465521
HOP-62,82146,3.1920840849402805
HuT 78,navitoclax-sorafenib (1-1 mol-mol),1.735834872159947
SF539,24779724,4.8810531030455415
SNU-216,24797083,1.440697359194003
KMS-12-BM,9927531,3.2870919606414963
SNU-213,374536,4.5761002458249695
HOP-62,alisertib-navitoclax (2-1 mol-mol),2.154425400396672
Namalwa,BRD-A02303741-carboplatin (1-1 mol-mol),5.328421612608537
OAW28,6918878,3.220005605820797
NCI-H1339,46174525,4.357687715736806
PF-382,selumetinib-UNC0638 (4-1 mol-mol),3.164054400704207
GOS-3,44589607,2.926429501470136
SNU-119,5278396,2.5454097325647904
Mono-Mac-1,444795,3.2832788866841573
TE 441.T,9825149,0.0204286562118866
PE/CA-PJ41 (clone D2),6610355,5.506554656769886
SNU-423,5329102,1.8220903603969243
SNU-119,16725315,4.275634814543551
L3.3,vorinostat-navitoclax (4-1 mol-mol),2.138826011171234
KO52,46191454,1.8283467695557307
BT 320,4917,2.82304614910839
KYSE-450,navitoclax-piperlongumine (1-1 mol-mol),3.113777220831491
OAW28,9956119,4.544482925716663
Becker,selumetinib-navitoclax (8-1 mol-mol),4.743429307691993
SNU-423,56963564,0.9363211448641164
JHUEM-7,11609586,1.0506407698142153
B-CPAP,navitoclax-sorafenib (1-1 mol-mol),1.07140085648009
HCC2108,72193861,0.1943107246781484
YD-8,9884685,0.4288602362117117
H-STS,24901704,3.405459257701186
SW1783,6610216,4.1970131352388265
YD-8,16725315,5.013629583525294
PF-382,135411,0.1083131735898056
Karpas-422,46199207,3.4102201085473007
KO52,44493528,4.373207696272561
HOP-62,2945648,3.444698948827361
ESS-1,selumetinib-MK-2206 (8-1 mol-mol),3.588494409489328
TE 441.T,3025944,3.9894481767551024
PE/CA-PJ41 (clone D2),23725625,6.914883641224904
PE/CA-PJ41 (clone D2),4917,3.8249790735030023
RKO,5278396,3.510721289362286
Ri-1,9840324,5.4110799890547545
KO52,100016,6.24417827042609
PF-382,3689413,-3.8661032289286488
Ri-1,49846579,-5.783613255423313
Lu-65,637858,2.878442664173332
BT 286,alisertib-navitoclax (2-1 mol-mol),-2.5565503486403576
AsPC-1,53325874,4.506725704395743
LXF 289,vorinostat-navitoclax (4-1 mol-mol),1.5886672686618393
HOP-62,11396600,3.498863261816077
Karpas-422,44491742,3.8079113446891424
B-CPAP,10322450,5.621210843033534
SNU-213,25262965,-1.4177959479680335
NCI-H196,44185566,3.19732340662783
AU565,6852167,0.824199435407992
SW1783,25102847,3.1302980289461124
HuT 78,16720766,0.837560054131659
RKO,11396600,3.504834935214814
BT 286,54649381,3.967150181655946
YD-38,selumetinib-navitoclax (8-1 mol-mol),-1.130877487567506
KO52,navitoclax-sorafenib (1-1 mol-mol),-1.8167289238614717
AsPC-1,51039095,3.058915175873227
BT 286,11317348,1.6450901998776757
SNU-886,71466578,3.8028981862440343
OE33,65064,5.377911946662184
RKN,9936388,2.306220468641662
SNU-213,15983966,1.7326463312194766
BT 248,6918638,2.3802175448525844
SNU-423,2858523,3.1102980621606213
Panc 02.03,136227924,3.0839082623333387
HOP-62,10385095,0.93787190415745
SK-MEL-5,123631,1.8735076791711176
CML-T1,2113511,4.359369559056824
ESS-1,4261,0.7524787521612106
Hs 611.T,46943432,2.371802595815265
YD-8,448949,1.587735779011906
HEC-108,4788,5.901110925385162
YD-8,53392493,2.3611593558483066
TE 441.T,46199207,3.399485077203314
BT 112,65064,5.244324782512833
HSC-3,vorinostat-navitoclax (4-1 mol-mol),2.1572530061323523
IST-Mes1,serdemetan-SCH-529074 (1-1 mol-mol),2.635765253356215
KE-39,53393127,4.4066047849251655
SNU-119,3552672,2.2512141905066203
OE33,44137675,3.2640779547469436
Kasumi-2,selumetinib-tretinoin (2-1 mol-mol),7.516580529144076
RERF-LC-MS,2828334,5.9123201087220325
SNU-213,3062316,0.5853814592942461
SNU-886,53245473,3.705172438832396
OE33,9903786,4.225835285233996
YD-8,20959075,0.9850613920765108
H-STS,navitoclax-sorafenib (1-1 mol-mol),1.7549262144899889
NCI-H2030,5282054,3.375861961069432
NCI-H1339,2828334,5.983574272220661
SF539,322968,4.641648660199269
KMS-12-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),5.565016030045443
YD-38,44632017,0.7623024199362133
KMS-12-BM,73707386,2.349774634710614
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
PE/CA-PJ41 (clone D2),31703,-1.1740452115890814
PE/CA-PJ41 (clone D2),3136844,4.269989384929203
OAW28,216345,3.8770767977792913
ChaGo-K-1,44632017,1.7469122629446598
MIA PaCa-2,73707398,0.9717738640313962
Lu-65,9926054,1.7186862089776234
SNU-423,5566,3.225192273921879
SNU-423,25227462,1.2332861285602368
SNU-886,6918328,-0.0533986128601594
SNU-119,4477,-0.101957157099522
PE/CA-PJ41 (clone D2),5738263,4.071016994612923
Becker,4788,5.864425996120983
KYSE-450,9903786,5.350068255808832
SK-UT-1,126941,-4.3077723126369944
JHUEM-7,3025944,3.7681035622574255
RKO,3025944,4.391654014934833
NCI-N87,11507802,1.464328650743575
PE/CA-PJ41 (clone D2),44566777,1.4460436063371125
GOS-3,6918837,-2.1176912664371144
NOMO-1,5311,-0.031303965270056
TE-14,10184653,-1.7986710500950338
KO52,44607531,1.055709895972932
NCI-H196,3815108,3.850058544040323
Kasumi-2,53495165,-3.989635350263354
Ri-1,5738263,2.2065663042204844
ChaGo-K-1,vorinostat-carboplatin (1-1 mol-mol),3.971958802147907
RKN,9911463,4.114615883902867
KLE,decitabine-navitoclax (2-1 mol-mol),-1.0020457102212554
H-STS,16720766,0.6181925299457043
KE-39,doxorubicin-navitoclax (2-1 mol-mol),0.2720331289565558
OAW28,6918328,-0.6493981710218658
BT 328,44185566,3.0844866112877916
NCI-H196,5281321,2.863278470278903
Lu-65,9936388,-8.009646164485344
OAW28,65064,5.229460149894731
HSC-3,10184653,0.3696496653889782
BT 320,11455910,4.86644863423661
BT 328,46398810,2.9413062884147014
Hs 611.T,4917,2.7287652733771157
OE33,1716436,3.5856703745637195
KO52,12003241,-1.0632598943321483
CML-T1,4477,-0.6676342393752774
WM793,322968,3.984805339497546
BFTC-909,136227924,2.3418993883842134
Panc 02.03,176870,4.923826321280428
Becker,89183176,4.612342413190254
SNU-119,46398810,2.4146356603703527
SK-UT-1,6610216,4.443950873518219
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397
SNU-423,71466578,4.7810266206946945
HuT 78,3689413,-1.8719775604380453
NCI-H2030,124202324,3.552041324911957
Mono-Mac-1,2708,2.725116801773413
BT 286,135999136,1.5966853845263294
BT 112,4259181,0.804943209632055
Lu-65,SNX-2112-bortezomib (250-1 mol-mol),-2.8589416478019403
Panc 02.03,216345,4.682043945218969
JHUEM-7,11625818,3.132369782082216
ACC-MESO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7593645992319382
Karpas-422,11497983,-3.582797451507803
Hep 3B2.1-7,11152667,0.7681962822393275
KMRC-20,25126798,4.0465189677431646
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
OE33,448949,1.5374919283154538
NCI-H1339,23582824,1.3537108550784316
KLE,11656518,-1.5343189257668943
AU565,5291,4.2478378741719105
Lu-65,36314,-5.907229491355618
Hep 3B2.1-7,4096211,4.158740683452708
Mono-Mac-1,5328940,-1.985592469607955
Karpas-422,11178236,-5.8379981642330625
SNU-119,5291,3.2986963310167714
HSC-3,676352,1.9440177898110005
ChaGo-K-1,3825829,4.445461759620719
LMSU,984333,0.4760983232851017
WM793,159324,3.425736366761861
GOS-3,216345,3.7028655718770502
MIA PaCa-2,15953870,2.730980253379173
BT 112,54618164,3.5492837733522205
SNU-216,BRD-K55473186,3.911233764269249
HCC2108,11497983,4.98436619743709
PE/CA-PJ41 (clone D2),2858523,3.268562133786411
L3.3,51039095,3.7013514518444617
KYSE-180,46199207,3.0515921936822092
KO52,45279963,2.0128357488117694
Hs 611.T,6918736,-1.9778844605478405
NCI-H1339,2742550,4.5254309197539735
Kasumi-2,445091,5.553993217061133
KLE,navitoclax-pluripotin (1-1 mol-mol),-4.415890697426241
Hs 611.T,9840324,5.787468969670089
PF-382,alisertib-navitoclax (2-1 mol-mol),-3.018293825143377
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
SNU-423,11455910,2.439649543978504
NCI-H2030,44491742,2.996823060755576
TE 441.T,25062766,1.8861185060010517
OAW28,24978538,-0.39276463694641
TE 441.T,BRD-A02303741-navitoclax (2-1 mol-mol),1.1952494012190105
SNU-423,969516,2.699391176615435
NCI-H196,6505803,-2.584709085122825
ESS-1,71751553,4.681072103352448
BFTC-909,3038522,3.685618431455981
GOS-3,51039095,2.831868271027857
AU565,36314,-7.774521242942876
GOS-3,676352,1.7019961079374837
OE33,3062316,1.1582623844191091
OAW28,3081361,1.8855664708831448
WM793,452548,1.1404647506174352
LMSU,42642645,1.4355208101232508
OE33,71751553,4.3154384433130355
MIA PaCa-2,3465537,1.2213186133491942
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
SNU-216,2828334,6.28449233238118
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
B-CPAP,11404337,-1.1633647036433346
KMRC-20,25183872,-0.3631829438506245
BT 286,11257553,3.066784891840144
LXF 289,23725625,4.938564251049365
H-STS,446155,2.3675618978932924
KO52,tanespimycin-gemcitabine (1-1 mol-mol),-1.9669297663564216
SK-MEL-5,135411,0.7753321282520284
Becker,31703,1.0919022553440236
AsPC-1,439501,-1.6009280184427317
ESS-1,42642645,1.3351553509560612
OAW28,9915743,2.8675584787684456
SK-UT-1,11626560,3.0514544041221043
NCI-H929,5311281,3.339013406601059
PF-382,5280436,3.3535132704910784
NCI-H1339,53495165,-0.4722640551033099
SNU-423,5113032,5.670902663678431
BT 286,54143018,-0.4077318593794814
NCI-H2030,selumetinib-vorinostat (8-1 mol-mol),2.944898179545911
SNU-213,54619267,4.402773025327593
AsPC-1,4788,5.925917601642537
MJ,docetaxel-tanespimycin (2-1 mol-mol),-7.655243886133082
HEC-108,selumetinib-navitoclax (8-1 mol-mol),1.4557838229690625
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
KE-39,54618771,0.8543301924142261
KE-39,11964036,1.1014936748281658
BT 286,BRD9876-MK-1775 (4-1 mol-mol),1.848774169614639
AU565,16725315,3.19394291041594
KMRC-20,3543504,4.387857873550899
NOMO-1,135421197,1.2386186938920458
SK-UT-1,24753719,3.8954683516034194
RKO,11214940,1.6564081526645635
LMSU,11626560,2.53911445992309
NCI-H1339,24180125,3.3577258152264635
L3.3,3384730,1.5710194033023062
SNU-1077,erlotinib-PLX-4032 (2-1 mol-mol),3.997115114671339
NCI-H196,44489367,4.4813360413597705
HEC-108,123631,2.3972749886256266
CML-T1,5281672,4.316508820409711
GOS-3,72376,-1.137393114335449
SW1573,107970,2.0608182724975266
BT 286,675434,4.334118060963705
KO52,7251185,1.4009576735019478
KYSE-180,9866186,0.5701832390810861
RT-4,navitoclax-sorafenib (1-1 mol-mol),1.0712554861689316
OAW28,53232,2.960609854482466
ESS-1,444795,3.9723378710264985
RKO,46199207,3.448070090368443
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
SF295,46199207,3.279135151816124
BT 248,54678924,1.5069949057557903
KLE,11626560,2.541931063465937
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
L3.3,25154868,5.156852655599311
RERF-LC-MS,6610216,4.063402980130349
Mono-Mac-1,5335621,4.625887085201477
ESS-1,135984461,4.427051677708814
SNU-119,navitoclax-piperlongumine (1-1 mol-mol),1.89121393785076
SNU-1077,16722836,1.5669441897808989
Namalwa,123631,2.7984892241691735
SNU-423,5978,-2.486643599039795
KYSE-450,11167602,4.298081277499996
SNU-213,6918328,0.0948868684210311
HOP-62,12003241,-2.147728480634193
Mono-Mac-1,216239,1.788861131685611
TE-14,11507802,1.0111349435521184
SNU-886,49867926,2.0094382345952377
BT 112,46215462,1.7689414169857487
TE-14,246676,5.320033654623924
SK-UT-1,54454,4.804941672260084
LMSU,9936388,2.8786407463456656
HEC-108,5282054,4.01625624429958
BT 112,135875424,2.6326015677965087
SNU-1077,246676,5.4377451130468435
SNU-886,73707398,1.147330182406101
NCI-N87,46398810,2.1002609832839187
YD-8,322968,3.497203303162591
Becker,26596,-2.013233579681989
KYSE-450,9840324,5.8174625933687265
Hs 611.T,148198,-3.7604102025742345
L3.3,26596,-0.871586326159775
Namalwa,vorinostat-carboplatin (1-1 mol-mol),1.7606445191986038
SNU-1077,9868037,3.077547755538649
Lu-65,11707110,-4.197253533392251
NCI-N87,54649381,3.6397596564561487
BT 328,66577038,3.3966345058951974
ESS-1,9956119,4.049525614029127
MIA PaCa-2,53392493,1.9193988487134044
HCC2108,136227924,3.562843531024723
L3.3,docetaxel-tanespimycin (2-1 mol-mol),-3.9282194992049546
BT 248,46224516,2.5816980785990875
Becker,72734382,4.483386097403077
BT 328,9952709,3.885158695523131
KMS-12-BM,448949,1.575561913547924
SK-MEL-5,56946209,-3.269494146912073
KMS-12-BM,selumetinib-MK-2206 (8-1 mol-mol),1.5718969310043658
HOP-62,135423438,1.5837123025968611
BT 112,36314,2.3721535443352013
Mono-Mac-1,16720766,-1.4946997026536737
PF-382,navitoclax-gemcitabine (1-1 mol-mol),-3.611460525938325
BT 286,6918736,-1.805383943708912
AsPC-1,4521392,4.0696198883268275
Kasumi-2,5311281,1.4543587988632989
OAW28,5328940,1.8035592963336344
HSC-3,49836020,-1.9036219787804456
KLE,262093,2.3874885119076668
PF-382,selumetinib-decitabine (4-1 mol-mol),-0.112942711472379
TE-14,erlotinib-PLX-4032 (2-1 mol-mol),2.1473842568297608
SNU-119,9884685,1.7075636021097025
PE/CA-PJ41 (clone D2),JQ-1-vorinostat (2-1 mol-mol),1.551802384723893
GOS-3,60700,-0.2943345936745988
TE 441.T,252682,3.603333128187029
BT 328,54618771,1.300712581347958
ChaGo-K-1,135440466,3.4162124936554172
BT 248,10385095,1.1706577035646757
Namalwa,6918878,-0.0380235771387645
SNU-423,3854666,1.5881763460824465
Lu-65,9927531,5.027796470849251
AsPC-1,16065773,2.935886834183449
BT 112,409805,3.8696760433856774
BT 248,46907787,3.027762940742573
NCI-H1339,57519531,2.1207390625581968
NCI-H1339,241158,4.172701274103716
IST-Mes1,9935249,3.876611894197404
HOP-62,5978,3.979985245309929
Hep 3B2.1-7,12003241,-1.3373877223864783
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
KO52,31703,-1.3814684432186313
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
AU565,9927531,4.912755977802547
SNU-216,421610,2.757393166744035
SK-MEL-28,51039095,3.7679772711161887
NCI-N87,5460769,3.352422042402732
RERF-LC-MS,10074640,3.277461458690314
PF-382,46174525,2.636073374054482
RERF-LC-MS,4261,2.068565192175152
RERF-LC-MS,2708,5.106155932743474
BT 248,71304818,1.6499217451033
B-CPAP,5311281,2.231361409647184
SNU-213,44589607,3.464882112143256
Mono-Mac-1,46943432,0.6845329233652461
NCI-H209,1750826,-3.5869009293489507
TE 441.T,11222830,1.0550250936664465
BT 248,241158,3.909930885156875
KMS-12-BM,11175137,1.8406353702051843
OAW28,10074640,2.8656652346665545
SF539,49766530,-1.8483208282069583
Namalwa,44137675,1.71079520317736
Ri-1,24785538,0.9665697902420332
RKO,6917907,-7.36544436443182
Panc 02.03,6918328,1.3018368822202735
RT-4,12003241,-1.8542714118634884
YD-38,135398738,5.078320133426464
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
BT 248,46215462,2.381699206499341
MIA PaCa-2,6184667,3.130245182492798
Mono-Mac-1,387447,-4.177588984938143
LMSU,53325874,5.502506435516271
KYSE-180,20959075,-3.178555830663627
B-CPAP,9840324,3.889396997757569
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
Panc 02.03,65064,5.367712415574159
Kasumi-2,docetaxel-tanespimycin (2-1 mol-mol),-5.507046356769771
Hs 611.T,252682,6.093732220647968
SK-MEL-28,53232,4.789899773327052
SK-MEL-5,JQ-1-vorinostat (2-1 mol-mol),2.0202682324830077
NCI-H929,135398516,-0.7887215182835613
Kasumi-2,vorinostat-navitoclax (4-1 mol-mol),-2.345570206946048
SF539,16013152,3.768432455806556
KO52,44632017,0.0907134536946377
BFTC-909,16725315,4.495652912061774
SNU-216,56649450,0.2964485531702788
CML-T1,3384730,0.9879066704986152
SK-UT-1,5351362,2.3369266208176556
OAW28,24785538,1.1869022382798196
SNU-213,10184653,0.2023790634763856
SW1783,24771867,4.842203084909567
HCC2108,selumetinib-vorinostat (8-1 mol-mol),2.476774013379894
Panc 02.03,25102847,3.3458680072040603
KMS-12-BM,5282054,2.7090393270562796
MIA PaCa-2,46943432,1.539225582233631
ESS-1,2749,1.483117566277163
RKN,3552672,1.948192158503618
ESS-1,6610355,4.793916265981142
ACC-MESO-1,11364421,1.3421413429971474
Kasumi-2,1242560,3.251932247793875
NCI-N87,42642645,0.5523493290598761
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
PF-382,1750826,-5.215741275914632
KYSE-180,docetaxel-tanespimycin (2-1 mol-mol),-5.030018128034541
NCI-N87,26596,-0.8687464208841552
Namalwa,11656518,1.1355675996213976
Lu-65,135411,0.4933451720371167
Hs 611.T,46215462,0.5630490865398994
KMRC-20,241158,6.296391412542069
BT 112,JQ-1-navitoclax (2-1 mol-mol),4.422337220171912
YD-8,10385095,1.4410870728115226
BT 286,navitoclax-sorafenib (1-1 mol-mol),1.1049126484346263
RERF-LC-MS,24821094,3.899392046553833
CML-T1,54649381,3.615747973120369
TE 441.T,73707371,7.119622486558907
Kasumi-2,11719255,0.7919357371697194
NOMO-1,44137675,1.7607667559168472
H-STS,3825829,3.5499806421209854
L3.3,1641662,3.117391597616944
AsPC-1,5329102,1.9734309343360383
SNU-1077,4259181,2.3802371330202137
NCI-N87,54686904,4.2918164398278815
Mono-Mac-1,24748573,1.5404241948644124
KYSE-450,387447,-4.1038253742642725
BT 248,2949965,2.620236046838219
LMSU,135398516,3.1825333446331547
L3.3,123631,2.1308858538649456
KLE,46907787,0.6768942529427939
KO52,vorinostat-carboplatin (1-1 mol-mol),1.526755959462623
HuT 78,135440466,0.5263420458199721
LMSU,2828334,6.025176975178222
Hs 611.T,675434,3.7211808615746977
RKO,8515,4.32265921632429
Hs 611.T,11719255,0.8283937909943156
ACC-MESO-1,76446078,4.183302819310867
SNU-216,9444,3.917162944195096
Ri-1,53232,3.9417926556630154
OAW28,23725625,6.509051762822527
L3.3,216345,4.451682719982746
BFTC-909,3815108,3.5118939741133075
MIA PaCa-2,11612883,2.6735044266109917
HuT 78,23582824,1.377489502141806
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937
MIA PaCa-2,6918878,0.9930766335426112
Mono-Mac-1,44607531,0.4504172572847592
SNU-886,9907093,3.676979603066549
SNU-886,17755052,1.4860081485560532
SK-MEL-5,JQ-1-UNC0638 (2-1 mol-mol),3.706409053077637
SW1573,6610355,4.129027118562099
OE33,100016,6.493432597771833
Mono-Mac-1,262093,2.3689622956108107
BT 328,6610216,4.43822058219873
RT-4,25262965,-0.987005470802566
LXF 289,241158,4.717778097263283
BT 328,5328940,3.187680057709996
KE-39,46174525,4.365046515434029
ESS-1,BRD-A02303741-navitoclax (2-1 mol-mol),4.070395472210358
EHEB,24964624,0.9586889430420278
RERF-LC-MS,5287620,-3.2415128958876123
KMRC-20,44241473,4.734926633770504
AU565,57519531,1.889615726213954
YD-8,11404337,-1.7651477779753342
Ri-1,3825829,3.218260810941893
LMSU,selumetinib-piperlongumine (8-1 mol-mol),4.680339218702476
BT 112,11977753,-1.1582463708963373
BT 286,erlotinib-PLX-4032 (2-1 mol-mol),3.302249298038756
EHEB,25183872,-1.17879257651429
PF-382,73707440,6.113676619987129
YD-8,57519531,2.847740049841003
KLE,serdemetan-SCH-529074 (1-1 mol-mol),1.7024898854961308
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
SNU-216,9915743,-0.7074992417120266
AsPC-1,969516,2.9281765712067447
Namalwa,4477,-0.3247155167185905
KLE,25154868,4.76220314265069
MIA PaCa-2,docetaxel-tanespimycin (2-1 mol-mol),-0.3990888618952469
ACC-MESO-1,navitoclax-pluripotin (1-1 mol-mol),0.0190140508303161
SF539,6438330,1.6386797479013289
AU565,135875424,4.732736146663846
JHUEM-7,46843906,1.6266748117762575
NOMO-1,67156097,-2.629595584457773
Ri-1,2945648,1.0308232221327251
BT 248,51039095,3.103752706938284
MIA PaCa-2,selumetinib-decitabine (4-1 mol-mol),3.3034989346058397
HEC-108,6623618,3.02110008293671
RKO,452548,0.942587279069954
RT-4,262093,3.3301279648450985
KYSE-450,44462760,5.018979644026392
PF-382,selumetinib-tretinoin (2-1 mol-mol),4.149133041999036
MIA PaCa-2,44491742,3.8709962970987464
SK-UT-1,5281321,0.6651666607918505
Ri-1,9444,3.077798333832145
Lu-65,1242560,4.017707407743541
CML-T1,16722836,0.8135653137043857
RERF-LC-MS,24856436,0.2419222597799965
RKN,56946209,-4.407104587623599
AsPC-1,327653,4.351823995090995
TE-14,10322450,4.592810153102171
Karpas-422,445455,4.469696048434685
SW1573,119607,3.675967979424282
ChaGo-K-1,BRD-A02303741-navitoclax (2-1 mol-mol),3.5476583978507015
TE 441.T,25227462,-4.6466783434013434
KMRC-20,71304818,2.472376058947576
OAW28,71304818,3.062868675930112
YD-38,25062766,1.8351513575471845
Mono-Mac-1,2828334,5.6358472407180695
KYSE-180,9903786,3.667884143051944
SNU-886,10127622,1.388505353743375
ChaGo-K-1,2871966,0.7471035022397239
MJ,9915743,1.766638415426978
Lu-65,54626689,4.680171395498018
B-CPAP,135440466,2.00446155370997
HCC2108,73707398,1.1119632364432313
Lu-65,JQ-1-navitoclax (2-1 mol-mol),1.6809303944234784
LXF 289,135440466,1.0541158239349229
Lu-65,7326481,2.282359860124297
SNU-886,23635314,-2.1595159166484685
BFTC-909,637858,2.264716830291231
H-STS,53392493,1.7634078986228434
OE33,16038120,1.3807426405769108
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
SF539,613000,2.586710034954353
PF-382,44241473,4.707549872781651
ChaGo-K-1,66577038,3.1807983442187715
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
WM793,104842,-1.8319129864722523
Kasumi-2,3543504,3.4583921680412413
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
HSC-3,24785538,1.6945658877136145
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
KE-39,9911463,3.415693188275342
HOP-62,54454,2.939267875512383
HOP-62,11964036,0.1349768729321491
RERF-LC-MS,374536,3.716253113618047
SK-UT-1,9933475,2.6906239244816352
OAW28,216239,4.152270593115834
YD-8,11977753,-2.68445470248679
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252
BT 112,11485656,1.9046121738712176
PF-382,piperlongumine-MST-312 (1-1 mol-mol),3.2738168360218727
RT-4,54649381,5.182810489152522
AsPC-1,11625818,4.311821961769238
SW1783,5281321,-0.3453049143187137
SNU-119,2841722,2.795149248179567
RERF-LC-MS,9866186,0.0636323256725951
B-CPAP,17759555,3.7290371728281944
SNU-423,4477,0.5093616133902202
BT 286,54618771,0.8427122634128117
SNU-1077,46199207,3.446749693577103
B-CPAP,navitoclax-pluripotin (1-1 mol-mol),-1.221055695527546
ACC-MESO-1,89928392,2.8278402664706803
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
KO52,9967941,3.749170046879557
Hs 611.T,54143018,1.1106544508037073
LXF 289,9967941,3.6599941581067057
BT 498,135999136,3.3192669973744273
Lu-65,tanespimycin-gemcitabine (1-1 mol-mol),-1.4852703394729607
RERF-LC-MS,46199207,3.61094494328213
SNU-119,erlotinib-PLX-4032 (2-1 mol-mol),0.7167448472722272
Mono-Mac-1,375860,-0.4295713018664168
BT 328,4788,5.982911703327575
AsPC-1,5287969,-0.8371135357044818
Lu-65,9935249,3.101131829236005
Becker,448949,1.5877010563376748
SF295,docetaxel-tanespimycin (2-1 mol-mol),-1.3504710645288256
BFTC-909,11647372,1.2423847125416496
KMS-12-BM,5287620,-2.183306507553873
NOMO-1,327653,2.81345515165661
RERF-LC-MS,6450551,1.967154760545028
CML-T1,24964624,2.008023563128915
Kasumi-2,8515,3.2781378887974775
MIA PaCa-2,375860,-0.6403278633855397
CML-T1,2858523,2.0919777443937715
IST-Mes1,2858523,3.245314531932087
RKO,4096211,2.0568907070726397
Becker,5113032,4.8230203093991815
Karpas-422,JQ-1-navitoclax (2-1 mol-mol),-1.4008867544394668
Panc 02.03,46843906,3.852893526574364
HEC-108,44185566,2.966044024818036
Lu-65,5394,4.420956778785719
KO52,11214940,1.4370538288764154
MJ,73707398,1.2722011507797648
NOMO-1,3385,1.8227638422939128
Lu-65,156422,5.054623050878907
BT 286,1716436,2.8152439824486244
SNU-216,1714884,3.44111438656502
KMS-12-BM,carboplatin-etoposide (40-17 mol-mol),0.8739137522045413
SNU-216,5278396,3.6820180950330057
JHUEM-7,5278396,3.6718347402198614
BT 112,135999136,1.34167975240954
AsPC-1,42642645,1.2436203489585118
BFTC-909,3634881,3.6308731463535704
ACC-MESO-1,2742550,5.050370416732392
Becker,16736978,1.6726604349760967
HuT 78,11977753,-0.8983403403257315
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
SNU-119,selumetinib-MK-2206 (8-1 mol-mol),2.741948442476576
Hs 611.T,49793307,-4.88808281505329
KO52,4096211,1.0563203120780016
PF-382,selumetinib-piperlongumine (8-1 mol-mol),2.6362885856450724
OE33,doxorubicin-navitoclax (2-1 mol-mol),0.8925970329334316
KO52,55508,2.226115215062858
LMSU,6852167,2.6209493875982277
MJ,25102847,2.2666887172970367
KO52,3025986,-1.0982287315100452
BT 498,44589607,2.960128909864039
KYSE-180,piperlongumine-MST-312 (1-1 mol-mol),1.4705753188677493
Karpas-422,25183872,-1.8512729311509144
AsPC-1,107970,2.236934549480267
SK-UT-1,400769,-1.5923135433790303
BT 328,piperlongumine-MST-312 (1-1 mol-mol),1.83335233808469
Mono-Mac-1,1566236,1.6378087380099338
SK-UT-1,9907093,4.521774895830979
ChaGo-K-1,5287620,0.378035829194828
TE 441.T,2733487,6.33277661976693
SNU-216,613753,3.1139728260488484
SNU-119,51039095,2.8116554470827086
HEC-108,135999136,4.441314867436916
BFTC-909,25126798,3.8219929141120166
IST-Mes1,36462,4.9786696220654845
SNU-423,54618164,4.040713940867877
SK-UT-1,49793307,-1.387353739951522
NOMO-1,24753719,4.496099764979975
KMRC-20,4788,5.828719135556259
RKO,24772860,-3.046302255649564
MIA PaCa-2,135423438,2.2894715060157553
KYSE-450,2871966,1.4934903304989255
TE-14,54618771,0.7402705360744307
NOMO-1,439501,-2.35226533453039
SK-UT-1,10113978,3.4066925150008864
SF539,72193861,-0.071360284593044
MIA PaCa-2,25262965,-3.121356079036344
SNU-886,selumetinib-JQ-1 (4-1 mol-mol),2.185309080254947
JHUEM-7,navitoclax-pluripotin (1-1 mol-mol),-2.7805642205903593
SF295,doxorubicin-navitoclax (2-1 mol-mol),-1.7398898013341806
NCI-H196,11427553,3.4194506465962977
KE-39,24180125,2.8951506389407053
RT-4,4261,2.418492483102545
Lu-65,168313016,6.388486365629365
CML-T1,400769,-1.2523952078832103
BFTC-909,119607,6.015893315993201
ACC-MESO-1,2858523,4.1548273733947605
Hep 3B2.1-7,44137675,3.4497824153941528
ChaGo-K-1,1242560,3.30727018349844
YD-38,151289,-0.2665025738669385
KO52,23725625,4.165793696925613
PE/CA-PJ41 (clone D2),72376,-0.3106711811041045
YD-8,3689413,-2.153430400522153
Becker,44462760,5.965848986366406
KE-39,568763,1.2890727054350877
H-STS,5291,3.872294840120784
Ri-1,navitoclax-piperlongumine (1-1 mol-mol),-3.5258320570039285
ChaGo-K-1,selumetinib-JQ-1 (4-1 mol-mol),2.371471699435725
SK-MEL-5,16038120,2.3323122199408215
GOS-3,285033,-3.584870880949546
ACC-MESO-1,1750826,-0.1495576178007003
SNU-1077,54619267,4.150403156100443
MIA PaCa-2,46843906,1.917381207952335
BT 328,53392493,3.725538863996033
SF539,73707438,4.098722810092626
Hep 3B2.1-7,46191454,3.0876078258592248
BT 286,4788,5.375781609747508
Becker,JQ-1-vorinostat (2-1 mol-mol),2.247746806810153
AsPC-1,11955716,-2.13511164723979
KLE,ISOX-bortezomib (250-1 mol-mol),1.0539315287787143
H-STS,24951314,0.6840074671900861
SK-MEL-28,54678924,3.6337720025858
BT 328,16725315,5.116957818378766
TE-14,4788,5.86758680209458
YD-8,3038522,3.692005573373659
IST-Mes1,11175137,3.00105789094782
L3.3,44819697,-3.2466678771673427
ChaGo-K-1,156414,1.5604886005920922
OE33,5311,1.2863561200816664
OE33,42642645,0.9705663776809944
HSC-3,9825149,2.288348548385444
Kasumi-2,16219061,1.087081093705916
SF539,104842,-5.162287402795691
OE33,2871966,0.1098909707191732
SF295,2729026,3.154243256509534
NCI-H196,107985,-2.614031076452801
AsPC-1,9911463,3.4970941612274693
AsPC-1,9935249,3.639166614114404
TE 441.T,44607531,0.5546870829701779
RERF-LC-MS,3062316,3.070306969339253
HOP-62,10184653,2.0915708533115587
Namalwa,5329102,1.349042289795257
RERF-LC-MS,6918837,-3.051376318733669
SF295,969516,3.3546679619380564
LXF 289,107985,-2.691798131563437
OAW28,46907787,2.388022074777516
Hs 611.T,9926054,1.8280926290746755
Hep 3B2.1-7,25195348,2.955791428131732
KE-39,216468,3.956294605283877
SK-MEL-5,crizotinib-PLX-4032 (2-1 mol-mol),2.2894089732020886
KE-39,439501,-0.0752815835977172
Kasumi-2,tretinoin-navitoclax (4-1 mol-mol),-1.7233092596957704
BT 112,9866186,-0.3818998278365069
KE-39,9444,5.314846845399724
RKO,9911830,2.9376280530386123
GOS-3,81146,4.428248018506032
Hs 611.T,10113978,2.000755909117364
AU565,9803433,4.3672163986823085
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
YD-8,6610355,5.07814691981883
Lu-65,168313200,3.8994737452267945
YD-8,6918328,0.3268020780062931
SNU-213,54618771,0.1807958320323681
LMSU,9907093,4.778478105374332
JHUEM-7,6918837,-3.184749956799345
KLE,12003241,-1.9975693903430911
PE/CA-PJ41 (clone D2),11494412,6.141663454426873
SNU-213,25154868,4.992321030185977
AsPC-1,107970,2.236934549480267
Ri-1,9884685,-4.0721071535449065
Hep 3B2.1-7,4788,4.732837755236901
OAW28,44185566,1.918306011480311
OAW28,1750826,-3.338956149870334
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
LMSU,71751553,4.583903358050372
EHEB,ISOX-bortezomib (250-1 mol-mol),0.0742448904105083
Hep 3B2.1-7,168313047,2.740154506541457
EHEB,docetaxel-tanespimycin (2-1 mol-mol),-5.11927619590754
RERF-LC-MS,11364421,-3.8493036468537265
ChaGo-K-1,44607530,2.2725472381038503
MIA PaCa-2,5280436,2.0338405377694806
OAW28,25262965,-0.9519808245592094
ACC-MESO-1,5351362,2.4055173887272496
YD-8,54143018,4.014642236255498
IST-Mes1,448949,2.0697752718967677
L3.3,73707398,1.2944525096848456
KMS-12-BM,4259181,-0.5634255522920182
GOS-3,9825149,2.947863727591062
KE-39,54618305,4.948156947347383
RKO,11364421,1.233720517884939
NCI-N87,73707398,0.9429301881187698
H-STS,5335621,4.075403306660697
TE 441.T,54619267,3.62579615105429
OAW28,25102847,1.9718431113444057
LMSU,5278396,3.836734271411514
YD-38,107985,-3.704885076305192
SW1573,5328940,2.8151731448483424
Ri-1,2746,1.8815592761229076
KYSE-180,5746,1.1685724105246271
Lu-65,45279963,3.542981128293979
Panc 02.03,19582717,5.117031119305748
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
Kasumi-2,67291369,1.3044869974839717
AsPC-1,2708,5.587707055847425
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
TE 441.T,24901704,3.444757616833086
EHEB,5566,2.7898733391986994
ESS-1,46199207,3.803521594847931
AsPC-1,5351362,2.4874401689371033
KYSE-180,51037431,2.26453575909295
Karpas-422,2708,4.388605602289197
B-CPAP,2749,3.278243683054658
HuT 78,5978,-3.8963684246064014
SK-MEL-28,11485656,3.743045528473451
KE-39,71304818,2.3198950996012515
NCI-N87,49793307,-2.95740399691262
ESS-1,262093,3.0427773228942057
BT 248,3038522,2.764297682711703
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
SNU-423,3038522,1.9901012300049743
TE 441.T,3689413,-1.0112421393817166
TE-14,6914657,-4.4319819983205715
SNU-119,445643,3.745068929793647
TE 441.T,vorinostat-carboplatin (1-1 mol-mol),3.7419271028225687
YD-38,252682,7.500045069347969
Mono-Mac-1,11427553,-0.2417321050983487
BT 248,56649450,1.4607260014057133
BT 328,10184653,3.731010322665131
BT 498,24978538,1.086721793823347
SK-UT-1,15953870,4.0206121025368216
LMSU,46843906,3.905857502626125
HuT 78,46191454,0.2646394750770171
SNU-216,16722836,1.1608339021538483
NCI-H1339,44632017,1.0152846867592873
Namalwa,135440466,1.047510792241919
Namalwa,5470400,5.015667749445751
ACC-MESO-1,2874250,4.963672999573585
AU565,24797083,1.2091873523376886
AsPC-1,10127622,2.6030187662085384
JHUEM-7,ISOX-bortezomib (250-1 mol-mol),0.2456218281827208
IST-Mes1,11507802,2.196367921071978
RERF-LC-MS,5278396,3.382202757419261
YD-38,67156097,-1.8583293127593263
AsPC-1,5282054,4.143624610165464
SNU-119,5287620,-2.0634192053301623
Mono-Mac-1,72734382,2.478752444995056
SF539,44137675,2.552438639753458
ACC-MESO-1,54613361,4.477829702351627
H-STS,60750,-4.358992814054535
SK-MEL-5,3854666,2.922871568885423
AsPC-1,44202524,5.110549363526631
BT 320,71729975,3.655690084257896
EHEB,2945648,4.948774095176571
KE-39,navitoclax-birinapant (1-1 mol-mol),0.0912747000919814
BT 286,vorinostat-navitoclax (4-1 mol-mol),1.1734217347995668
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
JHUEM-7,9887053,4.4427477773471145
NCI-H209,44607530,2.40492464566077
KMS-12-BM,3384730,0.2737397742242424
NCI-H2030,24964624,3.4158063313495393
Mono-Mac-1,ISOX-bortezomib (250-1 mol-mol),0.3219679032848082
RKO,46907787,4.104881837237831
Karpas-422,44607531,1.274772844929052
RT-4,51039095,3.6513947715077135
HuT 78,10410894,2.2762155045304295
HCC2108,10427712,4.666619490685044
YD-8,6184667,3.1421858236064235
PE/CA-PJ41 (clone D2),10427712,5.991443692046267
HSC-3,navitoclax-MST-312 (1-1 mol-mol),1.2665262183799604
HuT 78,erlotinib-PLX-4032 (2-1 mol-mol),4.780125064629265
Namalwa,216468,0.3360162821959921
BT 286,11955716,-2.2212839478685393
ESS-1,SNX-2112-bortezomib (250-1 mol-mol),-1.8592325691556872
GOS-3,2749,1.7643517607481882
Karpas-422,11719255,3.5310729907349305
GOS-3,374536,2.2437065899634843
AsPC-1,5278396,3.912005463923024
BT 286,9911830,2.3367947096317927
ESS-1,613753,3.280704528327703
Lu-65,49793307,-2.235561608271653
IST-Mes1,5281321,-0.504099135222913
AU565,56946209,-4.483098881483793
BFTC-909,11175137,1.859642091823866
EHEB,6914657,-4.098891510643266
KYSE-450,4477,0.7200921978595938
SK-MEL-28,selumetinib-decitabine (4-1 mol-mol),2.13770336621051
AsPC-1,148198,-3.729188282050714
KO52,54618771,1.4631554759036511
AsPC-1,24748573,4.519934140177759
KLE,126941,-0.581421523160804
HEC-108,11625818,4.313201084341855
YD-8,1641662,3.7116044926087146
KLE,11152667,-1.6090314572433455
BT 498,11626560,2.542570965173451
Becker,9911463,4.366530732677302
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
TE-14,637858,2.3337222437177454
SNU-213,6610216,4.06770286109328
Panc 02.03,10127622,3.4148938287456776
SK-MEL-28,25150857,3.0463129162914875
ESS-1,52912189,1.4491066421108545
Hs 611.T,2858523,2.9943974026631084
SW1783,24964624,3.0506533345729245
SNU-216,123631,-0.3500729676131077
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292
NCI-H1339,11977753,-0.4583860757329758
NCI-H2030,vorinostat-navitoclax (4-1 mol-mol),2.0180777261594463
SNU-423,24180125,3.626785562106237
B-CPAP,3825829,3.169966347621692
TE 441.T,6918638,0.7814615450050921
NCI-H209,5978,-2.9776109822230565
HOP-62,24753719,5.014649450364504
HEC-108,JQ-1-vorinostat (2-1 mol-mol),2.7336649081261437
EHEB,54618164,4.264105290178519
AU565,11494412,-0.7938994603064
KE-39,JQ-1-MK-0752 (1-1 mol-mol),1.6726733394588664
PE/CA-PJ41 (clone D2),10231331,2.737757357175731
AsPC-1,702558,5.7476960936684565
SK-UT-1,5291,3.873544658482056
OAW28,5287969,-1.4958665626980858
HCC2108,navitoclax-piperlongumine (1-1 mol-mol),3.2345753523038536
NCI-H1339,ISOX-bortezomib (250-1 mol-mol),0.3050611513978097
HSC-3,3025986,-0.4532276268650599
JHUEM-7,selumetinib-BRD-A02303741 (4-1 mol-mol),4.810620689703725
AsPC-1,selumetinib-MK-2206 (8-1 mol-mol),1.6860334273273738
CML-T1,25126798,3.796147395391691
SNU-216,135423438,1.816422149531831
JHUEM-7,44202524,1.495097381233924
NCI-H1339,5287969,-2.094492411794171
KE-39,selumetinib-PLX-4032 (8-1 mol-mol),6.861097822886508
ESS-1,46907787,0.8695499024183594
GOS-3,49836020,5.837697611269413
OAW28,135875424,4.470041991889524
SNU-119,11222830,0.2284603651401007
TE 441.T,2733526,4.0345216500732235
PF-382,387447,-5.996282081470132
OE33,15547703,3.1621106125500127
NCI-H196,10184653,1.7255647355935626
RKO,16741245,1.399079485469943
KO52,445643,3.829050066229971
Karpas-422,375860,-0.2340212994929422
LXF 289,doxorubicin-navitoclax (2-1 mol-mol),0.6583204224583108
PE/CA-PJ41 (clone D2),1242560,3.4666813536449284
KO52,5284329,4.405190261988607
Karpas-422,72193861,1.151901981366233
JHUEM-7,409805,3.8541488067969785
RKN,10113978,4.430129932581481
OAW28,2708,5.3328257603707545
KMRC-20,446155,3.8428728494703432
LMSU,erlotinib-PLX-4032 (2-1 mol-mol),3.803932013345548
RKO,387447,-4.452540898932811
Mono-Mac-1,46199207,2.723327941357597
SNU-216,57519531,2.0798230337162296
Namalwa,119607,5.137391391620056
RT-4,16038120,1.2849695111816888
OAW28,702558,5.716785737298097
AU565,322968,2.504214157528526
SK-MEL-5,24964624,2.9124247923536783
HEC-108,BRD-A02303741-navitoclax (2-1 mol-mol),1.0152806773342118
Kasumi-2,2828334,5.794074438385768
RKN,49766530,-3.8574490235665584
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
SW1783,53232,4.066111432329494
LMSU,54613361,5.3504383264150235
TE 441.T,375860,0.1054494227896346
SNU-886,400769,-1.7874528673919734
NCI-N87,5281672,5.2421020595736145
H-STS,36462,-1.1706487337003968
Karpas-422,107970,2.1264000948746555
KE-39,44241473,4.750329858029805
BT 328,11364421,2.7356800342957777
KE-39,387447,-3.456484721663708
KMS-12-BM,9444,3.443513988010703
KYSE-450,25183872,-0.8618407646936664
KE-39,16720766,4.546084140767303
SNU-1077,serdemetan-SCH-529074 (1-1 mol-mol),3.0247217263802493
Namalwa,11228183,3.284342185048067
LXF 289,25183872,-1.882522005728347
BT 320,10074640,3.68399538142115
Mono-Mac-1,54143018,-1.0580597648683372
GOS-3,44566777,1.372759140356778
MIA PaCa-2,5746,1.2927758062815462
YD-38,568763,0.0925266784242715
HuT 78,15983966,-6.777458587771195
LXF 289,656346,1.157307128170796
OE33,44589607,2.028602004448122
AsPC-1,10074640,3.638861482782184
LXF 289,3854666,2.0847029854583377
Panc 02.03,56649450,3.905458120664549
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
RKN,5287620,-2.679516494579474
SNU-119,26596,2.579410873890194
RT-4,3025986,-0.629141422701896
Lu-65,9840324,5.622509691828773
Hep 3B2.1-7,119607,3.8735911841342783
RKN,36462,2.460575122343829
HSC-3,ISOX-bortezomib (250-1 mol-mol),1.6231606918452472
RKN,89928392,1.2442310560485252
L3.3,5278396,3.196787051990793
KYSE-180,57519531,3.399978539206015
KYSE-450,71466380,4.437575150411749
Namalwa,decitabine-navitoclax (2-1 mol-mol),-1.051646403003791
BT 286,5738263,3.830646188768121
Lu-65,56649450,2.0971819083510512
SW1573,2828334,5.538488922798482
SNU-119,11964036,1.0686978114131611
NCI-H196,387447,-3.86918133998242
PF-382,322968,1.8904688275492667
AsPC-1,12001922,2.2862775547931675
L3.3,11404337,0.7171912876466348
RKO,107970,2.3673735748138265
Lu-65,65064,5.373865875652577
EHEB,selumetinib-tretinoin (2-1 mol-mol),4.625312744108104
Karpas-422,23582824,0.2486359902092493
Kasumi-2,9935249,-0.6704419087402653
NCI-N87,10410894,1.83413876253328
CML-T1,JQ-1-UNC0638 (2-1 mol-mol),0.1970824478028413
NCI-H1339,carboplatin-etoposide (40-17 mol-mol),2.749450753466417
Namalwa,crizotinib-PLX-4032 (2-1 mol-mol),1.0699462995067208
SNU-423,65628,4.328235834084208
TE-14,25062766,2.4465300984427834
WM793,135440466,3.4729537866645828
Lu-65,25262965,-1.8559569622213667
Mono-Mac-1,9908783,5.903020339725522
Ri-1,3543504,2.7587120084990855
SF539,54143018,-1.099127333554906
SW1573,42642645,1.1024283721976142
B-CPAP,ISOX-bortezomib (250-1 mol-mol),0.9973864966848812
LXF 289,selumetinib-tretinoin (2-1 mol-mol),2.6390813886621203
NCI-H1339,3081361,3.920928785225322
SF539,16065773,1.5731134772148812
LXF 289,387447,-4.093727880786265
PF-382,10026128,4.370506492826604
Hep 3B2.1-7,44589607,3.2305437071939127
SNU-423,375860,-0.141425947999252
PF-382,ISOX-bortezomib (250-1 mol-mol),-0.6876277836304979
BT 328,25105715,3.784465780287459
KYSE-180,23635314,-1.91549509503103
HOP-62,46174525,5.003008160940451
HSC-3,135984461,4.3923039521515985
MJ,10302451,4.214297869660198
OAW28,4788,5.61832216329738
AsPC-1,24821094,4.10595231639086
BT 248,11640390,5.783520002908773
SF539,5281321,-2.202189901262438
AsPC-1,11612883,5.278069767960674
TE 441.T,6917907,-6.579118960193998
BT 248,3062316,2.7315660903773606
NCI-H209,doxorubicin-navitoclax (2-1 mol-mol),-1.980488433431222
KE-39,9825149,1.9410582316331728
BT 498,2949965,3.1308462818813467
HSC-3,12003241,-1.4285198417789524
NCI-H1339,9926054,1.7994324687191725
SNU-216,44507138,2.1948578780938814
IST-Mes1,11640390,3.2581579646920966
SNU-423,107970,2.9468491759606303
SNU-423,16722836,2.1126180298649824
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317
BT 112,6918837,-0.2659992739621661
HCC2108,serdemetan-SCH-529074 (1-1 mol-mol),2.3033726270926
YD-38,216345,4.4915437818048325
Kasumi-2,54626689,4.779746030866953
KMRC-20,erlotinib-PLX-4032 (2-1 mol-mol),4.001025542089447
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
BT 498,119607,5.8425982216003405
SK-UT-1,54626689,4.825189757508342
BT 248,119607,5.038088774684491
Hs 611.T,52912189,1.5591574596969118
Kasumi-2,56946209,-4.865772879743349
HOP-62,16725315,3.3332717418500155
MIA PaCa-2,7326481,2.6127958061584984
SNU-423,2729026,3.1858852581930197
HuT 78,9903786,-0.2471360619469426
YD-38,25102847,4.016473882164608
HuT 78,1641662,3.992228724834443
KO52,135999136,3.8823895578085743
RERF-LC-MS,65628,5.693639897620667
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
SNU-423,49766530,-2.309056121887604
KE-39,3038522,3.2295476949923874
Becker,25262965,-3.2984826575287567
KMS-12-BM,15983966,-6.367162129369465
AU565,54618771,1.1954147839624212
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
SNU-216,5738263,3.544912371195603
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
HSC-3,6184667,4.256789074152558
NCI-H929,54454,1.0391277721640106
NOMO-1,23635314,-2.3321691272104697
Becker,24856436,1.009680150246275
NOMO-1,16722836,0.125485002235246
SW1573,10026128,4.237670104162456
KE-39,6610216,4.077734835238396
NOMO-1,421610,4.35383474826381
CML-T1,6438330,0.4811462042672619
Hs 611.T,3136844,4.24096122939903
SK-UT-1,2828334,6.192773622415013
Panc 02.03,46199207,3.8452319744534886
Hep 3B2.1-7,2858523,2.0978501918047026
NOMO-1,24772860,-3.4546209155075687
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
SNU-119,1716436,3.1005632385597237
Panc 02.03,6438330,3.381062774421129
SW1783,10427712,4.612980278868
SF295,49793307,1.7013463653748198
Ri-1,54143018,-1.264443943913558
SNU-213,4261,2.536630318307326
TE 441.T,65064,3.1243900665572384
NCI-H929,24753719,4.216810454357832
KE-39,54618164,4.766262408385177
NCI-H196,2708,6.724723846319038
NCI-H1339,11964036,1.884295102990518
ChaGo-K-1,446155,4.065867494589203
KO52,73707398,0.5433059802196046
KE-39,122327,6.317857137620034
BT 328,65064,5.830382460342701
LMSU,1716436,3.7603795285051818
KMS-12-BM,9903786,0.6537757100604409
NCI-H1339,11152667,-1.000017899668529
KE-39,selumetinib-JQ-1 (4-1 mol-mol),1.3971527695941195
CML-T1,24180719,2.7823494948279373
IST-Mes1,16722836,0.916062842065302
SNU-216,6918837,-3.2579868157497707
MIA PaCa-2,2733526,4.136774974442715
RKO,44185566,2.4837284923488063
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918
LXF 289,65064,4.964411921317377
Mono-Mac-1,53495165,-1.384513911752195
RT-4,44202524,1.5489412364823092
RKO,3815108,2.4813915623878264
RT-4,44632017,1.2730155033067565
LXF 289,49793307,-1.960491877422628
SNU-1077,984333,1.7185936454570083
SF539,16722836,1.315642485980416
BT 320,6918837,0.518825985636162
B-CPAP,5329102,2.213007712516747
Ri-1,135421197,1.0934360104975305
BT 248,24964624,0.9785580517881716
H-STS,23635314,-4.332307696037408
BT 248,54649381,3.7327878949357394
HEC-108,6918736,-2.1205057865818633
HEC-108,135398738,5.1700626311097935
Mono-Mac-1,219104,2.665185592268247
MIA PaCa-2,46926350,-5.336909626139248
H-STS,219104,3.0414715393637937
OE33,vorinostat-carboplatin (1-1 mol-mol),3.3331184929351183
PE/CA-PJ41 (clone D2),6914657,-2.4889855415654223
RT-4,24180125,3.633157370927589
HCC2108,10184653,1.422898929180728
JHUEM-7,10410894,4.599491297270876
SF295,5351362,1.2959766054388189
WM793,9935249,4.106686148008307
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
SW1573,71466380,3.629171273590213
MIA PaCa-2,46191454,1.026049198507862
AU565,46907787,3.197599854412173
Ri-1,6918736,-3.10014909157418
SF539,16725315,3.19850826981026
BT 328,107985,-2.461939045328001
ESS-1,49766530,-0.3205579652733103
MIA PaCa-2,25105715,3.4465386312083734
YD-8,11364421,1.2930032708337824
SF539,6436223,-5.188827537901569
Karpas-422,11640390,3.2653656586739084
RT-4,65064,5.007603522761181
RKO,89928392,1.6264666324972337
SK-UT-1,984333,0.8652999578170681
SNU-423,ISOX-bortezomib (250-1 mol-mol),0.2587809522365415
OAW28,10074640,2.8656652346665545
BT 286,10184653,1.951842124920023
SK-UT-1,5282054,3.4735400684673077
RKO,57330099,4.8516025997257275
SK-MEL-5,54618164,3.941567949618183
SNU-423,5291,3.88942094627468
NCI-N87,24772860,-4.531203546207334
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
PF-382,11364421,-5.01539048557423
JHUEM-7,241158,3.726297808510672
SK-MEL-5,4096211,2.3960357631286326
SNU-423,5287620,-0.5057300619999656
OE33,67291369,1.7664014894471822
RERF-LC-MS,56649450,3.38813984116235
AsPC-1,46174525,4.390753346499015
HSC-3,54618771,0.6642536113718133
RKN,241158,3.8611150596916577
SF295,25126798,4.081083799796345
RKN,44493528,4.408823872302737
BFTC-909,702558,5.601571619782522
KE-39,11238147,3.713228695438772
Hs 611.T,JQ-1-carboplatin (1-1 mol-mol),1.233772265287216
KMS-12-BM,selumetinib-PLX-4032 (8-1 mol-mol),4.308028949995008
H-STS,675434,4.034994029543359
SK-MEL-28,16741245,3.085707484967514
SW1783,2871966,1.533691405345237
JHUEM-7,5328940,0.6709710255807081
SNU-1077,10113978,1.921238205807409
OAW28,135928012,4.847644989583831
NOMO-1,46224516,2.27353152393119
SNU-213,46191454,2.292491387475712
RERF-LC-MS,5282054,4.065617468844444
RKN,2708,5.19327789915259
Namalwa,25161177,4.36797235746559
KE-39,4788,5.3862218822227925
KO52,46174525,3.5997508179953615
B-CPAP,36462,2.9049699830233733
SK-MEL-5,54649381,4.626873834001773
Namalwa,9911463,2.7572577056870022
AU565,45279963,3.869118795762884
LMSU,8515,4.269991680871031
L3.3,72193861,1.4096427828350668
IST-Mes1,9915743,1.0557522455188102
KO52,11640390,3.55946469667695
BT 328,3543504,5.231432946006072
KYSE-450,25150857,3.125664809349332
NCI-H2030,5351362,2.185216793526661
SNU-216,selumetinib-vorinostat (8-1 mol-mol),2.415634869676137
SNU-423,219104,4.0496831719135775
KMS-12-BM,9825149,-0.3079276938801488
HSC-3,5460769,0.5796773846600773
BT 248,9868037,3.916296675967623
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
KYSE-450,11404337,-0.7664225185438103
SK-MEL-28,11175137,3.580764276336763
Kasumi-2,11317348,0.9834435800612674
L3.3,9935249,4.2075706542966955
OE33,11640390,3.4389828580946027
NCI-H2030,216468,4.3643018896295365
Kasumi-2,675434,3.537694279705698
TE 441.T,selumetinib-PLX-4032 (8-1 mol-mol),5.081053140358277
MJ,3038522,3.33569699650525
JHUEM-7,219104,3.3113513931291036
YD-38,selumetinib-tretinoin (2-1 mol-mol),0.1336494168228399
AsPC-1,6918638,0.7071735542476161
Hep 3B2.1-7,54649381,3.772857705678292
Hep 3B2.1-7,11238147,3.2165923834999335
KMS-12-BM,20959075,-3.73832330619988
WM793,15547703,2.941015852165493
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
YD-8,54454,1.7837031222985251
BT 498,11404337,1.4735257645837956
SF295,216345,4.417343990747713
PF-382,15953870,2.669476849035499
SNU-213,656346,4.349548786088633
Kasumi-2,16720766,-0.2515973340383426
AsPC-1,10184653,1.884059851333118
B-CPAP,navitoclax-MST-312 (1-1 mol-mol),0.2564145417879402
BT 112,selumetinib-BRD-A02303741 (4-1 mol-mol),5.118428363435484
WM793,16065773,2.8314108092374
JHUEM-7,135411,0.5518757066941595
MIA PaCa-2,73707371,5.326975910300329
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
ACC-MESO-1,400769,-0.2870983394084955
LMSU,24821094,3.02517753591971
Hep 3B2.1-7,219104,3.647803204428215
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
KYSE-450,57519531,6.208309628107499
HEC-108,24964624,3.1655733599312126
OAW28,5746,2.6048591865024657
MJ,5281321,1.2441841726389662
PE/CA-PJ41 (clone D2),23582824,0.3090990193641486
TE 441.T,216239,1.860492007917197
JHUEM-7,5282054,3.350633038728166
PE/CA-PJ41 (clone D2),24180719,4.2890339364841505
KE-39,637858,2.1285067674718374
PF-382,71304818,1.2599854334325824
Ri-1,JQ-1-carboplatin (1-1 mol-mol),-0.4957222903174305
B-CPAP,262093,2.8121848345775784
RKN,2858523,3.2318364946727653
BT 112,25102847,2.5247869657619395
Lu-65,11404337,-0.485331944829254
RERF-LC-MS,15983966,-4.090154567310139
BT 498,6610355,5.488343588917727
Becker,24964624,2.1875256687582256
PF-382,5278396,3.0663374884499266
KMS-12-BM,44493528,3.477782404349953
BT 112,67156097,-1.0460495753019483
HEC-108,969516,3.1177295269090664
SNU-119,4378219,1.466515976267717
OAW28,16725315,3.4000122970226196
PE/CA-PJ41 (clone D2),135659046,4.325865774807889
HCC2108,2858523,2.774928001952886
SNU-886,441298,0.5019863351835324
SF539,227681,3.913765849966807
HOP-62,carboplatin-etoposide (40-17 mol-mol),3.0329769796472
SF539,10074640,2.2789640038336394
KMS-12-BM,285033,-4.098643381088682
OAW28,5351362,2.5555782345102407
KYSE-450,53392493,3.727068470803864
SK-MEL-28,tanespimycin-gemcitabine (1-1 mol-mol),3.7506715255055343
SK-MEL-5,3503,2.718146130273396
ChaGo-K-1,71304818,1.816739783520312
Ri-1,5566,2.004549606027771
RKO,46215462,1.869666408515056
EHEB,10302451,2.5081035375606295
PE/CA-PJ41 (clone D2),1716436,3.6798676111614457
WM793,10410894,3.504687642816823
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
SK-MEL-5,44589607,3.099496776426073
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
OAW28,46199207,3.397949359639469
MIA PaCa-2,5311,0.9776668834294896
ESS-1,9967941,4.268050907247004
NCI-H209,11404337,0.938734555574242
RERF-LC-MS,44607531,1.5104561529736475
OAW28,11977753,-1.87780111267196
KE-39,10385095,1.3052459079941114
KMS-12-BM,24901704,2.3878689097063424
SNU-119,135423438,2.0179604003543288
MJ,6505803,-0.8623373124046138
Lu-65,5287620,-2.128449758644444
KMRC-20,57330099,4.053303525305033
HEC-108,168313047,3.5343278963000033
SK-MEL-5,135440466,3.311967478820367
KE-39,2871966,0.1277928781522726
AsPC-1,24753719,4.618559637878285
MIA PaCa-2,446155,1.1238502373282009
OAW28,6918878,3.220005605820797
BFTC-909,2733526,3.41724914482818
SNU-216,54619267,4.091283104128005
AU565,60700,-0.684074891390158
KMS-12-BM,doxorubicin-navitoclax (2-1 mol-mol),-2.1380196151601845
RERF-LC-MS,5113032,4.48589538963195
MIA PaCa-2,5291,3.0537829500454614
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
OE33,4259181,0.9178629586058104
KYSE-450,57330099,4.469167864214201
SNU-216,7251185,1.8033335851683228
SK-MEL-5,3825829,3.883151083406129
ACC-MESO-1,25183872,0.7454056301967538
BT 320,45279963,4.337631582225757
PE/CA-PJ41 (clone D2),selumetinib-JQ-1 (4-1 mol-mol),1.3944144559858256
AU565,9967941,3.769081839228565
NCI-H196,carboplatin-UNC0638 (2-1 mol-mol),3.541252771410712
LMSU,100016,7.332455698517509
HuT 78,11238147,3.7315717543629057
WM793,675434,6.301966569766523
SF295,10302451,4.330260751201553
BT 320,644241,3.936570500455286
KMS-12-BM,piperlongumine-MST-312 (1-1 mol-mol),1.2051347484874666
NCI-H1339,6252,-0.4207585995125426
B-CPAP,448949,0.8631671075369705
Kasumi-2,3025944,3.902952987709838
SNU-119,445091,4.135214962682557
Ri-1,19582717,3.0629165045655764
KE-39,11234052,4.426214441977921
AU565,11960529,4.91307375329511
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415
BT 112,45279963,3.846989137571412
ChaGo-K-1,3465537,1.3270593672392677
SF539,10127622,4.044481500829827
BT 248,448949,1.935087924253196
HEC-108,675434,4.085694536082024
TE-14,25105715,3.27330564947439
SNU-119,5702613,2.9838920774559483
Kasumi-2,9911463,3.4999156831259524
ESS-1,10113978,3.392450898705775
WM793,1641662,4.965953189176842
SNU-423,126941,-1.4095759658666385
Hs 611.T,6505803,0.4096396664447451
Mono-Mac-1,11396600,1.2647728617805982
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
SNU-213,31703,0.5753594315199101
SF295,5311281,3.133467459671144
KMS-12-BM,24978538,-1.4319691213923784
KYSE-450,3825829,4.738351974491715
BT 286,16659841,3.8289465528596542
SW1573,60700,0.5293530759970745
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
SNU-1077,11964036,1.4394318176037413
KO52,57519531,1.8439662124610676
MIA PaCa-2,3854666,0.8531836291018433
SF539,1242560,3.791681789864431
Lu-65,24772860,-2.8621529229367417
SW1573,17759555,4.342323370433329
PF-382,73707398,0.3361294473850881
SK-UT-1,docetaxel-tanespimycin (2-1 mol-mol),-3.9315857495546735
PE/CA-PJ41 (clone D2),72193861,3.673729386606365
RERF-LC-MS,6505803,-0.6931241555509828
TE 441.T,5281672,3.596407838275987
OE33,3025944,4.2858612810653005
HOP-62,5291,3.833370883851296
SNU-213,10302451,1.063572133551757
HuT 78,9911830,2.253743254641726
TE-14,56649450,2.166599598587956
PF-382,26596,-2.06856872789975
Panc 02.03,262093,3.467425891303458
NCI-H2030,54619238,5.583163368588451
KE-39,4521392,3.820577252344618
Mono-Mac-1,6610355,3.782829055188725
BT 498,12001922,1.1592789388500984
Ri-1,11213558,-0.1281148771629731
ESS-1,25102847,3.139039712214138
SK-MEL-28,6450551,3.516250339851913
EHEB,11612883,2.202439191099921
PE/CA-PJ41 (clone D2),10074640,3.7957214869884424
Mono-Mac-1,73707398,0.6980623217810987
ACC-MESO-1,24901704,3.483315834042047
KE-39,439501,-0.0752815835977172
WM793,4261,1.9169510803510963
Lu-65,15953870,3.741719586955095
YD-8,11152667,-1.506864416830652
TE 441.T,carboplatin-etoposide (40-17 mol-mol),0.9968923804280664
SF539,11657048,3.82012123465622
PE/CA-PJ41 (clone D2),9887053,5.327755452479389
Karpas-422,11955716,-2.575404342374506
ESS-1,5311281,1.2479290608780562
IST-Mes1,25102847,1.8280194065910471
KYSE-180,216345,4.057216202518236
CML-T1,doxorubicin-navitoclax (2-1 mol-mol),-4.289526889070848
IST-Mes1,1641662,3.7606227939030528
AU565,104842,-3.8153307910583014
SW1783,3062316,3.7843864001460585
SW1783,44197249,1.0547858460239052
MIA PaCa-2,637858,1.1483651516118356
KMRC-20,11626560,2.2175468532986353
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
SK-UT-1,5328940,1.756043494249043
KO52,9549297,1.130259430761993
LXF 289,984333,0.880488465949386
EHEB,262093,2.39806678929768
YD-8,3062316,-2.7006453915936497
SK-MEL-28,7326481,2.655717270384107
ChaGo-K-1,JQ-1-MK-0752 (1-1 mol-mol),1.6532654417593031
LXF 289,3025944,3.4981276099044134
SK-MEL-5,60750,-4.3522881886018885
MIA PaCa-2,65064,5.109896885791301
BFTC-909,656346,-0.1018552101429806
AsPC-1,3503,2.1995832473977157
SK-MEL-5,46199207,3.4414275272252137
Hs 611.T,11396600,2.963461604358696
TE 441.T,6184667,3.173920114410577
SNU-119,decitabine-navitoclax (2-1 mol-mol),1.261288354016859
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
IST-Mes1,6918328,0.8508470020259952
YD-38,6917907,-5.942937976928353
OAW28,60700,1.95920843974679
Lu-65,vorinostat-navitoclax (4-1 mol-mol),0.9928473166705348
KE-39,BRD9876-MK-1775 (4-1 mol-mol),3.886379360768492
BT 286,SNX-2112-bortezomib (250-1 mol-mol),-2.9534628064080732
IST-Mes1,46907787,2.643041583848796
YD-38,262093,2.9761292729070954
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808
SNU-886,3815108,2.9264370464975817
Kasumi-2,439501,-3.441659601561783
B-CPAP,135398516,1.1534562761305718
BT 286,10427712,4.414930862618797
ChaGo-K-1,4261,2.1016705661768684
L3.3,46191454,1.113033924578524
NCI-N87,6184667,4.346047693042568
BT 320,11404337,0.6966185269279856
HSC-3,400769,-1.1119474923220969
ESS-1,216468,-0.8835255749902827
BT 248,5287620,-3.0713737356172484
JHUEM-7,44819697,-0.2962478078392037
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
LMSU,168313200,4.186982561512388
Becker,11404337,1.8814700373648592
TE-14,9825149,2.4662096098050754
LMSU,72193861,3.006947657487573
LMSU,11404337,0.046862413597458
LMSU,44185566,3.2605987232959035
MIA PaCa-2,54596558,4.174983268743628
SNU-216,decitabine-navitoclax (2-1 mol-mol),2.181603295226871
MIA PaCa-2,3081361,1.8008604148856877
ChaGo-K-1,11507802,1.056587148436248
SNU-216,44185566,2.8284110720577944
NCI-H196,piperlongumine-MST-312 (1-1 mol-mol),1.4023349702680732
Karpas-422,44493528,4.27188958418413
Panc 02.03,73707398,1.687012904299387
BT 286,serdemetan-SCH-529074 (1-1 mol-mol),1.5009672883066811
SK-MEL-5,1750826,1.6566055402218314
Hs 611.T,10184653,0.97935180213632
RKN,676352,2.5860960344205175
GOS-3,2113511,5.9542710024554
MIA PaCa-2,11977753,-1.247147741906793
LXF 289,11640390,5.398484732926136
NCI-H1339,446155,2.168467694487421
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561
YD-8,400769,-0.3423435574112426
BFTC-909,60700,0.4554202898414442
BT 286,44607531,1.3385588713906706
Namalwa,6917907,-5.8599003249265555
H-STS,216345,2.2143657283557854
KYSE-180,969516,2.4529447975335117
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
CML-T1,4259181,-0.9247208790621684
SK-MEL-5,31703,-0.2732129481584813
Kasumi-2,56649450,1.224051068091054
BT 286,24856436,1.1067701612857763
NCI-N87,6918837,-4.459129390963203
AsPC-1,3689413,-2.062701377390924
Namalwa,19582717,2.3448185040183622
EHEB,135398516,1.2491473291998236
NCI-H2030,216345,4.536107937609808
SK-MEL-5,25262965,-1.2315424629364211
NCI-H209,3384730,2.626651922378795
RKO,23725625,3.9986828157613616
HOP-62,56946209,-2.0884661212322317
NOMO-1,2729026,1.9247353379999697
OAW28,9935249,3.684332158484572
HOP-62,31703,-0.8503417724593266
Lu-65,selumetinib-BRD-A02303741 (4-1 mol-mol),0.2536220160137153
KMS-12-BM,71466578,1.9338301399273083
KE-39,2126,5.971386354859058
BT 112,60750,-4.243293157722899
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
KO52,11485656,1.6797102251271416
BT 328,9935249,3.0923830009934843
OAW28,51039095,2.7471743585791075
NCI-N87,322968,2.9452063604799417
HuT 78,11656518,1.0208848045852064
SNU-119,16741245,5.112197771644654
HOP-62,24797083,1.208432344733137
SK-UT-1,6918736,0.0102936907283031
AsPC-1,54618771,1.0442216511349782
KO52,10296883,3.770873498157397
NCI-H929,9926054,0.4409605375156073
PF-382,637858,0.850873658302796
NCI-H929,135421197,1.062377968485951
ChaGo-K-1,11178236,-3.285468505296693
ChaGo-K-1,3634881,3.518956616921623
H-STS,SNX-2112-bortezomib (250-1 mol-mol),-2.995018705819844
TE-14,11234052,5.269902194419078
AsPC-1,6852167,3.622461858977091
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
AsPC-1,3503,2.1995832473977157
RKO,19582717,4.345992572306107
SNU-216,71751553,4.1520368918370965
ChaGo-K-1,ISOX-bortezomib (250-1 mol-mol),0.189557717286372
ACC-MESO-1,53232,2.123309987866441
KMRC-20,44185566,2.4119459095392215
Becker,135875424,4.35709039626534
MIA PaCa-2,5738263,2.6368998007843456
TE-14,selumetinib-JQ-1 (4-1 mol-mol),0.562522938991472
YD-8,54678924,2.5377672134217435
RT-4,52947716,0.9303091042236448
SNU-213,24785538,1.9191054152787268
PE/CA-PJ41 (clone D2),46398810,3.7550130580304697
Namalwa,11238147,1.4159052686917426
BT 286,UNC0638-navitoclax (1-1 mol-mol),1.4427957482860168
TE-14,439501,-3.001573063863178
RT-4,176870,3.685175817332376
RT-4,5278396,3.4020225081996744
B-CPAP,8515,3.305571052734727
MJ,doxorubicin-navitoclax (2-1 mol-mol),-3.4914578181494007
NCI-N87,51039095,3.189774410902983
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
BT 328,107970,2.1571810870296333
RKN,613753,3.037549827357118
CML-T1,31703,-3.375342626899218
Hs 611.T,1242560,4.168507953483356
BT 320,969516,5.171798432399237
LXF 289,navitoclax-gemcitabine (1-1 mol-mol),-0.2472011757618401
SNU-423,6918638,0.4106402962761268
RT-4,1242560,3.444710229960461
Lu-65,JQ-1-vorinostat (2-1 mol-mol),1.3673322876667977
OAW28,10302451,2.68651474445359
OE33,219104,2.3175757982951932
SK-UT-1,71751553,5.981983562576585
KYSE-180,441298,2.642638918815539
RT-4,44185566,2.540534847490806
HuT 78,426756,2.038203464685228
KO52,6610355,3.452775078666614
Lu-65,89183176,5.539944953304831
SW1783,16659841,3.197521836887965
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
OE33,104842,-1.0297306276566784
SK-MEL-5,11222830,1.7200317816996988
KMRC-20,44607531,1.5618763783818437
RT-4,452548,0.6609517448162834
Namalwa,5351362,0.7383034640998063
SNU-213,44819697,-0.0885228429048293
L3.3,400769,-0.1977482396353321
L3.3,613753,4.077511547969464
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
KO52,5460769,4.4327211318187745
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
TE-14,135984461,4.3356196573929
B-CPAP,322968,4.123801708547431
SNU-1077,24180719,3.4105724970727302
KYSE-180,4259181,-2.278337111185809
KMS-12-BM,44202524,0.8101877803602248
Karpas-422,16013152,4.291888200698237
WM793,25062766,2.181773031529765
IST-Mes1,637858,2.1376990366589905
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
KYSE-450,49793307,-1.8889821153375816
SK-UT-1,10074640,3.5856267596228713
NCI-H196,3503,2.7199080939505427
H-STS,65064,3.392920845714817
NOMO-1,11497983,-3.443590431300748
BFTC-909,9866186,1.150003196853964
HCC2108,5282054,3.0861306329764964
HSC-3,246676,5.897694948115853
PE/CA-PJ41 (clone D2),5284616,3.399079248697445
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
B-CPAP,123631,2.319451820706569
SW1783,6610355,5.017799798077197
Ri-1,637858,0.8978114122705031
SK-MEL-5,71466445,2.1269711311282373
RKO,1566236,3.4833841973625725
SK-MEL-5,71304818,2.344029822810695
PF-382,135398738,1.569926041171407
ACC-MESO-1,702558,5.575552464926079
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
HOP-62,135659046,3.835086594204883
SNU-119,82146,3.4402803249569964
KMRC-20,54618771,1.1098897337437623
Lu-65,46926350,-4.186313662197296
NCI-H1339,135875424,4.767141568633495
Ri-1,16722836,-0.0556472902275583
AsPC-1,11364421,-1.021042778985214
Karpas-422,doxorubicin-navitoclax (2-1 mol-mol),-1.5981473164277809
NCI-H1339,selumetinib-JQ-1 (4-1 mol-mol),2.2666299614605143
KYSE-180,638278,3.4681101119910243
Lu-65,15547703,2.7015957132035235
GOS-3,serdemetan-SCH-529074 (1-1 mol-mol),2.2992374685315533
SNU-213,serdemetan-SCH-529074 (1-1 mol-mol),2.3489182261592396
LMSU,3552672,1.9414918603747835
HOP-62,3025944,4.708754552283396
Karpas-422,selumetinib-piperlongumine (8-1 mol-mol),2.6929607327143468
ChaGo-K-1,444795,4.90712509154543
WM793,68056272,3.787649254718563
HCC2108,25183872,1.312487478805732
Panc 02.03,24964624,3.328827283539013
NCI-N87,46191454,1.700307220457573
BT 320,44486219,4.486546687955142
HOP-62,tanespimycin-gemcitabine (1-1 mol-mol),-1.4683521467310283
ChaGo-K-1,56649450,3.184271746518033
NCI-N87,387447,-5.408237770865747
KE-39,54596558,4.365324822394714
HOP-62,11238147,2.977850239032067
NOMO-1,46215462,1.6253213091786816
ChaGo-K-1,24775005,3.8919444347065344
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
LMSU,4477,0.3546299550753337
YD-8,4096211,2.9365859982689315
BT 328,selumetinib-navitoclax (8-1 mol-mol),1.1111417470564258
Kasumi-2,44185566,0.8464196954941686
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
L3.3,3081361,5.558675862138055
ChaGo-K-1,1566236,2.038584840253616
ChaGo-K-1,5329102,2.841007298547535
Lu-65,3689413,-0.1410308041132627
KMS-12-BM,25102847,2.517658940945127
SF295,2749,2.7004315966238757
HEC-108,10302451,3.916028655528669
B-CPAP,11178236,-2.8753118537912226
KE-39,5287620,-2.6517518735784495
HCC2108,6505803,-0.7557590797286265
NCI-H1339,176870,5.0790709272100285
RKN,11507802,1.1392194525963166
SF539,11228183,3.1050293541734475
CML-T1,7326481,2.1414014754107735
MIA PaCa-2,613753,3.093440383606966
BT 112,6610216,4.1837874586497765
MIA PaCa-2,5351362,1.024245072191309
PF-382,445455,3.8799836217704664
Becker,10074640,3.78121889041583
KMS-12-BM,6918289,1.1845429294568763
TE-14,72376,-1.758934357423353
BT 498,44607530,1.702028923848098
SNU-1077,23635314,3.6537158971816392
TE-14,44491742,4.678720015809428
KMRC-20,2749,2.7463667580182816
ACC-MESO-1,24753719,6.460305862241897
SF539,BRD9876-MK-1775 (4-1 mol-mol),-0.024962409910424
LMSU,4378219,1.9748882526366265
Namalwa,24753719,3.8228113675826063
NCI-H929,4788,5.842901865932074
Hep 3B2.1-7,BRD-K13185470,4.484971730521959
SNU-119,57330099,4.379346087111643
RKO,11640390,5.295981617059328
KE-39,24785538,4.0612751994912335
BT 328,71304818,3.21596633578744
KO52,SNX-2112-bortezomib (250-1 mol-mol),-0.6640872675170002
Hs 611.T,9444,3.2553177810802048
TE 441.T,66577038,2.551752209338962
HuT 78,56649450,2.503642191453737
HEC-108,12001922,1.836445664605824
WM793,11609586,2.945181998270863
HOP-62,54618305,4.329207399796136
IST-Mes1,10113978,3.525341044523829
Ri-1,71680916,3.540235110410058
ESS-1,168312962,3.040527705732362
AsPC-1,2742550,5.133078791264603
Lu-65,54613361,0.2288955023122638
L3.3,10410894,2.582309203973784
KMRC-20,44493528,4.509843443263092
Hs 611.T,selumetinib-UNC0638 (4-1 mol-mol),2.0633053659958387
ChaGo-K-1,53232,4.008670122627816
KYSE-450,16722836,3.1649590100923732
Lu-65,322968,4.84113499629306
Ri-1,73707398,0.2154037021026328
JHUEM-7,navitoclax-sorafenib (1-1 mol-mol),1.8815532041113092
AsPC-1,11404337,0.3809720735493328
Hs 611.T,5284616,-6.061980923687256
RERF-LC-MS,1242560,3.610791422912421
ChaGo-K-1,9911830,2.4299534095194084
RERF-LC-MS,4096211,1.8582313750529689
H-STS,6918837,-3.5766968439685662
MIA PaCa-2,26596,-1.1158295610303952
BT 286,11222830,1.070248725926738
KLE,3025944,3.8646829194893546
AU565,219104,2.449004695507307
EHEB,26596,-2.0876334457911727
YD-38,15983966,-3.779713141534824
KYSE-180,31703,-0.5178877164646636
KO52,25183872,-2.4696387093627807
KMS-12-BM,9935249,1.0143045497874623
KE-39,421610,5.566154561454864
LMSU,65628,4.981021352317802
SF539,2945648,2.8527116162154353
KE-39,9825149,1.9410582316331728
IST-Mes1,24180125,3.710624760267412
AsPC-1,2871966,-0.1237405253519755
TE 441.T,9911830,2.062678121502997
KMRC-20,9936388,1.9781775187030703
SK-UT-1,216468,3.1165109524206676
Karpas-422,51037431,4.098391545359284
Ri-1,54454,5.695791954111341
PE/CA-PJ41 (clone D2),126941,-0.78713258555783
HCC2108,4261,0.8119370263303683
RERF-LC-MS,1641662,3.403538628142178
Namalwa,53232,2.2331592104894917
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
IST-Mes1,216345,3.619183672475448
OE33,11494412,2.705114225479706
SNU-423,5282054,4.220806432863004
SNU-216,5287620,-2.2856125915273067
Ri-1,387447,-5.205370002845584
SK-UT-1,46174525,5.191035054740717
SK-MEL-28,400769,0.2291963522634262
H-STS,10410894,3.204211008569323
RERF-LC-MS,1716436,4.437154842045929
BT 286,24821094,3.0634317138315756
Hs 611.T,44137675,1.8104045902610284
SK-MEL-5,navitoclax-MST-312 (1-1 mol-mol),1.0759478439480712
SF539,5284373,2.3802646906930485
Ri-1,3062316,-4.680369659310852
LMSU,445455,5.438135882086382
KO52,11960529,4.1257752289583225
NCI-H196,6852167,3.0057734574295765
LXF 289,2858523,3.038787864461457
HEC-108,72193861,0.4949264975227585
KMS-12-BM,568763,0.1321382887617515
BT 286,navitoclax-piperlongumine (1-1 mol-mol),1.4762165911418568
TE-14,25161177,4.28175027465073
HSC-3,52912189,2.1489213461057424
H-STS,selumetinib-tretinoin (2-1 mol-mol),4.002593719006082
HuT 78,122327,5.365599791501648
KMS-12-BM,54613361,-2.0656544481167085
TE 441.T,4917,2.892871092151233
Namalwa,2828334,5.967356000456756
CML-T1,5311,-0.0657355385312412
ChaGo-K-1,10127622,5.691652618871857
SNU-119,421610,2.8611579206364315
HOP-62,erlotinib-PLX-4032 (2-1 mol-mol),3.2366767860483145
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857
PF-382,60700,-3.3166709344214342
NCI-N87,9936388,-5.070095106907016
NCI-H1339,5287620,-3.928120713935858
WM793,216345,3.0524169144377615
MIA PaCa-2,11955716,-2.798852632916128
NCI-H1339,135411,0.7339446872015564
KMRC-20,216345,4.461604453697398
AU565,53495165,0.1395352595616783
KYSE-180,656346,0.5035259214869502
ACC-MESO-1,445643,4.1355040989789025
KO52,123631,3.1226138864158903
Hs 611.T,53392493,1.8410371016257832
AsPC-1,123631,3.3144447888973048
OE33,11404337,0.6160671156841868
SK-MEL-5,6623618,1.9915835426594244
NCI-H196,navitoclax-piperlongumine (1-1 mol-mol),2.767680054960315
TE 441.T,11494412,0.8893803866671172
Hs 611.T,11152667,-4.000300813330283
BT 328,5282054,4.480246853772489
NCI-H929,44259,-0.1109306277503226
Ri-1,46843906,1.47284812548098
KLE,11214940,0.7817459379434555
SF539,72734382,5.710474447466601
BT 320,9549297,2.275077325933936
Hep 3B2.1-7,6914657,-4.207104834520046
LXF 289,3689413,0.4542816941401804
SNU-423,135398516,1.3477258713042957
SNU-213,56946209,-3.0832917036517475
NCI-N87,9952709,5.048469263792704
KE-39,24775005,3.7793317686622903
PF-382,4915,5.4300848417035725
SF295,25062766,1.8265353330761955
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
NCI-N87,3815108,3.1427265495234513
SW1783,BRD-A02303741-carboplatin (1-1 mol-mol),4.341275119932719
IST-Mes1,11364421,-1.7965673619245748
HSC-3,107970,2.329842902304128
MIA PaCa-2,135999136,4.438724153803844
OAW28,68056272,3.642995313586114
KMS-12-BM,10427712,2.780946081565878
Hs 611.T,2871966,-2.368490368475895
BT 112,56963564,-0.0795668388707357
SNU-216,3689413,1.0802163076061988
PF-382,9907093,3.754844367394135
Karpas-422,24180125,1.2333390816210612
SK-UT-1,56963564,2.7705405230221967
TE-14,72734382,4.5399953302309735
ChaGo-K-1,11612883,3.1360501741625484
BT 286,25102847,2.006913594269484
HuT 78,5494449,0.26098093907273
BT 498,400769,-0.381234378827963
NCI-H1339,9935249,3.107250994389658
ESS-1,10296883,4.371449070908232
KLE,675434,4.244667851386391
Hs 611.T,119182,-1.580209779636656
Karpas-422,5328940,1.907258053285574
KO52,19582717,4.02566372539437
PE/CA-PJ41 (clone D2),6917907,-5.703070030958968
BT 498,5738263,3.648812853075705
B-CPAP,104842,-3.0909198505111144
YD-38,11175137,3.1873863961797233
CML-T1,9911830,-1.528510322337235
NCI-H1339,SNX-2112-bortezomib (250-1 mol-mol),-2.3734966856408883
OAW28,12001922,1.8847589611064504
AsPC-1,71304818,2.27524368423619
SNU-423,67156097,-0.5877978282373478
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009
TE 441.T,25150857,0.8690399659770709
BT 328,11404337,1.5843001055688009
Mono-Mac-1,6610216,3.235922016233304
WM793,3825829,4.563508127916012
RT-4,44137675,4.764559708105059
BFTC-909,15547703,3.647732910564925
SK-MEL-5,44491742,4.058095878540579
SNU-216,BRD-A02303741-navitoclax (2-1 mol-mol),3.1738229754094496
RKN,11396600,3.670395083293249
BT 286,2842253,6.302891068687999
TE 441.T,11234052,4.2146720804176265
CML-T1,654092,-1.9909155078044125
KLE,439501,-2.1797784747958477
IST-Mes1,126941,-2.6873860553959754
NCI-H2030,24785538,3.3209864186545377
SW1783,66577038,3.5105114202230396
PF-382,selumetinib-BRD-A02303741 (4-1 mol-mol),5.510058878321319
Lu-65,6505803,-2.14133792645673
Mono-Mac-1,11234052,4.576402418208917
NCI-H929,44819697,-1.4685499411762664
SF539,25126798,3.558928885650203
YD-8,676352,2.488164336749702
KYSE-180,400769,-0.4834890789520504
MJ,52912189,1.9135725109340456
SF539,24180125,3.915045335194428
Kasumi-2,5738263,2.363328574896373
SNU-1077,3503,2.435554549347499
WM793,44493528,4.356787444460569
SK-MEL-5,107985,-2.7442566338787473
HOP-62,4917,2.990342105399023
SNU-213,9967941,3.2264836336541767
HCC2108,89928392,0.7050545298033302
PF-382,serdemetan-SCH-529074 (1-1 mol-mol),1.5995010454222542
Lu-65,16659841,4.400532062307719
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
KE-39,11964036,1.1014936748281658
KE-39,168312962,1.831477708522254
TE 441.T,23635314,3.6399625079566778
NCI-H196,5311,1.2798513187769205
ChaGo-K-1,navitoclax-birinapant (1-1 mol-mol),3.1686613266141013
BT 328,9911463,3.726223215474182
WM793,241158,3.83369214528036
NCI-H1339,3025986,-0.7108239777279446
Kasumi-2,navitoclax-sorafenib (1-1 mol-mol),-1.696804912117395
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505
HCC2108,65064,5.202771624484401
SK-MEL-5,11485656,3.020253832456298
KLE,68056272,3.842115579712106
HOP-62,984333,0.4675048788051116
Kasumi-2,25183872,-1.7482434423211834
KO52,11964036,1.6912487507512317
HSC-3,SNX-2112-bortezomib (250-1 mol-mol),-2.001735081038066
BT 112,71304818,2.5450175334418987
EHEB,49850262,3.0589099968114986
SW1783,5328940,3.054752986364744
H-STS,10302451,3.908664464224374
PE/CA-PJ41 (clone D2),9933475,2.0891360136562644
AU565,52947716,0.8422274137680903
NOMO-1,36314,1.6795260413615891
MIA PaCa-2,selumetinib-UNC0638 (4-1 mol-mol),1.630767658500955
PE/CA-PJ41 (clone D2),46199207,3.5307806574812046
SK-MEL-5,984333,1.0316499260206258
Panc 02.03,7251185,3.0530850004567767
YD-38,selumetinib-MK-2206 (8-1 mol-mol),1.040437108024878
Hep 3B2.1-7,9903786,2.792162090587101
SF295,124202324,3.278195850827405
KYSE-180,46398810,2.9758827771155003
MIA PaCa-2,6918328,-0.7045799700299202
JHUEM-7,25154868,5.093350914915029
H-STS,31703,-3.181617009980154
OAW28,24951314,0.5571772807313425
BT 320,42642645,3.0201339489728563
YD-38,navitoclax-gemcitabine (1-1 mol-mol),-1.376406906038253
SK-MEL-28,119607,5.84656156074382
B-CPAP,11626560,1.847886697389426
SNU-119,9927531,4.042335314323924
HOP-62,9866186,0.6362395623867438
IST-Mes1,262093,3.164571948045499
IST-Mes1,JQ-1-vorinostat (2-1 mol-mol),0.3770936853030046
WM793,44607530,2.440109588672552
ChaGo-K-1,3062316,2.2658461036316213
Namalwa,148198,-5.5603375502023
Namalwa,9927531,3.1365070733929663
IST-Mes1,JQ-1-MK-0752 (1-1 mol-mol),2.655505520266403
SNU-1077,72376,3.5182408095269073
AU565,4477,0.8975719043136093
KLE,navitoclax-birinapant (1-1 mol-mol),-3.2783800505738956
LXF 289,135398744,6.087135496005038
NCI-H1339,9549297,3.877142055462748
KE-39,9868037,3.621529869698051
KYSE-450,5287969,-1.404660564702432
CML-T1,135398738,1.6792363237461696
EHEB,3136844,4.591447211361851
HuT 78,9952709,1.8932187114351076
Kasumi-2,2842253,5.767696299842194
AU565,44462760,4.31661778136252
SK-UT-1,219104,4.058043606422707
BT 286,426756,1.913868896716008
OAW28,46199207,3.397949359639469
IST-Mes1,446155,1.803889787209672
KE-39,25183872,0.9093858643796752
ChaGo-K-1,53495165,-1.145661881311857
ACC-MESO-1,159324,5.7222118158510344
KE-39,6184667,4.527415561727204
SK-MEL-5,2828334,5.833391997776046
BT 286,9868037,4.125737289056318
Ri-1,11404337,-1.810959317313917
BT 320,SNX-2112-bortezomib (250-1 mol-mol),1.4191259031936097
MJ,5470400,1.1074139352068628
BT 286,navitoclax-gemcitabine (1-1 mol-mol),-3.19115614959178
KMRC-20,5566,3.02131820134641
YD-38,10427712,4.8867086879497545
PF-382,135984461,1.6582229573318208
KMS-12-BM,9911463,2.0749809508981256
AU565,11497983,3.5183187315924185
PF-382,5746,-0.5974019482348806
MJ,6918638,-0.2004138762975409
CML-T1,selumetinib-navitoclax (8-1 mol-mol),1.8946920670328231
B-CPAP,16722836,1.2819939562752407
SNU-119,selumetinib-BRD-A02303741 (4-1 mol-mol),5.373099730339768
YD-8,24180125,3.6955333195671938
Mono-Mac-1,5281321,-2.6672170422542507
HEC-108,9911830,3.642303707567872
SNU-213,9825149,1.6899494716129702
PF-382,15547703,2.5313681976208056
ChaGo-K-1,11626560,2.009486144157491
BT 328,1566236,2.4214904059930156
BT 328,168313200,2.3539430397400523
RT-4,11609586,3.0565970282052475
NCI-H196,156414,2.0892379474459037
LMSU,9866186,2.2286939019864813
SF295,SNX-2112-bortezomib (250-1 mol-mol),-1.0029952457856188
NCI-H1339,selumetinib-PLX-4032 (8-1 mol-mol),4.614004496430995
BT 286,322968,3.816277861601749
PF-382,5113032,5.313987207149933
OE33,JQ-1-MK-0752 (1-1 mol-mol),0.4290491817441692
KE-39,9935249,3.082096285966509
HCC2108,126941,-1.9407933202051555
KMS-12-BM,11507802,0.0118265671826585
EHEB,46174525,4.557834321859672
GOS-3,5282054,3.980081801292934
SF539,122327,5.038371430182477
BT 112,11626560,1.4312107958608666
SNU-119,9444,4.392660959332783
EHEB,374536,2.309110674045564
NOMO-1,16065773,2.6012917178973405
KO52,72734382,3.7619867854642663
KMS-12-BM,tretinoin-carboplatin (2-1 mol-mol),1.5291573634197104
KO52,11719255,2.53220812210846
TE-14,262093,3.712272001874861
KMS-12-BM,54678924,0.980772180306658
Karpas-422,613753,2.8960805608319244
NCI-H929,4917,2.9629665385410227
Hep 3B2.1-7,carboplatin-etoposide (40-17 mol-mol),3.715246114743024
BT 112,3634881,1.0045650301958045
TE-14,25126798,3.739030053617067
RKO,5746,2.147448518007633
PE/CA-PJ41 (clone D2),navitoclax-pluripotin (1-1 mol-mol),-0.5987061323431718
KLE,168313047,2.8113927253020203
IST-Mes1,navitoclax-piperlongumine (1-1 mol-mol),2.2991023643561115
NCI-H929,5284329,5.087247954769154
NCI-H2030,73707398,1.6875070689591785
PE/CA-PJ41 (clone D2),11455910,-0.0174306689930347
HSC-3,44489367,4.725999442167047
BT 286,568763,-0.0474884133388832
TE 441.T,25126798,3.702297594434671
CML-T1,9956119,2.073633266475815
IST-Mes1,10184653,1.5276072056435492
KMS-12-BM,44486219,2.8899607356045443
SK-MEL-5,25126798,4.177648861488895
KE-39,ISOX-bortezomib (250-1 mol-mol),0.8981560210811207
Ri-1,159324,0.7122942359336857
BT 328,16038120,0.9793977548017024
TE 441.T,11404337,-0.8068289898007032
EHEB,216345,1.2200668921328206
L3.3,44202524,1.4046743198353957
NCI-H2030,9911463,4.399921690700774
H-STS,71680916,3.817960068109933
EHEB,2858523,2.936982583884496
SNU-216,11494412,1.6343036804588515
YD-38,11625818,3.4273815897822817
NCI-H1339,46224516,4.957875644044714
BT 286,409805,3.8987037297039056
PE/CA-PJ41 (clone D2),10385095,0.9808392410745812
WM793,123631,2.8618988617204253
PF-382,3011155,1.384120809938285
HOP-62,5329102,1.983120425869131
KE-39,107970,2.31854003043047
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
Hep 3B2.1-7,10184653,2.312706900660966
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
AsPC-1,9911463,3.4970941612274693
CML-T1,alisertib-navitoclax (2-1 mol-mol),-1.6309921665617133
HuT 78,6450551,0.5524678941583652
SNU-216,3854666,1.5615804262646893
BT 286,24772860,-2.7013383956612684
Namalwa,3825829,3.564454365962588
HSC-3,15983966,0.0470426194362112
KE-39,9908783,5.748750979730715
BT 498,107970,2.860609306082874
Namalwa,JQ-1-navitoclax (2-1 mol-mol),-0.9649533324047836
HSC-3,doxorubicin-navitoclax (2-1 mol-mol),-0.4787085696617523
GOS-3,216239,2.237593713178657
ESS-1,decitabine-carboplatin (1-1 mol-mol),5.337587299103004
ChaGo-K-1,25062766,2.5286145290937903
RT-4,6252,2.4296681174551664
RKO,11404337,-0.3534280477619294
BT 286,89928392,0.4676933846077264
OAW28,10427712,4.195688642509306
PF-382,8515,3.0389731440801224
PF-382,11964036,0.0769506444989081
NCI-H929,135999136,4.255812797167961
YD-38,17759555,2.700828571888378
SK-UT-1,9911830,2.8726761747893756
BT 112,262093,1.8523945417932268
ACC-MESO-1,5328940,1.919032168884594
H-STS,46199207,2.757122877037558
Karpas-422,selumetinib-PLX-4032 (8-1 mol-mol),5.101056087927793
KMRC-20,9926054,2.16526453404653
Panc 02.03,16065773,3.1661848504472023
KMRC-20,10302451,3.571501385736242
ESS-1,753704,4.74318722205844
WM793,24951314,1.9814754728046269
B-CPAP,1750826,-3.823823351631485
BT 328,262093,2.379096363022233
SNU-423,65064,5.2614156203806735
KO52,11494412,-1.6308846276697513
BT 286,salermide-PLX-4032 (12-1 mol-mol),4.140353758250688
OAW28,6610355,6.153508691776863
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
SW1783,54619267,3.631106969239044
HEC-108,ISOX-bortezomib (250-1 mol-mol),0.3460694218807578
KYSE-450,2828334,6.299741287777087
Lu-65,erlotinib-PLX-4032 (2-1 mol-mol),3.032800279318878
Ri-1,11647372,-5.7202974695301805
YD-8,168312962,3.8254536486741
Mono-Mac-1,322968,2.235320264259914
ChaGo-K-1,44185566,2.9413507138853943
Lu-65,11964036,2.1963927399033376
Ri-1,selumetinib-decitabine (4-1 mol-mol),1.4786911056222252
H-STS,135875424,3.212810522479317
NCI-H929,168313047,1.9193676847223529
Ri-1,676352,1.7475794658703674
ChaGo-K-1,107970,1.9284648709268049
OAW28,168313047,2.064989846569142
MIA PaCa-2,doxorubicin-navitoclax (2-1 mol-mol),-2.304183042067753
KE-39,2949965,4.248558977491982
SNU-423,3825829,4.083312388937309
KYSE-180,selumetinib-JQ-1 (4-1 mol-mol),4.706272098527088
Hep 3B2.1-7,3815108,3.427138188438471
AsPC-1,11396600,3.3240147605355506
H-STS,2113511,5.446449899751943
HCC2108,selumetinib-MK-2206 (8-1 mol-mol),3.375677921262827
SNU-119,122327,4.167274545692746
TE 441.T,60700,-2.323903916183343
SK-MEL-28,selumetinib-MK-2206 (8-1 mol-mol),1.0745935629977668
BT 328,5329102,2.931007183375298
Karpas-422,11485656,3.579952167071255
Kasumi-2,11364421,-5.792134203695654
NCI-H196,409805,4.55561469724075
NCI-H196,2729026,3.1386730408201187
SK-UT-1,2874250,6.155994559300563
EHEB,44632017,1.189004229648695
IST-Mes1,44632017,4.619480314320218
Namalwa,25150857,1.9088019645088363
YD-8,46398810,2.5554282020008094
PE/CA-PJ41 (clone D2),53392493,3.504289946236342
AsPC-1,56946209,-4.100794030874608
PE/CA-PJ41 (clone D2),46224516,2.950334969022111
TE-14,4705,1.5857323028822543
NCI-H1339,9907093,4.242858415135094
Kasumi-2,6450551,0.5816635943537883
KE-39,2858523,2.690923627236344
Hep 3B2.1-7,23725625,5.5559924316278435
BT 248,135421197,1.5349499708791383
NCI-H1339,2749,2.6760815783008787
SNU-1077,4917,3.55336300375808
OE33,24821094,3.54635565995629
MJ,25183872,-3.3306106480928683
L3.3,67156097,-1.9530361511710264
NCI-H209,4261,0.8103975012989882
TE 441.T,11657048,4.303158298953813
Kasumi-2,54454,5.727506476700654
MIA PaCa-2,25126798,3.924004652513405
EHEB,JQ-1-vorinostat (2-1 mol-mol),0.2631441629277845
Lu-65,4788,5.124191932628282
SF539,9956119,2.7951996654139664
TE-14,3689413,2.902593123647125
OAW28,675434,4.444033298399729
AsPC-1,5479543,3.7451312348556582
Kasumi-2,25062766,0.6905738640208902
SNU-1077,5328940,2.132939036215286
HuT 78,6252,0.7757631208196515
KMS-12-BM,16065773,1.4565661119909743
SNU-886,44137675,2.6120412235311856
BT 248,15983966,1.8194061419836256
SW1783,445091,3.700343726063664
KLE,107985,-4.625155684647364
SNU-213,5746,2.024805354713622
WM793,11178236,-2.656687439817939
RKN,11364421,-3.590581417405073
NCI-H1339,45279963,4.172949640647973
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507
JHUEM-7,11626560,1.4043790745396552
HuT 78,6917907,-7.494534936281525
CML-T1,navitoclax-sorafenib (1-1 mol-mol),0.8856526530243491
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
NOMO-1,23582824,0.0799476906959343
SNU-213,135398516,0.0152388717051578
HOP-62,10231331,1.3709968490270463
RERF-LC-MS,9908783,5.63449812951243
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
Karpas-422,89928392,0.7937418388010543
NCI-N87,3854666,1.2679317332294615
Mono-Mac-1,49766530,-2.16205133655403
MIA PaCa-2,vorinostat-navitoclax (4-1 mol-mol),1.0493649363864128
PF-382,11656518,1.6205835275243787
IST-Mes1,123631,3.330483874726673
SF295,54649381,4.030819741798211
WM793,24785538,4.089053013969586
TE-14,104842,-2.7863717541611597
BT 328,navitoclax-gemcitabine (1-1 mol-mol),1.6667788304977649
AsPC-1,9935249,3.639166614114404
ESS-1,vorinostat-navitoclax (4-1 mol-mol),0.8107114414663552
Namalwa,25183872,-2.048735574706111
YD-38,selumetinib-piperlongumine (8-1 mol-mol),1.5896132857534184
BT 328,52947716,2.920977634750811
KYSE-450,676352,2.3888034274358536
BT 328,BRD-K55473186,3.4747994390176027
Mono-Mac-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.310124768965731
Karpas-422,16722836,0.9584493031420234
AU565,446155,4.298434988536317
Ri-1,navitoclax-gemcitabine (1-1 mol-mol),-5.665001564745378
ESS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.6491539318106514
SF539,docetaxel-tanespimycin (2-1 mol-mol),-4.4379333242133
KYSE-180,3062316,1.1998242220985431
HCC2108,carboplatin-etoposide (40-17 mol-mol),4.105964444699461
SNU-119,6917907,-5.873983095672985
AU565,23635314,-4.115690790244737
ESS-1,4705,3.449305158476875
RT-4,448949,1.759750827005002
PE/CA-PJ41 (clone D2),56973724,5.008283021237775
GOS-3,135421197,1.697146176044067
RT-4,5978,-0.8712015854260087
AsPC-1,9952709,5.897814669584309
CML-T1,126941,-3.100237153288417
HEC-108,51037431,2.239611554360474
SNU-886,11647372,1.0041621658196034
SF295,11214940,1.0789191404244332
KLE,421610,3.1712689131891074
EHEB,9868037,2.9297052804513934
RT-4,44607530,3.804226542421099
Mono-Mac-1,89928392,-0.1187995872067037
TE 441.T,119182,-1.0590771583172296
Ri-1,5280436,1.738295922392693
CML-T1,16741245,3.55536863016822
Ri-1,119607,3.524560001231187
Panc 02.03,16725315,5.289216895099664
Hs 611.T,3025944,3.853000998701116
RERF-LC-MS,73707371,5.9060077591992375
RKO,2113511,4.623772297498578
BT 328,44607530,2.310615312338521
LMSU,6918328,1.1714083340130723
Hs 611.T,16659841,3.0693508217497936
B-CPAP,11497983,6.291424169078015
Ri-1,60750,-4.598583451004258
Mono-Mac-1,49867926,4.920962083206566
KE-39,400769,-0.5095886152507402
RERF-LC-MS,9933475,2.253072026550434
BT 328,46224516,3.135960011776331
KMS-12-BM,1566236,0.5726482736694104
MIA PaCa-2,123631,3.2782041554498944
YD-8,3543504,4.346865658912418
KYSE-450,5311,3.212765544074189
SNU-216,11977753,-2.621089063571139
SF539,4477,-0.2990330117959373
AU565,9911463,3.1332064122278687
Hep 3B2.1-7,15953870,2.3473696237911175
ESS-1,322968,2.8286903155082137
KE-39,5738263,4.084504768293086
KMS-12-BM,tretinoin-navitoclax (4-1 mol-mol),-1.130622835397235
Kasumi-2,5460769,1.467216518279754
Panc 02.03,10074640,3.562403354758929
Namalwa,216345,4.441431133973052
MIA PaCa-2,9866186,0.7636785286436597
EHEB,135875424,3.250653126047009
KE-39,3465537,4.350124533164427
Karpas-422,11364421,-4.613053554314196
SNU-1077,675434,5.370968264478288
ACC-MESO-1,piperlongumine-MST-312 (1-1 mol-mol),2.5356121721724354
BT 112,135440466,3.4260770877758207
RT-4,5282054,3.801249889065471
ChaGo-K-1,3689413,-1.075301905965469
RERF-LC-MS,4521392,4.229663793191115
RERF-LC-MS,10427712,4.250983789220692
Hep 3B2.1-7,637858,2.0545585773513517
RKO,54678924,1.753529637740366
RERF-LC-MS,54596558,4.400747096440468
NOMO-1,9911463,3.1879476164010243
HuT 78,9866186,-0.7405908316391746
NCI-H196,11609586,4.6494437662664465
CML-T1,navitoclax-PLX-4032 (1-1 mol-mol),0.956704604832818
AsPC-1,19582717,4.191920632274723
SF539,969516,2.5473257168551666
BT 112,73707398,0.9645515230778364
Hs 611.T,selumetinib-piperlongumine (8-1 mol-mol),2.2399185708917124
SW1783,5566,2.9899549454947305
HEC-108,4259181,0.4931043474853455
Mono-Mac-1,selumetinib-vorinostat (8-1 mol-mol),2.0513617036591323
OE33,25126798,4.081846745518951
HOP-62,selumetinib-MK-2206 (8-1 mol-mol),1.4114337530028662
B-CPAP,9926054,2.1103473685311043
BT 112,7326481,3.170225390322452
BT 286,46926350,-4.263889446024459
NCI-H1339,5738263,3.75824578425613
NOMO-1,54143018,-1.1216489579847602
TE 441.T,753704,4.281731848171136
JHUEM-7,44607531,1.4804103640247843
BT 286,10302451,3.989436421266635
KYSE-180,11427553,3.160880704621236
BT 320,crizotinib-PLX-4032 (2-1 mol-mol),2.9020632961686537
PF-382,navitoclax-sorafenib (1-1 mol-mol),-1.747600817008782
BT 248,6438330,0.9229397913759128
SNU-119,5282054,3.91901589659366
CML-T1,9887053,1.7753443459725933
B-CPAP,salermide-PLX-4032 (12-1 mol-mol),4.772900953481165
CML-T1,serdemetan-SCH-529074 (1-1 mol-mol),0.193373711840136
Ri-1,42642645,-0.2308158770997515
KE-39,11175137,3.362137577301979
PE/CA-PJ41 (clone D2),676352,1.7961404336249642
SNU-1077,24964624,3.288685400990077
CML-T1,327653,2.5732071532781866
JHUEM-7,54619267,3.930692600684294
Ri-1,44507138,0.6592887443998028
NCI-H929,5287620,-2.9527713293437734
YD-38,3025986,-0.8375229391852794
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
GOS-3,5281321,1.1585317053456523
YD-8,vorinostat-carboplatin (1-1 mol-mol),3.421403122872885
MIA PaCa-2,156414,1.6924569137824248
SNU-216,445091,5.253145466035039
RT-4,107985,-3.170589180041932
SK-MEL-28,44607531,2.134976600780572
B-CPAP,2126,3.7809134747205433
TE-14,156414,0.150817369290719
PF-382,25262965,-1.7427075899260709
SK-MEL-5,11178236,-2.684555956133374
SW1573,89928392,2.032641459256584
NCI-N87,44620216,3.650574309449747
TE-14,46174525,4.633748098628278
L3.3,60750,-5.123801682120219
HOP-62,9887053,4.379241554178957
NCI-H929,568763,0.1324523108623163
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
Panc 02.03,104842,-1.6275579890051994
SNU-1077,5311,1.163107558524668
SNU-886,5281321,-2.4775522134293846
AU565,2949965,1.8156290557963255
KYSE-450,1750826,-1.5410905710283038
HuT 78,2749,0.3933024099015727
Hep 3B2.1-7,4261,3.51877017672355
KLE,tretinoin-navitoclax (4-1 mol-mol),0.0197424431924765
HuT 78,9935249,1.327110293574704
KE-39,400769,-0.5095886152507402
YD-38,5329102,2.015856396773705
HEC-108,15983966,2.2350760521339024
SF539,374536,1.1024692735749633
HCC2108,123631,2.550362488689637
HEC-108,25262965,0.7530764000502068
JHUEM-7,107970,1.950560118304485
BT 248,9956119,4.3886748820117925
OAW28,984333,0.3792215902143511
ChaGo-K-1,9903786,4.114689259573735
RKO,216239,1.9979551619375524
WM793,1242560,3.830743442552037
ACC-MESO-1,4259181,0.8154176587876882
RKO,969516,2.537841036798478
Panc 02.03,2729026,3.1511226959620715
KMRC-20,16038120,1.6460192975899484
MIA PaCa-2,carboplatin-etoposide (40-17 mol-mol),2.457685275331116
NCI-N87,71304818,2.1951958800989133
AsPC-1,45279963,4.120012544363151
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245
ESS-1,65064,5.283025860998633
SW1573,54686904,4.039437320121271
BT 328,57519531,5.35390801053985
SK-MEL-28,JQ-1-MK-0752 (1-1 mol-mol),3.9574265003121942
NCI-H1339,4578,5.067713769422355
NCI-H929,11647372,-2.313105757149245
Kasumi-2,753704,4.42700120937948
PF-382,3038522,2.759643282415116
KYSE-450,11626560,3.018886838641868
BT 248,2708,3.971792549478314
SF295,6914657,-4.928801611366654
KYSE-450,1566236,2.943712788473633
Namalwa,10322450,3.877307531453308
HSC-3,11152667,0.7686574426782067
Lu-65,984333,-0.592717922586905
SK-MEL-5,11626560,2.320856597589919
HuT 78,44462760,3.856546411209862
SK-UT-1,11609586,3.614390292326568
MIA PaCa-2,71304818,2.5129056072181113
ChaGo-K-1,navitoclax-sorafenib (1-1 mol-mol),1.7217103067030983
SNU-423,57519531,1.7803888021546357
EHEB,11964036,0.5022634413862269
Panc 02.03,387447,-4.21908064053878
RT-4,2729026,2.8165603599873306
HuT 78,carboplatin-UNC0638 (2-1 mol-mol),1.5408742669191249
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
Namalwa,5280436,1.768996655798306
LXF 289,135398516,1.6034740470130215
KYSE-180,9444,4.788423248663199
LMSU,216239,2.7784961545541216
WM793,65628,5.352978394453619
BT 498,2130404,2.5951087655925043
SNU-119,3825829,3.624299392396196
TE-14,16065773,3.8068226311803457
BFTC-909,4788,5.986704833543041
SNU-216,637858,1.4153180245301518
SNU-1077,selumetinib-UNC0638 (4-1 mol-mol),4.639240284834
BT 112,36462,-0.1329200912201302
Kasumi-2,9903786,1.7296917357536032
HOP-62,71304818,2.773626162825868
ChaGo-K-1,selumetinib-MK-2206 (8-1 mol-mol),4.060516227486996
LMSU,11175137,2.5387478659601324
ChaGo-K-1,10322450,2.8130717345361336
HuT 78,9826308,-1.5248554066187403
SNU-216,11609586,3.629418809049709
JHUEM-7,6252,-0.6838813235058673
KYSE-450,216239,1.9385995729786167
HOP-62,60700,-1.6777236199232357
GOS-3,SNX-2112-bortezomib (250-1 mol-mol),-0.0982198118702868
SNU-886,9926054,2.2284003182480774
AsPC-1,24951314,2.0738112971970275
SNU-1077,51039095,2.124353715617282
SK-MEL-28,262093,2.757579366484628
ESS-1,46174525,4.298251988925839
Lu-65,136227924,3.620246561182502
Becker,72193861,0.1888089388769935
SK-UT-1,navitoclax-gemcitabine (1-1 mol-mol),-2.364824391850715
SK-MEL-5,JQ-1-carboplatin (1-1 mol-mol),5.709362170357264
NOMO-1,6610355,3.932739350210071
JHUEM-7,navitoclax-gemcitabine (1-1 mol-mol),-2.6519969618816877
SK-MEL-5,409805,5.871261975473595
NCI-N87,11683005,3.6426598339920297
Namalwa,66577038,3.005730564471273
H-STS,11455910,0.6438795438543947
BFTC-909,44202524,2.4582417316930916
Ri-1,16038120,0.0455465003903266
RKO,73707398,0.9128481241529548
SNU-1077,selumetinib-tretinoin (2-1 mol-mol),4.583316472072012
KYSE-180,136227924,3.113518519432139
OAW28,439501,-0.9322268226633188
NCI-H1339,49766530,0.922676999768476
SNU-1077,3385,5.110303692270896
Kasumi-2,65628,2.2018759133614987
RERF-LC-MS,136227924,4.560045704487339
NCI-H196,3038522,4.30216886044297
HSC-3,119182,-1.5654598491843
Ri-1,208908,2.1688582057505275
BT 112,119607,5.928336850661068
ESS-1,24856436,-0.1726658691519087
Mono-Mac-1,16725315,4.63798082197868
HuT 78,135423438,1.6811720044411254
TE-14,15983966,-4.6031079614695525
HuT 78,piperlongumine-MST-312 (1-1 mol-mol),0.3660386442956273
KMRC-20,89928392,2.0741009557442487
IST-Mes1,24180719,3.838804357743771
JHUEM-7,2729026,2.278155757312377
BT 112,60700,-2.8896776101219515
SK-UT-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4516773204775215
Hep 3B2.1-7,409805,6.120261984134354
HSC-3,25150857,2.2248636704221476
BT 286,66577038,1.2367598503014738
BT 112,3689413,-2.4519950955667764
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
SNU-1077,135440466,1.2504033920677526
ChaGo-K-1,448949,1.8199000013041025
SNU-423,446155,0.4016067899943888
Becker,1750826,0.1399288732745424
Lu-65,9907093,4.5002962124125245
RERF-LC-MS,54143018,1.1379926617289184
SNU-423,11404337,0.0022687984612849
Kasumi-2,135398516,1.3882982648798712
TE-14,168312962,3.4603256122768355
NCI-N87,2708,3.9537199090854673
NCI-H1339,46199207,3.766066508345173
EHEB,46191454,0.8192064691223043
KO52,374536,-2.868980977087777
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453
RKO,6914657,-2.9196237708628505
RKO,11497983,5.954072388877685
CML-T1,168313047,1.9633067789473095
KMRC-20,76446078,4.8666377437919985
NCI-H1339,carboplatin-UNC0638 (2-1 mol-mol),5.522805054348321
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
KYSE-450,17755052,4.184551596541284
HSC-3,23635314,-1.4139768262692471
SF295,25154868,5.07468348600147
HCC2108,10385095,1.3545455997149978
L3.3,11455910,1.84757483649511
WM793,135875424,3.1604105075223656
SNU-423,24856436,0.8656773751864265
GOS-3,46843906,3.599659815664158
RERF-LC-MS,135984461,4.284403636339015
Hep 3B2.1-7,11485656,2.176020084132011
BT 498,73707398,4.023335284833002
H-STS,selumetinib-MK-2206 (8-1 mol-mol),2.3802158766857935
BT 112,9887053,4.183653051540166
OAW28,11175137,3.6697867992343607
GOS-3,56946209,-4.9562360028209795
SF539,11167602,1.5763974980915605
EHEB,4521392,4.976004028778806
JHUEM-7,448949,1.0789337294372523
Mono-Mac-1,42611257,2.522098896743852
OE33,613753,3.411474615027808
RKO,5291,3.391339544898264
KLE,2828334,4.827132086641668
Lu-65,54143018,1.3160828330251422
BT 320,25102847,3.622666729654605
LMSU,66577038,3.684475971972106
Karpas-422,5280436,-0.2684967291987384
NCI-H196,19582717,3.121711938945128
SK-UT-1,6918328,1.9440877838795103
PE/CA-PJ41 (clone D2),122327,4.362025797266764
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
KYSE-450,navitoclax-pluripotin (1-1 mol-mol),0.3166156605789935
OAW28,25154868,4.5321266568460805
SNU-213,piperlongumine-MST-312 (1-1 mol-mol),3.0367843929765206
Mono-Mac-1,126941,-2.3144424159721
OAW28,3062316,-0.5042902382709098
AsPC-1,135421197,1.8824248695595285
TE-14,2126,4.8645468757468
KYSE-450,piperlongumine-MST-312 (1-1 mol-mol),1.338613375106185
H-STS,11234052,1.696059842903999
BT 112,5280436,1.7556445184150695
KYSE-180,10385095,1.0867111286980162
Panc 02.03,322968,4.613737356937267
BFTC-909,42642645,1.561027146692027
SF295,11427553,2.948387594592759
HCC2108,36462,2.7422106684318077
RKN,60700,0.8209474049972991
AU565,11317348,4.006750700524709
EHEB,44507138,1.7056650657187078
KLE,216239,3.024053239186479
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
HSC-3,123631,3.70813832669854
Hs 611.T,3543504,4.5569056437018425
SK-MEL-5,49850262,3.835719127247764
RERF-LC-MS,25126798,3.475546322259903
OAW28,11964036,1.3272537866850969
NCI-H196,25183872,-0.1581676895244862
RKN,89183176,6.327700475537756
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
KO52,56946209,-4.209607693817565
ChaGo-K-1,216468,4.582013123120093
KLE,SNX-2112-bortezomib (250-1 mol-mol),3.268766111238186
EHEB,119182,-1.3653952638717988
HuT 78,doxorubicin-navitoclax (2-1 mol-mol),-0.8174100340859971
Becker,7326481,2.0225268509287253
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
KE-39,25102847,2.4320728341381517
Mono-Mac-1,67291369,0.1054152136065154
IST-Mes1,51037431,5.172794571797409
SNU-213,selumetinib-BRD-A02303741 (4-1 mol-mol),0.82373667635177
KYSE-450,5746,2.912407446662149
B-CPAP,3552672,3.704866420763203
JHUEM-7,15547703,2.9203929854808317
Mono-Mac-1,6918289,-1.537953506191046
NCI-H209,20959075,-3.666427517945176
Becker,navitoclax-MST-312 (1-1 mol-mol),0.542067489060191
L3.3,1566236,3.261153981033622
AU565,54613361,-1.6068695222158444
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
HEC-108,11178236,-4.583978166396032
BT 498,6438330,1.9724723295366628
BT 498,10302451,4.23204741279201
TE-14,24785538,3.6660323705503832
B-CPAP,445455,3.02228700826093
HuT 78,219104,1.1531069030640524
TE-14,1714884,3.6737599462044583
KE-39,104842,1.1494054436800256
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
Namalwa,16013152,3.948657270974704
IST-Mes1,49867930,4.491137344342606
AU565,15953870,2.093538779145719
AsPC-1,2858523,3.256128469853813
ESS-1,44566777,0.5104790978676739
CML-T1,54143018,-0.824314936779772
HEC-108,11364421,2.372411654135638
TE-14,46398810,2.467371666565784
Hep 3B2.1-7,5329102,2.0312161402251556
Ri-1,BRD-K03911514,4.2263735934291775
AsPC-1,216239,1.707935704723652
SNU-216,176870,1.140167349620938
YD-38,49793307,-3.338323519960946
KE-39,67156097,5.133612548665442
L3.3,11609586,3.8992408569207018
Mono-Mac-1,4917,3.0045902586541713
H-STS,doxorubicin-navitoclax (2-1 mol-mol),-4.029519086979923
SNU-886,3025944,4.270077013000682
SNU-216,11640390,3.7653393946493776
SK-MEL-28,969516,4.521483044042875
ESS-1,107985,-4.436359650155883
HSC-3,4788,5.36548063999016
L3.3,2729026,3.1026966432102863
SNU-423,25150857,2.785663245467314
MIA PaCa-2,navitoclax-gemcitabine (1-1 mol-mol),-2.3995955359028107
AsPC-1,1566236,2.844580785967763
PF-382,11625818,1.6689494002323595
BT 320,168313200,3.0477072720221936
BFTC-909,11612883,3.5324782187628827
HSC-3,44185566,1.8853350434555631
YD-38,SNX-2112-bortezomib (250-1 mol-mol),-2.1871556108671255
PE/CA-PJ41 (clone D2),135875424,2.9357060771459245
Hep 3B2.1-7,11656518,0.170791411533647
KLE,5311281,3.4471397801732477
SK-MEL-28,11455910,1.7343524639503471
Kasumi-2,17755052,-2.6649013271346744
BT 320,3025944,4.750339696858045
HSC-3,11507802,1.06595538315282
LMSU,24951314,3.1918307701084276
AsPC-1,65064,5.237570806440869
RKN,46843906,3.906010302389018
Becker,5311281,1.1907774458631617
SNU-213,navitoclax-piperlongumine (1-1 mol-mol),2.8810672171216085
WM793,doxorubicin-navitoclax (2-1 mol-mol),-0.741764803207122
KE-39,409805,5.860910954246773
KE-39,409805,5.860910954246773
TE 441.T,9907093,4.1774168455492955
NCI-N87,20959075,-3.4539866912118784
RKN,5351362,2.529766574998156
YD-38,56963564,-0.5588398385004562
BT 320,5329102,3.0266079626967928
BT 112,5287620,-2.7532847329497883
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005
Mono-Mac-1,10385095,1.4007420160965849
Hep 3B2.1-7,3689413,-0.8676280815745859
NCI-H1339,46191454,1.8711538033054396
Hep 3B2.1-7,5311281,2.4201746510263495
BT 498,selumetinib-JQ-1 (4-1 mol-mol),4.316550369510256
Karpas-422,24785538,1.2576413722636424
BT 498,doxorubicin-navitoclax (2-1 mol-mol),-0.3911006180562948
SNU-886,49793307,-1.2846012118525447
IST-Mes1,16065773,3.0641757349077925
Kasumi-2,16659841,3.619219766502468
SNU-423,24180719,4.009058877663273
Becker,5335621,4.427331566156457
NCI-H1339,216239,3.528390744524712
HOP-62,4578,4.644037168879469
SW1783,135875424,4.794068332474245
Mono-Mac-1,57519531,1.6991291407588482
AsPC-1,5281321,-1.206156098851657
SK-UT-1,5113032,5.060629024627444
HOP-62,9927531,4.3195662996069855
NCI-H1339,462382,1.2176103463091026
IST-Mes1,12001922,2.6228240364869113
KMS-12-BM,2113511,4.224689679804032
LXF 289,44241473,4.688676931788039
Kasumi-2,322968,1.3079365029289678
Kasumi-2,3385,2.4314400955221576
KO52,9911463,3.5355164060453004
Lu-65,5282054,4.5299048818747325
OAW28,5113032,5.506773811436986
KO52,444795,3.710694398794004
MJ,25126798,0.3363545399318757
BFTC-909,46907787,2.3649992203474515
SF539,9823820,1.6245183308883937
B-CPAP,4917,2.9839600010766896
SK-MEL-28,9866186,3.06280870304389
NCI-H2030,vorinostat-carboplatin (1-1 mol-mol),4.06983462737207
SNU-886,SNX-2112-bortezomib (250-1 mol-mol),-2.93847148542514
SNU-216,6610216,4.217598364125196
Lu-65,5278396,3.729280751884731
Becker,crizotinib-PLX-4032 (2-1 mol-mol),1.695188234860732
BT 112,salermide-PLX-4032 (12-1 mol-mol),5.150071894755857
OAW28,24753719,4.434201172795376
AsPC-1,216345,4.477392842458871
HuT 78,12003241,-1.0527217193191982
HSC-3,6252,1.360193253312079
KMS-12-BM,JQ-1-vorinostat (2-1 mol-mol),-2.5260495197970525
SK-MEL-28,9911830,3.7902815277231663
WM793,44607531,2.1972673735163326
SNU-213,52912189,1.8515796327492853
NCI-H1339,53232,2.307445546958286
RKN,3854666,2.132003481112045
KMS-12-BM,25150857,1.6071345823937382
ESS-1,carboplatin-etoposide (40-17 mol-mol),0.969659746088125
NCI-H929,3025944,3.918293488310436
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
Namalwa,11396600,2.5581294543218616
ChaGo-K-1,31703,-1.2510653357476624
L3.3,44486219,4.220339607908531
Kasumi-2,71466578,1.9217240593305729
RKO,135875424,3.829354185480349
KE-39,navitoclax-birinapant (1-1 mol-mol),0.0912747000919814
Namalwa,445455,4.434639779414414
RKN,54618771,1.93479648501244
PE/CA-PJ41 (clone D2),44137675,3.861270231400088
BT 248,53232,4.253838861384023
Hs 611.T,65628,3.4812835817833183
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
HSC-3,17759555,3.5917299026109375
TE 441.T,31703,-4.286329362488478
GOS-3,tanespimycin-gemcitabine (1-1 mol-mol),3.128044986938021
Mono-Mac-1,107970,1.267448776766495
RKN,3038522,4.332475047921768
Ri-1,3815108,1.201236864182909
SNU-886,53232,-1.4461211490785335
TE-14,44507138,1.8251480731942025
SW1783,selumetinib-tretinoin (2-1 mol-mol),5.0766221097450845
SNU-119,11427553,3.011079133606584
KLE,piperlongumine-MST-312 (1-1 mol-mol),0.99514194367968
PE/CA-PJ41 (clone D2),46926350,-4.147494245167489
SK-UT-1,676352,1.600998738511555
SF539,53495165,-1.7347604840136983
KE-39,12001922,1.538248730222034
Kasumi-2,136227924,1.9658135956042504
TE 441.T,5479543,3.431992856190103
IST-Mes1,219104,4.071310239310072
NCI-H929,3543504,4.657244806127615
ChaGo-K-1,644241,2.384389937346898
B-CPAP,5281321,-1.80536114011693
PE/CA-PJ41 (clone D2),42611257,3.82431664602614
Ri-1,246676,4.619716207885173
SNU-216,5978,-3.1004514665439835
KE-39,216468,3.956294605283877
AsPC-1,4261,2.35820288641389
BFTC-909,31703,-0.9928331583982526
MIA PaCa-2,10074640,2.6457096957685495
SNU-119,49793307,-3.2764253324389268
KYSE-450,23725625,7.184930321255073
Namalwa,72193861,0.4860643993613396
LMSU,15983966,1.8709586957084512
Ri-1,44185566,1.1229828302850782
BT 286,11167602,0.1521684661712007
Lu-65,11609586,2.7049330243878584
KMS-12-BM,3689413,-2.359728446736426
NCI-H1339,5278396,3.869150001588174
HCC2108,42611257,3.7693662038027
SK-MEL-5,6918878,1.446817120772073
Hs 611.T,107970,1.3823074139293197
OAW28,42642645,0.9360886571737812
OE33,selumetinib-MK-2206 (8-1 mol-mol),2.157124299869845
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
ESS-1,72193861,1.305557473991512
RKO,51039095,3.7257826703811014
BT 320,11626560,2.4160208902080713
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
Hs 611.T,JQ-1-MK-0752 (1-1 mol-mol),1.6004197834829663
HOP-62,57519531,2.2403791786945377
Hs 611.T,49766530,-2.7427307114148545
SNU-213,5460769,1.7717518807864931
AsPC-1,10231331,1.7826677656602696
AU565,9549297,3.94244046983191
Ri-1,10113978,1.818759778383803
BT 286,36314,-4.002945974636151
SNU-423,11640390,3.650531771581836
CML-T1,5460769,1.000954417912476
Ri-1,vorinostat-carboplatin (1-1 mol-mol),1.3287966003987923
Becker,6918837,-2.985823176035118
KMS-12-BM,17755052,-0.7211534532736694
KE-39,445091,4.999033906756457
KE-39,56649450,4.017414806264263
BT 328,72193861,3.7422212299852946
H-STS,12003241,-1.720451684377523
SK-MEL-5,216239,1.7796395684770618
NCI-H2030,11612883,2.4957659850651774
TE-14,23635314,-2.563783577017973
KYSE-450,53325874,4.377584660975113
Mono-Mac-1,9840324,5.352033005026378
Hs 611.T,25262965,-5.382583142350373
Lu-65,12001922,1.746900064695359
MIA PaCa-2,selumetinib-navitoclax (8-1 mol-mol),2.356546555669427
KMRC-20,6852167,4.09361379982572
BT 286,3025944,4.579041975607849
YD-8,285033,-1.8984148294735084
Lu-65,52912189,2.4478972750798587
NCI-H209,72376,-4.141163112569914
BT 328,9926054,3.720062864226824
HSC-3,24856436,3.0509145508427675
AsPC-1,10074640,3.638861482782184
BT 286,9967941,4.666112297990241
SK-UT-1,24856436,-0.0772181005247894
SNU-423,46907787,4.032406628203726
LMSU,11717001,4.418665943257039
SNU-216,11455910,0.3573804688779068
BFTC-909,11317348,4.568727931072339
CML-T1,3385,2.6066574492649184
Ri-1,9926054,1.5974379061435915
NCI-H196,JQ-1-navitoclax (2-1 mol-mol),1.860973028750606
Kasumi-2,54596558,4.023508952920703
LXF 289,11964036,0.5627528071719251
AU565,135411,0.1136824900578053
Hs 611.T,6450551,2.170846858416241
KYSE-450,10184653,1.1641913359919105
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
Namalwa,60750,-4.795998727085379
SNU-423,10074640,3.5708164577593453
H-STS,1242560,3.458516939321499
AU565,151289,0.4389765151464501
ACC-MESO-1,6918328,1.0135488660695875
AU565,17755052,-0.9729531204394496
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282
CML-T1,10385095,0.9719029483379856
NOMO-1,5281321,-2.1390969134868656
Mono-Mac-1,5284616,1.041829592246337
PE/CA-PJ41 (clone D2),6918328,0.3452251982206104
ESS-1,5311037,3.6560576458162295
RERF-LC-MS,25227462,0.8140348385016122
Hep 3B2.1-7,3825829,4.187718301348179
PE/CA-PJ41 (clone D2),4788,5.9726689722253
LXF 289,2828334,5.402872149224608
AU565,9956119,3.3766215860348368
CML-T1,5335621,4.035243944386916
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
KYSE-180,123631,1.841294475412796
Kasumi-2,219104,1.7742372806275355
RT-4,docetaxel-tanespimycin (2-1 mol-mol),-2.3839682334999823
OAW28,49793307,-1.8076729764727852
PF-382,24901704,1.4040004124632075
IST-Mes1,11178236,-2.2337214332221023
B-CPAP,702558,4.9966107855915025
SK-MEL-5,216345,4.294680632537732
KMS-12-BM,ISOX-bortezomib (250-1 mol-mol),-0.4496875645415525
MIA PaCa-2,107970,1.625165459581556
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557
NCI-H196,675434,5.131658227650978
AsPC-1,15953870,5.362858272792295
SNU-119,36314,-3.9355379366515586
Kasumi-2,1641662,2.7685254402742183
OE33,44607531,1.334237424525441
HOP-62,135440466,0.703284490040229
NCI-N87,16720766,-1.168414694473064
OAW28,445455,5.326899909172617
NOMO-1,702558,2.777027807122979
BT 112,54618305,3.877432993303292
KLE,vorinostat-carboplatin (1-1 mol-mol),1.9329749700220415
NCI-H929,676352,1.778414026340849
LXF 289,168312962,1.364587801939814
H-STS,11427553,1.5169535049673049
Becker,6610216,4.575848391008017
BT 112,216345,1.4586490487599502
LMSU,3025986,-1.1384200565557423
KE-39,9868037,3.621529869698051
KO52,637858,1.0718331271712598
BT 328,135440466,1.9729468656409803
SW1783,7251185,1.718988263559794
Kasumi-2,piperlongumine-MST-312 (1-1 mol-mol),0.99360798269259
SF295,9825149,2.95912191329992
OE33,9911463,4.318006925608157
BT 320,439501,-1.927418392306892
HuT 78,72376,-3.326794088490654
RKO,262093,2.7220373961576834
KO52,JQ-1-UNC0638 (2-1 mol-mol),0.0630474759486333
SNU-423,piperlongumine-MST-312 (1-1 mol-mol),1.4300428603015891
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413
BT 498,10074640,3.4496274756730503
YD-38,3503,2.7991916820325136
YD-38,119607,6.099875538236118
HOP-62,11494412,2.9227878689679105
NCI-H929,20959075,-3.1953287844218417
SF539,5702613,3.2712252993550384
BT 286,54618164,4.321497968648174
KMS-12-BM,156414,0.8404794203086158
AsPC-1,31703,0.7807561035178269
SK-MEL-5,5278396,3.5563438270192274
AU565,702558,5.325524002647016
HuT 78,11167602,1.7844027861507523
B-CPAP,25102847,2.584814595115363
BT 328,3825829,4.625111565622426
ESS-1,2742550,4.194579887734085
Hep 3B2.1-7,1242560,3.0144913298726306
YD-38,26596,-1.5752818654632963
KO52,135411,0.3217608625451301
RKN,25262965,-0.5506090189051945
KYSE-450,11625818,5.066786117132594
JHUEM-7,decitabine-navitoclax (2-1 mol-mol),1.3680027102230077
Panc 02.03,2874250,4.438896474206821
SNU-886,UNC0638-navitoclax (1-1 mol-mol),-7.5974579555081725
GOS-3,135411,0.9391696009475228
KE-39,JQ-1-vorinostat (2-1 mol-mol),0.4197456531616845
SNU-886,439501,-0.6078207224909147
Becker,selumetinib-UNC0638 (4-1 mol-mol),4.645955748496869
AU565,46174525,5.4998307146624255
AU565,4578,4.456552707084199
Mono-Mac-1,44607530,0.7163266856169314
SNU-216,9936388,0.9315958331188322
Kasumi-2,24180125,1.6711646659047346
OAW28,11404337,-1.5682838378564492
KE-39,navitoclax-sorafenib (1-1 mol-mol),0.8141438831550822
Hs 611.T,vorinostat-navitoclax (4-1 mol-mol),0.7220678906769918
Panc 02.03,24180719,3.694319415808187
SW1573,23582824,0.5044187481506299
KMRC-20,1750826,-3.609233849414064
Kasumi-2,11214940,0.2886545067447796
LXF 289,9911463,2.935801973679381
HuT 78,11455910,0.0216709312460527
SF539,12001922,1.3704910391128322
ChaGo-K-1,3543504,4.252620977795733
JHUEM-7,23635314,-4.250939063965602
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
YD-38,2828334,6.420211851938811
AU565,24180125,2.1910645714042634
BT 498,11175137,3.589277332996231
SW1783,8515,3.491142478274941
KYSE-450,4261,3.512938253123631
KE-39,2746,3.4287978126101337
NCI-H929,navitoclax-gemcitabine (1-1 mol-mol),-2.8250972812481714
Namalwa,tretinoin-navitoclax (4-1 mol-mol),3.8973285666851543
YD-38,2749,1.6680500375808704
KMS-12-BM,11222830,0.3420058811643648
ChaGo-K-1,123631,3.4556827131054
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
NCI-H1339,7326481,2.9042986781727596
Hs 611.T,6918328,-1.1939211929881746
AsPC-1,44462760,4.701078704400346
SNU-216,11964036,0.2683367381565513
OAW28,44819697,-1.5562690526140308
SNU-216,serdemetan-SCH-529074 (1-1 mol-mol),2.5997678860617985
ACC-MESO-1,2841722,4.126179141670728
Lu-65,16065773,3.747390125773909
SK-MEL-5,11238147,2.4714738225484947
IST-Mes1,10302451,1.9071808976959603
BT 498,216345,4.450396918440382
Lu-65,446155,0.5614057813043029
Ri-1,9908783,0.8388131027576593
Lu-65,carboplatin-UNC0638 (2-1 mol-mol),3.766616901554207
SNU-423,9926054,1.7894708985292902
BT 286,375860,0.1606437193581575
YD-8,9903786,2.667696713101927
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
OAW28,11485656,3.2643123414600645
Karpas-422,3543504,5.717794293894826
LXF 289,5978,0.6093029371771528
Ri-1,227681,2.7126035937005923
RT-4,24951314,2.159360193185554
HEC-108,2113511,5.8682734581201705
KE-39,2113511,5.681400956118445
HEC-108,168313016,6.1351198054698575
SNU-119,400769,-0.9034553072694146
SNU-886,5284616,2.6710721615639765
CML-T1,168313016,4.15358640853123
EHEB,23725625,4.849566011145166
EHEB,6438330,0.8032584071441157
AU565,135659046,3.967998335471068
Namalwa,doxorubicin-navitoclax (2-1 mol-mol),-3.10943912888444
AU565,9933475,1.5968241540352486
JHUEM-7,1750826,-2.1362292193438965
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
OAW28,25126798,4.214847534438453
KMS-12-BM,9956119,2.7211618813495257
ACC-MESO-1,11640390,5.7204309821765715
PE/CA-PJ41 (clone D2),4477,0.8581598158487629
RKN,5113032,5.131058822839954
TE 441.T,637858,0.3313302982061412
NCI-H209,15953870,2.4365262020056195
RKO,322968,3.8471310775605216
Mono-Mac-1,71466578,3.003674036562798
LXF 289,2749,2.818144236178911
PE/CA-PJ41 (clone D2),60700,-0.746077064191772
B-CPAP,BRD-K27188169-navitoclax (2-1 mol-mol),4.542627193137736
HCC2108,1242560,3.356321570563672
HuT 78,16065773,1.7912473078063993
YD-38,3543504,4.296053294803378
EHEB,11485656,2.717011543878295
YD-8,5311,1.737118017629579
Becker,9926054,2.0290907819284283
SK-UT-1,5280436,0.2448868472823603
Ri-1,241158,1.4314385956610491
HCC2108,6918837,-2.190970663092924
HEC-108,9926054,2.177226179063823
Hs 611.T,6610216,4.160309523547129
AsPC-1,16065773,2.935886834183449
Namalwa,10296883,3.754455655563699
OAW28,11626560,1.7877294085158288
HOP-62,36462,1.2556592517294145
OAW28,24856436,0.1607500363529794
HuT 78,7326481,3.898377103940941
SW1783,72193861,3.9823565234230314
LMSU,9911830,1.6369573582733428
SNU-119,176870,1.4867362217138953
HCC2108,52947716,-4.821545884859311
OAW28,71466380,4.3449274646859495
Hs 611.T,1714884,3.592336326448464
AsPC-1,46398810,3.192713565122567
MIA PaCa-2,25102847,1.798683379599451
HCC2108,JQ-1-vorinostat (2-1 mol-mol),1.5555198543953237
BFTC-909,49867926,6.076136735210805
AU565,11485656,2.0156354686346174
B-CPAP,16038120,1.2112783851664366
Kasumi-2,702558,4.897760229735286
RKO,11222830,1.6656419736189183
LMSU,25161177,5.357505084661806
CML-T1,60750,-4.308471121020489
HOP-62,409805,5.513075555987367
NOMO-1,151289,1.0922355572005962
SF539,3062316,-1.76598803310592
Ri-1,68056272,2.942516708587133
KYSE-180,25183872,-0.5863433825832977
TE-14,carboplatin-UNC0638 (2-1 mol-mol),3.8273262495621143
NCI-H1339,11707110,5.363420889185477
Mono-Mac-1,46843906,0.8948290671337527
Hep 3B2.1-7,5738263,5.008705895489243
AsPC-1,56973724,5.500241353025212
H-STS,selumetinib-navitoclax (8-1 mol-mol),5.1723559591536015
AsPC-1,135398516,2.7517064972229415
RERF-LC-MS,753704,5.128075002459309
BT 286,44507138,4.569933407994329
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
NCI-H196,44507138,1.669275276934409
TE 441.T,4259181,0.3231515403820576
JHUEM-7,11485656,1.7197285505227566
BT 112,9933475,1.5933394130611254
B-CPAP,72734382,5.762194800032224
SNU-119,4917,2.930723431336195
H-STS,carboplatin-etoposide (40-17 mol-mol),0.1150499890044187
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
TE 441.T,25102847,1.567543065001864
SNU-119,984333,1.4760065970514793
ACC-MESO-1,3676137,6.061513328745112
JHUEM-7,11234052,3.906986952802379
Mono-Mac-1,4096211,1.4458168023329625
Becker,11485656,3.616159279519061
ChaGo-K-1,54765302,6.273541453946622
AsPC-1,24785538,0.8298650260870277
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
PE/CA-PJ41 (clone D2),5351362,1.231122848271496
Mono-Mac-1,selumetinib-navitoclax (8-1 mol-mol),1.236534180983602
ChaGo-K-1,15547703,3.6843699542516273
BT 320,erlotinib-PLX-4032 (2-1 mol-mol),4.456521882362605
Kasumi-2,676352,0.386616578071509
YD-8,148198,-3.6074550947406863
KO52,9823820,4.034259962160193
GOS-3,46398810,2.269718225041391
WM793,219104,4.075990982755825
L3.3,6918328,0.6582944097969459
NCI-H196,6918328,0.149769113265571
NCI-H2030,44259,1.1835601637938251
SK-MEL-5,387447,-4.830533625987401
YD-8,42611257,3.19679980391278
BFTC-909,54143018,0.6300785047889099
SK-UT-1,16013152,4.42318413525966
BT 248,42642645,1.464081071598135
KE-39,3025944,4.4635566230619945
AsPC-1,53232,3.925663364010775
SW1783,25262965,3.8156807624637734
Karpas-422,54619267,4.140871616777423
PE/CA-PJ41 (clone D2),doxorubicin-navitoclax (2-1 mol-mol),-1.4596299758397953
NCI-H1339,54618164,4.412872879489402
AsPC-1,11238147,2.0906654911229796
SF539,46224516,1.728004349053643
Mono-Mac-1,16741245,3.315980924789545
BT 328,11178236,-3.1111942702784092
HuT 78,448949,0.4485717539901531
Mono-Mac-1,3384730,0.9129507679094716
PE/CA-PJ41 (clone D2),322968,4.827437551622912
HCC2108,11178236,-3.6455661628602742
LXF 289,9840324,4.681234496405457
Mono-Mac-1,navitoclax-sorafenib (1-1 mol-mol),-2.8345587791213727
JHUEM-7,3503,1.4827187688333288
Panc 02.03,11427553,3.85172253134883
SNU-886,107970,2.7037771874608034
YD-38,9907093,4.292442922710312
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
CML-T1,navitoclax-MST-312 (1-1 mol-mol),0.6606923209980897
SNU-423,168312962,4.085540824042528
HSC-3,71304818,2.245255922653997
RT-4,73707398,0.8448009736616658
ESS-1,16736978,2.6908591982967645
BT 112,11427553,3.7884247720646873
SNU-119,2733526,3.002199231384174
KMS-12-BM,10302451,3.4855488172991924
NCI-H929,10385095,0.7754305798230204
SNU-119,6184667,2.2923669732173093
RERF-LC-MS,11175137,3.6286013190581503
LMSU,3062316,-2.3200924553246183
BT 320,11427553,4.124967356317301
YD-38,656346,-0.1512212437985599
MJ,374536,1.9717818313070976
Panc 02.03,5281321,1.7682996743542674
BT 286,46843906,3.946750094075013
KE-39,selumetinib-PLX-4032 (8-1 mol-mol),6.861097822886508
AsPC-1,9907093,4.363482739155403
NCI-H929,9956119,1.818516846968062
GOS-3,46215462,1.654053851935072
TE-14,44489675,3.6400910314318606
NCI-H929,446155,1.246736711414303
WM793,11404337,-0.7690985454206903
BT 320,46224516,3.0907007884048636
SK-UT-1,52912189,5.034004666881923
CML-T1,241158,2.0968023336421227
SW1573,3543504,3.864321270652805
MIA PaCa-2,400769,-0.5001352159542624
ChaGo-K-1,24771867,3.5582145966940697
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
NOMO-1,9444,3.521396869825756
PF-382,17759555,3.607895848401572
RT-4,SNX-2112-bortezomib (250-1 mol-mol),-1.6895298123650488
SNU-119,23635314,-0.7073360701887041
BT 286,3634881,2.47192305940937
RKN,11626560,2.593417875894138
ESS-1,446155,0.8462553588843746
BT 328,25062766,3.0045654818886507
Karpas-422,53232,2.9652087025502687
Mono-Mac-1,54618771,1.1455775902832934
NCI-H1339,6438330,3.671694196593789
BT 112,6917907,-5.932626557425448
BT 328,44484893,4.396363776297363
HuT 78,46174525,1.5214422285401947
Hep 3B2.1-7,159324,3.436377788042606
IST-Mes1,25183872,0.0748637978909832
KE-39,122327,6.317857137620034
NCI-H2030,72376,-2.1157661371890044
SF539,2871966,0.3943318332274005
CML-T1,638278,3.0153915179905098
BT 112,387447,-5.550366096650992
SK-UT-1,11152667,-1.0251821128308043
Lu-65,16725315,5.265309122236909
NCI-H2030,168313047,3.7381994867050703
Ri-1,3038522,4.739795846773267
KMS-12-BM,444795,2.0247311602920415
Namalwa,7251185,1.266481522188178
NCI-N87,72193870,2.948099148236623
NCI-H209,alisertib-navitoclax (2-1 mol-mol),-1.2257273779937763
SNU-216,11955716,-0.8822249769229805
BT 248,969516,3.2750512548532136
HOP-62,168312962,3.1091715829143216
ESS-1,54613361,0.2104463314777853
OAW28,24753719,4.434201172795376
OE33,89928392,1.5742114105683112
BT 286,637858,1.913556569209282
HuT 78,vorinostat-carboplatin (1-1 mol-mol),1.4699381378496317
BT 286,107970,1.9511501669936515
Ri-1,12003241,-5.9425936829646435
LMSU,36462,2.6264812061116127
TE 441.T,9926054,1.7722508105545176
L3.3,3025986,-0.2391966335119921
SNU-216,42642645,0.8137216939792844
Hep 3B2.1-7,44486219,4.406709015852199
KE-39,3503,2.236149027269379
RKO,20959075,-2.9107192765247536
KE-39,44486219,6.242583973184527
SF539,73707371,2.192047905744571
SNU-886,135999136,4.094662341834861
OAW28,46191454,1.726492969979986
LXF 289,25150857,2.4132050810476
SK-UT-1,24951314,2.3185939064766954
CML-T1,52912189,1.3905308136477008
BT 286,11178236,-5.080102511527813
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
SNU-119,119607,5.736335030874665
SNU-1077,100016,6.64200464659652
Lu-65,5978,-3.596221870039605
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
PE/CA-PJ41 (clone D2),52947716,3.214276450173903
MIA PaCa-2,31703,-1.8338416127618913
SF539,4096211,1.1700950606218037
ChaGo-K-1,241158,4.201927221282135
KYSE-450,42642645,1.660330797131617
SK-MEL-5,9952709,2.563288864294084
Karpas-422,675434,4.111382767941029
Lu-65,15983966,-0.8514170816781186
RKO,51037431,1.443783779144223
TE 441.T,984333,-0.9428429639665394
SNU-216,9926054,1.7628487898715297
SK-MEL-5,56649450,4.398184828401185
BT 328,44607531,1.5766345227803793
KLE,25105715,3.782155123781723
Namalwa,54618771,0.6847017954935718
RKO,9444,4.448790979485227
Karpas-422,1242560,3.007133880363242
RKO,24180719,5.308193040989237
BT 286,5470400,-2.2970279935898033
TE-14,57519531,1.7705437656842578
B-CPAP,navitoclax-gemcitabine (1-1 mol-mol),-1.2071982143787798
GOS-3,6917907,-5.627090987822961
Karpas-422,9907093,0.8832915232740778
OAW28,9840324,5.735695909737487
SK-UT-1,119182,-0.2389735645577043
SNU-886,156414,1.8221946579264756
HEC-108,5280436,4.260553189863144
SNU-886,51037431,2.211047490267374
PE/CA-PJ41 (clone D2),135999136,4.2765037519460565
L3.3,49850262,4.243504406455669
RKO,9935249,5.020114551473781
YD-8,44491742,4.162245932134171
HSC-3,navitoclax-pluripotin (1-1 mol-mol),-0.9987365285156716
AU565,135999136,4.178255303593246
OAW28,46174525,4.143540766033049
JHUEM-7,23582824,-0.4134518845075093
MJ,31703,-4.653725426044044
SNU-216,BRD9876-MK-1775 (4-1 mol-mol),0.716748175884836
BT 112,216468,1.2826036756590016
IST-Mes1,5311281,1.4883568311904505
NCI-H1339,89928392,1.587053114541893
TE-14,44486219,3.6443522708971745
BT 286,11640390,1.6291068565211342
RKN,135984461,0.6080422026652917
SK-MEL-28,6918837,0.4014054147330933
AsPC-1,44137675,4.002233175780649
LMSU,navitoclax-birinapant (1-1 mol-mol),3.8096655259250167
KO52,119607,5.619128288871563
BT 248,25195348,5.391578709053811
MIA PaCa-2,54626689,4.534739947118546
KMS-12-BM,135984461,1.7287315424792562
HuT 78,36462,0.7819646320410331
SNU-216,9826308,0.915829887667062
SF539,5291,3.503530356529322
PF-382,72193861,0.0573496234018987
SNU-119,5311,3.0436313599319673
LMSU,JQ-1-MK-0752 (1-1 mol-mol),4.2327882239703
BT 248,54618795,3.2071840181570477
KYSE-450,44819697,-0.2732564479087796
NCI-H2030,serdemetan-SCH-529074 (1-1 mol-mol),3.1997041761285834
BT 248,135398516,2.090653291947233
BT 286,168313200,1.66103693738852
BT 286,702558,3.161046018103092
RKN,51037431,2.467401650082352
BFTC-909,375860,-1.1901103647211757
CML-T1,54454,4.932328921432074
NCI-H929,23725625,4.820953347318842
ChaGo-K-1,9911463,3.7968497419655094
SNU-886,24901704,3.3518234737220265
SF539,4261,3.034812096929495
MIA PaCa-2,54143018,0.7884510241483783
Lu-65,navitoclax-gemcitabine (1-1 mol-mol),-1.4233092303710124
PF-382,53232,2.4647050421770005
KO52,46199207,2.692692607294932
SNU-1077,322968,3.904848920505325
LXF 289,16065773,1.584092119185821
MIA PaCa-2,11222830,1.3825683444330394
LMSU,11213558,1.28166790207028
JHUEM-7,5113032,4.7199076302075875
Karpas-422,6918736,-0.9495569711563258
L3.3,44589607,3.517286764473911
Becker,676352,1.735579238816336
KO52,753704,4.242778315458095
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
NOMO-1,53232,3.2414615649348772
RKN,16722836,2.340122812915413
OAW28,10296883,4.314409366833216
RT-4,2749,3.2785054841162022
Ri-1,46174525,2.671851467732814
HuT 78,23725625,5.900572836007656
HSC-3,36462,2.0858436100123847
KLE,9956119,2.1756146990139893
TE 441.T,5287969,-2.5247854073249245
SNU-213,crizotinib-PLX-4032 (2-1 mol-mol),1.6829565666585489
KMRC-20,25062766,3.4155735971940704
Kasumi-2,erlotinib-PLX-4032 (2-1 mol-mol),2.6918027963335827
Karpas-422,10113978,3.2783736500447263
Becker,4096211,1.303178754778439
Karpas-422,71466578,2.1474385211920297
TE-14,3081361,1.8442660048159123
AsPC-1,selumetinib-vorinostat (8-1 mol-mol),2.1619817893004805
HSC-3,54143018,-0.1249296162497747
RT-4,9929138,7.578104590024713
BT 286,44566777,-1.350747922279793
BFTC-909,46901937,4.445112058189045
JHUEM-7,9884685,-1.60078111934439
NCI-H929,50905018,3.952577942902894
ESS-1,11626560,2.39928314153679
ChaGo-K-1,5746,1.5665459857254316
ESS-1,285033,-3.536353243580582
YD-8,navitoclax-PLX-4032 (1-1 mol-mol),3.137916156556902
TE 441.T,11719255,2.6614811304249417
BFTC-909,11507802,1.7199271215311116
L3.3,285033,-1.389904047242399
EHEB,375860,-0.9049347764221136
LMSU,135875424,4.495921610081383
RERF-LC-MS,4705,3.292681011259135
BT 320,54143018,4.726719249085395
SF539,448949,0.5600320112814784
KE-39,327653,3.149148027412197
SK-UT-1,25227462,1.0186750982564137
BT 320,15983966,3.4202708205912087
TE-14,9884685,0.211407416382201
CML-T1,5329102,0.8946748960608596
RERF-LC-MS,637858,3.156110522031532
ChaGo-K-1,2729026,2.395257991695926
HOP-62,56973724,3.21471823934275
YD-38,10184653,-3.82777915318855
SNU-216,5351362,1.0978136193927086
Kasumi-2,89183176,5.250973362639219
RKN,3825829,4.2934517576030276
EHEB,24180125,1.8891722665908557
HuT 78,tretinoin-navitoclax (4-1 mol-mol),-2.2971670367223243
OAW28,5281672,6.00346703144391
Mono-Mac-1,71466380,3.259446139455592
YD-8,6918837,-2.6695996874336605
OAW28,53495165,3.30177539085494
KMS-12-BM,54618771,-0.8802136937205215
NCI-H929,3825829,4.289333234926349
CML-T1,441298,0.5187670078326817
OAW28,3025944,4.579278298637093
HuT 78,9927531,5.1568522769540674
Panc 02.03,6450551,4.166761052507323
CML-T1,selumetinib-UNC0638 (4-1 mol-mol),2.45517668205048
SNU-886,2949965,3.980374171773664
SK-MEL-5,5287620,-3.404659087231204
NCI-H196,navitoclax-MST-312 (1-1 mol-mol),1.3127280488868007
LXF 289,docetaxel-tanespimycin (2-1 mol-mol),-5.172665265297567
NCI-H209,124202324,0.7427053501525159
KE-39,10184653,0.6332517224813795
SF539,19582717,5.548936804809817
EHEB,3384730,2.786060611815292
BT 498,vorinostat-navitoclax (4-1 mol-mol),2.200974334120634
AsPC-1,selumetinib-tretinoin (2-1 mol-mol),1.7169571239818917
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132
Karpas-422,12003241,0.4573968210074843
BT 248,56963564,4.0439806336642175
SF539,71751553,4.845342915681748
OAW28,12003241,-0.542287488877267
SNU-213,SNX-2112-bortezomib (250-1 mol-mol),-1.4533865129200167
L3.3,navitoclax-MST-312 (1-1 mol-mol),2.4950782279808656
TE 441.T,11152667,-1.20408962070059
TE 441.T,19582717,3.7615233646109134
Namalwa,44819697,-3.151735066093753
KE-39,54626689,5.72659105113371
Ri-1,168312962,-0.6145879740945622
SNU-886,11455910,-0.4283095081187237
H-STS,11178236,-6.19923215257486
NOMO-1,1716436,2.6410194121109773
KE-39,46398810,2.5573643680926432
RERF-LC-MS,15547703,2.8085711207925015
TE-14,322968,4.83635080811504
HEC-108,9911463,4.37199271437254
SNU-216,10074640,3.344868705507218
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
PF-382,444795,3.785413836559396
OAW28,24797083,1.7501511491860735
SNU-213,25183872,-0.4867996852076448
PE/CA-PJ41 (clone D2),136227331,5.555158250699494
BT 320,11485656,3.3413754154715796
KYSE-450,24951314,3.0584617604997058
Kasumi-2,89928392,-0.7212883806223124
HuT 78,1566236,0.8672075486868017
YD-8,123631,2.5277035528733145
Hep 3B2.1-7,11178236,-2.0767038859193803
HuT 78,tretinoin-carboplatin (2-1 mol-mol),-1.6984319930029828
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
SNU-1077,25062766,2.424890615917259
BT 286,16038120,0.3961753230479998
Mono-Mac-1,3385,1.9570122377763095
EHEB,60750,-4.448701675460919
JHUEM-7,676352,1.6647076610932632
YD-8,107970,2.31722941739338
WM793,44137675,3.8583923269749465
KE-39,4917,2.6993900205990866
TE 441.T,68056272,3.6011483392674863
KLE,49850262,3.3302068182628393
GOS-3,462382,0.0265721167554945
CML-T1,5278396,2.8291940129393054
Hs 611.T,9903786,0.3508528062947837
BT 286,11427553,1.8654884790282549
RERF-LC-MS,54613361,-1.445874788963763
Karpas-422,46398810,1.673723968461422
KMS-12-BM,46224516,1.363965419553059
L3.3,navitoclax-sorafenib (1-1 mol-mol),2.85899880302019
OAW28,4477,1.0036814180565996
MIA PaCa-2,44566777,0.7650908790499256
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553
H-STS,5978,-3.0576178887146592
JHUEM-7,6505803,0.2461537124409258
SW1573,11609586,3.686627979451031
LXF 289,6918736,-2.4177135652368476
MIA PaCa-2,448949,1.723715555169293
WM793,6852167,3.317398724097228
KYSE-180,15547703,3.316205173217497
Ri-1,4917,2.03951216141433
YD-8,9911463,3.690343271752708
Becker,168313016,4.48609238913996
LXF 289,17759555,2.434653643868842
NCI-N87,5479543,3.770784511292927
H-STS,25183872,-1.8884511256941123
SNU-886,9927531,4.416743823533711
HuT 78,56949517,4.088339707137809
BT 112,crizotinib-PLX-4032 (2-1 mol-mol),1.4315306190333636
HuT 78,54618164,4.24138057284203
PF-382,5394,4.4607333976243435
WM793,637858,1.8553013176450457
NCI-H1339,126941,-5.139235423752655
SNU-216,4477,0.9014976111645492
KLE,65628,4.416189153864011
KE-39,4261,1.550964775863626
YD-8,docetaxel-tanespimycin (2-1 mol-mol),-1.5629664362824751
Kasumi-2,71729975,0.1244547207122276
HuT 78,2742550,1.9478816710996465
RT-4,navitoclax-gemcitabine (1-1 mol-mol),-4.248755815605392
SF539,46926350,-4.3784915774606175
HCC2108,49766530,-2.150620999142696
SK-MEL-28,42642645,1.6429344569807516
Mono-Mac-1,9825149,1.1152139328912305
LXF 289,10427712,4.0701965709145504
Hs 611.T,2746,3.500782789021053
Namalwa,51039095,1.869745632471808
JHUEM-7,73707398,0.8849918098478027
AsPC-1,327653,4.351823995090995
RERF-LC-MS,107985,-3.0933260647006215
KO52,285033,-3.0760712671003896
LMSU,73707398,1.6424339360302744
SNU-119,16720766,2.4248018282214283
ChaGo-K-1,11977753,-0.9113561720132052
KMS-12-BM,9549297,2.2758198611545035
HEC-108,3543504,4.706207337036549
Karpas-422,446155,2.8317664081108687
BT 248,6505803,-0.8385222866943476
SK-MEL-5,17759555,4.048629860745806
HuT 78,36314,-5.690425807572839
CML-T1,10322450,3.1347292789416934
NCI-H209,JQ-1-navitoclax (2-1 mol-mol),0.3443784292512838
Panc 02.03,5566,2.8367562997211815
SK-UT-1,51037431,1.6639996533413053
Namalwa,1566236,0.962108735319634
BT 248,15953870,3.6832035377423216
SF295,11396600,4.282405011310363
Lu-65,44462760,4.548896782935523
HuT 78,11485656,1.3035734242835073
RKO,11238147,3.3996395604326977
YD-38,10074640,2.9234644137530448
TE-14,44607530,1.4398604991203954
RERF-LC-MS,49766530,0.7744144603938863
B-CPAP,24785538,1.7494023419831553
SF539,1641662,3.001281709092091
EHEB,3025944,4.323656262321947
KMS-12-BM,219104,2.1179947044049396
Karpas-422,24901704,3.470448454583004
KE-39,119607,4.996260341403349
EHEB,9903786,1.657877258917439
CML-T1,36314,-5.131510797683319
KMS-12-BM,82146,2.660947076146562
KE-39,53392493,2.6188157997279817
OAW28,322968,3.926433659329745
RKO,11612883,3.106052261550285
RKO,15983966,1.976330033309676
PF-382,9936388,-6.688930185968071
MIA PaCa-2,984333,1.281535756123921
KYSE-180,3384730,1.3990214479335077
SNU-216,25105715,3.66555605767721
HuT 78,9936388,-7.168553730777331
SNU-886,387447,-3.9367278767128617
OAW28,5566,3.0868855994062137
Hs 611.T,3825829,3.8788340383084767
MJ,44607531,1.34909742288371
HSC-3,439501,-2.291291548686292
Karpas-422,462382,1.2043639070752885
HuT 78,44589607,1.1336903613451157
BT 498,322968,4.296939625448221
NCI-H929,638278,2.7948371949110205
KLE,10074640,3.248880197029389
Lu-65,104842,-1.667070260430244
RT-4,445455,5.670983982398453
RKN,5311,1.8833679583763572
BT 248,445643,3.6752138638176057
ACC-MESO-1,656346,3.4615508285005956
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
BT 248,16219061,2.5057647005845354
NCI-H196,44259,1.5530683783507429
NCI-H1339,252682,6.483729619076123
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
YD-38,25150857,2.2281189620323008
KYSE-450,24785538,3.6513103906304942
Kasumi-2,168312962,2.3104598884340515
SNU-119,54618164,3.949548457526877
TE 441.T,54678924,3.0050403923877997
SF539,25154868,4.846757922777188
KYSE-450,16741245,5.34317896453295
PF-382,vorinostat-navitoclax (4-1 mol-mol),-0.4263827729642097
SF295,54454,0.017400250409685
Ri-1,56963564,-0.683540701908738
BT 498,selumetinib-UNC0638 (4-1 mol-mol),4.90022051040507
SNU-886,selumetinib-navitoclax (8-1 mol-mol),-7.607672884091839
NCI-N87,11152667,-0.2953714197447944
H-STS,10385095,1.1550393753572457
SNU-216,11647372,-0.4885753208043211
PE/CA-PJ41 (clone D2),65064,6.0820970563721835
BT 286,44137675,3.839918217335364
EHEB,navitoclax-MST-312 (1-1 mol-mol),0.6175908191033533
Hep 3B2.1-7,49793307,-3.270961359893231
YD-8,53232,1.7923845474925033
LXF 289,5287620,-2.3080718171081385
EHEB,5351362,0.8229401281543347
SK-MEL-28,11656518,2.5099458397006145
Becker,445091,4.9889444875802464
Mono-Mac-1,25262965,1.0629902073080637
OE33,selumetinib-tretinoin (2-1 mol-mol),6.078218001134302
TE-14,5566,3.109422527023262
SK-UT-1,6917907,-5.759127548873742
SK-MEL-5,11152667,1.6641946386501631
TE 441.T,135875424,2.9590043348173225
H-STS,17755052,1.4518907441282063
Becker,119607,5.773340917710597
SK-UT-1,10184653,1.553177213936907
MIA PaCa-2,24753719,4.169307227992716
NCI-N87,15547703,1.070685995489879
AsPC-1,navitoclax-piperlongumine (1-1 mol-mol),1.083172716520978
SF295,44185566,3.169316962823794
NCI-H929,11238147,1.9557398811989737
Mono-Mac-1,11455910,1.2371744705316827
BT 112,54596558,3.9811658460437673
MIA PaCa-2,6450551,2.264163954553481
SF539,24964624,1.5849083379984652
HEC-108,9967941,3.882245660335456
SNU-423,11612883,3.406869193670429
B-CPAP,67291369,2.842700694962032
SK-MEL-28,107985,-2.7940500151600296
Karpas-422,54613361,0.0102420299691995
JHUEM-7,navitoclax-piperlongumine (1-1 mol-mol),0.3587972188720395
KYSE-180,selumetinib-MK-2206 (8-1 mol-mol),4.332919329436686
RKO,11175137,2.9264569639519906
SK-MEL-28,navitoclax-PLX-4032 (1-1 mol-mol),0.389238788180305
ACC-MESO-1,3825829,5.620049570908759
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
Namalwa,JQ-1-vorinostat (2-1 mol-mol),-0.8440437734227959
MIA PaCa-2,4261,1.9783874519377245
BT 286,selumetinib-UNC0638 (4-1 mol-mol),-0.4867103603027745
SNU-213,3854666,3.663424826303367
CML-T1,11228183,0.9343365693589996
HSC-3,9936388,1.0714511856923938
HuT 78,123631,3.101357526527429
CML-T1,12001922,1.44047939392769
RT-4,676352,2.39607769576444
NCI-N87,262093,3.0008468279122607
YD-38,46191454,0.601497502213216
KMS-12-BM,selumetinib-vorinostat (8-1 mol-mol),2.1031452809096827
B-CPAP,5280436,3.7013840992858986
KMS-12-BM,46398810,1.728920729166526
BT 248,24797083,0.3482207661961916
SNU-216,46843906,3.868254626427013
Lu-65,9903786,2.0553359532496875
L3.3,44489675,4.5650706631267175
BT 286,12003241,-0.6969940125697452
SNU-119,JQ-1-navitoclax (2-1 mol-mol),0.5509382626965866
PF-382,3384730,1.4668655115256852
ESS-1,44632017,1.0852608734168645
RERF-LC-MS,25183872,-0.4545636564638026
HuT 78,JQ-1-MK-0752 (1-1 mol-mol),-1.2241508901650953
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
AsPC-1,11238147,2.0906654911229796
BT 248,613753,3.1927723368663976
PE/CA-PJ41 (clone D2),selumetinib-UNC0638 (4-1 mol-mol),2.6809565117678984
OE33,168312962,3.257297372441536
B-CPAP,54454,-0.0949556487225395
SF295,31703,1.2019493541868402
BT 320,JQ-1-UNC0638 (2-1 mol-mol),3.976442415564575
Panc 02.03,216239,3.7763245170365183
NCI-H2030,54618305,5.554359715807879
Kasumi-2,4917,2.8909802401946565
NCI-H2030,navitoclax-piperlongumine (1-1 mol-mol),3.2614918076249357
PE/CA-PJ41 (clone D2),135411,0.8293994588997935
KO52,9803433,5.79600278203547
SNU-216,135398516,1.937669925049277
PE/CA-PJ41 (clone D2),25227462,1.527949554972427
ESS-1,67156097,-1.3750835854420782
PF-382,216468,0.5105473489323931
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
SNU-423,carboplatin-etoposide (40-17 mol-mol),4.41939125050277
PE/CA-PJ41 (clone D2),409805,5.090011413594482
BT 112,5278396,3.7905260034746218
Becker,ISOX-bortezomib (250-1 mol-mol),0.428200248169345
AsPC-1,6918328,0.3822733035015269
SW1783,448949,1.229106792188085
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
KYSE-450,67156097,3.411841611974051
SK-UT-1,24772860,-2.1685737338015505
KMRC-20,SNX-2112-bortezomib (250-1 mol-mol),0.4424721588448694
HOP-62,10427712,5.542499439845473
CML-T1,3543504,3.744639287704583
KLE,252682,6.230481421217852
AU565,9936388,-7.122590364363415
SF295,selumetinib-MK-2206 (8-1 mol-mol),3.90263595003992
KYSE-180,selumetinib-vorinostat (8-1 mol-mol),4.1823671735531835
EHEB,56963564,-0.4749386373308739
JHUEM-7,11612883,1.3024764146581809
Karpas-422,11404337,-0.752603119365503
PF-382,2113511,5.305319424437295
KMS-12-BM,11152667,-2.0033121328533054
BFTC-909,122327,4.590877432942681
NCI-H929,16115403,-5.6578245507090905
KYSE-180,16725315,4.4704171730121685
KO52,6918878,1.008757664965314
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884
B-CPAP,246676,4.303313026788405
Hs 611.T,136227331,5.417316134562269
HCC2108,9444,3.448443284867183
Mono-Mac-1,vorinostat-carboplatin (1-1 mol-mol),1.5624224218664264
PF-382,2949965,-4.532431292910685
Hs 611.T,216345,0.9522164623488846
RERF-LC-MS,11612883,2.474683430971872
BT 112,44185566,2.3471539577419835
Panc 02.03,44819697,-0.6097657869730747
NCI-H929,salermide-PLX-4032 (12-1 mol-mol),5.56611074354939
KO52,1242560,3.1925977163120267
BFTC-909,3062316,2.03384364484094
HuT 78,46843906,0.7162246400250988
NCI-N87,8515,4.286102801865053
BT 498,46907787,4.416353779526344
Becker,navitoclax-pluripotin (1-1 mol-mol),0.2111715680577011
SF539,984333,-1.8112760815883828
MIA PaCa-2,285033,-4.694923786796806
HOP-62,16722836,1.3353272495590989
BT 286,11656518,0.2537918660411107
ChaGo-K-1,2126,4.076708327869872
YD-38,49850262,4.287575827533871
KYSE-180,6918878,4.793960218409927
BT 112,2708,2.9934356963189304
WM793,15983966,-0.2219786467978368
SK-MEL-28,46199207,3.878150631525568
Becker,1566236,1.7807841622280378
BT 112,448949,1.863535813652351
OAW28,446155,3.9986810531407486
LXF 289,4705,5.10311909598278
AU565,11178236,-4.26632575473861
NCI-H1339,6918328,1.022201685863086
OAW28,227681,3.168890693964491
SF295,66577038,3.081420284451991
EHEB,11404337,0.0364567319098325
ChaGo-K-1,374536,0.6604540670834225
YD-38,6623618,2.1348072370285345
ChaGo-K-1,107985,-4.444294596677252
SK-MEL-5,5280436,3.174001621654815
NCI-H196,9911463,4.433350594042992
YD-8,selumetinib-navitoclax (8-1 mol-mol),4.335023783206367
MIA PaCa-2,11647372,1.8214453136696007
NCI-H1339,119607,5.442601852865253
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
Namalwa,135984461,4.336205571620734
Ri-1,44137675,-1.093711141379852
RERF-LC-MS,2858523,3.0171071482923826
NCI-H196,ISOX-bortezomib (250-1 mol-mol),0.7504794663682204
BT 248,439501,-2.3411963573363104
Kasumi-2,4477,0.978376283081578
TE 441.T,5291,3.789452149362892
SK-MEL-28,72193861,3.1864248921579716
YD-8,10231331,5.266552071230695
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
SNU-1077,navitoclax-pluripotin (1-1 mol-mol),-1.01883972326763
WM793,73707398,0.9042820542427616
AU565,46199207,2.977397460043432
NCI-H1339,11427553,3.3170617363487342
CML-T1,445455,4.626862894514658
SK-UT-1,107970,2.916039273405532
TE-14,9936388,-5.01118425035393
CML-T1,71466380,3.6658800118854673
RKN,24856436,1.2279395925477072
NCI-H2030,6610355,3.582243758633091
KYSE-450,11455910,0.6287655004796859
L3.3,54454,4.824648171697031
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
KO52,54143018,0.4285373524333706
SF539,9884685,-0.5281104713803977
BT 320,navitoclax-gemcitabine (1-1 mol-mol),3.195871969497656
HCC2108,387447,-3.2029305155754657
CML-T1,9868037,1.2045012402986977
SNU-216,327653,3.2539044842694183
ChaGo-K-1,piperlongumine-MST-312 (1-1 mol-mol),1.266782615898129
NOMO-1,11175137,1.3676050257567425
TE 441.T,24772860,-4.205282472336712
CML-T1,6918736,-1.6116924986143133
YD-8,122327,5.600297817210885
ChaGo-K-1,6610216,4.215426179079186
WM793,448949,1.628822965430235
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
Mono-Mac-1,SNX-2112-bortezomib (250-1 mol-mol),-2.764721763135708
SNU-423,53495165,0.0371718834478377
NOMO-1,10385095,1.0593467546243338
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
BT 498,613753,4.782193759336145
H-STS,46843906,3.4319919456792296
Ri-1,2858523,2.761311128229238
CML-T1,71304818,1.5782846307483736
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
SK-MEL-5,5978,-3.2421152375449656
HCC2108,135440466,2.000453402842669
BT 286,5287620,-2.4250248709269124
Mono-Mac-1,6918736,-2.4376027103946662
HuT 78,5335621,4.006139745042012
Mono-Mac-1,23725625,5.447781404402003
JHUEM-7,selumetinib-UNC0638 (4-1 mol-mol),6.50365850141335
TE 441.T,9884685,0.7848536864337075
SNU-216,9866186,3.275692258984255
BFTC-909,2842253,5.585220688564769
KE-39,12003241,0.559414259019648
SK-UT-1,246676,5.689307282465742
BT 286,46398810,1.741988220933819
SNU-216,16659841,4.323338252730809
SNU-886,2126,2.9580246654622275
SNU-216,4378219,1.8378393827834911
NCI-H929,9911830,2.939236367729051
BT 498,alisertib-navitoclax (2-1 mol-mol),3.3650849812101544
ChaGo-K-1,322968,4.114664124130711
CML-T1,6252,-3.9112690302721265
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
RERF-LC-MS,2945648,2.437954541344266
PF-382,2841722,3.918402091561414
OAW28,9935249,3.684332158484572
SF539,11640390,3.628112258998275
Hs 611.T,46398810,1.3540621284715122
IST-Mes1,6852167,3.791716512628995
IST-Mes1,49836020,4.276541253138442
HuT 78,decitabine-navitoclax (2-1 mol-mol),0.5260270362971856
SF295,navitoclax-MST-312 (1-1 mol-mol),1.0395557070559365
LMSU,702558,5.700567867563839
YD-38,5287620,-2.950057087169329
NCI-H196,135999136,4.3823476311898855
JHUEM-7,3552672,1.9150315294075648
HuT 78,selumetinib-UNC0638 (4-1 mol-mol),-2.012028836437227
B-CPAP,9903786,2.2781712830719316
Hep 3B2.1-7,107970,2.24352532481949
Mono-Mac-1,208908,2.4390801171858327
YD-38,135421197,2.8276318584619022
KE-39,navitoclax-sorafenib (1-1 mol-mol),0.8141438831550822
B-CPAP,navitoclax-piperlongumine (1-1 mol-mol),1.412897736514235
PF-382,135875424,3.2130182861195076
KO52,676352,1.6863796828761293
LXF 289,3503,2.5386473527097837
Karpas-422,11234052,4.0626170100794186
MJ,3385,2.025237733510993
SNU-119,24889392,3.5636549899822194
CML-T1,53232,4.305570613336498
KE-39,5494449,3.012336343565584
Becker,3503,1.2240350209605926
KYSE-450,54626689,5.089860588921688
BT 112,11238147,2.441031684026273
KE-39,3136844,4.342976017638663
NCI-H929,9884685,-3.111418876103824
HEC-108,vorinostat-carboplatin (1-1 mol-mol),3.8874971320983143
ChaGo-K-1,753704,5.290331139863328
GOS-3,3825829,4.328758127334123
SK-MEL-5,119182,-0.6540271157928708
Kasumi-2,3503,1.0805615825532868
ESS-1,11175137,1.5326050179721749
MIA PaCa-2,16720766,0.4830207288204527
SNU-216,46926350,-4.054835664798021
KLE,5566,3.110078979332344
JHUEM-7,637858,1.2462680133442194
TE-14,3503,1.5755695310571736
L3.3,9444,4.344069420298931
RERF-LC-MS,11152667,0.0782441689403026
Karpas-422,11612883,2.1985682639193023
EHEB,crizotinib-PLX-4032 (2-1 mol-mol),1.830977421252466
NCI-H2030,1714884,3.7040002436428394
OE33,148198,-2.7707811749574196
NOMO-1,44632017,0.9405041708842384
OE33,439501,-1.244619642300935
EHEB,5280436,3.866090373293539
NCI-H2030,17759555,3.677599129227919
Kasumi-2,65064,2.9473106091456467
BFTC-909,148198,-2.03933057080943
JHUEM-7,11964036,0.7648051456612326
BT 320,54649381,5.331321773509753
KE-39,15547703,1.7331793905971136
AsPC-1,44566777,0.4941234322675649
MIA PaCa-2,46199207,3.3310599597253843
SF539,3384730,1.03759179550133
LXF 289,5311,1.216776445363927
BT 328,5566,3.1707222601804803
SNU-213,11626560,1.2138536733413132
Mono-Mac-1,702558,6.913431597800472
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
NOMO-1,24856436,-0.4465471145990737
BT 286,navitoclax-pluripotin (1-1 mol-mol),-1.088965440208862
SNU-423,5311,1.94726746362996
Panc 02.03,44589607,4.606435993835204
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948
MIA PaCa-2,5335621,4.5851883371080655
NCI-H929,452548,-1.297254287564457
SW1573,10074640,3.956421484938757
OAW28,66577038,2.5027239379183666
Mono-Mac-1,135398516,1.6736296018854304
BT 320,107970,2.3152930812829497
BT 498,selumetinib-PLX-4032 (8-1 mol-mol),5.785043307214588
NCI-N87,44632017,1.346248550233927
ACC-MESO-1,5278396,4.0330276972141
AU565,24821094,-3.121521346886189
MIA PaCa-2,135659046,3.7193443303471727
Hep 3B2.1-7,10113978,1.4411484963843444
SK-MEL-28,73707386,4.4832416514767335
Kasumi-2,5281321,-3.5035572972621916
MIA PaCa-2,67156097,-1.2297933208564042
NCI-H929,24180719,3.664799403319753
BT 286,65628,3.2626686935167544
HSC-3,322968,3.758052812431369
RKO,9823820,5.913042612438718
OE33,23582824,0.7259333766636283
ESS-1,11719255,3.627821400565806
MIA PaCa-2,72376,-2.0402961051166164
JHUEM-7,15953870,4.009699489789049
HuT 78,49867926,4.101314288502533
NOMO-1,11719255,2.6566855899212944
RERF-LC-MS,3503,1.2198018250646854
SNU-1077,10127622,3.7411047555393937
Ri-1,6610355,3.840292325756221
KE-39,11640390,4.498462110577166
RERF-LC-MS,44543605,4.169252612552019
BT 328,5113032,4.3388133731022585
OAW28,148198,-3.8662210541116977
KMS-12-BM,53495165,-2.246082698996139
ESS-1,49836020,-4.193111027878734
BT 112,24785538,-0.31795448088545
BFTC-909,12003241,-0.8371396827795129
BT 248,9866186,3.3997152825838515
LXF 289,selumetinib-JQ-1 (4-1 mol-mol),1.3410904156119008
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864
L3.3,54649381,4.658116253691046
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
TE 441.T,serdemetan-SCH-529074 (1-1 mol-mol),0.9246707880688446
EHEB,67291369,2.0490464679075813
H-STS,45279963,3.2018194703407095
NCI-N87,56963564,-0.4773091963101655
HSC-3,selumetinib-UNC0638 (4-1 mol-mol),4.596860577258544
B-CPAP,25262965,0.0515151425678239
ChaGo-K-1,selumetinib-vorinostat (8-1 mol-mol),2.615914600490853
HuT 78,65628,5.4520261644264165
BT 112,navitoclax-piperlongumine (1-1 mol-mol),3.2143536144775084
OAW28,285033,-1.6788024908058845
MIA PaCa-2,UNC0638-navitoclax (1-1 mol-mol),2.8894676156365
PE/CA-PJ41 (clone D2),4578,4.817726712421044
B-CPAP,10113978,3.7412132766741895
ACC-MESO-1,654092,0.4220956302588627
HuT 78,6918328,-2.2367447807827405
SNU-216,56963564,1.0977043213495503
SNU-216,alisertib-navitoclax (2-1 mol-mol),1.1611123296094812
KMRC-20,135440466,2.836143933224848
KE-39,11222830,1.621114920928245
SNU-119,5978,-4.047164032584213
KE-39,54618305,4.948156947347383
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
AsPC-1,15953870,5.362858272792295
RKO,89183176,-5.254565057669901
KE-39,decitabine-navitoclax (2-1 mol-mol),1.2325731360672605
HSC-3,2729026,3.0997094123177527
ChaGo-K-1,5328940,1.1886194190450794
Ri-1,selumetinib-JQ-1 (4-1 mol-mol),-0.2329470107135907
Ri-1,navitoclax-PLX-4032 (1-1 mol-mol),-2.9137015839307265
HCC2108,11364421,-0.8828017389399302
BT 286,168312962,3.8822415532561863
HEC-108,100016,6.393272881400893
SK-MEL-5,ISOX-bortezomib (250-1 mol-mol),1.3006689889653265
ChaGo-K-1,54618164,3.816944034787713
YD-38,3081361,0.0909927406814885
ESS-1,selumetinib-vorinostat (8-1 mol-mol),3.369239403980627
KO52,44137675,4.99436004315741
Lu-65,serdemetan-SCH-529074 (1-1 mol-mol),1.9278893488035571
TE-14,446155,3.6247355762230975
HCC2108,12003241,-1.7779849182593923
Hs 611.T,25154868,4.657650960162059
Hep 3B2.1-7,135875424,3.596529657657783
CML-T1,6852167,0.9836314645814764
SNU-216,216468,4.120916530747277
LMSU,5311281,1.1859008880059876
HSC-3,60750,-2.881991949302989
TE 441.T,1285940,4.276454926516712
AsPC-1,6917907,-5.50087073609159
RERF-LC-MS,11717001,4.567893424272946
Namalwa,11455910,-0.4529585092669797
LXF 289,5281321,-2.4870532876216487
KYSE-180,6610216,4.857625528938267
KE-39,46224516,3.9046510157068255
Kasumi-2,5328940,0.1344355450802072
ChaGo-K-1,387447,-4.0313743226417875
Ri-1,JQ-1-UNC0638 (2-1 mol-mol),-0.2670899012636173
AsPC-1,10127622,2.6030187662085384
OE33,135398516,1.655767694154752
BT 286,31703,-3.5254505333334594
NCI-H2030,25126798,3.671839570354219
NOMO-1,5329102,1.5937414073922636
RT-4,1750826,-0.6566840301254596
ChaGo-K-1,72193861,1.1879509711321792
OAW28,25183872,-1.003855010480259
NCI-H1339,46398810,3.698809091636484
NCI-N87,11178236,-2.6087498623354977
SNU-886,10113978,1.5939546192174308
YD-8,selumetinib-vorinostat (8-1 mol-mol),2.8906615427618982
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559
BT 320,57519531,6.301542560729613
NOMO-1,11625818,1.7683333213472852
Mono-Mac-1,6184667,2.8246190436164453
TE 441.T,5113032,4.52213527523865
TE 441.T,3825829,4.967629977359632
ESS-1,5460769,-0.3251379363550979
BT 112,9926054,1.759668872476805
WM793,24772860,-1.904667330479004
KLE,25150857,3.036039064371872
Karpas-422,24821094,0.1426723029223498
RKN,66577038,3.4891743358782104
AsPC-1,52947716,3.328482082087177
SNU-886,322968,1.7797157277210858
PE/CA-PJ41 (clone D2),9884685,0.9202237029017308
AsPC-1,9952709,5.897814669584309
TE-14,11494412,0.7185329040944464
SF539,5113032,4.5569437183020485
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
Namalwa,65064,5.205979247876378
RT-4,11497983,5.0525297457562335
ESS-1,168313200,3.675041672586614
Mono-Mac-1,4261,-0.1747295903201891
HOP-62,9884685,0.5036019018396981
Becker,15547703,3.827394424157001
BT 498,54618771,3.343910197755889
PE/CA-PJ41 (clone D2),11178236,-3.5733613875059262
KYSE-180,56946209,-3.779813924696878
BT 320,24951314,2.328206990278251
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772
HSC-3,675434,4.441932850910441
BT 320,4261,3.457041279765096
KYSE-450,148198,-3.4919685284150876
NCI-N87,5978,-2.9043455823279185
CML-T1,6917907,-6.247910968385368
WM793,3025986,-0.3370576533498906
LMSU,11955716,0.1089430802506861
PE/CA-PJ41 (clone D2),51039095,3.82696027623671
Ri-1,44589607,0.9824671459990256
Panc 02.03,44607531,1.9299895981807216
Panc 02.03,753704,5.09544361232119
BT 328,serdemetan-SCH-529074 (1-1 mol-mol),2.5091917299328315
NCI-N87,54618164,3.997308077582706
BT 248,5328940,2.875094995002875
KLE,4261,0.7692438055073919
KMS-12-BM,42642645,-0.399689528391991
PF-382,107970,1.4805149558229411
HOP-62,BRD9876-MK-1775 (4-1 mol-mol),4.491099162688316
PF-382,126941,-3.067039026453267
AsPC-1,5311,1.9705564216623497
TE-14,67156097,-1.6218628153120256
WM793,54618771,0.892561932009902
JHUEM-7,selumetinib-navitoclax (8-1 mol-mol),2.7635146626485256
Mono-Mac-1,5311281,3.37380571795301
PF-382,JQ-1-MK-0752 (1-1 mol-mol),-3.722439254577736
HCC2108,24951314,2.6304731468995457
YD-38,2729026,3.0794771028962753
WM793,10427712,4.81488735871317
ESS-1,45279963,4.196559746594957
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
HCC2108,2708,7.692601684388862
SNU-216,46907787,3.852045832322763
CML-T1,51037431,4.458839280310569
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
Karpas-422,52912189,-0.586182118148126
NCI-H2030,3062316,-0.7983590245700212
RT-4,135440466,1.5975390058414984
NCI-H1339,2871966,2.5357996601271013
HuT 78,10302451,3.5523158684911764
RKO,53392493,2.7606647137416616
L3.3,carboplatin-etoposide (40-17 mol-mol),2.812808375332559
PE/CA-PJ41 (clone D2),448949,2.558263610741337
RERF-LC-MS,10385095,0.7812016081678173
OAW28,44493528,4.631141764792384
TE 441.T,5738263,2.5234570345783047
CML-T1,57519531,1.0516100309241616
KMS-12-BM,4915,4.427523198943996
KLE,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7158414512435143
Panc 02.03,285033,-1.023489563814438
NCI-N87,1750826,1.3506728687975464
MIA PaCa-2,11404337,-1.8965485173920145
AU565,67156097,-2.287523284177128
RKN,71466380,6.199959456698308
Hs 611.T,11404337,-3.0246332650270777
PE/CA-PJ41 (clone D2),SNX-2112-bortezomib (250-1 mol-mol),-0.1200657947269847
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
Lu-65,53495165,0.9943425194888544
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
LMSU,carboplatin-UNC0638 (2-1 mol-mol),4.1197571889036455
YD-8,3676137,3.885314783218408
JHUEM-7,4917,3.1457767862931054
OAW28,5311281,1.8509970799423736
GOS-3,6438330,5.388884852572475
SK-MEL-28,10184653,3.6821110044494056
PE/CA-PJ41 (clone D2),10410894,5.555061016937591
KE-39,24180719,4.116999771545502
LMSU,docetaxel-tanespimycin (2-1 mol-mol),-0.129764308689889
Karpas-422,12001922,1.302445651758517
Lu-65,10302451,3.851828229272266
GOS-3,11964036,2.3854684921529525
NCI-H209,11214940,0.3157566488603621
SNU-216,135421197,1.0326096520006542
EHEB,11960529,4.94849976240243
HuT 78,57519531,1.7150629071467791
NCI-H929,9444,4.093260386369905
ACC-MESO-1,11612883,5.078595864486127
SNU-423,10302451,3.566969310878258
NCI-N87,9926054,1.7069639615174013
KMS-12-BM,selumetinib-navitoclax (8-1 mol-mol),1.0992303518305886
SF295,11178236,-2.041777779057679
BFTC-909,5281672,4.401358042981416
B-CPAP,53232,0.8188511536428992
SK-UT-1,11485656,2.414217391257394
EHEB,2729026,2.652912157322486
HOP-62,5284616,2.917606348987241
B-CPAP,11152667,-0.1979921497288642
HuT 78,4259181,-0.3142311669352864
Mono-Mac-1,5278396,3.5372373573667373
JHUEM-7,11977753,-4.885412245364533
Hep 3B2.1-7,57519531,1.9372348197743336
SK-MEL-28,9926054,3.4888277398466765
CML-T1,17759555,3.491613035913433
RKO,17755052,3.988455753476612
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
WM793,54619267,5.3024181995472635
TE 441.T,1566236,2.5728062109815335
CML-T1,135984461,1.8956927240773784
PE/CA-PJ41 (clone D2),3503,2.850031755363566
KMRC-20,10184653,1.8099581366329816
PF-382,24978538,-1.2784497861997195
BT 320,11364421,3.2966905188906717
CML-T1,5291,-1.725219795873105
Kasumi-2,9907093,3.255145953057051
Lu-65,selumetinib-UNC0638 (4-1 mol-mol),0.61966716985046
LMSU,10127622,5.3178116835445195
PE/CA-PJ41 (clone D2),9840324,6.5625963406787005
BT 286,JQ-1-carboplatin (1-1 mol-mol),3.0626602949719226
Hs 611.T,89928392,-0.4076263350125617
SNU-886,44589607,2.7373909096390743
TE-14,4378219,4.491971036424627
Namalwa,462382,0.2685889730086447
PF-382,1641662,3.045007940950309
SF295,serdemetan-SCH-529074 (1-1 mol-mol),2.458023046026203
KYSE-450,25262965,0.1139193640059102
OE33,9884685,-1.0024057051138902
KMS-12-BM,11497983,2.267788359318396
EHEB,65628,3.796785261187004
YD-8,24821094,2.929241602776678
AsPC-1,6918638,0.7071735542476161
KO52,44819697,-2.4820963764953707
ESS-1,54618771,1.2318880484657342
AsPC-1,5329102,1.9734309343360383
Ri-1,11719255,1.9146528709587665
BT 248,637858,2.256250159493538
Kasumi-2,19582717,2.3340571924025326
Lu-65,19582717,4.909054003445902
HuT 78,11717001,2.148899417206966
KE-39,5351362,1.2382997191060965
L3.3,56649450,3.0657913461458564
BT 112,10302451,3.727610987508193
Hs 611.T,10410894,1.861902823105788
Hep 3B2.1-7,5287620,-3.003659512886778
ESS-1,25022340,0.9618153764188746
KLE,637858,1.7560393431403896
WM793,984333,0.8846427573574175
RERF-LC-MS,3689413,0.4263782886644774
JHUEM-7,11175137,1.5119865026515042
Karpas-422,3503,1.3324407002806058
OAW28,71680916,5.167013104004298
AsPC-1,984333,1.2969820633088274
CML-T1,676352,1.5222388602604249
NCI-H1339,navitoclax-pluripotin (1-1 mol-mol),0.5930684699171267
YD-38,6610355,4.249088051905564
SK-UT-1,285033,-2.26051652032599
B-CPAP,6623618,2.626931921666511
MIA PaCa-2,11640390,2.9644725686892777
SNU-119,46224516,3.0258187740166083
SK-UT-1,9884685,5.1525602917749875
Kasumi-2,15983966,-4.769110499873103
KE-39,753704,5.009174848734236
KMS-12-BM,54143018,-1.751115897433141
Ri-1,5328940,-0.3334425744780813
HOP-62,17755052,2.482423793609025
BT 498,11455910,2.7063920015971084
OAW28,374536,3.018534312402979
CML-T1,8515,3.304453494146528
HOP-62,BRD-A02303741-navitoclax (2-1 mol-mol),2.8444726864007612
BT 320,vorinostat-carboplatin (1-1 mol-mol),4.235025979591699
NOMO-1,409805,3.6617718212828874
NCI-H929,6252,0.9780799453656184
Hs 611.T,445643,4.326929012679254
NCI-N87,5278396,3.196450874168962
PF-382,4477,-0.0830303421102948
HOP-62,carboplatin-UNC0638 (2-1 mol-mol),4.291543478845534
AsPC-1,6505803,-1.959385905579291
NCI-H2030,selumetinib-JQ-1 (4-1 mol-mol),3.0704561739948737
IST-Mes1,9911830,1.5716425903239464
L3.3,2828334,6.9353242086196225
NCI-H196,56946209,-3.322371827574061
LXF 289,11152667,-0.4789950074309144
ChaGo-K-1,navitoclax-PLX-4032 (1-1 mol-mol),3.5988961173594975
TE-14,24964624,2.246959171939491
HuT 78,44566777,1.359437800629114
Panc 02.03,3081361,3.1546648300373357
MJ,375860,-0.5648982341601144
BT 248,9933475,1.8575466823142976
CML-T1,selumetinib-MK-2206 (8-1 mol-mol),2.7460107356112644
SW1783,44493528,4.220460910824872
Hs 611.T,31703,-4.374956167524402
SK-MEL-5,168313016,6.194351632392148
SK-MEL-28,67156097,4.393624339595105
SNU-119,219104,2.9063855496873416
NCI-H196,72193861,2.0230633120282153
TE 441.T,4705,3.429293976923017
BT 248,5282054,3.4340814823816324
NOMO-1,54613361,-1.5441782746277026
LXF 289,25102847,1.656353256373218
BT 498,serdemetan-SCH-529074 (1-1 mol-mol),2.9202400422580745
BT 112,56946209,-5.137911214748189
KO52,675434,4.169961289776668
MIA PaCa-2,11364421,-4.9428281339026325
SNU-216,54626689,5.715021569760538
RKN,10184653,1.939164173873933
RKO,6610216,3.958403220086871
KYSE-450,5329102,3.4097073656415615
PE/CA-PJ41 (clone D2),16725315,5.310170656438465
KE-39,72193861,3.4588346249762534
KLE,51039095,3.662417805217731
LMSU,11609586,4.078801405634202
KMS-12-BM,1716436,2.2490231702489956
Mono-Mac-1,57330099,3.764598523152759
SW1573,11228183,1.3544411199442492
NCI-H2030,44484440,3.521549989015301
CML-T1,322968,2.5082577681036473
OAW28,9907093,4.094861416701174
Ri-1,JQ-1-MK-0752 (1-1 mol-mol),-0.6260374122813487
LXF 289,124202324,2.1762748500922657
AsPC-1,16736978,1.4850226649426823
SK-MEL-5,6184667,2.419101173147099
Kasumi-2,10074640,2.978792769082284
Karpas-422,5460769,4.127517160029383
BT 498,17755052,4.125935712570811
CML-T1,46191454,-1.3100798451488396
RKO,44589607,3.597229089573096
OE33,11485656,2.057023759496841
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
SNU-1077,409805,6.04127283545163
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
MIA PaCa-2,46215462,1.498613405861276
GOS-3,71304818,3.432284958440276
PE/CA-PJ41 (clone D2),9927531,5.176178802230399
BT 286,49836020,4.709879888093613
BT 286,selumetinib-piperlongumine (8-1 mol-mol),-0.2965188310208848
SF539,72199292,1.9939606105084
Hep 3B2.1-7,selumetinib-BRD-A02303741 (4-1 mol-mol),2.249491244384491
NOMO-1,9936388,-6.523282887173488
KO52,56973724,2.0714628306435507
NCI-H196,3025944,5.09320822042266
BT 248,3689413,-0.3734654016267222
KO52,3854666,-0.4105607896605044
SK-UT-1,168313200,3.914325756565286
TE 441.T,54454,3.576402500194246
NCI-N87,60750,-4.457686499395666
WM793,piperlongumine-MST-312 (1-1 mol-mol),1.4459627223482716
YD-38,168313047,2.6440382714586277
HuT 78,4521392,3.8389754666454254
AsPC-1,57330099,4.415374546363204
TE 441.T,5978,4.23833386156951
Karpas-422,135984461,4.3057747311374746
TE-14,10074640,3.2849249616435165
HOP-62,11612883,1.7191799143900155
BT 320,11640390,5.348028911341183
Karpas-422,JQ-1-carboplatin (1-1 mol-mol),-0.5867346052444206
BT 112,25227462,0.01299535421097
Ri-1,3025944,3.3507725240035864
SK-UT-1,72376,-0.4045590861192394
KYSE-180,24785538,2.7061039911851723
RKN,6505803,1.4092626649390017
SNU-216,9884685,-1.507922407291845
SK-MEL-28,9936388,2.4934378473061902
NCI-H2030,53232,1.866580630651426
Hs 611.T,11656518,-0.5876662235303677
MIA PaCa-2,66577038,2.983091139827387
BT 286,10385095,0.5786279467469033
NCI-H196,selumetinib-UNC0638 (4-1 mol-mol),4.422806576622298
SNU-119,50905018,4.442332120900816
RERF-LC-MS,16659841,3.453543705685564
Ri-1,2729026,1.3989648629345883
HuT 78,11427553,0.3947942526358813
IST-Mes1,doxorubicin-navitoclax (2-1 mol-mol),-0.5203692654605504
JHUEM-7,49766530,-0.0352390480057696
NCI-H1339,4477,0.5176181920473496
SF295,446155,0.7972651769701273
BT 498,52947716,1.0091545143518104
Kasumi-2,6610216,3.59110037414398
GOS-3,navitoclax-MST-312 (1-1 mol-mol),2.0809346375553877
TE-14,9868037,4.140324513825515
OAW28,46843906,3.2241568449076556
TE-14,216239,2.5939682730829188
YD-38,6918837,-1.9603786582931453
Karpas-422,5284616,-7.1986779453146825
SK-MEL-5,25105715,3.094932274246352
H-STS,JQ-1-vorinostat (2-1 mol-mol),0.6269555463342106
ESS-1,10302451,3.294150768882909
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
Panc 02.03,119607,6.223236877281167
HOP-62,2858523,3.0590549447697275
BT 286,644241,2.213968846177929
SK-MEL-5,11427553,3.5667407987526607
Hs 611.T,637858,0.871054087636222
JHUEM-7,6610216,4.204761293016812
KE-39,49850262,4.0074037431422385
JHUEM-7,6450551,1.7942384478328788
Hep 3B2.1-7,15547703,3.062790819925602
HuT 78,51039095,2.102033530869646
NCI-H209,42642645,-0.6980833637264824
Namalwa,1641662,2.840791178800267
KYSE-180,54454,2.017904173526763
KE-39,navitoclax-MST-312 (1-1 mol-mol),0.6605550109712996
SNU-423,25183872,-1.1443314850386328
KYSE-180,44486219,4.201637826044419
AU565,81146,6.247262332137589
L3.3,5281321,2.3391738882410813
MIA PaCa-2,navitoclax-PLX-4032 (1-1 mol-mol),3.5319614963047035
SNU-423,439501,-3.458666497477645
AsPC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3046725635070757
KYSE-180,68056272,3.810471876524393
AsPC-1,25262965,-4.011117827244764
NOMO-1,10296883,3.647443685498321
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
Hep 3B2.1-7,10302451,4.252461968415576
LXF 289,54618771,-0.5375230222620658
OAW28,3025944,4.579278298637093
KO52,alisertib-navitoclax (2-1 mol-mol),-3.629170972120534
SNU-119,11178236,-5.208015951508076
HOP-62,25102847,2.967758593907596
JHUEM-7,25227462,-6.059565497478323
MIA PaCa-2,409805,3.7490389776997466
KO52,10231331,-1.770944789563704
KMS-12-BM,57519531,1.217688684529343
NCI-H1339,613753,3.230985138130339
HCC2108,676352,1.822640586009688
HuT 78,119182,-0.4026937660621582
PE/CA-PJ41 (clone D2),9911830,2.474692527897134
SF295,selumetinib-PLX-4032 (8-1 mol-mol),4.690355242967967
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
KMS-12-BM,6505803,-0.6027320108546551
HSC-3,702558,5.870270989424734
BT 498,136227924,4.389685115045935
MIA PaCa-2,16038120,0.1859845686132181
Karpas-422,3385,3.70826421332824
OAW28,107970,2.4537130721494105
HuT 78,445091,4.391722157853981
IST-Mes1,24901704,2.6411672165981965
KLE,12001922,1.8770805284945848
OAW28,135875424,4.470041991889524
BT 320,54618795,3.6611780989616514
NCI-N87,1242560,3.6090545678814983
RKN,5311281,3.300248210659573
HOP-62,23582824,-0.2188858267384983
SNU-1077,9903786,3.350516769184116
BT 498,11317348,2.1875513655438876
SNU-1077,9911830,1.9332136731221603
TE-14,375860,-0.5133657303817126
B-CPAP,613753,3.3144945395536003
YD-38,46199207,3.3090935288824115
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
KMS-12-BM,11396600,1.1666466615999174
SNU-216,3503,1.445976442365677
NCI-H209,9967941,2.470617171151905
KMRC-20,ISOX-bortezomib (250-1 mol-mol),1.611645137466779
Namalwa,52912189,-1.1471104729897783
TE-14,19582717,3.998622953586376
NOMO-1,4521392,4.093982124965485
PE/CA-PJ41 (clone D2),11656518,2.318391318734742
AsPC-1,637858,2.8111542457272605
Kasumi-2,selumetinib-decitabine (4-1 mol-mol),-0.5593050771503721
Mono-Mac-1,654092,-1.4403827648525325
Hs 611.T,119607,6.043778506723619
RKO,49793307,-1.4433237106321422
Namalwa,selumetinib-MK-2206 (8-1 mol-mol),2.37951803478302
CML-T1,5113032,5.118103556540756
ESS-1,25105715,3.705428666019564
KMS-12-BM,10296883,2.976049270226853
SNU-1077,11175137,2.980099739351046
NCI-H929,135411,0.3622558435964065
HSC-3,4259181,0.6256880265153872
Becker,docetaxel-tanespimycin (2-1 mol-mol),-6.393493307906233
MIA PaCa-2,5328940,1.3715341713371223
ChaGo-K-1,6918638,0.8510727110172542
WM793,753704,5.060805642150714
L3.3,25195348,5.818157346447802
HuT 78,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.768713578692631
Namalwa,6438330,0.9334291886497746
EHEB,4788,5.846509507330705
YD-8,54618164,4.2297332581599525
BT 498,208908,2.540282915890303
KLE,vorinostat-navitoclax (4-1 mol-mol),-1.450020647356142
ACC-MESO-1,2828334,6.678342989737849
TE-14,68056272,3.626133272295782
ACC-MESO-1,66577038,3.862944855540308
HuT 78,1750826,-2.627767008630374
BT 248,24779724,5.957496049021181
B-CPAP,10385095,0.9210921841581224
RT-4,10113978,3.079983585040923
KMRC-20,3025944,4.366878976688431
TE 441.T,tretinoin-carboplatin (2-1 mol-mol),4.105803267618285
AU565,24856436,-0.2368560911374172
KMRC-20,17755052,4.273856933322851
Ri-1,49850262,2.1062573336402357
AsPC-1,5746,2.3674241916356755
SK-MEL-28,4705,3.074639735007158
BT 320,24797083,3.954904976663047
B-CPAP,selumetinib-vorinostat (8-1 mol-mol),2.3348701814890904
ACC-MESO-1,6914657,-4.821892559924658
Lu-65,613753,3.4021482681658393
BT 112,168312962,1.7814785578943482
SK-MEL-28,25183872,-1.0681222891293745
Becker,11609586,3.8238987470849897
BT 112,2945648,1.3917420344498488
BT 328,6438330,1.8463189750437397
PE/CA-PJ41 (clone D2),25062766,3.3062311369970137
Hs 611.T,2729026,2.5246263779141453
AsPC-1,73707398,2.3690176063372888
BT 112,16659841,3.2885249851469065
SNU-1077,11364421,-1.165916970108604
RKO,54649381,4.449908747747005
TE 441.T,11707110,3.68916480155614
Namalwa,12003241,-3.0032452893334596
KLE,46199207,2.9361016730339697
Namalwa,5738263,2.2051594160726067
OAW28,24978538,-0.39276463694641
ACC-MESO-1,17759555,4.251515989904748
NCI-N87,23725625,5.7035859672182125
ACC-MESO-1,5311,2.6640640328267744
ChaGo-K-1,4705,3.918553629962962
KYSE-180,53232,2.4967121988382983
Karpas-422,71751553,4.158262906049952
RT-4,969516,2.145135966433337
MIA PaCa-2,119607,5.2591327300907835
NCI-H929,3815108,2.046773234087797
Ri-1,9907093,0.4090438219291824
LMSU,5470400,3.850959102601626
PE/CA-PJ41 (clone D2),tretinoin-navitoclax (4-1 mol-mol),4.488669009711073
Namalwa,11178236,-7.034373828105963
SNU-216,12003241,-2.3730818081536955
EHEB,doxorubicin-navitoclax (2-1 mol-mol),-3.104964273062398
SNU-1077,ISOX-bortezomib (250-1 mol-mol),0.925773470547737
BFTC-909,51037431,4.63288955594681
Mono-Mac-1,3025944,2.9896268645900483
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
RKN,25154868,3.091821445991922
SK-UT-1,51039095,3.5731759350620345
Namalwa,409805,3.552483226107591
SK-MEL-28,53495165,3.601883113184374
IST-Mes1,11152667,-0.1137559634255308
Ri-1,10296883,1.1182456491009578
JHUEM-7,208908,1.9888781233805737
SNU-886,3854666,1.448080837770843
LMSU,4259181,1.0604093757007595
SF539,9927531,4.183842431586729
SK-MEL-5,375860,0.3634288608432608
Kasumi-2,56973724,0.9281139851854971
NCI-H1339,969516,2.528006193946809
KE-39,11955716,-1.4895818134404846
H-STS,5281672,5.306153738631839
ESS-1,676352,2.507808041358265
GOS-3,11222830,1.7526889108260606
HCC2108,44819697,4.4512579007259605
OE33,446155,2.7014033624900056
KLE,452548,0.408592435214394
NCI-H209,selumetinib-piperlongumine (8-1 mol-mol),2.1280942303913197
BT 328,selumetinib-MK-2206 (8-1 mol-mol),3.5375003025596596
KO52,25102847,1.7246116477249929
LMSU,2858523,3.056643520102809
Ri-1,374536,1.215254129911067
KO52,9907093,4.4065902785902304
NCI-N87,151289,0.0450530603050232
SK-UT-1,89928392,1.5133465040909966
CML-T1,375860,-0.8039918924580166
SK-MEL-5,6918736,-0.2565259857456182
WM793,71680916,6.03913470036381
KE-39,17759555,3.152380592963218
SNU-216,4705,1.5383436923122542
HEC-108,124202324,3.003291050730973
OAW28,9956119,4.544482925716663
Hs 611.T,71751553,2.589968262099222
LMSU,navitoclax-PLX-4032 (1-1 mol-mol),3.8157620441746833
Kasumi-2,54678924,1.0609274738962189
RKN,16720766,0.5941206863048918
TE-14,9903786,3.4903828938175354
MIA PaCa-2,2871966,1.166927532814639
Namalwa,53481919,3.785858901194669
YD-38,31703,-1.0114412442149527
SNU-423,11494412,1.245479972676825
RT-4,11427553,3.5858806335596483
ESS-1,JQ-1-UNC0638 (2-1 mol-mol),1.0012685328426527
NCI-H2030,31703,0.2472817555604013
KE-39,4096211,4.989230592504944
KMS-12-BM,644241,2.605305599492216
SNU-886,637858,1.4418078006770565
JHUEM-7,7326481,2.983877429785858
RT-4,3062316,1.5013745922534365
NCI-H1339,7251185,3.0289389350094047
PF-382,107985,-3.9923551873687497
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
ACC-MESO-1,5566,4.169029471712344
OAW28,12003241,-0.542287488877267
BT 286,9825149,1.2617601682397392
YD-8,136227924,3.733712180219105
LMSU,10184653,1.8439035095967675
Lu-65,2746,3.448286012693329
Becker,11214940,5.239157871042591
ChaGo-K-1,9956119,3.903719385984719
CML-T1,6918289,0.3823031541189219
WM793,54613361,2.2041091886662736
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
YD-38,168312962,3.566909723958424
Lu-65,selumetinib-MK-2206 (8-1 mol-mol),0.5653370026157463
SNU-119,637858,2.7399101747630867
L3.3,448949,2.9670184834605244
CML-T1,navitoclax-piperlongumine (1-1 mol-mol),0.6324311645871261
OAW28,25195348,5.036760517156048
PE/CA-PJ41 (clone D2),docetaxel-tanespimycin (2-1 mol-mol),-0.3463731783951276
JHUEM-7,49793307,-5.223906833613333
KE-39,10302451,3.0941257531868858
HOP-62,73707438,4.879888857078066
AsPC-1,148198,-3.729188282050714
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
KLE,176870,4.949336345274128
SK-UT-1,vorinostat-carboplatin (1-1 mol-mol),4.302325577715062
TE 441.T,5743,3.6433871182506175
HOP-62,262093,4.19078744138027
KE-39,3689413,-1.8420159541718293
Karpas-422,16065773,2.8753471194811433
SNU-119,2858523,2.542556177546106
Mono-Mac-1,24856436,-2.470151993177535
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
AsPC-1,72193861,3.428817244246792
TE 441.T,44607530,1.859279931276101
TE 441.T,16736978,0.9580178538653972
NOMO-1,3543504,4.095340640265792
Ri-1,decitabine-carboplatin (1-1 mol-mol),0.1199514595226231
HuT 78,46398810,2.0725080388247927
JHUEM-7,46215462,1.2748682455186626
TE 441.T,135999136,1.6397829738151082
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
KYSE-450,73707398,1.7321370562114622
SW1783,2749,2.9108764618452456
SF539,65628,3.9792533711127582
NCI-H1339,15983966,-4.134600252769006
KO52,36462,1.66960340133658
TE-14,56963564,-0.0020475710880836
BT 498,vorinostat-carboplatin (1-1 mol-mol),4.07022017256592
HOP-62,5278396,3.1649905019319107
Namalwa,5291,3.7006229898027128
KO52,262093,1.2878327274871448
SNU-423,JQ-1-vorinostat (2-1 mol-mol),1.4797620883628588
SK-UT-1,9926054,1.807396230777958
EHEB,119607,5.753474154470325
SK-UT-1,3136844,6.414538606040479
Mono-Mac-1,BRD-K27188169-navitoclax (2-1 mol-mol),0.3663100658261126
SF539,119607,5.330074057823079
KE-39,docetaxel-tanespimycin (2-1 mol-mol),2.396953201231709
YD-38,89928392,0.9805718232086792
HOP-62,docetaxel-tanespimycin (2-1 mol-mol),4.606611900152602
NCI-H196,5566,3.8820743046521127
PE/CA-PJ41 (clone D2),1566236,3.025698807379891
HSC-3,6623618,2.2678621841397644
SNU-213,3384730,5.276674415765901
NCI-H1339,crizotinib-PLX-4032 (2-1 mol-mol),2.596594679687944
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
BT 248,12003241,-0.5635987052840526
HuT 78,9803433,5.134294603794936
ESS-1,5351362,1.0632420043003554
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
SK-MEL-28,24797083,2.1143227978428714
HSC-3,72193861,0.8237499088640272
SNU-213,9911463,3.827165589896959
NCI-H929,9825149,-1.6436750133006153
Ri-1,56946209,-5.333405443135551
SNU-1077,168313047,3.2162291034503703
BT 328,448949,2.700509720099411
RKO,5738263,3.4166283525852523
BT 328,409805,5.840944403536212
KO52,49846579,4.097285176904078
SK-UT-1,448949,1.7923015437003926
NCI-H1339,selumetinib-UNC0638 (4-1 mol-mol),4.735041004813278
TE-14,BRD9876-MK-1775 (4-1 mol-mol),0.905009353447916
KO52,erlotinib-PLX-4032 (2-1 mol-mol),3.627940402925763
Kasumi-2,168313016,3.99242446715415
SK-MEL-5,49766530,5.144736864268162
SF539,9935249,2.423475425325452
Namalwa,100016,3.934978584241161
NCI-H2030,11238147,3.895551084717726
BT 328,11257553,2.5148124289145217
MIA PaCa-2,23582824,0.8302475552181157
SF539,11609586,2.890542664621997
Mono-Mac-1,65628,3.8711624211456215
H-STS,5566,3.25870422892361
RKN,10410894,1.511663597063748
L3.3,52947716,-5.849313058865459
Namalwa,6918328,-2.1802160819991943
Hep 3B2.1-7,selumetinib-PLX-4032 (8-1 mol-mol),2.307602355683176
SNU-423,5278396,4.2566078482147205
BFTC-909,11152667,-0.3524603871752078
IST-Mes1,54613361,2.804102088673467
BT 320,16065773,4.123538520669632
H-STS,5328940,1.248159196656948
HOP-62,448949,1.84106276173181
HCC2108,637858,1.810315688111992
RKN,446155,3.7628691651204234
KMRC-20,100016,7.210629640241846
NOMO-1,24901704,1.738276567126731
SK-UT-1,107985,-4.193387591911345
SK-UT-1,2708,5.491455066314142
BT 286,25154868,4.894925288023734
ESS-1,25227462,-2.235408931429562
SNU-423,2742550,3.778188563180187
MIA PaCa-2,4578,4.4453332581389535
LMSU,219104,4.323800749255201
MIA PaCa-2,216345,3.471588700144882
SNU-213,selumetinib-decitabine (4-1 mol-mol),0.9662990781402068
HCC2108,675434,4.657843907712605
HSC-3,46907787,0.9324024386936162
Panc 02.03,1566236,1.9322803720882225
JHUEM-7,375860,-0.5506223236134746
TE-14,5329102,2.4513756587511857
H-STS,3543504,2.597342605893142
SW1573,10322450,3.835483834832597
SNU-1077,5351362,2.377712922072383
HSC-3,49766530,-2.4571890524447553
Kasumi-2,216345,1.8251746878221435
WM793,44185566,2.5245605998161404
Hep 3B2.1-7,136227924,5.40641673036814
ChaGo-K-1,44486219,4.293398866953343
B-CPAP,JQ-1-vorinostat (2-1 mol-mol),1.1019909807743078
SW1783,11214940,3.7998857791777287
JHUEM-7,46199207,2.803889105727764
JHUEM-7,439501,-3.5721158792487646
AU565,753704,4.59624742359194
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
KMS-12-BM,969516,2.2529798908048244
BT 248,72376,-0.6579483524735774
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
BFTC-909,11455910,1.958059547603208
Panc 02.03,66577038,3.3089612685646985
SNU-423,11427553,2.9805935522696685
CML-T1,753704,4.085313154725238
KYSE-180,tanespimycin-gemcitabine (1-1 mol-mol),-0.7772592135179538
HuT 78,11494412,0.3707002136667609
Karpas-422,2746,1.689970111701259
BFTC-909,54618771,2.8225313881877545
KMS-12-BM,24748573,1.031059985436439
SNU-1077,159324,3.2853516722485994
KE-39,16720766,4.546084140767303
RKO,135411,0.3039750611139232
BT 248,24772860,-1.8114686790878316
AsPC-1,46398810,3.192713565122567
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
BT 328,17755052,2.7457916392526247
KYSE-180,doxorubicin-navitoclax (2-1 mol-mol),0.1491747369052168
ChaGo-K-1,24821094,3.1681477916504144
TE 441.T,409805,4.133178498098395
BT 498,9926054,3.200560952387037
SK-UT-1,168312962,-2.178754145996638
KYSE-180,5470400,0.6957962839919276
BT 498,decitabine-carboplatin (1-1 mol-mol),4.946076038312435
BT 328,9933475,2.2718026120514216
NCI-H209,285033,-0.5036060100929018
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999
Mono-Mac-1,19582717,2.6339018489596957
TE 441.T,3503,3.456719899712937
AsPC-1,SNX-2112-bortezomib (250-1 mol-mol),0.1734990544717531
HuT 78,2945648,3.150096975155089
SW1573,54454,1.176648172779268
SF539,123631,1.7030857136426885
KMRC-20,5746,0.6434885523366748
Kasumi-2,46943432,0.9724659287269805
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
SNU-1077,navitoclax-PLX-4032 (1-1 mol-mol),4.284771622261252
GOS-3,42642645,0.8540004409462456
BT 286,11494412,1.6157020309527923
CML-T1,44259,0.1754844857900887
LXF 289,66577038,2.7615792990535937
AsPC-1,5738263,4.8764899816054905
BFTC-909,3136844,3.2427360302120403
TE-14,52912189,0.4775769524845665
KMS-12-BM,24797083,1.2365117165456094
Kasumi-2,327653,2.4977161394914953
KE-39,3465537,4.350124533164427
L3.3,60700,-1.0594098724228993
OAW28,5280436,5.165372214799318
LMSU,54618771,1.0017714306772694
MIA PaCa-2,49867926,4.1553717841567215
RERF-LC-MS,16065773,2.958049600168222
JHUEM-7,16659841,3.5134635694670524
SNU-886,serdemetan-SCH-529074 (1-1 mol-mol),2.464759395102203
SNU-216,6505803,0.9385001329114314
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
JHUEM-7,3689413,-2.2301251225415255
SF295,3038522,3.824879559064492
TE 441.T,5426,4.225704142481899
H-STS,46926350,-4.349495266854958
SNU-213,1750826,-0.3902581059910673
PE/CA-PJ41 (clone D2),44607530,1.5651540354177746
Lu-65,49766530,1.0861089243329392
SF539,crizotinib-PLX-4032 (2-1 mol-mol),1.8440004340376177
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
ChaGo-K-1,2858523,2.9669113899986135
SNU-423,4259181,1.1208846332757925
Lu-65,9915743,2.050551276197927
BT 248,409805,5.374494739188799
SNU-119,11175137,3.479199701022153
Lu-65,11612883,3.0642065357892623
NOMO-1,4477,1.0767445259598296
PE/CA-PJ41 (clone D2),6852167,3.048314493941667
HOP-62,1641662,3.962871086552293
NCI-N87,11228183,1.1576925814137384
SK-UT-1,5278396,3.7471831605219665
H-STS,26596,-2.569417697964928
ESS-1,ISOX-bortezomib (250-1 mol-mol),0.2324495051743559
TE 441.T,15953870,3.627702948690547
SF295,5329102,3.14028540074618
HOP-62,5460769,2.443615735481444
BT 320,5281321,2.315886758261944
KE-39,11213558,4.569088998170507
Hs 611.T,676352,1.6943733521846909
Ri-1,4261,0.0314759848451894
NCI-N87,44507138,1.5580904379761216
Karpas-422,44202524,1.2512598284574767
Mono-Mac-1,10296883,2.780550097818586
NCI-H1339,6918878,2.975408494274888
SNU-119,11364421,1.6270559776007496
Panc 02.03,327653,3.634511095206161
KE-39,5287620,-2.6517518735784495
B-CPAP,2729026,3.008270694147531
CML-T1,5328940,-0.6883003462747955
YD-8,11612883,2.3714565826019247
PF-382,568763,-0.4200136453948588
IST-Mes1,selumetinib-UNC0638 (4-1 mol-mol),3.472834598034016
KYSE-180,3038522,3.921557797457244
NCI-N87,24901704,2.2078626603453664
Ri-1,53245473,3.751494812612455
SNU-119,5284616,1.0337608354309102
KO52,65628,3.991598666523216
BT 112,navitoclax-pluripotin (1-1 mol-mol),-0.5614812394120877
H-STS,5280436,0.3080604203440315
SNU-1077,54618771,3.2500418975361347
SF539,decitabine-carboplatin (1-1 mol-mol),4.471103195582989
KLE,71304818,2.924630717517275
SNU-216,285033,-0.9871717950363058
EHEB,49766530,-1.6427312921557593
Ri-1,9825149,1.4325053245443746
WM793,11485656,2.688663515558037
YD-38,11396600,4.074151932666014
L3.3,25150857,3.2841029560324246
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
TE 441.T,24779724,4.334447186977638
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286
BFTC-909,11404337,0.4468911705694049
JHUEM-7,doxorubicin-navitoclax (2-1 mol-mol),-2.086233890960524
SW1783,25150857,3.7084233172602543
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
LMSU,16659841,3.696369337873645
SK-UT-1,25183872,-1.299930208238578
Kasumi-2,5479543,2.6831620827512004
KMS-12-BM,135398516,0.3252714266903287
MJ,2746,3.266657890633373
MIA PaCa-2,2874250,4.325876303213778
RERF-LC-MS,54678924,1.4734481784853186
SNU-213,11427553,3.13292622218242
H-STS,676352,1.5630553052267655
Lu-65,2749,1.4261505855725336
SNU-1077,387447,-4.3711527711694185
HSC-3,16720766,0.1935986019014492
YD-38,9825149,2.3945743779420328
Ri-1,23635314,-2.3371584217228705
HOP-62,44185566,3.047597660054579
CML-T1,9936388,-6.3994005254305995
Mono-Mac-1,9935249,2.3948099372524965
Karpas-422,16725315,3.0879220385886774
KE-39,159324,3.584614004631027
SNU-423,5738263,2.530771634166199
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
SK-UT-1,9936388,-5.820733292214098
PE/CA-PJ41 (clone D2),24821094,0.7752416250698981
SNU-886,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1159003486040796
H-STS,24771867,-2.0225510536358353
NCI-H196,119607,5.902084524849619
IST-Mes1,16659841,2.7339021092282527
Hep 3B2.1-7,9907093,4.032589776825258
SK-MEL-5,2708,5.160333011661181
JHUEM-7,44632017,0.9432703317183572
Mono-Mac-1,crizotinib-PLX-4032 (2-1 mol-mol),1.1974443887432722
BT 498,2708,6.0510362109636455
NCI-H929,9967941,4.011440111055957
KO52,1750826,-4.467141679047344
AsPC-1,54618771,1.0442216511349782
EHEB,11238147,2.9573925088138537
NCI-H929,selumetinib-decitabine (4-1 mol-mol),2.969724213776984
HOP-62,selumetinib-piperlongumine (8-1 mol-mol),3.458683839970051
JHUEM-7,23725625,6.309121610229004
Karpas-422,151289,0.9778807831289208
SNU-216,5113032,4.5325079385306735
NCI-H1339,44819697,0.5202266859972607
Hep 3B2.1-7,selumetinib-JQ-1 (4-1 mol-mol),1.068007517221539
LXF 289,serdemetan-SCH-529074 (1-1 mol-mol),1.9875604335847448
SNU-216,3384730,2.2202403454445117
BT 286,selumetinib-MK-2206 (8-1 mol-mol),-0.8651778836923494
Kasumi-2,11960529,3.120745126362072
BT 286,2729026,1.1931369747850211
WM793,10302451,3.996584762768067
KO52,11612883,1.73729331381162
Karpas-422,11455910,0.7211757450052372
GOS-3,3025944,4.406147026305863
AsPC-1,11640390,5.159931420709134
SNU-423,119607,5.357124425124211
OAW28,51037431,5.214608262969992
SF539,148124,-5.79726265481526
PE/CA-PJ41 (clone D2),5335621,4.800366392306084
IST-Mes1,46224516,1.3511239581863117
NOMO-1,54454,3.4949720971193083
NCI-H1339,11612883,2.8336309454873674
NCI-N87,16736978,0.698711777805788
KLE,53232,1.234342412255229
NCI-H929,tretinoin-navitoclax (4-1 mol-mol),-0.4664155813684951
ACC-MESO-1,123631,3.3434313523705144
BT 286,156414,1.5712991446224744
SF539,15983966,-3.97733563141033
SK-MEL-28,441298,3.154659413422743
OAW28,2828334,6.258958244852924
KMRC-20,vorinostat-carboplatin (1-1 mol-mol),3.852034524239012
BT 112,9907093,5.482705363653191
MIA PaCa-2,5329102,1.5000029259047023
PE/CA-PJ41 (clone D2),selumetinib-tretinoin (2-1 mol-mol),3.593635705218729
KMRC-20,135398516,5.837743145524966
RERF-LC-MS,119182,-0.645974794966856
RKO,123631,2.6120370559458155
SNU-886,24772860,-3.3986263976004913
PE/CA-PJ41 (clone D2),984333,1.6296190436427669
RERF-LC-MS,23725625,5.011639185934848
TE 441.T,25161177,4.57869352023314
SF539,JQ-1-UNC0638 (2-1 mol-mol),0.3445992267657
L3.3,11485656,2.040790548836277
SK-MEL-5,16736978,1.3366068727007083
SK-MEL-5,selumetinib-MK-2206 (8-1 mol-mol),1.6236684340065015
SF295,11485656,3.5430104374180806
SNU-1077,241158,4.367473186933375
Mono-Mac-1,25195348,3.3020482611967927
Panc 02.03,9935249,3.920507280118285
AU565,168313200,1.787588028354966
OAW28,148124,5.441417229348929
NCI-H196,24951314,1.598865298962579
L3.3,126941,-2.2408794553514735
Lu-65,8515,3.512181420890395
LXF 289,selumetinib-MK-2206 (8-1 mol-mol),2.3074669489760296
BT 286,208908,2.223006881461146
SNU-886,1716436,2.5748440651933766
PE/CA-PJ41 (clone D2),16659841,4.668346825790493
NCI-H209,56973724,3.023144714958246
BT 328,216239,3.5186612290950148
ACC-MESO-1,4261,3.2786620703894584
NCI-N87,409805,4.5069551273823585
B-CPAP,107985,-3.233876642304658
AsPC-1,72193861,3.428817244246792
Hs 611.T,crizotinib-PLX-4032 (2-1 mol-mol),1.0036854600016174
YD-38,11626560,1.7689072058111928
SF539,613753,3.180215487125264
NCI-N87,25183872,-2.1426120555107824
Karpas-422,753704,4.670762479174696
SK-UT-1,4917,3.615993600878312
NCI-H1339,11404337,0.2277853658172252
Kasumi-2,25105715,3.2709711323954536
HuT 78,1242560,3.6169776257670345
NCI-H929,doxorubicin-navitoclax (2-1 mol-mol),-2.4469674599934574
IST-Mes1,2113511,6.40207592921409
Namalwa,9884685,-0.9006349124358586
H-STS,5329102,1.888507265760659
KE-39,322968,3.9954940366420297
CML-T1,119182,-4.6073645657146285
Lu-65,448949,1.923751722037902
KO52,24772860,-1.0448231719232914
Becker,5291,4.297720804141337
KYSE-450,49766530,0.7642756518369849
IST-Mes1,3384730,4.026476803757859
YD-38,6918328,0.3729203345521322
YD-8,24772860,-1.4663739289558224
NOMO-1,11626560,1.0628914473501356
H-STS,2828334,6.0228832587508006
KMRC-20,9915743,2.261900740642606
HSC-3,44819697,-1.2152124180192134
ESS-1,16013152,5.626524469878935
WM793,9825149,2.4189460978958266
RKN,1716436,3.648262431092988
TE-14,11404337,-0.8774681002045693
RKO,10231331,2.816804700080647
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924
BFTC-909,216239,2.6603594422751136
BFTC-909,24771867,4.730369684143592
IST-Mes1,168312962,2.5289389848934647
YD-8,9936388,2.2646667902608724
HSC-3,3543504,4.437917604645005
YD-8,11507802,2.799805869196936
SF539,426756,4.818547451090759
SNU-1077,123631,2.741510645866922
Ri-1,54649381,2.8324832014718155
SNU-119,23725625,6.436017901271369
NCI-N87,56946209,-4.157058230951839
OE33,11455910,2.709307324033481
SF539,3543504,3.049224466295834
Kasumi-2,135423438,1.5853456579896534
Kasumi-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9653989283259805
NCI-H2030,10074640,4.267882831955008
OAW28,16720766,3.888951908869231
KMS-12-BM,262093,1.1865999929989532
SNU-423,262093,3.077382051759327
KO52,tretinoin-carboplatin (2-1 mol-mol),3.6636707238793624
KMS-12-BM,11647372,-0.2688616751164015
YD-38,alisertib-navitoclax (2-1 mol-mol),3.864824475515297
H-STS,2871966,-0.6937217649488046
HOP-62,11364421,0.1939440207571194
SK-MEL-5,322968,4.821456208157591
Lu-65,10231331,-0.1827270457349836
SNU-886,11485656,2.594845566887895
HEC-108,71304818,2.263440211327266
NCI-H2030,3038522,4.390336919265978
IST-Mes1,135411,1.0362911335756892
KE-39,168313200,1.6918255094583214
Lu-65,387447,-3.75008165482626
LXF 289,46398810,1.8383298322371264
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
TE-14,15953870,3.387978036470922
AU565,44620216,3.755834453350393
RKO,441298,2.3183923582018107
SK-MEL-5,72734382,4.773475794539037
Ri-1,6450551,1.5942274465310526
Mono-Mac-1,44493528,3.807460562047893
LXF 289,3025986,-0.453776319374568
NCI-H196,168313047,3.552426610249759
B-CPAP,252682,6.481152760334254
Hep 3B2.1-7,44507138,4.806183926619429
Lu-65,selumetinib-vorinostat (8-1 mol-mol),0.948619360922771
SNU-119,25062766,2.2168629550530663
EHEB,219104,3.08550903293029
BT 498,71729975,3.1089495974635835
L3.3,3385,2.739789505554014
NCI-N87,65628,4.009039012864223
BT 320,vorinostat-navitoclax (4-1 mol-mol),3.086351264141679
KO52,148198,-6.726627358418003
SNU-886,1750826,-2.8015436455469493
NCI-H209,135411,0.7970408532487251
KO52,71304818,3.049404193562579
KO52,54678924,2.3208002144974778
NCI-H929,100016,3.8135603062591
SK-MEL-28,SNX-2112-bortezomib (250-1 mol-mol),0.1110740577987287
JHUEM-7,11214940,1.5777405725342055
ESS-1,11427553,2.850757771456098
Namalwa,10184653,1.1583544921124178
AU565,4521392,3.744925242939049
Becker,11507802,0.7319410814237062
TE 441.T,44137675,2.4216853844667985
SK-UT-1,49766530,-1.8212556826920157
SNU-213,151289,2.6508507215309556
Hs 611.T,11625818,1.6161775946459724
RKN,246676,4.414592383854902
SF539,2949965,2.7185790269908003
Karpas-422,216239,3.091609126676661
SF295,71304818,2.8074932440890352
EHEB,6918878,1.3489098367208612
NCI-H2030,72193861,2.967483909024043
Lu-65,3543504,4.861867816458105
NCI-H2030,400769,-0.4492735508687972
KLE,6438330,2.393391106186865
AsPC-1,9956119,2.16125044927063
SNU-119,4096211,1.6502614157208848
KE-39,9915743,-0.5446321163343049
L3.3,702558,3.3585745644546474
KO52,8515,2.033649946407287
Panc 02.03,2113511,6.868929428825361
EHEB,124202324,1.636771857102227
HSC-3,11214940,0.9661571472664509
KLE,15953870,2.3268887568767767
SF539,10184653,1.7813996446939269
RT-4,55283,3.030224345806742
WM793,119607,5.577999044145194
RKO,5282054,3.8735499096789856
Kasumi-2,44491742,3.800345149395397
B-CPAP,65064,5.136940139923551
NCI-H196,44589607,3.0896712074396895
SF295,25183872,-0.4443256775822993
KYSE-450,6918638,1.5500469019976144
KO52,6918837,-5.47001608437254
PE/CA-PJ41 (clone D2),crizotinib-PLX-4032 (2-1 mol-mol),2.663673400146886
OE33,5291,4.100901259612058
BT 248,327653,3.4402013175237394
KMRC-20,54618164,4.251401203478906
HOP-62,5280436,3.564174206782728
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
SW1783,46398810,3.5693364639360747
HOP-62,9935249,3.1113084784743
KO52,71576739,5.251943964885362
OAW28,54618164,4.207465894202405
CML-T1,25183872,-2.27655686726873
SNU-1077,67156097,4.729819017533421
KYSE-180,4917,2.992329233033062
WM793,3503,2.6868893579078006
KYSE-180,159324,3.323934124765763
SK-MEL-5,10410894,3.059644403817
HSC-3,54613361,0.1816905747423905
SW1573,448949,2.6434946381292703
MIA PaCa-2,11625818,4.432768975944194
SK-MEL-5,navitoclax-birinapant (1-1 mol-mol),3.7438137761587287
HuT 78,selumetinib-decitabine (4-1 mol-mol),-2.9552795966960823
SNU-423,25102847,3.0694416219969876
SNU-423,erlotinib-PLX-4032 (2-1 mol-mol),4.135123666689958
WM793,135984461,3.5730556754970175
KLE,25062766,1.4887652323177143
Becker,56649450,3.4802228057114073
KE-39,15983966,1.9494927934805544
YD-8,11222830,1.0279037219326927
PE/CA-PJ41 (clone D2),54454,3.556753106123293
KMS-12-BM,decitabine-carboplatin (1-1 mol-mol),-3.2192264428924755
SNU-1077,4788,5.080655668711155
KO52,5287620,-2.460280488193722
LXF 289,9911830,2.045852319971143
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
PE/CA-PJ41 (clone D2),25262965,-1.0517358381882034
BT 286,387447,-4.984845769910886
BT 112,675434,4.248539137201915
BT 286,2871966,0.9709949836637652
KO52,decitabine-navitoclax (2-1 mol-mol),-1.7889510477453996
Hs 611.T,10385095,0.6904393672995198
WM793,12003241,-0.659721194491695
ACC-MESO-1,4477,0.0409070539342514
NCI-H929,9935249,2.217272904882535
WM793,31703,-1.1808506154596277
H-STS,54613361,-0.8413528716163291
ESS-1,60750,-3.419429492485854
OAW28,67291369,5.503883029091299
KMS-12-BM,5280436,2.8744585986860236
Panc 02.03,45279963,4.323488067826322
EHEB,46199207,2.926466130058298
WM793,selumetinib-navitoclax (8-1 mol-mol),2.773218065087456
NCI-H1339,piperlongumine-MST-312 (1-1 mol-mol),1.2826174925611926
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
Karpas-422,49836020,3.572840137931533
KYSE-180,selumetinib-tretinoin (2-1 mol-mol),6.206720364804737
Mono-Mac-1,4788,4.990760691798778
Karpas-422,44507138,3.472250272722531
MIA PaCa-2,10127622,3.0415633804655187
RT-4,25150857,3.012978370734418
KO52,11152667,-1.2056266729151108
KE-39,15547703,1.7331793905971136
HOP-62,5328940,2.0909155724009287
Panc 02.03,10385095,1.3097039910351371
KE-39,11625818,4.741005492826134
GOS-3,vorinostat-carboplatin (1-1 mol-mol),4.212232190110438
SNU-423,11364421,-5.437656498518107
NCI-H929,6914657,-3.822913484179682
SW1573,54678924,1.9184875438403524
YD-38,219104,3.8700105403979
PF-382,44185566,1.017432682942044
SF539,5351362,1.1304414550964104
RKN,1566236,1.687441004968786
LXF 289,4788,5.213081732847737
Karpas-422,9915743,0.8862360651040179
ChaGo-K-1,5311,1.8438071976377644
CML-T1,11497983,1.5281324652658594
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
SK-MEL-5,613753,3.2985063698452826
PF-382,219104,1.153997513178665
SNU-213,107970,2.2765725167688045
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
WM793,24753719,4.8266947199238786
PE/CA-PJ41 (clone D2),49793307,-1.9834196995445272
MIA PaCa-2,2708,5.768507038607672
HCC2108,2945648,3.0780429998691723
SF539,5951923,5.228397463824485
JHUEM-7,44495899,4.33874446499724
NCI-H929,1750826,-3.89812639428639
BT 248,3552672,1.5840638178238662
RT-4,6918328,0.8848146288984396
ChaGo-K-1,11625818,4.687307934112527
TE-14,2729026,3.0361749345722626
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
NCI-H929,54613361,-0.2364744908060287
SK-UT-1,3062316,3.08976408403466
WM793,24748573,4.504607526938656
Ri-1,11427553,1.3261471799784323
HuT 78,71466578,1.9923030103429336
AU565,25154868,3.4836730381065424
BT 112,11222830,1.5105140978241234
IST-Mes1,327653,2.848745693869025
SNU-213,400769,-0.2995381710407024
SF295,25262965,-0.3132434701889637
SNU-216,19582717,4.5653066313925645
RT-4,44819697,1.9904234220349264
SNU-423,54454,0.6144277931079349
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
SW1783,107970,3.037635999927972
B-CPAP,46224516,3.1901698351737537
BT 328,6914657,-4.350943519439018
ACC-MESO-1,31703,0.0673520740882152
KMS-12-BM,44507138,1.2526701604401855
NCI-H929,44589607,1.024401977018112
LMSU,445091,4.667050820468158
PF-382,216239,2.163237785332069
TE 441.T,46224516,0.283738462352693
ChaGo-K-1,168312962,3.0507546612682823
Namalwa,11175137,2.736911908909365
SF539,168312962,3.6488542113401614
AU565,5494449,3.8187307918252262
Kasumi-2,salermide-PLX-4032 (12-1 mol-mol),2.944713771170232
HCC2108,262093,2.915848941362045
NCI-H1339,tretinoin-carboplatin (2-1 mol-mol),5.766498387623692
AU565,2126,4.335330080531479
BT 498,11612883,4.017951205392113
Kasumi-2,navitoclax-birinapant (1-1 mol-mol),-3.1912080416511355
BT 112,4096211,1.2803456710080927
RKO,136227924,3.256787131627037
KYSE-180,navitoclax-pluripotin (1-1 mol-mol),-0.399119188986255
SNU-213,3385,5.795373664597125
HuT 78,4261,-0.4546763762816934
TE-14,10427712,4.366154841577515
AsPC-1,44491742,4.429887143828186
NOMO-1,6852167,1.234836949550939
Karpas-422,carboplatin-etoposide (40-17 mol-mol),1.0968345901116812
PF-382,54649381,2.3884242532831768
BT 320,89928392,3.842726131224359
CML-T1,11234052,1.4016611587884042
Ri-1,44607531,-2.466333838341234
ChaGo-K-1,salermide-PLX-4032 (12-1 mol-mol),5.454543144681506
BT 498,135411,3.2287003420197458
Namalwa,89183176,2.615366381833868
SF539,2130404,3.7538105132797304
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196
SF295,119607,5.866143301773754
TE 441.T,7326481,2.610340700385677
LXF 289,637858,2.285720521187594
H-STS,89928392,0.800005419398714
EHEB,2749,0.1808975316830207
BT 112,54613361,-2.861738596856594
KO52,1716436,3.4089505729900615
KE-39,16725315,3.5990851811512403
CML-T1,9840324,5.6593047828259495
NCI-H1339,25102847,3.622460842241946
B-CPAP,24180719,2.0507449605485033
KYSE-180,5278396,3.1226563629461705
SNU-119,444795,1.2975403527774965
Ri-1,71466380,3.5240850403725426
AsPC-1,219104,4.54762024266609
MIA PaCa-2,439501,-4.331404793236993
SF539,11222830,0.6495721704540977
BT 112,tretinoin-carboplatin (2-1 mol-mol),4.36566401221058
HuT 78,selumetinib-navitoclax (8-1 mol-mol),-3.3209959202803323
LMSU,439501,-3.1304465735998153
KE-39,10113978,4.138536532448647
MIA PaCa-2,24889392,4.053420963482879
SW1783,136227924,2.7676121780420364
WM793,navitoclax-gemcitabine (1-1 mol-mol),-2.7261707189545783
JHUEM-7,5311,2.0992694237496203
HuT 78,46199207,3.332923671335415
EHEB,9908783,5.71177990312006
BFTC-909,10074640,3.0053798884123837
Mono-Mac-1,11719255,0.6442430615646344
SNU-119,2828334,5.778213563087879
OAW28,6610216,3.9661844518771185
SNU-119,613753,3.5891543536371184
Namalwa,2126,3.4152061939625136
KE-39,44484440,3.4843450825893973
SK-MEL-5,8515,4.00227623893396
L3.3,23582824,1.1997888978910711
OE33,4261,0.4728815735010953
HEC-108,23725625,5.683398539557035
EHEB,656346,0.7724879117712764
KMS-12-BM,10322450,2.7501974340219575
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
TE-14,46907787,0.3694296946140285
ESS-1,navitoclax-pluripotin (1-1 mol-mol),-0.2560996080158209
MIA PaCa-2,erlotinib-PLX-4032 (2-1 mol-mol),3.754648518897779
HuT 78,selumetinib-MK-2206 (8-1 mol-mol),-3.652138343341758
Kasumi-2,tanespimycin-gemcitabine (1-1 mol-mol),-5.446919177897971
SK-UT-1,53232,1.9955922885483088
Becker,65064,5.59556726027644
SNU-119,11396600,3.5657342992920547
ESS-1,6918837,-2.928241796985352
KYSE-180,4477,0.5315017524747986
SF539,6252,2.539418639524388
CML-T1,2126,4.385584292912835
MIA PaCa-2,675434,3.942298358915322
BT 248,53495165,3.0905684330313803
KLE,49836020,-2.0520357560351714
RT-4,400769,-0.8649429705916083
KMS-12-BM,25154868,4.096426210892481
NCI-H2030,452548,0.7027193175453731
TE 441.T,54618771,1.354234974700439
AsPC-1,448949,1.7535133746232512
BT 112,72193861,1.04293508394768
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636
SF539,JQ-1-vorinostat (2-1 mol-mol),0.5454424746711817
BT 248,5284616,2.1714532824885473
NCI-H1339,11396600,3.0711399080961934
BT 328,4259181,1.754792833603723
OE33,9967941,4.5959638784699814
YD-8,216239,2.8857236357634655
PF-382,12003241,-3.7051147214471114
PF-382,65064,3.049277713091966
EHEB,72193861,-0.1168553281087315
Becker,49793307,0.1745324597336718
SNU-423,71466380,4.294535058973081
Lu-65,71751553,4.665406208764287
NCI-H2030,3025986,-0.2193329556503326
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
Karpas-422,25161177,5.207009803272956
BT 286,1242560,3.590885965949965
SNU-216,11656518,1.6381880956311667
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
BT 328,25126798,5.564385085332987
NCI-H2030,387447,-2.9646513764291726
NCI-H1339,16725315,5.173954321185271
Kasumi-2,24951314,-0.5780068322267972
NCI-H2030,46191454,1.6513830993355236
RT-4,24797083,2.4952556091999347
NCI-H929,10231331,2.673485705852421
SNU-216,25154868,4.898166250003578
H-STS,135928012,3.8653043239054976
LXF 289,16741245,5.010251526780332
BT 248,23582824,0.3842375588836932
Becker,46199207,3.68158924353219
JHUEM-7,2708,5.089129361016784
BT 498,44185566,3.051411567565442
Lu-65,5281321,-0.5328695352213001
RKO,24771867,6.323343540042099
SF539,126941,-2.8509530485587065
JHUEM-7,53495165,-3.1314756111432236
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
NCI-H1339,salermide-PLX-4032 (12-1 mol-mol),5.736856833548513
SNU-216,448949,2.4814824001359463
SK-MEL-28,675434,4.199457479728167
PF-382,54619238,4.57773905156779
HSC-3,6610355,4.654791000572877
OE33,12003241,0.2230817721074321
SF539,3825829,3.026626259970261
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
JHUEM-7,25262965,-4.73461775117277
EHEB,3543504,5.334270443674065
KMS-12-BM,984333,0.8199562104848779
B-CPAP,46191454,1.9154724168312085
AU565,12001922,1.255153902569356
KE-39,9911463,3.415693188275342
L3.3,5311281,4.47128753759965
OE33,969516,2.632797629373086
SW1783,3854666,3.296513769962362
NCI-H1339,44137675,3.1401606981690646
PE/CA-PJ41 (clone D2),73707398,2.4931970679708972
KLE,676352,1.979256710786136
RKN,24785538,4.869460471506453
AU565,54618795,2.974070020268914
LXF 289,54619267,4.7435335143288935
OAW28,89183176,4.823946494889004
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
PF-382,11152667,-1.8592814828562831
TE 441.T,11178236,-2.618794428548956
BT 112,322968,2.3735338663741192
ESS-1,3503,2.154082374677134
OAW28,446155,3.9986810531407486
Karpas-422,docetaxel-tanespimycin (2-1 mol-mol),-5.263561049867699
HSC-3,89928392,1.3069545260692466
KYSE-450,erlotinib-PLX-4032 (2-1 mol-mol),3.596980184500655
Ri-1,675434,3.90496175093301
HuT 78,UNC0638-navitoclax (1-1 mol-mol),0.0082226538693411
SF539,doxorubicin-navitoclax (2-1 mol-mol),-1.7413374971116728
ESS-1,5746,0.0804906650229093
SK-MEL-5,doxorubicin-navitoclax (2-1 mol-mol),-0.1967922597194684
ESS-1,5284616,3.0410604134986405
RKO,24779724,5.847036108864024
TE-14,16722836,0.976659761466278
CML-T1,452548,-3.528686830959828
SNU-213,119607,5.874440203176763
HuT 78,5282054,1.191616800468705
LXF 289,119607,4.549732560104057
OAW28,2729026,2.5871569751548047
BT 328,11222830,1.4031048122319796
Karpas-422,262093,3.033308575813637
SNU-886,3552672,3.544596634627867
MJ,2749,1.2624455241951358
BT 248,676352,1.654368845250315
YD-8,36462,2.7241354710815
BT 248,3025986,2.9298231166336297
MIA PaCa-2,44589607,2.9560404415477533
Mono-Mac-1,navitoclax-PLX-4032 (1-1 mol-mol),0.2984522529277024
HEC-108,656346,1.215673304181218
ACC-MESO-1,25062766,1.64302611578302
NCI-N87,5280436,4.116578666931142
KMS-12-BM,67156097,-3.200598726498201
WM793,676352,2.515815978900982
YD-8,piperlongumine-MST-312 (1-1 mol-mol),2.2719488759687385
EHEB,44607531,1.253327134816266
AU565,6610216,3.647426232490327
RERF-LC-MS,445455,4.41080153827665
KLE,31703,-0.6562509778186947
SNU-216,16038120,1.3117535051919935
RKO,2858523,3.1569923390566332
NCI-N87,46224516,3.4075734240800624
Hs 611.T,6917907,-6.1157509983755345
LMSU,24964624,3.0894427581884334
Karpas-422,25126798,3.878954460710037
PE/CA-PJ41 (clone D2),2945648,3.0815607397196207
LMSU,54619267,4.386146647321598
Hs 611.T,5460769,0.2348324565646969
EHEB,89183176,4.165917160627171
HSC-3,65064,5.231951688651485
H-STS,11507802,0.4528511080463978
SF539,alisertib-navitoclax (2-1 mol-mol),-0.0974409144974691
PF-382,docetaxel-tanespimycin (2-1 mol-mol),-5.687046056145867
GOS-3,24821094,3.805948767285243
OAW28,9933475,1.6622343224708085
ACC-MESO-1,10074640,3.497274494427276
KMRC-20,11609586,2.572780033443364
BT 112,3503,0.8637202569317721
NCI-H929,136227924,1.899057841083653
KO52,11656518,1.0654338145229658
IST-Mes1,7251185,3.206804970970884
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
KLE,9866186,1.5006756729771336
NCI-H929,57519531,1.5644006725496582
HEC-108,17759555,3.905037779906696
OAW28,44819697,-1.5562690526140308
L3.3,9911830,2.6705572013337195
PF-382,71466578,2.892192903824988
PE/CA-PJ41 (clone D2),10184653,-0.8548111367788473
Hs 611.T,24856436,-1.828552922418544
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
KE-39,16038120,1.0564410098934849
RERF-LC-MS,322968,4.758979615786181
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955
HEC-108,11175137,3.357797200724247
ChaGo-K-1,11657048,4.982961492034328
LMSU,156414,1.5302250641749746
Hep 3B2.1-7,5311,1.3035655137086448
ACC-MESO-1,54619267,4.83150874109993
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
ChaGo-K-1,285033,-2.8760812177959347
OE33,11977753,-4.125573657432353
OAW28,107970,2.4537130721494105
KO52,71466380,4.947279567827718
SK-MEL-5,52947716,-6.537803077416063
WM793,6505803,-1.695252066312567
MIA PaCa-2,56946209,-5.316828012783855
ChaGo-K-1,navitoclax-gemcitabine (1-1 mol-mol),3.7271167983392433
Karpas-422,451668,0.3348454552678767
NCI-N87,6918878,2.817621762559668
KE-39,9929138,5.605001473491643
MIA PaCa-2,24180125,2.6361206455792066
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
Mono-Mac-1,25126798,3.343794523028253
AsPC-1,10302451,4.160835682979353
KYSE-450,24753719,4.912608563377894
NCI-H196,445091,5.113159041837577
Karpas-422,4521392,4.321390005947519
ChaGo-K-1,44137675,3.810994198806368
SNU-213,219104,4.630858879868153
KLE,5335621,6.0454813938491405
HuT 78,selumetinib-PLX-4032 (8-1 mol-mol),-3.310365038603551
BT 112,375860,-0.4292821848483891
NCI-N87,2841722,4.410495760007658
SNU-216,54596558,4.461743711323361
GOS-3,409805,3.6304586799066967
KMS-12-BM,9936388,-7.442749057312851
PF-382,16722836,0.500687178002076
L3.3,36462,1.8942720792997911
RT-4,89928392,1.3155194503405725
SNU-119,11485656,2.5966291939022192
HOP-62,3634881,4.27388992864853
OAW28,637858,2.2776250733597085
NCI-H2030,65064,5.8435941201320825
BFTC-909,54613361,0.5481358040879688
JHUEM-7,135398744,6.411220982649173
NCI-H1339,6450551,3.0443618718545244
CML-T1,107970,1.8137988275945616
CML-T1,tretinoin-carboplatin (2-1 mol-mol),3.366911214203907
OAW28,25154868,4.5321266568460805
KO52,72193861,-1.1014673459413422
OAW28,208908,1.9779710002494069
Namalwa,4096211,1.0256721526458017
KO52,51039095,1.8517691823265992
RT-4,6918736,0.057811102641414
KLE,10231331,5.289162464767698
NCI-H929,11364421,-2.397738455551311
KLE,42642645,1.516537245777594
KYSE-180,5978,-1.6510640748820715
OAW28,9926054,1.976123345191561
SNU-216,753704,4.505570675332015
RKN,10074640,3.313081701902331
HEC-108,73707398,1.5484357778063762
NCI-N87,54619267,3.778794485594146
KMS-12-BM,409805,3.008136654369979
SK-MEL-5,5311,1.005186361519784
BT 320,9444,6.119535049609411
SK-MEL-5,25150857,2.2941529310638877
SNU-216,46174525,4.3204118405279255
ChaGo-K-1,11238147,3.908632567260728
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
Ri-1,11222830,1.002314004002837
KE-39,decitabine-navitoclax (2-1 mol-mol),1.2325731360672605
BT 498,11152667,1.974918691110967
BT 112,637858,1.3708104354326625
Namalwa,6610216,4.155862937962793
Ri-1,44202524,1.1523860177568743
YD-38,3815108,3.839333644300384
ACC-MESO-1,124202324,3.762951160491622
H-STS,72376,-2.162494963695944
Ri-1,1242560,2.284731901733303
Namalwa,JQ-1-UNC0638 (2-1 mol-mol),-1.843208201635932
KO52,ISOX-bortezomib (250-1 mol-mol),-0.2750046766745305
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
OAW28,1641662,3.6011202742070014
ESS-1,5287620,-2.0869622348593624
NCI-N87,17755052,-1.4521000328048816
OAW28,71466380,4.3449274646859495
HCC2108,72376,-2.554295384171075
LXF 289,10410894,3.939992216810496
KYSE-180,16720766,1.7167051312732595
BT 498,24775005,3.556771957231718
NCI-H1339,navitoclax-gemcitabine (1-1 mol-mol),-4.509040126661822
SK-MEL-5,selumetinib-PLX-4032 (8-1 mol-mol),2.720334370628281
KMS-12-BM,7326481,2.7761421195772544
Lu-65,55283,4.17804485585188
SNU-213,135421197,2.2792835673188687
NCI-H1339,JQ-1-navitoclax (2-1 mol-mol),1.6105623837388292
ACC-MESO-1,72193861,3.3380031142897684
CML-T1,49766530,-2.849769761760908
B-CPAP,4788,5.4024442798763905
BFTC-909,5311,1.6846521587280363
HOP-62,2949965,2.889476445152641
Lu-65,445091,3.92858193162068
SF295,60750,0.8931682172733182
YD-8,4259181,0.3383272267042485
SK-MEL-5,51037431,2.2293778167880864
AsPC-1,445091,6.474898015897582
KYSE-450,5280436,3.3266706371790264
SNU-886,67291369,0.2726616209500875
HSC-3,31703,-0.4062327367714799
ESS-1,44137675,3.2480943550658576
SNU-216,5460769,1.6923637113112366
SNU-1077,25183872,-0.8765596964039514
KO52,vorinostat-navitoclax (4-1 mol-mol),-2.6787404148123843
YD-8,doxorubicin-navitoclax (2-1 mol-mol),-0.757010809719607
IST-Mes1,3689413,0.9013533734229402
SK-MEL-5,16741245,2.8689553776613494
Lu-65,107985,-2.4100126884744015
TE-14,445091,5.539095923057867
Hs 611.T,44607531,0.8847893661786449
RKN,5278396,4.050807510430523
PF-382,16115403,-5.914744850998346
SNU-213,446155,3.297839333720223
AU565,25227462,0.9575642046813388
NCI-H929,44491742,4.424394304638718
KMS-12-BM,navitoclax-gemcitabine (1-1 mol-mol),-3.5560923194390006
OE33,24797083,1.6231264177904576
ChaGo-K-1,60700,0.6299469520284973
IST-Mes1,5282054,4.276236228318484
RERF-LC-MS,23582824,0.1470987082457378
BT 328,15983966,3.6622955294931865
Becker,44819697,-0.6778092127374704
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
GOS-3,45279963,4.315465934949481
ChaGo-K-1,5284616,3.0899776435340027
KMS-12-BM,2749,1.1667301765067617
Hs 611.T,JQ-1-navitoclax (2-1 mol-mol),0.3532354709872614
BT 320,56963564,5.490825870792066
SNU-886,24978538,-8.014318851835679
L3.3,doxorubicin-navitoclax (2-1 mol-mol),-0.9996417914636118
SK-UT-1,613753,3.318153471243221
EHEB,216468,1.5463895294433374
OAW28,11609586,2.8574541529278883
LMSU,navitoclax-MST-312 (1-1 mol-mol),1.1685647983741614
BT 286,71680916,4.257745459661519
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
WM793,44819697,-0.03600588144364
Hep 3B2.1-7,9911830,1.7769280634909912
KO52,15953870,3.5562610214324653
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
YD-38,17755052,0.4117641046622947
BT 498,122327,5.198903507544806
ChaGo-K-1,16013152,4.057243427628333
Hs 611.T,9866186,-0.2161850451138603
NCI-N87,216345,3.97830172236079
HOP-62,73707371,2.551931688807385
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
KE-39,2708,5.6188157628289925
Hep 3B2.1-7,216345,4.196710950743181
ChaGo-K-1,54618305,4.246058769958448
RT-4,doxorubicin-navitoclax (2-1 mol-mol),-0.4200341898170817
KMS-12-BM,selumetinib-UNC0638 (4-1 mol-mol),2.7847421040854603
BT 112,6918328,1.0363276408883513
AsPC-1,24772860,0.3605797719579043
NCI-H2030,15983966,1.0787102395140626
HEC-108,2708,6.110657664739327
RKO,1750826,1.760307875609834
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
KO52,2746,2.0900422497447906
MIA PaCa-2,104842,-2.85264341377728
RKN,67156097,-0.5718675734992968
BT 248,135875424,2.546043839111523
TE-14,5978,-3.20065607846914
IST-Mes1,44185566,3.025290337876495
SW1783,navitoclax-sorafenib (1-1 mol-mol),4.194590797982974
Hep 3B2.1-7,16722836,1.6346770689455403
JHUEM-7,57519531,2.2164320410194063
Mono-Mac-1,17755052,0.0767939682825722
IST-Mes1,5113032,4.841043294054768
PE/CA-PJ41 (clone D2),11497983,4.526154771713417
SK-UT-1,54619267,4.514007614998197
KO52,24180125,3.3572012584638613
NCI-N87,57519531,1.4365599080949227
SK-MEL-28,5351362,1.7510141514144195
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
SF539,11656518,1.229269486951703
YD-8,vorinostat-navitoclax (4-1 mol-mol),2.141910659803834
KMRC-20,638278,3.6532270710098818
KO52,9903786,1.3206822748757847
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
NCI-H1339,11214940,4.423314112627096
KYSE-180,3025986,-1.575125214964891
RKO,400769,-0.364727826621167
IST-Mes1,12003241,-1.7187710036837192
ESS-1,23725625,4.356874799520387
SF539,71304818,2.242612100692728
BT 498,135875424,3.150429417088691
EHEB,654092,-1.857578615070723
SNU-886,20959075,-1.9195531644083397
IST-Mes1,969516,2.6899901133592103
HuT 78,44137675,1.3553085189057965
Becker,11175137,2.5882807141403363
AsPC-1,3634881,3.56845743908184
KE-39,44487872,4.457727251314366
Panc 02.03,5281672,4.500820026656837
Karpas-422,alisertib-navitoclax (2-1 mol-mol),-1.6367289046584168
BT 498,5287620,-2.66292935604836
SNU-216,400769,-0.8267203800498377
HuT 78,55508,4.04712313060397
Namalwa,11222830,1.004223683138916
LMSU,46199207,3.57619912371696
SW1573,31703,0.7694714266266048
YD-38,984333,0.696067523171479
Kasumi-2,54649381,3.5158481033233593
SNU-213,11640390,3.703838959573684
KMS-12-BM,24821094,2.863970661783892
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
AsPC-1,12003241,0.1897400127907629
SK-MEL-28,5328940,2.9501467839577744
ESS-1,5738263,3.9330786709823986
Namalwa,2113511,4.478594560568948
CML-T1,1641662,2.8295390269831464
ACC-MESO-1,67291369,5.853456682413024
SF539,24180719,2.4860980350614073
SNU-119,carboplatin-etoposide (40-17 mol-mol),4.59312893478617
YD-38,25195348,3.0604251570911587
AU565,10184653,-2.737102807310711
AsPC-1,11234052,4.540853045838434
HuT 78,tanespimycin-gemcitabine (1-1 mol-mol),-3.1990435340994043
KO52,2708,3.123821220671842
BT 320,2729026,2.399631543883215
Karpas-422,56946209,-7.918567186496904
Kasumi-2,6918736,-2.315158162333665
PE/CA-PJ41 (clone D2),24978538,3.2708324415161116
SK-UT-1,675434,4.504318177888332
NCI-H929,36314,1.7139372343272217
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305
Becker,71751553,4.672382658610356
KE-39,42642645,1.367345124375733
BT 248,11427553,3.5134734510694687
NCI-N87,5329102,2.120238068250485
RERF-LC-MS,44462760,4.251912039026111
ACC-MESO-1,44589607,4.343564105396685
BT 112,9915743,1.837502115717176
ChaGo-K-1,136227924,2.8574479872364247
Ri-1,5335621,3.5849906536782252
GOS-3,24180125,3.35218152246705
MIA PaCa-2,57519531,3.173906038307624
Becker,25154868,5.49474478911542
SF539,JQ-1-MK-0752 (1-1 mol-mol),0.6318948649394762
BFTC-909,72376,-1.4314875177558029
OAW28,71466445,4.188405368682896
TE-14,25183872,-0.523282113433947
LMSU,11625818,5.059170877046766
KO52,44495899,4.429122430834432
AsPC-1,53325874,4.506725704395743
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
SNU-423,25126798,3.799827359638474
NCI-H2030,46199207,3.2278610843944313
SK-MEL-28,656346,3.623925904090985
Ri-1,44493528,4.227657049972306
HuT 78,208908,2.8130928881015422
YD-38,60700,0.7565499239393401
SNU-216,6918638,0.1724072866575592
NCI-H2030,9926054,2.071654789099982
BT 328,2858523,3.1475044170181996
OAW28,1716436,3.318226269910468
Lu-65,44137675,3.671350913807576
SNU-119,9868037,3.103417825493656
L3.3,1242560,3.353722310779613
SK-MEL-5,65064,5.630976284944332
Lu-65,53232,1.761486710748555
SK-MEL-28,25105715,3.414843394812394
HSC-3,16722836,1.7284043741706685
SK-MEL-5,1716436,0.9417842907205056
BT 248,3384730,2.3830241448741987
HCC2108,25150857,2.994087068367986
SNU-119,15953870,2.479349019849552
Namalwa,15547703,2.517060625499504
HuT 78,alisertib-navitoclax (2-1 mol-mol),-1.6997195751754324
ACC-MESO-1,51037431,1.6325795920503512
IST-Mes1,46843906,1.738626305357275
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
Mono-Mac-1,11485656,2.9972427080576836
LXF 289,44607530,1.309750089611443
HOP-62,2708,4.639919882442816
TE 441.T,26596,-1.4712296697044354
AU565,9884685,0.3686008824574254
HSC-3,10113978,3.768062627679758
Mono-Mac-1,2113511,3.959955844054084
BT 286,24775005,3.227465140595902
SF539,46191454,1.070261484173304
HuT 78,31703,-1.631625857843589
SNU-216,11719255,3.4273768528884982
AsPC-1,2729026,3.0501658646319796
Hs 611.T,10074640,2.358628598504818
SNU-886,BRD-A02303741-navitoclax (2-1 mol-mol),-5.741782833272406
KE-39,9915743,-0.5446321163343049
KMS-12-BM,11213558,1.176856532865763
EHEB,73707398,0.3528380726382398
YD-8,11213558,0.4605208185550022
B-CPAP,tretinoin-navitoclax (4-1 mol-mol),3.2232408113370745
MJ,49766530,1.2980181747447994
B-CPAP,71680916,4.790234553157112
Karpas-422,24964624,-1.061360838070699
LXF 289,5328940,2.0490491787199687
RT-4,3385,4.126461688410087
ESS-1,51039095,3.5660815776575228
Becker,selumetinib-BRD-A02303741 (4-1 mol-mol),6.881234663908775
KE-39,753704,5.009174848734236
SNU-423,89183176,6.316481371266781
Karpas-422,selumetinib-MK-2206 (8-1 mol-mol),0.7605062920110189
BT 498,docetaxel-tanespimycin (2-1 mol-mol),0.8722065410112619
SNU-119,16038120,0.2287829434664864
EHEB,navitoclax-piperlongumine (1-1 mol-mol),0.5125225467542266
Karpas-422,439501,-2.968319248514649
KLE,5329102,2.881910158775446
HCC2108,168312962,1.890328048752136
TE-14,JQ-1-navitoclax (2-1 mol-mol),0.0318613867060366
HEC-108,6918837,-1.8871962922774617
IST-Mes1,44819697,0.965138597180618
LMSU,119607,5.586825661807856
SF295,637858,2.706804834358429
TE 441.T,5328940,1.8162925297446155
MIA PaCa-2,2746,3.119583352790748
SK-MEL-5,54678924,1.4850480657343377
KMS-12-BM,123631,1.8519032403273297
BT 286,5113032,4.411456497828677
BT 328,44566777,0.5494237323450607
H-STS,9840324,5.735130502734432
MIA PaCa-2,50905018,4.410833032676193
TE 441.T,49867926,3.93813153662813
NCI-N87,49850262,3.22497182450996
NCI-N87,984333,0.3233765721021273
AsPC-1,2708,5.587707055847425
SNU-423,107985,-4.181882942370829
Ri-1,selumetinib-navitoclax (8-1 mol-mol),-1.125961619919062
RT-4,36462,2.6630323769700013
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
NCI-H196,9826308,0.9763243446580108
NCI-H196,448949,2.6638024526067
SNU-423,44498493,4.431214994890045
YD-8,107985,-2.331165064329628
B-CPAP,19582717,5.278680589390403
HOP-62,BRD-A02303741-carboplatin (1-1 mol-mol),5.56274182787722
BT 248,65628,4.438815715072134
BT 248,9549297,1.6274014594604191
BT 328,9936388,2.1535847087745386
TE 441.T,227681,2.4502408119810006
Karpas-422,11228183,1.4854836377169958
ACC-MESO-1,71304818,1.697730113527269
BT 328,119607,6.140002337362805
SNU-886,25126798,4.09091896335188
OAW28,11455910,2.4986666790908583
SNU-216,45279963,3.88317733361902
SK-UT-1,66577038,3.2613537535167874
Hs 611.T,126941,3.528520091647756
YD-38,969516,2.5252476984932852
KE-39,176870,3.2545182858471953
KLE,135875424,3.394401628511705
KE-39,2733526,4.766803704899474
KMS-12-BM,23635314,-2.3782143441311954
WM793,44241473,6.43700199521037
CML-T1,123631,1.8980514916470088
BFTC-909,24951314,2.3445794180209565
Ri-1,24771867,-1.201447409529902
PE/CA-PJ41 (clone D2),6505803,-0.4507500369158054
ChaGo-K-1,44241473,4.641604791111675
PF-382,448949,1.3962904970520496
MJ,6252,-0.2110286359243735
Mono-Mac-1,5329102,-0.8933301485342183
KMS-12-BM,24856436,-0.1996093117488152
MIA PaCa-2,JQ-1-carboplatin (1-1 mol-mol),-0.0764118739989751
BT 328,5311,4.9120281347164525
TE 441.T,285033,-3.368841628531522
GOS-3,16736978,3.431687375441577
Hs 611.T,decitabine-navitoclax (2-1 mol-mol),1.5457683598430108
BT 320,11178236,-2.5149680405736095
MJ,25262965,-4.055624562220278
SNU-213,6852167,2.322505898014435
OE33,4917,4.192196732252219
NCI-H1339,148124,-5.674249092402399
SNU-119,72376,-2.5899020632208742
KE-39,67156097,5.133612548665442
RKN,65064,4.855719732775604
SK-MEL-28,16722836,3.336821512402233
Ri-1,656346,0.6144452864067766
TE 441.T,54613361,0.582802224737856
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991
OAW28,613753,3.2856198284724742
BT 328,9868037,5.326885818831123
HEC-108,16725315,4.671671470713106
PE/CA-PJ41 (clone D2),7251185,3.1222161198320104
OAW28,5329102,1.8792475137868745
EHEB,10074640,2.9654868346265024
SF539,24797083,0.4526611461759284
SNU-886,4259181,0.9120616711669954
Ri-1,135928012,2.2309450357468994
Hep 3B2.1-7,72376,-2.5842514891624884
Hs 611.T,navitoclax-piperlongumine (1-1 mol-mol),0.4922158073235406
RKN,159324,4.081844329649501
RERF-LC-MS,17755052,1.8057357372617977
OAW28,54619267,3.96587417417148
BT 320,16722836,3.1587292617762435
Panc 02.03,44566777,1.8066319547984584
KE-39,54649381,3.8116402123721578
BT 248,7251185,2.921625124470224
SNU-213,3689413,0.5464532854962126
TE 441.T,46843906,3.455798223811649
OAW28,675434,4.444033298399729
KLE,136227924,3.154327848580928
AsPC-1,42611257,3.6284330949745094
SNU-119,60700,-0.1085854321234963
BT 112,JQ-1-vorinostat (2-1 mol-mol),1.5924494369146067
KMRC-20,613753,3.2568220179713614
PF-382,25150857,0.9357192544570664
BT 286,53495165,-2.917577853080983
BT 498,219104,4.156833951191354
BT 320,46398810,3.263265417740268
SF539,156414,1.5385171897873895
JHUEM-7,72193861,0.706328795322279
CML-T1,11656518,-0.3565307280161567
NCI-H929,10074640,2.9963817325731807
IST-Mes1,10127622,4.960728342788448
Becker,4917,3.690734626467594
L3.3,2874250,6.457091097770646
HSC-3,9926054,2.205728912393848
NOMO-1,11455910,0.2303469505827257
KMS-12-BM,71680916,2.263503265107647
SNU-886,15547703,2.7270775608273174
JHUEM-7,44486219,4.165203149222617
AsPC-1,24901704,4.152315193440913
SW1783,24951314,2.5031295891577083
SF295,439501,-2.4386536619135137
SNU-213,44607531,1.4164757901683374
TE 441.T,374536,-8.101704814309118
BFTC-909,44589607,3.3115887945185496
Hs 611.T,24753719,2.639825501985761
YD-8,11455910,2.3608003231552717
CML-T1,46943432,2.522264418529326
KE-39,11152667,0.74958800909379
KLE,73707398,0.4840000511633914
ACC-MESO-1,6450551,3.561931878479919
BT 320,5280436,4.79134990721052
SK-MEL-5,46191454,2.492923802582545
Hs 611.T,15983966,-4.349041198579808
Namalwa,135398516,1.579840615104451
EHEB,1641662,3.4928026962929075
HOP-62,1716436,2.852163068438644
PF-382,17755052,0.5460645234403898
SK-UT-1,alisertib-navitoclax (2-1 mol-mol),3.539585462588412
MJ,9444,4.239360752969744
L3.3,5311,1.4084906886854671
SNU-216,44819697,-1.895882945285985
IST-Mes1,11222830,1.7720886037954378
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
H-STS,11719255,3.4202837995113025
NCI-H196,4378219,2.689374955193756
OAW28,46398810,2.3633613380182386
OAW28,3025986,-0.5681838773369163
L3.3,4261,2.1698969963780055
H-STS,11175137,3.379012041415036
LXF 289,36462,2.912637639845359
HOP-62,44566777,-0.9345431833780878
Mono-Mac-1,serdemetan-SCH-529074 (1-1 mol-mol),1.0195185640061482
RERF-LC-MS,9967941,1.5454786965180345
Hep 3B2.1-7,docetaxel-tanespimycin (2-1 mol-mol),0.6913294153617894
BT 112,5282054,3.2552997941378226
LXF 289,5470400,3.745756378340341
Lu-65,crizotinib-PLX-4032 (2-1 mol-mol),1.337779445328492
NOMO-1,44493528,4.211717002525977
SNU-213,16741245,5.672249183986696
KE-39,3543504,4.7094782670385475
B-CPAP,445643,3.9372212515223985
YD-8,60750,-0.3003196445505364
Becker,5746,2.3579978479166384
KO52,6918328,-1.4981845438810923
NCI-H929,656346,1.0360928512144068
HOP-62,216345,4.191400178728098
Ri-1,89928392,-1.6393201076464738
JHUEM-7,11494412,0.4868890434989014
ESS-1,5282054,2.6666271713695906
SK-MEL-28,24180125,3.6660135560508142
PF-382,67156097,-2.0916414621390387
KE-39,3854666,4.449857131704124
ChaGo-K-1,71751553,4.486695284730435
ACC-MESO-1,44607531,1.6516898403362088
ACC-MESO-1,969516,3.1968217861477015
SNU-1077,9907093,4.090287424165682
OAW28,11494412,4.413959214794941
SNU-119,52947716,2.3236850993344285
H-STS,53495165,-1.641069756041938
KLE,568763,0.509610011546881
H-STS,262093,1.3358664140686949
AU565,3038522,2.241670788617941
KMS-12-BM,168313016,3.5287146199889805
RERF-LC-MS,3634881,4.923247717838372
YD-8,24785538,0.9876350008475095
HuT 78,selumetinib-tretinoin (2-1 mol-mol),-3.3029302026602125
GOS-3,3689413,-2.185831490776692
NCI-H929,25126798,3.7313671343137673
B-CPAP,3815108,2.49779395406492
KMS-12-BM,24772860,-3.763334552284853
OE33,53232,3.686167488343025
GOS-3,9936388,2.12022290506738
AsPC-1,2749,1.937127114514975
SNU-213,327653,3.9341238423164127
AsPC-1,73707398,2.3690176063372888
OAW28,135999136,1.5944266420299655
CML-T1,9915743,1.9836361869709076
SNU-213,969516,2.999480362119821
GOS-3,11175137,2.721300894926601
KYSE-450,docetaxel-tanespimycin (2-1 mol-mol),-3.366078664284114
SNU-423,11626560,1.6493886052642734
ChaGo-K-1,54619267,3.9042384056884942
EHEB,selumetinib-UNC0638 (4-1 mol-mol),3.5739302718016597
KE-39,11657048,4.694406687626931
KLE,71466578,4.494231116067741
SF539,136227331,3.3252279599925085
L3.3,10074640,3.5317966219825414
SK-MEL-5,9907093,6.380326986267721
SNU-1077,11178236,-4.2956560843661205
NCI-H929,5311,0.6524822711391439
IST-Mes1,5566,2.9881744281003373
Panc 02.03,969516,3.806573436208542
RKO,1716436,3.795795915163565
SNU-1077,selumetinib-JQ-1 (4-1 mol-mol),1.9000830670563744
KMS-12-BM,6918328,-3.473135115653443
NCI-N87,119182,-3.621619524843969
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
Becker,11178236,-3.172073747487462
SNU-216,carboplatin-etoposide (40-17 mol-mol),3.92091665954738
AU565,2842253,5.995707097044385
AsPC-1,doxorubicin-navitoclax (2-1 mol-mol),0.4165226995067387
KMS-12-BM,56963564,-1.528308653494457
RT-4,selumetinib-UNC0638 (4-1 mol-mol),3.4689576164003664
Namalwa,31703,-3.2423376321614996
AU565,6918837,-4.408945103298963
HOP-62,637858,3.261273294662145
L3.3,54613361,-0.6336215633441857
Kasumi-2,24180719,3.447908092121991
ESS-1,4477,0.5531720696297147
BFTC-909,3854666,1.1654585644167257
OAW28,4096211,1.5501495805084426
NOMO-1,5746,1.3002002606442051
SK-MEL-28,613753,3.2736385592087527
LMSU,11640390,3.606539387611797
TE 441.T,1323703,3.650886184693926
SNU-216,107970,2.273840953303944
SNU-886,5282054,3.1814794510018514
YD-38,16720766,-0.2528373809891789
SK-MEL-5,119607,4.558840645647786
NOMO-1,24889392,4.281820029392572
GOS-3,5746,1.4150119127186604
SNU-886,168313047,3.810150500353015
BT 286,9952709,2.5643743915301145
SNU-423,5746,3.145468816022035
HSC-3,3854666,1.1819322162410355
LXF 289,5460769,3.06478422280727
Becker,148124,-6.351335533141373
SNU-1077,6918837,-2.0302065892211916
Kasumi-2,262093,1.7604912977671856
EHEB,9926054,1.8810570858595552
ESS-1,46398810,3.012711144030241
ACC-MESO-1,54454,2.2105554463598924
RKN,54619267,4.894700718514424
NCI-H1339,44607531,1.9218786847890523
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
HuT 78,445643,3.9069827228558234
KE-39,46398810,2.5573643680926432
SNU-213,carboplatin-UNC0638 (2-1 mol-mol),3.219769925540834
HEC-108,216468,0.5077016894807419
SNU-1077,676352,2.603885974708996
WM793,54454,5.104198308699605
BT 498,6852167,6.0420041098120985
NCI-H929,5280436,3.412366721606299
NCI-H2030,11364421,0.5606861319843897
CML-T1,11427553,0.3447104584156399
BT 498,262093,3.072055867790356
SNU-423,2113511,5.831364294214667
TE 441.T,16038120,-0.9393028579439044
SW1573,409805,6.568626512075582
NOMO-1,44507138,0.557170216692965
Hep 3B2.1-7,51039095,-0.2751836050394881
Mono-Mac-1,doxorubicin-navitoclax (2-1 mol-mol),-2.387887810132074
Kasumi-2,25126798,3.908076551751955
HCC2108,613753,3.4104972330481615
BT 248,156414,1.4948422332158926
GOS-3,10302451,4.10350760632464
AsPC-1,4788,5.925917601642537
ESS-1,11152667,-1.1144895141014577
OE33,24785538,1.6498643953368404
JHUEM-7,9911463,3.659236793496393
AU565,49793307,-1.974878634968376
Hep 3B2.1-7,4917,3.013547990910925
Kasumi-2,9549297,1.4131024835139536
KO52,5351362,0.8431188891689549
HOP-62,53495165,2.032704303702465
SNU-119,selumetinib-PLX-4032 (8-1 mol-mol),3.3924189372513123
Panc 02.03,3689413,0.2165954212360822
Hs 611.T,54618164,3.758252372543717
KMS-12-BM,7251185,3.495873339291499
HEC-108,docetaxel-tanespimycin (2-1 mol-mol),-4.808010092677581
AU565,31703,-1.2264921928318224
KMS-12-BM,53392493,1.4932523405392888
KMS-12-BM,1317464,5.551631719777859
L3.3,3854666,3.761529361474975
Mono-Mac-1,54619267,1.8356475642400525
NCI-H196,4259181,0.9744150084112732
MJ,11955716,-2.5618962222638575
SK-MEL-5,54618771,0.7093345512366925
Hs 611.T,12003241,-4.3632527403619425
ChaGo-K-1,5280436,1.6029209874008523
RT-4,16065773,3.1312717151284155
GOS-3,168313016,4.456848917287458
HOP-62,4259181,1.6890698920595109
SNU-423,135875424,3.328445896940313
ESS-1,9933475,2.1540018278931448
AsPC-1,selumetinib-navitoclax (8-1 mol-mol),0.9742361501395068
BT 112,6252,1.5654239988674197
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
KE-39,selumetinib-tretinoin (2-1 mol-mol),6.162287151844962
AsPC-1,16659841,4.5181069426631
BT 248,135659046,3.5168747963796636
NOMO-1,25126798,3.9519848152055848
WM793,25195348,2.400822719494433
RT-4,25126798,3.4225327599877096
OAW28,20959075,-3.9569108449030295
Panc 02.03,6918837,-1.2317043962492993
NCI-H1339,6918638,0.2750671891608724
RKN,11455910,3.815213247766997
YD-38,20959075,-3.5580886326999175
KMS-12-BM,25105715,2.85606918803758
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
NCI-H2030,4788,5.845910727996914
SF295,72193861,3.9622997215908087
HOP-62,72376,-0.6435309634126237
LXF 289,10296883,3.609856485747645
KLE,71466380,4.290621032590563
BT 328,25102847,3.596555529465503
AU565,119607,5.010456243294951
OAW28,25227462,0.9824255132553372
SNU-119,5311281,2.891953115435588
ESS-1,4259181,0.7076598943715965
KE-39,124202324,2.527643739765998
KMRC-20,navitoclax-gemcitabine (1-1 mol-mol),-1.4557054407433547
SNU-1077,25154868,4.181521053773788
ACC-MESO-1,6610216,4.642819431262072
H-STS,JQ-1-UNC0638 (2-1 mol-mol),1.212466073546629
Kasumi-2,5291,3.833785516332381
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815
NCI-H196,navitoclax-gemcitabine (1-1 mol-mol),0.0406343766358786
SK-MEL-5,49793307,-1.9293314616169488
ACC-MESO-1,carboplatin-etoposide (40-17 mol-mol),3.981012697138959
RKN,52947716,-5.912196482956353
ChaGo-K-1,10113978,3.5588806520341283
GOS-3,vorinostat-navitoclax (4-1 mol-mol),3.0226897716285905
KE-39,24771867,5.944751904846296
HOP-62,11175137,2.747771523845805
TE-14,44566777,1.206992079610698
KMS-12-BM,11625818,2.552202137572075
KO52,11178236,-1.9034207953273736
ACC-MESO-1,148198,-2.036295291578454
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068
MJ,11507802,0.1827831368767201
SF539,SNX-2112-bortezomib (250-1 mol-mol),-2.8372291884695326
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992
AsPC-1,46199207,3.695579616421397
NCI-H929,119607,5.121308216855954
YD-38,9967941,4.915948737435257
RKO,285033,-2.0365968290915393
H-STS,3854666,0.1561624900748555
YD-8,2130404,2.9369369304984994
SF295,9936388,1.8656949469177304
OAW28,5329102,1.8792475137868745
HSC-3,25062766,1.5460878624268062
SNU-216,11214940,3.6076029036400383
ESS-1,16722836,2.4138886266191086
SW1783,52912189,3.916642045529953
Becker,24797083,1.1548920477152247
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
BT 320,156414,4.178952757446285
YD-38,11404337,-1.21391516825444
HOP-62,445643,3.769891604939145
SF295,9929138,4.960030945136907
Lu-65,148124,-0.361922200988903
ESS-1,1285940,5.086751580497306
CML-T1,11717001,4.07494523492724
HEC-108,57519531,4.18371886542851
NCI-H929,51039095,0.5625919712885992
MIA PaCa-2,421610,1.6474550079189487
SNU-423,36314,-6.274263194422466
KO52,49766530,-2.9689315906411413
BFTC-909,11485656,2.882750602975944
HuT 78,285033,-3.0605390542745092
NCI-H1339,9956119,4.080996534733852
HCC2108,3062316,3.16488906574129
NCI-N87,11427553,2.9770783714757005
LXF 289,JQ-1-MK-0752 (1-1 mol-mol),0.1352273684724335
SNU-216,salermide-PLX-4032 (12-1 mol-mol),4.687186515637412
CML-T1,656346,-0.3506831167953311
LXF 289,10074640,2.806214579062189
SF539,8515,4.265018963639613
KE-39,25183872,0.9093858643796752
EHEB,24951314,0.722947577043057
HOP-62,5311,1.2768541791254775
PF-382,3503,1.22639137886012
Hs 611.T,123631,1.6815281040146308
NOMO-1,5280436,3.413613220161409
NCI-N87,2733487,6.3981873446173285
SF295,46907787,3.23145207595968
HOP-62,24785538,1.3439344503188932
RERF-LC-MS,135421197,1.554065103888189
YD-38,selumetinib-JQ-1 (4-1 mol-mol),-0.3338451182587707
MIA PaCa-2,136227924,2.1731844460154743
HSC-3,16038120,1.4145642849720264
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306
NCI-H1339,16065773,3.0125822193221525
SNU-423,11175137,2.118483191381137
ESS-1,9823820,4.0277339286187
Mono-Mac-1,400769,-0.1377248267804078
NCI-H209,9936388,1.6716697805480627
SW1783,10385095,3.137926014779676
PF-382,135999136,1.3874167482573283
TE 441.T,156414,0.839328879560188
SK-UT-1,65064,5.311545954072784
ChaGo-K-1,9915743,2.151950733066917
NCI-H196,5280436,4.249264897117882
RERF-LC-MS,60700,0.497286081450591
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
SNU-119,1242560,2.269349854429625
TE 441.T,6610355,3.6430841955039375
B-CPAP,6917907,-4.328736065913287
HuT 78,2130404,3.85812044436517
BT 248,25105715,2.686391114115495
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
OAW28,5282054,3.6220988157242946
SNU-213,10231331,0.6074693800366775
Panc 02.03,71304818,4.256945507775637
PE/CA-PJ41 (clone D2),104842,-2.4434720439613127
SF539,445643,3.7676894820893896
TE 441.T,25105715,3.584471780752103
SNU-1077,753704,5.47540794782016
B-CPAP,6610216,4.017338863517876
KE-39,9907093,4.662236703806896
B-CPAP,24856436,0.7730146540222972
B-CPAP,148198,-2.876725444252461
L3.3,16722836,1.76831050763334
BT 498,4917,3.1875438777941167
AU565,49836020,5.742264990221176
BT 286,10296883,4.151589590813863
MIA PaCa-2,54618164,3.936263034196557
KE-39,568763,1.2890727054350877
SW1573,5479543,3.675213844165782
JHUEM-7,2746,3.3298840403754153
OAW28,24901704,3.441244042276163
SNU-216,24951314,0.6082856978526928
BT 328,SNX-2112-bortezomib (250-1 mol-mol),-2.692646777339037
Becker,25183872,-0.6086335185182962
Namalwa,11977753,-2.7430299621207563
Karpas-422,BRD-A02303741-navitoclax (2-1 mol-mol),2.7556561737270626
Lu-65,11234052,4.358706299792741
MIA PaCa-2,219104,3.665575033373056
SW1573,135411,2.599466343128946
BT 286,2746,4.414216796759687
KE-39,11719255,3.4808501191509147
RERF-LC-MS,135411,0.496828330774242
KYSE-180,16741245,1.8564307397104032
SNU-119,4788,5.600954059003079
TE 441.T,9887053,1.638763624659808
HuT 78,navitoclax-PLX-4032 (1-1 mol-mol),0.749332467745858
SNU-213,selumetinib-PLX-4032 (8-1 mol-mol),-0.364480846216524
LXF 289,navitoclax-piperlongumine (1-1 mol-mol),2.4157701472871005
BT 286,54618795,3.5839759074897937
KYSE-180,654092,0.3510982053718326
ChaGo-K-1,400769,-0.9998240126612606
Kasumi-2,36314,4.106836250050073
JHUEM-7,984333,1.1979599882445968
SF539,71729975,3.876423931998654
Namalwa,5284616,2.9338527651265824
KMS-12-BM,216345,3.047571531104052
Kasumi-2,46398810,1.7112254413455064
ACC-MESO-1,49793307,0.3404426654654701
MIA PaCa-2,navitoclax-birinapant (1-1 mol-mol),3.251928877119314
SNU-423,54613361,-0.0593712811961012
CML-T1,16725315,3.685793664289718
YD-8,11167602,2.315498397427602
OAW28,doxorubicin-navitoclax (2-1 mol-mol),-0.325587572552389
Ri-1,25195348,1.73301830515513
Ri-1,24772860,-4.365675374144319
ChaGo-K-1,42611257,3.592729168280832
KYSE-180,151289,0.6004966681509784
SNU-216,erlotinib-PLX-4032 (2-1 mol-mol),1.89111562006772
BFTC-909,66577038,2.856590203747272
PE/CA-PJ41 (clone D2),5281321,-1.4532998106593589
SNU-423,4788,5.865866484331293
ESS-1,25062766,1.641098624401774
PE/CA-PJ41 (clone D2),16722836,2.611972062158048
MJ,24771867,-4.046707231281286
NCI-H2030,11152667,0.1486125355085492
PE/CA-PJ41 (clone D2),216239,3.289521243210842
MIA PaCa-2,16219061,3.125044749529742
SNU-886,71304818,2.0640703956829003
Karpas-422,9840324,5.92160025158539
RERF-LC-MS,57519531,1.5399611647939
SF539,9911463,3.3415175792660854
BT 248,2729026,1.163283415080523
RKO,176870,5.862868084879783
HuT 78,24797083,1.4167690374824495
YD-8,10127622,4.990106068897982
Namalwa,374536,0.8945549847595208
SNU-119,11404337,-0.1265251374759644
SF539,2749,0.9972456277180648
HOP-62,45100481,5.138647464622458
NCI-H196,613753,2.6616424659877005
ChaGo-K-1,5291,4.023558989002335
MJ,24772860,-2.9241484283006565
AsPC-1,5328940,1.7821313082315045
Mono-Mac-1,56963564,0.1465814447816201
JHUEM-7,44607530,1.0267127591964027
YD-8,15983966,1.014640671892096
NCI-H2030,6918837,-1.7786733607203498
AsPC-1,44589607,3.181986375917279
YD-38,9935249,3.800527323611882
GOS-3,44607531,1.5266968302788424
TE-14,11222830,1.8970734039157555
L3.3,11234052,5.199825372855332
BT 328,100016,6.778172011931934
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
Ri-1,49766530,-2.264065529315868
SW1573,9936388,3.0507391751654698
BT 248,54618164,4.1848059637542585
Ri-1,135398516,-0.9997229127952316
BT 320,5494449,4.096191424375148
BT 320,72193861,4.258668508473769
KYSE-450,107970,3.4899067291718717
SK-UT-1,24785538,2.9370151695629985
AsPC-1,5281321,-1.206156098851657
SNU-216,46224516,2.6643084527718286
WM793,73707438,4.408840784597168
GOS-3,10385095,1.261141423395055
NCI-H929,11683005,1.6623595675282548
EHEB,12001922,1.634649199110844
H-STS,2746,2.861217997075228
L3.3,135398744,6.452563021638662
B-CPAP,1641662,2.641871424967457
ACC-MESO-1,10385095,1.944189744357827
L3.3,452548,-0.800912327932342
TE 441.T,51039095,1.4475325378615844
SK-UT-1,24180125,3.450035886510637
SNU-216,54613361,1.5924941592542603
ChaGo-K-1,46843906,1.9586607185407423
Namalwa,2742550,3.645148069005769
PF-382,156414,0.6060441396240198
SNU-886,44819697,2.856258446406514
PE/CA-PJ41 (clone D2),51037431,5.889878803115624
YD-38,5281321,0.675198030693185
NCI-H929,15983966,1.8742462336946937
HSC-3,5280436,3.640312984510688
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
CML-T1,6505803,-0.3633146304142068
MIA PaCa-2,salermide-PLX-4032 (12-1 mol-mol),5.361033693011522
SNU-119,644241,2.7771526168962084
KMS-12-BM,11964036,-0.4657573927084836
LMSU,60700,0.2696486188737008
SF539,31703,-1.523395674641048
BT 286,984333,-1.1632809313667252
BT 112,5311281,1.2927719080632414
LXF 289,55283,4.7983814176360715
Mono-Mac-1,445643,2.6169348294716164
RERF-LC-MS,6852167,1.8897499878184068
PE/CA-PJ41 (clone D2),3465537,3.306521730536944
BT 286,5284373,3.081382449720317
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
BT 112,navitoclax-gemcitabine (1-1 mol-mol),-4.253008173611593
KYSE-450,16720766,2.1902157415608836
TE 441.T,421610,1.6817541866444998
KE-39,11455910,-0.1151631297895284
Kasumi-2,3634881,1.9476495169521624
NCI-H196,JQ-1-vorinostat (2-1 mol-mol),-1.4598355433927688
RERF-LC-MS,6918638,0.4520678244574614
SNU-216,51039095,2.9385235111794827
ACC-MESO-1,navitoclax-MST-312 (1-1 mol-mol),0.9370622659916767
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
KE-39,vorinostat-navitoclax (4-1 mol-mol),0.0592807411548529
Ri-1,5282054,1.736002290271582
NCI-N87,4788,6.175336883845895
Hs 611.T,219104,1.9028887164922637
NOMO-1,60700,-1.0021705320646457
TE 441.T,1641662,3.5521434775790137
Hs 611.T,SNX-2112-bortezomib (250-1 mol-mol),-2.8445731465395023
SNU-119,15547703,3.1947959639355834
KO52,72376,-3.1710971417333726
SF539,11964036,0.8812555480716474
BT 286,5566,2.4505971297549927
HCC2108,31703,-0.3826417360031045
MIA PaCa-2,89183176,4.530070181887671
KMRC-20,11485656,3.1191450490376673
SNU-1077,15953870,3.3476247633777585
SNU-119,24964624,2.885020861025008
Mono-Mac-1,6505803,-1.0735015571845192
PE/CA-PJ41 (clone D2),9915743,0.2241511570918921
HEC-108,selumetinib-BRD-A02303741 (4-1 mol-mol),6.22303090572745
EHEB,241158,3.817598938948392
GOS-3,9926054,2.0544356724695776
JHUEM-7,2874250,4.229178527781167
LXF 289,9936388,-5.793518221083613
HuT 78,44507138,1.1414703687130772
KYSE-180,387447,-4.108861459218713
KE-39,UNC0638-navitoclax (1-1 mol-mol),0.4083822928083427
RT-4,159324,1.8094112077356237
BT 320,JQ-1-vorinostat (2-1 mol-mol),2.723123137570139
TE 441.T,piperlongumine-MST-312 (1-1 mol-mol),-0.0477223559946464
KE-39,216345,4.364087845878577
CML-T1,6918878,-0.7643857619236708
RKN,262093,2.5285063130840344
SW1783,10296883,3.940377993774996
RT-4,6918837,-1.3567481481628696
KLE,89183176,-2.483352111006337
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
GOS-3,24785538,1.563454655561809
SK-UT-1,1317464,3.8102371333241023
CML-T1,crizotinib-PLX-4032 (2-1 mol-mol),-0.082010794969092
Ri-1,25102847,1.6589673431928054
TE-14,11257553,0.8839079809046841
Hep 3B2.1-7,11404337,0.0289427466491547
AsPC-1,216468,5.354333542051531
BT 286,2126,4.4745148481835235
NCI-H196,5113032,4.880688917429165
OAW28,2746,2.637952220594215
HSC-3,piperlongumine-MST-312 (1-1 mol-mol),1.829264345451848
PF-382,10427712,3.727131590251748
ESS-1,2113511,5.741051028329071
SNU-423,selumetinib-tretinoin (2-1 mol-mol),4.112042588554093
SNU-216,104842,-1.0763257291976505
EHEB,71466445,3.460498363916868
HCC2108,446155,1.94698082724245
CML-T1,3689413,-2.671933251411637
SK-UT-1,15983966,-3.143048923201685
CML-T1,46174525,3.020182372643586
ESS-1,5566,3.65596879307383
SNU-886,46907787,3.408086497020091
GOS-3,54596558,4.225745385987354
Karpas-422,3689413,0.6826110279753447
NCI-H929,104842,-3.822816655471148
OE33,44607530,1.1212304736058718
SW1783,219104,3.206819219402643
NCI-H929,26596,-1.2167182000669836
BT 286,17755052,1.4603603440503543
BT 498,15983966,3.4496360554797256
BT 498,6918837,0.8299871100943732
KMRC-20,23725625,4.838709119621016
RERF-LC-MS,11625818,4.251014876931036
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
OE33,54618771,0.6463967742027482
SK-UT-1,45279963,3.814266670258307
BT 112,3552672,1.4281271446672807
AsPC-1,60700,1.1964352024151823
AsPC-1,6450551,4.162604073037061
LMSU,5746,2.5570316142886136
BT 498,10410894,3.105544275008135
BT 328,11656518,4.018032711371447
HuT 78,10322450,2.3335862951913726
Karpas-422,54678924,1.4366135782104994
KLE,24748573,2.547641121756725
TE 441.T,327653,2.387297951651056
Kasumi-2,25227462,-2.512802493882235
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
SNU-216,5329102,2.019950725447892
YD-8,16736978,2.484760794127255
BT 112,16065773,1.6561708801047088
AsPC-1,6610216,4.465191830296224
RKO,9926054,1.883626680074333
IST-Mes1,1566236,1.9315527075511711
SK-UT-1,72193861,1.4667643802381731
Namalwa,676352,1.5925385443412192
Lu-65,16720766,0.6350447621100811
TE-14,11485656,2.3244152057135934
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644
SNU-886,5351362,1.18697411300336
Karpas-422,3025986,-1.6736184897187318
KMS-12-BM,44241473,4.1211159216828035
CML-T1,9926054,1.696565612874625
LXF 289,613753,3.241655631161551
MIA PaCa-2,10410894,2.918838225153396
LMSU,25183872,-1.684481128175181
HEC-108,135875424,4.07561778301408
AsPC-1,409805,5.083096669481897
Hs 611.T,72199292,0.7741467404813812
LXF 289,54618164,3.0378434141224617
BT 248,54626689,4.44361910749143
SNU-423,46215462,1.6217220916583457
NCI-H1339,docetaxel-tanespimycin (2-1 mol-mol),-6.507911757530347
NCI-H196,16038120,2.220488644828489
PE/CA-PJ41 (clone D2),5280436,2.0981550433518947
Hep 3B2.1-7,25154868,4.296826538489659
KYSE-450,16065773,3.8243324962121914
NCI-H2030,navitoclax-sorafenib (1-1 mol-mol),1.3272751544111323
PF-382,44259,0.4010800943421826
KYSE-180,3689413,3.064535959483158
KYSE-450,613753,3.352975816171232
IST-Mes1,selumetinib-decitabine (4-1 mol-mol),6.500937496154089
BT 286,3465537,0.9211618438378432
Kasumi-2,5284616,2.846557055185116
RKN,104842,-2.3241286690000265
Becker,6918638,0.8308628231051842
SK-MEL-5,676352,2.4631090651558476
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
ESS-1,4788,5.85778957294441
PF-382,3025944,3.98071208263538
LXF 289,71680916,5.339150924844951
RKO,409805,3.580644131410829
SF539,3503,1.023946445304806
KE-39,46224516,3.9046510157068255
Hs 611.T,24901704,2.091215429755936
AsPC-1,67291369,5.582806392200744
Kasumi-2,2945648,2.1908336830751436
JHUEM-7,selumetinib-decitabine (4-1 mol-mol),4.060789479990773
SNU-886,89928392,0.8718165666636013
KMRC-20,44197249,3.899612901236983
MIA PaCa-2,44607531,1.828336008484694
H-STS,135984461,1.3384437031548353
Karpas-422,56949517,1.4379353462298257
Namalwa,11625818,4.000691082929696
LXF 289,11507802,1.7765111516543377
RKN,5566,3.4992110401170944
YD-8,navitoclax-MST-312 (1-1 mol-mol),1.7163356064773547
Lu-65,12003241,0.1595843887204832
BFTC-909,568763,0.745825262149274
L3.3,107985,-3.199791523822717
SNU-213,409805,3.467553308221755
SNU-216,JQ-1-carboplatin (1-1 mol-mol),3.8633664512106622
KMS-12-BM,crizotinib-PLX-4032 (2-1 mol-mol),1.6093595565016696
LXF 289,JQ-1-navitoclax (2-1 mol-mol),-0.1811537886614743
KMRC-20,44507138,4.202309918297686
Lu-65,10184653,1.797968418926877
KLE,6918289,2.4096746231988995
OAW28,452548,1.2278646078369797
OE33,44185566,2.1268011513186784
SNU-1077,6852167,3.093534637774652
BT 498,3854666,4.451868649055675
B-CPAP,5328940,1.9207769307249352
HEC-108,25126798,3.8368047255927937
SW1573,53232,-0.4627324496874346
JHUEM-7,216345,1.7329243793640925
SNU-119,selumetinib-navitoclax (8-1 mol-mol),2.401180921765086
PE/CA-PJ41 (clone D2),675434,4.34619521110513
OE33,10410894,3.5996316585738057
B-CPAP,44819697,-2.6722684986578247
SNU-1077,44589607,2.849893862801054
CML-T1,42642645,-1.8637300463446456
SNU-213,71304818,2.05795076129124
ChaGo-K-1,3025986,-1.4135171905436132
SK-UT-1,568763,0.546342581161539
NCI-H929,44507138,1.4351733932332458
AU565,46943432,5.0196372017891555
RT-4,168313047,2.65705548195288
SF539,49793307,-4.242973153830116
SK-MEL-5,6450551,3.017299477344576
WM793,9911830,2.975609583515234
HOP-62,24856436,2.288141937054854
BT 248,11656518,0.6524098808252552
BT 286,24785538,-1.6779940438439616
RT-4,54613361,0.2615829847949534
RERF-LC-MS,10231331,0.9954911948227504
KMRC-20,5351362,2.3053530473648776
Panc 02.03,100016,6.582809568040202
BT 320,9840324,5.908905325340882
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
SF539,4705,3.4621418210440296
Ri-1,2828334,5.647865236669552
Mono-Mac-1,72193861,0.5225127451155739
SF539,selumetinib-navitoclax (8-1 mol-mol),2.7228502818299556
SNU-213,5282054,4.422121273871097
Kasumi-2,24856436,-1.5154163657154227
SNU-213,107985,-3.586157663071436
MIA PaCa-2,7251185,2.099852340885803
OAW28,227681,3.168890693964491
SK-MEL-5,24797083,1.0656460799543117
NCI-H1339,322968,3.982114951842054
KYSE-180,702558,5.1302684030030905
SK-UT-1,5287620,-0.1399962541405603
NOMO-1,3384730,0.781590014898287
KE-39,54618771,0.8543301924142261
SF539,6610355,4.186308559739079
HOP-62,15983966,0.519021924007884
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
KE-39,piperlongumine-MST-312 (1-1 mol-mol),2.040458418548574
TE 441.T,57330099,4.3680398337150095
IST-Mes1,73707398,1.324483483158502
NCI-H929,11222830,0.7259966040230217
L3.3,11178236,-1.5128667899079982
KMS-12-BM,6610216,3.741234433073347
KO52,44491742,3.2759729423779103
SK-MEL-5,2945648,2.9185214709568172
KE-39,3081361,1.3988203553755596
OAW28,46398810,2.3633613380182386
SF539,tanespimycin-gemcitabine (1-1 mol-mol),-2.9863403068380614
ChaGo-K-1,9952709,3.267431153016336
TE 441.T,12001922,1.15774914966468
L3.3,4788,5.85214112282752
Panc 02.03,5329102,3.1751218779490404
KMS-12-BM,17759555,4.020532745562922
Hs 611.T,9884685,-2.4852647330534383
BFTC-909,445091,4.3207806819680625
LMSU,9903786,3.928631993031556
SF539,24748573,0.9472280680221892
Hep 3B2.1-7,46174525,4.569141878122872
MIA PaCa-2,148124,-8.04655725116999
RERF-LC-MS,675434,4.646232548137413
NCI-H929,46907787,-2.2229329095691495
IST-Mes1,135440466,1.140650487435685
RKO,44507138,3.480554434186059
Lu-65,6450551,2.7504557030292536
RERF-LC-MS,4477,-0.1141702320643991
Karpas-422,65628,4.69981691134154
Lu-65,445643,4.085540954686197
Ri-1,5311281,0.8433532864146127
Becker,16065773,3.089193480337579
MIA PaCa-2,15547703,4.29520313125994
HuT 78,400769,-0.7325888332601455
SNU-119,6438330,1.1490589890035967
Hep 3B2.1-7,SNX-2112-bortezomib (250-1 mol-mol),-2.3755334670867025
HuT 78,2842253,5.94786669464028
SNU-213,25126798,3.874546717760269
Ri-1,3634881,2.329895582823285
NCI-H929,11964036,-1.4756093749186814
RERF-LC-MS,387447,-4.351660250848144
KLE,10302451,4.42053427640389
L3.3,piperlongumine-MST-312 (1-1 mol-mol),2.794540893097308
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
HOP-62,6918638,0.8791129287698843
SW1573,9866186,2.2605214925080035
Hs 611.T,984333,1.4054326287403642
ChaGo-K-1,JQ-1-UNC0638 (2-1 mol-mol),1.6534960397455791
KMRC-20,6610216,4.741983793565595
NCI-H209,5281321,-2.3877363696817944
KYSE-180,selumetinib-BRD-A02303741 (4-1 mol-mol),6.582201455750035
OAW28,11222830,1.7030270245193828
KO52,969516,2.728197317619067
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
SNU-119,54626689,4.267759657725626
SNU-213,navitoclax-MST-312 (1-1 mol-mol),3.685779370841315
B-CPAP,15983966,-3.675968487068789
KMRC-20,6623618,2.3324454815197546
Namalwa,56973724,1.9576150822856104
SNU-423,doxorubicin-navitoclax (2-1 mol-mol),0.6046265004556602
NCI-H196,15547703,5.48928690632669
RERF-LC-MS,5280436,-0.2566098032119844
OAW28,409805,4.888216855585461
HEC-108,262093,2.510970460452122
BT 286,9887053,1.2721711931799218
PE/CA-PJ41 (clone D2),5282054,4.186584535772045
TE-14,5311,1.7407317026621147
BT 328,doxorubicin-navitoclax (2-1 mol-mol),-0.3035540353070404
WM793,49850262,4.533978488158691
NCI-H2030,10184653,1.4604745429556456
Kasumi-2,11609586,-0.6223010091545076
Karpas-422,44632017,0.8686663662207279
EHEB,89928392,-0.0785047887437129
KO52,9866186,-0.5103275036604222
HSC-3,24964624,2.6735244242436864
SNU-213,3038522,4.259011590979997
Becker,selumetinib-MK-2206 (8-1 mol-mol),3.018075586447546
EHEB,51039095,2.793639508249939
HEC-108,44486219,4.957991177382761
Becker,53392493,3.211103768073299
MJ,52947716,4.013188084373533
Hs 611.T,piperlongumine-MST-312 (1-1 mol-mol),0.9947686553129172
B-CPAP,3543504,4.96016997847966
RERF-LC-MS,24901704,2.6292316786888295
HSC-3,11238147,1.6158665960047474
BT 320,216345,4.58398991647949
SNU-423,568763,0.9972810479944874
NCI-H1339,11234052,4.400085931998601
OAW28,168313016,5.164256635335989
SF295,60700,-0.7516800911363736
MIA PaCa-2,16659841,4.320188843200875
KO52,selumetinib-decitabine (4-1 mol-mol),-2.793838380317763
SK-MEL-28,salermide-PLX-4032 (12-1 mol-mol),7.2362275808894925
HOP-62,89928392,2.9587285225742477
BT 248,445091,5.158109648340294
MIA PaCa-2,5281321,-2.236046377402632
SF539,6184667,1.7310938600147268
BT 320,2828334,6.462824713587457
NCI-N87,72376,-2.7230406051655676
BT 320,9936388,1.7913306244505192
Kasumi-2,selumetinib-navitoclax (8-1 mol-mol),-1.4155555334459644
NCI-N87,5311,0.9556802173694716
EHEB,4917,2.7157925783041073
HOP-62,285033,-1.086459700106236
Ri-1,15983966,-5.526352456110755
KMS-12-BM,2708,2.6805418133728747
TE-14,135411,0.5329688265157383
AsPC-1,44607531,1.5574724897590664
KE-39,11626560,1.956808029215874
NCI-H2030,11964036,1.7484747301817396
BT 498,navitoclax-piperlongumine (1-1 mol-mol),2.5013615718204742
Becker,2749,2.963090834179414
SW1573,51039095,4.568767182944777
HOP-62,135875424,2.89405317867683
Namalwa,5311,0.3963470202077738
NCI-N87,5470400,-1.6354434063399317
KE-39,5328940,1.2417733744928583
Mono-Mac-1,3543504,4.1625450552704875
H-STS,3689413,-4.4758570940331515
RKN,654092,-2.299209260296745
LMSU,25150857,3.1228438520338253
WM793,5470400,2.631713444324304
PE/CA-PJ41 (clone D2),107970,2.3655447470564774
HuT 78,11175137,-0.1403149097241058
SK-MEL-5,3689413,3.463644790263917
LMSU,3025944,4.305577187870561
Lu-65,11497983,4.173704063300202
B-CPAP,5460769,4.36425483182296
OE33,676352,2.6182948450693027
NCI-H1339,2858523,3.31126282085598
BT 248,5494449,3.476308084030369
SF539,3081361,1.6013360559039176
SNU-216,11396600,3.905215698607568
SF539,89928392,1.1675794201375844
HEC-108,5978,-1.7034022834061815
Kasumi-2,72734382,3.1758679904650715
BT 112,11955716,-2.698255200036422
NOMO-1,9903786,1.612481289648159
Mono-Mac-1,168312962,1.743961844717124
SF295,5746,1.3493075789474522
Kasumi-2,2749,0.3805959448623131
KO52,24753719,3.780928273062828
KYSE-450,alisertib-navitoclax (2-1 mol-mol),2.776253910680575
SF539,24951314,1.5641800235140235
LMSU,6918837,-1.4182367040159407
Hep 3B2.1-7,serdemetan-SCH-529074 (1-1 mol-mol),2.322040052367719
SK-MEL-5,89928392,1.837778592471805
MJ,JQ-1-navitoclax (2-1 mol-mol),0.5482971466923605
EHEB,17755052,0.9739934122056938
Mono-Mac-1,11214940,2.191892992947718
TE-14,176870,1.5270121681279905
BFTC-909,5282054,4.21714099973987
H-STS,24797083,1.5630657554706655
IST-Mes1,4788,5.898872389352922
HuT 78,9825149,1.9871661414815665
SF295,262093,3.7346493602329462
PE/CA-PJ41 (clone D2),9936388,2.7789010886628422
BT 248,11222830,0.9088188698521174
HOP-62,1750826,-0.2990217230122637
NCI-H1339,46215462,3.074364246378648
AsPC-1,vorinostat-navitoclax (4-1 mol-mol),0.981904018137164
HuT 78,126941,-2.6954395482949844
B-CPAP,374536,5.570137344225874
WM793,25262965,-0.5623706777584844
Karpas-422,49867930,6.07229360568805
KYSE-180,11507802,1.642318486353166
BT 328,salermide-PLX-4032 (12-1 mol-mol),4.7270242729207625
YD-8,UNC0638-navitoclax (1-1 mol-mol),2.814214671394628
H-STS,11214940,-0.2831016216432358
JHUEM-7,71751553,3.8993350668195874
NCI-H1339,568763,0.4787351372359879
HEC-108,65628,4.442011228839073
OE33,67156097,2.2455878358369725
Namalwa,4261,-0.1998131485517298
SNU-423,7251185,2.0978048773368823
B-CPAP,36314,-5.684441003557772
BFTC-909,11626560,2.2197507332783735
Becker,241158,3.23499622526182
KYSE-180,44484440,3.483431565437074
HOP-62,1566236,4.388769459301917
H-STS,439501,-3.713409181758543
MJ,11222830,1.6104329121472218
Kasumi-2,selumetinib-MK-2206 (8-1 mol-mol),1.1378728727000402
EHEB,753704,4.57215255992242
B-CPAP,46907787,3.372107688619731
NCI-H2030,24772860,-1.256504466195007
KMS-12-BM,2733526,2.511527741006988
ESS-1,24779724,4.457445117995274
SK-MEL-28,49793307,2.4799743183356897
Becker,327653,3.7069027046220024
Karpas-422,246676,4.416007405024325
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
NCI-H1339,71466578,4.86926698619994
NOMO-1,44819697,-3.3724853213010895
ESS-1,374536,5.146738438727042
JHUEM-7,25102847,1.6787689105881445
EHEB,4261,0.2305529532215675
BT 328,11455910,1.1431162062454217
Namalwa,alisertib-navitoclax (2-1 mol-mol),-1.1691420603669722
HSC-3,6918328,0.3384783511123991
KMS-12-BM,3825829,2.160644220643388
KO52,53392493,1.8648519897041975
SK-MEL-28,docetaxel-tanespimycin (2-1 mol-mol),3.8902509419677105
AsPC-1,16219061,4.6595447221902955
ChaGo-K-1,11964036,2.321636114711196
Hep 3B2.1-7,5280436,3.8626122969934262
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084
LMSU,5282054,4.011761884092238
Becker,11625818,4.324027571559308
PF-382,11485656,2.17330616168877
KYSE-180,135411,0.6343145122787996
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
LXF 289,3825829,3.6707575370566534
TE-14,25102847,2.1237054903905306
Becker,107970,3.0116017692585406
RT-4,3815108,3.2555557052481
SF539,4578,4.594464802750392
NCI-H1339,11609586,3.50234715510395
NCI-H2030,5287620,-1.3151289536016495
SNU-423,36462,3.755778828040023
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
AU565,439501,-2.8703859168743384
OE33,7251185,2.7830194550177216
TE 441.T,salermide-PLX-4032 (12-1 mol-mol),4.956216871423134
NOMO-1,969516,2.327280884248625
B-CPAP,6505803,1.185723298587951
Hs 611.T,serdemetan-SCH-529074 (1-1 mol-mol),0.4492810877743362
SW1783,navitoclax-gemcitabine (1-1 mol-mol),2.361367842252142
AsPC-1,3825829,4.335500071907528
Ri-1,4705,2.754354482473573
NCI-H196,176870,5.213807422921147
KO52,46398810,1.739829044633002
CML-T1,1242560,3.0102013740079783
AsPC-1,10385095,2.76496705920137
ESS-1,selumetinib-JQ-1 (4-1 mol-mol),2.1651949829821353
IST-Mes1,241158,4.374014389295604
NCI-H1339,11455910,0.5713481488212533
EHEB,11234052,4.167418528594196
ESS-1,16065773,2.1890853873316596
RERF-LC-MS,67156097,-1.006688958645714
AsPC-1,42611257,3.6284330949745094
KMS-12-BM,5746,0.0880156660447664
RKN,10127622,5.371150210721622
Kasumi-2,44137675,1.606596454570492
ChaGo-K-1,5470400,0.2648797109153149
SNU-213,11175137,2.461932867567342
RKO,56649450,4.8662264096692684
NCI-H929,25062766,1.424722824964366
BFTC-909,6610216,4.898578232775107
ACC-MESO-1,73707398,1.5001086563583304
PF-382,decitabine-carboplatin (1-1 mol-mol),-0.7722926629328009
SK-MEL-5,66577038,3.092435629541179
SK-MEL-5,11609586,2.982945620933936
PE/CA-PJ41 (clone D2),11222830,1.6922518785490088
Kasumi-2,12003241,-2.245419673861097
NCI-H196,262093,3.244471483790871
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559
SNU-216,11238147,2.1537777107230416
SK-MEL-5,10427712,4.3012034852444
ChaGo-K-1,decitabine-navitoclax (2-1 mol-mol),3.968732833750204
BT 248,2871966,0.7814721484275546
YD-38,11507802,1.1214950322056845
KMRC-20,36462,3.67134556506655
LXF 289,12001922,1.5738020993239468
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
JHUEM-7,46926350,-4.455736364930407
YD-8,6505803,-0.4521993512764767
KO52,5280436,1.3391511343144182
LMSU,10074640,3.239182097688426
SK-MEL-5,11228183,3.692037298067025
EHEB,4378219,1.3108988632273402
KMRC-20,262093,3.714553986632731
Ri-1,426756,4.640789349676716
NCI-H196,49836020,1.0558785681395022
SF539,erlotinib-PLX-4032 (2-1 mol-mol),2.8421126789574913
HEC-108,107985,-3.7063937347849696
Hep 3B2.1-7,73707398,1.151761195316654
YD-38,4259181,0.0281637492495702
AsPC-1,12003241,0.1897400127907629
Kasumi-2,6852167,0.8229890671000598
YD-38,44493528,4.189502567524798
KYSE-180,11485656,1.9289585779871232
RERF-LC-MS,11977753,-0.575574044510787
SK-MEL-5,5284616,3.1246661587067446
B-CPAP,10127622,5.805135395633265
HOP-62,4705,3.552280933872326
SK-UT-1,4788,5.266389502617288
RERF-LC-MS,676352,1.6328584527608256
ACC-MESO-1,16722836,1.9772459884622784
KYSE-450,serdemetan-SCH-529074 (1-1 mol-mol),2.594112814660752
SK-UT-1,9911463,4.1504947350424315
HuT 78,navitoclax-gemcitabine (1-1 mol-mol),-2.9372402673732205
NOMO-1,3025986,-1.4139862297409005
HuT 78,71751553,4.273670469751914
Karpas-422,54143018,1.1390909602039778
SNU-1077,doxorubicin-navitoclax (2-1 mol-mol),-0.1731301626607988
Hep 3B2.1-7,702558,5.48943695230274
Mono-Mac-1,3854666,0.6969728274023116
SNU-119,3025944,4.367446555553435
ESS-1,3552672,1.6370770083868251
NCI-H929,71466380,3.795978498823376
KE-39,5281321,1.7518256992041978
Namalwa,11364421,-5.95321406074749
OE33,9927531,5.791665708309609
CML-T1,5566,2.203374574789853
PF-382,241158,3.333523301157689
Hs 611.T,11364421,-6.081344851630196
CML-T1,387447,-5.712019248069361
BFTC-909,46398810,2.674147192871529
Kasumi-2,10322450,3.5434418993684114
NCI-H1339,vorinostat-carboplatin (1-1 mol-mol),3.7601817566263818
Kasumi-2,5281672,3.402650415017694
BT 286,11717001,2.163953812936934
ACC-MESO-1,44489367,5.824107451823484
KO52,24821094,2.869182341163551
CML-T1,54618164,3.634689828068523
TE 441.T,135928012,2.9186612392594107
SW1783,5278396,3.782003108499985
Lu-65,11364421,-2.73779838513083
SF539,53392493,1.7253246594854623
BFTC-909,49850262,4.237463012213885
SK-MEL-28,23635314,4.127704587314434
ChaGo-K-1,71680916,5.526927965273148
TE 441.T,24951314,1.2174355092637226
Kasumi-2,44202524,1.2131871054756846
SF295,9967941,5.1416848590318995
LXF 289,12003241,-2.348837864712453
KMS-12-BM,100016,3.5545657198194873
AsPC-1,445643,4.30663769172778
CML-T1,44589607,0.9502853682806348
KE-39,BRD-A02303741-navitoclax (2-1 mol-mol),0.7696843090662393
LMSU,4096211,2.6268822987004947
Panc 02.03,44462760,5.147948611944762
AsPC-1,5287969,-0.8371135357044818
WM793,46199207,3.3538268783703895
RERF-LC-MS,9936388,-8.273067767637817
SNU-423,16736978,1.660698360063597
IST-Mes1,9933475,1.3564169932051346
AsPC-1,selumetinib-JQ-1 (4-1 mol-mol),1.077922067972621
KE-39,9967941,2.56940062250581
SF295,6918289,2.5556705911617654
YD-38,53232,2.21843429082388
SNU-423,135999136,4.547106106138672
Kasumi-2,9927531,4.453654232617923
Mono-Mac-1,3689413,-2.253738856829829
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
TE-14,selumetinib-navitoclax (8-1 mol-mol),3.149058873033737
SK-MEL-28,selumetinib-tretinoin (2-1 mol-mol),2.7944825477960062
KE-39,crizotinib-PLX-4032 (2-1 mol-mol),2.410215231277302
BT 328,156414,4.0443464949872645
RERF-LC-MS,44632017,0.7768655843829712
OE33,2708,6.821069396590593
KE-39,71751553,4.448067406832394
SNU-886,3689413,-0.3695618539773043
SNU-1077,10427712,5.108868018236591
RKN,11175137,3.1657803092866224
Ri-1,2113511,3.984428046872122
SNU-216,6852167,2.5800071539870846
NCI-H196,9825149,2.985706018384809
AsPC-1,11719255,5.644609733763846
Karpas-422,2749,1.5953519603424242
CML-T1,44507138,0.8933545312764144
ChaGo-K-1,56946209,-4.866978275420876
YD-8,55283,2.8386191542284007
YD-38,24856436,0.3286492857202097
NOMO-1,44607530,2.1799605259844914
ChaGo-K-1,168313200,1.878692270372672
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
NCI-H929,71304818,2.3374127467417467
OE33,119607,5.889584953438252
HuT 78,46907787,-2.3061129610788833
SF295,36462,2.0611349093400926
AsPC-1,6918837,-2.7365580441764155
Kasumi-2,2858523,3.136381143278692
HCC2108,9903786,2.237017286795856
KO52,10385095,0.862604455305029
SNU-216,UNC0638-navitoclax (1-1 mol-mol),2.629430823091792
NCI-H209,5284616,-2.6002796256202254
AsPC-1,60700,1.1964352024151823
KO52,60750,-4.433214876259525
PE/CA-PJ41 (clone D2),25126798,4.075940103267287
BT 328,5351362,3.058518390164376
ChaGo-K-1,9935249,2.017228734725955
HuT 78,135421197,0.0616295171222303
SW1783,25126798,4.288989102632611
ESS-1,5328940,1.6515492105558514
PF-382,71466445,1.9189761436188
RKO,9825149,2.459088339864112
AsPC-1,10302451,4.160835682979353
H-STS,23939,4.59491472423784
MIA PaCa-2,4917,3.10668536131689
TE 441.T,135411,0.5500346816082857
KYSE-180,613753,3.360667218558787
JHUEM-7,60700,-1.134830771722302
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
B-CPAP,44589607,3.2580421536509574
KLE,15983966,-4.1530046682155435
SK-MEL-5,104842,-2.299697057796787
SF539,52947716,2.4386423311018284
KE-39,42642645,1.367345124375733
Mono-Mac-1,2733487,4.00561651175431
LMSU,9884685,1.8441382051797008
RT-4,654092,0.6230468978254379
BT 320,11175137,3.303235141929386
KO52,2742550,3.525067743551677
Karpas-422,46843906,1.03468307378118
B-CPAP,3062316,-0.9733025466609652
KMS-12-BM,9967941,3.0004287957561875
H-STS,72734382,4.174468427359164
BT 320,44566777,1.538730078733798
HOP-62,46843906,3.1260529463455726
ChaGo-K-1,11485656,1.7653957410813437
HCC2108,6852167,3.7271551469098583
SNU-423,6438330,2.845782859540362
NCI-H1339,426756,4.378478200663483
SNU-423,2828334,6.005008017468347
SF539,10172275,5.0855442389334105
BT 248,44566777,-0.50911829246694
BT 498,3689413,1.8744771197995864
ESS-1,9866186,0.1543463253926908
Karpas-422,969516,2.27875212195007
SK-UT-1,135398516,5.33568205462979
YD-38,5284373,-0.9392180251426282
SNU-886,2828334,8.007819818360458
CML-T1,3503,1.2439697949752524
Mono-Mac-1,285033,-3.4365762455863895
TE-14,44137675,3.833594169028412
CML-T1,BRD-K27188169-navitoclax (2-1 mol-mol),1.24494098413804
IST-Mes1,71751553,5.350652566949457
ChaGo-K-1,148198,-4.908529159972166
HuT 78,6918638,-1.8650927856269544
BT 498,44607531,1.7990314038019075
RKO,31703,-1.8438289452025527
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955
Ri-1,11364421,-5.60623006121576
KYSE-450,6914657,-3.3347468513388994
BT 328,42642645,1.526904383487112
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
KE-39,24753719,4.8851025960405074
KYSE-180,6184667,4.098294905261503
KO52,BRD-A02303741-navitoclax (2-1 mol-mol),-1.279248349469784
AsPC-1,navitoclax-birinapant (1-1 mol-mol),2.1190799837985597
SNU-886,2742550,3.913973677845718
KMS-12-BM,452548,-2.9349157486062736
TE-14,4477,0.6111489051508033
Hs 611.T,3854666,0.606015378482523
RT-4,54619267,4.475901221652596
KE-39,10410894,3.265010081493446
ChaGo-K-1,676352,1.608582687112449
BFTC-909,9826308,0.9467806471528852
JHUEM-7,10184653,0.8524941419446748
AsPC-1,16038120,0.5677006157285766
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
SK-UT-1,16722836,2.949695748270546
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
SF295,9926054,3.0771086967152845
Karpas-422,135440466,2.948344321983633
PE/CA-PJ41 (clone D2),6184667,3.24058579753897
BFTC-909,46199207,3.2760821272908753
Hep 3B2.1-7,9915743,1.8474397407384695
SNU-216,6450551,3.3089706641589887
KYSE-180,2113511,7.401895265754639
SNU-119,9967941,5.644960862211108
Kasumi-2,135421197,0.8154486687594628
SF539,135398738,4.183953288764079
Namalwa,227681,2.1728209408907295
Panc 02.03,9926054,1.881153725115377
WM793,46191454,1.3645728185603727
KLE,36462,1.5319564725809691
Becker,53495165,2.7375596088041103
KYSE-450,25126798,4.042128905943723
WM793,5281672,4.440104889072824
KE-39,selumetinib-BRD-A02303741 (4-1 mol-mol),5.809798702623815
ESS-1,119182,0.4984219071249969
PF-382,decitabine-navitoclax (2-1 mol-mol),-2.1904802536786305
OE33,selumetinib-piperlongumine (8-1 mol-mol),3.379459589159851
Lu-65,6438330,4.885617436818886
SNU-423,66577038,3.060627668659738
SF539,2733526,2.647768601693724
L3.3,SNX-2112-bortezomib (250-1 mol-mol),1.42333058116923
OE33,54618305,4.272506927413016
SW1783,44185566,3.100049600805726
SNU-423,2945648,3.085895507775502
HEC-108,9903786,3.9980769668892706
L3.3,6852167,2.807934515358382
TE 441.T,46398810,1.584533251647572
Mono-Mac-1,8515,3.2918667240053643
L3.3,159324,3.32597872906173
MIA PaCa-2,49836020,4.16350045307359
Mono-Mac-1,7326481,2.5894382859741625
BT 248,24889392,1.8419989874192408
MIA PaCa-2,151289,1.9491714685560824
HEC-108,44484440,3.2684255567443
SK-UT-1,12001922,1.8761579048113184
OAW28,135421197,1.4901490212875883
NCI-H2030,135984461,5.0269440888877135
ChaGo-K-1,2828334,6.905279023540132
OAW28,119607,5.347849335106357
AU565,9887053,5.902090445564702
SNU-213,11609586,2.9747545588590776
KYSE-450,374536,3.719128608597957
NCI-H196,4917,3.669562562302993
H-STS,10184653,1.7921408702106925
Hep 3B2.1-7,24180125,2.3898780520203164
OAW28,53392493,2.314719178940984
B-CPAP,11364421,-3.632311492746059
NCI-H929,24901704,2.6576899414441897
NCI-H929,44202524,1.214176399548459
CML-T1,10410894,3.3337757256136245
LXF 289,9903786,1.8485652979864533
H-STS,decitabine-navitoclax (2-1 mol-mol),1.503430207514452
BT 328,11612883,4.649689158242477
BFTC-909,9825149,2.463033939289578
SW1573,25183872,-2.56928333929943
L3.3,135440466,3.532632366582018
Kasumi-2,5351362,0.8391907710572402
MIA PaCa-2,5460769,2.8270884799697833
SNU-216,25062766,1.683528058325665
SW1573,11626560,2.096503053081923
NCI-H1339,72734382,4.418833505137817
AU565,9908783,4.7252597511686965
ESS-1,9907093,4.140542010053599
KMS-12-BM,56946209,-5.052101721159677
KMS-12-BM,10410894,1.7534583743773589
YD-38,12001922,1.852128176270752
Lu-65,vorinostat-carboplatin (1-1 mol-mol),3.813757203413742
PF-382,5284329,4.993412059506353
LMSU,15547703,4.748920610126263
NCI-H196,11404337,0.5983725190796483
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
OE33,135411,0.1035302974867378
NCI-H929,9907093,2.342525327576932
SF295,decitabine-navitoclax (2-1 mol-mol),4.786128519521136
KMS-12-BM,9823820,3.407131386822144
Ri-1,285033,-2.9347943900721645
EHEB,selumetinib-JQ-1 (4-1 mol-mol),-0.0163446257701156
TE-14,11955716,-1.565971579396732
SNU-213,9911830,2.5887674571936827
BT 320,4788,6.027753085231011
HCC2108,24964624,3.042744623925763
Namalwa,10385095,0.4710651537039255
IST-Mes1,46215462,2.5624084058363676
SK-UT-1,11494412,1.7393092296584682
SK-UT-1,71680916,6.2215373772831875
B-CPAP,11640390,4.47725622860835
GOS-3,5329102,1.5794439698416267
KLE,9826308,0.0278909201933885
MIA PaCa-2,71576739,4.483139378007073
NCI-N87,11396600,3.282772907192936
Ri-1,5291,3.0570905184934896
B-CPAP,5311,1.0199016089886117
KE-39,serdemetan-SCH-529074 (1-1 mol-mol),2.1213072373059885
Ri-1,54618164,3.351620474259991
RT-4,9840324,5.695184545393867
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
RKO,10184653,1.6814092199651305
ESS-1,6438330,2.0697444258880173
HOP-62,6505803,-0.0366684489798773
SNU-119,151289,0.6680539907323628
AU565,5351362,0.5336942302969934
KYSE-180,9868037,4.629723429656334
Mono-Mac-1,452548,-2.4901637647281847
NCI-H2030,638278,4.046309354650408
NCI-H1339,9903786,4.835064182647526
SF539,5280436,3.2977322800026463
Kasumi-2,426756,1.7072417198911318
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
ACC-MESO-1,9967941,3.035265547475742
Ri-1,6918289,3.0917931737632647
RERF-LC-MS,12001922,2.43602915295576
SNU-1077,10074640,3.2926421330033837
L3.3,serdemetan-SCH-529074 (1-1 mol-mol),2.4729213733544366
KMRC-20,doxorubicin-navitoclax (2-1 mol-mol),0.9051296535641696
ESS-1,9903786,1.7886366060040666
SNU-423,11507802,1.2328580377251226
SW1783,11222830,3.574830884827046
BFTC-909,448949,2.818327130228084
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
BT 286,55508,2.1421401977564245
BT 286,446155,4.765644032421615
AsPC-1,135984461,3.722049898583642
BFTC-909,644241,3.062866082016443
AsPC-1,navitoclax-gemcitabine (1-1 mol-mol),1.0785149117899562
JHUEM-7,10302451,1.7373663186818131
OE33,24856436,0.7398013776341883
SNU-213,16722836,1.1537884204596969
HSC-3,49793307,-2.517203900284079
KMS-12-BM,44493952,5.238647579582932
GOS-3,135440466,3.2261535122506295
B-CPAP,24951314,0.9268221935923368
AsPC-1,462382,1.1756614609859282
HuT 78,10113978,2.521071548009062
JHUEM-7,3634881,2.904041587079114
LXF 289,3038522,4.104388560491244
Hs 611.T,11485656,1.370862895697381
KLE,tretinoin-carboplatin (2-1 mol-mol),4.643010553497707
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083
SK-UT-1,9967941,4.506671205621334
JHUEM-7,6918736,-3.584037511653784
RKN,124202324,3.704376342602573
Hs 611.T,135875424,2.7263445003410536
Hep 3B2.1-7,66577038,2.9908776065937497
MIA PaCa-2,53232,1.8749527399509325
CML-T1,6918328,-2.287128701752201
SNU-423,67291369,3.047724729546425
Panc 02.03,53392493,3.617637281515077
JHUEM-7,2871966,0.3047669100796996
AsPC-1,57330099,4.415374546363204
OAW28,49766530,-0.5315014966120291
SF539,54618795,3.1497169107131944
SNU-119,44137675,3.0443625578269096
HuT 78,445455,2.369844577955314
WM793,16722836,1.9523853795205277
B-CPAP,446155,2.447419494553645
KO52,12001922,1.5749423624462988
BT 286,285033,-1.921415895264567
SF539,46199207,2.5581705364942193
KMRC-20,25150857,2.3131751126804616
ACC-MESO-1,11152667,1.137280520783936
PE/CA-PJ41 (clone D2),25183872,-0.14942285161157
MIA PaCa-2,12001922,1.5564360891917508
NOMO-1,10074640,3.0496099519927435
AsPC-1,11485656,3.206693439346989
LXF 289,6610216,3.700752852024682
HEC-108,9866186,0.8605945036267506
MJ,navitoclax-sorafenib (1-1 mol-mol),1.3487900981296097
KMRC-20,44259,2.7583820903803695
SF539,216468,4.034624291224008
RT-4,24856436,1.1504694171178176
Namalwa,56949517,4.132859022124254
SW1573,16725315,3.253832365815957
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906
HSC-3,9903786,2.4966748748730025
BT 112,2858523,2.609953955894282
HuT 78,107985,-4.626222476681204
SNU-119,46199207,2.9147124779042435
B-CPAP,12003241,-1.7111954205398938
SW1573,656346,0.5263129478884733
KMRC-20,5278396,3.577157973061421
EHEB,168312962,3.113364364376791
ESS-1,5278396,4.110324353246352
HSC-3,5291,3.263159547564743
ACC-MESO-1,168313047,3.680243112419498
HCC2108,409805,5.256429084033282
SNU-423,46199207,3.733643800535606
L3.3,3815108,3.6939531026178
Namalwa,42611257,2.9717502787591883
ESS-1,11455910,0.1046831634026344
HEC-108,439501,-2.3418750446111347
TE 441.T,2949965,2.2899971760803073
KMRC-20,5113032,5.593210295000311
RERF-LC-MS,7251185,3.4578262740878976
HOP-62,24772860,-2.449488462755842
EHEB,5281321,-1.964184492535214
H-STS,16725315,4.449964499354371
RT-4,selumetinib-JQ-1 (4-1 mol-mol),2.9367807248544233
BT 112,66577038,3.1162446017420575
Hs 611.T,44486219,3.678181271691003
B-CPAP,676352,2.971281112098332
Becker,6438330,3.285356333936618
H-STS,tretinoin-navitoclax (4-1 mol-mol),4.079592330676085
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
SNU-423,11609586,3.037399927166333
YD-8,selumetinib-decitabine (4-1 mol-mol),5.345294149747968
BT 286,4705,3.0604993750879834
AsPC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4648978933330232
SF539,135411,-0.8521595547181242
Lu-65,2742550,4.528880941958593
IST-Mes1,3634881,3.096696127840678
KMS-12-BM,UNC0638-navitoclax (1-1 mol-mol),-0.7236362684252565
RKN,6917907,-6.438038185084336
H-STS,49793307,-5.0868612084063995
ACC-MESO-1,44507138,3.273543440527104
PF-382,148198,-4.947878541405711
BT 286,25126798,4.985091475140932
Panc 02.03,6610216,4.56797737488032
TE 441.T,45279963,3.895495545742963
KMRC-20,46907787,3.5898907650473855
Lu-65,400769,0.4689570429959745
AsPC-1,1641662,3.9838157290035
Hep 3B2.1-7,9936388,1.3594944323688356
GOS-3,219104,4.122096403169316
Hep 3B2.1-7,3025944,4.2120956813862325
NCI-H929,2708,3.7525965920977007
SK-UT-1,15547703,4.119517534228275
AU565,16065773,1.4318565791423328
Lu-65,24964624,2.8804147061404075
RKO,36462,3.4370564574699185
HCC2108,9926054,2.5765466804926445
NCI-H1339,65064,5.348039511094046
RT-4,ISOX-bortezomib (250-1 mol-mol),1.1242037732608314
BT 320,375860,4.032556785404055
AsPC-1,11964036,1.5618628535664978
KMS-12-BM,53232,3.5585540988187176
HEC-108,1641662,3.2650548064529237
AU565,7251185,1.9736319172199277
AU565,46215462,1.837951563203271
Panc 02.03,49766530,0.9655059796360064
SNU-886,11152667,-0.5084903707284607
KYSE-450,6918328,1.5468903828461986
KYSE-180,208908,4.633003996676137
YD-38,16722836,1.1307328441727311
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
BT 112,10113978,3.5580397718856496
SF539,5746,0.7777386338638989
BT 498,72376,-0.0404401265218914
BT 498,25105715,3.8825206027116734
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
ACC-MESO-1,11404337,0.4174226395883805
JHUEM-7,JQ-1-vorinostat (2-1 mol-mol),-1.265812269763504
HOP-62,65064,5.008164277666244
PF-382,6914657,-5.488618534431668
BT 286,24951314,1.7166749305741291
SNU-886,26596,-1.4881272997493236
YD-8,135999136,6.481795126986557
HOP-62,11485656,2.83083000651899
ACC-MESO-1,25150857,2.6233395806994104
EHEB,tanespimycin-gemcitabine (1-1 mol-mol),-4.432752806947547
NCI-H1339,JQ-1-vorinostat (2-1 mol-mol),2.0008841316187125
BT 112,3062316,2.6021941524202674
SNU-423,73707371,4.995198662873275
RT-4,9935249,3.446453833049965
SNU-119,31703,-1.023889627752851
SK-MEL-28,445091,4.3007151256708465
SNU-886,11214940,1.3041085761730546
RT-4,9956119,3.103226813532622
KYSE-450,135440466,3.4784789863702112
HOP-62,1714884,3.484379130958529
KLE,25183872,1.4445815878101878
Ri-1,4259181,-1.255290292535843
ChaGo-K-1,5460769,6.469611673758945
TE-14,6918328,-0.3790829330672501
TE 441.T,16065773,1.8800785086294824
HEC-108,navitoclax-gemcitabine (1-1 mol-mol),-1.2713189320537277
KE-39,613753,3.317859583771952
SK-UT-1,1242560,4.227021541575825
YD-8,decitabine-navitoclax (2-1 mol-mol),3.994685595112437
KMRC-20,54454,3.590685195653472
OAW28,17759555,2.4276686354020223
SW1783,54618164,3.832878612817737
SF539,60700,-3.506506897271602
Mono-Mac-1,44137675,2.169476353998281
SK-MEL-28,navitoclax-birinapant (1-1 mol-mol),3.597068820497229
SK-UT-1,5746,2.0150479755751425
BT 286,11228183,2.2609540883188712
SNU-119,54454,1.8992360561821908
AU565,6918638,0.3564513775218086
BFTC-909,654092,0.6323398211983356
TE 441.T,135440466,1.4153428871143716
SW1783,44491742,3.6997355499837217
NCI-H929,11640390,-3.3259312039438216
PF-382,57519531,1.1953154667352015
AsPC-1,piperlongumine-MST-312 (1-1 mol-mol),2.821737440312523
BT 328,12003241,0.43959296828198
BT 286,15983966,1.706586921281891
KO52,9884685,2.8647583667584553
OE33,11964036,1.4744458350921272
BT 320,9911463,3.706038906545982
B-CPAP,6438330,1.022180565528926
Hs 611.T,25150857,0.721592680667691
BT 328,navitoclax-MST-312 (1-1 mol-mol),1.0481188204981575
Becker,72376,0.2339482318167731
Kasumi-2,11404337,-1.9658161518336
WM793,24856436,4.423556463104999
SF539,119182,0.3961519921597609
HuT 78,67156097,-1.4779973758207117
Namalwa,46926350,-5.521834277640312
ESS-1,702558,5.643160750991067
KLE,selumetinib-decitabine (4-1 mol-mol),3.7726080772360784
RKN,4788,5.902938799554125
Kasumi-2,BRD-A02303741-carboplatin (1-1 mol-mol),3.1733704189118894
NCI-H929,5743,-1.0610868770493211
EHEB,JQ-1-navitoclax (2-1 mol-mol),-0.4814265909259828
PE/CA-PJ41 (clone D2),46843906,3.732979270115668
Lu-65,208908,2.2463872486590235
HOP-62,16013152,3.830141163681858
SF295,654092,0.0189018784899866
SNU-423,3081361,3.1308652078280104
LMSU,448949,2.5624283498682594
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
GOS-3,100016,7.242262816552233
BT 112,54618771,1.3381626551406447
KMS-12-BM,25262965,-2.9423224876958525
BT 328,11175137,3.2083588182965705
Lu-65,24748573,1.9267593359475736
KMS-12-BM,5328940,0.5023752913374658
SNU-423,navitoclax-gemcitabine (1-1 mol-mol),-0.7752835571487771
KMRC-20,5328940,1.6552901694758546
LMSU,24785538,3.035127880697954
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
Mono-Mac-1,9952709,2.6915799998926966
BFTC-909,9956119,4.255413767268681
KE-39,262093,2.516325504276674
SK-MEL-5,23635314,-1.8855584102441283
NCI-H196,4261,0.7892412084491274
MIA PaCa-2,9952709,3.824307570177284
Panc 02.03,24797083,1.7288458125332262
CML-T1,6610355,4.414519429527798
GOS-3,11427553,2.487045066954577
BT 112,carboplatin-etoposide (40-17 mol-mol),1.4555391384046878
H-STS,JQ-1-carboplatin (1-1 mol-mol),1.6767150892638072
NOMO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.002133040962993
BT 320,3503,3.052625173384868
Mono-Mac-1,9866186,0.1265272205341433
NCI-H196,24964624,2.7632019893764124
BT 112,2729026,1.695580673596315
KYSE-450,702558,5.8139297537708
KLE,11427553,3.3715856930539316
HOP-62,40482356,5.176244995623167
AU565,24951314,-0.2220635763258615
SW1783,23725625,5.078273673319168
Mono-Mac-1,1716436,1.8382110406537744
AsPC-1,11625818,4.311821961769238
HuT 78,selumetinib-JQ-1 (4-1 mol-mol),-4.078257117596482
YD-8,11609586,3.1428816496644147
NCI-H2030,16720766,0.9971193506864836
HSC-3,5311281,3.0761228014048245
ACC-MESO-1,446155,2.9941213249489063
HOP-62,156414,1.5376490539390024
LMSU,JQ-1-navitoclax (2-1 mol-mol),3.886973336392811
PF-382,49850262,2.873386319481207
PF-382,135423438,0.1628237790601052
Panc 02.03,46174525,6.272327915554807
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
Hep 3B2.1-7,452548,0.6029668649629754
KE-39,11485656,2.227722528153515
BT 286,36462,-0.1751673749960541
Mono-Mac-1,5311,0.3309390956392478
MIA PaCa-2,67291369,2.035111955527258
HuT 78,2126,1.4144801662515558
SK-MEL-5,6438330,2.7940741044591126
SK-MEL-5,124202324,2.6727039143365148
GOS-3,168312962,3.853513662902144
AU565,10296883,3.47614106437246
YD-38,4096211,0.8582996852316679
YD-8,49766530,-2.0839194852213976
SK-UT-1,100016,6.311695779547894
RKN,9967941,2.6996754619948065
SNU-216,piperlongumine-MST-312 (1-1 mol-mol),1.4822768997213789
NCI-H929,JQ-1-navitoclax (2-1 mol-mol),-1.7995914527242012
SNU-216,1641662,3.8517544087442177
Kasumi-2,25262965,-2.503194884241619
TE-14,17755052,0.5442113476863433
AU565,156414,-1.7188953203880928
SNU-423,2130404,3.7015735691590623
LMSU,11427553,2.2667679897186757
RERF-LC-MS,285033,-2.0574538896256587
EHEB,3815108,2.965320927013124
HCC2108,42642645,0.687631636914302
Mono-Mac-1,decitabine-navitoclax (2-1 mol-mol),0.9115309079674628
SNU-213,9915743,1.2181447895342674
BT 112,6438330,0.2152284023246567
JHUEM-7,10113978,2.9707685491739357
SF539,2858523,3.000626783089259
JHUEM-7,1641662,3.469626078091439
SNU-213,176870,4.17726922356707
BT 248,9935249,2.246614582121965
ESS-1,8515,4.728832630346152
SK-MEL-5,107970,3.0501102581579977
JHUEM-7,9907093,2.991703648440714
SW1783,11964036,1.4624651747986186
SK-MEL-28,51037431,2.176317274658726
ESS-1,148124,-6.743563487136813
ESS-1,11955716,-2.238673877316504
BT 248,2828334,5.879853395133371
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
BT 112,16722836,2.2677202044282976
RKO,10427712,4.823698606341804
SW1783,148124,3.5822290901632545
KO52,11167602,0.9021081553845208
KMS-12-BM,60750,-3.781170987438112
BT 112,6505803,0.1257905254161033
SNU-1077,24856436,1.1327276677914395
NCI-H196,navitoclax-PLX-4032 (1-1 mol-mol),3.3889118353454704
Kasumi-2,11396600,2.2579616248243495
Hs 611.T,1750826,-3.331889142664563
HCC2108,439501,-2.3356100476768145
HSC-3,51039095,3.0016489760435294
RKO,126941,-5.081226966265268
PE/CA-PJ41 (clone D2),3038522,3.4117410479416432
ACC-MESO-1,135398516,3.573192480677428
SF539,11494412,-0.7610024681264586
KO52,25150857,1.2754464236425893
BT 320,136227331,4.5584663350036605
YD-8,72193861,2.3860591543368046
B-CPAP,2733487,6.302381879581772
SNU-1077,6918328,0.7978049082152888
WM793,25150857,2.2772862447818047
NCI-H929,tanespimycin-gemcitabine (1-1 mol-mol),-3.1675537812544516
EHEB,24856436,0.0947774634089656
HEC-108,54619238,5.029653380643683
Hs 611.T,44566777,0.4297176154550633
BT 286,46907787,3.635470224586541
Becker,3825829,4.088732787660409
HOP-62,selumetinib-JQ-1 (4-1 mol-mol),-0.1175997595945407
BT 286,439501,-3.2145304071914844
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
LMSU,6918638,1.4149573073550044
LXF 289,6610355,4.558728947318035
KMRC-20,selumetinib-vorinostat (8-1 mol-mol),2.4254013680145663
Kasumi-2,ISOX-bortezomib (250-1 mol-mol),-0.8608455854799354
KE-39,119607,4.996260341403349
H-STS,11152667,-1.2361022970372575
NOMO-1,73707398,0.2786764614411772
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
KYSE-180,9887053,4.517108897198139
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
EHEB,44202524,1.2346784446145649
PE/CA-PJ41 (clone D2),219104,4.25374512452242
BT 248,10427712,4.022427006719253
Kasumi-2,tretinoin-carboplatin (2-1 mol-mol),2.8935059772434792
KE-39,135984461,4.3782777468955745
YD-8,2842253,4.968157953189597
SNU-423,1641662,3.703023072171153
TE-14,3854666,0.9160893400358509
SF539,44607530,0.9511382642775598
Ri-1,16741245,2.5922161729617668
EHEB,1750826,-3.083056512698404
SW1783,docetaxel-tanespimycin (2-1 mol-mol),2.8206189802593733
JHUEM-7,44493528,4.303413387370261
HuT 78,11507802,0.6434442936513365
Namalwa,156414,1.5666485323210588
SNU-216,44489675,4.697421360276724
JHUEM-7,24901704,3.3697536869757547
BFTC-909,44137675,3.23817368119839
BT 112,3025944,4.482277488188436
LXF 289,6852167,2.2044562779321635
Hep 3B2.1-7,ISOX-bortezomib (250-1 mol-mol),0.8570911025892699
KMS-12-BM,11640390,-0.5684033392466148
WM793,11364421,-0.8939436431091912
Hep 3B2.1-7,10385095,2.639944911413333
SNU-213,322968,3.4615818853822127
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
KMS-12-BM,24753719,3.8340594609092
EHEB,409805,3.764078268707581
GOS-3,6505803,2.171469842265414
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
BT 320,5566,3.007077893151021
HuT 78,9926054,1.4431118641564118
PE/CA-PJ41 (clone D2),15953870,4.204773718329985
SF539,3465537,2.1777468091875125
MIA PaCa-2,1750826,-3.667978190943184
BT 320,navitoclax-MST-312 (1-1 mol-mol),1.1316480984239057
NCI-H196,216345,4.55519625209409
PE/CA-PJ41 (clone D2),89928392,3.005689968748253
YD-38,3854666,0.4955683731799087
Mono-Mac-1,227681,3.3122059805096185
KE-39,11175137,3.362137577301979
HEC-108,11222830,1.779874343530328
L3.3,54619267,4.657132666629917
OAW28,24951314,0.5571772807313425
Kasumi-2,3465537,0.5812514796989715
SNU-216,36314,-4.404810418439445
KE-39,12003241,0.559414259019648
Karpas-422,24951314,0.6964643593384264
SNU-423,10385095,0.9709432237153084
MIA PaCa-2,107985,-4.172242964909647
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972
BT 286,5460769,1.8515527065353563
MJ,26596,-3.924273415415616
TE-14,44185566,2.4599717728863735
NCI-H1339,24856436,0.5202265970203059
KE-39,46199207,2.43842073424698
SNU-216,11152667,-0.1857708456890594
MIA PaCa-2,5479543,3.424758886953834
SK-MEL-5,2858523,3.111072255115378
Hep 3B2.1-7,126941,-3.038985953830582
NOMO-1,100016,4.546215242968586
MIA PaCa-2,9915743,0.7812754347673511
SK-MEL-5,54454,2.090497805945611
BFTC-909,4259181,-0.0277162117211437
B-CPAP,4261,1.9002738315508088
L3.3,25062766,2.9099713416003463
PE/CA-PJ41 (clone D2),285033,-2.223317280953266
KO52,3689413,-4.063517257373306
AsPC-1,31703,0.7807561035178269
TE 441.T,135398516,1.7674231638740454
HCC2108,vorinostat-navitoclax (4-1 mol-mol),1.8283883364659943
HOP-62,119607,5.216667488123864
KO52,104842,-5.71337214933571
PF-382,9915743,0.1930622386086079
Panc 02.03,23582824,1.3457270338170706
AU565,26596,-1.0644098452654434
MIA PaCa-2,11494412,0.4238198089736678
BT 328,10385095,1.6482003129933624
Ri-1,3385,2.794410660318534
RKN,969516,2.6409066030454804
KLE,15547703,3.00093446443795
WM793,23939,4.513894312283566
RKO,11719255,3.406006587740275
Karpas-422,6914657,-5.262185677430442
KE-39,66577038,2.843797644710323
GOS-3,89928392,1.6340555670682608
AU565,6184667,2.5363760520525247
OE33,25102847,1.6700654423608574
Lu-65,2113511,5.91913102712555
KYSE-450,11364421,0.1587398851119797
SNU-216,44484893,4.190162590266464
OE33,72734382,5.2524587547950805
BT 112,navitoclax-PLX-4032 (1-1 mol-mol),3.450284426710319
Karpas-422,5566,2.9701636740435684
BT 286,44185566,0.9763246934051132
BT 286,11707110,-5.9587050063679605
NCI-H929,25262965,-4.479075794204223
HCC2108,135984461,3.878993075429708
SNU-213,JQ-1-vorinostat (2-1 mol-mol),1.219028136943463
SF539,carboplatin-etoposide (40-17 mol-mol),1.5231255103181107
BT 328,carboplatin-etoposide (40-17 mol-mol),5.134403751038302
BT 286,16725315,4.63641506470736
EHEB,135440466,1.7844203552470492
AU565,56649450,1.7738933823843377
PF-382,54686904,2.766917504531429
HOP-62,136227924,3.3249367186884564
NCI-H196,36314,-2.9149684646195624
SNU-213,54619238,4.377932230506036
Lu-65,3025944,4.489379745189235
Lu-65,46907787,3.3131734896161444
Ri-1,11175137,1.4705980177352482
ACC-MESO-1,675434,4.208302365354324
Namalwa,702558,3.15631292690116
ACC-MESO-1,11222830,2.54606187358561
TE-14,1566236,3.7463982876900177
SNU-423,23635314,-3.228765986553877
HuT 78,9549297,1.1531452884135298
Hs 611.T,72193861,0.334004825230036
JHUEM-7,135398738,4.332846858207987
RT-4,JQ-1-vorinostat (2-1 mol-mol),2.118819013371158
TE-14,44632017,1.9253849083982173
SNU-119,24771867,2.6075976586492624
Panc 02.03,5351362,2.6810485074832
Hs 611.T,44493528,4.184302816514897
MIA PaCa-2,3503,2.1121016304173468
Hs 611.T,3062316,-1.6126258430359726
KMRC-20,54649381,3.798675470632658
Hs 611.T,11977753,-5.421009329967
BT 328,1750826,2.2772741974811637
Becker,42642645,-0.0222198712525443
AsPC-1,5280436,2.0433035906644696
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
BT 112,44197249,1.805481072961874
LMSU,11455910,2.490355648913592
SK-MEL-5,148198,-1.053859411744173
BT 248,5280436,3.4551701194558935
BT 498,6918638,3.833356013639187
Ri-1,65064,2.4955274691972624
LMSU,11214940,4.711725342258078
Karpas-422,11214940,1.589328143840321
TE 441.T,71680916,3.746145752189325
Mono-Mac-1,16219061,0.7140738799397371
ESS-1,3384730,2.888530811754609
RERF-LC-MS,44137675,3.373454428855253
Hep 3B2.1-7,11964036,0.5496327492001817
HEC-108,5566,3.7962472662927143
RERF-LC-MS,24951314,1.4075693116182684
HEC-108,9868037,3.1019775097215554
Hs 611.T,5335621,4.030077497436074
BT 498,2729026,2.5400165852939196
HCC2108,5746,1.977916681532928
Namalwa,60700,-2.9629923455274776
TE-14,66577038,2.6979346894127
SNU-423,4261,1.6127122663674172
LXF 289,285033,-1.4335563326434544
BFTC-909,262093,3.5924629632259792
SF539,11717001,4.3610839531094525
OAW28,702558,5.716785737298097
OE33,5278396,3.859810746963463
HuT 78,9823820,3.0138958683813537
KE-39,4096211,4.989230592504944
MIA PaCa-2,2949965,2.338534195568356
Hs 611.T,49836020,3.6507368971801983
BFTC-909,3825829,4.25128930140834
KLE,24785538,1.6849105600387455
SNU-423,24772860,-1.7391670370922852
Hs 611.T,227681,1.8195839391673536
NCI-H196,3689413,0.3068410473600975
BFTC-909,168313047,1.967772312792883
Namalwa,9967941,3.9551429015919
KYSE-450,44185566,3.113770819226177
SNU-119,2708,4.611503362669174
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
B-CPAP,26596,-2.034534215785694
Hs 611.T,24771867,0.1006087367285268
Mono-Mac-1,2733526,3.4115034722598683
Hs 611.T,5291,3.6117786538687806
TE 441.T,1474550,4.431040328467024
Namalwa,24771867,-1.506492255683234
RKO,6505803,-0.9276151073099124
KLE,400769,-0.1230661741359576
SK-MEL-28,selumetinib-navitoclax (8-1 mol-mol),1.214744577584393
Hep 3B2.1-7,5281321,-1.2657392258228009
TE 441.T,675434,4.157451635723815
RKO,448949,2.722052887717566
YD-8,25062766,2.0362931594826055
TE-14,676352,2.265036527357979
JHUEM-7,JQ-1-MK-0752 (1-1 mol-mol),0.4170318281290994
BT 328,1716436,3.653949071950038
SNU-119,3062316,-1.081380158367377
Karpas-422,3025944,3.9022555318755305
NCI-H1339,46907787,4.303951587914797
TE 441.T,selumetinib-decitabine (4-1 mol-mol),5.065210849845612
SF539,10302451,2.624022513021108
SF539,11152667,-2.173581814614824
Mono-Mac-1,11625818,2.7738715371544407
HEC-108,11152667,0.9436637108805932
KE-39,16038120,1.0564410098934849
NOMO-1,72734382,3.160209893803666
Lu-65,5738263,3.5766641086315465
B-CPAP,11964036,2.6070306321605794
BT 112,6450551,1.6386256333107696
KYSE-180,11238147,3.6851797317879935
SNU-423,54678924,2.1389201541521405
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
NCI-H1339,72193861,1.3941268213904905
Kasumi-2,9926054,1.3771704127752784
L3.3,3689413,1.7908878640591075
TE 441.T,9935249,2.3228197055940556
NCI-H1339,4259181,-0.3541173382827977
Mono-Mac-1,11364421,-5.714614376132776
HuT 78,16659841,-0.357838633597325
BFTC-909,6917907,-4.2174557642594035
KLE,9915743,0.4681181116614699
KYSE-180,15953870,2.8572759517399677
Lu-65,11214940,4.598307339532426
Ri-1,6438330,0.7863948150709156
Ri-1,crizotinib-PLX-4032 (2-1 mol-mol),1.439549368158699
MIA PaCa-2,6914657,-3.194339390431366
KO52,44185566,1.2667683963107288
L3.3,11427553,3.3742390950754984
AsPC-1,25161177,4.641147259380914
KLE,3689413,-1.503166424361693
AsPC-1,216345,4.477392842458871
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
AU565,4378219,1.7809295710052302
OE33,44491742,5.719021846419829
PF-382,crizotinib-PLX-4032 (2-1 mol-mol),1.1615999412597993
Mono-Mac-1,60700,-2.5077544634616844
H-STS,4917,3.714262795675703
SNU-119,676352,1.897114472435228
JHUEM-7,25150857,3.01223903868364
B-CPAP,241158,3.71370211344078
KYSE-180,6852167,3.0076808179282213
SNU-216,11626560,2.093989475443438
BFTC-909,421610,2.763760389372973
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
TE 441.T,selumetinib-piperlongumine (8-1 mol-mol),4.4519093178463445
ESS-1,104842,-6.678898835642602
RKN,1641662,3.781184529562369
NCI-H1339,6852167,2.7157240163412206
EHEB,5335621,4.71040970914542
KYSE-450,11640390,4.647540881608271
B-CPAP,doxorubicin-navitoclax (2-1 mol-mol),0.582190958380646
ESS-1,5329102,1.725733095868152
PF-382,984333,-1.854257938200321
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
TE-14,44484893,5.1201558300438625
KE-39,54596490,4.684539429557116
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
LXF 289,71304818,2.1201305139291033
LXF 289,11178236,-2.9660816129263297
LMSU,25195348,4.0264247432996365
CML-T1,119607,4.0157878157192375
KMS-12-BM,16038120,-1.4386618861105946
BT 112,89928392,0.5920656256018224
SNU-423,54143018,1.1903406522322812
OE33,60750,-1.6166809824997617
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
B-CPAP,638278,3.199746181468372
RT-4,10302451,0.2321939311866163
ESS-1,11507802,2.580294278940104
Karpas-422,2729026,2.7362492758301187
NCI-H1339,25150857,3.1189812048347796
RT-4,16725315,3.7919214509937977
Kasumi-2,56963564,-0.3250682085247875
ESS-1,71466578,4.727259089012869
L3.3,16741245,2.275908063521695
SNU-119,12001922,1.855369676663499
IST-Mes1,6610216,4.781215155625892
RT-4,11485656,2.1371904728142
HCC2108,5278396,3.8392308280377425
CML-T1,selumetinib-PLX-4032 (8-1 mol-mol),3.463736211464864
SK-UT-1,44491742,5.121507877742128
KMS-12-BM,159324,-2.1850115101348
SNU-216,10113978,3.6175956355825543
ACC-MESO-1,selumetinib-vorinostat (8-1 mol-mol),3.6513542751877313
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
NCI-H929,3062316,1.7563437367831485
SNU-119,57519531,5.7777697645171795
Lu-65,3062316,2.546228679669324
Namalwa,1750826,-3.77700215521952
BT 112,23635314,-3.8768038728819025
Kasumi-2,11234052,3.910537949204277
NCI-H1339,135398516,2.559194515275264
IST-Mes1,2828334,6.0384225929755555
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
HEC-108,selumetinib-vorinostat (8-1 mol-mol),3.960684910603258
SNU-216,148198,-4.857755213358989
BFTC-909,2130404,3.366307483642889
B-CPAP,49850262,4.514828878116323
MJ,5746,-0.072159634538125
Hs 611.T,9911830,0.7898774616432335
BT 328,3062316,3.412447048158849
KMS-12-BM,19582717,2.19026036658904
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
Hs 611.T,285033,-5.093391478074478
Ri-1,5113032,4.679412130425412
KYSE-180,25262965,0.0419540229516487
SNU-886,3038522,3.968715088935437
SK-MEL-5,11404337,-0.86554047446545
BT 248,444795,4.817055384579841
Lu-65,123631,1.6427461920564876
HEC-108,3825829,3.356859835270974
SNU-1077,654092,-1.0014927314306907
KO52,3634881,3.08346578487488
BT 328,2126,6.023692748820712
AsPC-1,44819697,-0.3025066533854976
AsPC-1,44491742,4.429887143828186
TE-14,702558,5.373973014510599
YD-8,227681,3.132944737961843
Kasumi-2,3689413,-2.6905586087263043
GOS-3,16065773,2.51000734865302
RKO,15547703,3.988071110220001
YD-38,11427553,3.3100380685196
AsPC-1,11222830,1.755039918901926
ChaGo-K-1,10184653,2.772883802390891
GOS-3,9907093,6.267214731972656
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
ACC-MESO-1,selumetinib-PLX-4032 (8-1 mol-mol),4.943500149137048
HSC-3,176870,2.0282815166078523
Namalwa,11719255,3.200352082125332
LMSU,54626689,4.479048602124445
L3.3,6252,0.2429415263286948
RKO,3025986,-0.6013959236761957
Panc 02.03,71751553,4.925944110140211
Karpas-422,5743,-5.574243862705145
Panc 02.03,4578,4.394890119629889
ESS-1,5287969,-2.291544510973284
TE 441.T,71466578,6.000761540631799
RERF-LC-MS,31703,0.0184985959907658
Hep 3B2.1-7,navitoclax-pluripotin (1-1 mol-mol),-0.8139130493073924
BT 112,11234052,4.430633213786369
L3.3,11152667,-1.6552573738209355
Namalwa,15953870,2.955206613456957
Kasumi-2,11612883,1.7782552978814286
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
KMRC-20,3634881,4.3387746647694545
ChaGo-K-1,49867926,3.853414720504991
EHEB,168313047,2.145249955872484
ACC-MESO-1,216345,4.569735867855644
BT 112,17755052,2.3447671065006106
KYSE-450,23582824,2.052408979108203
BT 248,123631,2.103805835203493
HuT 78,151289,1.040242806613575
SF295,4259181,0.2902320947492574
Namalwa,44632017,0.5371915846662842
B-CPAP,25150857,2.3279804239835067
KYSE-450,637858,3.2826178661178003
SK-MEL-5,44607531,2.2436404414566424
LXF 289,2746,3.190299829163617
YD-8,2949965,3.0609642629133083
Namalwa,54619267,3.686644648242005
NOMO-1,73707438,4.2876330596581305
BT 320,44607530,2.9331646844346015
Mono-Mac-1,107985,-4.510683187416183
BT 328,selumetinib-piperlongumine (8-1 mol-mol),4.372590392700236
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
Mono-Mac-1,44185566,1.2179415517046666
PE/CA-PJ41 (clone D2),252682,6.970257263547699
MIA PaCa-2,49793307,-3.74631189087296
NCI-N87,25150857,2.476373943211786
SNU-423,24771867,3.564101413967203
Hs 611.T,navitoclax-MST-312 (1-1 mol-mol),0.5551074088401289
H-STS,6252,1.236462961602802
SNU-886,navitoclax-pluripotin (1-1 mol-mol),-8.136657717634877
BT 248,6918837,-0.6138774965830072
AsPC-1,17755052,1.5687054045124371
SNU-216,24180719,2.848757619364884
B-CPAP,9967941,2.4730364955418853
GOS-3,9967941,3.548284114921986
NCI-H929,25150857,1.5927885501879306
NCI-H196,25126798,4.528385606804446
Hs 611.T,4261,2.1145176676896487
LXF 289,4261,1.4002862892534345
AsPC-1,72734382,6.119259394736332
Becker,navitoclax-PLX-4032 (1-1 mol-mol),3.456000253563137
SNU-119,44486219,4.148857305108833
HSC-3,docetaxel-tanespimycin (2-1 mol-mol),-2.9988743376183575
LXF 289,1641662,3.640483694902119
PE/CA-PJ41 (clone D2),11626560,2.6434106801081265
RT-4,54678924,1.2087543441917363
KO52,16720766,0.6419660963639499
MIA PaCa-2,16722836,1.1361163699698982
JHUEM-7,11396600,4.730722840017514
Hep 3B2.1-7,5351362,2.675512677207152
SK-MEL-5,42642645,1.5986422400461986
SK-MEL-5,25183872,-1.4190506694494895
PF-382,168313016,4.6371186800984745
SF295,6438330,3.2704650749353728
GOS-3,10410894,4.409774071454934
Karpas-422,56649450,2.989450445379875
WM793,124202324,3.2510114503738894
KO52,10410894,3.6577566389370304
NCI-H929,56946209,-4.927465594530247
BT 286,9903786,1.725049982792706
PF-382,6918878,-0.2369499162228823
NCI-N87,73707386,2.4106113659233723
KE-39,JQ-1-MK-0752 (1-1 mol-mol),1.6726733394588664
RT-4,54618164,3.1267558882512803
SK-UT-1,1750826,-1.6569845659636762
HuT 78,5351362,0.379509393598873
PE/CA-PJ41 (clone D2),11214940,4.762762375853721
RERF-LC-MS,52912189,3.970931922009392
Panc 02.03,107970,3.0394503344184214
BT 328,568763,1.8540976735744827
KE-39,25262965,-0.0093824287359457
SNU-423,53232,1.233628163391212
YD-38,5746,1.894310930407794
L3.3,15983966,-2.6250326320128066
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
SNU-886,2842253,5.3530946546481815
BT 286,docetaxel-tanespimycin (2-1 mol-mol),-5.397859739208257
ChaGo-K-1,2708,6.0017156260200375
SNU-886,11175137,2.2177679587104935
SNU-119,4259181,-0.8929687482279648
HSC-3,decitabine-navitoclax (2-1 mol-mol),2.62326284379121
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
BT 112,135421197,2.023572470173789
IST-Mes1,44487872,4.402175961022997
Karpas-422,25062766,1.6649379096464605
SK-UT-1,crizotinib-PLX-4032 (2-1 mol-mol),2.7419345363185608
SNU-1077,5329102,2.42663042456867
Kasumi-2,11175137,1.5162390215690418
Kasumi-2,24748573,1.468920481488018
NCI-H929,135984461,1.9075332391524664
HEC-108,JQ-1-navitoclax (2-1 mol-mol),1.4144543388665205
CML-T1,24978538,-0.5146505107576096
KO52,107970,1.5787465596439585
BT 112,9911463,2.5169416957375015
GOS-3,26596,5.630360863540023
BT 112,3854666,0.1986005618410543
KMS-12-BM,54619267,2.4046016005161315
KE-39,44507138,1.957284753077253
IST-Mes1,24856436,3.396810776549086
SK-UT-1,navitoclax-MST-312 (1-1 mol-mol),0.81365218885664
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
AsPC-1,25105715,4.199758530142014
NCI-H209,docetaxel-tanespimycin (2-1 mol-mol),1.9080282467878955
SNU-1077,5113032,5.013204732466425
EHEB,5978,-2.167378408908765
SNU-216,54618771,-0.3617470583099299
RT-4,11364421,2.211361780662556
CML-T1,613753,3.0468922998366357
KO52,6505803,1.22031024799857
BT 498,navitoclax-pluripotin (1-1 mol-mol),1.792235845906525
SNU-216,selumetinib-MK-2206 (8-1 mol-mol),0.5399979997327916
BT 286,9915743,1.1038828678808648
LXF 289,JQ-1-carboplatin (1-1 mol-mol),0.2436296236972278
HCC2108,16722836,1.4931143772418354
KYSE-450,72376,0.4386506850457716
HCC2108,3689413,-1.830632797435868
HCC2108,10113978,2.890872158375319
MIA PaCa-2,3689413,-2.455927464924985
PE/CA-PJ41 (clone D2),2742550,5.692172963582456
Hep 3B2.1-7,168312962,0.9059799349779004
H-STS,44819697,-0.0809498053641322
Karpas-422,374536,2.0966843525351173
SNU-886,16736978,1.1893425576042655
GOS-3,5278396,3.876962723891849
Becker,vorinostat-navitoclax (4-1 mol-mol),1.0402549716197431
Kasumi-2,5287620,-1.535744105024607
NOMO-1,753704,4.4431191000277375
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
KYSE-180,6610355,3.592606427588536
RKO,124202324,3.4391315101947386
SK-MEL-5,2746,2.5702716912932337
CML-T1,46224516,0.9570028124056976
SNU-216,6914657,-4.877986434653472
RKO,44491742,4.905526099010324
Lu-65,3385,6.707810534579362
TE 441.T,135423438,2.5250342402764816
Hs 611.T,9825149,1.5292855639155298
Namalwa,25195348,1.420945820920828
Becker,44202524,1.1247864080321957
SNU-886,374536,0.8487393236537821
SK-UT-1,10127622,5.957744497618317
RKO,119182,-2.4803685643523
SF539,vorinostat-navitoclax (4-1 mol-mol),1.4705483951350276
SNU-213,9926054,2.110529432598139
KE-39,216345,4.364087845878577
OAW28,16065773,3.4526029247448973
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
KE-39,24964624,2.267142563952713
HOP-62,9911830,2.7524936884021223
NCI-H1339,25262965,-1.451773253208659
SW1783,54626689,3.693361817042254
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563
PE/CA-PJ41 (clone D2),54626689,4.875473167492311
Hs 611.T,6438330,0.9911371502414524
AsPC-1,3854666,3.565227366628202
HSC-3,409805,5.892445537848464
Karpas-422,15983966,-2.597972132371412
KYSE-450,11507802,4.680867496065348
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
Namalwa,25126798,3.8884375431248417
KMS-12-BM,3081361,2.7736505977581056
MIA PaCa-2,2742550,3.852651019611259
EHEB,6252,0.1933342673652495
OAW28,25150857,2.5691026408672957
TE 441.T,decitabine-navitoclax (2-1 mol-mol),1.414024011786789
SK-MEL-5,9911463,3.724914838124911
Namalwa,carboplatin-UNC0638 (2-1 mol-mol),3.639633422658992
Hs 611.T,23939,4.369791381281301
BT 248,72193861,2.013908806167315
Hs 611.T,24180719,3.465286559859583
HSC-3,selumetinib-piperlongumine (8-1 mol-mol),4.55078157659231
Lu-65,11427553,1.8001539504551751
ChaGo-K-1,135875424,3.8110724271208656
Kasumi-2,36462,-1.2000537391874553
JHUEM-7,serdemetan-SCH-529074 (1-1 mol-mol),2.0625230900739657
Karpas-422,53495165,-1.4820588452950412
Karpas-422,54618771,1.0964695949683176
Namalwa,5278396,1.1504569072002195
TE 441.T,10172275,2.5399848906693876
SNU-213,tanespimycin-gemcitabine (1-1 mol-mol),0.7260002272239208
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
LXF 289,135875424,3.2815298243266553
RKO,5281321,1.9988379902215376
SK-MEL-5,9926054,2.75949424585879
BT 286,53232,4.623732019696622
Hep 3B2.1-7,navitoclax-piperlongumine (1-1 mol-mol),2.342675220136375
SF295,327653,3.6466695589164857
B-CPAP,135421197,1.178862358485884
SK-UT-1,135999136,1.6451873526214251
LXF 289,56963564,0.2991276479966406
HOP-62,122327,5.042080848521016
BFTC-909,16038120,1.74161234898449
YD-38,107970,2.360175771455579
KMRC-20,2828334,6.318285048549249
PF-382,168313047,1.8210212384762663
SNU-1077,44507138,3.898901958117883
Ri-1,445643,0.8767098375675455
Becker,60700,0.0779655693307388
OE33,11175137,3.7940887690992855
ChaGo-K-1,2130404,3.2691972531193394
KMRC-20,5287620,-2.9460819990219687
KE-39,11364421,0.2339323182946827
SK-UT-1,SNX-2112-bortezomib (250-1 mol-mol),-2.387755678466967
Kasumi-2,5278396,3.160923329427041
MIA PaCa-2,navitoclax-pluripotin (1-1 mol-mol),-0.3437181769375965
AsPC-1,9936388,-0.8199656713038528
AsPC-1,5566,3.190935368909542
RT-4,135984461,3.767018649492271
SNU-886,3101542,4.147310950875089
OAW28,53392493,2.314719178940984
OE33,25262965,-3.0997225092728735
Kasumi-2,carboplatin-etoposide (40-17 mol-mol),0.2542153417603036
PE/CA-PJ41 (clone D2),9967941,3.5242615732915534
SF295,11364421,2.6561083557326195
NCI-H196,51039095,3.6341138272935622
L3.3,11612883,3.0937227516492767
ACC-MESO-1,23635314,4.805138762332019
TE 441.T,16725315,3.088519674994755
GOS-3,6914657,-2.554831261851343
Hep 3B2.1-7,11626560,1.834990976462628
SNU-216,126941,-3.6157884313638258
ChaGo-K-1,135398516,3.2001379900675357
NCI-H1339,1566236,2.281112121085828
KYSE-450,46843906,5.632374072388803
BT 112,piperlongumine-MST-312 (1-1 mol-mol),1.6765220415179445
Lu-65,16722836,3.079487594255957
OAW28,25262965,-0.9519808245592094
BT 328,5287969,-1.46849607666092
EHEB,71466380,4.118712365127363
HOP-62,4477,0.4859776870229825
OAW28,71751553,5.303505748888211
PF-382,44620216,3.605530573538089
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
OAW28,3634881,3.2370607224140473
EHEB,9911463,3.619047359567488
JHUEM-7,24821094,2.3762342489012047
Mono-Mac-1,10127622,4.4929712725026505
TE-14,9933475,1.5684971656253826
CML-T1,54686904,3.622967709931094
RERF-LC-MS,16725315,4.583339442818838
NCI-H929,444795,0.5078215400494521
KMS-12-BM,3815108,1.5057478423514148
NCI-H2030,56946209,-3.809257166478618
RKN,54613361,0.2026815444056028
Ri-1,17755052,-4.720683576415072
B-CPAP,15547703,2.731541485710416
AU565,42642645,1.544546710659079
TE 441.T,57519531,4.154057386971314
PF-382,6918736,-2.107719564435389
B-CPAP,1242560,3.0777193347384495
Hs 611.T,400769,-4.476338089842472
SK-MEL-28,216239,1.7130315366514903
AU565,71466380,5.723316888337632
RKO,9936388,0.8183869926163714
NCI-H196,71466578,5.048301146086872
Hep 3B2.1-7,24856436,0.5999508460122013
RKO,53495165,0.8925500623489324
KO52,568763,0.0919093108671874
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
SNU-886,2733526,4.210800511502518
L3.3,crizotinib-PLX-4032 (2-1 mol-mol),2.765628359334359
Ri-1,54686904,2.7416946204865997
KMS-12-BM,3543504,3.65561309678176
Namalwa,9823820,3.368866662810968
PF-382,tretinoin-navitoclax (4-1 mol-mol),0.5792978560561972
ESS-1,6252,2.853454302970564
YD-8,44589607,2.9595252781326784
SF295,vorinostat-carboplatin (1-1 mol-mol),3.5334833945464057
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
SNU-213,vorinostat-carboplatin (1-1 mol-mol),3.930687467685816
PF-382,6505803,0.1218702134100329
SNU-119,44607531,1.0035867478806315
IST-Mes1,67156097,2.0129233452386095
MIA PaCa-2,56973724,3.939860746778317
OAW28,42642645,0.9360886571737812
HSC-3,100016,6.558832951826536
BT 498,49793307,0.0294787754678871
TE-14,16725315,4.8843074522296295
EHEB,10090485,5.892161708902715
EHEB,52912189,0.500352140326513
HuT 78,46943432,0.3707901357093127
BT 286,3689413,-0.1900658377643967
LXF 289,68056272,4.660756431297166
Lu-65,9884685,0.6868572515984375
SNU-213,60750,2.5027121259815557
GOS-3,5113032,4.836446064307081
IST-Mes1,6918837,-3.247555275823077
PF-382,24951314,-0.325943641902455
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645
AU565,4259181,-0.781957409712965
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
KE-39,9444,5.314846845399724
ESS-1,11485656,1.966597488234831
BT 498,89928392,1.833655397128451
PF-382,6918289,-1.8568942087254432
TE 441.T,5311281,0.8068962369720073
Hs 611.T,UNC0638-navitoclax (1-1 mol-mol),0.5214150649691321
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
Ri-1,9887053,2.359250902526285
CML-T1,3081361,0.8904525598046117
Panc 02.03,54618164,4.482290203520866
EHEB,11427553,3.092795318424686
KYSE-180,11626560,2.00053897353166
NCI-H1339,navitoclax-sorafenib (1-1 mol-mol),4.7250529369838725
HuT 78,135984461,1.9427901339992903
SNU-886,5702613,4.595415249382652
Becker,JQ-1-navitoclax (2-1 mol-mol),4.827296641390771
ESS-1,6918638,0.5362706870956574
SNU-119,654092,-3.073300249988697
Becker,3062316,1.5685235643097857
JHUEM-7,216239,1.9657689443394817
TE-14,1750826,2.8876732240340246
Namalwa,72734382,3.923598258147051
MIA PaCa-2,44137675,3.4223653989045593
SK-MEL-5,54619267,3.938676828232531
ChaGo-K-1,10427712,4.586347903058592
KYSE-180,vorinostat-navitoclax (4-1 mol-mol),2.04555281689964
HOP-62,24779724,5.1203173517940135
ESS-1,3025944,4.241330613062884
ChaGo-K-1,11494412,-1.211362160076409
BT 112,46926350,-4.347811941752451
Lu-65,10127622,1.511770058636235
HOP-62,23725625,5.46334509708726
BT 328,9825149,2.1820811004987126
AsPC-1,5278396,3.912005463923024
Karpas-422,selumetinib-navitoclax (8-1 mol-mol),2.054969232289055
SNU-1077,12001922,2.14758213265239
KE-39,16065773,1.9907820848182145
TE 441.T,9936388,-8.412031296278057
ESS-1,6852167,2.0941643944902055
B-CPAP,navitoclax-PLX-4032 (1-1 mol-mol),1.4465369536509338
LMSU,ISOX-bortezomib (250-1 mol-mol),0.2979423367293473
HuT 78,4705,4.420154035532244
RERF-LC-MS,44819697,-0.3406635094896507
Hs 611.T,3101542,4.754983330166655
PF-382,4096211,0.5237091038371171
SNU-216,1716436,2.816824645868314
Hs 611.T,3552672,1.4860409791595686
NCI-H1339,25195348,3.198414569671987
PE/CA-PJ41 (clone D2),445091,4.262366084021789
MIA PaCa-2,24978538,3.3706281437981023
SNU-216,71729975,0.1345091184633045
SNU-1077,10184653,2.0946597853188833
KE-39,3676137,4.663329391632706
GOS-3,1641662,3.7460543636412535
HCC2108,ISOX-bortezomib (250-1 mol-mol),1.2590401469034869
SNU-1077,11152667,0.5302678511241536
RKN,5460769,5.79272629497122
SNU-423,selumetinib-navitoclax (8-1 mol-mol),2.4281091642149475
NOMO-1,2828334,5.727397129817869
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
HOP-62,16065773,1.872748547861876
NCI-H1339,2733487,7.603904657833405
RKO,119607,4.75876667689532
KMS-12-BM,613000,1.9257169552973945
RKN,11238147,3.9265768628415487
Ri-1,serdemetan-SCH-529074 (1-1 mol-mol),1.4624553326223522
Kasumi-2,9967941,2.996370075692804
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
LXF 289,ISOX-bortezomib (250-1 mol-mol),0.4085036355152772
BT 112,11494412,1.153463963183282
HCC2108,11214940,0.9644297504836672
Kasumi-2,3025986,-2.1480582997040325
ESS-1,6184667,3.505716491924749
KE-39,44185566,2.219569875640091
H-STS,docetaxel-tanespimycin (2-1 mol-mol),-7.723560174899757
HOP-62,2729026,3.06200446811759
TE-14,6918638,0.7581256744070354
B-CPAP,selumetinib-navitoclax (8-1 mol-mol),2.2794598948076525
CML-T1,2130404,3.1458672398900425
NCI-H2030,5746,1.2512356275194674
BT 498,9803433,4.273025703586365
BT 112,selumetinib-tretinoin (2-1 mol-mol),5.260723410115697
Ri-1,11612883,1.214475027954666
TE-14,89928392,2.6756823198343085
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
BFTC-909,5280436,4.2143472852581025
Namalwa,151289,0.4825051830903394
Lu-65,piperlongumine-MST-312 (1-1 mol-mol),1.0978652677191336
RKO,11152667,-2.010180339323448
Mono-Mac-1,20959075,-3.38453219938367
BFTC-909,10302451,3.622269240471498
EHEB,24772860,-2.594982066939884
SK-MEL-28,10302451,4.268902771891611
ESS-1,46191454,2.1127704272389805
OAW28,2858523,3.071437644261336
OE33,11625818,4.843865529588344
RERF-LC-MS,44241473,4.536869636330491
RKO,2828334,5.934464187728916
PF-382,11626560,-0.1561430168366412
KE-39,73707398,1.3252144554958445
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337
B-CPAP,54143018,-0.4654948157340908
SNU-886,11964036,2.034434534905483
Namalwa,49793307,-4.82638673619915
NCI-H1339,46926350,-4.1465404502416146
KMS-12-BM,119607,3.6226525677646313
LXF 289,24797083,1.462636821965973
OAW28,16725315,3.4000122970226196
NCI-H196,10385095,1.1966476706382554
KMRC-20,16725315,4.64742637635284
JHUEM-7,4096211,1.3301455757291742
Karpas-422,56963564,0.5479930709748855
RERF-LC-MS,5328940,2.240356815676024
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
KYSE-450,54143018,5.589609383601229
Kasumi-2,9803433,4.641295101837652
RT-4,6505803,-1.736360108528808
SNU-423,44486219,4.5785480934535725
LXF 289,73707398,1.5723760999376108
Becker,11234052,5.6053513923812925
SNU-423,docetaxel-tanespimycin (2-1 mol-mol),-4.7254091536928104
YD-38,selumetinib-decitabine (4-1 mol-mol),0.0898560222901214
SK-MEL-28,11404337,1.5828408993005263
SNU-119,3503,2.1114931973526425
GOS-3,5281672,4.273337523665355
Mono-Mac-1,54649381,3.5140339031114705
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
MJ,navitoclax-MST-312 (1-1 mol-mol),0.5350142291634327
EHEB,46224516,2.156286002861633
SNU-886,44185566,3.1834094102423083
Namalwa,16725315,4.579457546839429
NCI-H209,31703,-2.6785826900423206
PE/CA-PJ41 (clone D2),216468,4.149233535755013
SNU-1077,9936388,2.8901032001990954
BT 320,11257553,3.955696091315844
ChaGo-K-1,52912189,2.09928070426417
NOMO-1,9915743,0.4758643096003905
RKO,25195348,3.4491832635970585
HEC-108,16722836,2.6260322097351447
BT 320,676352,2.325208402765908
WM793,6914657,-2.064615991168629
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
H-STS,54639701,4.360992090113951
Karpas-422,1716436,3.743993231733117
NCI-H929,44486219,3.7960191523770135
Mono-Mac-1,2946601,4.595748556282713
NCI-H929,448949,0.7498835801993375
CML-T1,11167602,0.5863351465273275
ESS-1,16659841,3.2976235988863554
BT 320,2949965,3.703585539882772
SNU-216,11625818,3.7247477006141985
WM793,3854666,3.254480086465336
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
NCI-H1339,3385,5.726279931607606
LXF 289,16725315,3.2486511295045677
Panc 02.03,10296883,4.297264305827386
L3.3,10184653,0.0220617179423389
SK-MEL-28,5280436,4.781465110454219
SNU-216,136227924,2.452598137182288
Becker,5328940,2.4021986396944133
SNU-119,decitabine-carboplatin (1-1 mol-mol),5.089069342690692
PF-382,5335621,3.7996740659180688
SF539,26596,-2.288089999638428
IST-Mes1,16736978,2.528104664048346
KYSE-180,JQ-1-vorinostat (2-1 mol-mol),2.469302562652029
BT 286,4477,0.4436486581336739
B-CPAP,9911463,3.799628401356715
ACC-MESO-1,BRD-K27188169-navitoclax (2-1 mol-mol),3.904500927832786
JHUEM-7,25062766,1.192560693708174
HuT 78,3025944,4.291408043863783
HOP-62,46907787,2.3496891847816905
LMSU,alisertib-navitoclax (2-1 mol-mol),2.7596802469800026
SF539,9903786,2.8297220739955993
Lu-65,46174525,4.719153428448135
SNU-423,4705,3.684586446624816
Hep 3B2.1-7,89928392,1.396950134991398
AU565,68056272,3.4490660549666425
IST-Mes1,2874250,4.337377448058327
KLE,46174525,3.970027845055867
EHEB,4259181,-0.3918316132670805
IST-Mes1,9866186,0.9671533169607398
BT 498,JQ-1-carboplatin (1-1 mol-mol),6.0311872836348535
KMRC-20,25195348,4.57665452186817
BT 320,46199207,1.7709687668778378
B-CPAP,6918736,-2.2080588410094215
RKO,5280436,4.655813696583822
BT 248,1714884,3.688077995610216
HuT 78,11626560,-0.0583952728146231
HuT 78,JQ-1-carboplatin (1-1 mol-mol),-2.068765124024036
Kasumi-2,135984461,1.6284116850001094
MIA PaCa-2,54678924,3.5009557896469876
HOP-62,400769,-0.804531166567042
EHEB,3689413,-1.930959129148268
KO52,2113511,5.296200545877212
LMSU,9956119,4.695933157448729
SNU-119,navitoclax-sorafenib (1-1 mol-mol),2.4601153144436045
SNU-119,36462,1.6001107706429532
AU565,11612883,2.0019521527087982
LMSU,168313016,4.430377140485892
TE 441.T,10427712,3.217027471903541
Hs 611.T,11238147,1.6550317102691343
HuT 78,docetaxel-tanespimycin (2-1 mol-mol),-5.471210221464332
Lu-65,9933475,2.209817994970435
AU565,5113032,4.518377698044194
MJ,tanespimycin-gemcitabine (1-1 mol-mol),-2.1107286873488356
OAW28,54596558,4.423614985335385
BT 286,5978,-2.527076531897684
NCI-H1339,73707398,1.5517116600994163
SK-UT-1,5287969,-1.264654811647733
SNU-213,104842,-0.7066538476522156
Karpas-422,46943432,0.9846326291416436
Hs 611.T,4096211,1.356974463538243
SNU-119,327653,3.4048649042702364
HCC2108,168313047,3.002355785890527
ESS-1,969516,2.694807880886465
JHUEM-7,5280436,2.292992298066188
SW1783,9933475,2.066701345248221
SF539,11647372,0.1364544950678034
SNU-1077,8515,4.803726365696702
Kasumi-2,24901704,2.1856500624020994
BT 248,24748573,2.3039416185334556
KE-39,5566,2.5519005230377574
KYSE-450,135421197,2.3081928088852774
HCC2108,2749,3.7407563708836102
Hs 611.T,387447,-5.303952237268001
NCI-H1339,11717001,4.589198179129786
SF295,5311,1.7794369465589015
SK-MEL-5,44185566,3.090372433987207
KMS-12-BM,6438330,0.9422197844346454
OAW28,11175137,3.6697867992343607
RERF-LC-MS,71751553,4.213964581210796
PE/CA-PJ41 (clone D2),2113511,6.396262945032129
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
KE-39,crizotinib-PLX-4032 (2-1 mol-mol),2.410215231277302
Lu-65,4917,3.035155518535288
SNU-886,56963564,0.781074966857933
TE 441.T,4477,0.6885101231400689
NCI-H2030,36462,2.530734561122129
RT-4,25154868,4.28218091835124
SK-MEL-28,JQ-1-navitoclax (2-1 mol-mol),2.6430063634081877
KLE,219104,3.394006961912336
BT 286,3025986,-0.9461508297615284
HuT 78,24775005,3.660301435771245
SK-MEL-28,676352,2.519073281227085
LMSU,6610355,5.0974562936039645
HCC2108,SNX-2112-bortezomib (250-1 mol-mol),-2.1987674626028504
ChaGo-K-1,9933475,2.408030721375389
BFTC-909,9444,3.603329432205708
ESS-1,241158,3.69128431914065
PF-382,5281321,-2.364322655239298
RERF-LC-MS,241158,4.36087401910034
YD-38,piperlongumine-MST-312 (1-1 mol-mol),3.285608866825205
ChaGo-K-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2895987004290532
AU565,216239,2.683840039589205
KMS-12-BM,2842253,3.641564107870781
SNU-216,5746,3.315700427171305
YD-8,5335621,4.375821722730707
NCI-H1339,10302451,4.201130344992501
SF539,216345,3.6548053411240495
SK-UT-1,56946209,-1.4025300669134206
HOP-62,3825829,4.170218994796182
YD-38,322968,3.862943250611184
KO52,2729026,2.182339538385487
KE-39,123631,1.2600830788760988
L3.3,3062316,1.4450663843809155
SNU-119,11640390,2.9384325633103026
KMRC-20,5280436,3.9328974141799615
MIA PaCa-2,54613361,0.4679102497568742
SNU-119,446155,1.4772127449904695
TE 441.T,444795,4.4291459900533185
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179
KMS-12-BM,5479543,3.250022203761556
HuT 78,10074640,2.6664319662154625
Namalwa,25262965,-4.400546903132476
LMSU,54454,1.1076118788914329
Namalwa,6450551,1.7730795901303054
ACC-MESO-1,15547703,5.527714198479006
EHEB,613753,3.075305860436084
OAW28,10302451,2.68651474445359
NCI-H929,5746,0.47536469132715
LXF 289,46943432,1.4312531154305732
HOP-62,44607531,1.5421969187921007
L3.3,44185566,3.1226996854840836
HOP-62,135398516,2.003594389042817
Hep 3B2.1-7,135398516,2.0615134468665235
BT 328,5738263,4.558527530025055
KYSE-180,44202524,1.4429628152133265
SNU-423,2871966,0.8863330694044053
CML-T1,11175137,2.223157836501134
Lu-65,5460769,3.7972822070130494
KMS-12-BM,11977753,-3.492184366851405
Hep 3B2.1-7,656346,3.5555089253894026
B-CPAP,BRD-A02303741-navitoclax (2-1 mol-mol),1.892651156535057
IST-Mes1,decitabine-navitoclax (2-1 mol-mol),4.382542969117623
KLE,25126798,3.674885583881781
ESS-1,JQ-1-navitoclax (2-1 mol-mol),-0.1704578961514246
Namalwa,2871966,-1.9170848167407744
RT-4,44607531,2.8716913439843803
Ri-1,36314,3.2158141028558083
SNU-1077,5746,2.5393754891550877
KLE,4788,5.329574441575628
BFTC-909,9927531,5.31835549136936
PE/CA-PJ41 (clone D2),53495165,-0.6517072813998595
Lu-65,11152667,-1.8224670022620897
Ri-1,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3048620858233484
KYSE-450,15547703,4.417668058274178
NCI-H929,54649381,3.9072363732080535
NCI-N87,24180125,2.059368273959215
MIA PaCa-2,5281672,4.326280360096159
KYSE-450,15983966,1.931035725285284
NOMO-1,285033,-2.4289999699368923
L3.3,17755052,1.4516432874311858
BT 248,702558,5.9883095131036495
BT 328,1242560,3.7217728648483552
SF295,6852167,3.343016827643526
B-CPAP,5287620,-2.9540281885432735
AsPC-1,445643,4.30663769172778
SNU-213,24964624,2.577057311876958
BT 286,3552672,1.7054946735285288
Hep 3B2.1-7,3854666,3.158608075491721
RERF-LC-MS,10184653,1.661334722418144
BFTC-909,3384730,4.46542670181497
Lu-65,54618305,4.948052353708299
RT-4,2708,5.689057420087821
TE-14,docetaxel-tanespimycin (2-1 mol-mol),-2.865186321246779
LXF 289,selumetinib-UNC0638 (4-1 mol-mol),2.485737118348581
LXF 289,24753719,4.56569970094865
RERF-LC-MS,2874250,4.628157945253743
JHUEM-7,2749,1.3082739323619237
MIA PaCa-2,44489675,3.7736935827734706
NCI-H929,56963564,-0.3004346894334608
BT 320,65064,6.551398782521052
SNU-1077,24180125,4.514438880816518
SK-MEL-5,6610216,3.979150432082891
KMS-12-BM,11485656,1.287590694324435
RKO,67156097,-1.3338800856316015
PE/CA-PJ41 (clone D2),10302451,2.698134533156883
RERF-LC-MS,151289,1.06337646711186
Ri-1,3503,1.1678473170955408
NOMO-1,654092,-2.6158486127541343
KE-39,11396600,3.848773124810753
RT-4,10184653,0.8000143447696744
OAW28,24797083,1.7501511491860735
B-CPAP,4378219,2.1409307713074353
OE33,387447,-5.027649776547387
EHEB,5282054,3.0969047421141584
MIA PaCa-2,selumetinib-piperlongumine (8-1 mol-mol),2.0711294667177516
BT 286,24748573,1.9402593533465669
NCI-H1339,36314,-6.499724688901822
JHUEM-7,24785538,0.0330026249712562
Ri-1,11497983,2.566309956988992
SW1573,25126798,4.147065453172024
NCI-H929,49836020,2.30560189930029
SK-MEL-5,24771867,4.627335356714736
KE-39,5738263,4.084504768293086
ChaGo-K-1,selumetinib-piperlongumine (8-1 mol-mol),4.196281185550965
HEC-108,SNX-2112-bortezomib (250-1 mol-mol),-0.4374113289550588
NCI-N87,400769,-1.2757727144105298
OE33,ISOX-bortezomib (250-1 mol-mol),0.4854080775005868
GOS-3,12001922,1.73057519179838
NCI-N87,44202524,1.5092428544055756
IST-Mes1,119607,5.839609606963759
SW1783,salermide-PLX-4032 (12-1 mol-mol),6.068207873844662
SNU-886,selumetinib-decitabine (4-1 mol-mol),0.1903285486813963
Hs 611.T,11960529,3.955998634111423
TE-14,46199207,3.6455428697652112
SNU-213,selumetinib-piperlongumine (8-1 mol-mol),2.037048591352688
Karpas-422,10074640,3.4361637685293944
B-CPAP,151289,0.3803775246447248
HOP-62,3689413,-1.4977119259076146
BT 248,3825829,4.117903271720201
Namalwa,11234052,2.9664552534255155
AsPC-1,11427553,3.0222816384498237
BT 112,10296883,3.9999728699442607
SK-UT-1,9826308,0.8326524601340544
Hs 611.T,11647372,-1.5231732525531485
HOP-62,2871966,1.1314603098656817
KMS-12-BM,89183176,3.5435448288108056
TE 441.T,702558,3.4312087803919837
MIA PaCa-2,72734382,4.846117233609802
RKN,227681,3.7901732699912585
AsPC-1,navitoclax-sorafenib (1-1 mol-mol),1.6576308864505285
RKO,148198,-2.1467795088860875
PF-382,navitoclax-pluripotin (1-1 mol-mol),-4.412096991385023
Hep 3B2.1-7,25183872,-0.1200261699851997
GOS-3,24951314,2.597884619205853
RT-4,46199207,3.146589071997412
AsPC-1,2749,1.937127114514975
HSC-3,erlotinib-PLX-4032 (2-1 mol-mol),2.5171532957569864
SW1783,44137675,4.848183688866269
ACC-MESO-1,24856436,4.2649128901645605
YD-8,16065773,3.197824930494566
SNU-216,46199207,3.6310581715590673
AsPC-1,25150857,2.720712035994173
Ri-1,46191454,-0.1787336144336715
L3.3,erlotinib-PLX-4032 (2-1 mol-mol),3.685667045141098
KMS-12-BM,107970,1.2280769647153718
KE-39,9935249,3.082096285966509
NCI-N87,25262965,-2.609521679715104
PF-382,2749,0.594868187564988
KE-39,3038522,3.2295476949923874
SNU-119,5328940,0.3494705393628248
SK-MEL-5,285033,-1.4568960685730863
SK-MEL-28,46398810,3.208248420081512
MIA PaCa-2,136227331,4.243512473772355
HEC-108,9936388,-4.887528080420867
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828
KYSE-180,54613361,-0.6142200008025552
CML-T1,11612883,2.4336919382311253
ESS-1,6914657,-3.5334126406740594
HSC-3,53232,1.9828236974708795
PF-382,3062316,-2.906652546684618
ChaGo-K-1,16725315,3.255226634029485
RERF-LC-MS,11427553,2.91041132641442
KO52,1641662,2.14069731624562
SNU-886,JQ-1-navitoclax (2-1 mol-mol),-7.589926641213618
BT 286,123631,2.3130563445679733
JHUEM-7,SNX-2112-bortezomib (250-1 mol-mol),-2.50050098100693
PE/CA-PJ41 (clone D2),107985,-2.5138911601110254
L3.3,25126798,4.136340325033448
HSC-3,446155,2.7370474852392346
HSC-3,11612883,4.26819604770761
SF539,54596558,5.2593841125490135
BT 286,11238147,1.609564465759162
OE33,400769,-1.041750401680879
YD-38,24772860,-2.3179042011152355
EHEB,387447,-4.8695156526166175
YD-8,135440466,0.98060002871852
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
MIA PaCa-2,54618305,4.257702417709433
Ri-1,piperlongumine-MST-312 (1-1 mol-mol),0.5424428494600624
L3.3,10127622,6.808802938866309
BT 498,6917907,3.9423727482890456
ChaGo-K-1,24748573,2.5402055759228364
KE-39,24180125,2.8951506389407053
L3.3,9907093,5.18450339753338
SNU-423,3634881,3.418662921647716
MIA PaCa-2,25150857,1.2289089337297283
KMRC-20,107970,2.3183049291357953
AsPC-1,168312962,4.080126214508297
HCC2108,46191454,1.2793271361980716
TE 441.T,42642645,-0.7295119160835342
KYSE-180,24951314,1.8172088790949268
TE 441.T,49846579,1.6293260082614165
BT 112,53392493,1.8363086740890933
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
TE-14,613753,3.4385269932011
OAW28,15983966,1.5707780698474574
CML-T1,11396600,3.3654395371867425
KO52,24964624,2.970521329302971
BT 498,selumetinib-MK-2206 (8-1 mol-mol),4.151434834860726
RKN,9956119,4.4432647969313
KYSE-180,4788,5.873750540393015
SNU-213,654092,0.3556134430950528
Hs 611.T,135999136,3.4823204763051487
SNU-213,135440466,1.6712887821469151
H-STS,navitoclax-gemcitabine (1-1 mol-mol),-4.788943462701537
PE/CA-PJ41 (clone D2),11364421,2.0982795896653834
Hs 611.T,2113511,3.8884746215924455
GOS-3,25150857,1.9006273010690065
LMSU,46215462,1.6132445260269193
Namalwa,4917,3.4280609586493376
BT 320,11396600,4.5560356349666
SF295,5460769,2.0646753609737125
Panc 02.03,25183872,-0.079390979301081
Kasumi-2,24753719,3.2877720740856815
KMRC-20,44589607,3.662166795510174
KO52,24856436,-0.7085491514646743
PE/CA-PJ41 (clone D2),462382,1.0378209469483948
OE33,4378219,2.1039345864440433
HCC2108,400769,-0.6211962512708786
KO52,7326481,2.795216556097651
IST-Mes1,6505803,0.837907313306775
Lu-65,5328940,1.4363623184528207
BT 498,644241,2.2010744744476742
BT 286,400769,-0.6076188000996261
KO52,9825149,1.8631876044655673
BT 248,16038120,1.7409517230791791
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
Becker,3136844,4.385531960303477
SNU-216,2749,0.6721262653187517
AsPC-1,6918328,0.3822733035015269
SF295,6917907,-4.699028520371913
SW1783,24901704,2.457662340178976
OAW28,5460769,4.044755256654475
CML-T1,568763,0.104759642693247
Hs 611.T,42642645,0.1847495299149886
MIA PaCa-2,24775005,3.3138581445981106
IST-Mes1,vorinostat-carboplatin (1-1 mol-mol),3.785712345618982
AsPC-1,navitoclax-pluripotin (1-1 mol-mol),0.1867529421630529
NCI-H929,navitoclax-piperlongumine (1-1 mol-mol),1.7457744317764834
Mono-Mac-1,16038120,-0.6637799816204304
Kasumi-2,10184653,1.2356790109659648
NOMO-1,46191454,0.6880471005756411
CML-T1,tretinoin-navitoclax (4-1 mol-mol),0.9331911225781374
SNU-886,selumetinib-piperlongumine (8-1 mol-mol),-0.4939497647937791
HCC2108,374536,3.656255875705604
EHEB,135421197,1.2947733633872678
SW1783,3503,1.7276989845578277
HCC2108,11222830,1.6798861627317594
BT 328,11609586,3.6463226315951225
Mono-Mac-1,10074640,3.3063713625163857
HEC-108,selumetinib-JQ-1 (4-1 mol-mol),4.622936143310662
Kasumi-2,100016,5.973936097539331
NCI-H1339,9840324,6.07304514189999
NCI-N87,9967941,2.944195178928737
Mono-Mac-1,26596,-2.0508737654950036
LMSU,49766530,-0.1291663690745916
TE-14,9967941,4.79837679092974
SW1573,3384730,1.5192292760027193
YD-38,1641662,2.8671869639496386
HEC-108,10074640,3.0709446672134946
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
YD-8,613753,3.309509462802455
Ri-1,72734382,3.3487101348360824
IST-Mes1,6450551,1.123519877762822
RERF-LC-MS,8515,3.770178660744851
BT 112,navitoclax-sorafenib (1-1 mol-mol),1.1762931149119242
SK-MEL-5,15547703,3.136399381363894
Namalwa,24785538,0.8043164607604679
Becker,11427553,3.222722363158399
LXF 289,9956119,3.057634534881657
LMSU,selumetinib-vorinostat (8-1 mol-mol),4.672884739471154
TE-14,8515,4.691290159599005
SF539,23582824,-0.2198249685001801
NOMO-1,65064,5.083490310509571
KE-39,JQ-1-navitoclax (2-1 mol-mol),0.0790402407130846
PE/CA-PJ41 (clone D2),262093,3.3360750662244443
BT 112,9911830,1.5924575123512974
ACC-MESO-1,16038120,1.156287682803386
YD-38,JQ-1-MK-0752 (1-1 mol-mol),-3.746552719841539
KE-39,25022340,3.482670600325695
KLE,6918328,-0.4270629798657607
AU565,25062766,2.0331930756167234
ESS-1,44197249,5.299862122462015
KO52,5329102,1.292288709166054
Ri-1,10302451,1.5393417915178893
Mono-Mac-1,446155,1.9950711341343337
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
NCI-N87,6852167,1.8373876080574163
SF539,23635314,-2.6621769118066516
BT 248,208908,1.7719462620560902
SW1783,9907093,4.435721436933663
GOS-3,448949,2.9478585654130263
AsPC-1,135875424,4.124114476494282
SNU-423,72376,-0.5003659093552222
NCI-H1339,25126798,3.699685698057144
SNU-1077,216468,4.221133217458946
HSC-3,24180125,3.0095192248544897
TE 441.T,navitoclax-birinapant (1-1 mol-mol),-0.404464101851955
SNU-423,10127622,4.761112660173214
PE/CA-PJ41 (clone D2),24797083,2.207629580437647
KMS-12-BM,9907093,3.643463351047445
SNU-1077,44489367,4.954217803557541
Hep 3B2.1-7,2828334,6.035830704503776
SNU-1077,16725315,4.11344687119358
CML-T1,44137675,3.6793288779986377
SNU-423,1716436,3.438303267646366
HOP-62,11427553,2.766588497834141
SNU-119,navitoclax-gemcitabine (1-1 mol-mol),1.782334179456962
BT 286,2742550,3.3943072978834277
TE-14,5328940,1.6282109394306992
ChaGo-K-1,10074640,3.6205577288554394
YD-8,24797083,1.7826041410647693
Kasumi-2,9825149,1.9223862209950433
SNU-213,11485656,2.091894408723056
SK-MEL-28,637858,2.5948993681356276
OE33,SNX-2112-bortezomib (250-1 mol-mol),-1.4938738793145026
Becker,24901704,5.073780247486695
LMSU,676352,2.426612440121004
LMSU,9926054,1.9493229998791417
SNU-119,25105715,3.2927005530338933
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
TE-14,387447,-3.5543881689563483
NCI-H196,25105715,3.7516207923037586
SNU-423,3025944,5.553712511515966
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
BT 112,4917,2.125230450219151
BT 248,73707398,1.2475621750333084
Kasumi-2,16736978,0.2987482410922295
Hs 611.T,753704,3.904676648691391
YD-38,9911463,4.143159410614896
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
SF539,11626560,1.8375334326150123
CML-T1,52947716,-5.195799479557534
Mono-Mac-1,3552672,0.1467124788792889
SNU-213,25150857,2.2886972845490576
HEC-108,104842,-0.6030222866662514
PE/CA-PJ41 (clone D2),16736978,2.372818675587023
CML-T1,11625818,4.307055863962681
BT 286,6917907,-6.473043481736071
SNU-216,5311,0.7634319585662608
BT 320,BRD-K55473186,3.858960180173933
MJ,36462,-0.8152461099885887
SF539,salermide-PLX-4032 (12-1 mol-mol),2.8378152204226836
HOP-62,168313016,4.593663167068175
Becker,10296883,4.31752254310815
CML-T1,navitoclax-gemcitabine (1-1 mol-mol),-3.0033720863451467
YD-8,5282054,3.5246749530230996
IST-Mes1,54618164,4.8538718291352945
AsPC-1,25161177,4.641147259380914
SK-UT-1,216345,4.640105934271291
HEC-108,serdemetan-SCH-529074 (1-1 mol-mol),2.423945319779485
BT 286,23725625,3.3137349163221415
BT 248,54613361,5.122685224165604
L3.3,71466380,3.127104498422419
KLE,19582717,2.474003523492041
SW1783,446155,0.9196184562402074
SF295,100016,6.949657377166824
BT 112,5291,3.7853178637094262
Karpas-422,1566236,1.018431355816045
SNU-216,49793307,-3.858318805980409
SF295,11612883,3.737014041841419
KYSE-180,439501,-1.6605779697575254
LXF 289,46174525,4.3838011857350585
KO52,2858523,3.055649072846991
BT 498,82146,4.101761137978197
BT 328,3384730,1.2152683647278577
SF295,navitoclax-gemcitabine (1-1 mol-mol),0.7622773628981511
TE-14,26596,-1.531582993203474
ESS-1,462382,0.8866034659436756
IST-Mes1,66577038,2.5150906013236423
AsPC-1,57519531,4.317220146110072
BT 328,11396600,3.7528560222461858
ChaGo-K-1,25102847,2.843403225598923
ChaGo-K-1,15953870,3.0294240657930955
OE33,serdemetan-SCH-529074 (1-1 mol-mol),2.664502494439147
Kasumi-2,46215462,1.2219116069395664
B-CPAP,4096211,1.3547168629560964
KLE,11364421,-3.6177571319013455
KE-39,11707110,5.749858449286614
KYSE-180,11222830,1.7439687500469427
SNU-213,selumetinib-vorinostat (8-1 mol-mol),1.4256342092692729
BFTC-909,9911463,4.114346930944119
SK-MEL-5,10127622,3.8805251608719935
MJ,400769,-0.147050073653482
OAW28,25062766,3.2225198305631464
SNU-886,613000,2.2202815860905822
Mono-Mac-1,11964036,-0.102972472767287
KYSE-180,24964624,3.1608590023354712
HuT 78,54143018,-1.655797975805756
Kasumi-2,11427553,1.2029720763459597
NCI-H929,24180125,2.4641763284453795
Kasumi-2,11178236,-5.568204380320254
Namalwa,25105715,3.6831853039250033
SW1783,15547703,5.783856550562672
H-STS,24856436,0.4197930634847036
Karpas-422,11494412,1.1821757343676855
H-STS,3634881,3.254926671083326
NCI-N87,44137675,2.149558923433186
H-STS,24964624,0.7611885125245664
ACC-MESO-1,638278,3.50248621605198
PF-382,24180719,4.536989460755837
Namalwa,9887053,0.2875319408170879
RT-4,4259181,0.4956946540898031
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
SNU-213,124202324,3.2763512137021173
YD-38,5282054,3.830335657875788
SK-UT-1,4259181,0.5247904304596981
Becker,49867930,4.438387902904834
OAW28,44566777,2.367961844085161
SK-UT-1,2729026,3.1641569062038997
AU565,4705,1.275846161151896
YD-8,1716436,3.08383873816405
KLE,11404337,-0.1549034777249487
Ri-1,selumetinib-PLX-4032 (8-1 mol-mol),3.967143255386252
GOS-3,selumetinib-UNC0638 (4-1 mol-mol),3.7794346913779577
LMSU,24901704,3.2406983382817387
HOP-62,136227331,3.5608481617611165
AsPC-1,23725625,6.32859301599116
KYSE-180,3825829,3.0319007091325267
B-CPAP,3038522,3.5963516655253907
PE/CA-PJ41 (clone D2),168312962,3.915035257448421
OAW28,24821094,3.6183900250040497
NCI-H2030,44589607,2.9694652404648547
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
NCI-H196,44607531,1.7206917376940007
WM793,36462,4.293096910683363
KYSE-450,51039095,3.763234499146495
HuT 78,6438330,0.788518681331833
BFTC-909,10385095,0.9839595624316404
Mono-Mac-1,66577038,3.474147051168979
ACC-MESO-1,5738263,3.969640298508432
LMSU,9927531,5.404187778104352
Mono-Mac-1,52912189,-0.3351512701335604
SF539,439501,-3.28606941940852
ESS-1,56649450,2.890363396041127
NCI-H1339,5329102,3.0234364578964668
AsPC-1,6917907,-5.50087073609159
BT 328,11238147,2.054089677039581
BT 286,68056272,3.758013058674078
SNU-119,216239,2.5472186615534893
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
IST-Mes1,44589607,3.0309009389458605
RT-4,219104,3.5116723720438636
H-STS,327653,2.5353230161110014
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
ChaGo-K-1,4521392,4.240215977362856
SK-MEL-5,10302451,3.6618185056536574
Karpas-422,17755052,-0.3521481937168509
SK-UT-1,46199207,3.7020798689093466
SF539,11977753,-1.5349757438855824
RERF-LC-MS,2749,2.1448012118135176
KLE,2733526,3.099087274855166
ChaGo-K-1,5282054,2.4734190149171815
SNU-216,5291,3.786158286064785
MIA PaCa-2,11656518,2.3369200972194566
HOP-62,JQ-1-vorinostat (2-1 mol-mol),0.5006545993602405
PE/CA-PJ41 (clone D2),carboplatin-etoposide (40-17 mol-mol),3.538007302832437
SNU-423,17755052,2.0274211843455907
OAW28,4259181,0.9119817479539226
TE-14,selumetinib-vorinostat (8-1 mol-mol),2.42996649499285
AU565,1641662,2.8108586385203234
Namalwa,1242560,3.173059576229197
KLE,6917907,-6.139157013602895
ChaGo-K-1,53392493,1.973130575864384
H-STS,4096211,0.7701877892455814
HOP-62,25227462,0.8519692318516471
KMRC-20,selumetinib-MK-2206 (8-1 mol-mol),3.8802648290187225
Lu-65,73707398,1.7319675343544505
NCI-H929,60700,-1.1580289283938754
SF539,3038522,2.057800880949275
MJ,9935249,-0.0346265394865933
ACC-MESO-1,24785538,2.771715835479783
Becker,25227462,2.4003945013421575
AU565,3634881,4.304518749556461
KMS-12-BM,676352,1.9185611453511533
CML-T1,9825149,1.6129799202532635
KYSE-180,10427712,3.555551591768758
KMS-12-BM,68056272,2.2091741251856982
Namalwa,11497983,4.414210935166738
OE33,168313200,4.319769864025677
LXF 289,16038120,0.5250135720403194
PF-382,15983966,-4.881243933970009
PF-382,11640390,2.579258356674951
KMS-12-BM,16722836,0.1078471440950463
OE33,10296883,3.414380068882816
Karpas-422,71466380,4.4193301914367185
L3.3,12001922,2.4292832661010557
H-STS,6505803,0.5486553702983976
GOS-3,49793307,-1.7592424650384757
HEC-108,1750826,1.2012751309541916
SNU-119,3676137,3.8101807796539298
HSC-3,241158,3.419773075540372
KYSE-450,23635314,4.2538404105785
AsPC-1,9915743,1.396378280260739
BT 112,56649450,3.981227494013605
SK-MEL-28,doxorubicin-navitoclax (2-1 mol-mol),0.6137176516261809
RERF-LC-MS,16736978,2.30801467798398
OE33,12001922,2.146874521539325
KYSE-450,216345,4.4435224891329
SK-MEL-28,3062316,3.6672926372166
Panc 02.03,11626927,4.481877662185247
Lu-65,2874250,6.215177714586098
WM793,24964624,2.7889757819511996
HCC2108,6610216,4.333266627123119
NCI-H1339,selumetinib-MK-2206 (8-1 mol-mol),2.766531591740839
KO52,446155,3.831951232060963
NCI-N87,10231331,4.183605147658756
H-STS,5311,0.9489728897085792
SNU-886,16720766,-3.5476315542779364
Hs 611.T,5281321,-4.842109783490502
NCI-N87,6917907,-5.514556019160177
KYSE-180,4261,3.0762998469253366
IST-Mes1,6918878,2.524010054300984
ESS-1,984333,0.2604103930211148
HOP-62,71729975,2.57008704117282
OE33,168313016,4.477619540995002
Becker,3385,6.743991470359075
KO52,71751553,4.277873961450632
HSC-3,6918837,-2.212600896181265
Karpas-422,4578,4.102594872772706
ESS-1,11656518,2.306800559161758
RERF-LC-MS,11494412,1.0302757077826894
L3.3,2708,4.48343396675343
SNU-119,15983966,2.01130055779656
BT 328,ISOX-bortezomib (250-1 mol-mol),1.5922800813403362
BT 248,984333,1.3539050434846691
HOP-62,vorinostat-navitoclax (4-1 mol-mol),1.1061829362989206
NCI-H1339,36462,1.5499539192290197
RERF-LC-MS,135398516,2.452363199699896
EHEB,637858,1.5977612521222773
LMSU,2871966,3.076557585193087
RT-4,54143018,0.4678710422160503
KMS-12-BM,2733487,6.235161466652842
TE-14,73707398,2.073714083306327
Namalwa,6505803,0.5277329545448584
TE 441.T,49766530,-1.0459972469347878
BT 320,9926054,4.941319925063275
KMS-12-BM,4477,0.337852436385288
SF295,42642645,1.0127855753280748
HuT 78,46901937,3.36235026237692
YD-38,5460769,0.587016845611175
KLE,72376,-2.1064714455436855
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
KE-39,6917907,3.4636504669535215
Karpas-422,322968,2.538876581792157
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
KLE,54618771,1.0287660425791825
RT-4,9903786,1.1299984693284726
B-CPAP,SNX-2112-bortezomib (250-1 mol-mol),0.3419783541511122
OAW28,135421197,1.4901490212875883
AsPC-1,24180719,3.701309063973522
IST-Mes1,19582717,4.57770755362997
SNU-119,10427712,3.870149394322131
OAW28,11178236,-3.057015425639644
ESS-1,135440466,2.7026954574197424
RERF-LC-MS,52947716,-5.597592816818683
RKO,3385,4.410917651107157
BT 112,5394,4.526138920769001
KMRC-20,400769,-0.3273926657641918
Karpas-422,25154868,5.247703712225478
Hep 3B2.1-7,17755052,1.7931208619651735
Ri-1,3081361,2.3220085024904185
HuT 78,BRD-A02303741-carboplatin (1-1 mol-mol),3.8369942625366
SNU-886,selumetinib-vorinostat (8-1 mol-mol),0.3326918028445991
SF539,3854666,0.2673517991428248
H-STS,3503,1.3838886795992438
Karpas-422,60750,-4.565045356168419
EHEB,BRD-K27188169-navitoclax (2-1 mol-mol),5.0776573503309
KLE,72193861,1.934481049124771
EHEB,5113032,4.507896458249702
HSC-3,67156097,-0.140204998248407
B-CPAP,BRD-A02303741-carboplatin (1-1 mol-mol),4.469579900896245
Panc 02.03,462382,1.1832417961450334
MIA PaCa-2,25062766,2.214474129004581
ChaGo-K-1,25105715,3.5734509146637032
RT-4,135398516,2.327932490402957
ESS-1,9911830,2.1910771619648077
LXF 289,446155,3.7142968943868073
NCI-N87,452548,-1.772451424496647
KO52,168313200,1.5421636413024
SNU-886,15953870,3.508651864027871
TE 441.T,9952709,3.74423263883626
Becker,46224516,3.0790320889380376
NCI-H209,11317348,1.789123984926599
YD-8,64971,4.450912685829993
BFTC-909,44493528,4.370300807083883
KLE,3384730,5.5798007151101325
WM793,387447,-3.0647343941704603
SNU-119,1641662,3.269862503326484
SK-UT-1,11612883,4.583054819879112
KMRC-20,11964036,1.4818667570891622
AsPC-1,136227924,3.2025742465891938
LXF 289,11455910,1.909862916296106
PE/CA-PJ41 (clone D2),568763,1.0096666551502742
Becker,3038522,5.367160453178797
BT 112,1750826,-2.206420752683485
HCC2108,11152667,0.6161783395316693
SNU-1077,5287620,-2.139811632813461
OAW28,11364421,1.0555351676055402
SW1573,4261,3.544037815747042
Mono-Mac-1,72199292,0.6330197013887235
NCI-H196,24180125,2.7124009343781665
HOP-62,selumetinib-PLX-4032 (8-1 mol-mol),2.4428399643658603
OAW28,25102847,1.9718431113444057
ChaGo-K-1,11396600,3.1968353669128637
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
TE 441.T,17755052,0.8250315616483301
YD-8,5311281,1.1979218299648091
HEC-108,135411,0.6194051184569405
B-CPAP,42642645,1.2545407873532517
BT 328,227681,3.8990040378810544
HOP-62,25154868,4.686337763872305
SW1573,49766530,-2.79322841384178
WM793,66577038,3.1191342289924417
IST-Mes1,24951314,2.196137261882708
RKO,613753,3.427719504210608
ChaGo-K-1,25262965,-2.1300903092101384
L3.3,JQ-1-vorinostat (2-1 mol-mol),2.1502729900256807
SF539,148198,-6.422680321892083
HEC-108,613753,3.395991597715239
EHEB,9911830,3.0366000052999893
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
KYSE-180,119607,5.519962897909222
KYSE-180,2945648,3.004828096065946
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
KYSE-450,5291,4.139799755765828
LXF 289,24772860,-1.828128181459349
MIA PaCa-2,24901704,3.473377038111004
KMS-12-BM,selumetinib-JQ-1 (4-1 mol-mol),-0.820838989236415
SK-MEL-5,73707398,1.781035477419176
Namalwa,216239,1.624905694563111
MIA PaCa-2,15983966,-4.265990163763759
TE-14,selumetinib-MK-2206 (8-1 mol-mol),2.2863932915997256
SNU-213,2858523,3.0248572714746853
Panc 02.03,4788,6.040807258084593
LMSU,vorinostat-navitoclax (4-1 mol-mol),3.537964387470637
KMS-12-BM,5113032,5.435585194289586
NCI-H209,24978538,-1.1799487785033067
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
RKO,9911463,3.963116579454927
RERF-LC-MS,9907093,3.840365222907794
IST-Mes1,135875424,5.039969018342982
HCC2108,selumetinib-UNC0638 (4-1 mol-mol),4.394993613237598
Ri-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.018523415252616
KE-39,126941,-2.7828178616251984
KE-39,5284373,4.108960473804643
WM793,56649450,6.114929722972158
HCC2108,16725315,3.712302127233507
Namalwa,3038522,1.3634755739913815
HuT 78,16219061,1.2984020773766147
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402
B-CPAP,76446078,4.324455702979326
Karpas-422,11152667,-1.1823612296931902
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
YD-8,54613361,3.562533264649823
Karpas-422,148198,-3.5709854147128843
H-STS,15953870,3.89259126645257
RERF-LC-MS,53495165,1.4938275665549956
BT 328,168312962,4.074485851514308
BFTC-909,49793307,-2.946331542038894
SNU-216,tanespimycin-gemcitabine (1-1 mol-mol),2.5069863823835807
Kasumi-2,24964624,-0.4292953548999766
SF295,122327,5.77820322560813
BT 286,11152667,1.278732358262165
PF-382,24771867,-1.6533655868224757
YD-38,375860,-0.9666963323879848
LMSU,doxorubicin-navitoclax (2-1 mol-mol),0.2989425462047189
Karpas-422,54618164,3.784290437567208
HEC-108,6914657,-4.042403483970356
SNU-119,11228183,1.025523846387519
Mono-Mac-1,2126,3.9956645703631666
LXF 289,6918328,-0.239589445073231
SK-MEL-28,219104,4.539871765849737
KMS-12-BM,24180125,1.472923036280714
BT 248,10184653,1.5665149744328004
SNU-886,16038120,0.7187516548960445
B-CPAP,docetaxel-tanespimycin (2-1 mol-mol),-5.525522845954553
SF539,9915743,0.9219479584552366
GOS-3,16038120,1.102104110747453
SNU-423,BRD-A02303741-navitoclax (2-1 mol-mol),3.25284280837799
HEC-108,89928392,1.8334971858898483
LMSU,JQ-1-vorinostat (2-1 mol-mol),2.553257799343416
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
ChaGo-K-1,11404337,1.1508536619225571
LXF 289,135984461,4.539632657840611
AU565,6610355,3.967539400054512
PF-382,969516,2.499968363258948
L3.3,16065773,3.089788322580725
Ri-1,tretinoin-carboplatin (2-1 mol-mol),2.829663815817562
SK-MEL-5,9935249,4.115682360197781
HEC-108,navitoclax-MST-312 (1-1 mol-mol),0.398713254172199
EHEB,5311,0.7316765744080972
NCI-H1339,67156097,-1.183068157390194
TE-14,168313200,3.700677169997579
Hs 611.T,67156097,-2.5654198026723205
BT 112,5329102,1.915457190932002
BT 328,984333,0.810991187703125
LXF 289,71466380,3.888647536265504
AsPC-1,44607531,1.5574724897590664
TE 441.T,50905018,3.407727257087799
AsPC-1,219104,4.54762024266609
NCI-H1339,19582717,4.074457978506879
ChaGo-K-1,5566,3.0668549969604424
SNU-216,selumetinib-UNC0638 (4-1 mol-mol),4.785585222565971
Karpas-422,JQ-1-vorinostat (2-1 mol-mol),-1.372676579050444
Kasumi-2,46907787,-1.0712711351942366
YD-8,387447,-3.9759575932823377
BT 286,53481919,3.917510700943226
BFTC-909,24978538,2.589526114093726
HuT 78,5280436,3.170358590810086
AsPC-1,46174525,4.390753346499015
Hep 3B2.1-7,6918878,4.528640003086307
KE-39,135875424,3.891762591841876
KE-39,25126798,4.078237420502305
SNU-216,docetaxel-tanespimycin (2-1 mol-mol),-2.955516595615088
Kasumi-2,3081361,2.7656675201923555
BT 328,216345,4.606684867794206
BT 328,tanespimycin-gemcitabine (1-1 mol-mol),-0.0824560105444719
TE 441.T,5460769,2.227250069350157
SNU-119,387447,-4.116955767451351
SNU-119,49850262,4.203409740866064
BT 112,57519531,1.0837379770359268
NCI-H1339,10074640,3.6833793292295582
RKO,656346,1.2468664563159324
RERF-LC-MS,6917907,-5.461995819879327
HCC2108,15547703,2.896833120042048
SNU-119,11214940,-0.1259721095383459
L3.3,151289,1.4499844825237675
RKN,3062316,2.6330403907451863
YD-38,73707398,1.113777458655618
KLE,54649381,3.9923802992632687
Kasumi-2,54618795,2.2160859361178624
HSC-3,5951923,3.085598804572914
CML-T1,10113978,1.6264516706818362
RT-4,107970,2.3841738823851255
KMS-12-BM,navitoclax-piperlongumine (1-1 mol-mol),-0.5668023571576813
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
Kasumi-2,2729026,2.278256361901275
ESS-1,24772860,-2.7433674764679097
BT 498,65064,5.2071108704456
Kasumi-2,1714884,3.668347649937234
SF539,327653,3.3770394007544953
BT 112,2871966,-0.611805318298209
KE-39,25126798,4.078237420502305
SW1783,44543605,3.70035976615173
SNU-119,9936388,-1.2994148300283177
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
BT 112,426756,4.127837359215836
KMS-12-BM,135440466,0.2668313754655885
KE-39,9952709,5.01466122235801
ACC-MESO-1,5281321,1.7806950931960217
RKO,3825829,4.017808531984142
SK-MEL-28,3503,2.655926478699229
L3.3,23635314,-2.194996881934531
CML-T1,57330099,4.076691821950742
HuT 78,JQ-1-navitoclax (2-1 mol-mol),-0.7968607943270343
RKO,66577038,3.1469091340303637
Hs 611.T,3503,1.8435127052167164
BT 320,9933475,3.009143992406663
Becker,4521392,4.384697789712053
BT 286,15547703,2.95083845262102
OAW28,135440466,2.5697421477630273
PE/CA-PJ41 (clone D2),5460769,2.5777137088305184
KE-39,alisertib-navitoclax (2-1 mol-mol),1.220028581355411
H-STS,11955716,-2.312998810387399
NCI-H209,9866186,-1.4908819729941871
AU565,44489675,4.101715930322606
YD-38,16741245,4.556042333062202
BT 248,8515,3.628450909279232
Namalwa,5335621,4.013430994700431
Karpas-422,navitoclax-birinapant (1-1 mol-mol),1.786219624038126
NCI-H929,216345,1.9065836273896417
Lu-65,53392493,3.827142623727452
ACC-MESO-1,selumetinib-tretinoin (2-1 mol-mol),5.795682849308936
Mono-Mac-1,11647372,0.3918687541673694
SW1573,4259181,2.0061423198913766
KLE,5280436,4.013094882120016
Namalwa,71304818,2.0125087813378824
IST-Mes1,374536,3.187270781803884
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617
YD-38,135440466,2.581080778395821
Hep 3B2.1-7,11612883,4.071301915196382
SK-MEL-28,52947716,-6.546554666809958
B-CPAP,5470400,-0.1113879304471415
HCC2108,3543504,4.151618491560986
SNU-886,3062316,2.775013755019221
KMRC-20,1716436,3.2166067738770603
BT 248,25154868,4.640538278810453
TE 441.T,selumetinib-BRD-A02303741 (4-1 mol-mol),6.646410101697854
KMS-12-BM,23725625,4.892779562300822
KMRC-20,3038522,3.6781934886194056
ACC-MESO-1,107970,3.0129300087399744
RT-4,135421197,2.4643711937197756
AsPC-1,71680916,4.418583351869457
KMS-12-BM,216239,1.5581321141848137
SNU-213,3503,3.0772179743043253
AU565,262093,2.3992948308197093
IST-Mes1,45279963,3.842534876522704
BT 248,24753719,4.394714770526552
ChaGo-K-1,6450551,3.266612737246024
KLE,156414,1.5892150248130086
NCI-H196,docetaxel-tanespimycin (2-1 mol-mol),-4.384424728938734
KYSE-180,15983966,-3.249627780516399
BT 248,55508,3.993579478299883
HuT 78,3503,2.594592779968663
JHUEM-7,3854666,0.7941739350816123
SNU-216,16065773,2.9059591533260813
HOP-62,216239,1.9534304158746405
RT-4,25183872,-1.211160463214132
Mono-Mac-1,73707386,2.736178467367938
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
BT 248,262093,2.0571072545208926
Hs 611.T,11234052,3.914558100850381
RKO,46224516,2.430810450928805
EHEB,9915743,0.5785876427148751
SK-MEL-5,6918837,-2.5775816022488103
KO52,navitoclax-birinapant (1-1 mol-mol),-2.4193601330067267
PF-382,navitoclax-birinapant (1-1 mol-mol),-0.7298930011907772
PF-382,25102847,1.62616859805539
NCI-H1339,81146,4.4779522522382305
SK-MEL-28,JQ-1-vorinostat (2-1 mol-mol),2.398214143945904
IST-Mes1,67291369,1.9412797776758044
NCI-H929,327653,2.3561667456594986
SNU-213,168312962,4.562373659336835
NCI-H929,11455910,1.7265755247991157
OAW28,439501,-0.9322268226633188
SW1783,89928392,2.216727995281777
RT-4,753704,6.379934835187104
Karpas-422,selumetinib-vorinostat (8-1 mol-mol),1.6918556367520698
HOP-62,24821094,3.2771504338924995
OAW28,9825149,1.8591620922463772
ACC-MESO-1,navitoclax-gemcitabine (1-1 mol-mol),0.0530863875319522
MIA PaCa-2,5287620,-1.6803051400762947
Hs 611.T,4578,4.214276908646158
CML-T1,2841722,3.5416474270082796
LXF 289,654092,-0.8888310934038361
SNU-119,JQ-1-vorinostat (2-1 mol-mol),3.606308027934859
KO52,219104,1.56489843823841
Hep 3B2.1-7,selumetinib-piperlongumine (8-1 mol-mol),2.251634802355752
AsPC-1,4261,2.35820288641389
HCC2108,9911463,3.889332679655138
SF539,selumetinib-tretinoin (2-1 mol-mol),2.8969216636074635
YD-8,5278396,3.5154412560153068
NCI-H2030,2729026,3.166677954271788
ACC-MESO-1,vorinostat-navitoclax (4-1 mol-mol),0.9028362531018698
SNU-423,3025986,0.0846204421525102
Ri-1,doxorubicin-navitoclax (2-1 mol-mol),-3.5903984468333996
BT 112,11396600,2.640188999201151
KE-39,10410894,3.265010081493446
KE-39,24856436,3.387816018334062
BFTC-909,10127622,5.216996592058982
NCI-H209,439501,-3.220511958386942
PF-382,374536,2.6185584915406137
Namalwa,439501,-2.8468436546580524
KLE,46191454,0.8437389846099377
SNU-1077,17759555,4.679973171236535
Ri-1,6252,-0.4804929147517275
Hep 3B2.1-7,44607531,3.424824120427649
SK-UT-1,148198,-4.4190978779578565
TE-14,89183176,5.9644863398947905
SNU-119,168312962,2.91418669260086
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759
Mono-Mac-1,navitoclax-gemcitabine (1-1 mol-mol),-0.471295143456593
JHUEM-7,crizotinib-PLX-4032 (2-1 mol-mol),1.0528686048988958
IST-Mes1,65064,5.185430309398801
LXF 289,72193861,1.9781400147016948
KE-39,44507138,1.957284753077253
Kasumi-2,71680916,3.663022593238377
KMS-12-BM,46907787,-3.5146066785265746
YD-38,44819697,-0.750279161021677
Ri-1,969516,1.821646541672716
BFTC-909,11364421,-5.034674750215906
Karpas-422,9903786,1.5566107707645094
KMS-12-BM,3062316,1.283927819580485
WM793,53495165,1.4251272821754086
PF-382,doxorubicin-navitoclax (2-1 mol-mol),-3.127730367250044
SF539,11178236,-5.337725586791056
KYSE-180,1750826,2.4925152788264726
KLE,57519531,1.524352024978553
NCI-H196,6184667,3.014456731561885
NCI-H1339,9936388,3.3861732240332314
Hs 611.T,409805,3.119650007352079
BT 328,9444,4.598160630608248
SNU-886,6918837,-1.8312241518150647
KO52,46926350,-4.487744142578648
NCI-N87,52947716,-3.473486168283201
KLE,638278,2.977843699594415
RERF-LC-MS,10296883,4.230661493555322
AsPC-1,54618164,4.187549957668634
OE33,31703,0.6827631013317258
KMS-12-BM,6918736,-1.7905560703377923
BFTC-909,1750826,-0.1726466566192349
YD-38,54618771,0.1066197400708346
GOS-3,carboplatin-UNC0638 (2-1 mol-mol),3.2409123088113194
HuT 78,71466445,0.6237805812301164
Lu-65,107970,1.8814184481987688
KMRC-20,alisertib-navitoclax (2-1 mol-mol),1.9342461303816385
YD-8,navitoclax-gemcitabine (1-1 mol-mol),1.3225182449197073
AU565,3825829,3.6732705699214105
BT 328,969516,3.8664962726625416
SNU-216,71466380,5.187111337737049
BFTC-909,5746,0.5111824642409613
MIA PaCa-2,227681,1.9846741973787292
BT 286,10231331,-1.310629484482038
TE 441.T,9927531,5.546705362793043
KMRC-20,navitoclax-piperlongumine (1-1 mol-mol),2.618402251211732
KMS-12-BM,9826308,-0.4519305046408473
PF-382,11234052,3.0504434330399883
Kasumi-2,24779724,5.733659143451784
Lu-65,46191454,2.14257536499012
SK-UT-1,6918638,1.3984076220807655
MJ,135423438,2.050663035644961
LMSU,2708,4.741018084625804
NCI-H1339,54454,3.7472624418631617
RKN,72193861,2.3331130274465313
PF-382,9926054,1.6899693166343082
KYSE-180,carboplatin-UNC0638 (2-1 mol-mol),4.06711505487647
KMS-12-BM,148198,-2.3401169496211778
ESS-1,2708,3.2385388289614583
SF539,16038120,0.889897204295874
LXF 289,3081361,2.235375481166719
NCI-H1339,3634881,3.887494899039192
Lu-65,67156097,-0.9623130440812842
ChaGo-K-1,68056272,4.112191288499106
TE 441.T,5951923,4.312791643847806
SK-MEL-5,25062766,3.029124686982392
Kasumi-2,11626560,0.3916500490858549
SK-MEL-5,656346,3.708545747764347
LMSU,44607531,1.6909486121434856
BT 248,1716436,2.58950342299198
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
SW1783,44607531,2.045163268443033
AsPC-1,5287620,-2.2438477065180233
YD-38,6914657,-4.843121659772695
BT 286,60700,-3.766952299365687
SK-MEL-28,5311,2.6975320364679596
PF-382,151289,0.3016891931318033
OAW28,15953870,5.078636607909671
JHUEM-7,selumetinib-vorinostat (8-1 mol-mol),2.3580216719117284
KMRC-20,159324,3.723725061334236
SW1783,9967941,5.280203655099816
Kasumi-2,446155,3.789762475260846
Lu-65,72376,-1.8562106984479432
AsPC-1,24772860,0.3605797719579043
YD-38,23725625,6.081880019673405
Mono-Mac-1,5566,3.0273684033793624
CML-T1,25102847,0.4234360383549997
BFTC-909,42611257,4.384387627976705
HuT 78,SNX-2112-bortezomib (250-1 mol-mol),-3.095377009148787
Becker,4259181,1.0240306217869668
AsPC-1,JQ-1-vorinostat (2-1 mol-mol),1.708029438891557
RKO,10296883,4.075814636405189
NCI-H2030,3815108,5.353671583033201
BT 286,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.8313547577027046
ChaGo-K-1,navitoclax-pluripotin (1-1 mol-mol),0.8945727615491715
SK-MEL-28,10074640,3.547996724828609
IST-Mes1,11626560,1.5280230569409714
Mono-Mac-1,2749,1.219428226055154
HCC2108,135875424,3.411556630339189
KLE,613753,3.1630835497956884
NCI-H1339,54618771,2.498525802737919
BT 248,3503,0.874016545693445
JHUEM-7,56946209,-4.688751747414188
KMS-12-BM,56973724,1.1510862619514248
SK-UT-1,26596,0.4182972999713699
HSC-3,613753,3.3276317630899337
GOS-3,11497983,4.172510051232983
MIA PaCa-2,54619267,3.838868317387971
Hep 3B2.1-7,alisertib-navitoclax (2-1 mol-mol),1.3987072559750775
LMSU,9823820,5.175471992537328
SF539,6918837,-1.7926544447707695
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
Hs 611.T,11955716,-2.6596703890647606
ACC-MESO-1,alisertib-navitoclax (2-1 mol-mol),0.7857690269167803
SK-UT-1,16065773,2.499708535833016
B-CPAP,136227924,3.258845757188781
LMSU,25102847,2.404236783403615
H-STS,5287969,-2.1266541754976513
NCI-N87,241158,3.56045646229574
ChaGo-K-1,637858,1.5063352286209188
BT 320,11222830,2.3629400148118354
BT 112,42642645,0.6970367427086502
SK-MEL-28,2708,5.4002065413787275
KLE,9967941,2.835048263891985
KE-39,71729975,0.1981470064909886
B-CPAP,9826308,0.1917945613788681
LMSU,10302451,4.092585001279765
NCI-H929,16736978,-1.8944362557879229
KYSE-180,6918837,-1.892651842131766
SNU-119,12003241,-0.7435067493629696
SNU-886,3676137,3.017985964934311
RKO,10302451,3.926970734642152
SNU-886,navitoclax-PLX-4032 (1-1 mol-mol),-7.656166203992468
TE-14,10127622,7.546370019698208
HEC-108,44241473,4.4856951268247585
SNU-423,168313200,4.217782003449994
Becker,67156097,-1.305519261143652
LMSU,44137675,3.873281140485592
CML-T1,54613361,-1.4794949633252166
NCI-H2030,60700,1.034141125582276
HCC2108,10074640,3.185327985640923
EHEB,446155,2.5622028140590083
SNU-216,4788,5.268494458023438
LXF 289,15547703,4.3915240757493565
TE-14,25227462,0.6406425918845066
RERF-LC-MS,36314,3.6884025033565897
H-STS,11396600,3.334455384541719
SK-MEL-28,4477,0.9697986591939786
SNU-1077,16038120,0.7532653564850753
KE-39,107970,2.31854003043047
RKN,322968,3.2277505791227776
PF-382,439501,-2.5741395884768377
SW1783,11404337,0.7381457579106708
WM793,51039095,3.547305313608344
PF-382,11497983,-3.782661101953355
Ri-1,452548,-3.2717135557473376
Hs 611.T,5351362,0.8596120528570375
OAW28,5311,0.8600755425080211
BT 112,72734382,4.824193200647447
PF-382,262093,0.5149344400111652
Mono-Mac-1,24964624,0.6349800606366015
SNU-213,docetaxel-tanespimycin (2-1 mol-mol),-0.3946224211038461
YD-8,10296883,4.26925641885348
Karpas-422,16038120,0.9032962171449342
KO52,3025944,4.052272043795827
JHUEM-7,5738263,2.3845993272884027
PF-382,56946209,-4.827856930300663
KE-39,11404337,-0.6939323202576905
IST-Mes1,5978,0.1624820602578698
PE/CA-PJ41 (clone D2),6918638,0.5938730898283403
PF-382,navitoclax-piperlongumine (1-1 mol-mol),-0.2817270531493807
Namalwa,2729026,2.9646999473246125
HOP-62,73707398,1.728110403283316
KO52,56649450,4.374413775432872
SNU-423,navitoclax-pluripotin (1-1 mol-mol),-0.4289266734837184
SNU-216,54618795,3.171506842627551
EHEB,54454,1.897710954280459
Mono-Mac-1,56649450,3.2410705398980864
YD-38,10231331,-1.3870760442434895
Ri-1,445455,3.7143584213767777
KE-39,navitoclax-MST-312 (1-1 mol-mol),0.6605550109712996
KE-39,selumetinib-tretinoin (2-1 mol-mol),6.162287151844962
TE-14,3062316,1.0220468638658171
HOP-62,crizotinib-PLX-4032 (2-1 mol-mol),2.0744297613100375
Namalwa,6610355,3.6186379138370017
SK-MEL-5,6918289,3.341650767010156
SNU-886,25262965,-1.963536165555311
BT 320,6917907,3.364777316338114
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
Becker,44241473,5.200691051735636
NCI-H2030,doxorubicin-navitoclax (2-1 mol-mol),0.1120737931373815
BT 248,11647372,0.9807519416972552
Hep 3B2.1-7,387447,-4.1626491950883056
SNU-119,24951314,2.332589086371041
AU565,9915743,-3.6885201415408098
NCI-H2030,ISOX-bortezomib (250-1 mol-mol),1.4675443519714482
ESS-1,15547703,2.140429677940592
PF-382,104842,-5.768830303921508
BT 248,11455910,-0.0312737668402554
OE33,selumetinib-BRD-A02303741 (4-1 mol-mol),3.869393320615985
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
HuT 78,9868037,2.4738144029909908
L3.3,24785538,3.6784067404983394
Karpas-422,10296883,3.4516705884612704
NCI-H2030,17755052,4.328898176318331
CML-T1,448949,0.9677195275785144
SNU-216,navitoclax-gemcitabine (1-1 mol-mol),1.3591320236662334
AsPC-1,76446078,5.483716778202627
Karpas-422,7251185,1.4754335931389329
SNU-119,6610355,4.422886164754199
NCI-H929,3634881,1.384558879628874
Panc 02.03,11626560,2.1710424521283427
KMS-12-BM,BRD-A02303741-navitoclax (2-1 mol-mol),1.0941472093440388
MJ,5978,-4.258969391666035
BT 286,9803433,5.109975977606045
RKO,9915743,2.8851858618766957
Becker,5287969,-1.95903417594286
SNU-119,5738263,3.822274048298037
Hep 3B2.1-7,6610355,5.954765023044178
HEC-108,17755052,3.4677210523800936
KO52,16659841,2.257439927508027
Mono-Mac-1,2742550,3.3470269848726004
SNU-216,24785538,1.9334759902538288
HuT 78,2746,0.9832751477780014
PF-382,9887053,3.994345366087283
ESS-1,16038120,1.529167469529828
BFTC-909,11609586,2.9417391320909134
Namalwa,navitoclax-pluripotin (1-1 mol-mol),-1.959124206150004
SK-MEL-5,126941,-2.0410864203063244
ACC-MESO-1,11485656,3.7436435043406
Hs 611.T,16725315,2.898635520094024
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
Mono-Mac-1,168313047,1.7048785524305352
TE 441.T,1239801,3.434384801374823
KLE,9907093,4.3310456736816185
Lu-65,16736978,1.5327388647399771
RERF-LC-MS,49793307,-1.4864117200972382
KMS-12-BM,44491742,3.489197811217823
AsPC-1,44202524,5.110549363526631
NCI-H196,46199207,3.4877738394964175
NCI-H929,65064,3.1158427845285215
SNU-1077,44543605,4.154950294832259
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
Mono-Mac-1,JQ-1-vorinostat (2-1 mol-mol),-1.1078457929866472
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
Kasumi-2,4261,-0.415942894249068
BT 320,1566236,4.371560124605876
Karpas-422,navitoclax-PLX-4032 (1-1 mol-mol),3.265668039915953
L3.3,135398516,2.485669059846241
RKO,44607530,2.6096687798301677
AU565,11647372,-0.7623159020318493
NCI-H196,alisertib-navitoclax (2-1 mol-mol),0.6580146352998756
JHUEM-7,100016,7.782886537779513
Becker,24785538,1.980714235788152
ESS-1,216239,3.396393497889356
TE-14,984333,1.2070523658842751
OAW28,49850262,3.3861243312442264
SF539,navitoclax-PLX-4032 (1-1 mol-mol),2.1497325977392636
NCI-N87,656346,-0.0410900008101642
BT 112,5978,-4.255189500155859
HCC2108,23725625,5.803627153290559
RT-4,16720766,0.1240040302001555
NCI-H929,168312962,-0.2256493233866316
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
KYSE-180,5282054,4.445709887408605
B-CPAP,984333,-0.6051463992030891
SK-MEL-5,3815108,3.389102935160336
MIA PaCa-2,9911463,3.5885490135085663
SK-UT-1,409805,5.339094874610304
SNU-886,15983966,2.2650754807835622
Kasumi-2,6918878,1.1877992835952844
YD-38,6918736,-2.384834581056105
SF539,44462760,4.654163176504964
JHUEM-7,selumetinib-MK-2206 (8-1 mol-mol),2.058966868877447
YD-8,23725625,6.782116953404122
BT 328,24772860,-1.739359818332389
NCI-H929,46398810,2.168604614407646
Hs 611.T,135928012,2.863158989308795
HuT 78,56946209,-6.9577277527161625
NCI-H2030,navitoclax-gemcitabine (1-1 mol-mol),1.4501970702857692
BT 286,969516,2.60301064067439
Kasumi-2,decitabine-carboplatin (1-1 mol-mol),-0.2922568730993647
Mono-Mac-1,54618305,4.078084902520956
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
KE-39,2949965,4.248558977491982
TE-14,216468,5.501928961508749
Lu-65,71466578,6.359394115515498
WM793,carboplatin-UNC0638 (2-1 mol-mol),2.595896359447151
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
Mono-Mac-1,carboplatin-UNC0638 (2-1 mol-mol),2.892149328251194
Becker,9826308,0.0658327796307835
BT 112,107970,1.504371825071881
IST-Mes1,51039095,1.641675506171098
Namalwa,10113978,2.497019663606501
KMRC-20,selumetinib-navitoclax (8-1 mol-mol),4.19466226338092
LMSU,216468,4.5440038894644115
RT-4,5460769,0.3645225539442671
KYSE-450,44589607,3.132602917923117
SNU-213,10074640,2.758568829113537
PF-382,4259181,-0.6205773881868614
PE/CA-PJ41 (clone D2),53232,2.816121278001021
TE 441.T,9915743,0.2395120621423657
Karpas-422,676352,1.784030767129966
KO52,46943432,4.605559929302298
ESS-1,151289,1.069450318701332
KO52,11507802,0.3147818183904139
SNU-423,72193861,1.5776760665191312
YD-8,49850262,3.7509110667991736
Hep 3B2.1-7,selumetinib-tretinoin (2-1 mol-mol),2.5143967997897905
LMSU,54618164,5.037763382519864
BFTC-909,5738263,3.1091802601858185
SK-UT-1,6184667,3.933294050011487
ChaGo-K-1,46191454,1.732064551306023
Lu-65,24901704,4.087024583205145
H-STS,52912189,1.096529678362862
TE-14,10410894,4.7642256864799535
SK-MEL-28,carboplatin-UNC0638 (2-1 mol-mol),3.933934894554171
B-CPAP,2828334,5.722656317072071
L3.3,10113978,3.760524207236511
BT 286,441298,1.5194102888498262
Hs 611.T,5311281,2.8850029754458064
LXF 289,5311281,0.8902308213691446
MIA PaCa-2,25195348,3.726807791554416
NCI-N87,52912189,1.61892272115858
WM793,71304818,2.8457825987612293
PE/CA-PJ41 (clone D2),11647372,2.2083238406890473
NCI-N87,107985,-3.2122311985508136
EHEB,5281672,5.758571308107243
LXF 289,54143018,0.7636513295056184
NOMO-1,9927531,5.049638663441057
LMSU,6450551,2.7750286997333515
Hs 611.T,11214940,0.9743579305468372
HuT 78,135875424,3.0458075465752694
TE 441.T,navitoclax-MST-312 (1-1 mol-mol),0.3966866713301855
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
KE-39,135999136,4.6219900849735325
BT 498,JQ-1-vorinostat (2-1 mol-mol),3.377257047018318
PF-382,119182,-3.7281285699674873
NCI-N87,11625818,1.9405356473547937
SK-UT-1,65628,4.642853879953485
SK-UT-1,11497983,5.637939301868167
SNU-216,7326481,2.6936193795359533
AsPC-1,107985,-4.227741895863185
NCI-H929,5284373,-1.7427436127229046
YD-38,71304818,2.91033512553829
KMS-12-BM,6184667,2.2804186491767857
BFTC-909,26596,-1.7437210940555867
SF539,135928012,3.885367249068042
BT 320,119607,6.086126545734404
SNU-423,10322450,4.431866174300737
BT 112,44607530,0.8844189369301123
KMS-12-BM,327653,2.270237785805321
IST-Mes1,135421197,1.925463420817299
HSC-3,262093,2.860040873457059
SNU-119,11167602,2.3286246928254335
Kasumi-2,crizotinib-PLX-4032 (2-1 mol-mol),1.093787578488076
LMSU,11396600,3.695024866246392
CML-T1,60700,-4.046906202956944
AsPC-1,135999136,4.3448843965381965
SK-UT-1,7251185,2.9981286588919303
BT 320,3552672,1.9342456765414169
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
Mono-Mac-1,11977753,0.507212198852303
SNU-119,JQ-1-MK-0752 (1-1 mol-mol),1.0166640461128336
HCC2108,11964036,2.450976446990399
LMSU,241158,4.2548793295703025
Ri-1,8515,1.7161399430410786
LXF 289,11404337,0.1273620702572638
TE-14,10302451,1.496270675992236
HCC2108,5329102,2.0081576367450964
Kasumi-2,6914657,-5.1533998646952925
SK-MEL-5,16065773,1.1273169391673337
ESS-1,54596558,5.727088950348892
Hep 3B2.1-7,2749,1.4477080023113305
JHUEM-7,322968,2.718046514914308
SW1573,216468,2.7570678542174294
SF295,4261,1.626313472689182
RERF-LC-MS,613753,3.34976336152667
NCI-H2030,49793307,-3.2142989821735592
Hep 3B2.1-7,vorinostat-carboplatin (1-1 mol-mol),2.3068971453553435
Hs 611.T,navitoclax-birinapant (1-1 mol-mol),0.029722324205262
Hs 611.T,44607530,0.8778374574907751
Kasumi-2,42642645,-0.9002721123779656
SNU-216,23582824,-0.2398151877654648
JHUEM-7,136227924,2.4332957155572688
NCI-N87,135440466,2.814988966864087
SF539,navitoclax-piperlongumine (1-1 mol-mol),1.805753462968184
ChaGo-K-1,3676137,3.7968759357432464
SNU-213,51037431,4.174424071961102
NCI-N87,568763,-0.5346616138078667
AsPC-1,9933475,2.7319135281095908
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
HEC-108,3385,6.041983945648764
TE 441.T,168313200,1.7491212896878472
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609
Ri-1,tretinoin-navitoclax (4-1 mol-mol),-2.192947300647472
NCI-H1339,15953870,3.9739600190387128
YD-8,navitoclax-piperlongumine (1-1 mol-mol),2.544833640493428
SK-MEL-5,25195348,3.2915110992128658
Kasumi-2,4521392,4.1748849427500625
AsPC-1,387447,-4.291846387154746
LMSU,11612883,3.4193736852271206
SF539,49846579,1.5882622372705737
H-STS,25102847,2.763833752411945
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
SNU-1077,124202324,3.0238569925896113
SK-MEL-5,3384730,2.478323893384318
HOP-62,46215462,2.7155032630368443
NCI-H209,2749,1.5190087226766276
KLE,6918837,-3.4864458388429416
NCI-H196,71304818,3.304710493941327
SNU-119,tretinoin-navitoclax (4-1 mol-mol),1.7834789734876322
HSC-3,2858523,3.403454274190548
KE-39,44486219,6.242583973184527
PF-382,5351362,0.8995545334729175
Lu-65,24771867,3.5458119260189194
Ri-1,JQ-1-vorinostat (2-1 mol-mol),-1.3537009805514455
Becker,49766530,0.5239013848654858
MIA PaCa-2,5113032,4.609804183969185
ChaGo-K-1,2746,5.131732167485152
Mono-Mac-1,136227924,2.2269797620359864
BT 286,26596,0.1662425719802319
RKN,1750826,-6.055252220387113
RERF-LC-MS,11485656,1.5190166417661397
KMS-12-BM,5566,2.9351867752080887
BT 248,45279963,3.7107289938294135
KMS-12-BM,31703,-3.250328951463323
Becker,16725315,4.176702684464043
L3.3,16736978,2.121770338408602
RT-4,23635314,-1.9773718066539765
Kasumi-2,55508,1.5459922299360274
Kasumi-2,9952709,2.8950386128563985
SF539,53232,2.519991468251329
SNU-423,26596,-1.230407332735001
PF-382,44491742,5.368678247108403
KO52,9933475,1.739633318252188
ESS-1,24889392,3.924374920251665
KLE,44507138,1.5092224182482787
Karpas-422,navitoclax-piperlongumine (1-1 mol-mol),0.8534804042436965
AsPC-1,322968,4.827920048367381
RKO,3038522,3.342495330103654
CML-T1,89183176,3.024950752568636
KLE,54618164,4.225211860569233
AsPC-1,2871966,-0.1237405253519755
SNU-423,3062316,-0.4734418758890504
SK-MEL-28,6610216,4.386997968475678
SNU-213,387447,-4.101875903510779
WM793,135398516,2.614188359863261
Mono-Mac-1,piperlongumine-MST-312 (1-1 mol-mol),1.1779929114188603
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
HuT 78,637858,0.0090449520272635
AU565,1750826,-0.6805778178680736
SNU-216,24753719,4.261315806086272
SK-MEL-5,selumetinib-vorinostat (8-1 mol-mol),1.478441576802813
HSC-3,168313047,2.12803897774878
BT 286,44589607,2.85251609454855
Mono-Mac-1,409805,3.1107516004642406
TE-14,5113032,4.5670743899745245
TE 441.T,7251185,0.7748595428921464
Mono-Mac-1,11317348,1.4875586729173769
SNU-886,24771867,1.589817907725939
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
TE-14,navitoclax-gemcitabine (1-1 mol-mol),-2.5567633390591493
SNU-119,168313047,1.9562265924685545
SW1573,11640390,3.5338327701281176
SNU-886,10231331,-0.2281959370366189
KO52,9915743,1.1549502462375985
ChaGo-K-1,24901704,3.2868248459161538
GOS-3,123631,3.414822398468875
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474
WM793,5329102,2.675345821939075
SNU-213,6610355,4.708262799420277
PF-382,19582717,3.4720772442845296
HEC-108,44607531,1.840431852580758
AU565,135440466,3.093480574806016
AsPC-1,4705,5.582464580618905
TE 441.T,54626689,4.404200006363088
ESS-1,44486219,4.319485753082415
BT 328,11626560,2.3893583978213617
CML-T1,11640390,3.08306987111381
BT 328,613753,3.4687194971891184
AU565,3465537,1.0667310492419344
HSC-3,1750826,-3.2516156524402415
HuT 78,3634881,0.7628736071702301
KMS-12-BM,3634881,2.6463615699611807
ACC-MESO-1,135875424,3.861508499056134
NCI-H929,docetaxel-tanespimycin (2-1 mol-mol),-5.802184770793407
NCI-N87,168313047,2.984513904409232
WM793,11497983,4.66927640579722
SNU-216,15953870,2.862027857822619
TE 441.T,11497983,4.031475372359196
Becker,53232,4.57215785181602
AsPC-1,11656518,2.0782041289904845
NCI-N87,136227924,3.040461203265333
SNU-423,5328940,2.374403241706306
SNU-886,135928012,0.9415972865486992
YD-8,46224516,2.247250860191912
SNU-1077,327653,3.4488214544204108
CML-T1,selumetinib-decitabine (4-1 mol-mol),-0.3389481007221296
KMS-12-BM,3025986,-1.3403296282767831
KMS-12-BM,selumetinib-tretinoin (2-1 mol-mol),1.12843511460163
Karpas-422,57519531,1.4841127416839142
BT 112,5335621,3.6179814635651377
B-CPAP,73707398,1.14773007898321
SNU-423,151289,1.2049619409118173
BT 498,4788,5.870824964650662
TE-14,46191454,2.3442901104587857
BT 112,3136844,3.8258170991022222
ChaGo-K-1,3384730,3.6213619982801895
HuT 78,24951314,-0.9560314989082764
IST-Mes1,151289,3.762568892374828
IST-Mes1,72376,0.3576615812024088
SNU-213,11404337,0.895138111314107
SW1573,11404337,-1.3449252751203844
BFTC-909,16115403,-3.993091010962378
HuT 78,107970,1.6472037116063474
SNU-886,54454,-1.127756504065537
B-CPAP,10184653,1.9021781585872557
RT-4,5351362,2.6254562857357646
Namalwa,71466445,4.063090897069234
KMRC-20,676352,2.4695752697730056
NOMO-1,25262965,-2.043358942198166
MIA PaCa-2,4788,5.933145310837657
IST-Mes1,462382,1.0027449292382402
JHUEM-7,piperlongumine-MST-312 (1-1 mol-mol),1.1461002616382592
Namalwa,11955716,-2.6032735104865643
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
SK-MEL-5,25154868,3.9897594746456098
TE-14,42642645,1.3983104503701576
OAW28,2871966,-1.501513911524366
H-STS,3025944,4.171325659510201
OAW28,10385095,1.310156197215646
BT 286,56649450,2.979701469874902
TE 441.T,11647372,2.9005403388289865
NCI-H1339,285033,-1.5807051815557247
Karpas-422,6918878,0.8908244199335652
HCC2108,3815108,3.7436297083403938
AsPC-1,2742550,5.133078791264603
NCI-N87,3038522,3.5877635056945443
YD-8,219104,3.5957332803631323
Panc 02.03,439501,0.4668648826805023
MIA PaCa-2,4477,0.266407248170907
JHUEM-7,24180125,3.52789412824338
KO52,serdemetan-SCH-529074 (1-1 mol-mol),2.372423406417755
BT 248,57519531,6.254880017804167
WM793,3062316,1.9641420987669005
BT 112,400769,-1.0288775980123002
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
TE 441.T,ISOX-bortezomib (250-1 mol-mol),2.326213330158226
ESS-1,2945648,3.5685871452412137
KMS-12-BM,24964624,-0.7604581964304247
Mono-Mac-1,11213558,-3.0826510665478075
SK-UT-1,44202524,2.9453109499095853
NOMO-1,1750826,-5.797741098147838
SNU-423,5287969,-1.5815925133202535
Namalwa,11214940,1.1706932474053011
MIA PaCa-2,36314,-5.219745808616812
YD-8,5329102,1.6984603402864296
SNU-1077,5311281,2.675466174095196
SNU-1077,568763,0.523765917176441
NCI-H929,selumetinib-PLX-4032 (8-1 mol-mol),3.606448116077345
B-CPAP,2742550,3.2183332694531677
Hep 3B2.1-7,6918837,-2.1140364415973005
YD-8,119607,5.2875629658247805
PF-382,60750,-4.575665185057959
SK-MEL-5,67156097,-0.100012625717114
KMS-12-BM,421610,2.052297409032463
KO52,23582824,1.49303559449636
SNU-1077,3689413,-1.655364429789056
SNU-886,446155,-1.7757385621733988
TE-14,11612883,2.9605017038638497
SK-UT-1,BRD-A02303741-navitoclax (2-1 mol-mol),5.142165719819776
GOS-3,53392493,2.045340494319027
SK-MEL-5,4477,1.0694476690172137
ESS-1,25262965,-1.850856990715792
ACC-MESO-1,10113978,4.207808600250944
Panc 02.03,25195348,3.9334722209588735
YD-38,135398516,1.5709585782681432
B-CPAP,25183872,-0.7864118052297527
KMS-12-BM,42611257,2.4160280183147913
TE-14,72193861,1.3253754048467814
EHEB,71680916,4.542174615812289
WM793,16720766,1.530656675591024
Lu-65,54618164,4.000249960497271
Becker,11364421,-5.867324857945357
H-STS,16038120,1.2852053797527971
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
OAW28,5282054,3.6220988157242946
Lu-65,1566236,3.455735123137807
MIA PaCa-2,16725315,4.586093250425383
PF-382,11222830,1.048169261061167
KYSE-450,46926350,-4.1870362089493804
KO52,5278396,3.3505834178575964
LXF 289,4477,1.125394938272502
SNU-216,72376,-2.746748523707645
OAW28,46224516,2.3854099680927523
JHUEM-7,4521392,4.016477728370682
Namalwa,24797083,-0.1749047261384438
SK-MEL-28,89928392,1.8249955752671516
KE-39,11640390,4.498462110577166
AsPC-1,176870,5.289710540069244
Namalwa,400769,-1.6280294138695752
AsPC-1,4578,5.074011683523406
Hs 611.T,selumetinib-navitoclax (8-1 mol-mol),3.110658833620367
ESS-1,66577038,3.102682313302671
OE33,46398810,3.1246731128423275
KE-39,168313047,2.2332329252634584
RKN,46398810,3.1612721401313792
TE-14,46215462,1.938607091392658
ChaGo-K-1,selumetinib-decitabine (4-1 mol-mol),5.44157099070074
NCI-H209,24748573,0.014770013268607
KYSE-450,5351362,2.5381052639488715
BT 112,selumetinib-decitabine (4-1 mol-mol),6.418283242663844
BT 286,6436223,-5.721526180117037
SK-MEL-5,9903786,4.335376265950657
Ri-1,44819697,-1.3296656427670626
H-STS,9908783,4.356832739470904
Lu-65,44491742,4.485926174539046
IST-Mes1,25022340,4.432743731061051
PF-382,446155,1.656597721830262
NCI-H2030,51037431,2.706088429950605
WM793,11175137,2.573938317060376
BFTC-909,2841722,4.3094465275997536
AU565,135421197,1.4743648854968991
KMS-12-BM,selumetinib-decitabine (4-1 mol-mol),-1.3154987364301634
TE-14,969516,2.4677635627082397
SNU-1077,selumetinib-piperlongumine (8-1 mol-mol),4.266694584287947
TE 441.T,5280436,1.3742861420449088
CML-T1,9884685,1.1136090650670494
Kasumi-2,24821094,1.7820431474601306
BT 248,285033,1.6288115150650024
TE 441.T,3384730,2.376241707074279
MIA PaCa-2,25161177,3.85496737061916
SK-MEL-28,568763,0.9297123705024438
CML-T1,vorinostat-navitoclax (4-1 mol-mol),0.0862805898320609
SK-MEL-5,135398516,1.9789586439354627
PE/CA-PJ41 (clone D2),5278396,4.12050417476776
MIA PaCa-2,53495165,-1.0987819755309485
SF295,44819697,-1.169097334417276
NCI-H929,10302451,2.7551907478934465
JHUEM-7,11178236,-3.5105066295157843
SK-MEL-5,17755052,3.4815883106305137
KLE,54454,0.96963930140172
KO52,2874250,4.969283597945665
ACC-MESO-1,46199207,3.4428384584430303
Becker,5282054,3.7183306925435167
BT 320,5978,5.361358451203573
AU565,387447,-4.131425766006191
BT 248,44607531,1.181861447118321
HEC-108,3854666,0.9548518440486092
SF539,4917,2.886212068318384
HCC2108,54454,1.8049440069965668
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
HSC-3,selumetinib-JQ-1 (4-1 mol-mol),1.0715718666689311
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864
BT 328,51039095,3.5315864754377735
Kasumi-2,16725315,3.214174294489856
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
SNU-213,JQ-1-MK-0752 (1-1 mol-mol),2.5673364417924853
SNU-216,navitoclax-pluripotin (1-1 mol-mol),-1.7154939293198777
SF295,54618359,4.37820605202468
SF295,16722836,2.957473304888258
JHUEM-7,11455910,0.2186713515547739
Kasumi-2,4788,5.288898541322949
KE-39,11238147,3.713228695438772
HuT 78,156422,4.343521315297441
SF539,10026128,4.850110020898141
CML-T1,selumetinib-vorinostat (8-1 mol-mol),2.04753807538672
AU565,445643,3.872431437053606
RERF-LC-MS,4788,5.0822281264538365
KE-39,5281672,4.420099730026252
KO52,148124,-8.023122181205325
KMS-12-BM,16720766,-1.5729698680950066
NCI-N87,11656518,1.4544081811160725
SK-MEL-28,navitoclax-MST-312 (1-1 mol-mol),1.3794636689456534
SF295,5278396,3.96342600457057
TE-14,11427553,3.380820340782394
Karpas-422,16659841,3.690505948558723
BFTC-909,3503,3.411270469206907
ESS-1,10231331,5.566440371270769
TE-14,54596558,4.372286949597904
SNU-886,4261,-0.0852092865807919
NOMO-1,71466445,1.8310961714544176
JHUEM-7,docetaxel-tanespimycin (2-1 mol-mol),-6.631978799043623
ChaGo-K-1,2113511,5.882662121576482
Kasumi-2,44462760,0.6612462691358557
TE-14,135398744,6.394251875306054
KLE,448949,0.9264382828941904
KYSE-450,148124,3.78473118264584
LXF 289,11234052,4.719623128458786
HCC2108,5280436,4.355594613728095
WM793,docetaxel-tanespimycin (2-1 mol-mol),-1.36432681223834
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835
KMRC-20,4259181,0.4653117276954742
TE 441.T,JQ-1-navitoclax (2-1 mol-mol),0.9820543393276062
CML-T1,56973724,1.0958106846759064
NCI-H2030,89928392,1.93682484487372
Ri-1,15547703,1.021239227044065
ESS-1,9825149,3.69415886776762
SNU-1077,navitoclax-birinapant (1-1 mol-mol),2.274223223308886
KE-39,327653,3.149148027412197
JHUEM-7,tanespimycin-gemcitabine (1-1 mol-mol),-0.4399381866621512
BT 320,135875424,3.1120862947515255
BT 248,44241473,4.372252470027867
OAW28,11152667,0.0990704789630026
RKO,2729026,2.3662843020346753
KYSE-450,9911463,4.540289012412596
SK-MEL-5,vorinostat-carboplatin (1-1 mol-mol),3.0622263342910507
YD-8,452548,0.7666794967881028
Namalwa,23725625,3.168532097227349
SF539,16736978,2.0915382548726353
BT 112,12001922,0.29456942425987
BT 498,9935249,2.416260478208693
SNU-119,107985,-4.156641254925639
BT 248,5278396,3.9189937549477545
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
HSC-3,638278,3.3252951717806014
KMS-12-BM,2841722,2.937327067206498
BT 112,168313200,1.7991755506997456
BT 328,selumetinib-vorinostat (8-1 mol-mol),3.560914687145029
KLE,5281321,-2.410398691037867
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323
SK-UT-1,25062766,3.896240815707035
OAW28,5335621,5.136061685098042
Namalwa,44543605,5.038599911094309
HOP-62,71751553,4.571888658933869
Lu-65,51037431,1.5628873119577005
RT-4,11964036,3.812081086796839
OAW28,16720766,3.888951908869231
KMS-12-BM,49766530,-2.33896572420352
Mono-Mac-1,UNC0638-navitoclax (1-1 mol-mol),0.713076461951265
OAW28,25183872,-1.003855010480259
HEC-108,68056272,3.6278104442075736
BT 328,25150857,3.2556687678990612
BT 286,262093,2.2473217807206916
TE 441.T,11364421,1.5849770445720046
LMSU,carboplatin-etoposide (40-17 mol-mol),5.006172673673393
Ri-1,11717001,4.512033854446696
HEC-108,11612883,3.04097878516087
H-STS,24772860,-2.67708885899535
NCI-H1339,5566,3.600004227180683
Becker,selumetinib-JQ-1 (4-1 mol-mol),4.188822961792769
Kasumi-2,54619267,3.817493003311882
NCI-H929,107985,-4.785949324647598
BT 248,10410894,2.478264779428893
RKN,24772860,-0.333409077824626
KMRC-20,168312962,-1.9289630106650897
JHUEM-7,vorinostat-navitoclax (4-1 mol-mol),2.5378629346574946
KE-39,10184653,0.6332517224813795
ESS-1,12001922,2.286773298620945
SNU-423,25154868,5.138032001853866
BT 498,16722836,3.164527752748671
Karpas-422,135421197,2.168063446429243
BT 112,9840324,5.678931191449396
KYSE-450,11175137,3.731022611434211
EHEB,136227924,2.586993854279513
CML-T1,3815108,1.7472513397157303
SK-UT-1,11640390,4.3621330098002815
SNU-216,44607530,0.8853825110355424
MIA PaCa-2,crizotinib-PLX-4032 (2-1 mol-mol),1.2391956697808102
Karpas-422,4477,0.4453815636384887
ESS-1,11404337,-0.7954778123034105
HuT 78,71576739,-3.3283921388984155
EHEB,67156097,-1.752576547113972
SK-MEL-5,12001922,2.0688607607777856
YD-8,6610216,4.600166157453743
L3.3,5113032,6.1935482945866545
ESS-1,89183176,5.005336079724086
Karpas-422,51039095,2.7059855927348706
Kasumi-2,5335621,4.247176943532892
BFTC-909,52947716,3.1995758728854224
IST-Mes1,25262965,-0.2533063216587133
Karpas-422,6252,-0.618618589447053
Becker,135411,0.5687348881548171
SF539,55508,4.727617915120432
Ri-1,123631,1.8918959386766108
TE-14,46224516,3.000812964487585
BT 112,216239,1.682447495531753
Namalwa,135875424,3.1964963879327355
KYSE-180,219104,4.692697004252791
KMRC-20,71466380,5.209336168619487
WM793,49793307,-1.6505636238066363
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
ACC-MESO-1,168312962,-2.250253484188745
NCI-N87,3543504,4.249309596150935
RT-4,9907093,5.696541057936112
LXF 289,46191454,2.351463869671111
Becker,969516,2.296759639012105
IST-Mes1,46398810,2.0674819997592406
SF539,24785538,1.1616917641832667
Mono-Mac-1,53232,2.497204294555262
PF-382,5566,2.4095985038819947
Hs 611.T,969516,1.8842702632758987
Namalwa,56649450,1.7446151160804089
YD-8,25150857,2.3631685028134544
GOS-3,5566,2.9543896668680287
TE 441.T,135659046,3.3291028889346066
Karpas-422,3634881,3.1102850261434805
KO52,44566777,-0.2336377473007494
HEC-108,241158,3.683911292843857
ESS-1,7326481,3.8932312053689873
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
RT-4,124202324,3.016060322906711
RKO,4261,2.924548439505643
HuT 78,49766530,-1.6423396691241603
KO52,11609586,2.913368530947096
RERF-LC-MS,1750826,-0.5689233588179538
OE33,5351362,2.0764063167480256
NCI-N87,5282054,3.4882884399441125
Hs 611.T,16741245,4.2114778773539365
BT 286,selumetinib-navitoclax (8-1 mol-mol),-1.915867243382919
HSC-3,carboplatin-etoposide (40-17 mol-mol),2.0650995733711777
AsPC-1,25183872,-0.8583413037674358
Panc 02.03,44493528,4.298055948100647
BT 286,JQ-1-UNC0638 (2-1 mol-mol),2.9164898287399432
BT 112,107985,-2.3005939746155244
AsPC-1,25154868,4.981069474579037
ChaGo-K-1,7326481,2.958321983181722
Kasumi-2,44819697,-2.5261102007933154
KMS-12-BM,753704,4.548989794941243
RKO,3503,2.683687073265507
ESS-1,31703,-3.4275082307518807
SW1573,12003241,-0.6702221198842615
Hep 3B2.1-7,navitoclax-MST-312 (1-1 mol-mol),2.5026055464868007
YD-8,135423438,0.9954856602627224
KE-39,2874250,5.478930029290199
KE-39,46215462,1.6742241157614868
LMSU,216345,4.559958439384078
WM793,17755052,2.1349114715081345
Namalwa,9840324,5.609444873218537
YD-38,123631,-2.2340739565295133
KYSE-450,3062316,2.5043987549881725
KO52,46907787,0.3317813334576328
BT 498,5281321,2.76295217428265
RKO,100016,5.817852214634293
LXF 289,67156097,-1.7104573080698593
SK-MEL-28,selumetinib-PLX-4032 (8-1 mol-mol),2.641553313699231
HuT 78,6918878,-1.0659334174257225
LMSU,5280436,2.317492118597427
SK-UT-1,42642645,1.4382792591793798
NCI-H1339,selumetinib-piperlongumine (8-1 mol-mol),4.670247782356622
KYSE-450,969516,2.907932259173941
KO52,5284616,3.214737678420765
WM793,11238147,2.989890948344662
MIA PaCa-2,9956119,3.801226375239901
KYSE-180,72193861,-0.0777927374537977
TE 441.T,72193861,1.5185390994902612
AU565,11257553,-0.514738811981399
WM793,10385095,0.6081370186912695
SK-MEL-28,322968,3.9440584072931375
KLE,selumetinib-navitoclax (8-1 mol-mol),-0.4039228772243814
L3.3,168313016,5.4672449278411595
KE-39,selumetinib-MK-2206 (8-1 mol-mol),2.7514173486302544
ESS-1,26596,-1.5335330182559344
ChaGo-K-1,BRD-K55473186,4.776921073930659
SNU-886,11404337,1.5055907567781088
OAW28,5113032,5.506773811436986
EHEB,10385095,1.253390881214325
SNU-1077,3025944,4.915661762266775
OE33,6917907,-5.84340241991552
Becker,24821094,3.775477955133952
Namalwa,2949965,2.6372066790906903
NCI-H1339,54613361,-0.0549690451885617
KMS-12-BM,5284616,2.1225566255949047
BT 286,135398516,3.3849722776709923
BT 112,6852167,2.8502822773493315
Namalwa,decitabine-carboplatin (1-1 mol-mol),-0.3427123891632673
BT 112,219104,3.367056596744358
YD-8,5291,3.66370848447405
OE33,45279963,4.0955269526771865
LMSU,12003241,-1.0531077396215482
LXF 289,400769,-1.8947060859446272
H-STS,11625818,2.7941108082935755
BT 112,46174525,4.318783265075236
KMS-12-BM,439501,-2.5993845366115016
Ri-1,10074640,2.328205384294345
RERF-LC-MS,51037431,2.0455212647735364
SK-MEL-5,71466380,3.8965003815329906
ChaGo-K-1,55283,3.5819941327008507
TE 441.T,676352,1.4981171427085485
Karpas-422,8515,3.8543440231436135
H-STS,448949,1.6135505463804922
H-STS,73707398,1.2106724937411937
Karpas-422,216345,4.476804412824838
SNU-216,2733526,3.2341597144404073
HuT 78,6918837,-5.480154932078149
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
ACC-MESO-1,44819697,-1.5954499982774353
SNU-216,3062316,-2.85606665835974
BT 286,135659046,3.5488699738704432
L3.3,25262965,-0.71498955679679
Kasumi-2,7326481,4.035955767547482
KMRC-20,123631,2.7325982206325503
KYSE-180,148198,-3.2204698770091653
KLE,6852167,2.751103786046217
BT 498,9444,4.218280041925912
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295
KO52,1566236,1.4428264325400242
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
JHUEM-7,46943432,1.400588495445252
OAW28,17755052,1.3145864766951243
SK-UT-1,262093,2.998836933826174
BFTC-909,3385,6.578023483143935
ACC-MESO-1,tanespimycin-gemcitabine (1-1 mol-mol),1.2996427322835036
HOP-62,53232,0.9294550567608532
BT 320,52947716,3.1695176437652757
HSC-3,327653,3.9955925666561263
HSC-3,57519531,1.7430503426578488
H-STS,67156097,-2.7564383026884345
KLE,24978538,-2.416214785508645
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
Hep 3B2.1-7,65064,5.234298047086212
Panc 02.03,24821094,4.183998590604807
NCI-H196,60700,2.6116008481858275
SW1573,25150857,3.3863948467965717
PF-382,9935249,1.8009635209130423
TE-14,navitoclax-piperlongumine (1-1 mol-mol),2.8509611645469772
SF539,57330099,3.5033572869669327
KYSE-450,4259181,0.2433830255631184
IST-Mes1,11494412,3.57589790392084
KMS-12-BM,4705,2.431122737655679
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
SK-MEL-5,9866186,2.008250773590418
ChaGo-K-1,doxorubicin-navitoclax (2-1 mol-mol),-1.2819364209592068
ChaGo-K-1,24889392,5.7134252534785075
KYSE-450,72967,3.7351940397417023
OE33,11612883,3.5221161379379975
LMSU,104842,-1.1999760069124146
JHUEM-7,262093,2.8461427698978197
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706
CML-T1,10302451,-1.0288409878116755
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
H-STS,vorinostat-carboplatin (1-1 mol-mol),1.9243801953461248
HuT 78,23635314,-3.2203205513382023
HuT 78,6914657,-4.847386491977826
OAW28,16722836,1.5279923407751788
AsPC-1,6438330,3.2823568933486196
HOP-62,serdemetan-SCH-529074 (1-1 mol-mol),2.377021307588857
Mono-Mac-1,135398738,5.903458005359669
SF539,25195348,1.0596246311568
BT 248,4705,2.6318547262793386
BT 112,6918736,-3.569526346741858
HSC-3,9956119,3.902686667761622
RERF-LC-MS,36462,1.1230283698314445
Namalwa,46215462,1.3795153892876229
CML-T1,439501,-2.361432010025089
YD-8,5738263,3.505877458565359
Kasumi-2,54618164,3.8625919459899833
BT 248,16736978,2.1942612442020484
KE-39,156414,4.025830312298652
SF539,17755052,0.186903454349707
SNU-216,12001922,1.864153419618113
Panc 02.03,126941,-0.7071805078882285
Kasumi-2,11964036,-0.3814812468505845
ESS-1,11214940,1.1922635318190942
NCI-H1339,44185566,3.1608972179921504
YD-8,262093,2.4929271706284433
AsPC-1,46843906,4.099754684530221
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
ESS-1,9911463,4.377027533841143
SK-UT-1,25102847,3.856160399391282
L3.3,44607531,2.464561691878258
H-STS,135999136,1.636218584553822
SNU-119,5281321,-2.123473343303991
SW1573,51037431,1.8928004764191728
KE-39,10113978,4.138536532448647
SNU-119,BRD-A02303741-navitoclax (2-1 mol-mol),3.084106743145068
NCI-H929,5951923,6.150668957534198
BT 320,2858523,3.05792743854883
ACC-MESO-1,151289,4.084741165182866
ESS-1,6505803,-2.0071033756271106
BT 286,2949965,2.469719512433079
ACC-MESO-1,9903786,5.156493229165983
NCI-H929,11175137,1.2036169120329363
KE-39,638278,3.6133315433839455
SK-MEL-28,241158,4.1117452183175445
SF539,2828334,6.046575048370249
Namalwa,613000,2.319534394708418
YD-8,46907787,3.160935680087681
SK-MEL-5,135875424,3.6602054011582137
Becker,216239,2.021023688826764
BT 498,2858523,3.124320310328437
Becker,44607531,1.318290319409554
MIA PaCa-2,2828334,6.048303989502281
SNU-423,2749,2.17630076176396
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914
HuT 78,444795,-1.7173791831946914
NCI-H1339,decitabine-navitoclax (2-1 mol-mol),5.5290643616840285
SNU-216,10322450,3.800791101615317
CML-T1,2742550,2.9758871773228366
PF-382,11213558,1.6003517541111008
ChaGo-K-1,216239,1.9174193091465608
NCI-H2030,44185566,4.409465669932711
YD-38,5470400,0.3753067973764124
YD-38,doxorubicin-navitoclax (2-1 mol-mol),-0.2530652341021826
SNU-119,10322450,3.771322180088625
BFTC-909,71304818,3.116417285157316
AsPC-1,25150857,2.720712035994173
SF539,11707110,0.172094147016845
BFTC-909,3025944,6.464154930724253
JHUEM-7,selumetinib-PLX-4032 (8-1 mol-mol),4.4422752684891025
RT-4,67156097,-2.3409564010950343
GOS-3,3062316,3.7135401373010426
HOP-62,10074640,3.0888797836888053
GOS-3,4259181,0.7347951046145877
SNU-216,9868037,3.645721485009989
L3.3,5287620,-1.4617046509205764
BT 286,216345,1.230005134011574
ESS-1,6918328,-0.1703669492376587
LMSU,5329102,2.020452826888572
TE 441.T,24797083,1.0154681927969065
ChaGo-K-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8935336207243505
SW1573,168313200,1.7327341920391253
Mono-Mac-1,3062316,0.1210141261163289
SNU-1077,3634881,3.0237658175436204
Karpas-422,6918328,-1.5024187814152252
JHUEM-7,1716436,3.3976454809646426
HOP-62,71466445,1.9622269092656943
RERF-LC-MS,51039095,3.2453184174795324
SK-MEL-5,navitoclax-gemcitabine (1-1 mol-mol),-2.451034866388519
HEC-108,navitoclax-piperlongumine (1-1 mol-mol),-0.8310694921552283
NCI-H1339,4788,5.9220808605874256
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
NCI-N87,10184653,-5.297353828317573
KMRC-20,6918837,-1.6564527147795
KO52,selumetinib-UNC0638 (4-1 mol-mol),-0.866257907363459
TE 441.T,54596558,4.189884310587091
SW1783,6918837,0.7485271513756125
KE-39,135875424,3.891762591841876
KO52,54618164,3.705714044840163
SNU-886,9823820,0.0175156920594608
NCI-H929,702558,5.133204411961539
Ri-1,11626560,0.685551544754032
KE-39,3384730,3.7070900081119
TE 441.T,10127622,5.1659343374816125
ACC-MESO-1,16741245,1.697213973554462
Namalwa,46907787,-1.1716727326146228
Lu-65,9952709,2.0015111957714424
RERF-LC-MS,9884685,0.4531053665233772
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333
HEC-108,65064,5.34082663858378
OAW28,46907787,2.388022074777516
BT 248,4477,0.1181412005602309
OAW28,4477,1.0036814180565996
SW1573,89183176,3.862510153781557
SNU-216,26596,-1.178501170162628
LXF 289,439501,-1.653941874457911
AU565,5281321,-1.6701173206544262
H-STS,JQ-1-navitoclax (2-1 mol-mol),0.1797969837721217
NCI-H2030,44819697,2.8705865872962835
KO52,25262965,-1.468267644417411
KYSE-180,4521392,4.793023543550177
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
BT 320,448949,3.0267975144627894
AsPC-1,16720766,4.029008761480653
MIA PaCa-2,24821094,3.7530351784505234
Hs 611.T,5287969,-3.1044324087553963
Namalwa,5328940,1.0182998554643874
HOP-62,446155,1.0940351919742453
HuT 78,25105715,3.229078580605203
PE/CA-PJ41 (clone D2),400769,-0.2880595320475859
MJ,11214940,1.554079945659114
Becker,navitoclax-piperlongumine (1-1 mol-mol),2.5229326011074567
RKO,54618164,4.0326978900214705
KO52,54618305,4.665930774043992
H-STS,44607531,1.532888966032803
ESS-1,2874250,4.555685369292356
RKN,5329102,3.127163305072316
KO52,9444,3.771327538481611
B-CPAP,44202524,1.220918078886342
YD-8,4378219,2.399532986422255
KO52,322968,2.621400804192603
OAW28,5746,2.6048591865024657
EHEB,44137675,1.9983784239702664
KMRC-20,3689413,-2.0293333018936877
TE-14,216345,3.792651654584129
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
KE-39,11364421,0.2339323182946827
MIA PaCa-2,11609586,2.31009126134966
HSC-3,17755052,1.3936775853499024
LXF 289,24964624,1.3940062455599875
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
HSC-3,46199207,3.7875254196691617
SK-UT-1,241158,3.8222099850046054
SNU-886,10322450,3.968731934637612
Ri-1,104842,-11.03841530798714
WM793,60700,0.4501720050415228
B-CPAP,4259181,0.2789779013360439
KO52,5291,3.753312170095506
NCI-H929,6505803,-1.240454682973536
Panc 02.03,24771867,4.320948526904658
KMS-12-BM,3552672,5.9542999196624775
SF539,selumetinib-PLX-4032 (8-1 mol-mol),2.9753691858714575
TE-14,12003241,-0.291419040743519
ESS-1,54618164,4.192374601121606
Kasumi-2,44484893,-1.5195002495763423
Namalwa,6918638,-1.4599496749108598
IST-Mes1,71304818,2.7451890534908427
YD-8,46199207,3.544065292305842
BT 112,5460769,1.283415330936559
TE-14,23582824,1.075600439558685
HuT 78,11497983,0.3896895605416182
KYSE-450,54618771,1.2705031609145587
OAW28,15953870,5.078636607909671
Hs 611.T,6914657,-3.242080936188609
KYSE-180,vorinostat-carboplatin (1-1 mol-mol),3.9189821803734577
Ri-1,23582824,-4.965583795046114
NCI-H1339,10385095,0.8150638105924319
NCI-H929,3384730,2.4908246089676385
AsPC-1,selumetinib-PLX-4032 (8-1 mol-mol),2.574223553479829
CML-T1,16720766,-1.7114419714530344
PE/CA-PJ41 (clone D2),11719255,3.630354595850525
SNU-216,1750826,0.4145288494296801
Panc 02.03,16038120,1.606654693103348
HCC2108,60700,1.0851578183191786
AsPC-1,11175137,3.2351214827225956
BT 112,4788,5.347186098301908
HSC-3,11609586,3.4480340554706284
BT 498,46191454,3.027040351794544
KE-39,176870,3.2545182858471953
RKN,6438330,1.1013294242613172
KLE,9911830,2.855789588066899
SF539,BRD-A02303741-navitoclax (2-1 mol-mol),2.7425485852442866
ESS-1,387447,-5.037795986549112
HCC2108,54649381,3.8131747738004567
TE 441.T,54618164,3.69134760573576
SNU-216,2729026,3.021777506017218
RERF-LC-MS,100016,6.56071523320666
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
KE-39,selumetinib-navitoclax (8-1 mol-mol),1.4458639992966646
HEC-108,46907787,5.113191551513952
SF539,5284616,2.797909464914647
RKN,16038120,2.2721636156695357
BT 248,82146,3.895792146901818
KE-39,24978538,-0.2539808437524994
PF-382,216345,3.312440656550695
SW1783,54678924,1.5903593535652931
EHEB,BRD-K03911514,2.273371159476054
RKO,54143018,-0.3751060369564643
KLE,54686904,4.3325881562773185
LXF 289,selumetinib-navitoclax (8-1 mol-mol),2.675431188570136
HOP-62,navitoclax-PLX-4032 (1-1 mol-mol),2.7748975941487273
KMRC-20,6610355,5.471217304519157
SNU-886,54613361,0.1365764016308465
SF295,51039095,3.485537910967478
SNU-423,23582824,0.3032934737671689
Hs 611.T,5311,1.269126331833584
HOP-62,25150857,2.9059675286732864
SK-MEL-28,selumetinib-JQ-1 (4-1 mol-mol),-0.6682697886543986
Namalwa,26596,-3.71974803891978
KO52,60700,-2.426926956892104
NCI-H196,selumetinib-vorinostat (8-1 mol-mol),2.502166357099755
B-CPAP,23635314,-2.2199735472205395
KMS-12-BM,135999136,1.7056569950210811
PE/CA-PJ41 (clone D2),9866186,0.8086133009925387
SW1783,252682,7.233019917696589
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
BT 286,448949,2.088592715997419
OAW28,9911463,4.007690751229585
NOMO-1,6610216,4.0700997553747325
BT 286,ISOX-bortezomib (250-1 mol-mol),0.3407126531024899
AU565,49766530,1.448288738772077
Becker,17755052,1.6990126124044371
HEC-108,11485656,3.338600175698492
Lu-65,702558,5.6246593295299
Becker,46926350,-4.071547217187583
RERF-LC-MS,5746,1.1068525081764873
SNU-886,piperlongumine-MST-312 (1-1 mol-mol),1.4218788713745412
Hs 611.T,5281672,3.453848815463362
SK-MEL-5,446155,3.759030292305935
EHEB,6852167,1.7579387732994172
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
KYSE-180,54618771,0.8276624799970426
NCI-H2030,168312962,-2.4787410042856544
BFTC-909,5328940,1.2290524134113243
ACC-MESO-1,65064,3.065425412429416
Karpas-422,6852167,0.067435343224215
LMSU,53232,0.1669358057766225
BT 286,119182,-1.2057998884515009
CML-T1,12003241,-4.650247315633356
RKO,23635314,-2.140231911981244
NCI-H929,11404337,-0.6691193705825791
ESS-1,6918736,-1.7029949901876988
RT-4,navitoclax-pluripotin (1-1 mol-mol),-1.5234215141375285
YD-8,5328940,1.5878995115689818
Hep 3B2.1-7,5291,3.535966512674248
Hep 3B2.1-7,10127622,2.2069143160944895
Becker,24951314,1.348289322869654
BT 286,5351362,2.1492192428575203
SNU-1077,1716436,3.6351328790412993
GOS-3,984333,1.7865923354783255
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
Mono-Mac-1,46907787,-0.5681517995940845
RERF-LC-MS,25102847,0.6953191965745218
TE-14,11625818,5.294592263134467
CML-T1,2708,2.830885116766648
KYSE-450,selumetinib-MK-2206 (8-1 mol-mol),3.9509923248068928
BT 498,44819697,-0.3777975924200397
Kasumi-2,71751553,4.151047970892257
BT 248,11317348,2.524808263877468
Mono-Mac-1,2746,1.2768381662660928
SK-UT-1,2746,4.836098417840603
SK-UT-1,46907787,3.5849510733980265
GOS-3,60750,-1.363518575342279
B-CPAP,55283,0.7506377686050446
SK-MEL-5,11455910,0.3432757840716531
SNU-886,124202324,2.9202052759291024
YD-8,46843906,4.015586038915998
CML-T1,tanespimycin-gemcitabine (1-1 mol-mol),-3.893519256585349
HuT 78,3038522,2.0525522612169813
EHEB,11626560,1.520000059512031
OAW28,168313200,4.298133692275281
B-CPAP,10427712,4.570782311965759
CML-T1,piperlongumine-MST-312 (1-1 mol-mol),1.169857653831876
Karpas-422,3825829,3.984444104401659
GOS-3,1242560,4.3763601819059526
NCI-H929,2749,1.0943201778081362
HSC-3,9911463,3.6821530137729983
Becker,54618164,4.063586417108196
KE-39,ISOX-bortezomib (250-1 mol-mol),0.8981560210811207
KO52,613000,2.3498906607917345
H-STS,1566236,1.8552051664221092
NCI-H196,89183176,-2.228939888416075
SNU-119,navitoclax-pluripotin (1-1 mol-mol),-1.1228674398646514
NCI-N87,4259181,-0.3128226187706996
BT 320,44241473,4.3699389688619945
BT 286,107985,-3.490112295441736
NOMO-1,11404337,-0.1001889231988697
RKO,10127622,3.209405126939437
Kasumi-2,9915743,-0.5759730647314978
SW1573,11427553,4.057369297610019
LMSU,11178236,-3.271286165721627
KYSE-450,9915743,1.0249516523129705
KO52,2945648,2.667880655920765
HuT 78,241158,3.345962703014529
PE/CA-PJ41 (clone D2),ISOX-bortezomib (250-1 mol-mol),1.316043804584087
SNU-1077,navitoclax-piperlongumine (1-1 mol-mol),2.376186895274424
SW1783,11626560,2.73995450904139
OAW28,9926054,1.976123345191561
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
BT 328,2828334,7.045901610155557
Mono-Mac-1,9915743,-1.5760754079944657
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
OAW28,11625818,4.459236282412159
Ri-1,11485656,1.6570467994982818
JHUEM-7,72376,-2.504472205859212
KO52,11213558,1.2433594255309357
SNU-423,676352,1.6973821345572693
KMRC-20,4521392,5.860934935010035
ChaGo-K-1,53481919,3.8711533004139977
HCC2108,25126798,3.42355668622167
ChaGo-K-1,44819697,-1.7321119268385738
OAW28,4917,3.0899334279272046
ACC-MESO-1,JQ-1-navitoclax (2-1 mol-mol),0.2263973859128728
SK-UT-1,navitoclax-pluripotin (1-1 mol-mol),0.5029199208338406
KE-39,navitoclax-pluripotin (1-1 mol-mol),-0.4984280760345316
Mono-Mac-1,119182,-8.162617097236367
CML-T1,44491742,2.876043803936746
KLE,44489367,4.867561911603137
Hs 611.T,6852167,0.4305744814723918
RERF-LC-MS,168313200,3.896073258981905
Ri-1,11214940,1.364775390900072
BT 328,5470400,1.931366636892646
SNU-213,676352,1.9316561146461328
BT 112,2749,-0.764976916755987
ESS-1,6610216,4.607428871946369
B-CPAP,10302451,2.5954421947302344
NCI-H1339,53392493,3.5051602427052635
OE33,6610216,4.3835431989355635
BT 328,6917907,3.783088770502935
BT 286,6914657,-6.2929304393953975
SNU-119,16219061,3.5319077719330885
SNU-213,selumetinib-JQ-1 (4-1 mol-mol),1.0193842284675143
Karpas-422,409805,3.3322180704918876
KE-39,selumetinib-vorinostat (8-1 mol-mol),2.460157439364167
Kasumi-2,11485656,1.64011250363507
NCI-H929,3503,1.25684257431255
GOS-3,doxorubicin-navitoclax (2-1 mol-mol),-1.4068563769280584
Ri-1,568763,-1.1108517100164117
Hs 611.T,24797083,1.1787569066925891
Becker,3854666,0.4017122764286526
Kasumi-2,107985,-4.524149027848321
HCC2108,tanespimycin-gemcitabine (1-1 mol-mol),0.2372099864187673
HuT 78,387447,-5.436092440743046
RT-4,675434,4.226250873257813
RKN,375860,0.0559819210079563
JHUEM-7,46907787,-0.7019339701280191
Lu-65,135398516,2.8001749856176734
NCI-H929,11626560,-0.3439403672463312
YD-8,tanespimycin-gemcitabine (1-1 mol-mol),-0.3043825539609709
GOS-3,11609586,2.254603724376055
PF-382,9868037,2.2881920680680756
SF539,36314,-4.467415246608935
NOMO-1,24951314,-0.0494287054100275
CML-T1,969516,2.44416602520126
HSC-3,25154868,3.1280580624042416
RERF-LC-MS,44489675,3.7548789887197183
BT 286,57330099,3.888056128977329
Becker,navitoclax-gemcitabine (1-1 mol-mol),-0.9834702537896932
LMSU,107970,2.329788160301069
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
OAW28,123631,1.649178742735097
BT 286,73707438,3.831264447880484
AU565,3854666,0.9438607721687704
Kasumi-2,vorinostat-carboplatin (1-1 mol-mol),1.2501182531177977
TE 441.T,445091,4.523056258688619
SK-UT-1,11175137,3.4203767191490724
MIA PaCa-2,25227462,-3.7811371844480512
OAW28,219104,3.640461878438656
IST-Mes1,31703,-0.6384703159849433
KMRC-20,73707398,1.7254732299327342
BT 498,2126,4.791438742350041
SW1573,9926054,3.1618263718643513
Becker,45279963,3.89874578276641
BT 320,25227462,3.0496366497602025
TE 441.T,119607,5.682891982302103
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
RT-4,439501,-1.136247834932354
SF539,375860,-0.4378698388059482
KE-39,135659046,4.845551344520264
HOP-62,5738263,4.049243215173011
SNU-119,serdemetan-SCH-529074 (1-1 mol-mol),2.302427714477216
BT 248,107970,1.564508535325896
AU565,44185566,1.721131526136141
NCI-H929,375860,-0.8805079289764249
PF-382,71466380,3.7425525322216746
BT 286,BRD-A02303741-navitoclax (2-1 mol-mol),1.9078817739450291
OE33,44566777,0.6328964048889911
NCI-H196,selumetinib-PLX-4032 (8-1 mol-mol),4.604890036629208
BT 112,selumetinib-piperlongumine (8-1 mol-mol),3.6452165297650505
MIA PaCa-2,16065773,1.640511461382333
CML-T1,carboplatin-etoposide (40-17 mol-mol),-0.8203492199596885
YD-38,selumetinib-PLX-4032 (8-1 mol-mol),1.695274932451559
HuT 78,52912189,-0.7415735278682234
JHUEM-7,44489675,4.154647994164329
AsPC-1,6438330,3.2823568933486196
B-CPAP,452548,0.2886295190968743
HSC-3,656346,0.2990178564529029
SK-MEL-28,24951314,3.07054519973718
TE 441.T,11977753,-1.3955565522419031
Becker,9866186,0.2753414496739798
PF-382,JQ-1-vorinostat (2-1 mol-mol),-1.4348852294654668
MIA PaCa-2,44632017,2.533907166670847
NOMO-1,5470400,0.2862684612003833
HOP-62,5282054,4.1860195429662435
NCI-H929,409805,3.661820790042666
KE-39,54649381,3.8116402123721578
JHUEM-7,16038120,-0.0246766201458601
EHEB,selumetinib-MK-2206 (8-1 mol-mol),0.5537503173054988
NOMO-1,46398810,2.1682472320454504
Kasumi-2,67156097,-2.3799018148926363
SNU-213,5113032,4.529210101778295
BT 112,11175137,1.5585592210455712
CML-T1,135928012,3.921778036516406
SF539,10427712,3.91731820186957
BT 286,45279963,4.069315818685172
BT 248,5311,3.0798190942417363
PF-382,54454,2.1316538534788196
BFTC-909,107970,2.2861723254681774
ACC-MESO-1,51039095,2.5717576118399577
H-STS,16065773,1.8153092417887848
KLE,6918878,2.1026972133129616
Ri-1,9935249,2.110817780838048
NOMO-1,3854666,1.0231806307237967
WM793,11455910,1.0189470974054349
Karpas-422,3384730,1.9052527031441604
AU565,46398810,1.9802808058059196
Karpas-422,72734382,3.992792587505708
SF295,452548,-0.238215744941623
AU565,5566,3.0303294385930584
KE-39,alisertib-navitoclax (2-1 mol-mol),1.220028581355411
Panc 02.03,9933475,2.3025810529048205
SNU-119,65064,4.58104500437737
NOMO-1,11964036,-1.1045639043109698
KO52,tretinoin-navitoclax (4-1 mol-mol),-2.9404392116104767
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
AsPC-1,374536,-1.7506249493921369
HuT 78,72193861,0.6888403740474174
TE-14,11396600,4.264622215416366
HuT 78,9444,3.580412600741262
Hs 611.T,168313016,4.489282789911296
SF539,135999136,1.70209400272594
HOP-62,444795,4.062660222672805
Karpas-422,selumetinib-decitabine (4-1 mol-mol),0.4977391111196939
CML-T1,23635314,-1.5423479854884166
RERF-LC-MS,11234052,4.094456859515875
KYSE-450,462382,0.9133555690572344
KE-39,52947716,3.3015192136458205
AU565,46843906,2.01919943296107
BT 286,136227331,4.205096233968031
ACC-MESO-1,72376,-0.3966714785591665
PF-382,2858523,2.2172889178765733
AsPC-1,25105715,4.199758530142014
OAW28,4521392,4.353680801577448
ESS-1,4521392,4.16442971067231
TE-14,9444,3.9425992179299354
Becker,65628,4.34244809682726
KO52,carboplatin-etoposide (40-17 mol-mol),3.309104191597652
HuT 78,3081361,3.7119512098568945
KE-39,doxorubicin-navitoclax (2-1 mol-mol),0.2720331289565558
RT-4,23725625,5.6003160205481874
YD-38,9887053,5.000290179411191
BT 498,72193861,3.1486454761975917
TE 441.T,navitoclax-pluripotin (1-1 mol-mol),-1.1792340009266518
H-STS,54143018,0.5439646012734883
TE 441.T,54143018,4.031896610161229
TE 441.T,168312962,4.12920079144077
Mono-Mac-1,31703,-4.137829291800657
Lu-65,25227462,-2.994823242761513
NOMO-1,11507802,1.1250810428603863
SW1783,374536,1.729044945983793
SW1573,16065773,3.287625611468905
SK-MEL-28,4259181,1.166453283270818
PF-382,11404337,-1.5613133934389778
Hep 3B2.1-7,6852167,2.3004574615198656
BT 320,10410894,4.180150860885228
HCC2108,71466578,4.729290805364659
Hep 3B2.1-7,638278,3.5818606755202387
BT 286,6505803,-2.395900359039176
Mono-Mac-1,135440466,1.0237642683593615
ChaGo-K-1,126941,-6.179924649296775
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
HOP-62,51039095,2.57567623107321
SK-MEL-28,1750826,2.919051261248512
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552
KO52,2871966,-1.083117753240993
ACC-MESO-1,54618305,4.946353791859653
PF-382,9884685,-1.5269409733501682
RKN,10385095,1.0188882527918253
SNU-216,selumetinib-PLX-4032 (8-1 mol-mol),3.8013199947022462
KO52,carboplatin-UNC0638 (2-1 mol-mol),3.4121259588832538
SNU-213,11238147,2.964120806343807
IST-Mes1,72193861,3.6955595837075137
KMS-12-BM,25062766,1.5143080044468464
BT 286,6450551,1.4228047573938862
MJ,9866186,-0.7019525908206407
JHUEM-7,2858523,3.1374488987928992
YD-38,135411,0.5996233659487772
B-CPAP,44493528,4.579013970980452
PE/CA-PJ41 (clone D2),10296883,4.236451814997899
B-CPAP,54619238,5.255956817941979
Ri-1,46224516,2.535525926322653
Hs 611.T,11626560,0.7873376297842944
IST-Mes1,salermide-PLX-4032 (12-1 mol-mol),6.709164103992604
CML-T1,20959075,-3.2800173274392983
IST-Mes1,322968,3.0930404941453933
Becker,54619267,4.626572213417588
BT 248,24978538,0.997787879795877
KYSE-450,119607,5.938330428290203
OAW28,148198,-3.8662210541116977
ChaGo-K-1,45279963,2.8128871096969954
Kasumi-2,49766530,-3.7396811929647513
BT 248,16725315,3.27587483179283
RT-4,71304818,2.636098080172375
NCI-N87,135999136,4.294797881105147
Hs 611.T,25227462,-5.211715043272956
PE/CA-PJ41 (clone D2),salermide-PLX-4032 (12-1 mol-mol),5.637961880793886
L3.3,53392493,3.3534830778032045
HEC-108,3025986,-0.5174612953614975
HuT 78,24821094,3.2631800653476017
NCI-N87,3385,5.19418058853999
SK-MEL-5,2729026,2.1390901716806865
SNU-119,17759555,3.1197691897400435
NCI-H196,446155,2.4623098053751677
SNU-423,alisertib-navitoclax (2-1 mol-mol),-0.7020457415756507
ChaGo-K-1,5284329,2.795250008792205
Mono-Mac-1,3038522,2.1652868385768933
KE-39,11178236,-2.7855564912156128
BT 286,tanespimycin-gemcitabine (1-1 mol-mol),-2.647439718160363
L3.3,5351362,1.6156165657787482
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
NCI-H196,452548,1.1867613213126158
YD-38,3062316,-1.5307799933324873
TE 441.T,439501,-2.08185324910289
LXF 289,1750826,-0.5305094201812034
Panc 02.03,3854666,5.373190444337423
KYSE-180,252682,7.9563998050087745
L3.3,6918736,-1.7247535795274376
NCI-N87,5566,2.8110881508350567
BT 320,409805,6.1406982436622
ChaGo-K-1,219104,4.142543487513976
AsPC-1,439501,-1.6009280184427317
SK-MEL-5,24951314,1.4790209915709416
H-STS,15983966,-4.061111130827075
HOP-62,44507138,2.604389889395895
ACC-MESO-1,24951314,2.4018862580106344
KMS-12-BM,11719255,0.7474259860262262
BT 248,11404337,-1.3909400551472375
Becker,23725625,5.785203803556796
KYSE-180,25150857,2.8174172252005127
KLE,9935249,5.162792026951856
CML-T1,216239,1.5759445467703133
BT 286,navitoclax-birinapant (1-1 mol-mol),1.0621958537472391
Namalwa,246676,4.721429897591315
WM793,262093,3.640026682877067
NCI-N87,5311281,2.449994968111211
SW1783,44566777,2.310065302579828
MIA PaCa-2,navitoclax-sorafenib (1-1 mol-mol),2.5811605514663447
ChaGo-K-1,3081361,3.4773165896947384
SNU-119,16722836,1.1666058390455762
Becker,51037431,2.3347522905676037
SW1573,6918328,0.8267852089643692
KLE,119607,4.152483536976257
ACC-MESO-1,452548,0.999951222582263
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
RKO,11455910,0.1271196393609195
H-STS,navitoclax-pluripotin (1-1 mol-mol),-0.8846642449593193
RKO,2708,5.0364138660049935
AsPC-1,16659841,4.5181069426631
LMSU,5311,4.122063566653656
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367
SNU-216,selumetinib-piperlongumine (8-1 mol-mol),3.596313234861266
HEC-108,2858523,3.032487777915684
Kasumi-2,11167602,2.198810465874189
TE-14,9823820,4.620875838895175
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
LMSU,24771867,2.7605292141618945
SNU-1077,BRD-K99584050,5.679511546826054
SNU-423,SNX-2112-bortezomib (250-1 mol-mol),-1.6386202904690086
BT 248,6184667,2.4270302543682307
KE-39,65064,5.11272287356881
PF-382,24785538,-0.3675574083063133
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
SNU-213,alisertib-navitoclax (2-1 mol-mol),4.251686417889072
KYSE-180,11964036,1.5417763505782551
OAW28,216345,3.8770767977792913
KYSE-450,46199207,3.793080332052943
SW1783,16725315,5.184633472906502
HOP-62,9926054,1.899267170249981
ChaGo-K-1,4259181,-4.05678240495267
HOP-62,8515,4.458909571137292
YD-38,3634881,3.402679726514247
BT 112,100016,6.504213631006025
ESS-1,24901704,3.989977980383822
KMS-12-BM,SNX-2112-bortezomib (250-1 mol-mol),-3.02097095985075
NCI-H929,51037431,3.389715853394355
BT 286,2708,2.460649932488337
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757
SK-MEL-5,654092,0.5475945767149036
TE-14,5746,0.906830651267076
BFTC-909,73707398,1.325657316242966
ChaGo-K-1,25227462,1.4432760051535278
BT 112,25183872,-1.8103797909861916
MIA PaCa-2,5282054,3.8521450366894903
AsPC-1,16219061,4.6595447221902955
RERF-LC-MS,4578,4.625372786711685
CML-T1,24856436,-1.6072060020086385
NCI-H1339,navitoclax-piperlongumine (1-1 mol-mol),3.121869388124161
ChaGo-K-1,11222830,1.3421917137510389
KE-39,vorinostat-navitoclax (4-1 mol-mol),0.0592807411548529
SF295,6505803,0.007344164780963
AsPC-1,6914657,-2.819399047423078
Lu-65,11640390,4.172577765309866
AU565,71466445,4.046585104708946
BT 248,5566,1.2795658146577915
KE-39,208908,0.8342774772445833
Becker,6852167,2.488549626227047
NOMO-1,135411,-0.3073928829727976
HuT 78,JQ-1-vorinostat (2-1 mol-mol),-2.017178846521955
JHUEM-7,374536,2.8371018707127065
SNU-886,6450551,0.4843129346186465
AsPC-1,24964624,2.5492070232527424
Panc 02.03,16722836,2.9028860212849565
NCI-H929,1716436,3.574402272281363
KO52,5328940,1.2036469066601834
WM793,10296883,3.657255931485473
TE 441.T,tretinoin-navitoclax (4-1 mol-mol),3.320877684010679
BT 248,44819697,-0.5101915766327456
PE/CA-PJ41 (clone D2),navitoclax-birinapant (1-1 mol-mol),3.23386712784497
BT 498,5470400,2.7488625160963824
CML-T1,46907787,-0.5465083296094366
TE-14,53495165,-0.7615839944483337
AsPC-1,36462,3.6552458214160506
GOS-3,6610216,4.739620593848468
SNU-216,322968,3.383720063707372
SF539,246676,6.084250396214504
LXF 289,25126798,3.2757893610597923
NCI-H929,216239,2.215366899845667
NCI-H929,9903786,1.9183912305018265
AU565,6436223,-4.706952881213825
IST-Mes1,9936388,2.2275468363886763
WM793,2749,2.5461703794044452
Lu-65,375860,-0.0242259972210493
Mono-Mac-1,969516,2.650184266608886
NCI-H1339,9866186,0.8819529179959803
SNU-886,6918736,-1.3372974950718246
KE-39,11427553,2.9196701777014415
Hs 611.T,10302451,2.003286438841951
RT-4,10231331,3.499380927126235
SF539,54619267,4.325836901582148
OAW28,11719255,3.92549874892824
Panc 02.03,5311281,4.827416145020449
KMS-12-BM,124202324,0.0272958362457217
HuT 78,BRD9876-MK-1775 (4-1 mol-mol),0.7890849571488777
SNU-216,JQ-1-navitoclax (2-1 mol-mol),1.0505128735313087
NOMO-1,1641662,3.174576963224712
KO52,6914657,-6.464336066123526
HuT 78,135411,-0.1860381511558323
SNU-216,25102847,1.8923376874468665
BT 328,374536,4.943552861027733
KO52,227681,2.1146823151840715
BT 286,24753719,5.642521821790082
Lu-65,135875424,4.016301544047221
OE33,71304818,2.789862992520126
HSC-3,5566,2.855912953749529
HuT 78,227681,1.5978856071996634
LMSU,5281321,-2.8892706249231512
PE/CA-PJ41 (clone D2),selumetinib-BRD-A02303741 (4-1 mol-mol),2.2896148913317087
H-STS,753704,4.594437808877669
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
ChaGo-K-1,24180125,3.6677801491975006
HOP-62,11707110,0.0407603914396423
NCI-N87,448949,2.160730221150561
TE 441.T,4788,5.996671612745717
SNU-886,135398744,6.3424886084429435
YD-38,JQ-1-navitoclax (2-1 mol-mol),-0.452478253024042
LXF 289,24856436,0.8419130403195528
RKN,25126798,3.956068538327861
SNU-886,72376,-2.8445678356407043
KYSE-450,53232,2.6046887103681993
Namalwa,16038120,1.0132909592473565
B-CPAP,9956119,1.850613025177622
KYSE-180,2729026,3.0243505230230565
YD-8,1242560,3.4576125136726805
SF295,5282054,3.6326515094468976
SK-UT-1,446155,0.911002973182342
SNU-216,216239,2.119918357767876
GOS-3,navitoclax-piperlongumine (1-1 mol-mol),2.852873715439821
SF539,7251185,1.8205284874436192
KE-39,9929138,5.605001473491643
B-CPAP,24771867,2.555650366496606
AsPC-1,11647372,4.7024563360539675
Kasumi-2,25150857,1.3589874253765015
JHUEM-7,25195348,3.048899669301698
LMSU,3689413,-0.2257013593388283
HEC-108,11228183,1.0147252747004392
MJ,135875424,3.3337154689139914
RERF-LC-MS,5311,1.7201713868016182
SK-UT-1,1641662,3.5811505263635235
SNU-423,6917907,-5.559529881879768
KLE,441298,1.608704823737003
Hep 3B2.1-7,navitoclax-gemcitabine (1-1 mol-mol),2.7755624885487187
MIA PaCa-2,11234052,4.196582036386762
WM793,613753,3.3762732235563733
ESS-1,9927531,5.52249907084491
ACC-MESO-1,navitoclax-birinapant (1-1 mol-mol),1.2335149444368336
LXF 289,6505803,-2.367756082461904
OAW28,168312962,3.352489814007426
BT 112,26596,-1.3919420546275056
TE-14,2874250,5.1128953719748935
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
SK-MEL-28,navitoclax-sorafenib (1-1 mol-mol),2.0059633351475847
SNU-119,24772860,-1.5346173858714742
KLE,168312962,2.4682903625486077
GOS-3,7251185,3.0018815610418694
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959
NCI-H2030,tanespimycin-gemcitabine (1-1 mol-mol),1.9623173242369956
BT 498,568763,1.2156282548875836
Ri-1,10427712,0.5895660730768243
BT 112,1716436,2.062857445676959
BT 248,25183872,-1.6442953183353304
PE/CA-PJ41 (clone D2),24856436,1.5751990412346553
SNU-886,ISOX-bortezomib (250-1 mol-mol),1.1872724485340942
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
BT 248,44589607,2.2150317514642635
BT 286,4259181,0.6646990868644945
SNU-213,439501,-0.6838743591109449
NCI-N87,1716436,1.6921610156965474
OE33,6852167,2.347290735103793
SNU-1077,44493528,3.708438186415119
SW1783,16038120,2.009287788618318
BT 286,10410894,2.24933683770091
BT 286,25022340,6.1397690085034915
SF295,46398810,3.368980510961915
JHUEM-7,45279963,3.810394630077175
KMS-12-BM,89928392,-0.4987831925576881
RKN,23635314,-1.997093039658799
SF539,135423438,0.8139499502196877
NCI-H196,54618771,3.538687286650074
TE-14,5311281,4.284827588254178
WM793,11427553,3.4959048575417304
IST-Mes1,3062316,-4.79181247277669
BT 320,25183872,-0.2453721787274933
SNU-886,123631,3.0273089025763817
TE 441.T,23582824,0.3738805159209457
YD-8,72376,-1.7625580612803151
NOMO-1,46199207,2.5514936314753434
MIA PaCa-2,49766530,-2.3545367349028097
AsPC-1,11977753,1.3763157806720072
KMS-12-BM,6450551,2.204544668217096
HOP-62,navitoclax-birinapant (1-1 mol-mol),2.4233787895619487
Panc 02.03,4261,3.516583077320981
LMSU,135999136,4.828023886470807
SNU-1077,44137675,3.7361071963131858
HOP-62,439501,-3.0300699988747333
SNU-423,5311281,1.00024651229924
KYSE-180,3503,2.347380717343577
NCI-H929,54143018,-0.1441434705872438
Mono-Mac-1,2949965,2.609351900169026
NCI-N87,16115403,-3.919428944380448
KE-39,11178236,-2.7855564912156128
KE-39,44607531,1.2324934173201474
OAW28,25126798,4.214847534438453
AsPC-1,446155,5.1652347554602995
NCI-H209,carboplatin-etoposide (40-17 mol-mol),-0.98588134162935
GOS-3,11178236,0.4111622236569117
HSC-3,104842,-3.919620834903339
Ri-1,UNC0638-navitoclax (1-1 mol-mol),-3.130813752237708
LXF 289,10113978,1.6721223719755247
Becker,123631,3.6541086582376914
NCI-H1339,119182,-2.9193060131920405
Namalwa,selumetinib-tretinoin (2-1 mol-mol),4.718693062265593
Mono-Mac-1,9907093,2.924657758065781
JHUEM-7,carboplatin-UNC0638 (2-1 mol-mol),3.8228401587465273
Hs 611.T,462382,0.1674960625020105
Hs 611.T,11612883,2.2755649908010263
TE-14,doxorubicin-navitoclax (2-1 mol-mol),-0.0232060070462323
TE 441.T,44202524,3.7966072370628408
Panc 02.03,71680916,5.6819891784443595
CML-T1,25150857,1.621602747179882
L3.3,navitoclax-gemcitabine (1-1 mol-mol),-4.48479777241671
Ri-1,1716436,1.3694183290635549
LXF 289,9915743,1.5678711489122208
SNU-213,53232,4.908727917257865
LXF 289,10385095,0.5776298837700374
YD-38,54613361,-0.3869003944931092
RKO,36314,-4.63858923378885
BT 286,11455910,-0.3413435906946745
TE-14,selumetinib-BRD-A02303741 (4-1 mol-mol),3.442750300003047
NCI-H929,serdemetan-SCH-529074 (1-1 mol-mol),2.524144751229143
H-STS,24785538,0.7812018408159317
ESS-1,72734382,4.922090373409711
Namalwa,11707110,3.659331859404194
NCI-H929,crizotinib-PLX-4032 (2-1 mol-mol),1.1143694059459794
B-CPAP,89928392,1.5244385280363368
Kasumi-2,5287969,-1.8638241340536708
SNU-213,638278,3.3592322377614363
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
Namalwa,107970,1.960491610604563
KMS-12-BM,3025944,3.1800470659597284
BT 248,9825149,2.247604687491298
CML-T1,5282054,3.0197566265123754
RT-4,1716436,2.9161940059185985
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
LMSU,462382,0.7289653516874284
SF539,51039095,1.5941495610042506
HuT 78,135398516,3.648200603857496
KO52,5738263,2.2712409628703027
IST-Mes1,5281672,4.409062773089972
Namalwa,327653,2.6135050132049167
LXF 289,2874250,5.409057432200043
BT 286,navitoclax-PLX-4032 (1-1 mol-mol),1.6129490724419135
KO52,387447,-5.494795804144642
KYSE-450,6505803,0.925446652115482
SNU-216,8515,4.27176731188738
KO52,11234052,4.403544599113535
KLE,16038120,1.5676746205851106
RKO,219104,3.7756995047121658
YD-38,100016,6.21667674155364
RKO,3854666,1.2691133577357363
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
CML-T1,135999136,1.353337094400064
CML-T1,675434,3.803383794807122
YD-38,46398810,2.405298564513697
AsPC-1,65064,5.237570806440869
B-CPAP,11427553,2.722415626304352
B-CPAP,49766530,-2.4408790709837396
H-STS,285033,-3.6704179985350183
Kasumi-2,969516,1.973265868556714
BT 112,753704,3.3999292862808077
AU565,6505803,-0.7592801042803803
KMS-12-BM,135928012,2.4606603364640995
IST-Mes1,16725315,5.212250641781058
Karpas-422,46215462,1.4741959527668254
Namalwa,285033,-3.772881421892214
NCI-H929,6852167,0.2588908385559714
KYSE-180,126941,-3.004750085240848
TE 441.T,11640390,1.033452361518378
RKN,73707386,3.296207724675486
Lu-65,24180719,4.093355084092675
CML-T1,71680916,4.411758468982172
Ri-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.968451246064357
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
ESS-1,9887053,4.577592103187429
PF-382,10410894,2.6681125550608025
Panc 02.03,11222830,1.865607722872823
SNU-213,148198,-1.214073512813324
KMS-12-BM,tanespimycin-gemcitabine (1-1 mol-mol),-2.331991876675554
H-STS,1641662,3.378445220211116
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
AsPC-1,24797083,1.5655308519339004
TE 441.T,2113511,5.892047863834905
NCI-N87,71466578,5.1108247117444865
BT 498,387447,-2.1725153128348547
Lu-65,3503,1.319082259857831
AU565,5282054,3.2331302005717153
SNU-213,24856436,1.6786280884983995
KLE,5278396,3.889356862405411
KYSE-450,SNX-2112-bortezomib (250-1 mol-mol),-1.628342695469425
Ri-1,1641662,2.4942223839776463
Mono-Mac-1,5280436,2.9762388958592707
BT 248,44185566,1.9117845458549376
OAW28,168313016,5.164256635335989
KYSE-180,24180125,4.03262772641334
SK-MEL-28,107970,3.16887671769628
NCI-N87,17759555,3.435080423112301
HCC2108,navitoclax-gemcitabine (1-1 mol-mol),1.646339925390015
KMS-12-BM,navitoclax-birinapant (1-1 mol-mol),-0.785030684423409
NOMO-1,11396600,3.3888037624860674
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
NCI-H196,11640390,5.704404098029019
SNU-1077,42642645,1.1218523174966224
B-CPAP,3025986,-0.4402744991779203
Mono-Mac-1,53392493,0.4855947054327226
KYSE-180,10127622,5.464942572598225
BT 286,3503,0.7822186863791739
KO52,11977753,-0.926133463520109
YD-8,702558,4.53955953938176
SNU-216,9911830,2.1398912486664026
Mono-Mac-1,11640390,2.8193027776915605
LMSU,409805,5.989527903576905
TE 441.T,11955716,-2.4135075379254607
SW1573,5282054,2.2636648441362417
HEC-108,36314,3.0566190608483015
TE-14,136227924,3.1216716097465365
HEC-108,151289,0.8721533950647946
OE33,2729026,3.172703771276418
ACC-MESO-1,374536,3.768869201315052
ChaGo-K-1,11234052,4.170735457945669
ESS-1,2733487,7.1971924455192955
BT 328,2749,4.811351487491957
Hs 611.T,4259181,0.1161520407552913
ChaGo-K-1,24964624,3.0515539572091512
SNU-423,23725625,5.944584513695728
HOP-62,UNC0638-navitoclax (1-1 mol-mol),2.4690733929057385
NCI-H929,11427553,0.419395277417347
Hep 3B2.1-7,42642645,-0.3061550717373256
KE-39,10296883,3.8123665461282545
YD-8,salermide-PLX-4032 (12-1 mol-mol),5.298830023268121
SW1783,24821094,3.387006787045153
H-STS,crizotinib-PLX-4032 (2-1 mol-mol),1.0847078558510623
YD-8,25262965,-1.542928389011739
SNU-213,17755052,1.5850181646262569
GOS-3,piperlongumine-MST-312 (1-1 mol-mol),1.994862701912013
B-CPAP,969516,2.5464692939990834
BT 112,252682,6.130098211071154
KE-39,44489675,3.66901218347382
AsPC-1,67291369,5.582806392200744
IST-Mes1,375860,0.4088289358172842
KE-39,11396600,3.848773124810753
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
KLE,navitoclax-PLX-4032 (1-1 mol-mol),-1.3670051186656096
KMS-12-BM,4261,-0.5795047711854386
RT-4,6450551,2.2362160436961314
SF539,444795,3.755252396278318
Hs 611.T,JQ-1-UNC0638 (2-1 mol-mol),0.315420207793623
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
Panc 02.03,51039095,3.661030142872421
ChaGo-K-1,24753719,4.520891779779164
TE-14,135440466,2.7792250864497334
OAW28,2749,3.2113189756487683
Hs 611.T,5470400,2.207943495778688
HOP-62,11167602,2.5582425778829356
SF539,107985,-2.833720447652478
WM793,654092,0.4910491362613845
KYSE-180,10302451,1.5519577455009292
EHEB,9935249,3.177814055372344
Panc 02.03,11364421,0.2085573081853932
OE33,135421197,1.9963159792783505
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
BT 248,9927531,4.7076279917818225
BT 112,10385095,0.9487594139156588
ACC-MESO-1,219104,4.703668674528299
LXF 289,46907787,-0.1426698074457199
NCI-N87,72193861,-0.2047514956394879
KLE,60700,-0.7910024773146103
RKO,11964036,1.8153618806471208
HuT 78,5113032,3.627590183655839
Namalwa,15983966,-7.946057700179597
GOS-3,11625818,5.199223686092666
OAW28,89183176,4.823946494889004
IST-Mes1,carboplatin-UNC0638 (2-1 mol-mol),3.3529895985097675
NCI-H929,969516,1.5005590932517423
TE 441.T,73707398,2.754590712931621
ESS-1,53232,1.8155260046975692
L3.3,25183872,0.3957917888669793
Namalwa,4705,3.621778373883038
YD-38,44486219,3.4914572976209346
KMS-12-BM,65064,2.717641893492065
WM793,1716436,1.7539283172933289
Mono-Mac-1,637858,0.9949100169924338
Lu-65,navitoclax-MST-312 (1-1 mol-mol),0.9653028056890602
Hs 611.T,7251185,0.6156146774178182
YD-38,11178236,-2.848995889133555
TE 441.T,49836020,3.964912597269393
BT 320,51039095,3.427316698358292
YD-38,24785538,3.26638360961171
SW1573,25102847,2.4268351657646874
KMRC-20,crizotinib-PLX-4032 (2-1 mol-mol),2.3477359340418587
Karpas-422,11427553,1.391441421390955
KMS-12-BM,4917,2.744184399982424
AsPC-1,568763,2.040921390287386
HOP-62,3081361,2.3557787666723087
BT 112,208908,1.6511587160909196
OAW28,2729026,2.5871569751548047
WM793,selumetinib-UNC0638 (4-1 mol-mol),2.385330899983246
LMSU,54596490,4.907866417372536
SF539,3025944,4.088264008981447
SNU-423,24821094,2.9581810311098176
AsPC-1,carboplatin-UNC0638 (2-1 mol-mol),3.748908511395219
NCI-H929,654092,-1.4076135504033414
Kasumi-2,9933475,1.7570111474767809
SNU-119,71304818,1.7575129370546083
LMSU,9908783,4.430691687580579
Namalwa,5287969,-2.4617636559658593
GOS-3,16659841,4.90242511664039
SK-MEL-5,4521392,4.360009001043505
SNU-119,11625818,3.656882116182555
KE-39,24978538,-0.2539808437524994
IST-Mes1,25150857,2.301198962208278
NCI-H1339,11364421,-4.045000202269178
PE/CA-PJ41 (clone D2),36462,2.2016180933991594
SNU-119,439501,-2.3303537311085143
BT 248,52947716,0.6891318567706715
AsPC-1,262093,3.2992304028365926
Mono-Mac-1,252682,8.469235580129757
SNU-119,104842,-1.1389094996160742
NCI-H929,tretinoin-carboplatin (2-1 mol-mol),0.1432218131901559
Mono-Mac-1,navitoclax-MST-312 (1-1 mol-mol),0.5984340536339148
OAW28,54618771,1.1011370240470315
AU565,148124,-5.63717967948206
SNU-886,46191454,2.868449433002464
KMS-12-BM,6918878,0.6296559584919736
MIA PaCa-2,navitoclax-MST-312 (1-1 mol-mol),1.14230691570943
RKN,135875424,3.6230459419726526
SNU-119,44589607,2.031679026028789
SNU-423,6184667,3.1994764745463304
OAW28,11485656,3.2643123414600645
AsPC-1,vorinostat-carboplatin (1-1 mol-mol),3.776760089642386
NCI-H929,54618164,3.87455268818749
KE-39,219104,3.854039065759246
HOP-62,441298,1.1234788887045837
OE33,10385095,1.0575455043550728
Lu-65,31703,-0.7957665797454153
HSC-3,159324,3.228445723809223
ChaGo-K-1,5281321,-1.8819785009117511
SNU-216,66577038,3.122632953988705
SK-UT-1,11214940,1.922253876673372
BT 112,71466578,4.453393330882409
ACC-MESO-1,5329102,2.602640313364048
Kasumi-2,53232,4.135119610512006
ChaGo-K-1,216345,3.946288356324136
NCI-N87,10074640,2.8038201142488504
TE 441.T,151289,1.049398071450078
SW1783,119607,5.1966620860731965
PE/CA-PJ41 (clone D2),19582717,4.700549622049601
HOP-62,navitoclax-MST-312 (1-1 mol-mol),1.076073120479153
Mono-Mac-1,5746,-1.53803336813333
OE33,66577038,3.0840279389618077
KYSE-450,25227462,-0.8054559419348748
JHUEM-7,54613361,-0.8057680403927349
RT-4,56963564,2.308736271867476
TE 441.T,9933475,1.6906034306149391
Kasumi-2,10113978,2.7713645825563153
BFTC-909,1716436,3.115342072857748
Ri-1,11396600,2.305014362827753
AU565,54143018,-0.7127893506095456
Becker,16659841,3.7149025743042703
Namalwa,135411,-0.3844815221234907
NCI-H2030,9936388,0.4850325164954482
H-STS,57519531,1.7536520840543603
PF-382,89183176,-2.8788143153394476
SNU-119,6623618,1.934770207260526
YD-38,16038120,1.3512560240951477
RKO,5328940,1.7974237645790871
SNU-886,2841722,5.058350864200372
PE/CA-PJ41 (clone D2),439501,-0.7748943226504631
SNU-886,452548,-1.461802443454938
Lu-65,5566,3.0755263242303528
LXF 289,23582824,0.8647594683412683
OAW28,387447,-4.631995500074297
Kasumi-2,24978538,-3.812533145701136
Kasumi-2,3825829,3.3479634665685167
NCI-H196,71466445,5.320372938858583
AsPC-1,42642645,1.2436203489585118
SW1573,1566236,3.3872191513469025
SF539,1566236,1.697367188486211
Hep 3B2.1-7,969516,2.78544012674228
AU565,9868037,3.1053436778875843
SW1573,285033,-0.3175288260868649
SF539,57519531,1.493804886958663
CML-T1,17755052,2.353347963272661
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
Ri-1,5278396,2.4527389088774494
SK-MEL-28,serdemetan-SCH-529074 (1-1 mol-mol),2.401587214304783
BT 328,24797083,3.187781247629872
Hs 611.T,11609586,-0.3385496005015009
SK-MEL-28,24821094,3.6825272543365233
H-STS,ISOX-bortezomib (250-1 mol-mol),0.4695504712696665
HCC2108,71304818,2.5553265093356186
BT 320,11625818,5.9690326446968935
Panc 02.03,3503,2.8594786206641514
RT-4,3081361,2.257643054417338
KYSE-450,crizotinib-PLX-4032 (2-1 mol-mol),2.9466068447817126
BT 328,25183872,0.4527606216465452
LMSU,123631,3.4845106075088763
SK-MEL-28,452548,3.305743794456603
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
TE-14,11238147,2.2805487405204397
L3.3,56946209,-3.919110396505915
KO52,46215462,1.4911343495601384
BT 112,selumetinib-UNC0638 (4-1 mol-mol),4.250486145990314
Hep 3B2.1-7,25126798,3.844518464246068
KYSE-180,9926054,1.7654325832877988
HuT 78,8515,3.8606402282287657
NCI-H2030,637858,2.3348665143276843
H-STS,25262965,-3.423231216338223
ESS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.581305001836425
EHEB,6610216,4.931191689693455
KLE,11455910,3.332048563725763
Ri-1,72376,-4.8920412183546
BT 498,44566777,-0.1124506153493127
KYSE-180,156422,3.987230408696769
NCI-H929,25183872,-2.352025063826196
YD-38,5311,1.7266594401614792
KE-39,46843906,2.072114054574841
SW1783,54618771,3.657201070811366
YD-38,5351362,1.0893723537078008
SNU-216,24964624,3.0205376038107437
SK-MEL-5,11364421,0.3059082232055436
KMS-12-BM,5738263,2.600440253298569
ChaGo-K-1,4477,0.5485405501498112
PF-382,72734382,3.7745831304753894
Hs 611.T,262093,0.9776083871947168
BFTC-909,6918736,-1.9066217610366931
KYSE-450,135875424,4.8684130020868235
B-CPAP,119607,5.422554804486835
Karpas-422,135999136,3.6937273176122294
BFTC-909,400769,-0.3884900564724624
NOMO-1,11640390,1.5691640408186416
TE-14,JQ-1-vorinostat (2-1 mol-mol),-0.1779983088333628
IST-Mes1,5351362,3.046296530947078
ChaGo-K-1,675434,4.913986112322382
PF-382,5281672,3.504573563810081
SNU-886,navitoclax-gemcitabine (1-1 mol-mol),-7.729946623130621
OE33,5282054,4.473462161437885
CML-T1,89928392,0.2335848320544615
ACC-MESO-1,135440466,2.2679972756943987
HEC-108,135421197,3.884784600125324
L3.3,54618771,1.1558037208399272
HuT 78,3385,4.463035201043826
LMSU,6438330,2.2496708259228364
Mono-Mac-1,135928012,3.3963935861333816
BT 112,2828334,5.978817648129075
NCI-H2030,5281321,-1.9340682809287928
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559
BT 328,4705,3.594890989297502
Mono-Mac-1,5287620,-4.925359227811426
IST-Mes1,15547703,3.097349866450655
SF539,5311,1.7990759900663726
Lu-65,4261,0.8426070626178986
JHUEM-7,6918328,0.5362707723228177
Namalwa,10410894,2.360659903782703
HuT 78,5743,-2.915718812288148
CML-T1,262093,1.3151134240668207
Ri-1,9927531,3.385054072969868
CML-T1,19582717,1.9595186711365948
Hs 611.T,9907093,3.4448624086289987
CML-T1,176870,2.5950096151434345
BT 498,crizotinib-PLX-4032 (2-1 mol-mol),3.453127992243518
SNU-216,5284616,3.778121920515909
Becker,15953870,5.473273860376091
KLE,11228183,-0.1439343669453544
HuT 78,5278396,2.15665743131779
SF539,9952709,2.216028342098009
NCI-N87,135398516,0.1780104282584799
BT 498,11222830,1.8322344159731312
LMSU,11364421,1.7536295583512325
ChaGo-K-1,441298,1.668083723590158
AU565,7326481,2.6950900258123256
RKN,49793307,-1.2643121180608
HCC2108,24785538,0.6113377434133814
HuT 78,441298,1.9970992526454237
Karpas-422,46224516,1.1121151322289515
BFTC-909,71466380,5.267829049221599
SF539,3676137,4.118081240228259
KO52,5311,-0.0281160213778733
ACC-MESO-1,613753,4.536767429887022
KE-39,285033,0.1893383361723871
LXF 289,24821094,2.4128137194258215
MJ,54619267,3.7819804924234703
GOS-3,11485656,3.367022375162814
KMRC-20,9444,4.017663478109875
GOS-3,66577038,3.060096848137411
KYSE-450,246676,4.496442396396831
MIA PaCa-2,4521392,4.256949723260046
KYSE-450,1242560,3.7226437458360895
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
SK-UT-1,49867930,6.152644057002921
HOP-62,3543504,3.0589841179466264
ESS-1,24180125,3.331979674522133
KE-39,9866186,5.4228444415850525
RT-4,65628,4.4679434201664945
PF-382,44632017,0.9401237974673988
B-CPAP,44185566,3.01783805282662
H-STS,44493528,4.270078015163244
TE-14,25262965,0.1112542376470163
SK-MEL-28,vorinostat-carboplatin (1-1 mol-mol),4.275906027755069
MJ,24821094,3.517633488156914
RKO,54613361,0.2998145946125954
EHEB,11656518,-0.4921898134750562
LXF 289,piperlongumine-MST-312 (1-1 mol-mol),1.396630605927831
SNU-119,44259,0.785845765764312
TE 441.T,2126,5.200977994947506
AsPC-1,52947716,3.328482082087177
NCI-H2030,71304818,2.458601205050272
Namalwa,46199207,2.7519500516222912
KMS-12-BM,57330099,3.2111991420002215
Becker,15983966,-4.434782339210091
HSC-3,1242560,3.3956324395360427
OAW28,5351362,2.5555782345102407
EHEB,104842,-5.697629761421609
OE33,126941,-3.974727275368632
SW1573,124202324,3.209850220678193
KO52,5479543,3.70628144154809
HCC2108,66577038,3.559393194333952
Panc 02.03,4917,3.7856869354758342
OAW28,46174525,4.143540766033049
OAW28,9911830,2.567685352724645
OAW28,11364421,1.0555351676055402
Kasumi-2,4705,3.579279614719375
RKO,24753719,3.882573791668401
BT 498,9927531,5.612738328284819
TE-14,45279963,4.011483934941965
Ri-1,73707386,2.473234427573793
RKN,54143018,1.3184566027416504
L3.3,19582717,4.421931624871946
KO52,navitoclax-pluripotin (1-1 mol-mol),-1.853817353117152
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
AsPC-1,JQ-1-navitoclax (2-1 mol-mol),1.1906328907742711
LMSU,piperlongumine-MST-312 (1-1 mol-mol),1.415881107955257
HCC2108,44589607,3.0217801905225365
Mono-Mac-1,44632017,0.6207752840578831
SK-MEL-5,11612883,3.663296316497211
ESS-1,71466445,5.77037971840281
KE-39,452548,2.893764704485056
BT 112,erlotinib-PLX-4032 (2-1 mol-mol),5.222233695296922
B-CPAP,6918328,-0.1092026368614908
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
PE/CA-PJ41 (clone D2),12003241,-1.240840898142407
KMS-12-BM,71304818,1.2685254858454966
KE-39,5329102,2.0429162006260566
H-STS,135440466,1.636722926447895
Kasumi-2,451668,-1.101171086852316
OE33,216468,3.798936261748522
B-CPAP,400769,-0.8210838787379329
Lu-65,54619267,3.894734254993299
Ri-1,9915743,-1.2170005610109595
SK-MEL-5,1566236,2.4643263629353576
Lu-65,doxorubicin-navitoclax (2-1 mol-mol),-1.4221733970931094
SF539,54618771,0.9520052550930058
NCI-H196,11222830,1.4902122717783377
Hs 611.T,3385,2.153573733073161
ESS-1,JQ-1-carboplatin (1-1 mol-mol),1.200091134415551
SK-MEL-28,vorinostat-navitoclax (4-1 mol-mol),4.020713865160522
ChaGo-K-1,89928392,2.9195597645126945
B-CPAP,71304818,2.781278016768635
IST-Mes1,5287620,-1.7840398419727848
PF-382,613753,3.2428568441024535
AsPC-1,66577038,3.0978373542257973
JHUEM-7,135398516,1.61969532142052
RKN,23582824,1.7370647325872666
SK-UT-1,1716436,3.7795606206738337
RT-4,15547703,3.010002143922484
SF295,24951314,1.477967399067711
Hs 611.T,16065773,1.80760253955414
BT 498,3543504,5.593933324078399
YD-8,11625818,4.711571191575779
HSC-3,3025944,4.431435908143169
SF295,6918837,-2.4914384138435466
HEC-108,638278,3.526450795936247
SNU-213,66577038,2.1743073235901065
Ri-1,135440466,1.1729912767332191
YD-38,5978,-1.9530397384298024
Panc 02.03,11178236,-2.8028080099743624
BT 112,25150857,1.6816948486973082
LMSU,44566777,0.4597072613973534
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549
MIA PaCa-2,56649450,3.735395641127426
SNU-216,3025944,4.138947236971317
CML-T1,SNX-2112-bortezomib (250-1 mol-mol),-2.787489120690278
Hs 611.T,60750,-7.343264339076902
Hep 3B2.1-7,9911463,3.814987656182777
H-STS,25227462,-1.51229280635868
LXF 289,54613361,1.2100808209747431
AsPC-1,4917,3.701934006694463
KMS-12-BM,navitoclax-PLX-4032 (1-1 mol-mol),-0.94714190521785
SW1573,9884685,-1.2788581073527363
Karpas-422,168313016,4.1332698119868265
Kasumi-2,44486219,4.4104720165674145
CML-T1,11214940,-0.4703282723698588
GOS-3,10184653,2.042716455984749
Karpas-422,44819697,-0.4261845245346083
Lu-65,216345,4.515711815904248
KMRC-20,46398810,2.3963620862507717
LXF 289,JQ-1-vorinostat (2-1 mol-mol),0.5669885048273257
NCI-H1339,168312962,1.6385487975879267
Hs 611.T,26596,-1.6290206215335707
NCI-H929,241158,1.4883272197282302
TE 441.T,445643,4.053678977050013
SNU-216,3025986,-1.2543587626887052
Mono-Mac-1,54454,2.2047312672861676
HEC-108,44259,1.4684609831763502
BFTC-909,10410894,3.671861694905457
B-CPAP,6914657,-4.791775338722752
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
ChaGo-K-1,44607531,1.465791535592978
TE 441.T,3385,4.290076098692374
IST-Mes1,11717001,4.337000636344965
Namalwa,49867926,3.871708467281813
Karpas-422,10385095,1.106745644266175
MIA PaCa-2,36462,1.2671989611626788
NCI-H2030,446155,1.479611866961904
RT-4,4788,5.796241294754794
SF539,421610,3.0034514922655817
ESS-1,46843906,3.355969876815747
SNU-213,navitoclax-pluripotin (1-1 mol-mol),-0.537091332254985
NCI-H2030,11175137,3.165352687365522
Namalwa,44607530,1.4976967359197746
NCI-H209,selumetinib-navitoclax (8-1 mol-mol),0.4074969352699937
RT-4,71466445,5.089577793908251
KYSE-450,16725315,5.267357391878718
HCC2108,216468,5.043012995009322
MIA PaCa-2,676352,1.5948637153539005
HOP-62,123631,2.2603596444453116
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
SK-MEL-28,44819697,1.1558418850564092
BFTC-909,56973724,3.22598802973391
SK-MEL-28,227681,3.6340510763763367
SF539,11396600,2.4945499602014487
BT 328,702558,5.711275260817638
HEC-108,2945648,2.8918279332914074
Hep 3B2.1-7,439501,-1.9738642324779276
Panc 02.03,54454,5.027619058009229
KO52,25154868,5.228534318622467
KE-39,208908,0.8342774772445833
AsPC-1,46199207,3.695579616421397
HuT 78,73707398,-1.0733102034167783
CML-T1,23725625,2.2812581172519124
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
YD-8,216345,4.535987762651242
SNU-423,156414,1.5595439535021
Ri-1,444795,2.8789748064532823
KMRC-20,JQ-1-vorinostat (2-1 mol-mol),1.7391648557061274
KLE,selumetinib-PLX-4032 (8-1 mol-mol),4.210157254606348
SNU-119,53232,1.8966224291818248
Lu-65,3854666,0.9157071351936018
ChaGo-K-1,9927531,4.39504142130407
Mono-Mac-1,44507138,0.2590910226176092
MJ,60700,-0.4552708025681623
KYSE-450,24771867,3.24164368139856
SK-UT-1,439501,-2.663904937582399
SF295,89928392,1.4979001161224754
MIA PaCa-2,9840324,5.923337742177544
LMSU,374536,2.9263574161338046
SW1783,46174525,4.2531961544847885
OAW28,2708,5.3328257603707545
Namalwa,451668,-2.1603727921767666
SNU-886,49766530,-1.8017914460493445
PE/CA-PJ41 (clone D2),2733526,4.358750662295764
IST-Mes1,5738263,4.045528078129119
MJ,107985,-2.8858164405295015
SNU-1077,5566,3.5894057119663993
LMSU,vorinostat-carboplatin (1-1 mol-mol),4.433531570096117
NCI-H929,23939,4.224811778291157
Karpas-422,16736978,0.4633777346739987
BT 112,4261,1.960966237703145
SK-MEL-28,5284616,3.125378124469527
AsPC-1,10184653,1.884059851333118
BFTC-909,16722836,1.424017650466323
KLE,5284373,-1.0664955605853337
NCI-H929,54686904,2.5438684398285996
Hs 611.T,1566236,1.2731219518363013
SF539,4259181,0.2869057369152892
NCI-H2030,10385095,2.209603603161303
HuT 78,4788,5.194344825774489
OAW28,3025986,-0.5681838773369163
SK-UT-1,60750,-4.1322168678971956
OAW28,135440466,2.5697421477630273
KE-39,676352,2.0662009549778704
ChaGo-K-1,44589607,1.9883997231834751
ESS-1,2746,2.6118901158900423
Lu-65,10074640,3.7287414773273655
WM793,9915743,2.18814480431127
L3.3,5978,-0.2603821575839845
RKN,44607531,3.612700906890815
NCI-H929,8515,3.198792100225454
Becker,613753,3.3713137872968906
SK-MEL-5,selumetinib-piperlongumine (8-1 mol-mol),3.4239328434426546
SF539,12003241,-2.026733754371074
ChaGo-K-1,docetaxel-tanespimycin (2-1 mol-mol),-5.262192441392657
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
Hep 3B2.1-7,3503,1.329326984042977
BT 328,11427553,3.9535129095984054
RERF-LC-MS,11238147,2.4729298726299147
YD-38,136227924,2.6123275605059075
ChaGo-K-1,3854666,1.588542463335614
OAW28,11152667,0.0990704789630026
ACC-MESO-1,216468,4.389986400214309
OAW28,5311,0.8600755425080211
SK-UT-1,44632017,3.336083034229006
HSC-3,12001922,1.7016354189742475
NCI-H2030,10427712,5.726847799338336
KMRC-20,119607,3.891658736403049
SF539,6505803,-2.26727491960267
HuT 78,44632017,1.0845444881128212
Karpas-422,46174525,4.10467072834266
SK-MEL-5,46907787,3.947667418966643
ChaGo-K-1,23635314,5.83207100789115
OE33,2749,1.9089382041131728
KYSE-180,crizotinib-PLX-4032 (2-1 mol-mol),2.1918539304937332
BFTC-909,3552672,4.498195948808332
H-STS,11612883,2.0759775526312096
SF295,3062316,3.5425681199487085
OAW28,6852167,2.294169410796982
HEC-108,10184653,1.654851711294291
IST-Mes1,navitoclax-pluripotin (1-1 mol-mol),-0.6633970571557571
RT-4,5329102,2.779535568248952
L3.3,9936388,-5.444309252993802
ChaGo-K-1,UNC0638-navitoclax (1-1 mol-mol),3.3725673517370662
NCI-H1339,doxorubicin-navitoclax (2-1 mol-mol),-0.8830700703229586
BT 286,52947716,0.976045704659649
ChaGo-K-1,46926350,-4.424960815511268
TE-14,57330099,4.310700710168813
KLE,24901704,2.3973635656707204
HOP-62,4261,2.721798262464122
AU565,54678924,2.5293429329053763
RKO,6918736,-1.762610939534952
KYSE-450,4578,4.488057266772786
KO52,56963564,-1.0767290882933307
Namalwa,11612883,1.9664266013220393
YD-8,3081361,2.3090851828651835
PF-382,451668,-1.5679120589003597
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
Panc 02.03,12001922,2.5444953584324193
KLE,54626689,4.672839373899824
KLE,2858523,2.55520856351848
Hs 611.T,49867930,5.716629304512967
MIA PaCa-2,44185566,2.358125757500078
HuT 78,148198,-3.964995663982544
MJ,219104,2.3503160587955647
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
SNU-119,72193861,1.9875714401022249
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
SW1783,selumetinib-decitabine (4-1 mol-mol),5.3087613304483225
TE 441.T,1716436,1.8501117419808528
NOMO-1,3062316,2.517026306117631
Ri-1,11234052,2.0881087098511872
CML-T1,4521392,4.044943461780163
Becker,285033,-0.6028258460336342
YD-38,11497983,4.3604481340224
KO52,10127622,0.9080853553527672
SK-MEL-28,16038120,2.5189867530231065
HuT 78,44819697,-0.2139990316964177
SNU-1077,54649381,3.672520779647441
SW1783,31703,0.5342280043570855
HEC-108,23635314,-2.542270451290658
AsPC-1,44185566,2.682305355629655
IST-Mes1,1750826,2.0701004204652778
Lu-65,5470400,0.5460431386615598
OAW28,5566,3.0868855994062137
KE-39,46174525,4.365046515434029
SF295,44137675,5.032931190928139
SW1573,135421197,1.3915330004591782
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
Namalwa,52947716,2.8584194612059206
RERF-LC-MS,107970,3.001301355490032
KE-39,docetaxel-tanespimycin (2-1 mol-mol),2.396953201231709
H-STS,alisertib-navitoclax (2-1 mol-mol),-1.762059403403842
CML-T1,10127622,3.755726914771393
RT-4,crizotinib-PLX-4032 (2-1 mol-mol),2.875224727461572
KE-39,5284616,2.799589028326303
KE-39,6917907,3.4636504669535215
PF-382,25183872,-2.3437313264330433
BT 248,11609586,2.7692010936053064
BT 498,46398810,2.841976962151931
NCI-H196,6623618,3.122660560916228
ESS-1,doxorubicin-navitoclax (2-1 mol-mol),-3.174683950808786
NCI-H196,tanespimycin-gemcitabine (1-1 mol-mol),-1.8049409117597135
PF-382,52947716,-1.076920291398276
GOS-3,71466380,4.9000171792124
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
HCC2108,9936388,-4.897775231329417
EHEB,9967941,3.291160377443194
SNU-119,5329102,1.9834591388005431
LMSU,44487872,4.479427716264116
SK-UT-1,135440466,3.5602856179357327
MIA PaCa-2,71466445,3.52941204584422
TE 441.T,53232,3.927095243981295
SK-UT-1,135875424,3.143376991018657
TE-14,2842253,6.030990988096264
SNU-216,135984461,4.361470667524811
KE-39,24964624,2.267142563952713
SNU-886,969516,2.757505683401957
EHEB,5746,-0.445016034851696
LXF 289,11626560,1.452143156792952
HOP-62,11647372,1.1113076615645692
SF539,BRD-K55473186,4.334676081622515
Namalwa,4259181,0.072491305186228
L3.3,53495165,2.194695518305113
TE-14,piperlongumine-MST-312 (1-1 mol-mol),2.2546641574624027
Hs 611.T,65064,2.5117915945141513
AU565,54618164,4.092787142183454
Hep 3B2.1-7,6450551,2.1727853612128394
HOP-62,11719255,5.763967823522321
YD-8,24901704,3.1814238875583585
SNU-119,136227924,3.0573258202750253
Kasumi-2,9444,3.998890232290453
RKN,3025986,-0.1432368238740909
Hep 3B2.1-7,3385,5.57638309571322
BFTC-909,104842,-1.584917163766509
HSC-3,9907093,4.434110272404288
B-CPAP,159324,2.672075580393903
SK-MEL-28,148198,-1.1695105826491254
NOMO-1,6918328,-2.206625897840938
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
SF539,25150857,2.307908802702035
RKO,135440466,3.093117295091816
HuT 78,446155,1.49234207270104
SNU-886,262093,3.428603865365944
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985
SF295,3815108,3.3473077124451063
AU565,11656518,2.4577765871660353
BT 498,31703,1.193610486864811
KO52,44589607,1.6213501013448446
AsPC-1,25227462,2.9060868065293195
ESS-1,439501,-2.0978778954241215
PE/CA-PJ41 (clone D2),148198,-3.3597343554635652
KMRC-20,439501,-2.469138258710991
BT 286,81146,4.651385786966362
SNU-213,10385095,2.7554812107877065
NCI-H2030,4261,2.035787894419823
BFTC-909,126941,-2.0975077483758415
KMS-12-BM,675434,3.718693309292293
Mono-Mac-1,68056272,2.1960795131164357
Karpas-422,702558,5.38036572824696
H-STS,navitoclax-piperlongumine (1-1 mol-mol),0.9655635349297744
NOMO-1,66577038,2.985459327680272
Ri-1,1566236,0.746437074488416
AsPC-1,3634881,3.56845743908184
KMS-12-BM,24951314,-0.6430805237393931
PE/CA-PJ41 (clone D2),2708,5.346353434531731
SK-MEL-5,15983966,2.497430173814158
SNU-886,selumetinib-MK-2206 (8-1 mol-mol),1.439939334739481
MIA PaCa-2,42642645,0.3251150152649052
KYSE-180,11612883,2.294010181376236
LMSU,6914657,-3.5331603162899707
BT 286,156422,4.3114640256828
KE-39,15983966,1.9494927934805544
BT 286,1750826,-0.130592970617936
Kasumi-2,387447,-5.322857892005912
TE-14,serdemetan-SCH-529074 (1-1 mol-mol),2.350866314768636
KMRC-20,5281321,0.8825507605959158
Becker,6914657,-3.22649296417791
SNU-423,387447,-5.098598596433983
SNU-1077,151289,4.212022708260447
AU565,613753,3.214352381260741
B-CPAP,60750,0.8198284894100664
HuT 78,24901704,-0.7514069981488459
BT 286,25195348,4.118327733963511
Hs 611.T,alisertib-navitoclax (2-1 mol-mol),-0.8387808311928717
Becker,44566777,-0.649720439158945
ESS-1,72376,-3.01301826130781
OAW28,285033,-1.6788024908058845
Ri-1,6918878,0.3594446743212551
NCI-H2030,25102847,2.1233040695404486
YD-8,11719255,2.4151031872867397
PE/CA-PJ41 (clone D2),5566,3.1605313786079825
GOS-3,71751553,4.284016393111424
RKN,23725625,4.172652901782409
AsPC-1,11404337,0.3809720735493328
AU565,4096211,1.4857810053347718
PF-382,702558,2.625780781007821
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
KLE,10184653,1.244487800757798
SNU-886,6184667,1.0916410821784486
NOMO-1,54619267,3.207870909981956
HSC-3,124202324,3.390137695130575
SNU-119,9823820,3.989816323435888
MIA PaCa-2,53481919,3.693165756222
NCI-N87,4261,0.8200487533079858
KE-39,216239,3.497758173664419
BT 320,12001922,1.695610420399754
Hep 3B2.1-7,selumetinib-MK-2206 (8-1 mol-mol),2.068814020685818
SK-UT-1,753704,5.7414548623534305
YD-8,9967941,3.7717076559680702
KLE,66577038,4.579092184923065
BFTC-909,7326481,3.4905195575106527
SW1573,16013152,3.6979705228045354
PE/CA-PJ41 (clone D2),3062316,-1.418857079831338
BT 320,53392493,4.061896393500848
OE33,10113978,5.030208704856358
SW1783,676352,2.0801298645045274
NCI-H2030,16741245,3.551000644564588
YD-8,5978,2.5175590604708584
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073
Mono-Mac-1,49793307,-4.32207267885748
Namalwa,156422,4.036118027723875
KE-39,23725625,5.622319720398273
HCC2108,docetaxel-tanespimycin (2-1 mol-mol),-0.9383807284852752
LMSU,2126,3.9441153876668
RKO,24901704,3.90150667551114
SK-MEL-28,168312962,-1.5398903743512435
H-STS,12001922,1.5454673867103017
BT 328,439501,-3.1360046964577983
RERF-LC-MS,65064,5.274588293813746
SNU-216,10410894,3.834946704146114
MIA PaCa-2,3038522,2.485908488942159
SF539,676352,1.6554067162537418
B-CPAP,9907093,4.2889241184998825
YD-38,52912189,0.9413561313554776
OAW28,3062316,-0.5042902382709098
SNU-216,676352,1.9648190392617515
SNU-119,9903786,3.393165032525661
KLE,navitoclax-piperlongumine (1-1 mol-mol),-2.7147471251118143
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
HOP-62,4788,5.159973748153675
KMS-12-BM,11626560,0.494949626901472
Ri-1,SNX-2112-bortezomib (250-1 mol-mol),-3.4846614338424153
WM793,119182,-3.1543080825396173
Ri-1,2874250,4.4080910823074015
Karpas-422,6917907,-5.654366357922142
Karpas-422,3854666,1.0831762818043358
LXF 289,56946209,-4.292268406284497
HEC-108,387447,-5.079207916782074
NOMO-1,11612883,1.4996443311921075
SNU-213,123631,2.3363847745895683
GOS-3,selumetinib-MK-2206 (8-1 mol-mol),3.670573645172849
Karpas-422,24753719,4.137089222307065
NCI-H2030,11222830,2.304040670550321
CML-T1,73707440,4.384977554594534
LMSU,serdemetan-SCH-529074 (1-1 mol-mol),2.8216668636447313
RKN,5282054,3.624299707956654
NCI-H1339,11719255,5.227414732740707
SK-UT-1,25126798,4.142879524330263
RT-4,11507802,2.274211340245079
Hs 611.T,53495165,-2.569937214874966
HOP-62,16720766,1.4150148120607713
KYSE-180,10184653,1.7037524343136865
BT 286,2858523,2.9856997635440803
Becker,5281672,5.170616475815027
RERF-LC-MS,16038120,1.5599846769821624
PF-382,44589607,0.7007325594590731
ESS-1,11234052,5.5778807496063765
B-CPAP,15953870,3.3315928326884756
NCI-N87,135411,0.0487965919912929
NCI-N87,11404337,-0.8803091706648726
BT 286,9884685,0.8858351843955082
HuT 78,15547703,4.385354526396273
AsPC-1,702558,5.7476960936684565
EHEB,6918736,-2.350232551992923
Panc 02.03,5328940,2.397017671249583
YD-8,24889392,3.1391484247952777
MIA PaCa-2,322968,4.188739410962973
RKN,11152667,0.0617927102225113
Kasumi-2,216239,2.0875832120118605
CML-T1,2733526,2.616681149896765
SF539,piperlongumine-MST-312 (1-1 mol-mol),0.3137797380658941
NCI-H209,navitoclax-pluripotin (1-1 mol-mol),-2.817778574206939
Panc 02.03,11609586,3.3931905350155915
KE-39,54686904,4.41883981342939
NOMO-1,5351362,2.08054014163225
LXF 289,54649381,3.6309892426510406
NCI-H1339,44566777,1.0860363171374443
IST-Mes1,alisertib-navitoclax (2-1 mol-mol),2.2852376454563896
OAW28,135398516,2.0767833136681437
Karpas-422,26596,-1.4945297758647662
Karpas-422,445643,4.1594524904300085
Panc 02.03,57519531,5.330694472788803
LXF 289,17755052,1.3903450452706496
CML-T1,216345,1.8584843601432488
AU565,36462,0.154728470238132
SK-MEL-5,9911830,3.188235338246222
ChaGo-K-1,613753,3.0329005548779864
LXF 289,24180125,2.8590757937383517
BT 286,25105715,3.509672270573532
NCI-H1339,6918736,-2.7818792604398235
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
NCI-N87,36462,0.3600781388020123
MIA PaCa-2,9907093,4.239063733882627
KYSE-450,6450551,3.3363850258393124
BT 112,ISOX-bortezomib (250-1 mol-mol),-0.0253360091538834
IST-Mes1,216239,2.2087908746431517
SW1783,serdemetan-SCH-529074 (1-1 mol-mol),2.8062060654486953
MIA PaCa-2,11964036,1.3569409365148226
GOS-3,44185566,2.676138755124573
BT 112,selumetinib-PLX-4032 (8-1 mol-mol),4.754861395931308
OE33,24951314,1.570698013239212
OAW28,54618164,4.207465894202405
KYSE-180,9911830,2.764203258021631
YD-38,6852167,2.552467124707018
PF-382,navitoclax-PLX-4032 (1-1 mol-mol),-0.0589134631644863
JHUEM-7,156414,1.092092573669373
SK-UT-1,11404337,0.3155392200884543
BFTC-909,6505803,-2.7076869289136147
HCC2108,9907093,5.193371437314048
NCI-H196,676352,3.015082175831645
HOP-62,5566,3.0329633334860246
AU565,9444,3.6632568473184888
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272
BT 328,5281321,2.1998966981580073
RERF-LC-MS,252682,6.464777279315186
ACC-MESO-1,3062316,2.585794570393164
NCI-H2030,24951314,1.9329833507416223
TE-14,55508,4.487500956099637
KO52,piperlongumine-MST-312 (1-1 mol-mol),1.3163609440241515
Mono-Mac-1,10113978,2.823328923190202
SK-UT-1,10427712,4.800550596191128
RERF-LC-MS,25150857,3.1332692975488934
EHEB,16725315,3.5389292854080505
SNU-119,46907787,2.5271615138386054
HSC-3,44486219,4.38414181949899
KMS-12-BM,135398738,-0.0456622404629242
NCI-H209,9927531,3.5477571143466156
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
BT 320,216239,3.754471265318657
LXF 289,675434,4.434927450149955
NCI-N87,72734382,4.464771871646434
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
HSC-3,10427712,5.181090366625566
Becker,navitoclax-birinapant (1-1 mol-mol),5.226638008391343
KO52,5746,-1.4374461820450624
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029
SF539,44491742,4.105649274647132
Lu-65,11977753,-0.7315410872896725
JHUEM-7,5978,-3.12331603933377
BFTC-909,5291,3.495280995080932
Kasumi-2,11497983,-3.4342418883602406
ESS-1,3025986,-1.587368137911761
SNU-213,68056272,3.686200404295785
NCI-H929,5278396,3.025125883131511
SF539,6918638,1.218816827551867
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
Karpas-422,9911830,2.3048839894494653
YD-38,124202324,1.7206527447558553
KLE,crizotinib-PLX-4032 (2-1 mol-mol),3.0491582374844723
JHUEM-7,9926054,1.641999407547345
SNU-119,42642645,1.209873965485747
Kasumi-2,445455,4.224989809831099
KE-39,navitoclax-gemcitabine (1-1 mol-mol),0.4577354128073778
Hs 611.T,vorinostat-carboplatin (1-1 mol-mol),3.144700037898093
Kasumi-2,375860,-0.7090394918812726
SF295,387447,-4.188925622132866
L3.3,5328940,2.2327140114261597
Ri-1,49793307,-4.547425498308136
KE-39,11234052,4.426214441977921
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
BT 112,24951314,0.7149145611857288
OAW28,445455,5.326899909172617
YD-8,3025986,-0.972358646883598
NCI-N87,46199207,2.9512504868324565
BT 328,285033,-0.2548275745662432
OAW28,400769,-1.4620594490922918
OAW28,219104,3.640461878438656
SNU-423,11625818,4.3756500171926875
YD-8,644241,2.56753139102049
PE/CA-PJ41 (clone D2),piperlongumine-MST-312 (1-1 mol-mol),1.385125005299621
KO52,4917,3.71660896485238
SK-MEL-5,9915743,2.239295477459583
HuT 78,44185566,0.8459615226549172
BT 328,148198,-4.14614868661324
HCC2108,11625818,5.912984069907385
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
L3.3,241158,3.9670067644952702
Namalwa,375860,-0.654511262615756
BT 328,11152667,1.7027658226426858
HEC-108,44489367,4.45975641268053
Hep 3B2.1-7,71466445,5.312056535197058
NCI-H2030,navitoclax-MST-312 (1-1 mol-mol),1.17233719687161
NCI-H929,15547703,-0.209100400299692
BT 112,4578,5.535818023647584
KE-39,53232,3.986419715634147
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
TE-14,4261,2.2635095803242975
H-STS,5278396,2.5022643900173707
SNU-1077,1750826,-2.704976435926544
HSC-3,6438330,1.1603419304147438
SF539,decitabine-navitoclax (2-1 mol-mol),2.637439217970881
YD-8,4521392,4.941173654959916
OAW28,969516,2.7253654251657573
BT 498,25102847,3.5077914922175712
KMS-12-BM,44137675,1.9058431411693373
SW1783,25161177,4.268571653873596
KO52,44607530,1.0930355607333748
Hs 611.T,10427712,3.4989942349899645
Namalwa,11494412,-0.23219160030294
RT-4,46191454,2.354061820255486
KYSE-180,selumetinib-navitoclax (8-1 mol-mol),5.444648861161274
ChaGo-K-1,selumetinib-tretinoin (2-1 mol-mol),5.3341429737585235
HCC2108,53232,1.9986728385566
SNU-216,73707438,3.927379561891657
EHEB,10427712,4.001167017482681
NCI-H2030,16722836,2.241413928549511
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
Namalwa,3384730,2.2152164600769946
BT 328,16722836,1.9860843246282325
WM793,tanespimycin-gemcitabine (1-1 mol-mol),-0.8794425804429231
SK-UT-1,702558,5.233915547215681
OE33,25062766,1.618132937557501
SK-MEL-28,446155,4.354539024748469
RKO,56946209,-3.445993729976747
TE-14,24856436,0.2311061315082642
Karpas-422,44566777,-0.8369167569085558
JHUEM-7,11404337,0.6000529311141187
Hs 611.T,9911463,2.4472090052981104
HEC-108,135398516,2.4406871230924385
PE/CA-PJ41 (clone D2),5287620,-0.7845756481007433
SNU-119,ISOX-bortezomib (250-1 mol-mol),0.3565845670857949
MIA PaCa-2,56963564,0.5535442136787346
HOP-62,72193861,3.0602211877315364
Panc 02.03,54619267,4.6873070757127335
OAW28,71466445,4.188405368682896
LMSU,23582824,1.2634743444733094
KO52,3384730,2.162623457031388
SK-MEL-5,5281321,0.508645730860985
Kasumi-2,11222830,0.4757152299010318
MIA PaCa-2,9936388,-9.05612896602556
BT 248,148198,-3.920391313180545
IST-Mes1,676352,1.6027795070012942
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
SNU-213,135984461,4.435605101205859
SW1783,71304818,3.413551155589458
LMSU,11494412,2.9419044574604554
NCI-H1339,9933475,2.906210693951244
Panc 02.03,49793307,-1.288996397670963
Hs 611.T,6918837,-4.3807539990386095
BT 498,969516,4.501631868808794
HuT 78,104842,-4.970305265327912
BT 328,72376,0.5320465754189707
GOS-3,4578,4.471088168951713
KO52,5287969,-2.47195117056353
ACC-MESO-1,selumetinib-MK-2206 (8-1 mol-mol),3.944415523130493
BFTC-909,25062766,1.7422044094415416
RKO,2749,1.3580925102381314
SNU-886,46215462,1.5878302383488252
OE33,11955716,-2.0650128232823364
MIA PaCa-2,23725625,6.743361702812376
SK-MEL-28,9840324,5.381113811344041
AsPC-1,17755052,1.5687054045124371
YD-8,409805,3.827275743082073
SNU-213,54618305,4.384098644621688
KMS-12-BM,4788,4.217370600333275
NCI-N87,44607531,-2.3963447234482196
Mono-Mac-1,11222830,0.4197694115665174
BT 498,3503,1.2954687242486842
AsPC-1,7251185,2.99432826291256
AsPC-1,ISOX-bortezomib (250-1 mol-mol),1.1160066277256155
SNU-423,15547703,3.1301132391172146
PF-382,9549297,1.2295304859743053
KO52,66577038,3.1415883423480655
NCI-H2030,119607,5.632028507909797
ChaGo-K-1,1641662,2.43249974698459
NCI-N87,3025986,-2.1031012904407818
MIA PaCa-2,10385095,0.818601661096134
GOS-3,selumetinib-piperlongumine (8-1 mol-mol),4.534264258970437
RKN,46224516,3.695788234754723
NCI-H929,17755052,-1.864844387301065
Ri-1,5460769,1.1375471412538625
TE-14,9952709,2.981708246817344
HCC2108,3825829,4.6343664994608496
IST-Mes1,11609586,2.670649923207088
SNU-423,tanespimycin-gemcitabine (1-1 mol-mol),-0.2099310969798299
KYSE-180,6918328,1.6181247370511698
BT 498,15547703,5.01668051089873
BT 286,5282054,3.919367194238553
NOMO-1,984333,-1.7512214516120577
L3.3,46398810,3.0103098250539846
Panc 02.03,11404337,1.528571500956484
YD-8,44607530,2.028458223492934
Kasumi-2,568763,-0.985189730983464
Namalwa,navitoclax-gemcitabine (1-1 mol-mol),-4.909512690079978
NOMO-1,126941,-2.339513844414448
TE-14,44819697,-0.1519907050740515
RKO,15953870,3.3462063589818034
TE 441.T,4521392,4.893069505839197
SNU-216,68056272,3.411251532127361
MIA PaCa-2,72193861,1.772895681896366
WM793,107985,-3.039809125194022
SK-MEL-28,3854666,3.183656457854027
SF539,selumetinib-MK-2206 (8-1 mol-mol),2.7695496094715875
KMRC-20,6918328,1.7545350572530505
KMS-12-BM,241158,1.5195082823857844
SF539,46843906,2.6895390724819253
BT 498,25227462,1.3760459786660628
BT 498,56946209,-2.201109347231142
HOP-62,navitoclax-piperlongumine (1-1 mol-mol),2.558154539746264
KMRC-20,15953870,3.781161229519325
SF295,5280436,4.399869533580907
IST-Mes1,44566777,1.465871694296859
SNU-886,vorinostat-navitoclax (4-1 mol-mol),-7.798745987828545
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
KE-39,156414,4.025830312298652
MIA PaCa-2,445643,4.056602044586297
NCI-H1339,4917,3.747173592434861
AU565,5470400,-3.0594075513818995
NOMO-1,445455,4.303833401854377
Kasumi-2,24771867,-3.1023362721742607
RERF-LC-MS,11507802,1.168612691302407
ESS-1,4096211,2.024431300625148
B-CPAP,5335621,5.443588151339274
ACC-MESO-1,11178236,-5.172752088865678
HCC2108,navitoclax-sorafenib (1-1 mol-mol),3.578397373026766
KLE,10385095,2.1345695418673354
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
PF-382,16736978,2.1192377766227355
NCI-H196,44137675,5.149945093178445
EHEB,24785538,2.1074242406827044
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
SNU-119,24856436,-0.7380975951321199
KMRC-20,409805,5.905260063235434
KYSE-180,71304818,2.610394222514715
NOMO-1,11178236,-2.492998231075174
HuT 78,3465537,2.3062408835575923
SK-MEL-5,60700,0.0306860885893293
Mono-Mac-1,15547703,2.720539634744388
WM793,5311,2.1433101075982406
Namalwa,16736978,1.158404823156188
SF539,9926054,1.722417855539817
SNU-1077,216345,4.12510316244265
KE-39,54618164,4.766262408385177
HCC2108,159324,4.9915636231764005
NCI-H196,25150857,2.434166901288255
KE-39,16722836,1.1586688757429142
MJ,SNX-2112-bortezomib (250-1 mol-mol),-3.5361660121199545
Hs 611.T,44185566,1.6873461690440663
Panc 02.03,123631,3.5560371664842325
RKO,168313047,1.9322709085928884
SNU-216,16720766,0.8809846524435709
SF295,71466578,5.072600124872265
MIA PaCa-2,135398516,1.9665175565302655
RKN,46191454,2.1430961760764897
CML-T1,55283,-0.0221984323925449
AsPC-1,5746,2.3674241916356755
NCI-H929,4261,0.6477410637199463
BT 328,selumetinib-UNC0638 (4-1 mol-mol),5.206465568197119
HEC-108,11964036,3.068027447156284
KO52,selumetinib-JQ-1 (4-1 mol-mol),-1.2096541805376022
Mono-Mac-1,1750826,-3.0480548093833053
TE 441.T,2729026,1.9676389921183184
OAW28,654092,-1.8070222863139416
ChaGo-K-1,16722836,2.223487579942238
PE/CA-PJ41 (clone D2),erlotinib-PLX-4032 (2-1 mol-mol),2.956437823485526
SK-UT-1,462382,0.5572290876246132
PF-382,44543605,4.965650989009794
TE 441.T,9967941,3.4581563869345557
TE-14,9956119,4.291552086105828
NCI-N87,3025944,4.18610508240951
HuT 78,168313016,3.837657248427472
OAW28,5278396,3.588828047742794
TE 441.T,36462,0.1000718625113496
CML-T1,56963564,-0.6939066710243597
SNU-886,3081361,3.1313223505952132
CML-T1,73707386,2.9358077283853974
ChaGo-K-1,24785538,1.276067902472923
PF-382,5311281,0.0181022265462825
Namalwa,vorinostat-navitoclax (4-1 mol-mol),0.6445056951853491
BT 286,49793307,-4.224113468350936
KE-39,10427712,4.785980320384278
TE-14,24772860,-2.25752573478565
PE/CA-PJ41 (clone D2),11404337,1.298340763398175
HOP-62,5281321,-1.4991503511918276
BT 328,2949965,3.033023429372895
NCI-H196,16725315,4.056507781587541
YD-38,4917,3.089558829015848
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
TE-14,208908,0.6851238803419405
KMS-12-BM,72193861,-0.3059555505997974
BT 498,3062316,3.575496868301237
ChaGo-K-1,16038120,0.9722602056316896
AsPC-1,24785538,0.8298650260870277
SNU-119,2742550,2.8976089932934883
NCI-H929,10113978,2.6674788600772597
NCI-H2030,46398810,3.0729474851813023
HCC2108,24772860,-2.301082023311665
KO52,24748573,0.4293193487594113
Kasumi-2,10296883,1.6134498936175832
NCI-N87,3062316,-1.4174361948917271
KMS-12-BM,107985,-5.423573263916533
GOS-3,1750826,-2.070069963305823
CML-T1,1716436,3.108020123675437
Hep 3B2.1-7,crizotinib-PLX-4032 (2-1 mol-mol),1.8626333424530424
AU565,5335621,4.583819394214033
AsPC-1,462382,1.1756614609859282
KLE,4259181,-0.0203780302150134
Kasumi-2,72376,-3.459838502439841
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
LMSU,19582717,5.5691455475886595
BT 320,4378219,1.7610425663146678
Namalwa,24901704,3.273003218825604
ESS-1,23582824,0.5465688177901259
CML-T1,10077130,2.746402588915116
SNU-216,vorinostat-navitoclax (4-1 mol-mol),1.7629538031708885
Mono-Mac-1,52947716,-6.654817908600528
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643
AU565,9926054,0.9817648939808896
Ri-1,16720766,-3.633025161617667
AU565,72193861,-0.1764123403705666
MIA PaCa-2,46224516,1.6127588238587849
RKO,24797083,0.8657042008278414
SF539,44566777,1.5412322768682447
BT 112,439501,-2.896282798681624
SNU-216,JQ-1-MK-0752 (1-1 mol-mol),5.3985213291534
AU565,11228183,3.2105327090314133
B-CPAP,5113032,5.349013734099232
B-CPAP,44632017,0.6151309315152113
NCI-H929,11213558,0.6823472924014866
HOP-62,9915743,2.3333223593469947
WM793,selumetinib-tretinoin (2-1 mol-mol),2.5106551604776017
AU565,10322450,3.206832643999438
SK-MEL-28,5278396,4.387256339592576
CML-T1,6184667,4.239961832830672
ESS-1,11612883,3.2589568216623337
ACC-MESO-1,135421197,1.1131712845559925
SNU-423,44819697,-0.9263578160695418
ACC-MESO-1,25126798,4.023971823370827
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
SK-UT-1,selumetinib-UNC0638 (4-1 mol-mol),4.7391323910259935
BT 248,54596558,3.9995548839878503
SK-MEL-28,46907787,3.835105129876131
ACC-MESO-1,1641662,4.244033376768605
LMSU,46926350,-4.277372765646079
KO52,10113978,2.712870801438083
Namalwa,89928392,0.6743977588494114
EHEB,49793307,-3.85106101427491
HuT 78,66577038,2.508658596603646
OAW28,23725625,6.509051762822527
HEC-108,5746,2.057736968957512
H-STS,56946209,-4.578784798240611
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
PE/CA-PJ41 (clone D2),71304818,3.216974363463292
SNU-213,44507138,3.2200176081148224
ESS-1,2828334,6.174159424614295
OE33,selumetinib-vorinostat (8-1 mol-mol),1.9103124902448312
HuT 78,409805,4.736359437343851
ESS-1,selumetinib-piperlongumine (8-1 mol-mol),3.862491311780521
KLE,selumetinib-MK-2206 (8-1 mol-mol),2.611642542572268
SNU-886,6918289,1.884590673180862
TE 441.T,11612883,1.6595645159053918
BT 248,11612883,3.485439835170839
BT 112,24856436,0.5972809342094648
KMS-12-BM,445455,3.345017046406881
BT 320,7251185,3.9998923472411008
Mono-Mac-1,11609586,0.7295885847467773
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
OAW28,54618771,1.1011370240470315
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
Karpas-422,11626560,1.2123192441609394
BT 498,3025986,0.5586221106551145
BT 286,3384730,0.7645214338465928
NCI-H196,3062316,3.4269696902087965
NCI-H1339,9927531,5.416434112117517
Lu-65,carboplatin-etoposide (40-17 mol-mol),3.473831368176095
AU565,24753719,4.632017214490639
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
AU565,24785538,3.4507965915778387
KMRC-20,24856436,1.166150223062635
SNU-216,53392493,1.8000675338447445
YD-8,navitoclax-sorafenib (1-1 mol-mol),2.877352629511259
SF539,15547703,3.038141832537276
KYSE-180,25154868,3.555107240815876
SK-UT-1,9866186,0.9156760057280894
B-CPAP,66577038,3.003282888618189
Karpas-422,selumetinib-BRD-A02303741 (4-1 mol-mol),3.605523049740557
SNU-119,54649381,3.4431248050255636
TE-14,5281321,-2.027409379087563
NCI-H929,31703,-2.722564633295698
NCI-H196,6610216,4.943661751084643
SK-MEL-28,9956119,4.5331880736005745
B-CPAP,vorinostat-navitoclax (4-1 mol-mol),0.850582052340713
IST-Mes1,5278396,4.120493778859633
EHEB,10410894,2.894743254709859
HSC-3,44202524,1.6578409101204128
MJ,24180125,3.2687573062983484
BT 498,7251185,2.57671304723101
BT 328,25195348,5.638362277561031
SF539,11257553,0.3367320269985683
SNU-423,42642645,1.572075409923546
RKO,227681,3.9032876810461814
Hs 611.T,6252,-1.0281041849834551
PE/CA-PJ41 (clone D2),navitoclax-MST-312 (1-1 mol-mol),0.9803419699577952
JHUEM-7,54618771,2.242796216513649
SW1783,6918328,3.3453228504618995
TE-14,65064,5.250482767878561
KMS-12-BM,53245473,5.652555547777156
KE-39,54618795,3.2996037885705927
TE 441.T,selumetinib-tretinoin (2-1 mol-mol),4.961039192171221
SNU-216,135440466,1.959606006857138
HOP-62,6918878,4.215530396127894
NOMO-1,5460769,4.769752092364765
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
BT 286,25183872,-1.583688881910038
L3.3,984333,-1.3131333034824293
RERF-LC-MS,44493528,4.358183394704722
HCC2108,44185566,2.949072119702921
TE 441.T,6852167,2.229580798352396
BFTC-909,5311281,3.2468587214362175
Mono-Mac-1,6852167,1.1013775883292647
SNU-216,49836020,4.392080781330326
H-STS,613753,2.542792713259053
MIA PaCa-2,5566,3.1307632964005663
NOMO-1,31703,-1.8429032714500968
SNU-213,ISOX-bortezomib (250-1 mol-mol),1.194953783499087
Mono-Mac-1,54626689,3.913673897382288
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
KMRC-20,15547703,3.8030034015972807
SNU-213,73707398,1.7452345044805029
ESS-1,54765302,4.90712121180697
Ri-1,52947716,-7.563694998491287
NOMO-1,16725315,4.952538276899841
AU565,25161177,3.67389505129512
RT-4,15983966,1.8049995542525132
NCI-H1339,23725625,5.053497821139807
NCI-N87,89928392,0.9456157368763274
SF539,6610216,3.974614801985701
SNU-119,10231331,4.363406465804169
Becker,54613361,-0.3252327078859965
YD-38,66577038,2.4029252471110514
LXF 289,44489675,4.904101073680104
SNU-1077,54454,1.8410579173588877
SNU-216,9927531,4.928854217015946
NCI-H929,44137675,0.5857297222034469
Panc 02.03,4259181,2.0313571914007604
HuT 78,375860,-0.3004561584408421
KMS-12-BM,BRD-A02303741-carboplatin (1-1 mol-mol),5.576574018385502
BT 112,44137675,3.190081046640756
ChaGo-K-1,11640390,2.9098538749736833
ACC-MESO-1,4378219,4.550142070750771
YD-8,66577038,3.168300886602997
CML-T1,208908,1.88775844056814
Lu-65,2858523,3.053901623946623
NCI-H929,3689413,-2.331613234092956
HEC-108,11640390,4.025636872827305
SNU-423,49793307,-2.496229045283288
Kasumi-2,alisertib-navitoclax (2-1 mol-mol),-2.881127323252466
EHEB,11683005,4.401325437142657
B-CPAP,5278396,3.4451534548070804
Ri-1,25150857,1.9754346751489589
Mono-Mac-1,53301938,4.309444242776755
H-STS,11238147,1.8768672024064708
BT 320,322968,4.418694945814317
HCC2108,piperlongumine-MST-312 (1-1 mol-mol),1.4523587020205275
KMS-12-BM,24785538,-2.2279414711107943
SF295,104842,-3.799159416952957
HOP-62,4096211,2.550558881488983
HEC-108,selumetinib-PLX-4032 (8-1 mol-mol),6.183444970425624
Mono-Mac-1,3081361,1.9126925710117495
BT 498,19582717,5.618555005089504
SNU-423,148124,-5.293921885870976
L3.3,89928392,2.03013195184945
SK-UT-1,11719255,5.479588049288889
KE-39,16722836,1.1586688757429142
KYSE-180,navitoclax-gemcitabine (1-1 mol-mol),2.062581087909213
KE-39,44185566,2.219569875640091
HCC2108,51039095,3.0641076776382055
WM793,4259181,0.9321312927301734
SW1573,3503,1.662872296112478
PE/CA-PJ41 (clone D2),123631,3.305692644541571
EHEB,72376,-2.605248149465708
AU565,23582824,-0.1593812680979049
Hs 611.T,3081361,1.583848207218291
B-CPAP,carboplatin-etoposide (40-17 mol-mol),3.8440063702085463
JHUEM-7,71304818,2.591667999650727
HEC-108,10385095,1.228149017066595
Mono-Mac-1,445091,4.03507762760952
SNU-213,selumetinib-MK-2206 (8-1 mol-mol),-0.2586478319753106
SNU-119,216345,3.614862183808471
SW1783,selumetinib-MK-2206 (8-1 mol-mol),4.242449786456935
SF539,2708,3.2874630457066103
RERF-LC-MS,984333,0.876742343627688
Hep 3B2.1-7,44185566,2.8600797246910297
JHUEM-7,24753719,4.234902187840303
EHEB,25062766,1.0202887553204696
PE/CA-PJ41 (clone D2),3543504,4.90695304156819
TE 441.T,441298,3.105895146082189
HuT 78,2708,0.286348811973392
BT 112,11625818,4.486916503071115
SNU-216,53495165,-0.2866928310723041
AU565,123631,0.0519428975879534
KYSE-180,65064,4.87684368224317
BT 112,selumetinib-navitoclax (8-1 mol-mol),3.948164534074535
KE-39,72193861,3.4588346249762534
SNU-216,227681,4.069937917101889
ESS-1,36314,-8.425270671395753
KMS-12-BM,9915743,-0.3780298011492129
Hep 3B2.1-7,25150857,2.2110671335342733
AU565,148198,-3.941648532890003
Namalwa,135398738,2.090145253399199
PF-382,49793307,-4.049648642852728
SNU-213,44493528,4.322072480687394
KMS-12-BM,446155,2.3535681188168476
HuT 78,selumetinib-vorinostat (8-1 mol-mol),-4.277294994055841
SW1783,tretinoin-navitoclax (4-1 mol-mol),5.880695853154788
NCI-H2030,12003241,-1.1383124397984303
KE-39,5284373,4.108960473804643
Panc 02.03,6505803,-1.93196111296706
KO52,24978538,-3.3415990839313383
KE-39,24821094,1.6802928572858271
WM793,23582824,1.6229283221646535
BT 320,11152667,2.8584362453350427
KO52,54454,4.035257146285459
NCI-H2030,JQ-1-navitoclax (2-1 mol-mol),-0.3679807108564211
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077
BT 112,BRD-K55473186,3.914494657267586
KMS-12-BM,46191454,-0.8526827535334566
CML-T1,26596,-2.14043660837674
AU565,107985,-3.572249289009051
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
RKO,6918837,-1.4612228483082623
SF295,11964036,4.121760093461903
YD-8,10302451,2.519210773741685
Ri-1,54613361,-0.945053953894062
BT 112,24797083,1.2381958000259223
NCI-H196,24856436,-0.1495861740182834
RT-4,322968,4.646430873835076
KMRC-20,10127622,5.270569456722755
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114
BT 286,24180125,3.4057895340262445
ESS-1,25150857,2.554300661987261
MJ,11656518,0.1125344640542434
TE 441.T,navitoclax-piperlongumine (1-1 mol-mol),-0.1552458462581421
BT 248,51037431,4.063284976838012
KMS-12-BM,9868037,1.5063019992906226
B-CPAP,25062766,1.9365359844600436
AsPC-1,168313200,3.2842521999758523
HOP-62,387447,-3.823160514435493
OE33,11238147,1.8300303593829852
Kasumi-2,637858,0.3812755763700117
RERF-LC-MS,702558,6.005509402748126
NCI-H929,52947716,-4.644393709847638
SK-UT-1,2871966,0.4353806456595583
KMS-12-BM,6610355,3.820739817382138
CML-T1,67291369,-1.213032955096986
KYSE-180,375860,-0.0718407094344544
NCI-H929,2828334,5.894238913273239
Mono-Mac-1,44819697,4.760065022955159
Kasumi-2,23725625,0.6917734152233637
NOMO-1,5278396,3.0205756000124775
BT 112,969516,2.869310026352302
PF-382,136227924,2.0859082008018084
NCI-H2030,docetaxel-tanespimycin (2-1 mol-mol),-0.4991862010243447
AsPC-1,5328940,1.7821313082315045
JHUEM-7,426756,5.918413566488646
SW1573,4788,4.2029613497215195
MIA PaCa-2,2130404,3.0787780804735125
CML-T1,24951314,-0.110872768404616
Karpas-422,5282054,2.439551684268985
KO52,26596,-3.758446698642679
SNU-1077,selumetinib-BRD-A02303741 (4-1 mol-mol),4.189870854212877
SK-MEL-28,selumetinib-vorinostat (8-1 mol-mol),1.183939454839272
MIA PaCa-2,9903786,3.251255785633491
KO52,navitoclax-PLX-4032 (1-1 mol-mol),-2.6384653458181
TE 441.T,11238147,2.1227999933306663
RERF-LC-MS,46191454,1.934559197398404
Hs 611.T,327653,2.4585049182672525
Hs 611.T,136227924,1.5120677878583844
MIA PaCa-2,3385,4.980756808965862
SF539,10385095,0.5044778211988786
OE33,10302451,2.926424279202946
RKO,241158,4.5302703569847305
OE33,285033,-2.4461062565957685
RKN,17755052,4.615024850417848
HOP-62,6917907,2.3888384264440816
WM793,3038522,3.898471306442064
AsPC-1,387447,-4.291846387154746
Becker,tanespimycin-gemcitabine (1-1 mol-mol),-0.4424544755014754
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
WM793,11152667,-0.0685864179324616
MIA PaCa-2,23635314,-3.2931554939430203
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613
SNU-216,71304818,2.736477931679623
MJ,168313200,3.5794941200353514
BT 286,57519531,1.337766734279075
Lu-65,selumetinib-tretinoin (2-1 mol-mol),-0.9758707789928271
SNU-1077,54143018,3.614598545959328
SNU-119,11626560,1.6667374543655389
KYSE-180,11625818,4.6401032525686
BT 112,24753719,4.155930680700891
WM793,54626689,6.182066538200824
NCI-N87,16722836,0.5704530263405226
MJ,4096211,1.1855677594978866
BFTC-909,3676137,5.055523871435828
Namalwa,67156097,-2.959897720698589
YD-8,selumetinib-piperlongumine (8-1 mol-mol),4.259135274147536
PF-382,20959075,-3.2590708818446306
RKN,23939,4.640348748177221
ChaGo-K-1,3136844,3.608639859706436
BT 328,1714884,3.4592731205549225
Lu-65,26596,-0.6076566338784338
BT 320,selumetinib-PLX-4032 (8-1 mol-mol),4.7621521702079175
Namalwa,54678924,0.7353468971102918
Mono-Mac-1,54613361,-0.8229864401453336
RERF-LC-MS,3025944,4.157794890121567
PE/CA-PJ41 (clone D2),11955716,-1.9630087475563516
WM793,6918328,0.9320540007065896
SF539,262093,2.0596515913386786
Ri-1,613753,2.7044868241849165
SNU-886,4917,3.2978202495952336
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
Karpas-422,119607,5.478750501953686
KMS-12-BM,25126798,2.689658126945382
RT-4,10427712,4.289155491450476
Namalwa,46191454,0.6470954103125317
Namalwa,2842253,3.7074389000842696
NCI-H2030,135421197,3.075513669205883
ESS-1,25154868,5.124827046157549
YD-38,9936388,-5.278764060182601
H-STS,168313200,3.688822033835753
PF-382,135421197,0.9667662585436329
Mono-Mac-1,24785538,0.7882917783042087
AsPC-1,16722836,2.2980478994816425
SK-UT-1,vorinostat-navitoclax (4-1 mol-mol),2.160306849194933
NCI-H929,12001922,1.6200785055416655
AU565,421610,2.258686960610045
HOP-62,44462760,6.082940310622514
NCI-H1339,4261,1.2872784807283144
RKN,17759555,4.047966260499275
Namalwa,1716436,3.476053043060672
Mono-Mac-1,53325874,4.409017818896257
SF539,44632017,1.0950732195529729
Hep 3B2.1-7,49766530,-1.5968741678942395
Ri-1,11238147,1.7540053934106563
GOS-3,322968,4.726179979484062
KYSE-180,6917907,-5.842795191649857
TE 441.T,426756,4.4195589542827864
L3.3,5460769,1.7814582708772182
B-CPAP,selumetinib-piperlongumine (8-1 mol-mol),4.578396816065636
SW1783,11485656,3.310538702987134
SK-MEL-28,6917907,3.4714209878856463
GOS-3,148198,-2.930015056129616
SW1783,400769,1.007590054280138
OE33,6914657,-3.0788344071594738
SNU-119,46191454,1.5208499646959712
NCI-H196,vorinostat-carboplatin (1-1 mol-mol),3.2545067268890446
HuT 78,25227462,-5.166030621754822
IST-Mes1,2749,1.654199391381554
AsPC-1,5281672,6.419333790815674
SK-MEL-5,24753719,4.331970921396319
H-STS,107985,-3.371812219101193
SF539,selumetinib-decitabine (4-1 mol-mol),4.614699351264478
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
L3.3,44491742,6.349276489474054
PF-382,25126798,3.7444046465079888
Mono-Mac-1,119607,3.615184398714216
Kasumi-2,11257553,-0.3952076481824682
Lu-65,2871966,1.1705483639287513
KO52,448949,1.7278683789034708
NCI-N87,11964036,0.5275056986755973
HOP-62,24771867,2.21478649865432
NCI-H2030,54649381,4.795397326449117
SF539,60750,-3.745453789943656
OAW28,49766530,-0.5315014966120291
OAW28,135411,2.218427323792269
ACC-MESO-1,10231331,6.136184274550163
YD-38,65628,4.316413155478777
SK-MEL-5,4261,1.841323007747508
MIA PaCa-2,selumetinib-PLX-4032 (8-1 mol-mol),1.6013326620809585
AsPC-1,322968,4.827920048367381
SNU-213,11178236,-1.8376458893314875
PF-382,54613361,-0.7673282016613778
NCI-H1339,12003241,0.6707609457385758
NCI-H929,44489675,3.656307412577015
KYSE-180,25195348,3.031032559566134
Namalwa,11609586,-0.2919718897632319
SF539,25062766,1.2381389436565498
Lu-65,16741245,3.621639989162078
RKN,400769,-0.3685197718994141
KYSE-450,448949,2.8281207411790374
LMSU,3854666,2.6863801842781863
SW1783,216345,3.5979971294588147
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
PE/CA-PJ41 (clone D2),1750826,2.319325081181221
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
SNU-216,10302451,1.428515381214255
SNU-213,44185566,2.160657644781875
HEC-108,15547703,3.396555621710324
WM793,65064,3.5713682680127574
Kasumi-2,71304818,2.3604520648914136
Lu-65,2729026,3.1489264055636164
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
Namalwa,53495165,-2.2218010443485627
SNU-1077,73707438,4.486121622695642
SNU-1077,SNX-2112-bortezomib (250-1 mol-mol),1.1680740109276928
Panc 02.03,16720766,4.473005389666903
KMS-12-BM,654092,-2.2721779873504224
ACC-MESO-1,selumetinib-navitoclax (8-1 mol-mol),2.377842633957304
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
Becker,5281321,-1.5139545464417634
SK-MEL-28,71304818,2.250424055187842
TE 441.T,135421197,0.4096443090762519
Hs 611.T,tretinoin-navitoclax (4-1 mol-mol),2.8699882476270355
SNU-423,1566236,1.8226515664509473
SF539,25227462,1.1630748735531866
RT-4,104842,-2.837554052237836
SW1573,104842,-2.57352069349058
HuT 78,46224516,1.0193234135657596
NCI-H929,119182,-0.7271204435080775
NCI-H196,135411,1.5759989708641096
WM793,136227924,4.7819042035619255
KMS-12-BM,126941,-5.220907783111232
SF539,selumetinib-JQ-1 (4-1 mol-mol),1.3049218182358
MIA PaCa-2,vorinostat-carboplatin (1-1 mol-mol),2.756428927556822
HOP-62,44491742,4.640090000896823
BFTC-909,6623618,2.802037410677928
SF539,409805,5.790114720226367
IST-Mes1,9884685,0.6527999920478087
SW1783,46199207,2.830132612084652
NCI-N87,216239,2.2423368269273753
MIA PaCa-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.9095756818952287
Mono-Mac-1,24951314,0.195026284018331
NCI-H196,5282054,3.9384077821930186
Becker,46907787,3.975901887649669
IST-Mes1,6918638,1.4350648787515894
KMS-12-BM,46843906,0.1435996413551739
HOP-62,54649381,3.909621773040776
KYSE-450,24964624,3.228483882418733
SK-MEL-28,2749,2.6265102765061936
OAW28,252682,6.460081465786461
YD-8,4261,2.40406466094162
HuT 78,5746,-1.2054540829216351
BT 112,462382,-0.8334021028816797
PE/CA-PJ41 (clone D2),JQ-1-navitoclax (2-1 mol-mol),2.6711993613472194
B-CPAP,124202324,2.5126269670225994
NOMO-1,451668,-1.632426084818391
YD-38,6505803,-1.6031716801172209
PF-382,65628,3.430221294092043
GOS-3,5328940,2.3255367780793432
KE-39,2858523,2.690923627236344
Ri-1,16736978,-0.7212393996550502
HSC-3,selumetinib-vorinostat (8-1 mol-mol),1.9164073521640128
SNU-216,24772860,-2.09837085727617
NCI-H2030,3689413,1.2400324738328432
RT-4,44589607,2.871102674918077
BT 328,53495165,1.3387140928137258
SF539,10296883,3.7658288303305976
Lu-65,11175137,3.3632758039989277
IST-Mes1,3025944,4.475795844293571
Lu-65,9911830,1.689381922499865
YD-38,208908,-0.2609771273149361
BFTC-909,9907093,4.635414583134371
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
Hep 3B2.1-7,262093,2.5027011818139964
OE33,2828334,6.036524421736953
OAW28,17755052,1.3145864766951243
H-STS,5287620,-2.722598412844143
GOS-3,alisertib-navitoclax (2-1 mol-mol),5.122405699516746
PF-382,46224516,1.3839719713771603
HCC2108,107970,2.525568270617478
KMRC-20,selumetinib-JQ-1 (4-1 mol-mol),2.987450194991694
NCI-H196,6438330,3.1538625241863296
HuT 78,2871966,-0.2683725528046166
HuT 78,5287620,-2.72818029260661
PF-382,73707438,4.86482182399275
SNU-423,11955716,-1.3120452604292694
BFTC-909,44491742,4.0640318167931255
ESS-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.9725488510506712
SK-UT-1,3384730,2.824211371066942
TE 441.T,11609586,1.0030388735282174
OAW28,49793307,-1.8076729764727852
OE33,46199207,3.627716303184323
KE-39,16659841,4.997685648914552
RT-4,5311,2.127982619731648
KE-39,71466445,5.518940973386278
AsPC-1,11152667,-0.9426796832875202
PE/CA-PJ41 (clone D2),25154868,5.390664458057599
BT 320,6184667,3.5325258636094934
KMRC-20,9911463,4.198821616328526
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
LXF 289,262093,3.4150141342974605
YD-8,54619267,4.1728433428246365
NCI-H1339,11626560,2.340137119918929
KO52,15547703,3.0734769425929236
OAW28,124202324,1.9264961190623875
H-STS,3062316,1.2556156573704025
CML-T1,66577038,2.0285847507138017
RERF-LC-MS,9840324,5.508232790936476
TE 441.T,135984461,4.21306533466607
NCI-H1339,51039095,3.6896681502531585
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
SK-MEL-5,9967941,2.0132409445112707
CML-T1,JQ-1-vorinostat (2-1 mol-mol),-0.0778878507242399
Hep 3B2.1-7,5746,2.448675279478492
SF539,2742550,3.134990737020823
NCI-H209,9915743,-2.0620663235985797
SW1783,5738263,4.365489196720114
